
<html lang="en"     class="pb-page"  data-request-id="f634deb6-2158-4230-b1e6-604bdc239ee8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c00911;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria" /></meta><meta name="dc.Creator" content="Nicolas J.  Scheuplein" /></meta><meta name="dc.Creator" content="Nicole M.  Bzdyl" /></meta><meta name="dc.Creator" content="Emily A.  Kibble" /></meta><meta name="dc.Creator" content="Theresa  Lohr" /></meta><meta name="dc.Creator" content="Ulrike  Holzgrabe" /></meta><meta name="dc.Creator" content="Mitali  Sarkar-Tyson" /></meta><meta name="dc.Description" content="Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increasing antibiotic resistance in many bacterial species. The development of drugs with new modes of act..." /></meta><meta name="Description" content="Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increasing antibiotic resistance in many bacterial species. The development of drugs with new modes of act..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 13, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00911" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00911" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00911" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00911" /></link>
        
    
    

<title>Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00911" /></meta><meta property="og:title" content="Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0035.jpeg" /></meta><meta property="og:description" content="Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increasing antibiotic resistance in many bacterial species. The development of drugs with new modes of action is essential. A leading strategy is antivirulence, with the aim to target bacterial proteins that are important in disease causation and progression but do not affect growth, resulting in reduced selective pressure for resistance. Immunophilins, a superfamily of peptidyl-prolyl cis–trans isomerase (PPIase) enzymes have been shown to be important for virulence in a broad-spectrum of pathogenic bacteria. This Perspective will provide an overview of the recent advances made in understanding the role of each immunophilin family, cyclophilins, FK506 binding proteins (FKBPs), and parvulins in bacteria. Inhibitor design and medicinal chemistry strategies for development of novel drugs against bacterial FKBPs will be discussed. Furthermore, drugs against human cyclophilins and parvulins will be reviewed in their current indication as antiviral and anticancer therapies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00911"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00911">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00911&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00911&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00911&amp;href=/doi/10.1021/acs.jmedchem.0c00911" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 13355-13388</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00910" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00915" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Nicolas J. Scheuplein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas J. Scheuplein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas+J.++Scheuplein">Nicolas J. Scheuplein</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicole M. Bzdyl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicole M. Bzdyl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, University of Western Australia, 6009 Perth, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicole+M.++Bzdyl">Nicole M. Bzdyl</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emily A. Kibble</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emily A. Kibble</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, University of Western Australia, 6009 Perth, Australia</div><div class="loa-info-affiliations-info">School of Veterinary and Life Sciences, Murdoch University, 6150 Murdoch, Australia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emily+A.++Kibble">Emily A. Kibble</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Theresa Lohr</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Theresa Lohr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Lohr">Theresa Lohr</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulrike Holzgrabe</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulrike Holzgrabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>U.H.: email, <a href="/cdn-cgi/l/email-protection#bacfd6c8d3d1df94d2d5d6c0ddc8dbd8dffacfd4d397cdcfdfc8c0d8cfc8dd94dedf"><span class="__cf_email__" data-cfemail="196c756b70727c37717675637e6b787b7c596c7770346e6c7c6b637b6c6b7e377d7c">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulrike++Holzgrabe">Ulrike Holzgrabe</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0364-7278" title="Orcid link">http://orcid.org/0000-0002-0364-7278</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Mitali Sarkar-Tyson</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mitali Sarkar-Tyson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, University of Western Australia, 6009 Perth, Australia</div></div><span class="conrtib-corresp"><strong>*</strong>M.S.-T.: email, <a href="/cdn-cgi/l/email-protection#c3aeaab7a2afaaedb0a2b1a8a2b1eeb7bab0acad83b6b4a2eda6a7b6eda2b6"><span class="__cf_email__" data-cfemail="aec3c7dacfc2c780ddcfdcc5cfdc83dad7ddc1c0eedbd9cf80cbcadb80cfdb">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mitali++Sarkar-Tyson">Mitali Sarkar-Tyson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00911&amp;href=/doi/10.1021%2Facs.jmedchem.0c00911" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 13355–13388</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 13, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 May 2020</li><li><span class="item_label"><b>Published</b> online</span>13 August 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00911" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00911</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D13355%26pageCount%3D34%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNicolas%2BJ.%2BScheuplein%252C%2BNicole%2BM.%2BBzdyl%252C%2BEmily%2BA.%2BKibble%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D22%26contentID%3Dacs.jmedchem.0c00911%26title%3DTargeting%2BProtein%2BFolding%253A%2BA%2BNovel%2BApproach%2Bfor%2Bthe%2BTreatment%2Bof%2BPathogenic%2BBacteria%26numPages%3D34%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D13388%26publicationDate%3DNovember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00911"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1419</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00911" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;J. Scheuplein&quot;},{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;M. Bzdyl&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;A. Kibble&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Lohr&quot;},{&quot;first_name&quot;:&quot;Ulrike&quot;,&quot;last_name&quot;:&quot;Holzgrabe&quot;},{&quot;first_name&quot;:&quot;Mitali&quot;,&quot;last_name&quot;:&quot;Sarkar-Tyson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;13355-13388&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00911&quot;},&quot;abstract&quot;:&quot;Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increasing antibiotic resistance in many bacterial species. The development of drugs with new modes of action is essential. A leading strategy is antivirulence, with the aim to target bacterial proteins that are important in disease causation and progression but do not affect growth, resulting in reduced selective pressure for resistance. Immunophilins, a superfamily of peptidyl-prolyl cis–trans isomerase (PPIase) enzymes have been shown to be important for virulence in a broad-spectrum of pathogenic bacteria. This Perspective will provide an overview of the recent advances made in understanding the role of each immunophilin family, cyclophilins, FK506 binding proteins (FKBPs), and parvulins in bacteria. Inhibitor design and medicinal chemistry strategies for development of novel drugs against bacterial FKBPs will be discussed. Furthermore, drugs against human cyclophilins and parvulins will be reviewed in their current&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00911&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00911" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00911&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00911" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00911&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00911" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00911&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00911&amp;href=/doi/10.1021/acs.jmedchem.0c00911" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00911" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00911" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00911%26sid%3Dliteratum%253Aachs%26pmid%3D32786507%26genre%3Darticle%26aulast%3DScheuplein%26date%3D2020%26atitle%3DTargeting%2BProtein%2BFolding%253A%2BA%2BNovel%2BApproach%2Bfor%2Bthe%2BTreatment%2Bof%2BPathogenic%2BBacteria%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D22%26spage%3D13355%26epage%3D13388%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/jmcmar.2020.63.issue-22/20201125/jmcmar.2020.63.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0035.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Infectious diseases are a major cause of morbidity and mortality worldwide, exacerbated by increasing antibiotic resistance in many bacterial species. The development of drugs with new modes of action is essential. A leading strategy is antivirulence, with the aim to target bacterial proteins that are important in disease causation and progression but do not affect growth, resulting in reduced selective pressure for resistance. Immunophilins, a superfamily of peptidyl-prolyl <i>cis</i>–<i>trans</i> isomerase (PPIase) enzymes have been shown to be important for virulence in a broad-spectrum of pathogenic bacteria. This Perspective will provide an overview of the recent advances made in understanding the role of each immunophilin family, cyclophilins, FK506 binding proteins (FKBPs), and parvulins in bacteria. Inhibitor design and medicinal chemistry strategies for development of novel drugs against bacterial FKBPs will be discussed. Furthermore, drugs against human cyclophilins and parvulins will be reviewed in their current indication as antiviral and anticancer therapies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antibiotic resistance has been declared by the World Health Organization (WHO) as a serious threat to global public health, which requires immediate action. Antibiotic resistance in bacteria occurs over time due to genetic changes of a bacterium when challenged with antibiotics. This process is accelerated due to the misuse of antibiotics, and antibiotic resistant bacteria are now found in every country. It is predicted that without swift action, we will enter a “postantibiotic era”, where minor infections and injuries will be fatal once again. Currently, countries around the world are implicating antibiotic stewardship programs to improve the safe and appropriate use of antibiotics, with limited success.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is, therefore, imperative to identify new methods of combating antibiotic resistance.</div><div class="NLM_p">One such method is antivirulence therapy, which focuses on targeting virulence factors essential for infection of a host but not for growth in external environments. This method of combating pathogenic bacteria has gained momentum with antivirulence therapy possibly becoming an alternative treatment option for serious infections, as more bacterial species become resistant to available antibiotics.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Effectively disarming the virulence of a bacterium negates the evolutionary challenge to survive which can result in antibiotic resistance. The inhibition of bacterial virulence may help existing antibiotics and the host’s own natural immune response to efficiently eliminate infection, thereby presenting an attractive coadministered therapy option that would promote rapid clearance of bacteria. Targets for antivirulence therapy include factors involved in microbial attachment and invasion such as pilin, bacterial toxins, secretion systems, factors involved in biofilms, quorum sensing, and two-component systems.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> For example, the anticancer drug 5-fluorouracil (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has been shown to interfere with quorum sensing, preventing biofilm formation on catheters in large-scale clinical trials.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In <i>Pseudomonas aeruginosa</i>, synthetic halogenated furanone (<b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has been shown to inhibit quorum sensing resulting in reduced biofilm and bacteremia in a pulmonary mouse model.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Small molecules, peptides, and monoclonal antibodies targeting the type III secretion systems of various bacteria are currently in various phases of development including preclinical studies.<a onclick="showRef(event, 'ref2 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref6">(2,6)</a> Although many antivirulence compounds have been developed in an organism specific manner, broad-spectrum therapeutics inhibiting virulence targets that are common to multiple bacterial species is a highly attractive strategy for combatting multiple bacterial infections without the need for diagnostics. One such superfamily of proteins important for virulence in bacteria are the immunophilins; over the past 30 years they have been shown to be important for virulence in a number of pathogenic bacteria, leading to the development of novel inhibitors, some of which display broad-spectrum activity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the anticancer drug 5-fluorouracil (<b>1</b>, left), which has been shown to prevent biofilm formation on catheters<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and the halogenated furanone-derivative (<b>2</b>, right), which has been shown to interfere with quorum sensing and preventing biofilm formation in <i>P. aeruginosa</i>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">The Immunophilins, a Superfamily of Folding Enzymes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The <i>cis</i>–<i>trans</i> isomerization of peptide bonds preceding a proline residue is known to be a rate-limiting reaction in the process of protein folding.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The immunophilin superfamily contains enzymes exhibiting peptidyl-prolyl <i>cis</i>–<i>trans</i> isomerase (PPIase) activity (EC 5.2.1.8), which enable catalysis of this inherently slow reaction, allowing the rate of protein folding to increase (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As well as protein assembly, PPIases also facilitate protein chaperone and cell-division activities.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This PPIase protein superfamily includes three subfamilies: the FK506 (<b>3</b>) binding proteins (FKBPs), cyclophilins, and parvulins, which are all found in both eukaryotic and prokaryotic cells.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The PPIase activity of the immunophilins, such as the macrophage infectivity potentiator (Mip) protein, catalyzes the <i>cis</i>–<i>trans</i> isomerization of the peptide bonds preceding a proline residue in a polypeptide chain; P<sup>1</sup> = peptide chain 1 and P<sup>2</sup> = peptide chain 2. Due to steric hindrance, most amino acids have a strong energetic preference for the <i>trans</i> peptide bond conformation, but proline’s unusual structure stabilizes the <i>cis</i> form so that both isomers are populated under biologically relevant conditions, allowing the correct folding of polypeptide chains into correctly structured proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The FKBP family is named as such due to their ability to bind to, and be inhibited by, the immunosuppressive macrolide antibiotics FK506 (<b>3</b>) and rapamycin (<b>4</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). There are 18 known mammalian FKBPs to date, including the cytosolic FKBP12.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> FKBP12 complexes with FK506, creating an FKBP-FK506 complex that binds calcineurin, an enzyme important for T-cell activation. FKBP12 also complexes with rapamycin, creating a FKBP-rapamycin complex that binds to the mammalian target of rapamycin (mTOR), a kinase important for cell growth and proliferation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Murine cells lacking FKBP12 manifest cell cycle arrest in G1 phase.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In bacteria, the FKBP subfamily contains the macrophage infectivity potentiator (Mip) proteins and Mip-like (ML1) proteins, Trigger factor proteins, and is sensitive to lysis D (SlyD) proteins. Trigger factor and SlyD have been examined enzymatically and structurally; however, the role of these proteins in bacterial virulence is limited. In comparison, Mip and ML1 proteins have been widely investigated in Gram-negative bacteria and shown to be integral to the virulence of a variety of species with deletion of these genes resulting in decreased bacterial survival in multiple pathogens, including <i>Legionella pneumophila</i> and <i>Burkholderia pseudomallei</i> in animal infection models.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of the natural products rapamycin (<b>4</b>) and FK506 (<b>3</b>). The common pipecoline substructure is marked red. Blue dashed lines show approximate limits of the binding domain, which depend on the respective FKBP and the effector domains, which interact with mTOR in the case of rapamycin or with calcineurin in the case of FK506. The numbers are indicating the atom number of the longest ring structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cyclophilin subfamily is inhibited by cyclosporin A (CsA, <b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Humans have seven major cyclophilins (Cyp), including cytosolic CypA, which binds to cyclosporin A, forming a complex that inhibits the phosphatase activity and biological function of calcineurin.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Other human cyclophilins can be found within the endoplasmic reticulum, mitochondria, and nucleus.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Murine cells lacking CypA were able to grow normally and able to differentiate into hematopoietic precursor cells <i>in vitro</i> which indicates that cyclophilins are not essential for cell viability.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The role of human cyclophilin A (hCypA) has been found to be essential for viral replication; for example, drugs have been developed with strong antiviral properties against hepatitis C virus (HCV) and have shown promise in clinical trials.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Bacteria possess two cyclophilins, periplasmic/outer membrane PpiA and cytoplasmic PpiB. Bacterial cyclophilins have PPIase and chaperone activity and are involved in several biological processes, such as cellular signal transduction, adaptation to stress, control of pathogens virulence, and modulation of host immune response.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the cognate inhibitor of cyclophilins, cyclosporin A (CsA) (<b>5</b>, left), and of parvulins, juglone (<b>6</b>, right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The parvulin subfamily is irreversibly inhibited by juglone (<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Parvulin proteins include human PIN1, <i>Escherichia coli</i> Par10, and survival protein A (SurA).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Parvulins are the most recently discovered subfamily of the immunophilins and can range from 10 to 68 kDa in size, normally consisting of one parvulin domain with various N- and C-terminal extensions.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Eukaryotic PIN1 has been found to be involved in a variety of cellular functions, such as transcriptional regulation, mitotic cell control, and phosphorylation-dependent signal transduction pathways.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28">(24−28)</a> The important role of PIN1 in cellular functioning has stimulated interest in the development of drugs for anticancer therapies.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Prokaryotic parvulins have varied effects; in <i>E. coli</i> parvulins SurA and Ybau (also known as PpiD) are important for assembly of outer membrane proteins, with null mutations in both genes resulting in lethality.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In nitrogen assimilating bacteria such as <i>Klebsiella pneumoniae</i> and <i>Azotobacter vinelandii</i>, the parvulin NifM ensures the activity of the nitrogenase reductase protein.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><div class="NLM_p last">This Perspective aims to provide an overview of each immunophilin subfamily and their role in bacterial virulence and pathogenesis, and a comprehensive review of the development of novel drugs against each subfamily along with structure–activity relationships and their efficacy against pathogenic bacteria. Currently, there are no drugs targeted to bacterial cyclophilins and parvulins; however there has been a number of drugs developed as antivirals and anticancer therapies which will be discussed in this review. The successes in anticancer and antiviral drug development pave the way for designing specific therapies that target bacterial cyclophilins and parvulins. It is clear from the literature that immunophilins, although representing promising antivirulence targets, are in the shadows of other virulence factors such as type 3 secretion systems and quorum sensing. This review highlights the advances in our knowledge of these enzymes in pathogenic bacteria and also the key strategies already undertaken to effectively target these enzymes with great potential to be broad-spectrum antivirulence therapeutics in our battle against antibiotic resistant bacteria.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">FK506 Binding Proteins in Bacteria</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22762" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22762" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As already mentioned, the FKBP subfamily comprises a group of distinct protein types: Mip and ML1 proteins, Trigger factor proteins, and SlyD proteins. Mip proteins are classically approximately 28 kDa in size, consisting of two distinct domains, an N-terminal dimerization domain linked to a domain containing the FKBP fold exhibiting PPIase activity. These proteins are believed to form a homodimer on the outer membrane of the bacterial cell of approximately 60 kDa.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> ML1 proteins possess the FKBP fold domain but lack the dimerization domain, resulting in an approximately 12–14 kDa protein with PPIase activity, believed to be located within the cytoplasm or periplasm of the bacterial cell.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Trigger factor proteins are approximately 48 kDa in size with three distinct domains. The N-terminal domain is homologous to parts of chaperone protein Hsp33 and is involved in ribosome docking of the protein.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The C-terminal domain is homologous to the chaperone protein SurA and has been shown to prevent protein aggregation. These two domains are linked by a central domain, containing the FKBP fold that exhibits PPIase activity.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">SlyD proteins contain two domains: an N-terminal domain with the FKBP fold responsible for the PPIase activity of the protein, and an insert-in-flap (IF) domain, which has been shown to increase the rate of PPIase activity of the FKBP domain by 200-fold.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> SlyD has also been shown to be involved in metal-dependent enzyme assembly. Thereby, SlyD displays both PPIase and chaperone activity and has been shown to be responsible for increasing solubility of aggregation-prone proteins in the <i>E. coli</i> cytoplasm.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Presence or absence of each of these proteins varies by bacterial species; for example, FkpA (a Mip protein homologue), Trigger factor, and SlyD have all been found to be present in <i>E. coli</i>, while <i>Mycoplasma genitalium</i> has been found to possess Trigger factor as its only folding isomerase protein.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Regardless, FKBPs have been implicated in the virulence of many pathogenic bacteria, summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the Known Functions of FKBPs in Bacteria<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">()</a><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">()</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">()</a><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">()</a><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">()</a><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">()</a><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">()</a><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">()</a><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0028.gif" alt="" id="GRAPHIC-d7e510-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>1</sup></sup><p class="last">Cellular location: RB, ribosome bound; CM, cytoplasm; PM, periplasm; OM, outer membrane; IM, inner membrane; ERB, elementary body bound and reticulate body bound.</p></div><div class="footnote" id="t1fn2"><sup><sup>2</sup></sup><p class="last">Protein size (kDa) and cellular location were ascertained from the associated references where possible; if not, UniProt, NCBI, and the algorithm PSORTb were used to determine kDa and cellular location.</p></div><div class="footnote" id="t1fn3"><sup><sup>3</sup></sup><p class="last">Unable to fully classify subcellular localization.</p></div></div><div></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Role of FKBPs in Gram-Positive Bacteria</h3><div class="NLM_p last">Investigation of FKBPs is limited in Gram-positive bacteria. Specifically, only Trigger factor has been studied in bacterial species including <i>Bacillus subtilis</i>, <i>Streptococcus pyogenes</i>, and <i>Listeria monocytogenes</i>, resulting in various phenotypes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In <i>B. subtilis</i> deletion of Trigger factor showed no effect on heat, osmotic, or oxidative stress, and only a double deletion in combination with a cyclophilin gene, <i>ppiB</i>, resulted in decreased growth under starvation conditions.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Trigger factor, known as RopA in <i>S. pyogenes</i>, has been found to be required for maturation and expression of the secreted cysteine proteinase (SCP).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Absence of Trigger factor results in impaired survival of <i>L. monocytogenes</i> in the presence of heat and ethanol stresses, and while no effect on intracellular survival was seen, the Trigger factor gene deletion strain did show reduced capacity to persist in the spleens and livers of infected mice.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> These initial and promising results prove that more research is required to understand the role these FKBPs may play in Gram-positive bacterial infections.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Role of FKBPs in Gram-Negative Bacteria</h3><div class="NLM_p">Trigger factor has been investigated in <i>E. coli</i>, and while a single Trigger factor mutant showed no phenotype under tested conditions, a combination deletion with chaperone protein DnaK resulted in lethality to the organism.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> An <i>E. coli</i> SlyD mutant was found to stabilize the E lysis protein of bacteriophage φX174, allowing for accumulation to levels required to exert a lytic effect. E lysis protein contains five proline residues, which may explain the importance of the presence of SlyD in order for its full maturation.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> A transposon insertion mutant of SlyD in <i>Salmonella enterica</i> serovar Typhimurium resulted in a 50% decrease in numbers of colonized chicks.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Clearly, a range of phenotypes are observed in the absence of the FKBPs Trigger factor and SlyD, and these proteins and their effects on bacterial functioning require further investigation.</div><div class="NLM_p">The most well studied FKBP is the macrophage infectivity potentiator (Mip) protein and the closely related ML1 proteins. They have been implicated in the virulence of a variety of human bacterial pathogens including <i>L. pneumophila</i>, <i>B. pseudomallei</i>, <i>Neisseria meningitidis</i>, <i>Neisseria gonorrhoeae</i>, <i>S. enterica</i>, and <i>Chlamydia trachomatis</i>.<a onclick="showRef(event, 'ref14 ref15 ref33 ref34 ref37 ref44 ref46 ref48 ref50 ref63'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref33 ref34 ref37 ref44 ref46 ref48 ref50 ref63">(14,15,33,34,37,44,46,48,50,63)</a> Consistently, Mip and ML1 proteins have been found to have a pleiotropic effect on virulence across all of these bacterial species. Deletion of Mip in <i>L. pneumophila</i> was found to reduce invasion capability in U937 monocytic cells and explanted human macrophages, as well as reduced survival in both the amoebae, <i>Acanthamoeba castellanii</i>, and a guinea pig infection model, as well as reduced bacterial growth at suboptimal temperatures.<a onclick="showRef(event, 'ref14 ref33 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref14 ref33 ref48 ref49 ref50">(14,33,48−50)</a> Similarly, in the closely related organism, <i>Legionella longbeachae</i> deletion of Mip results in reduced intracellular survival in the human leukemia cell line HL-60, a decreased invasive capability in <i>A. castellanii</i>, and the inability to cause lethal disease in an aerosolized guinea pig model.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> A mutant in <i>S. enterica</i> lacking FkpA (Mip homologue), resulted in decreased survival in Caco-2 intestinal epithelial cells as well as J774A.1 murine macrophages after 6 h.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Similarly, deletion of Mip in <i>Aggregatibacter actinomycetemcomitans</i> resulted in a 4-fold reduction in survival after 6 h infection in HeLa cells.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The Mip-like gene (<i>ML1</i>/<i>fbp</i>) in <i>B. pseudomallei</i> was also shown to be important for intracellular survival with a Mip-deletion mutant showing reduced invasion and survival in both macrophage and epithelial cell lines and ultimately resulted in decreased virulence in the BALB/c mouse infection model.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In the pathogenic <i>Neisseria species</i>, deletion of the Mip gene has resulted in decreased survival of <i>N. gonorrhoeae</i> in macrophage cells and decreased survival of <i>N. meningitidis</i> in blood.<a onclick="showRef(event, 'ref34 ref44'); return false;" href="javascript:void(0);" class="ref ref34 ref44">(34,44)</a> While the exact mode of action of Mip proteins is still unknown, the homology between Mip and Mip-like proteins in Gram-negative bacteria and its role in the virulence of these pathogens intracellularly make these attractive drug targets. This has led to the testing of small molecule inhibitors against the Mip and ML1 proteins of <i>L. pneumophila</i>, <i>B. pseudomallei</i>, <i>C. trachomatis</i>, <i>N. gonorrhoeae</i>, and <i>N. meningitidis</i>.<a onclick="showRef(event, 'ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref68">(66−68)</a> Pipecolic derived compounds inhibited enzymatic activity of the LpMip; however, this enzymatic reduction had no detrimental impact on the infectivity of inhibitor-treated bacteria.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Similarly, inhibitors were designed against <i>B. pseudomallei</i> Mip (BpML1), with these inhibitors demonstrating inhibition both enzymatically and in <i>in vitro</i> infection of macrophages.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The Mip inhibitor-treated <i>C. trachomatis</i>, <i>N. gonorrhoeae</i>, and <i>N. meningitidis</i> were also shown to be impaired in invasion and survival within host cells.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The implication of Mip and Mip-like proteins in the persistence and survival of a varied range of pathogenic bacteria within human host cells is quite clearly demonstrated and reinforced by the few studies that have tested and shown Mip to be required for virulence of bacteria <i>in vivo</i>.</div><div class="NLM_p last">While more investigation into the role of the FKBPs SlyD and Trigger factor in bacterial virulence is necessary, it is clear that a subset of FKBPs, the Mip and ML1 proteins, play an important role in the pathogenic potential of a wide variety of bacterial species. This group of evolutionarily distant organisms all utilize Mip and ML1 proteins in similar ways for virulence, with gene deletion mutants all exhibiting decreased survival in macrophages and animals. The conservation and homology between these proteins among pathogenic bacteria indicate the importance of Mip and ML1 proteins for bacterial function. While the precise folding partners of these proteins remain unknown, there is much data to prove the necessity of Mip and ML1 proteins in infectivity and survival within the host. The structural conservation suggests Mip and ML1 proteins are broad spectrum antivirulence drug targets, with already promising results.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Development of Inhibitors to the Mip Protein in Gram-Negative Bacteria</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Commercially Available FKBP Inhibitors and Their Complexes</h3><div class="NLM_p last">Rapamycin (<b>4</b>, sirolimus) and FK506 (<b>3</b>, tacrolimus) are commercially available drugs initially isolated from <i>Streptomyces hygroscopicus</i> and <i>Streptomyces tsukudaiensis</i>, respectively, and their chemical structures are shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> They are potent inhibitors of FKBPs including the bacterial Mip proteins; however they exhibit immunosuppressive activity. FKBP-FK506 complexes bind to calcineurin in cells which prevents the dephosphorylation of nuclear factor of activated T-cell (NF-AT) that is required for interleukin 2 (IL-2) gene expression and T-cell activation.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> Rapamycin (<b>4</b>) also complexes with FKBPs; however, the complex interacts with the mammalian target of rapamycin (mTOR) instead of calcineurin and induces immunosuppressant activity.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> The immunosuppressant activity of these compounds makes them unsuitable as antibacterial therapies; fortunately the domain responsible for the immunosuppressive effects is separate from the enzyme binding domain, a characteristic that has been exploited by several groups to design small molecule inhibitors lacking the immunosuppressive action.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> This has been shown to be a successful strategy, particularly with the use of rapamycin (<b>4</b>) as the basis for the design of small molecule inhibitors of bacterial Mip proteins.<a onclick="showRef(event, 'ref67 ref69'); return false;" href="javascript:void(0);" class="ref ref67 ref69">(67,69)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationships of the Rapamycin-FKBP12 Complex</h3><div class="NLM_p">Alluded to above, the effector domains of rapamycin (<b>4</b>) and FK506 (<b>3</b>), which lead to immunosuppressant activity, are different from the PPIase binding domain. In both structures, the PPIase binding domain can essentially be traced back to the already mentioned pipecolic acid moiety. Depending on which FKBP is binding, the overlap extends approximately from C31 to C16 for rapamycin (<b>4</b>) and C14 to C26 for FK506 (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a> Due to the homology between human FKBP12 and Mip, detailed analysis of FKBP12 using structure–activity relationship (SAR) with rapamycin (<b>4</b>) has significantly aided design of inhibitors to Mip proteins. However, differences in their binding modes have also helped toward design of tailor-made inhibitors for each target. There are two main interactions between rapamycin (<b>4</b>) and FKBP12, hydrophobic interactions with the piperidine (Tyr26, Phe46, Trp59, Phe99) and hydrogen bonds (a total of three) formed between the α-ketoamide functions of rapamycin (<b>4</b>). Both subunits dive deep into FKBP12, while other parts of the rapamycin (<b>4</b>) structure attach rather superficially. The C9-carbonyl plugs into a specific small binding pocket of FKBP12, which is formed by the edges of Tyr26, Phe36, and Phe99 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). As a consequence of the different spatial orientation in Mip compared to FKBP12 and the resulting lack of cavity, this hydrogen bond between the amide carbonyl cannot be formed. Therefore, the lead structure for Mip-inhibition needed modification. The tetrahydropyran ring of rapamycin (<b>4</b>) is involved in numerous interactions with FKBP12 (Phe36, Asp37, Ile90, Ile91), and the C10 hydroxyl forms a hydrogen bond with the Asp37 side chain, on the edge of the binding domain. At the other edge of the binding pocket the cyclohexyl ring interacts with FKBP12 (Gln53, Glu54, Val55, Ile56); additionally a hydrogen bond occurs between the C40 OH group and the main-chain carbonyl of Gln53. Another hydrogen bond is located between C28 OH, which is orientated toward FKBP12, and the Glu54 oxygen (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Detailed FKBP12 interactions with rapamycin (<b>4</b>), representative for other FKBPs. Black dashed lines indicate hydrogen bonds. Green amino acids show points of contact deep in the binding pocket and blue amino acids on its surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Inhibitors of the <i>Legionella pneumophila</i> Mip Protein</h3><div class="NLM_p last">The first bacterial FKBP to be targeted for the development of potent inhibitors was the Mip protein from <i>Legionella pneumophila</i>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The interactions between inhibitors and the <i>L. pneumophila</i> Mip (LpMip) protein were pivotal to design a lead structure for selective targeting, due to the binding pockets of FKBP12 and the LpMip having an almost identical amino acid sequence. Despite this similarity, the rapamycin–protein complexes show significant differences with respect to the orientation of rapamycin (<b>4</b>) in the binding pocket of both proteins. The Tyr109 of LpMip, projecting deep into the binding pocket, reduces its overall size in comparison to the FKB12 pocket, resulting in different binding modes of the pipecoline moiety of rapamycin (<b>4</b>) with respect to the orientation of the aliphatic ring in the hydrophobic pocket, the conformation of the ester, and the hydrogen-bonding pattern of the carbonyl groups.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Inhibitor Assay for <i>K</i><sub>D</sub> and IC<sub>50</sub> Determination</h3><div class="NLM_p">In order to evaluate the extent of Mip inhibition in <i>L. pneumophila</i>, an enzymatic PPIase assay was used to determine the <i>K</i><sub>D</sub> and IC<sub>50</sub> of the inhibitors. In most cases, a protease-coupled enzymatic assay is suitable to quantify the inhibitory effect of the new compounds <i>in vitro</i>. In brief, a short <i>p</i>-nitroaniline labeled amino acid sequence is used as substrate, while α-chymotrypsin serves as an auxiliary protease, which only cleaves <i>trans</i>-linked Phe-Pro substrates. The conversion can be measured by absorption at 390 nm, owing to released <i>p</i>-nitroaniline. Initially, the absorption increases rapidly due to the 85% <i>trans</i>-proline that is in equilibrium in aqueous buffer (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In the next phase of the reaction, the slow isomerization at room temperature leads to a moderate increase in absorption. In the presence of Mip, which catalyzes the isomerization from <i>cis</i> to <i>trans</i>, the absorption rises rapidly until the substrate is completely converted. An inhibitor screen can be performed by adding compounds to the assay, which prevents this catalytic isomerization and thus leads to reduced absorption values. This assay was first described by Fischer et al.,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> but it is not appropriate for large scale screening, due to some drawbacks like high consumption of peptide and enzyme and its high susceptibility to temperature variation. In order to develop a medium throughput assay with improved robustness and higher reproducibility, Vivoli et al. optimized the assay conditions and created an improved version of PPIase assay.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> This involved a temperature controlled plate reader which enabled semiautomated medium throughput assays increasing the number of samples to 84, a potentially 4-fold increase in the number of assays that can be run in a single day.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Illustration of the absorption spectra during the protease-coupled reaction (with and without PPIase or rapamycin). Mip PPIase activity catalyzes the conversion from <i>cis</i> to <i>trans</i> of the substrate, and the absorption increases rapidly, while rapamycin, as a Mip inhibitor, prevents this effect. The reaction reaches equilibrium as all substrate is turned over to a <i>trans</i> state. (B) Residual activity curve of compounds. In the PPIase assay the catalytic efficiency of the unbound enzyme (without inhibitor) was assumed to be 100% of the enzyme activity, and all other efficiency values (with inhibitor) were compared. The residual activity of the enzyme could thus be maintained at different inhibitor concentrations, and therefore, the IC<sub>50</sub> value for each compound can be determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Structure–Affinity Relationship of LpMip Inhibitors</h3><div class="NLM_p">Two pipecolic acid-type lead structures were identified, and their binding affinity was compared to FKPB12 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Starting point for investigations were two FKPB12 inhibitors were tested for LpMip inhibition. Affinities of ligand <b>7</b> (<i>K</i><sub>i</sub> = 0.010 μM)<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> and ligand <b>8</b> (<i>K</i><sub>i</sub> = 0.230 μM) to FKBP12 were described before.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Docking studies revealed comparable binding modes of the pipecoline groups of ligands <b>7</b> and <b>8</b> in FKBP12<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> but differences in LpMip. The binding of ligand <b>7</b> to LpMip is weak compared to ligand <b>8</b>, which offers a very favorable hydrophobic interaction with the benzylsulfonamide group, which promises even better results than docking with FKBP12 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). This effect can be explained by the less voluminous sulfonamide group of ligand <b>8</b> compared to the α-ketoamide moiety of ligand <b>7</b>, which is a better fit into the narrow binding pocket of Mip. Due to steric hindrance, larger ligands like the α-ketoamide of compound <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) lead to weak inhibition. On the basis of these data, a series of inhibitors were synthesized and tested for their ability to reduce the PPIase activity of LpMip.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Top-binding mode of ligand <b>8</b> in LpMip justifies its selection as first lead structure. The pipecoline ring is placed deep in the active-site pocket, whereas the phenyl ring of the sulfonamide moiety occupies a subpocket and the trimethoxyphenyl moiety lies on the surface.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Reproduced with permission from <i>Journal of Medicinal Chemistry</i>, Juli et al.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The comparison of phenyl ligand <b>9</b> and benzyl ligand <b>10</b> substituted sulfonamides (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) reveals a positive effect on binding affinity of the methylene group in LpMip, which was not observed with FKBP12. A meta substitution of the phenyl ring with nitro or amino groups substantially reduces the inhibitory effect; however, the nitro group is tolerated rather than the amino function.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of the sulfonamide residue shows that the benzyl moiety in <b>10</b> is superior to phenyl (<b>9</b>) for Mip inhibition, and substitution B in meta position is possible and was also investigated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the R″ moiety, a large substituent attached to the ester seems to be crucial for a notable binding affinity to the LpMip (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). A small ethyl ester leads to a weak Mip inhibition but less so in FKBP12. A second aromatic ring R’, as it appears in ligand <b>7</b>, next to the carbonyl function has an unfavorable effect on the affinity to both proteins. Optimal results were achieved with a large propyltrimethoxyphenyl, ligand <b>11</b>, or -pyridine group, ligand <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), which may result in greater water solubility while maintaining activity. Additionally, checking the activity of both enantiomers revealed the <i>S</i>-enantiomer to be clearly superior to the <i>R</i>-enantiomer, with the racemate hinting to a stereoselective effect and, thus, a specific binding. Taken together, the <i>S-</i>pipecoline sulfonamides is a promising lead structure for selective LpMip inhibition that may have broad-spectrum activity against other bacterial Mip proteins.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Optimization of the R″ residue showed that bulky trimethoxyphenyl (<b>11</b>) or pyridine rings (<b>12</b>) are moieties of choice in terms of Mip inhibition. Additionally, a pyridine residue promises an improved solubility of the compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cycloheximide–Adamantane Hybrids</h3><div class="NLM_p">Cycloheximide (<b>13</b>),<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and adamantane (<b>14</b>),<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> or hybrids of both,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> constitute different classes of inhibitors, which also bind to the PPIase domain of the LpMip (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Cycloheximide (<b>13</b>), a natural product from <i>Streptomyces griseus</i>, was found in a screening campaign for nonimmunosuppressive FKBP inhibitors.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> It represents an efficient inhibitor of eukaryotic protein synthesis, by inhibiting the activity of the peptidyl transferase on the 60S subunit of ribosomes, thus hindering successful translation. This unwanted effect can be prevented by N-substitution of the piperidine group. Structure–activity relationships in a series of synthesized cycloheximide derivatives with regard to cytotoxicity against eukaryotic cells is described by Christner et al.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> An extensive analysis of BpML1 protein and its binding modes with cycloheximide compounds was carried out by Norville et al.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Interestingly, they discovered a conformation of cycloheximide <i>N</i>-ethylethanoate mimicking the conformation of a helical peptide, which was found in the crystal structure of BpML1 protein and is similar to human TGF (transforming growth factor) receptor, an activation modulator.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Hit compounds of the nonimmunosuppressive FKBP ligand screening: cycloheximide (<b>13</b>, left) and adamantane (<b>14</b>, right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Adamantane (<b>14</b>), however, has been a hit of a custom-tailored computational prediction of the FKBP12-FK506 complex. Since, adamantane (<b>14</b>) and cycloheximide (<b>13</b>) target different areas of the active site of LpMip, the synthesis of various compounds consisting of both favorable hit characteristics seems to be a promising strategy in order to achieve a cumulative inhibitory effect. Adamantane (<b>14</b>) overlaps with the pipecolic acid area of FK506 (<b>3</b>), while cycloheximide (<b>13</b>) binds near the enzymatic cleft. Almost all tested inhibitors were far more efficient at inhibiting FKBP12 than LpMip as determined using the PPIase assay, except for the weakest compound <b>15</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The best inhibitor, a double methylated adamantane compound <b>16</b>, surprisingly reduces the gap between LpMip and hFKBP12 binding affinity.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Several hybrids, highest to lowest activity. Hit compound <b>16</b> had 10-fold lower IC<sub>50</sub> values for LpMip than for FKBP12; the hydroxylation decreased the affinity especially for LpMip. The weakest compound <b>15</b> (<i>tert</i>-butyl instead of adamantane and N-methylation) significantly worsens the affinity, especially for FKBP12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Coupling of adamantane and cycloheximide results in 4 times lower IC<sub>50</sub> values as seen with compound <b>15</b> compared to compounds <b>16</b>–<b>18</b> (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), in which the activity increased with nonpolar substitution on the adamantane backbone, such as methylation or ethylation in compounds <b>16</b>–<b>18</b>, while introduction of polar groups such as hydroxyl (compound <b>19</b>) was not beneficial. All these trends of binding affinity associated with substitutions also hold true for FKBP12. However, despite some success against recombinant LpMip protein, the inhibitory effects could not be observed on <i>L. pneumophila</i> growth in liquid cultures containing compound or on bacterial replication rates during macrophage infection. Moreover, there was no difference between wild-type and isogenic Mip-deficient mutants of <i>L. pneumophila</i> indicating that these compounds exhibited off target effects.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Inhibitors of <i>B. pseudomallei</i> Mip (BpML1)</h3><div class="NLM_p">LpMip inhibitors was used as a starting point for the development of compounds toward BpML1,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> with further optimization achieved through structural studies of BpML1 cocrystallized with rapamycin (<b>4</b>) and novel compounds <b>20</b>–<b>23</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) by Begley et al. (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Cocrystallization trials with BpML1 were carried out with several pipecolic acids. Compounds <b>20</b>–<b>23</b> delivered crystals with sufficient X-ray data for structure determination. Compound <b>22</b> represents the <i>S</i>-enantiomer of compound <b>21</b>, while all others were introduced as racemates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structure ensemble for pipecolic acids binding to BpML1. Four crystallographic poses were observed for compound <b>21</b> (pink), while two poses each were obtained for compounds <b>20</b> (green), <b>22</b> (blue), and <b>23</b> (yellow). A full model complex for compound <b>23</b> is postulated (gray) and is based on NMR data and available space in the crystal structure. Non-carbon atoms for each compound are colored as follows: red, oxygen; blue, nitrogen; gold, sulfur.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Reproduced with permission from   <cite><i>Antimicrobial
Agents and Chemotherapy</i></cite>, <contrib-group>Begley</contrib-group> , Volume <em>58</em>, Issue 3, pp 1458–1467, Copyright <span class="NLM_year">2014</span> American Society for Microbiology, DOI: <pub-id pub-id-type="doi" type="simple">10.1128/aac.01875-13</pub-id>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In general, two to four different binding positions could be identified for each compound, with the largely conserved binding of the pipecolic acid moiety across all four complexes. Compounds <b>20</b>, <b>21</b>, and <b>22</b> show a hydrogen bond between the sulfonyl oxygen and Y89; the carbonyl ester coordinates with the amide backbone of I63; the terminal phenyl ring forms a π-edge-stacking interaction with F43. The position of the trimethoxyphenyl residue appears to be more variable in the compound-BpML1 cocrystals, but the most common conformation overlaps the same binding pocket that occupies the methoxycyclohexanol substructure of rapamycin (<b>4</b>) and FK506 (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). The enantiospecific preference of the inhibitors was confirmed by docking studies, cocrystallization and associated X-ray data, NMR measurements, and PPIase assay, which generally led to a 4-fold higher binding affinity of the <i>S</i>-enantiomer compared to the racemate. As already mentioned, compounds <b>20</b>–<b>22</b> show similar binding poses (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), in contrast to compound <b>23</b>. First, the rotation of the carbonyl ester in compound <b>23</b> prevented any interaction with I63 within the crystal, compared with compounds <b>20</b>–<b>22</b>. Second, the uptake of the nitrobenzol ring into the flexible outer loop A94 to I98, as observed for the benzyl residue of compounds <b>20</b>–<b>22</b>, seems to be possible, but the positioning of the nitro group is unlikely for compound <b>23</b> due to the lack of the methylene moiety.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Crystal structures of BpML1 bound to FK-506 (<b>3</b>, brown; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UQB">3UQB</a>) and compound <b>22</b> (cyan; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G50">4G50</a>). The conformational change within the R92-I98 loop accommodates the terminal phenyl group of compound <b>22</b> (bottom), relative to the FK-506-bound structure (top). The R92 side chain is not modeled in the FK-506 structure (top) due to insufficient electron density.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Reproduced with permission from   <cite><i>Antimicrobial Agents and Chemotherapy</i></cite>, <contrib-group>Begley</contrib-group> , Volume <em>58</em>,
Issue 3, pp 1458–1467, Copyright <span class="NLM_year">2014</span> American Society for Microbiology,
DOI: <pub-id pub-id-type="doi" type="simple">10.1128/aac.01875-13</pub-id>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The solution NMR characterization was carried out with <sup>15</sup>N-labeled, native BpML1, which was titrated with the pipecoline acid derivatives to calculate biophysical binding constants. The mean dissociation constants (<i>K</i><sub>D</sub>) were calculated by using SOFAST-HMQC pulse sequence, based on the chemical shift perturbations (CSPs) of equally spaced amino acid residues around the binding site of BpML1. Compound <b>20</b>, which is lacking a large R<sup>1</sup> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), showed the weakest affinity to BpML1, hence indicating a significant contribution of this region to enzyme inhibition. Nevertheless, the NMR analysis predicted similar affinity to the active site by compounds <b>22</b> and <b>23</b>; however the <i>in vitro</i> PPIase assays revealed enzymatic inhibition with compound <b>22</b>. Detailed structural information obtained by SOFAST-HMQC spectra showed a strong chemical shift for V62 and I63 and a weak shift for F53, confirming the hypothesis that the trimethoxyphenyl or pyridine moiety shares the same pocket as methoxycyclohexanol. The largest CSP occurred at I63, indicating a hydrogen bond with the carbonyl ester, and in contrast to rapamycin (<b>4</b>) and FK506 (<b>3</b>) generated unexpected shifts of the terminal aromatic ring of compounds <b>21</b>–<b>23</b>, which implies a new interaction area. Numerous other CSPs occurred for compound <b>23</b>, indicating a conformational change in solution, and the strong CSP for Y89 suggests interactions with the nitro group.</div><div class="NLM_p">The lactate dehydrogenase (LDH)-release from murine macrophage J774A.1 cells was used to analyze the cytotoxicity caused by <i>B. pseudomallei</i> infection in the presence or absence of Mip inhibitors. Compounds <b>21</b>–<b>23</b> reduced the cytotoxicity by a magnitude of 30–40%, with no significant difference between the respective compounds, while compound <b>20</b> showed less activity compared to the other compounds. An inhibitor’s cytotoxicity against J774A.1 cells themselves could not be determined for <b>20</b> and <b>23</b>, whereas <b>21</b> and <b>22</b> showed an effect less than 10%. This can be explained by their increased cell permeability due to increased lipophilicity. Compounds <b>20</b>–<b>23</b> are also active against recombinant Mip proteins from <i>Yersinia pestis</i> and <i>Francisella tularensis</i>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">Since a crystal structure of BpML1 bound to lead structure <b>21</b> was available and the binding mode was comparable with the postulated one obtained by docking studies for LpMip, a compound library starting from compound <b><i>S</i>-<b>21</b></b> was synthesized by Seufert et al.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The application of hot-spot analysis combined with docking studies and biological screenings revealed a high homogeneity for both binding pockets except for the subpocket resulting in clear hot spot regions for hydrophobic substituents in para position of region R″ (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Due to less pronounced hot spots in LpMip, at best small hydrophobic substituents can be tolerated. Moreover, for an increased affinity toward BpML1, well-placed hydrogen bond donors are necessary to address carbonyl functions of Phe43 and Ala94. On the other hand, an increased affinity toward LpMip is even more pronounced because hydrogen bond donors can target the Phe65 and the Val114 as well as a suitable acceptor targets the NH of Gly116. Therefore, R′ and R″ (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were selected as modification areas, and SARs were described for LpMip and BpML1. The exchange of the trimethoxyphenyl ring to pyridine is desirable because of its nonspecific binding behavior to BpML1 as well as trimethoxyphenyl’s high toxicity in macrophages and poor water solubility.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Compounds Derived from the Primary Lead Structures <b>22</b> Have Spawned a New Lead Structure <i><b>S</b></i><b>-24</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0029.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last">Modifications were carried out in R″, R′, and bridge section and IC<sub>50</sub> values determined for BpML1 and LpMip using the protease-coupled PPIase assay, with trim = trimethoxyphenyl and pyr = pyridine in region R′.</p></div></div><div></div></div><div class="NLM_p">An enantiospecific binding of compound <b>21</b> was observed for LpMip, as it was described by Holt et al. for FKBPs before.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> In addition, previous docking studies showed an unfavorable distorted orientation of <i>R</i>-enantiomer in the binding pocket. As can be seen from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and expected from previous studies, compounds with an <i>S</i>-configuration always inhibit the PPIase more potently than the <i>R</i>-isomers. Thus, the next starting point of optimization was the new lead structure <i><b>S-</b></i><b>24</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>). With regard to the modifications of the benzyl substitution (R″) especially compounds with a para halogen and nitro substitution show high levels of PPIase inhibition by a para-fluorine compound <i><b>S-</b></i><b>25</b> for BpML1 (IC<sub>50</sub> value of 0.072 ± 0.03 μM) and para-chlorine <i><b>S-</b></i><b>26</b> for LpMip (IC<sub>50</sub> of 2.4 ± 0.1 μM) compared to lead structure <i><b>S-</b></i><b>24</b>. Meta substituted compounds, like meta-chlorine <i><b>S-</b></i><b>30</b> or meta-nitro <i><b>S-</b></i><b>31</b>, also inhibited well, whereas larger residues are not tolerated in any position leading to significantly worse results. As a bridge between the pipecolic acid and the aromatic moiety, a second ester group <i><b>S-</b></i><b>27</b>, an amide <i><b>S-</b></i><b>28</b>, or an ether <i><b>S-</b></i><b>29</b> was investigated. The diester inhibitors showed the highest activity, though the diester structure was prone to hydrolysis in buffer. Hence, it cannot be ruled out that the high inhibitory activity is due to active hydrolysis products. Replacement of the additional ester by an amide increases the stability but slightly decreases the activity.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. For BpML1 inhibition the new lead structure <b>S-24</b> could be identified and was a starting point for further optimization.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Taken together, with the <i>S</i>-configuration of the carbon atom carrying the carboxylic group at the piperidine ring, a pyridine ring attached to an amide in the bridge section combines promising approaches in terms of activity, solubility, and stability for drug-like BpML1 inhibitors. The optimization of the benzyl area with para halogen substitution promotes affinity in BpML1 and LpMip.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Inhibition of <i>C. trachomatis</i>, <i>N. gonorrhoeae</i>, and <i>N. meningitidis</i> Mip Proteins</h3><div class="NLM_p">The Mip hit compound <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) and a limited series of compounds having a meta- and para-nitro substitution at the benzylsulfonamide moiety were also screened against other Gram-negative pathogens to determine if these compounds had broad spectrum activity. The obtained IC<sub>50</sub> values from protease-coupled PPIase assay were compared to rapamycin (<b>4</b>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The activity of <i>C. trachomatis</i> Mip protein (CtrMip) is inhibited by rapamycin (<b>4</b>) with an IC<sub>50</sub> value of 0.0079 ± 0.0006 μM.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The synthesized pipecoline acid derivatives were observed to be slightly less potent than rapamycin (<b>4</b>), with para-nitro compound <b>21P</b> showing 3.7-fold higher potency against CtrMip compared to the meta-nitro <b>21M</b> compound (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Interestingly, both the para-nitro (<b>21P</b>) and meta-nitro compound <b>21M</b> inhibitors were still highly effective when screened directly against the development cycle of <i>C. trachomatis</i> in HeLa cells. In brief, the lysates of infected cells containing chlamydial progeny were treated with inhibitor prior to infecting new cells. Next to no infectious progeny could be produced in the presence of rapamycin (<b>4</b>) or meta-nitro compound <b>21M</b> treated cells, whereas para-nitro <b>21P</b> reduced the infectivity levels by 50%.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Values of Rapamycin and Compounds <b>21M</b> and <b>21P</b> Determined by the Protease-Coupled PPIase Sssay for CtrMip and NgMip<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> for CtrMip [μM]</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> for NgMip [μM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rapamycin (<b>4</b>)</td><td class="colsep0 rowsep0" align="left">0.0079 ± 0.0006</td><td class="colsep0 rowsep0" align="left">0.0158 ± 0.0042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">meta-NO<sub>2</sub> <b>21</b> (<b>21M</b>)</td><td class="colsep0 rowsep0" align="left">0.241 ± 0.031</td><td class="colsep0 rowsep0" align="left">2.79 ± 0.78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">para-NO<sub>2</sub><b>21</b> (<b>21P</b>)</td><td class="colsep0 rowsep0" align="left">0.0646 ± 0.011</td><td class="colsep0 rowsep0" align="left">0.0956 ± 0.022</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">NgMip is a representative for both <i>Neisseria</i> species. Rapamycin (<b>4</b>) is still the most potent agent and <b>21P</b> seems to be superior to <b>21M</b> in this assay.</p></div></div></div><div class="NLM_p last">The neisserial Mip proteins NgMip and NmMip show 97% amino acid identity and leads to the assumption of similar enzyme activity, hence NgMip recombinant protein was used as a representative of both species. Similar observations were made for NgMip in the PPIase assay as with CtrMip; however, the IC<sub>50</sub> values of the meta and para have a greater difference in potency (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Due to the different cellular habitats of <i>N. gonorrhoeae</i> and <i>N. meningitidis</i>, two survival assays were performed. In the presence of inhibitors the survival of <i>N. gonorrhoeae</i> was reduced in neutrophil granulocytes, with meta-nitro compound <b>21M</b> showing greater potency then para-nitro compound <b>21P</b>. The opposite was observed for survival of <i>N. meningitidis</i> in Detroit 562 pharyngeal epithelial cells, where the para-nitro compound <b>21P</b> demonstrated greater potency.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> These results and previous observations made for LpMip<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and BpML1<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> are strong indications that functions, other than the PPIase activity of Mips, are important for bacterial virulence and intracellular survival. In addition, NgMip-deletion mutants also responded to the inhibitors; thus, Mip-independent mechanisms may also be targeted by these inhibitors, and this needs to be investigated further.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Antibacterial Activity of Other Human FKBP Compounds</h3><div class="NLM_p">Beyond ligand-induced immunosuppression, human FKBPs, like FKBP12, 12.6, 51 and 52, are involved in several physiological mechanisms.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a> Many of them are of great therapeutic interest due to their role in calcium signaling, metabolic and psychiatric disorder, or chronic pain. In particular, <i>S</i>-C<sup>5</sup> substituted aza[4.3.1]bicyclic sulfonamides, which represent a group of promising human FKBP-inhibitors, were screened against pathogens such as <i>Candida albicans</i>, <i>Plasmodium falciparum</i>, <i>Chlamydia pneumonia</i>, <i>C. trachomatis</i>, and <i>L. pneumophila</i>. Compound <b>32</b>, a highly potent inhibitor of human FKBP12, FKBP51, and FKBP52, was the starting point for the analysis of the SAR and offers three regions for modifications (R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>) (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. In a screening campaign potent human FKBP inhibitors were tested against several pathogens to find new hits for the respective microbial Mips. The common framework of this series of compounds offers three regions to modify (R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>). Hit compound <b>32</b> for human FKBP inhibition was the starting point of microbial investigations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The inhibitory activity decreased depending on the level of sequence homology to hFKBP12 in the following order: CaFKBP12 (<i>C. albicans</i>) > PfFKBP35 (<i>P. falciparum</i>) ≫ CpMip (<i>C. pneumonia</i>) ≈ LpMip (<i>L. pneumophila</i>) > CtrMip (<i>C. trachomatis</i>). It was observed that almost all compounds inhibited hFKBPs far more efficiently than microbial Mip proteins, which diminishes the opportunity to develop selective Mip inhibitors without significant hFKBP inhibition. Nevertheless, Hausch et al. successfully synthesized specific microbial Mip inhibitors.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Initially, the second nitrogen of the bridged pipecolic acid moiety (R<sup>1</sup>) was widely substituted with alkyl ethers of different lengths, heterocycles, alkynes, nitriles, amines, short esters, and others. Interestingly, the position of the ether is essential, and all other moieties do not influence the reduction of PPIase activity significantly. Removal of the ether group (R<sup>1</sup> = H, Me, −CH<sub>2</sub>–CH) marginally compromised the affinity but can be restored by introducing alternative hydrogen bond acceptors. Replacement of the 3-dimethoxy phenyl ether of <b>32</b> (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>) with pyridine analogues (pyrazine, pyrimidine) is well tolerated because of similar hydrogen bond acceptor behavior, and therefore, a picolyl moiety was kept for further modifications in R<sup>2</sup> and R<sup>3</sup>. In contrast, phenyl or five-membered heterocycles instead of the pyridine led to lower Mip inhibition except for <i>Chlamydia</i> Mip, whose hit compound <b>33</b> contains a furanylmethyl moiety in R<sup>1</sup> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). Second, halogen substitutions in the meta position of the phenyl ring R<sup>2</sup> increase the potency for Mip and FKBP-inhibition compared to unsubstituted analogs. Especially in the case of Mip, a nitrile moiety is advantageous. A pyrimidine ring enhanced affinity just for <i>C. albicans</i> Mip. Modifications in region R<sup>3</sup>, e.g., a substitution of hydroxymethyl to methoxymethyl, have low influence on the affinity, but carbonyl groups decrease the affinity dramatically. Interestingly, all modification regions are independent of each other, apart from hydrogen bond acceptors in regions R<sup>1</sup> and R<sup>2</sup>, which might interact with the same hydrogen donor. Taking everything in consideration, compound <b>34</b> combines many positive substructures for hFKBP and microbial Mips and can be regarded as a new lead structure. Modification of compound <b>34</b> led to the hit compound <b>35</b> for <i>P. falciparum</i> and <i>L. pneumophila</i>, which has high affinity even to multiresistant strains in the case of <i>P. falciparum</i> and shows a dose-dependent reduction of the proliferation of <i>L. pneumophila</i> in human THP-1-monocytes (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). For <i>C. trachomatis</i> the determined IC<sub>50</sub> value of compound <b>33</b> was even lower than the IC<sub>50</sub> of FK506 (<b>3</b>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. New hit compounds for microbial Mip inhibition were found by the screening of known human FKBP inhibitors. Compound <b>33</b> represents an exclusive inhibitor of the <i>Chlamydia</i> Mip protein, whereas compound <b>34</b> combines many advantageous structural elements for a broad spectrum of microbial Mip proteins and, with some modification, becomes a potent inhibitor of <i>Plasmodium</i> and <i>Legionella</i> Mip.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A multipronged approach to the design of inhibitors against the macrophage infectivity potentiator proteins has led to the development of compounds with relatively high levels of efficacy against these bacterial proteins. <i>In vitro</i> efficacy has been demonstrated for numerous generations of compounds across a multitude of bacterial species, many of which are antibiotic resistant. Moving forward, the broad-spectrum effects of these compounds would need to be demonstrated, as well as preclinical efficacy studies. The specificity of lead compounds to eukaryotic FKBPs would also need to be investigated for any possible off target effects. To summarize, lead compounds demonstrating efficacy against multiple pathogenic bacteria have been successfully synthesized with exciting future prospects.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Cyclophilins in Bacteria</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first reports on the role of cyclophilins in <i>B. subtilis</i> and <i>E. coli</i> started in the early 1990s.<a onclick="showRef(event, 'ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref93 ref94 ref95">(93−95)</a> Since then, technology has drastically evolved and so has our understanding of the pleiotropic role of immunophilins within pathogenic bacteria. As previously mentioned, bacteria possess a maximum of two cyclophilins, unlike the human genome which encodes for 17 cyclophilin paralogues,<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96,97)</a> perhaps a reflection of the complexity of the organism and the number of PPIases required to function. In bacteria, cyclophilin A (PpiA) is located in the periplasm and outer membrane in Gram-negative and Gram-positive bacteria, respectively. Also present is cyclophilin B (PpiB) which is located in the cytoplasm. Interestingly PpiB is present in all bacteria, unlike PpiA which has, in some instances, been completely lost, for example, in <i>Clostridioides difficile</i> and <i>B. subtilis</i>, indicating differences in the relative importance of PpiB and PpiA with the latter playing a less significant role.<a onclick="showRef(event, 'ref95 ref98'); return false;" href="javascript:void(0);" class="ref ref95 ref98">(95,98)</a> Gene deletion studies of either PpiA or PpiB in bacteria suggests pleiotropic functions of these cyclophilins in protein folding, stress response, motility, and virulence. As such, bacteria with gene deletions in either of these cyclophilins display an array of phenotypes ranging from indistinguishable to parental strains to complete attenuation in animal models clearly demonstrating the variable and, in some instances, essential roles of cyclophilins in the virulence of pathogenic bacterial species (summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of the Known Functions of Cyclophilins in Bacteria<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0030.gif" alt="" id="GRAPHIC-d7e2191-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>1</sup></sup><p class="last">Cellular location: CM, cytoplasm; PM, periplasm; SX, surface exposed.</p></div><div class="footnote" id="t4fn2"><sup><sup>2</sup></sup><p class="last">Protein size (kDa) and cellular location were ascertained from the associated references where possible; if not, UniProt, NCBI, and the algorithm PSORTb were used to determine kDa and cellular location.</p></div></div><div></div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Role of Cyclophilins in Gram-Positive Bacteria</h3><div class="NLM_p">In Gram-positive bacteria, the commonly surface-exposed PpiA, also known as SlrA in the <i>Streptococcus</i> spp., have been shown to be important for internalization into mammalian cells. Both in <i>Streptococcus mutans</i><a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> and <i>Streptococcus gordonii</i><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a><i>slrA</i> gene deletion mutants have increased internalization into phagocytic cells compared to wild-type; however, interestingly, no change in intracellular survival was observed. Using animal models of infection deletion of the PpiA homologues, <i>slrA</i> and <i>Ef1534</i>, in <i>Streptococcus pneumoniae</i> and <i>Enterococcus faecalis</i>, respectively, resulted in attenuation and increased animal survival demonstrating the importance of cyclophilin A in these species for virulence.<a onclick="showRef(event, 'ref101 ref103'); return false;" href="javascript:void(0);" class="ref ref101 ref103">(101,103)</a> Bhaduri et al. demonstrated that PpiA of <i>M. tuberculosis</i> was phylogenetically and structurally closer to human cyclophilin A rather than other prokaryotic cyclophilin A proteins.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Furthermore, <i>M. tuberculosis</i> PpiA contained a unique N terminal signal sequence “MADCDSVTNSP”, absent in nonpathogenic <i>Mycobacterium</i> species, and is vital for secretion of PpiA to interact with the host proteins. Further details of the interactome of secreted PpiA of <i>Mycobacterium tuberculosis</i> investigated using a bacterial two-hybrid system identified interactions with human lung proteins involved in iron storage, signal transduction, and immune response.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> This is the first study that shows how pathogens have evolved to use their cyclophilins to their advantage, in this case to function as an effector mimic against the host cyclophilin A. Further studies like this are required to explore this interaction in detail and to understand how this ultimately impacts the virulence of certain pathogenic bacteria in host and animal infection models.</div><div class="NLM_p last">The cytoplasmic cyclophilins in Gram-positive bacteria have a more subtle effect on the cell. In <i>B. subtilis</i> deletion of the <i>ppiB</i> gene shows no discernible phenotype under any conditions tested.<a onclick="showRef(event, 'ref39 ref94 ref95 ref99'); return false;" href="javascript:void(0);" class="ref ref39 ref94 ref95 ref99">(39,94,95,99)</a> In contrast, deletion of the sole cyclophilin gene, <i>ppiB</i>, in <i>C. difficile</i> reduces cysteine tolerance and increases eukaryotic cell cytotoxicity associated with toxin production.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Reflecting the diverse roles of immunophilins, unlike in most studies to date, deletion of <i>ppiB</i> gene in <i>C. difficile</i> results in the strain causing increased toxicity in host cells rather than attenuation as observed in other pathogens, with further studies needed to establish if this is also the case <i>in vivo</i>. In <i>Staphylococcus aureus</i> PpiB is required for the efficient folding and secretion of secreted nuclease and hemolysin, both of which are important virulence factors for optimal infection. This was confirmed using the mouse infection model where the <i>S. aureus</i>Δ<i>ppiB</i> mutant was attenuated with decreased bacterial burdens in all studied organs.<a onclick="showRef(event, 'ref105 ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref105 ref106 ref107">(105−107)</a> These two pathogens indicate that cytoplasmic cyclophilins in Gram-positive bacteria play a role in either folding secreted virulence factors directly or regulating secretory pathways which pathogens utilize to invade host cells and cause disease; further research is required to determine the exact mechanisms behind this.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Role of Cyclophilins in Gram-Negative Bacteria</h3><div class="NLM_p">In Gram-negative bacteria the periplasmic cyclophilins appear to play a lesser role in virulence compared to their cytoplasmic counterparts. In <i>L. pneumophila</i> and <i>Acinetobacter baylyi</i> deletion of their periplasmic cyclophilins, <i>Lpg1962</i> and <i>rotA</i>, respectively, resulted in no phenotype under the tested conditions.<a onclick="showRef(event, 'ref109 ref115'); return false;" href="javascript:void(0);" class="ref ref109 ref115">(109,115)</a> In <i>E. coli</i> deletion of the <i>ppiA</i> gene results in increased swimming motility and biofilm production; the latter was independent of its PPIase activity.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Meanwhile, in <i>Brucella abortus</i>, the causative agent of brucellosis, both cyclophilins CypA (PpiA) and CypB (PpiB) were essential for virulence with increased susceptibility to cellular stresses and decreased ability to cause chronic infection in hamsters shown. The reduction in virulence was restored when complementation studies were done with either cyclophilin indicating cyclophilins from <i>B. abortus</i> play a similar, interchangeable role.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></div><div class="NLM_p">The cytoplasmic cyclophilin, PpiB, in <i>E. coli</i> is a negative modulator of biofilm production, swarming and swimming motilities with a <i>ppiB</i> gene deletion strain showing increased biofilm production and motility,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> with modulation of swimming motility found to be independent of the PPIase activity of PpiB.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a><i>L. pneumophila</i> Lcy (PpiB) is important for tolerance to cold temperatures with the <i>Δlcy</i> mutant strain displaying reduced growth at 16 °C. This mutant was also attenuated in an <i>Acanthaeomba castellanii</i> model of infection.<a onclick="showRef(event, 'ref50 ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref50 ref109 ref110">(50,109,110)</a> Rasch et al. determined that Lcy and the FKBP, Mip, are able to partially compensate for the loss of the other protein, indicating that there is interplay between the different families of immunophilins within bacterial cells.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">One of the most exciting phenotypes seen was in the cytoplasmic cyclophilin B mutant in <i>B. pseudomallei</i>, <i>BpsΔppiB</i>, which was interestingly avirulent in the mouse model of infection. On closer examination, PpiB is critical for replication in macrophages and the formation of multinucleated giant cells, which is the main mechanism by which <i>B. pseudomallei</i> successfully spreads intracellularly. These results strongly suggest that the <i>ppiB</i> gene is essential for <i>B. pseudomallei</i> to cause disease in mice. To identify which pathways had been disrupted in <i>BpsΔppiB</i>, proteomic analysis was conducted and demonstrated proteome-wide disruptions of multiple virulence pathways including type 6 secretion systems, important for <i>B. pseudomallei</i> virulence.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p last">Cyclophilins play a pleiotropic role in bacteria which is apparent with the vast array of phenotypes displayed in gene deletion studies. Instances of opposing phenotypes such as between <i>E. coli</i> PpiB and <i>B. pseudomallei</i> PpiB, where biofilm production and motility have an opposite effect upon deletion of PpiB, demonstrate that our knowledge of the function of cyclophilins in bacteria remains in its infancy. What is abundantly clear is that, although not always essential, cyclophilins maintain a balance within a cell and their loss leads to pathogenic bacteria being unable to cause infection to the same degree as wild-type strains.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Potential To Develop Inhibitors of Bacterial Cyclophilins</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Targeting cyclophilins in bacteria has not been thoroughly investigated, probably due to the lack of information on the essentiality of these proteins and therefore their potential as therapeutic targets. A large amount of studies have been conducted to target human cyclophilin A as a novel antiviral. This work will be discussed here to stimulate research into adapting some of this technology for novel antibacterial studies. As shown with PpiB from <i>B. pseudomallei</i>, targeting this cyclophilin would be successful in disabling the bacterium from causing serious infection, a key strategy in our fight against multidrug resistant bacteria.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Overview of Human-Based Cyclophilin A Inhibitors for HCV/HBV Infections</h3><div class="NLM_p">The peptidic macrocycle cyclosporin A (CsA (<b>5</b>), <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), first isolated from broths of the insect-pathogenic fungus <i>Tolypocladium inflatum</i>,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> binds strongly to cyclophilins.<a onclick="showRef(event, 'ref8 ref80'); return false;" href="javascript:void(0);" class="ref ref8 ref80">(8,80)</a> CsA (<b>5</b>) has noncytotoxic immunosuppressant activity <i>in vivo</i>, by reversibly inhibiting cytokine secretion from stimulated T-cells.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> CsA (<b>5</b>) achieves this by simultaneously binding to the active site of cyclophilin A (hCypA) and interacting with the protein calcineurin, inhibiting its phosphatase activity.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> However, dividing CsA (<b>5</b>) into separate cyclophilin and calcineurin binding domains is not entirely accurate (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The large macrocycle is very flexible and bulky and even substitution at the P1-position can lead to decreased calcineurin binding, as this group extends from the cyclophilin binding interface to a region very near the calcineurin-binding region.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> Moreover, substitution at the P4-position can have an impact on cyclophilin binding.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> So far, CsA (<b>5</b>) is the only approved drug that inhibits cyclophilins, but its immunosuppressive activity limits its clinical uses to transplantation and autoimmune diseases.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> However, new natural cyclic peptides like NIM811 (<b>36</b>) have been discovered, which strongly inhibit hCypA but lack the ability to bind calcineurin, thereby lacking in immunosuppressive properties (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Further studies with peptides such as NIM811 (<b>36</b>) have demonstrated that human cyclophilins are involved in diseases such as asthma, cancer, and even viral infections.<a onclick="showRef(event, 'ref126 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128">(126−128)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Structures of Cyclosporin A (CsA, <b>5</b>) and Its Nonimmunosuppressive Analogues Alisporivir (<b>37</b>), SCY-635 (<b>38</b>), NIM811 (<b>36</b>), and NIM258 (<b>39</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0031.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p last">Certain viruses rely heavily on host cyclophilins, as their genome does not encode all of the necessary proteins essential for their survival and replication in host cells.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Several cyclophilins are known to contribute to the life cycle of hepatitis C virus (HCV) with strong evidence that hCypA interacts with the viral NS5A protein to stimulate viral RNA replication.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> In contrast to most direct-acting antiviral (DAA) drugs, significant resistance to cyclophilin inhibitors, so-called host-targeting antivirals (HTA), is rarely observed and cyclophilin inhibitors are effective across all HCV genotypes.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129,130)</a> For human immunodeficiency virus (HIV) and HCV, participation of cyclophilins in viral amplification has been well documented and the effectiveness of compound treatment in clinical trials has been proven.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Unfortunately for HIV, there are naturally occurring coat protein mutants that are resistant to treatment with cyclophilin inhibitors, restricting their use against HIV.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Lack of these natural coat proteins in HCV means that cyclophilin inhibitors are a very promising treatment option. Three compounds have been studied in clinical trials, NIM811 (<b>36</b>), alisporivir (<b>37</b>), and SCY-635 (<b>38</b>), with each showing good therapeutic efficacy (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132,133)</a> However, all cyclophilin inhibiting drug candidates faced obstacles that stopped their development.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The first nonimmunosuppressive cyclophilin inhibitor to enter clinical trials, alisporivir (<b>37</b>), was associated with hyperbilirubinemia, an increase in circulating levels of conjugated and unconjugated bilirubin, in a subset of patients which was attributed to inhibition of transporters.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> CsA (<b>5</b>), alisporivir (<b>37</b>), NIM811 (<b>36</b>), and the other early cyclosporin analogues are potent inhibitors of important endogenous biological transporters such as organic anion transporting polypeptide OATP1B1, multidrug-resistance-associated protein MRP2, and multidrug resistance protein MDR1.<a onclick="showRef(event, 'ref124 ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref124 ref132 ref133">(124,132,133)</a> Inhibition of these transporters can cause drug–drug interactions and interfere with the normal excretion of biomolecules,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> which is critical, because addition of cyclophilin inhibitors such as alisporivir (<b>37</b>) or NIM811 (<b>36</b>) to pegylated IFN-α (PegIFN-α) and ribavirin (RBV) can improve their efficacy in HCV therapy significantly.<a onclick="showRef(event, 'ref132 ref134'); return false;" href="javascript:void(0);" class="ref ref132 ref134">(132,134)</a> Sweeney et al. from Novartis have tried to address the transporter liability associated with alisporivir (<b>37</b>) and developed NIM258 (<b>39</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).<a onclick="showRef(event, 'ref124 ref135'); return false;" href="javascript:void(0);" class="ref ref124 ref135">(124,135)</a> The Novartis group showed that a methyl group at the P3 position improves Cyp binding affinity.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Moreover, a β-branched side chain at the P4 position also enhances Cyp binding affinity and decreases calcineurin interaction. More importantly, P4 substitution with hydrophilic, amine-containing analogues decreases transporter interactions and improves pharmaceutical properties.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Compared to alisporivir (<b>37</b>), NIM258 (<b>39</b>) has a better <i>K</i><sub>D</sub> = 1.2 nM to hCypA (CsA (<b>5</b>), <i>K</i><sub>D</sub> = 2.2 nM), a slightly better inhibition of replication of a subgenomic HCV replicon (EC<sub>50</sub> = 40 μM, compared to CsA (<b>5</b>), EC<sub>50</sub> = 46 nM), and a decreased inhibition of OATP1B1 transporter activity (<i>K</i><sub>i</sub> = 6.1 μM, compared to CsA (<b>5</b>), <i>K</i><sub>i</sub> = 0.8 μM).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> All in all, new cyclosporins have promising pharmacokinetic profiles in preclinical species, are not immunosuppressive <i>in vitro</i>, and have good potency in cellular antiviral assays.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Sanglifehrins</h3><div class="NLM_p">The sanglifehrins are another class of immunosuppressive macrocyclic natural products that bind to cyclophilins.<a onclick="showRef(event, 'ref123 ref136'); return false;" href="javascript:void(0);" class="ref ref123 ref136">(123,136)</a> Like the cyclosporins, sanglifehrin A (SfA, <b>40</b>, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), the most abundant member of this class of molecules, binds to hCypA about 60 times stronger than CsA (<b>5</b>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> SfA (<b>40</b>) binds in the active site of cyclophilin A,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> but immunosuppressive activity is not caused by calcineurin binding (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Additionally, there is no inhibition of mTOR or of the purine/pyrimidine <i>de novo</i> synthesis.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> The mechanism of immunosuppression seems to be connected to dendritic cell (DC) chemokine and migration inhibition but remains to be fully elucidated.<a onclick="showRef(event, 'ref123 ref138'); return false;" href="javascript:void(0);" class="ref ref123 ref138">(123,138)</a> Degradation studies on SfA (<b>40</b>) revealed that removal of the C24 polyketide side chain (corresponding to R<sup>1</sup> in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) eliminated the immunosuppressive properties of the molecule while maintaining the nanomolar binding affinity to hCypA, -B, and -C.<a onclick="showRef(event, 'ref128 ref136 ref140'); return false;" href="javascript:void(0);" class="ref ref128 ref136 ref140">(128,136,140)</a> One of these nonimmunosuppressive sanglifehrins, AAE931 (<b>41</b>, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), showed potent anti-HCV activity in the replicon assay (IC<sub>50</sub> = 130 nM).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Structures of Sanglifehrin A (SfA, <b>40</b>) and the Nonimmunosuppressive Sanglifehrin Analogues AAE931 (<b>41</b>) and NVP018 (<b>42</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0032.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">Investigation of the X-ray crystal structure of a nonimmunosuppressive analogue of AAE931 (<b>41</b>) complexed with hCypA revealed that the unique piperazic acid functionality occupies the same hydrophobic pocket as the Val11 of CsA (<b>5</b>), while some additional important hydrophobic interactions are maintained between hCypA and the valine group of the sanglifehrin analogue.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Thus, this part of the ligand is also known as the recognition domain (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> The C13–C26 fragment, also known as the spacer domain, extends on the surface of the complex and plays a critical role in maintaining the molecule in the optimal three-dimensional conformation.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Researchers at Biotica converted the C26–C27 oxidative cleavage intermediate to the corresponding amides, which led to a series of compounds, termed sangamides, with potent antiviral activity.<a onclick="showRef(event, 'ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref141 ref142">(141,142)</a> The sangamide NVP018 (<b>42</b>) is more potent against anti-HCV and anti-HIV cellular assays than alisporivir (<b>37</b>) and more importantly is only a weak inhibitor of OATP1B1 and OATP1B3. Unfortunately, NVP018 (<b>42</b>) seems to be still poorly orally bioavailable in mouse pharmacokinetic experiments.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><div class="NLM_p">In an earlier publication Mackman et al. described two initial leads <b>43</b> and <b>44</b> (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) derived from the sanglifehrin A analogue AAE931 (<b>41</b>), with potent hCypA inhibition and modest anti-HCV activity but poor pharmacokinetics.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> In a more recent article, Mackman et al. reported the structure-guided optimization of the sanglifehrin <b>44</b> to the highly orally bioavailable macrocycle <b>45</b>, which was performed in three steps.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> First, the styrene moiety was replaced by isoquinoline and the size of the macrocycle was reduced to a 21-membered ring. These modifications improved binding affinity and anti-HCV replicon potency while lowering human plasma protein binding. In a second step, the C1 lactone and C13 lactam groups were switched and isoquinoline was changed to quinoline, which introduced an intramolecular hydrogen bond (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>), resulting in significantly improved membrane permeability leading to high oral absorption. In a final step, modification of the C14 substituents to a spiro-1,3-dioxane lowered log <i>D</i>, reduced oxidative metabolism, and reduced pregnane X receptor (PXR) related drug–drug interactions. This macrocycle <b>45</b> demonstrates potent CypA inhibition (<i>K</i><sub>D</sub> = 5 nM), potent anti-HCV 2a activity (EC<sub>50</sub> = 98 nM), and high oral bioavailability in rats (100%) and dogs (55%).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Sangliferin <b>41</b> derived Cyp A inhibiting macrocycles <b>43</b> and <b>44</b> were turned to the highly orally bioavailable macrocycle <b>45</b> by structure guided optimization by Mackman et al.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Small Molecule Cyclophilin Inhibitors</h3><div class="NLM_p">The existing macrocyclic inhibitors, derived from CsA (<b>5</b>) or SfA (<b>40</b>), have disadvantages, which are related to their size, such as a high synthetic effort, poor cell permeability, and drug–drug interactions because of transporter inhibition.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Recent studies revealed that large, hydrophobic peptides are often OATP inhibitors.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> To overcome these disadvantages, Gouichou et al. focused on developing small molecule inhibitors.<a onclick="showRef(event, 'ref145 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref145 ref146 ref147">(145−147)</a> Using a fragment-based drug design (FBDD) approach, in which over 34 409 fragments were screened to fit into the CypD binding pocket, they identified two lead fragments in the initial step.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Superimposition of those fragments with the known structures of CsA (<b>5</b>) and SfA (<b>40</b>) suggested that a urea moiety could be used as a linker between the two fragments because of one hydrogen bond with Gln63 and two with Asn102.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Further structure-based compound optimization included the introduction of a thiomethyl group, which increased binding affinity by establishing a transient contact with Arg55 Nε. Addition of a phenyl ring adjacent to the urea group and the carbonyl function stabilized the bioactive conformation by a π–π interaction between the two phenyl moieties and a 3-fold gain of anti-PPIase activity was achieved, resulting in hit compound <b>46</b> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Overall, Guichou et al. was able to generate a new family of nonpeptidic, small-molecule cyclophilin inhibitors, unrelated to CsA (<b>5</b>) or SfA (<b>40</b>), which potently inhibit hCypA, CypB, and CypD.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> These small molecules have a potent PPIase inhibitory activity, antiviral activity against HCV, HIV, and coronaviruses <i>in vitro</i>, and druggable properties.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures of small molecule cyclophilin inhibitors <b>46</b>, <b>47</b>, and <b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Ni et al. also discovered potent small molecule hCypA inhibitors by using a <i>de novo</i> drug design approach.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Starting with a lead compound containing an acylurea motif (IC<sub>50</sub> = 31.6 ± 2.0 nM, hCypA PPIase), further SAR studies resulted in nanomolar level hCypA inhibitors like compound <b>47</b> with a fluorene site and an ortho bisubstituted phenyl ring, connected with an acylurea-linker (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>). Unfortunately, their compounds were only poorly soluble and gave variable results in the PPIase assays.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Furthermore, no crystallographic structure of the compounds complexed with cyclophilins could be obtained.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Shore et al. made use of the compounds of Guichou et al. as a starting point for further lead optimization targeting hCypD. They established that the <i>R</i>-stereoisomer at the proline ring is the preferred form for binding to hCypD (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Substitutions between the urea and the carbonyl moiety seemed to mimic the (4<i>R</i>)-4-[(<i>E</i>)-2-butenyl]-4-methyl-<span class="smallcaps smallerCapital">l</span>-threonine (Bmt) group of CsA (<b>5</b>), with an <i>S</i>-methionine showing the best affinity. By means of lead optimization, Shore et al. obtained a cyclophilin inhibitor <b>48</b> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) with <i>K</i><sub>i</sub> = 99 nM against hCypD, compared to CsA (<b>5</b>) with <i>K</i><sub>i</sub> = 8.2 nM.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Up to now, all reported cyclophilin inhibitors are potent inhibitors of at least human cyclophilins A, B, and D.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Selective, small molecule inhibitors of cyclophilins would be an interesting tool for further studying cyclophilin biology.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Targeting Bacterial Cyclophilins</h3><div class="NLM_p last">Development of inhibitors against bacterial cyclophilins would require a concerted effort. First, a screen of compounds that have been developed against human cyclophilins could be conducted to identify any lead structures. It is well-known that the bacterial cyclophilin <i>E. coli</i> RotA has a 500-fold greater resistance to CsA binding compared to hCypA which is attributed to the change of a highly conserved tryptophan residue in the enzyme active site to a phenylalanine.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The tryptophan residue is highly conserved in eukaryotic cyclophilins, and interestingly this tryptophan to phenylalanine change is widely distributed in bacterial cyclophilin sequences, a change that could be exploited to create compounds with increased efficacy and specificity to bacterial cyclophilins. Additionally, a fragment-based drug design (FBDD) approach could be adopted to develop compounds with bacterial cyclophilin inhibition in order to determine the best scaffold upon which to elaborate. Ideally a compound that can specifically bind to bacterial cyclophilins while having low affinity to hCyp’s should be developed, but the use of cyclophilin inhibitors as HTA’s indicates that low binding affinity to human cyclophilins could be tolerable to the human body upon administration.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Parvulins</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parvulins were formally identified in 1994 by Rahfeld et al.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> and represent the most recent addition to the immunophilin superfamily, although it must be acknowledged that various parvulins had been studied by earlier groups but not based on their PPIase activity. Parvulins have been well researched in relation to their chaperone ability, with the role of individual parvulins difficult to determine at times due to many studies looking at genetic mutation strains containing multiple gene deletions, making it unclear as to the exact role of the parvulin protein.<a onclick="showRef(event, 'ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref150 ref151">(150,151)</a> However, numerous studies have also investigated the role of individual parvulins in bacterial virulence, and these will be discussed here (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Summary of the Known Functions of Parvulins in Bacteria<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">()</a><a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0033.gif" alt="" id="GRAPHIC-d7e3026-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0034.gif" alt="" id="GRAPHIC-d7e3027-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>1</sup></sup><p class="last">Cellular location: PM, periplasm; IM, inner membrane; SX, surface-exposed.</p></div><div class="footnote" id="t7fn2"><sup><sup>2</sup></sup><p class="last">Protein size (kDa) and cellular location were ascertained from the associated references where possible; if not, UnitProt, NCBI, and the algorithm PSORTb were used to determine kDa and cellular location.</p></div></div><div></div></div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Parvulins in Gram-Positive Bacteria</h3><div class="NLM_p"><i>B. subtilis</i> utilizes the parvulin, PrsA, to fold post-translocated exoproteins into their correct formation,<a onclick="showRef(event, 'ref156 ref157 ref158 ref161'); return false;" href="javascript:void(0);" class="ref ref156 ref157 ref158 ref161">(156−158,161)</a> with deletion of the gene leading to decreased secretion of mature α-amylase and the protease subtilisin.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a><i>B. subtilis</i> PrsA mutants also display a decrease in secreted proteins as well as changes with cellular morphology resulting in filament formation prior to cell lysis.<a onclick="showRef(event, 'ref158 ref160'); return false;" href="javascript:void(0);" class="ref ref158 ref160">(158,160)</a> These results indicate that PrsA plays a pivotal role in controlling the folding and secretion of essential proteins in <i>B. subtilis</i>. This phenotype was found to be the result of PrsA folding penicillin binding proteins (PBPs) which in <i>B. subtilis</i> are responsible for lateral cell wall growth as a cell divides.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> This lethality is independent of PPIase activity with complementation of enzymatically inactive PrsA capable of rescuing cell death.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Similarly in <i>S. aureus</i> a PrsA mutant was found to have decreased secreted protease and phospholipase activity.<a onclick="showRef(event, 'ref105 ref107'); return false;" href="javascript:void(0);" class="ref ref105 ref107">(105,107)</a> It also displayed an increased rate of autoaggregation and more readily adhered to A549 epithelial cells. Reports on attenuation of virulence are conflicting with Keogh et al.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> seeing no attenuation in virulence in an abscess and systematic model of infection, while Lin et al. reported a substantial decrease in animal mortality in an intravenous model of infection with a <i>S. aureus prsA</i> mutant.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Additionally an increased susceptibility to cephalosporin antibiotics as well as oxacillin (<b>49</b>) and the glycopeptides teicoplanin (<b>50</b>) and vancomycin (<b>51</b>) was observed in the <i>S. aureus prsA</i> mutant (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152,153)</a> Membrane-bound levels of PBP2A were also significantly decreased,<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> explaining the increase in susceptibility and indicating that PrsA is involved in the folding of PBPs in <i>S. aureus</i> as well as in <i>B. subtilis</i>. Furthermore, in <i>S. aureus</i> PrsA expression is transcriptionally controlled by VraRS two-component system in response to cell-wall stress.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of the antibiotics oxacillin (<b>49</b>) and the glycopeptides teicoplanin (<b>50</b>) and vancomycin (<b>51</b>) to which an increased susceptibility was observed in the <i>S. aureus</i> prsA mutant.<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152,153)</a> The antibiotic ampicillin (<b>52</b>) was also found to have an increased efficacy against <i>E. faecalis</i>Δ<i>ef0685</i>Δef1534.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The antibiotic, penicillin G (<b>53</b>), displayed increased efficacy in the PrsA2 mutant, indicating that PrsA2 was involved in PBP folding, thus mediating penicillin G resistance.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In <i>S. pneumoniae</i> the parvulin PpmA, putative proteinase maturation protein A, is a surface associated lipoprotein important for pneumococcal colonization of the murine nasopharynx in CD-1 mice. The mutant was also more readily taken up by both human polymorphonuclear (PMNs) and murine macrophage cells, suggesting a role in immune evasion.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Sharing homology to <i>S. pneumoniae</i> PpmA is the protein Ef0685 from <i>E. faecalis</i> and is the only parvulin encoded by this bacteria.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Deletion of the <i>ef0685</i> gene in <i>E. faecalis</i> results in increased susceptibility to osmotic stress, with this susceptibility heightened when double mutations in both <i>ef0685</i> and the cyclophilin encoding gene <i>ef1534</i> were made. This double mutant was also more susceptible to ampicillin (<b>52</b>, <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) and interestingly more resistant to quinolone-derived antibiotics.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> In a <i>Galleria mellonella</i> model of infection, the <i>E. faecalis ef0685</i> gene deletion mutant was highly attenuated, with 90% larvae survival compared to ∼15% of those infected with a wild-type strain surviving. Infection of Caco-2/T7 epithelial cells resulted in low levels of cell cytotoxicity indicating that the parvulin Ef0685 in <i>E. faecalis</i> is involved in cellular cytotoxicity.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Ef0685 was also found to be a protective antigen against <i>E. faecalis</i> infections in mice, indicating it is either secreted or present on the outer membrane and is potentially a vaccine candidate.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></div><div class="NLM_p"><i>Listeria monocytogenes</i> encodes for two PrsA homologues, PrsA1 and PrsA2. Deletion of the <i>prsA2</i> gene in <i>L. monocytogenes</i> results in decreased invasion of murine macrophages, an 80% reduction in plaque size in L2 fibroblast cells, and decreased levels in secreted factors listeriolysin O (LLO) and a broad-specificity phospholipase (PC-PLC) both of which are important for virulence in <i>L. monocytogenes</i>. The <i>prsA2</i> gene is also important for establishing an infection <i>in vivo</i> with the mutant strain demonstrating a 5- and 6-log decrease in bacterial burden seen in the liver and spleens, respectively, of Swiss mice using an intravenous model of infection.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> An increase in sensitivity to penicillin G (<b>53</b>) (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>) was also observed in the PrsA2 mutant, indicating that PrsA2 was involved in PBP folding, as shown with several other parvulin proteins.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Interestingly, PrsA1 does not play a role in the virulence of <i>L. monocytogenes</i>.<a onclick="showRef(event, 'ref162 ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref162 ref163 ref164">(162−164)</a></div><div class="NLM_p last">These studies demonstrate the importance of parvulins in the virulence of a number of pathogenic Gram-positive bacteria. As discussed, multiple bacteria use PrsA to fold PBPs during bacterial cell division, resulting in abhorrent cell shape and an increase in susceptibility to cell-wall attacking antibiotics.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Parvulins in Gram-Negative Bacteria</h3><div class="NLM_p"><i>E. coli</i> is perhaps the most studied organism in the field of parvulin research, probably due to the ease of handling, manipulation, and availability of molecular tools and libraries such as the easily accessible Keio library.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Mutations in the <i>E. coli</i> parvulin gene <i>surA</i> have a slightly increased doubling time of 60 min at 30 °C (vs 45 min) and are also highly susceptible to novobiocin (<b>54</b>, <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) and detergents, indicating membrane instability and a change in the composition of outer membrane proteins (OMP).<a onclick="showRef(event, 'ref30 ref56'); return false;" href="javascript:void(0);" class="ref ref30 ref56">(30,56)</a> Increased susceptibility to novobiocin (<b>54</b>) was also seen in a SurA mutant constructed in a uropathogenic strain of <i>E. coli</i>, UTI89. This pathogenic strain of <i>E. coli</i> also displayed a decrease in hemeagglutination of guinea pig erythrocytes as well as a reduction in binding and invasive ability against 5637 human bladder epithelial cells.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> A quad mutant of <i>E. coli</i> with deletions in periplasmic cyclophilin, FKBP, and parvulins (ppiA, fkpA, ppiD, surA) displayed a diminished growth defect in media.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Compared to the <i>E. coli surA</i> mutant, the quad mutant strain had enhanced susceptibility to novobiocin (<b>54</b>), bacitracin (<b>55</b>, <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), and vancomycin (<b>51</b>), indicating that there is a degree of overlap between the functions of all the periplasmic immunophilins.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> SurA is also important for piliation in <i>E. coli</i> with electron microscopy showing that strains lacking SurA were much less piliated and there was a decrease in the outer membrane usher protein, FimD, expression.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Loss of SurA results in altered levels of outer-membrane proteins with the σ<sup>E</sup> factor cell envelope stress response being strongly induced.<a onclick="showRef(event, 'ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref176 ref177">(176,177)</a> PpiD was identified as a parvulin in <i>E. coli</i> that has structural similarities to that of SurA. It is induced during heat shock and localizes to the periplasmic interface of the inner membrane, where it is anchored with a single transmembrane α-helix.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Deletion of the <i>ppiD</i> gene in <i>E. coli</i> results in increased susceptibility to hydrophobic antibiotics such as novobiocin (<b>54</b>), as well as to detergents indicating that there was a loss of membrane integrity in the mutant strain. Interestingly, a double mutant strain of <i>ppiD</i> and <i>surA</i> could not be created, with the loss of both parvulins reportedly leading to synthetic lethality.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> However, a few years later, Justice et al. successfully constructed a double deletion mutant in the same MC4100 <i>E. coli</i> strain.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Membrane preparations show that in both the <i>ppiD</i>- and <i>surA</i> mutant strains there is a change in outer membrane proteins (OMPs), indicating that both of these periplasmic parvulins play a role in either the chaperoning or folding of essential proteins which are directed to the outer membrane.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Due to the fact that many studies on <i>E. coli</i> parvulins have been conducted on K12 derivatives, which are common laboratory strains of <i>E. coli</i>, further investigation needs to be conducted on pathogenic strains, as done by Watt et al.,<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> to determine if the phenotypes seen correlate with infectious strains of the bacterium. Moving into pathogenic, disease-causing strains would also allow investigation into the roles of parvulins <i>in vivo</i> using animal models of infection.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures of antimicrobials novobiocin (<b>54</b>) and bacitracin (<b>55</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>Shigella flexerni</i> lacking <i>surA</i> displayed a reduced ability to produce plaques in Henle epithelial cells, as well as a decreased presentation of the outer membrane protein IcsA (VirG) on its surface.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> The <i>Salmonella enterica</i> serovar Typhimurium <i>surA</i> mutant displayed decreased adhesive and invasive capability in human epithelial type 2 (HEp-2) cells and was highly attenuated when administered orally in BALB/c mouse infection model. Furthermore, mice immunized with <i>S. enterica</i> serovar Typhimurium <i>surA</i> mutant were protected against subsequent infection with wild-type strains 10 weeks postexposure.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a><i>Yersinia pseudotuberculosis</i> mutants of periplasmic PPIases displayed no individual discernible phenotypes apart from a <i>surA</i> mutant which had membrane leakiness and increased susceptibility to vancomycin (<b>51</b>), bacitracin (<b>55</b>), and bile salts, as well as detergents. The <i>Y. pseudotuberculosis surA</i> mutant displayed a 40-fold decrease in its ability to adhere to HeLa epithelial cells.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> In the BALB/c mouse infection model, <i>Y. pseudotuberculosis surA</i> mutant was attenuated, demonstrating asymptomatic disease.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><div class="NLM_p last">Parvulin research in Gram-negatives has focused primarily on the chaperone roles of parvulins in the periplasm. Only a handful of studies have looked at the role of these proteins in bacterial virulence. As highlighted here, it is clear that parvulins are very important in virulence, and further research is required to elucidate their mechanisms of action. Despite this, they show promise as drug targets especially in important bacterial infections caused by pathogens such as UPEC, <i>Shigella flexerni</i>, and <i>Salmonella</i> Typhimurium, bacteria that belong to the family <i>Enterobacteriaceae</i>, which are associated with increased global morbidity and mortality<a onclick="showRef(event, 'ref178 ref179'); return false;" href="javascript:void(0);" class="ref ref178 ref179">(178,179)</a> and have been labeled as a serious threat to human health by the Centers for Disease Control and Prevention (CDC).</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Parvulin Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As with the cyclophilins there is limited research published on inhibitors to bacterial parvulins. In contrast, the human parvulin, PIN1, is a very druggable and attractive target, as it has a well-defined active site and high substrate specificity with limited expression in normal tissues.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180,181)</a> In most human cancers, PIN1 is activated and its overexpression causes chromosome instability and tumorigenesis. PIN1 inhibition or knockout suppresses cancer cell growth <i>in vitro</i> and tumorigenesis in mice.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> In contrast to FK506 (<b>3</b>) binding proteins and cyclophilins, the parvulin family of peptidyl-prolyl <i>cis</i>–<i>trans</i> isomerases cannot be inhibited by FK506 (<b>3</b>) or by cyclosporin A (CsA, <b>5</b>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Therefore, the cancer promoting properties of human PIN1 and its druggability give this target great therapeutic potential. Drug discovery strategies against PIN1 will be summarized here, and their potential to target bacterial parvulins will be discussed.</div><div class="NLM_p">PIN1 binds to phosphopeptides through a positively charged surface, which makes it unique among the PPIases. Therefore, PIN1 inhibitors must navigate this pocket feature by including highly electronegative substituents, which is challenging as the same features often reduce membrane permeability.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> 5-Hydroxy-1,4-naphthoquinone, commonly known as juglone (<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), was the first discovered and most prominent irreversible parvulin inhibitor.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Juglone (<b>6</b>) covalently interacts with the catalytic domain of PIN1, more specifically with the cysteine residue in the catalytic center of the first discovered parvulin in <i>E. coli</i> parvulin Par10 (Cys69) and human <i>h</i>PIN1 (Cys113).<a onclick="showRef(event, 'ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref183 ref184">(183,184)</a> However, juglone (<b>6</b>) has a relatively simple structure that affects its specificity.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> In fact, juglone (<b>6</b>) has several off-target effects and manifests PIN1-independent activities as its 1,4-naphthoquinone moiety covalently modifies all accessible cytoplasmic cysteine residues available in a cell.<a onclick="showRef(event, 'ref181 ref184 ref185'); return false;" href="javascript:void(0);" class="ref ref181 ref184 ref185">(181,184,185)</a> In one approach by Wildemann et al. a combinatorial cellulose-bound peptide library of 5-mer acetylated peptides containing nonproteinogenic amino acids surrounding a <span class="smallcaps smallerCapital">d</span>-phosphothreonine residue was screened against the PPIase domain of PIN1 and bound hits were detected by Western blot.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> With its <i>S</i>-pipecolate core, hit-compound <b>56</b> (<i>K</i><sub>i</sub> = 18 nM; <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) resembles a lot of known FKBP inhibitors. Switching the orientation of the phosphothreonine residue to the <span class="smallcaps smallerCapital">l</span>-isomer resulted in a 30-fold loss in activity (<i>K</i><sub>i</sub> = 550 nM), and removal of the phosphate group disrupted the interaction.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Peptide PIN1 inhibitor <b>56</b> by Wildemann et al., which was discovered by screening a cellulose-bound peptide library of 5-mer acetylated peptides containing nonproteinogenic amino acids surrounding a <span class="smallcaps smallerCapital">d</span>-phosphothreonine.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Shown is a comparison of the active sites of human PIN1 and FKBP complexes. (a) Chemical structure of peptide <b>56</b>. The <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-stereoisomers differ on the marked carbon atom C*. (b) Comparative binding modes of the <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-stereoisomer of peptide <b>56</b> to human PIN1 shown as superimposed images. The <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-isomer-bound structures of PIN1 are identical to each other. The PIN1 amino acid side chains involved in peptide recognition are shown as half-colored bonds with carbon shown in brown for the <span class="smallcaps smallerCapital">d</span>-isomer complex and yellow for the <span class="smallcaps smallerCapital">l</span>-isomer complex. <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-isomers are depicted as half-colored bonds with carbon colored light gray for the <span class="smallcaps smallerCapital">d</span>-isomer and cyan for the <span class="smallcaps smallerCapital">l</span>-form. (c) A close-up view rendered in a slightly different orientation than panel a. (d) Surface of PIN1 complexed with the <span class="smallcaps smallerCapital">d</span>-isomer of <b>56</b>. The intramolecular hydrogen bond (dashed red cylinders) between the carbonyl oxygen of Phe1 and the amide nitrogen of Nal4 defines a bound peptide conformation that closely resembles the conformation and binding mode of rapamycin bound to FKBP depicted in panel d (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKB">1FKB</a>). (e) Rendered 3D structure of the FKBP12/rapamycin complex. In PIN1, the Pip residue forms several hydrophobic interactions with Phe134 and Leu122 in the PIN1 active site. In the FKBP–rapamycin complex this interaction is spatially conserved with Phe46 and Trp59 in human FKBP12 sequestering the Pip moiety of rapamycin.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Reproduced with permission from <i>ACS Chemical Biology</i>, Zhang et al.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Crystallization of both stereoisomers (<span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-form at C*, <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>a) of compound <b>56</b> with PIN1 resulted in almost identical conformations, where the electronegative phosphate group was anchored in the phosphate recognition pocket of the PPIase domain and interacted with Lys63 and Arg69 (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>b,c). While both PIN1 domains, the phosphorylation on Ser or Thr residue WW domain and the PPIase domain, are capable of binding to phosphorylated targets, inhibitor <b>56</b> specifically bound to PIN1’s PPIase domain, leaving the WW domain untouched.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> On basis of their structures, the reasons for the huge difference of the two stereoisomers in binding affinity were not obvious. Interestingly, the PIN1 active site bound to these peptides adopted a conformation that is very similar to FKBP12 bound to rapamycin (<b>4</b>), with both pipecolic rings having almost identical orientations (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>d,e). Since rapamycin (<b>4</b>) has no measurable affinity for PIN1, the affinity of peptide <b>56</b> for PIN1 is likely to depend on the phosphate-binding surface.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Finally, an intramolecular hydrogen bond observed in the peptide <b>56</b>/PIN1 complex mimics the cyclic conformation of FK506 and rapamycin (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>d). Thus, Wildemann et al. suggested that a cyclic peptide polyketide bridge, like that found in FK506 (<b>3</b>) and rapamycin (<b>4</b>) or a similar linkage, may significantly improve the binding affinity of structure-based PIN1 inhibitors.<a onclick="showRef(event, 'ref186 ref187'); return false;" href="javascript:void(0);" class="ref ref186 ref187">(186,187)</a></div><div class="NLM_p">To solve problems of the peptide PIN1 inhibitors for <i>in vivo</i> studies such as proteolytic degradation and poor permeability through the cell membrane, Liu et al. developed several cyclopeptide PIN1 inhibitors.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> In addition, due to its reduced conformational freedom, cyclization can lead to a higher binding affinity and specificity than their linear peptide counterparts. Thus, the Liu group screened a library of cyclic peptides containing a tripeptide core with an electronegative amino acid, an isomerizable hydrophobic residue, and a general hydrophobic, aromatic, or positively charged residue.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Their hit compounds comprised a D-pThr-Pip-Nal (pThr: phosphothreonine) mark in the figure motif, with the flanking residues having only minimal effects on the binding affinity. These cyclic peptides were then rendered cell permeable either by attaching an octaarginine sequence to the side chain using a disulfide linker, which is reduced in the cytosol (compound <b>57</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>), or by direct incorporation of arginine residues into the cyclic peptide backbone (comparable to their later compound <b>58</b>, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>). Even though their first cyclic peptides were relatively potent inhibitors of PIN1 <i>in vitro</i> with IC<sub>50</sub> values in the nanomolar range, they exhibited only a modest antiproliferative activity in cell culture, which indicated poor cell-permeability of the peptides. In subsequent SAR analysis and sequence optimization some structural features of peptides proved to be critical for high cellular entry efficiency such as peptide cyclization, the presence of both arginine and hydrophobic residues, and small ring sizes (≤9 aa).<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> In this way, further work by Bedewy et al. was able to improve compound <b>57</b> to a small, cell-permeable, and biologically active cycloheptapeptide <b>58</b> (see <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> It was suggested that these compounds enter cells by endocytosis and subsequently exit from the endosome into the cytosol by a vesicle budding and collapsing mechanism.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Top: First generation, cyclic peptide PIN1 inhibitor <b>57</b> by Bedewy et al.,<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> attached to an octaarginine sequence using a disulfide linker, which is reduced in the cytosol.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Left: Cell-permeable and biologically active cycloheptapeptide <b>58</b>.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Right: Cell-permeable and metabolically stable nonphosphorylated bicyclic peptide <b>59</b>.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To improve the cell permeability of their cyclic inhibitors, Lian et al. also explored a bicyclic system in which the cell-penetrating peptide (CPP) motif is placed in one ring whereas the target-binding sequence constitutes the other ring.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> This cell-penetrating peptide efficiently escapes the endosome and “delivers” the target-binding peptide to the cytosol (comparable to later, nonphosphorylated compound <b>59</b>).<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> Treatment of cervical cancer HeLa cells with these compounds resulted in inhibited cell growth and increased stability of the PIN1 substrate, promyelocytic leukemia protein (PML). However, the phosphoamino moiety remains susceptible to hydrolysis by the nonspecific phosphatases in human serum and also contributes to a poor membrane permeability. Jiang et al. developed a cell-permeable and metabolically stable nonphosphorylated bicyclic peptide <b>59</b> (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>).<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Although removal of the phoshpoamino group resulted in a reduction in binding affinity <i>in vitro</i>, the improved cell permeability makes compound <b>59</b> a more potent PIN1 inhibitor for <i>in vivo</i> applications.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Thus, treatment of HeLa cells with inhibitor <b>59</b> resulted in dose-dependent inhibition of cell growth (45% inhibition after treatment for 3 days at 20 μM inhibitor), whereas the impermeable predecessors had no effect. Peptides lacking the phosphate group were internalized by HeLa cells around 4-fold more efficiently than their phosphate-containing analogues. Presumably, the negative charged phosphate group interacted electrostatically with the positively charged CPP motif and reduced the cellular uptake efficiency of the latter.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Moreover, compound <b>59</b> inhibited the intracellular PIN1 activity in cultured mammalian cells but had little effect on other isomerases such as PIN4, FKBP12, or cyclophilin A.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a></div><div class="NLM_p">Although competitive assays suggest that compound <b>59</b> binds to the active site of PIN1, future structural studies will hopefully elucidate the exact binding, especially the important binding interactions independent of the phosphate-binding site.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Beyond this, Dougherty’s review is worth mentioning, in which they discuss the challenges and tools in finding cell-penetrating peptides (CPPs).<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></div><div class="NLM_p">By structure-based rational design, a series of peptidomimetic inhibitors of PIN1 have been identified such as conformationally <i>cis</i>-locked phosphorylated peptide-mimetic inhibitors (e.g., compound <b>60</b>, <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>) by Wang et al. and Xu et al.<a onclick="showRef(event, 'ref194 ref195'); return false;" href="javascript:void(0);" class="ref ref194 ref195">(194,195)</a> Core structures of several small-molecule PIN1 inhibitors mostly contain a phosphate group like compound <b>61</b> (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>) by Guo et al.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> or their later inhibitors, where the phosphate was replaced by a carboxylate group.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Potter et al. developed PIN1 inhibiting α-benzimidazolyl-substituted amino acids such as compound <b>62</b>,<a onclick="showRef(event, 'ref198 ref199'); return false;" href="javascript:void(0);" class="ref ref198 ref199">(198,199)</a> which address the phosphate-binding pocket of the PIN1 active site (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>).<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Although compound <b>62</b> has a low affinity in the nanomolar scale <i>in vitro</i>, it is inactive in cells like compounds <b>60</b> and <b>61</b> because the negatively charged phosphate or carboxylate moiety of these inhibitors makes them almost cell impermeable, which is a common problem in the development of new PIN1 inhibitors.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Small molecule, phosphate or carboxylate containing PIN1 inhibitors <b>60</b>, <b>61</b>, and <b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2003, Uchida et al. identified some tetraoxobenzophenanthroline compounds and other similar polycyclic derivatives that competitively blocked PIN1 PPIase activity to low micromolar IC<sub>50</sub> values <i>in vitro</i>. Among these, tetraoxobenzophenanthroline derivative PiB (<b>63</b>, <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) showed the best IC<sub>50</sub> of 1.5 μM, had the least nonspecific toxicity, and inhibited the growth of several cancer lines <i>in vitro</i>.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> Since the low solubility of compound <b>63</b> in DMSO limited studies of its effectiveness as an anticancer agent, the Uchida group screened for more soluble compounds and identified dipentamethylene thiuram monosulfide (DTM, <b>64</b>, <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) as an effective inhibitor of PIN1 PPIase activity.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> However, DTM (<b>64</b>) did not show strong antifungal and/or anticancer activities, inhibiting proliferation of HCT116 colon carcinoma cells only with a half maximal effective concentration (EC<sub>50</sub>) of 10 μM.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structures of the small molecule PIN1 inhibitors PiB (<b>63</b>),<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> DTM (<b>64</b>),<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> and ATRA (<b>65</b>).<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> ATRA (<b>65</b>) is already being used for the medical treatment of acne and acute promyelocytic leukemia (APL).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Wei et al. identified the vitamin A derivative all-<i>trans</i> retinoic acid (ATRA, <b>65</b>, <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>), which had previously been used for the medical treatment of acne and acute promyelocytic leukemia (APL), as a PIN1 inhibitor by mechanism-based drug screening.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> ATRA (<b>65</b>), also known as tretinoin, binds to the proline binding pocket in the catalytic center and inhibits PIN1 at a submicromolar range (<i>K</i><sub>D</sub> = 0.8 μM).<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> The cyclohexene ring anchors into the proline binding pocket, with the alkene chain extending the carboxylic acid into the cationic phosphate binding region.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> By inhibiting PIN1, ATRA (<b>65</b>) induces its degradation and thereby destabilizes its substrate, the fusion oncoprotein promyelocytic leukemia-retinoic acid receptor α (PML-RAR-α), allowing treatment of APL in cell and animal models and even in human patients.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> However, regular ATRA (<b>65</b>) formulation has a very short half-life of only 45 min in humans, limiting its efficacy against solid tumors.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> To overcome these limitations, biodegradable, nontoxic controlled release formulations of ATRA (<b>65</b>) with a longer half-life are under development.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Kozono et al. showed that PIN1 can be synergistically targeted by arsenic trioxide (ATO, <b>66</b>) and ATRA (<b>65</b>), which could be helpful in combating breast and other cancers.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> ATO (<b>66</b>) inhibits and degrades PIN1 and suppresses its oncogenic function by noncovalent binding to PIN1’s active site. While ATRA (<b>65</b>) inhibits PIN1 itself, it increases cellular ATO uptake by up-regulating aquaporin 9. A combination of ATO (<b>66</b>) and ATRA (<b>65</b>) cooperatively inhibits PIN1 to block numerous cancer-driving pathways and inhibits the growth of triple-negative breast cancer cells and tumor-initiating cells in cell and animal models.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a></div><div class="NLM_p">The major flavonoid in green tea, epigallocatechin-3-gallate (EGCG, <b>67</b>, <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>), a heavily studied cancer chemopreventative, inactivates PIN1 by blocking the binding sites for pSer-Pro substrates within the PPIase and especially the WW-domain.<a onclick="showRef(event, 'ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref206 ref207">(206,207)</a> In 2017, Campaner et al. developed the covalent PIN1 inhibitor KPT-6566 (<b>68A</b>, <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>).<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> It irreversibly blocks the active catalytic center of PIN1 by transferring its sulfanyl-acetate moiety to PIN1 Cys113, forming a disulfide bridge to the cysteine residue and leading to the byproduct KPT-6566B (<b>68B</b>, <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>). This species, in turn, being released in the cellular compartment, interacts with different cellular molecules. Both structures contain a quinone-mimicking substructure with the potential to generate reactive oxygen species (ROS) like H<sub>2</sub>O<sub>2</sub> and induce oxidative stress response.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> In addition, KPT-6566-B (<b>68B</b>) is a highly reactive electrophile that can interfere with different nucleophilic species in the cancer cells, in which PIN1 is overexpressed, causing DNA damage by forming DNA adducts and ultimately leading to cell death.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> Campaner et al. observed a strong suppression of all tested cancer-related phenotypes depending on PIN1 function, namely, proliferation, colony formation, invasion, and cancer stem cells (CSC) maintenance, caused by the simultaneous impairment of several PIN1 targets. In contrast to juglone (<b>6</b>) or PiB (<b>63</b>), which also exert their effect through parvulin-14-inhibition, KPT-6566 (<b>68A</b>) is highly specific toward PIN1 and mainly ineffective in cells deprived of PIN1.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of the small molecule PIN1 inhibitors EGCG (<b>67</b>) and KPT-6566 (<b>68A</b>) and its byproduct KPT-6566-B (<b>68B</b>).<a onclick="showRef(event, 'ref183 ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref183 ref206 ref207">(183,206,207)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although many PIN1 inhibiting molecules, mainly noncovalent inhibitors, have been discovered to date, none of them have reached clinical trials due to poor pharmacological performance in terms of potency, selectivity, solubility, cell permeability, and stability.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Furthermore, there are complications in terms of possible long-term side effects of PIN1 inhibition. Ho-Lee et al. demonstrated that PIN1 has an essential and conserved role in regulating telomeric repeat-binding factor 1 (TRF1) stability, telomere maintenance and aging, especially preventing neurodegeneration.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> In PIN1<sup>–/–</sup> mice they noticed an accelerated telomere loss and a wide range of premature-aging phenotypes from which they concluded a pivotal role of PIN1 in preventing aging. Furthermore, Atchison et al. found that PIN1 regulates the timing of proliferation of primordial germ cells (PGCs) during mouse embryonic development. PGCs give rise to male and female germ cells to transmit the genome from generation to generation, and defects in PGC development often result in infertility. In fact, both the male and female PIN1<sup>–/–</sup> mice had profound fertility defects.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> Results like those from Ho-Lee et al. and Atchison et al. suggest that PIN1 inhibition could have long-term side effects such as neurodegeneration, Alzheimer’s disease, and infertility. However, on a positive note, short-term cancer treatment with PIN1 inhibitors could be free of these side effects, especially if the inhibitors cannot pass through the blood–brain barrier and blood–testis barrier.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a></div><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Targeting the Bacterial Parvulins</h3><div class="NLM_p">As previously mentioned, there are limited studies on the effect of inhibitors on bacterial parvulins. Structural studies have indicated that the peptide binding region of <i>E. coli</i> SurA and PpiD adopts a homologous shape to that of PIN1,<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> although there is a range of reported catalytic activities due to slight variations in sequence. Similar to cyclophilins and cyclophilin inhibitors, a screen of to-date PIN1 inhibitors would need to be conducted to determine if any are capable of binding to and inhibiting PPIase and chaperone activity of bacterial parvulins. Cocrystal structures with any inhibitor hits would allow for a more targeted approach to optimizing compounds to allow for increased specificity to bacterial proteins rather than the human equivalents. If this approach was unsuccessful in identifying lead compounds, a structure-based drug design could be employed in order to find an initial scaffold upon which further generations of inhibitors could be designed.</div><div class="NLM_p last">The evidence to date suggests that parvulins are heavily involved in bacterial membrane stability. They are therefore attractive antibacterial targets; inhibitors to bacterial parvulins potentially will destabilize and weaken bacteria, and when used in combination with current antibiotics, they may render them highly effective against antibiotic resistance bacteria.<a onclick="showRef(event, 'ref101 ref162 ref163 ref164 ref172'); return false;" href="javascript:void(0);" class="ref ref101 ref162 ref163 ref164 ref172">(101,162−164,172)</a> However, caution needs to be taken with designing inhibitors, making sure there is no or very little binding to the human parvulin PIN1 to avoid adverse effects.</div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Concluding Remarks</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">It is clear from this review that the immunophilin proteins in bacterial pathogens are an exciting, underexplored group of targets for drug discovery. Due to the pleiotropic roles immunophilins play in bacteria, multiple pathways can be targeted simultaneously with a single inhibitor. Pathways such as those involved in antimicrobial resistance, cell to cell spread, and stress responses are all important targets that would result in disarming the pathogen without the challenge of resistance rising. Inhibitors to the macrophage infectivity potentiator (Mip) protein are a clear example of how effective inhibitors can be in ultimately reducing survival of multiple pathogens in many different cell infection models. The drug design strategy and medicinal chemistry used to develop Mip inhibitors are an example of how target specific action can be achieved, an important consideration in the development of drugs against immunophilins which are universal proteins throughout life. Furthermore, targeted development of inhibitors against the other two families of bacterial immunophilins is an exciting prospect. Cyclophilin B has been shown to play an essential role in <i>B. pseudomallei</i> virulence, while the parvulin, PrsA, has been shown to render antibiotic resistant bacteria sensitive to β-lactam-based antibiotics once more. These targets could prove to be just as druggable as Mip, and inhibitors could demonstrate increased efficacy in future studies. Furthermore, as discussed in detail, there are a large amount of novel inhibitors already available and that can be used as a basis to design target specific inhibitors. A key consideration in drug discovery is the ability to synthesize drugs with the appropriate pharmacology for successful clinical trials; in the case for immunophilins drugs there are several that meet these requirements and are used routinely for various medical treatments. It is feasible therefore to develop inhibitors that will act only on a specific immunophilin protein and use medicinal chemistry to generate drugs that are effective in clinical trials.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00911" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrike Holzgrabe</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy and Food Chemistry, University
of Würzburg, Am Hubland, 97074 Würzburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0364-7278" title="Orcid link">http://orcid.org/0000-0002-0364-7278</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d8adb4aab1b3bdf6b0b7b4a2bfaab9babd98adb6b1f5afadbdaaa2baadaabff6bcbd"><span class="__cf_email__" data-cfemail="d5a0b9a7bcbeb0fbbdbab9afb2a7b4b7b095a0bbbcf8a2a0b0a7afb7a0a7b2fbb1b0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitali Sarkar-Tyson</span> - <span class="hlFld-Affiliation affiliation">Marshall
Centre for Infectious Diseases Research and Training, School of Biomedical
Sciences, University of Western Australia, 6009 Perth, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e984809d888580c79a889b82889bc49d909a8687a99c9e88c78c8d9cc7889c"><span class="__cf_email__" data-cfemail="721f1b06131e1b5c0113001913005f060b011d1c320705135c1716075c1307">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas J. Scheuplein</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy and Food Chemistry, University
of Würzburg, Am Hubland, 97074 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole M. Bzdyl</span> - <span class="hlFld-Affiliation affiliation">Marshall
Centre for Infectious Diseases Research and Training, School of Biomedical
Sciences, University of Western Australia, 6009 Perth, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily A. Kibble</span> - <span class="hlFld-Affiliation affiliation">Marshall
Centre for Infectious Diseases Research and Training, School of Biomedical
Sciences, University of Western Australia, 6009 Perth, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Veterinary and Life Sciences, Murdoch
University, 6150 Murdoch, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Lohr</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacy and Food Chemistry, University
of Würzburg, Am Hubland, 97074 Würzburg, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>N.J.S. and N.M.B. are equal first authors, and U.H. and M.S.-T. are equal corresponding authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Nicolas J. Scheuplein</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=BIO-d7e4153-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nicolas J. Scheuplein</b> is an organic chemist (M.Sc.) and currently a final year Ph.D. student at the Julius-Maximilians-University of Würzburg (Germany) under the supervision of Prof. Dr. Ulrike Holzgrabe. Besides synthesizing fluorescent tool compounds to improve the testing of Mip inhibitors, he is focusing on the development of more drug-like Mip inhibitors. Before this, he has worked on the synthesis of molecules for selective immunotherapy in cancer treatment. In addition, he has contributed to the teaching and supervision of students and Masters research students.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Nicole M. Bzdyl</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=BIO-d7e4158-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nicole M. Bzdyl</b> is a molecular microbiologist and currently a final year Ph.D. student at the University of Western Australia (Australia) under the supervision of Dr. Mitali Sarkar-Tyson focusing on understanding the roles of cyclophilins in the bacterium <i>Burkholderia pseudomallei</i>. In addition she has contributed to the teaching and supervision of multiple Honors and Masters research students.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Emily A. Kibble</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=BIO-d7e4166-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Emily A. Kibble</b> is a third year molecular microbiology Ph.D. student at Murdoch University (Australia). She is supervised by Dr. Geoff Coombs, as well as Dr. Mitali Sarkar-Tyson and Dr. Charlene Kahler at the University of Western Australia (Australia). Her Ph.D. is focused on investigating the function of FK506 binding proteins in the human pathogen, <i>Neisseria meningitidis</i>.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Theresa Lohr</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=BIO-d7e4174-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Theresa Lohr</b> is currently a Ph.D. student at the Julius-Maximilians-University of Würzburg (Germany) under the supervision of Prof. Dr. Ulrike Holzgrabe. She is focusing on testing well-known inhibitors of the macrophage infectivity potentiator protein and synthesizing new tailor-made compounds for <i>Trypanosoma cruz</i>i. She will further analyze the possibility of using the hit compounds as drugs. In addition, she has contributed to the teaching and supervision of students and Masters research students.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Ulrike Holzgrabe</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=BIO-d7e4182-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ulrike Holzgrabe</b> received her Chemistry diploma at Marburg University (1979), her Pharmacy approbation (1982), and her Ph.D. in Pharmaceutical Chemistry at Kiel University (1983). After habilitation (1989) she became Associate Professor at Bonn University (1990–1999). She was a postdoc (1988) at Bath University, U.K., and a Visiting Professor at Erlangen University with Gasteiger (1994) and at the University of Illinois at Chicago with Hopfinger (1995). Since 1999, she holds a full professorship at Würzburg University (declining offers from Tübingen, Münster, Berlin). She served as Vice-Rector of Bonn University, as President of the German Pharmaceutical Society, and as Vice President of Wuerzburg University. She received the “Bayerischen Verdienstorden” (2019). Her main research interest is the development of antiinfectives. She is co-owner of Aamuthera, a company dealing with anticancer drugs.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Mitali Sarkar-Tyson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=BIO-d7e4187-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mitali Sarkar-Tyson</b> is the Le Souef Research Fellow within the School of Biomedical Sciences at the University of Western Australia since 2016. Prior to that, she was a Principle Scientist at the Defence Science Technology Laboratory, United Kingdom, for 13 years, and in this role she led the medical countermeasures program to identify and characterize novel bacterial targets for drug discovery. She has collaborated extensively with international groups to focus on the inhibition of immunophilin proteins in bacteria with Mip as the main target. At UWA, she has grown her research team to focus on understanding the molecular role of immunophilins in Gram-negative bacteria and developed screening methods of novel inhibitors in cell infection assays and animal models.</p></figure></div><div class="ack" id="ACK-d7e4200-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14833" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14833" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the North Atlantic Treaty Organization (NATO), Brussels, Belgium, Grant SPS 984835, and the German Research Foundation (DFG, Bonn, Germany; Grant SFB 630) for the development of Mip inhibitors against <i>Legionella pneumophila</i> and <i>Burkholderia pseudomallei</i>, respectively, and The Federal Ministry of Education and Research for the development of Mip inhibitors against <i>Trypanosoma cruzi</i> given to U.H. This paper includes research that was supported by DMTC Limited (Australia). The authors have prepared this paper in accordance with the intellectual property rights granted to partners from the original DMTC project.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">PPIase</td><td class="NLM_def"><p class="first last">peptidyl-prolyl <i>cis</i>–<i>trans</i> isomerase</p></td></tr><tr><td class="NLM_term">MIP</td><td class="NLM_def"><p class="first last">macrophage infectivity potentiator</p></td></tr><tr><td class="NLM_term">hCypA</td><td class="NLM_def"><p class="first last">human cyclophilin A</p></td></tr><tr><td class="NLM_term">FKBP</td><td class="NLM_def"><p class="first last">FK506 binding protein</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">ML1</td><td class="NLM_def"><p class="first last">Mip-like protein</p></td></tr><tr><td class="NLM_term">SlyD</td><td class="NLM_def"><p class="first last">sensitive to lysis D</p></td></tr><tr><td class="NLM_term">surA</td><td class="NLM_def"><p class="first last">survival protein A</p></td></tr><tr><td class="NLM_term">CsA</td><td class="NLM_def"><p class="first last">cyclosporin A</p></td></tr><tr><td class="NLM_term">SfA</td><td class="NLM_def"><p class="first last">sanglifehrin A</p></td></tr><tr><td class="NLM_term">kDa</td><td class="NLM_def"><p class="first last">kilodalton</p></td></tr><tr><td class="NLM_term">NF-AT</td><td class="NLM_def"><p class="first last">nuclear factor of activated T cell</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">TGF</td><td class="NLM_def"><p class="first last">transforming growth factor</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">CSP</td><td class="NLM_def"><p class="first last">chemical shift perturbation</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactose dehydrogenase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure activity relationship</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>D</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibitory concentration of 50%</p></td></tr><tr><td class="NLM_term">DAA</td><td class="NLM_def"><p class="first last">direct-acting antiviral</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatits C virus</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HTA</td><td class="NLM_def"><p class="first last">host-targeting antiviral</p></td></tr><tr><td class="NLM_term">FBDD</td><td class="NLM_def"><p class="first last">fragment-based drug design</p></td></tr><tr><td class="NLM_term">CPP</td><td class="NLM_def"><p class="first last">cell-penetrating peptide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DTM</td><td class="NLM_def"><p class="first last">dipentamethylene thiuram monosulfide</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 212 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, I. M.</span></span> <span> </span><span class="NLM_article-title">Antibiotic Stewardship: Overcoming Implementation Barriers</span>. <i>Curr. Opin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1097/QCO.0b013e3283483262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1097%2FQCO.0b013e3283483262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21587070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC3MnktValsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=357-362&issue=4&author=A.+M.+Balauthor=I.+M.+Gould&title=Antibiotic+Stewardship%3A+Overcoming+Implementation+Barriers&doi=10.1097%2FQCO.0b013e3283483262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic stewardship: overcoming implementation barriers</span></div><div class="casAuthors">Bal Abhijit M; Gould Ian M</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Antimicrobial stewardship is now recognized as a formal strategy for curbing the upward trend in antibiotic resistance.  Literature on antimicrobial stewardship has focused on areas of strategic importance and operational delivery.  A number of barriers have been recognized in the implementation of successful programs.  These include lack of physician participation, lack of diagnostic facility, absence of formal mechanism of data collection, variation between countries, and lack of cooperative strategies.  In this review, we suggest strategies to overcome these barriers.  RECENT FINDINGS:  In the last few years, it has been recognized that an executive program is necessary for successful implementation of strategies to control the growing antibiotic resistance.  Efforts have been made at higher levels of government through organizations such as the European Centre for Disease Prevention and Control.  The need for community healthcare involvement has also been recognized.  At a local level, strategies to promote cooperation between various committees (e.g. infection control and antimicrobial management teams) have been proposed and adopting antibiotic care bundles as part of patient safety and healthcare is being explored.  SUMMARY:  We suggest that executive level planning, local cooperation, sustained education, emphasis on de-escalation, and use of care bundles could stem the tide of growing resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrfVLBD0YLIFw2ofyr07jXfW6udTcc2eZjZSNOkC7aCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnktValsw%253D%253D&md5=f8fbd35b19db35b90c92ab78775de075</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e3283483262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e3283483262%26sid%3Dliteratum%253Aachs%26aulast%3DBal%26aufirst%3DA.%2BM.%26aulast%3DGould%26aufirst%3DI.%2BM.%26atitle%3DAntibiotic%2520Stewardship%253A%2520Overcoming%2520Implementation%2520Barriers%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D24%26issue%3D4%26spage%3D357%26epage%3D362%26doi%3D10.1097%2FQCO.0b013e3283483262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasko, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, V.</span></span> <span> </span><span class="NLM_article-title">Anti-Virulence Strategies to Combat Bacteria-Mediated Disease</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1038/nrd3013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnrd3013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20081869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=117-128&issue=2&author=D.+A.+Raskoauthor=V.+Sperandio&title=Anti-Virulence+Strategies+to+Combat+Bacteria-Mediated+Disease&doi=10.1038%2Fnrd3013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-virulence strategies to combat bacteria-mediated disease</span></div><div class="casAuthors">Rasko, David A.; Sperandio, Vanessa</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibiotic resistance is one of the greatest challenges of the twenty-first century.  However, the increasing understanding of bacterial pathogenesis and intercellular communication has revealed many potential strategies to develop novel drugs to treat bacteria-mediated disease.  Interference with bacterial virulence and/or cell-to-cell signaling pathways is an esp. compelling approach, as it is thought to apply less selective pressure for the development of bacterial resistance than traditional strategies, which are aimed at killing bacteria or preventing their growth.  Here, we discuss the mechanisms of bacterial virulence and present promising anti-virulence strategies and compds. for the future treatment of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_XHw8YsfL7Vg90H21EOLACvtfcHk0limlHk7jhe5-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D&md5=e46d5501a1a28a3deb2e3b2432dff66a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3013%26sid%3Dliteratum%253Aachs%26aulast%3DRasko%26aufirst%3DD.%2BA.%26aulast%3DSperandio%26aufirst%3DV.%26atitle%3DAnti-Virulence%2520Strategies%2520to%2520Combat%2520Bacteria-Mediated%2520Disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D2%26spage%3D117%26epage%3D128%26doi%3D10.1038%2Fnrd3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cegelski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldridge, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">The Biology and Future Prospects of Antivirulence Therapies</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnrmicro1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18079741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVaqt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=17-27&issue=1&author=L.+Cegelskiauthor=G.+R.+Marshallauthor=G.+R.+Eldridgeauthor=S.+J.+Hultgren&title=The+Biology+and+Future+Prospects+of+Antivirulence+Therapies&doi=10.1038%2Fnrmicro1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The biology and future prospects of antivirulence therapies</span></div><div class="casAuthors">Cegelski, Lynette; Marshall, Garland R.; Eldridge, Gary R.; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-27</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting bacterial virulence is an alternative approach to antimicrobial therapy.  This Review considers recent efforts towards antivirulence-based drug discovery in the framework of marketable drugs, and discusses what challenges remain and the factors that are crucial to developing the antivirulence therapeutic approach.  The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches.  Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium.  Certain virulence factors have been shown to be potential targets for drug design and therapeutic intervention, whereas new insights are crucial for exploiting others.  Targeting virulence represents a new paradigm to empower the clinician to prevent and treat infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOBVkXUSVSbVg90H21EOLACvtfcHk0liFLHmQmxQzRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVaqt7vF&md5=42b72b7a52f5b83c0c1c949ee73f03ef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1818%26sid%3Dliteratum%253Aachs%26aulast%3DCegelski%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26aulast%3DEldridge%26aufirst%3DG.%2BR.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Biology%2520and%2520Future%2520Prospects%2520of%2520Antivirulence%2520Therapies%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2008%26volume%3D6%26issue%3D1%26spage%3D17%26epage%3D27%26doi%3D10.1038%2Fnrmicro1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avelar, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longtine, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heard, S. O.</span></span> <span> </span><span class="NLM_article-title">Anti-Infective External Coating of Central Venous Catheters: a Randomized, Noninferiority Trial Comparing 5-Fluorouracil with Chlorhexidine/Silver Sulfadiazine in Preventing Catheter Colonization</span>. <i>Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2095</span>– <span class="NLM_lpage">2102</span>, <span class="refDoi"> DOI: 10.1097/CCM.0b013e3181f265ba</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1097%2FCCM.0b013e3181f265ba" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20711070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSqur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2095-2102&issue=11&author=J.+M.+Walzauthor=R.+L.+Avelarauthor=K.+J.+Longtineauthor=K.+L.+Carterauthor=L.+A.+Mermelauthor=S.+O.+Heard&title=Anti-Infective+External+Coating+of+Central+Venous+Catheters%3A+a+Randomized%2C+Noninferiority+Trial+Comparing+5-Fluorouracil+with+Chlorhexidine%2FSilver+Sulfadiazine+in+Preventing+Catheter+Colonization&doi=10.1097%2FCCM.0b013e3181f265ba"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-infective external coating of central venous catheters: A randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization</span></div><div class="casAuthors">Walz, J. Matthias; Avelar, Rui L.; Longtine, Karen J.; Carter, Kent L.; Mermel, Leonard A.; Heard, Stephen O.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Care Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2095-2102</span>CODEN:
                <span class="NLM_cas:coden">CCMDC7</span>;
        ISSN:<span class="NLM_cas:issn">0090-3493</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: The antimetabolite drug, 5-fluorouracil, inhibits microbial growth.  Coating of central venous catheters with 5-fluorouracil may reduce the risk of catheter infection.  Our objective was to compare the safety and efficacy of central venous catheters externally coated with 5-fluorouracil with those coated with chlorhexidine and silver sulfadiazine.  Design: Prospective, single-blind, randomized, active-controlled, multicentered, noninferiority trial.  Setting: Twenty-five US medical center intensive care units.  Patients: A total of 960 adult patients requiring central venous catheterization for up to 28 days.  Interventions: Patients were randomized to receive a central venous catheter externally coated with either 5-fluorouracil (n = 480) or chlorhexidine and silver sulfadiazine (n = 480).  Measurements and main results: The primary antimicrobial outcome was a dichotomous measure (<15 colony-forming units or ≥15 colony-forming units) for catheter colonization detd. by the roll plate method.  Secondary antimicrobial outcomes included local site infection and catheter-related bloodstream infection.  Central venous catheters coated with 5-fluorouracil were noninferior to chlorhexidine and silver sulfadiazine coated central venous catheters with respect to the incidence of catheter colonization (2.9% vs. 5.3%, resp.).  Local site infection occurred in 1.4% of the 5-fluorouracil group and 0.9% of the chlorhexidine and silver sulfadiazine group.  No episode of catheter-related bloodstream infection occurred in the 5-fluorouracil group, whereas two episodes were noted in the chlorhexidine and silver sulfadiazine group.  Only Gram-pos. organisms were cultured from 5-fluorouracil catheters, whereas Gram-pos. bacteria, Gram-neg. bacteria, and Candida were cultured from the chlorhexidine and silver sulfadiazine central venous catheters.  Adverse events were comparable between the two central venous catheter coatings.  Conclusions: Our results suggest that central venous catheters externally coated with 5-fluorouracil are a safe and effective alternative to catheters externally coated with chlorhexidine and silver sulfadiazine when used in critically ill patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3C3LeljOZCbVg90H21EOLACvtfcHk0liFLHmQmxQzRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSqur7L&md5=c06a2463e7fa255e8b1547d80918b0c2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2FCCM.0b013e3181f265ba&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCCM.0b013e3181f265ba%26sid%3Dliteratum%253Aachs%26aulast%3DWalz%26aufirst%3DJ.%2BM.%26aulast%3DAvelar%26aufirst%3DR.%2BL.%26aulast%3DLongtine%26aufirst%3DK.%2BJ.%26aulast%3DCarter%26aufirst%3DK.%2BL.%26aulast%3DMermel%26aufirst%3DL.%2BA.%26aulast%3DHeard%26aufirst%3DS.%2BO.%26atitle%3DAnti-Infective%2520External%2520Coating%2520of%2520Central%2520Venous%2520Catheters%253A%2520a%2520Randomized%252C%2520Noninferiority%2520Trial%2520Comparing%25205-Fluorouracil%2520with%2520Chlorhexidine%252FSilver%2520Sulfadiazine%2520in%2520Preventing%2520Catheter%2520Colonization%26jtitle%3DCrit.%2520Care%2520Med.%26date%3D2010%26volume%3D38%26issue%3D11%26spage%3D2095%26epage%3D2102%26doi%3D10.1097%2FCCM.0b013e3181f265ba" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hentzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givskov, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of Quorum Sensing for the Treatment of Chronic Bacterial Infections</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1172/JCI20074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1172%2FJCI20074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14597754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=1300-1307&issue=9&author=M.+Hentzerauthor=M.+Givskov&title=Pharmacological+Inhibition+of+Quorum+Sensing+for+the+Treatment+of+Chronic+Bacterial+Infections&doi=10.1172%2FJCI20074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections</span></div><div class="casAuthors">Hentzer, Morten; Givskov, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1300-1307</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Traditional treatment of infectious diseases is based on compds. that aim to kill or inhibit bacterial growth.  A major concern with this approach is the frequently obsd. development of resistance to antimicrobial compds.  The discovery of bacterial-communication systems (quorum-sensing systems), which orchestrate important temporal events during the infection process, has afforded a novel opportunity to ameliorate bacterial infection by means other than growth inhibition.  Compds. able to over-ride bacterial signaling are present in Nature.  Here, the authors discuss the known signaling mechanisms and potential antipathogenic drugs that specifically target quorum-sensing systems in a manner unlikely to pose a selective pressure for the development of resistant mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxemnrP5U9EbVg90H21EOLACvtfcHk0liFLHmQmxQzRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGqsro%253D&md5=c0e525617af51d91070720dbd22e4570</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1172%2FJCI20074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI20074%26sid%3Dliteratum%253Aachs%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DGivskov%26aufirst%3DM.%26atitle%3DPharmacological%2520Inhibition%2520of%2520Quorum%2520Sensing%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Bacterial%2520Infections%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26issue%3D9%26spage%3D1300%26epage%3D1307%26doi%3D10.1172%2FJCI20074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fasciano, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaban, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecsas, J.</span></span> <span> </span><span class="NLM_article-title">Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target</span>. <i>EcoSal Plus.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1128/ecosalplus.ESP-0032-2018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2Fecosalplus.ESP-0032-2018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=261-276&author=A.+C.+Fascianoauthor=L.+Shabanauthor=J.+Mecsas&title=Promises+and+Challenges+of+the+Type+Three+Secretion+System+Injectisome+as+an+Antivirulence+Target&doi=10.1128%2Fecosalplus.ESP-0032-2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2Fecosalplus.ESP-0032-2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fecosalplus.ESP-0032-2018%26sid%3Dliteratum%253Aachs%26aulast%3DFasciano%26aufirst%3DA.%2BC.%26aulast%3DShaban%26aufirst%3DL.%26aulast%3DMecsas%26aufirst%3DJ.%26atitle%3DPromises%2520and%2520Challenges%2520of%2520the%2520Type%2520Three%2520Secretion%2520System%2520Injectisome%2520as%2520an%2520Antivirulence%2520Target%26jtitle%3DEcoSal%2520Plus.%26date%3D2019%26spage%3D261%26epage%3D276%26doi%3D10.1128%2Fecosalplus.ESP-0032-2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandts, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halvorson, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, M.</span></span> <span> </span><span class="NLM_article-title">Consideration of the Possibility that the Slow Step in Protein Denaturation Reactions is due to Cis-Trans Isomerism of Proline Residues</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4953</span>– <span class="NLM_lpage">4963</span>, <span class="refDoi"> DOI: 10.1021/bi00693a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00693a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaE28XhsVOk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=4953-4963&issue=22&author=J.+F.+Brandtsauthor=H.+R.+Halvorsonauthor=M.+Brennan&title=Consideration+of+the+Possibility+that+the+Slow+Step+in+Protein+Denaturation+Reactions+is+due+to+Cis-Trans+Isomerism+of+Proline+Residues&doi=10.1021%2Fbi00693a026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues</span></div><div class="casAuthors">Brandts, John F.; Halvorson, Herbert R.; Brennan, Maureen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4953-63</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A model is proposed for the apparent 2-phase kinetics in the denaturation of small proteins.  It is suggested that only 1 of these phases, the fast 1, is actually an unfolding process.  The slow phase is assumed to arise from the cis-trans isomerism of proline residues in the denatured protein.  From model compd. data, the expected rate for isomerism was in satisfactory agreement with the rates actually obsd. for protein folding.  A simple model of protein unfolding based on the isomerism concept was very successful in accounting for many known exptl. characteristics of the kinetics and thermodn. of protein denaturation.  Thus, the model is able to predict that 2 kinetic phases will be seen in the transition region while none are seen in the base-line regions, that both the fast and slow refolding phases lead to the native protein as the product, that the fast phase becomes the only observable phase for jumps ending far in the denatured base-line region, that most or all small proteins show a limiting low-temp. activation energy of ∼20,000 cal, and that the relaxation time for the slow phase seen in cytochrome c denaturation is much shorter than for all other small proteins.  By utilizing double-jump expts., it was shown directly that the slow phase is not part of the unfolding process, but corresponds to a transition among ≥2 denatured forms which have identical spectroscopic (286.5 nm) properties.  Thus, the slow relaxation is invisible except in the transition region where it couples to the fast unfolding equil.  Finally, since the present model assumes that only 1 of the major kinetic phases seen in denaturation reactions is concerned with the denaturation process per se, it is in agreement with numerous thermodn. studies which show consistency with the 2-state model for unfolding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUGXF5gCyaC7Vg90H21EOLACvtfcHk0lgYMI0P_8Sa7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XhsVOk&md5=8a20b90b6d768ab845f58b48b28e321a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi00693a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00693a026%26sid%3Dliteratum%253Aachs%26aulast%3DBrandts%26aufirst%3DJ.%2BF.%26aulast%3DHalvorson%26aufirst%3DH.%2BR.%26aulast%3DBrennan%26aufirst%3DM.%26atitle%3DConsideration%2520of%2520the%2520Possibility%2520that%2520the%2520Slow%2520Step%2520in%2520Protein%2520Denaturation%2520Reactions%2520is%2520due%2520to%2520Cis-Trans%2520Isomerism%2520of%2520Proline%2520Residues%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26issue%3D22%26spage%3D4953%26epage%3D4963%26doi%3D10.1021%2Fbi00693a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Catalysis of Protein Folding by Prolyl Isomerase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>329</i></span> (<span class="NLM_issue">6136</span>),  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1038/329268a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2F329268a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=3306408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2sXmtlajsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=268-270&issue=6136&author=K.+Langauthor=F.+X.+Schmidauthor=G.+Fischer&title=Catalysis+of+Protein+Folding+by+Prolyl+Isomerase&doi=10.1038%2F329268a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Catalysis of protein folding by prolyl isomerase</span></div><div class="casAuthors">Lang, Kurt; Schmid, Franz X.; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">6136</span>),
    <span class="NLM_cas:pages">268-70</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Peptidyl-prolyl cis-trans isomerase (PPIase), from pig kidney, efficiently catalyzes slow steps in the refolding of the Ig light chain from mouse, porcine RNase, and the S-fragment of bovine RNase A.  Refolding of intact bovine RNase A is not catalyzed by PPIase, probably because proline peptide bonds are inaccessible.  The data suggest that proline cis-trans isomerization is rate-limiting in some slow protein folding reactions, where fast- and slow-folding isomers coexist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWfpD4lpp_vrVg90H21EOLACvtfcHk0lgYMI0P_8Sa7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtlajsLs%253D&md5=c02562503173799e552c2ff058ec7ec2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F329268a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329268a0%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DK.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DCatalysis%2520of%2520Protein%2520Folding%2520by%2520Prolyl%2520Isomerase%26jtitle%3DNature%26date%3D1987%26volume%3D329%26issue%3D6136%26spage%3D268%26epage%3D270%26doi%3D10.1038%2F329268a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiene-Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span> <span> </span><span class="NLM_article-title">Receptor Accessory Folding Helper Enzymes: the Functional Role of Peptidyl Prolyl Cis/Trans Isomerases</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>495</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(01)02326-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0014-5793%2801%2902326-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11322937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFehu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=1-6&issue=1%E2%80%932&author=C.+Schiene-Fischerauthor=C.+Yu&title=Receptor+Accessory+Folding+Helper+Enzymes%3A+the+Functional+Role+of+Peptidyl+Prolyl+Cis%2FTrans+Isomerases&doi=10.1016%2FS0014-5793%2801%2902326-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases</span></div><div class="casAuthors">Schiene-Fischer, C.; Yu, C.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">495</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 66 refs.  Receptor accessory peptidyl prolyl cis/trans isomerases (PPIases) of the FKBP and cyclophilin types form receptor heterocomplexes with different stabilities.  PPIases have been found to assoc. with other receptor heterocomplex constituents via either proline-directed active sites or addnl. domains of the enzymes.  The single-domain PPIases FKBP12 and FKBP12.6 are shown to interact with receptor protein kinases and calcium channels at their active sites.  In contrast, heterooligomeric nuclear receptors contain multi-domain PPIases like FKBP51, FKBP52 or cyclophilin 40 that directly interact with the chaperone hsp90 via the tetratricopeptide repeat modules of the folding helper enzymes.  PPIases play a crit. role in the functional arrangement of components within receptor heterocomplexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBogMjRhrxTrVg90H21EOLACvtfcHk0lh3gMTRcjqJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFehu7w%253D&md5=4567c349d7371106117ca5c06da29930</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2902326-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252902326-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchiene-Fischer%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26atitle%3DReceptor%2520Accessory%2520Folding%2520Helper%2520Enzymes%253A%2520the%2520Functional%2520Role%2520of%2520Peptidyl%2520Prolyl%2520Cis%252FTrans%2520Isomerases%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D495%26issue%3D1%25E2%2580%25932%26spage%3D1%26epage%3D6%26doi%3D10.1016%2FS0014-5793%2801%2902326-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span>; <span class="NLM_string-name">Aumüller, T.</span></span> <span> </span><span class="NLM_article-title">Regulation of Peptide Bond Cis/Trans Isomerization by Enzyme Catalysis and its Implication in Physiological Processes</span>.  <i>Reviews of Physiology, Biochemistry and Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1007/s10254-003-0011-3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2Fs10254-003-0011-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=105-150&author=G.+Fischer&author=T.+Aum%C3%BCller&title=Reviews+of+Physiology%2C+Biochemistry+and+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10254-003-0011-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252Fs10254-003-0011-3%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DRegulation%2520of%2520Peptide%2520Bond%2520Cis%252FTrans%2520Isomerization%2520by%2520Enzyme%2520Catalysis%2520and%2520its%2520Implication%2520in%2520Physiological%2520Processes%26btitle%3DReviews%2520of%2520Physiology%252C%2520Biochemistry%2520and%2520Pharmacology%26pub%3DSpringer%26date%3D2003%26spage%3D105%26epage%3D150%26doi%3D10.1007%2Fs10254-003-0011-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghartey-Kwansah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of FKBP Family Protein: Evaluation, Structure, and Function in Mammals and Drosophila melanogaster</span>. <i>BMC Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.1186/s12861-018-0167-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1186%2Fs12861-018-0167-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29587629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsFWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=7&issue=1&author=G.+Ghartey-Kwansahauthor=Z.+Liauthor=R.+Fengauthor=L.+Wangauthor=X.+Zhouauthor=F.+Z.+Chenauthor=M.+M.+Xuauthor=O.+Jonesauthor=Y.+Muauthor=S.+Chenauthor=J.+Bryantauthor=W.+B.+Isaacsauthor=J.+Maauthor=X.+Xu&title=Comparative+Analysis+of+FKBP+Family+Protein%3A+Evaluation%2C+Structure%2C+and+Function+in+Mammals+and+Drosophila+melanogaster&doi=10.1186%2Fs12861-018-0167-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of FKBP family protein: evaluation, structure, and function in mammals and Drosophila melanogaster</span></div><div class="casAuthors">Ghartey-Kwansah, George; Li, Zhongguang; Feng, Rui; Wang, Liyang; Zhou, Xin; Chen, Frederic Z.; Xu, Meng Meng; Jones, Odell; Mu, Yulian; Chen, Shawn; Bryant, Joseph; Isaacs, Williams B.; Ma, Jianjie; Xu, Xuehong</div><div class="citationInfo"><span class="NLM_cas:title">BMC Developmental Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7/1-7/12</span>CODEN:
                <span class="NLM_cas:coden">BDBMA7</span>;
        ISSN:<span class="NLM_cas:issn">1471-213X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: FK506-binding proteins (FKBPs) have become the subject of considerable interest in several fields, leading to the identification of several cellular and mol. pathways in which FKBPs impact prenatal development and pathogenesis of many human diseases.  Main body: This anal. revealed differences between how mammalian and Drosophila FKBPs mechanisms function in relation to the immunosuppressant drugs, FK506 and rapamycin.  Differences that could be used to design insect-specific pesticides. (1) Mol. phylogenetic anal. of FKBP family proteins revealed that the eight known Drosophila FKBPs share homol. with the human FKBP12.  This indicates a close evolutionary relationship, and possible origination from a common ancestor. (2) The known FKBPs contain FK domains, i.e., a prolyl cis/trans isomerase (PPIase) domain that mediates immune suppression through inhibition of calcineurin.  The dFKBP59, CG4735/ Shutdown, CG1847, and CG5482 have a Tetratricopeptide receptor domain at the C-terminus, which regulates transcription and protein transportation. (3) FKBP51 and FKBP52 (dFKBP59), along with Cyclophilin 40 and protein phosphatase 5, function as Hsp90 immunophilin co-chaperones within steroid receptor-Hsp90 heterocomplexes.  These immunophilins are potential drug targets in pathways assocd. with normal physiol. and may be used to treat a variety of steroid-based diseases by targeting exocytic/endocytic cycling and vesicular trafficking. (4) By assocg. with presinilin, a crit. component of the Notch signaling pathway, FKBP14 is a downstream effector of Notch activation at the membrane.  Meanwhile, Shutdown assocs. with transposons in the PIWI-interacting RNA pathway, playing a crucial role in both germ cells and ovarian somas.  Mutations in or silencing of dFKBPs lead to early embryonic lethality in Drosophila.  Therefore, further understanding the mechanisms of FK506 and rapamycin binding to immunophilin FKBPs in endocrine, cardiovascular, and neurol. function in both mammals and Drosophila would provide prospects in generating unique, insect specific therapeutics targeting the above cellular signaling pathways.  Conclusion: This review will evaluate the functional roles of FKBP family proteins, and systematically summarize the similarities and differences between FKBP proteins in Drosophila and Mammals.  Specific therapeutics targeting cellular signaling pathways will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovBGPdYUHS3LVg90H21EOLACvtfcHk0lh3gMTRcjqJwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsFWrsbk%253D&md5=0268a18ca62377e521cc2f59a6d16e43</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2Fs12861-018-0167-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12861-018-0167-3%26sid%3Dliteratum%253Aachs%26aulast%3DGhartey-Kwansah%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DF.%2BZ.%26aulast%3DXu%26aufirst%3DM.%2BM.%26aulast%3DJones%26aufirst%3DO.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DIsaacs%26aufirst%3DW.%2BB.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DComparative%2520Analysis%2520of%2520FKBP%2520Family%2520Protein%253A%2520Evaluation%252C%2520Structure%252C%2520and%2520Function%2520in%2520Mammals%2520and%2520Drosophila%2520melanogaster%26jtitle%3DBMC%2520Dev.%2520Biol.%26date%3D2018%26volume%3D18%26issue%3D1%26spage%3D7%26doi%3D10.1186%2Fs12861-018-0167-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">FKBP Ligands—Where We Are and Where to Go?</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1425</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffphar.2018.01425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30568592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1425&author=J.+M.+Kolosauthor=A.+M.+Vollauthor=M.+Bauderauthor=F.+Hausch&title=FKBP+Ligands%E2%80%94Where+We+Are+and+Where+to+Go%3F&doi=10.3389%2Ffphar.2018.01425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP Ligands-where we are and where to go?</span></div><div class="casAuthors">Kolos, Juergen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1425</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  In recent years, many members of the FK506-binding protein (FKBP) family were increasingly linked to various diseases.  The binding domain of FKBPs differs only in a few amino acid residues, but their biol. roles are versatile.  High-affinity ligands with selectivity between close homologs are scarce.  This review will give an overview of the most prominent ligands developed for FKBPs and highlight a perspective for future developments.  More precisely, human FKBPs and correlated diseases will be discussed as well as microbial FKBPs in the context of anti-bacterial and anti-fungal therapeutics.  The last section gives insights into high-affinity ligands as chem. tools and dimerizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBr9H6aE3nrVg90H21EOLACvtfcHk0ljt6cG7cQqiqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK&md5=72403a782e5d7e96352188f9e88821d9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01425%26sid%3Dliteratum%253Aachs%26aulast%3DKolos%26aufirst%3DJ.%2BM.%26aulast%3DVoll%26aufirst%3DA.%2BM.%26aulast%3DBauder%26aufirst%3DM.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DFKBP%2520Ligands%25E2%2580%2594Where%2520We%2520Are%2520and%2520Where%2520to%2520Go%253F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D1425%26doi%3D10.3389%2Ffphar.2018.01425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aghdasi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">FKBP12, the 12-kDa FK506-Binding Protein, is a Physiologic Regulator of the Cell Cycle</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2425</span>– <span class="NLM_lpage">2430</span>, <span class="refDoi"> DOI: 10.1073/pnas.041614198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1073%2Fpnas.041614198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11226255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslKnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=2425-2430&issue=5&author=B.+Aghdasiauthor=K.+Yeauthor=A.+Resnickauthor=A.+Huangauthor=H.+C.+Haauthor=X.+Guoauthor=T.+M.+Dawsonauthor=V.+L.+Dawsonauthor=S.+H.+Snyder&title=FKBP12%2C+the+12-kDa+FK506-Binding+Protein%2C+is+a+Physiologic+Regulator+of+the+Cell+Cycle&doi=10.1073%2Fpnas.041614198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle</span></div><div class="casAuthors">Aghdasi, Bahman; Ye, Keqiang; Resnick, Adam; Huang, Alex; Ha, Hyo Chol; Guo, Xin; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2425-2430</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type I receptor.  We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection.  This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1.  The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12.  Cell cycle arrest is prevented by transfection with a dominant-neg. TGF-β receptor construct.  TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways.  SMAD signaling is down-regulated in FKBP12-/- cells.  Inhibition of ERK/MAP kinase fails to affect p21 up-regulation.  By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38.  Thus, FKBP12 is a physiol. regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_od66DYf4y7Vg90H21EOLACvtfcHk0ljt6cG7cQqiqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslKnu7k%253D&md5=df78bd5811d28ad431c5cf6d003f3326</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.041614198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.041614198%26sid%3Dliteratum%253Aachs%26aulast%3DAghdasi%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DResnick%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DHa%26aufirst%3DH.%2BC.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DFKBP12%252C%2520the%252012-kDa%2520FK506-Binding%2520Protein%252C%2520is%2520a%2520Physiologic%2520Regulator%2520of%2520the%2520Cell%2520Cycle%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D5%26spage%3D2425%26epage%3D2430%26doi%3D10.1073%2Fpnas.041614198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanghänel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüneberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Functional Analyses of the Mip Protein: Influence of the N-Terminal Half and of Peptidylprolyl Isomerase Activity on the Virulence of Legionella pneumophila</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4389</span>– <span class="NLM_lpage">4397</span>, <span class="refDoi"> DOI: 10.1128/IAI.71.8.4389-4397.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.71.8.4389-4397.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12874317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BD3szlvFSgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2003&pages=4389-4397&issue=8&author=R.+K%C3%B6hlerauthor=J.+Fangh%C3%A4nelauthor=B.+K%C3%B6nigauthor=E.+L%C3%BCnebergauthor=M.+Froschauthor=J.-U.+Rahfeldauthor=R.+Hilgenfeldauthor=G.+Fischerauthor=J.+Hackerauthor=M.+Steinert&title=Biochemical+and+Functional+Analyses+of+the+Mip+Protein%3A+Influence+of+the+N-Terminal+Half+and+of+Peptidylprolyl+Isomerase+Activity+on+the+Virulence+of+Legionella+pneumophila&doi=10.1128%2FIAI.71.8.4389-4397.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila</span></div><div class="casAuthors">Kohler Rolf; Fanghanel Jorg; Konig Bettina; Luneberg Edeltraud; Frosch Matthias; Rahfeld Jens-Ulrich; Hilgenfeld Rolf; Fischer Gunter; Hacker Jorg; Steinert Michael</div><div class="citationInfo"><span class="NLM_cas:title">Infection and immunity</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4389-97</span>
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The virulence factor Mip (macrophage infectivity potentiator) contributes to the intracellular survival of Legionella pneumophila, the causative agent of Legionnaires' disease.  The protein consists of two domains that are connected via a very long alpha-helix (A.  Riboldi-Tunnicliffe et al., Nat.  Struct.  Biol. 8:779-783, 2001).  The fold of the C-terminal domain (residues 100 to 213) is closely related to human FK506-binding protein (FKBP12), and like FKBP12, Mip exhibits peptidylprolyl cis/trans isomerase (PPIase) activity.  The alpha-helical N-terminal domain is responsible for the formation of very stable Mip homodimers.  In order to determine the importance of the homodimeric state of Mip for its biochemical activities and for infectivity of Legionella, a truncated, monomeric Mip variant [Mip((77-213))] was overexpressed in Escherichia coli and characterized biochemically.  In vitro isomerase activity assays revealed that the altered protein exhibits full isomerase activity towards peptide substrates.  However, the deletion resulted in a dramatic loss in the efficiency of refolding of reduced and carboxy-methylated RNase T(1).  By cis complementation of the Mip-negative mutant strain L. pneumophila JR32-2, we constructed the strain L. pneumophila JR32-2.4, which expresses an N-terminally truncated variant of Mip.  Infection studies with these strains revealed that the N-terminal part and the dimerization of Mip but not its PPIase activity are necessary for full virulence in Acanthamoeba castellanii.  Infection of guinea pigs showed that strains with dimerization-deficient Mip (JR32-2.4) or a very low PPIase activity (JR32-2.2) were significantly attenuated in the animal model.  These results suggest a different role of the PPIase activity and the N-terminally mediated dimeric state of Mip in monocellular systems and during the infection of guinea pigs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRpWFC3n1ojUHdcurJClFcfW6udTcc2eZWx-JXJesXv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szlvFSgsA%253D%253D&md5=d1cc6f210819d5dbadc0d28f12e82cf1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FIAI.71.8.4389-4397.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.71.8.4389-4397.2003%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DR.%26aulast%3DFangh%25C3%25A4nel%26aufirst%3DJ.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26aulast%3DL%25C3%25BCneberg%26aufirst%3DE.%26aulast%3DFrosch%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26aulast%3DHilgenfeld%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DBiochemical%2520and%2520Functional%2520Analyses%2520of%2520the%2520Mip%2520Protein%253A%2520Influence%2520of%2520the%2520N-Terminal%2520Half%2520and%2520of%2520Peptidylprolyl%2520Isomerase%2520Activity%2520on%2520the%2520Virulence%2520of%2520Legionella%2520pneumophila%26jtitle%3DInfect.%2520Immun.%26date%3D2003%26volume%3D71%26issue%3D8%26spage%3D4389%26epage%3D4397%26doi%3D10.1128%2FIAI.71.8.4389-4397.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titball, R. W.</span></span> <span> </span><span class="NLM_article-title">A Burkholderia pseudomallei Macrophage Infectivity Potentiator-like Protein has Rapamycin-Inhibitable Peptidylprolyl Isomerase Activity and Pleiotropic Effects on Virulence</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4299</span>– <span class="NLM_lpage">4307</span>, <span class="refDoi"> DOI: 10.1128/IAI.00134-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00134-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21859853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=4299-4307&issue=11&author=I.+H.+Norvilleauthor=N.+J.+Harmerauthor=S.+V.+Hardingauthor=G.+Fischerauthor=K.+E.+Keithauthor=K.+A.+Brownauthor=M.+Sarkar-Tysonauthor=R.+W.+Titball&title=A+Burkholderia+pseudomallei+Macrophage+Infectivity+Potentiator-like+Protein+has+Rapamycin-Inhibitable+Peptidylprolyl+Isomerase+Activity+and+Pleiotropic+Effects+on+Virulence&doi=10.1128%2FIAI.00134-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence</span></div><div class="casAuthors">Norville, Isobel H.; Harmer, Nicholas J.; Harding, Sarah V.; Fischer, Gunter; Keith, Karen E.; Brown, Katherine A.; Sarkar-Tyson, Mitali; Titball, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4299-4307</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Macrophage infectivity potentiators (Mips) are a group of virulence factors encoded by pathogenic bacteria such as Legionella, Chlamydia, and Neisseria species.  Mips are part of the FK506-binding protein (FKBP) family, whose members typically exhibit peptidylprolyl cis-trans isomerase (PPIase) activity which is inhibitable by the immunosuppressants FK506 and rapamycin.  Here we describe the identification and characterization of BPSS1823, a Mip-like protein in the intracellular pathogen Burkholderia pseudomallei.  Recombinant BPSS1823 protein has rapamycin-inhibitable PPIase activity, indicating that it is a functional FKBP.  A mutant strain generated by deletion of BPSS1823 in B. pseudomallei exhibited a reduced ability to survive within cells and significant attenuation in vivo, suggesting that BPSS1823 is important for B. pseudomallei virulence.  In addn., pleiotropic effects were obsd. with a redn. in virulence mechanisms, including resistance to host killing mechanisms, swarming motility, and protease prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonwE-0EBbhELVg90H21EOLACvtfcHk0li1Z6xqK7PJTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsb3J&md5=e3e843c0b64df456016cac4a01184d80</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FIAI.00134-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00134-11%26sid%3Dliteratum%253Aachs%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DHarding%26aufirst%3DS.%2BV.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DKeith%26aufirst%3DK.%2BE.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DTitball%26aufirst%3DR.%2BW.%26atitle%3DA%2520Burkholderia%2520pseudomallei%2520Macrophage%2520Infectivity%2520Potentiator-like%2520Protein%2520has%2520Rapamycin-Inhibitable%2520Peptidylprolyl%2520Isomerase%2520Activity%2520and%2520Pleiotropic%2520Effects%2520on%2520Virulence%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26issue%3D11%26spage%3D4299%26epage%3D4307%26doi%3D10.1128%2FIAI.00134-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. D.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Calcineurin is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(91)90124-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0092-8674%2891%2990124-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1715244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1991&pages=807-815&issue=4&author=J.+Liuauthor=J.+D.+Farmerauthor=W.+S.+Laneauthor=J.+Friedmanauthor=I.+Weissmanauthor=S.+L.+Schreiber&title=Calcineurin+is+a+Common+Target+of+Cyclophilin-Cyclosporin+A+and+FKBP-FK506+Complexes&doi=10.1016%2F0092-8674%2891%2990124-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span></div><div class="casAuthors">Liu, Jun; Farmer, Jesse D., Jr.; Lane, Willam S.; Friedman, Jeff; Weissman, Irving; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Although the immediate receptors (immunophilins) of the immunosuppressants cyclosporin A (CsA) and FK506 are distinct, their similar mechanisms of inhibition of cell signaling suggest that their assocd. immunophilin complexes interact with a common target.  The authors report that the complexes cyclophilin-CsA and FKBP-FK506 (but not cyclophilin, FKBP, FKBP-rapamycin, or FKBP-506BD) competitively bind to and inhibit the Ca2+- and calmodulin-dependent phosphatase calcineurin, although the binding and inhibition of calcineurin do not require calmodulin.  These results suggest that calcineurin is involved in a common step assocd. with T cell receptor and IgE receptor signaling pathways and that cyclophilin and FKBP mediate the actions of CsA and FK506, resp., by forming drug-dependent complexes with and altering the activity of calcineurin-calmodulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfN8mg-hNhLVg90H21EOLACvtfcHk0li1Z6xqK7PJTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D&md5=00c4883ea86e6b2c554f8f72ed717ac9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990124-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990124-H%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DJ.%2BD.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DCalcineurin%2520is%2520a%2520Common%2520Target%2520of%2520Cyclophilin-Cyclosporin%2520A%2520and%2520FKBP-FK506%2520Complexes%26jtitle%3DCell%26date%3D1991%26volume%3D66%26issue%3D4%26spage%3D807%26epage%3D815%26doi%3D10.1016%2F0092-8674%2891%2990124-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span> <span> </span><span class="NLM_article-title">The Cyclophilins</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">226</span>, <span class="refDoi"> DOI: 10.1186/gb-2005-6-7-226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1186%2Fgb-2005-6-7-226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15998457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BD2Mzks1Ohsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=226&issue=7&author=P.+Wangauthor=J.+Heitman&title=The+Cyclophilins&doi=10.1186%2Fgb-2005-6-7-226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilins</span></div><div class="casAuthors">Wang Ping; Heitman Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">226</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclophilins (Enzyme Commission (EC) number 5.1.2.8) belong to a group of proteins that have peptidyl-prolyl cis-trans isomerase activity; such proteins are collectively known as immunophilins and also include the FK-506-binding proteins and the parvulins.  Cyclophilins are found in all cells of all organisms studied, in both prokaryotes and eukaryotes; humans have a total of 16 cyclophilin proteins, Arabidopsis up to 29 and Saccharomyces 8.  The first member of the cyclophilins to be identified in mammals, cyclophilin A, is the major cellular target for, and thus mediates the actions of, the immunosuppressive drug cyclosporin A.  Cyclophilin A forms a ternary complex with cyclosporin A and the calcium-calmodulin-activated serine/threonine-specific protein phosphatase calcineurin; formation of this complex prevents calcineurin from regulating cytokine gene transcription.  Recent studies have implicated a diverse array of additional cellular functions for cyclophilins, including roles as chaperones and in cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS24wrjwlZ9Y4NpW7w2tapOfW6udTcc2eYh9CTfvXEtqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mzks1Ohsg%253D%253D&md5=eed8b951aea639edbafabd50568d2ac8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2Fgb-2005-6-7-226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2005-6-7-226%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DHeitman%26aufirst%3DJ.%26atitle%3DThe%2520Cyclophilins%26jtitle%3DGenome%2520Biol.%26date%3D2005%26volume%3D6%26issue%3D7%26spage%3D226%26doi%3D10.1186%2Fgb-2005-6-7-226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luban, J.</span></span> <span> </span><span class="NLM_article-title">Isolation, Characterization and Targeted Disruption of Mouse Ppia: Cyclophilin A is not Essential for Mammalian Cell Viability</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1006/geno.2000.6295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1006%2Fgeno.2000.6295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10964515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVaks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=167-178&issue=2&author=J.+Colganauthor=M.+Asmalauthor=J.+Luban&title=Isolation%2C+Characterization+and+Targeted+Disruption+of+Mouse+Ppia%3A+Cyclophilin+A+is+not+Essential+for+Mammalian+Cell+Viability&doi=10.1006%2Fgeno.2000.6295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, characterization and targeted disruption of mouse Ppia: cyclophilin A is not essential for mammalian cell viability</span></div><div class="casAuthors">Colgan, John; Asmal, Mohammed; Luban, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-178</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Cyclophilins (CyPs) are a family of proteins found in organisms ranging from prokaryotes to humans.  These mols. exhibit peptidyl-prolyl isomerase activity in vitro, suggesting that they influence the conformation of proteins in cells.  CyPs also bind with varying affinities to the immunosuppressive drug cyclosporin A (CsA), a compd. used clin. to prevent allograft rejection.  The founding member of the family, cyclophilin A (CyPA), is an abundant, ubiquitously expressed protein of unknown function that binds with nanomolar affinity to CsA.  Here, we describe the isolation and characterization of mouse Ppia (mPpia), the gene encoding CyPA.  Ppia was isolated using a PCR screen that distinguishes the expressed gene from multiple pseudogenes present in the mouse genome. mPpia consists of 5 exons and 4 introns spanning roughly 4.5 kb and maps to chromosome 11 near the centromere.  Sequence anal. of a 369-bp fragment from the proximal promoter region of mPpia revealed the presence of a TATA box and sites recognized by several transcriptional regulators, including Sp1, AP-2, GATA factors, c-Myb, and NF-IL-6.  This region is sufficient to drive high-level reporter gene expression in transfected cells.  Both copies of Ppia were disrupted in murine embryonic stem (ES) cells via gene targeting.  Ppia-/- ES cells grow normally and differentiate into hematopoietic precursor cells in vitro, indicating that CyPA is not essential for mammalian cell viability.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTk1hMnKpswrVg90H21EOLACvtfcHk0li1_ViKW0w61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVaks74%253D&md5=c8e33a9460afa4e3dd1b02bc420134a2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1006%2Fgeno.2000.6295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.2000.6295%26sid%3Dliteratum%253Aachs%26aulast%3DColgan%26aufirst%3DJ.%26aulast%3DAsmal%26aufirst%3DM.%26aulast%3DLuban%26aufirst%3DJ.%26atitle%3DIsolation%252C%2520Characterization%2520and%2520Targeted%2520Disruption%2520of%2520Mouse%2520Ppia%253A%2520Cyclophilin%2520A%2520is%2520not%2520Essential%2520for%2520Mammalian%2520Cell%2520Viability%26jtitle%3DGenomics%26date%3D2000%26volume%3D68%26issue%3D2%26spage%3D167%26epage%3D178%26doi%3D10.1006%2Fgeno.2000.6295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frausto, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span> <span> </span><span class="NLM_article-title">Cyclophilins as Modulators of Viral Replication</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1684</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.3390/v5071684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Fv5071684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23852270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Squ7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1684-1701&issue=7&author=S.+D.+Fraustoauthor=E.+Leeauthor=H.+Tang&title=Cyclophilins+as+Modulators+of+Viral+Replication&doi=10.3390%2Fv5071684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilins as modulators of viral replication</span></div><div class="casAuthors">Frausto, Stephen D.; Lee, Emily; Tang, Hengli</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1684-1701</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Cyclophilins are peptidyl-prolyl cis/trans isomerases important in the proper folding of certain proteins.  Mounting evidence supports varied roles of cyclophilins, either pos. or neg., in the life cycles of diverse viruses, but the nature and mechanisms of these roles are yet to be defined.  The potential for cyclophilins to serve as a drug target for antiviral therapy is evidenced by the success of non-immunosuppressive cyclophilin inhibitors (CPIs), including Alisporivir, in clin. trials targeting hepatitis C virus infection.  In addn., as cyclophilins are implicated in the predisposition to, or severity of, various diseases, the ability to specifically and effectively modulate their function will prove increasingly useful for disease intervention.  In this review, we will summarize the evidence of cyclophilins as key mediators of viral infection and prospective drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzkac6M6NnLbVg90H21EOLACvtfcHk0li1_ViKW0w61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Squ7nF&md5=ce32f7f31012ac027240193c31f384d8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3390%2Fv5071684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5071684%26sid%3Dliteratum%253Aachs%26aulast%3DFrausto%26aufirst%3DS.%2BD.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DH.%26atitle%3DCyclophilins%2520as%2520Modulators%2520of%2520Viral%2520Replication%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26issue%3D7%26spage%3D1684%26epage%3D1701%26doi%3D10.3390%2Fv5071684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span> <span> </span><span class="NLM_article-title">Microbial Cyclophilins: Specialized Functions in Virulence and Beyond</span>. <i>World J. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">164</span>, <span class="refDoi"> DOI: 10.1007/s11274-017-2330-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2Fs11274-017-2330-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28791545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1cflvFajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2017&pages=164&issue=9&author=M.+Dimouauthor=A.+Venierakiauthor=P.+Katinakis&title=Microbial+Cyclophilins%3A+Specialized+Functions+in+Virulence+and+Beyond&doi=10.1007%2Fs11274-017-2330-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial cyclophilins: specialized functions in virulence and beyond</span></div><div class="casAuthors">Dimou Maria; Venieraki Anastasia; Katinakis Panagiotis</div><div class="citationInfo"><span class="NLM_cas:title">World journal of microbiology & biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">164</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclophilins belong to the superfamily of peptidyl-prolyl cis/trans isomerases (PPIases, EC: 5.2.1.8), the enzymes that catalyze the cis/trans isomerization of peptidyl-prolyl peptide bonds in unfolded and partially folded polypeptide chains and native state proteins.  Cyclophilins have been extensively studied, since they are involved in multiple cellular processes related to human pathologies, such as neurodegenerative disorders, infectious diseases, and cancer.  However, the presence of cyclophilins in all domains of life indicates a broader biological importance.  In this mini-review, we summarize current advances in the study of microbial cyclophilins.  Apart from their anticipated role in protein folding and chaperoning, cyclophilins are involved in several other biological processes, such as cellular signal transduction, adaptation to stress, control of pathogens virulence, and modulation of host immune response.  Since many existing family members do not have well-defined functions and novel ones are being characterized, the requirement for further studies on their biological role and molecular mechanism of action is apparent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH-SHNg_NDmpdYoSR9eyvsfW6udTcc2eYHuYr9R0O5Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cflvFajsw%253D%253D&md5=abd1fbd47eb869f056a8b18b7e383137</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11274-017-2330-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11274-017-2330-6%26sid%3Dliteratum%253Aachs%26aulast%3DDimou%26aufirst%3DM.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKatinakis%26aufirst%3DP.%26atitle%3DMicrobial%2520Cyclophilins%253A%2520Specialized%2520Functions%2520in%2520Virulence%2520and%2520Beyond%26jtitle%3DWorld%2520J.%2520Microbiol.%2520Biotechnol.%26date%3D2017%26volume%3D33%26issue%3D9%26spage%3D164%26doi%3D10.1007%2Fs11274-017-2330-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipping, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucknagel, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kullertz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Selective Inactivation of Parvulin-Like Peptidyl-Prolyl Cis/Trans Isomerases by Juglone</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5953</span>– <span class="NLM_lpage">5960</span>, <span class="refDoi"> DOI: 10.1021/bi973162p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi973162p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXislKksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=5953-5960&issue=17&author=L.+Hennigauthor=C.+Christnerauthor=M.+Kippingauthor=B.+Schelbertauthor=K.+P.+Rucknagelauthor=S.+Grableyauthor=G.+Kullertzauthor=G.+Fischer&title=Selective+Inactivation+of+Parvulin-Like+Peptidyl-Prolyl+Cis%2FTrans+Isomerases+by+Juglone&doi=10.1021%2Fbi973162p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone</span></div><div class="casAuthors">Hennig, Lars; Christner, Claudia; Kipping, Marc; Schelbert, Birte; Rucknagel, Karl Peter; Grabley, Susanne; Kullertz, Gerd; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5953-5960</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In contrast to FK506-binding proteins and cyclophilins, the parvulin family of peptidylprolyl cis/trans-isomerases (PPIases; EC 5.2.1.8) cannot be inhibited by either FK506 or cyclosporin A.  Here, the authors found that juglone (5-hydroxy-1,4-naphthoquinone) (I) irreversibly inhibited the enzymic activity of several parvulin PPIases, like E. coli parvulin, yeast Ess1/Ptf1, and human Pin1 PPIases, in a specific manner, thus allowing selective inactivation of these enzymes in the presence of other PPIases.  The mode of action was studied by analyzing the inactivation kinetics and the nature of products of the reaction of E. coli parvulin and its C69A variant with I.  For all parvulins investigated, complete inactivation was obtained by a slow process that was characterized by pseudo-1st-order rate consts. in the range of 5.3 x 10-4 to 4.5 x 10-3 s-1.  The inactivated parvulin contained 2 I mols. that were covalently bound to the side-chains of Cys-41 and Cys-69 because of Michael addn. of the SH groups to I.  Redox reactions did not contribute to the inactivation process.  Because SH group modification was shown to proceed 5-fold faster than the rate of enzyme inactivation, it was considered as a necessary but not sufficient condition for inactivation.  When measured by far-UV CD, the rate of structural alterations following SH group modification paralleled exactly the rate of inactivation.  Thus, partial unfolding of the active site of the parvulins is thought to be the cause of the deterioration of PPIase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRTKWIkst6ibVg90H21EOLACvtfcHk0li1_ViKW0w61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislKksbg%253D&md5=82ced741f4f63486c8c677a9a05915dc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi973162p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi973162p%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DChristner%26aufirst%3DC.%26aulast%3DKipping%26aufirst%3DM.%26aulast%3DSchelbert%26aufirst%3DB.%26aulast%3DRucknagel%26aufirst%3DK.%2BP.%26aulast%3DGrabley%26aufirst%3DS.%26aulast%3DKullertz%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DSelective%2520Inactivation%2520of%2520Parvulin-Like%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%2520by%2520Juglone%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D17%26spage%3D5953%26epage%3D5960%26doi%3D10.1021%2Fbi973162p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tradler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a 14 kDa Human Protein as a Novel Parvulin-Like Peptidyl Prolyl Cis/Trans Isomerase</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>446</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00239-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0014-5793%2899%2900239-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10100858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVCmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=1999&pages=278-282&issue=2%E2%80%933&author=T.+Uchidaauthor=F.+Fujimoriauthor=T.+Tradlerauthor=G.+Fischerauthor=J.-U.+Rahfeld&title=Identification+and+Characterization+of+a+14+kDa+Human+Protein+as+a+Novel+Parvulin-Like+Peptidyl+Prolyl+Cis%2FTrans+Isomerase&doi=10.1016%2FS0014-5793%2899%2900239-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase</span></div><div class="casAuthors">Uchida, Takafumi; Fujimori, Fumihiro; Tradler, Thomas; Fischer, Gunter; Rahfeld, Jens-U.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">2,3</span>),
    <span class="NLM_cas:pages">278-282</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A second member of the parvulin family of peptidyl-prolyl cis/trans isomerases was identified in a human lung cDNA library.  The gene encoded a protein named hPar14 that has 131 amino acid residues and a mol. mass of 13676 Da.  Sequence comparison showed 34.5% identity to E. coli Par10 and 34% identity to human Pin1 (hPar18) within a C-terminal region of 87 or 120 amino acid residues, resp.  In comparison to the E. coli Par10, hPar14 possesses a N-terminal extension of 41 amino acid residues.  This extension does not contain a polyproline II helix-binding motif typical of the known eukaryotic parvulins.  The hPar14 does not accelerate the cis to trans interconversion of oligopeptides with side chain-phosphorylated Ser(Thr)-Pro moieties as hPin1 did.  In contrast, it showed preference of an arginine residue adjacent N-terminal to proline.  Northern blot anal. revealed expression of the gene within various human tissues like heart, placenta, liver, kidney and pancreas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraEVwDIawjfbVg90H21EOLACvtfcHk0lgS7m0DJW4vfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVCmtbo%253D&md5=540534ee06ec8471d467cdd60489beb8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900239-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900239-2%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DT.%26aulast%3DFujimori%26aufirst%3DF.%26aulast%3DTradler%26aufirst%3DT.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%252014%2520kDa%2520Human%2520Protein%2520as%2520a%2520Novel%2520Parvulin-Like%2520Peptidyl%2520Prolyl%2520Cis%252FTrans%2520Isomerase%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D446%26issue%3D2%25E2%2580%25933%26spage%3D278%26epage%3D282%26doi%3D10.1016%2FS0014-5793%2899%2900239-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kühlewein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez Alvarez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemmecker, G.</span></span> <span> </span><span class="NLM_article-title">Solution Structure of Escherichia coli Par10: The Prototypic Member of the Parvulin Family of Peptidyl-Prolyl Cis/Trans Isomerases</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2378</span>– <span class="NLM_lpage">2387</span>, <span class="refDoi"> DOI: 10.1110/ps.04756704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1110%2Fps.04756704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15322281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1eltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=2378-2387&issue=9&author=A.+K%C3%BChleweinauthor=G.+Vollauthor=B.+Hernandez+Alvarezauthor=H.+Kesslerauthor=G.+Fischerauthor=J.+U.+Rahfeldauthor=G.+Gemmecker&title=Solution+Structure+of+Escherichia+coli+Par10%3A+The+Prototypic+Member+of+the+Parvulin+Family+of+Peptidyl-Prolyl+Cis%2FTrans+Isomerases&doi=10.1110%2Fps.04756704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Solution structure of Escherichia coli Par10: The prototypic member of the Parvulin family of peptidyl-prolyl cis/trans isomerases</span></div><div class="casAuthors">Kuehlewein, Angelika; Voll, Georg; Alvarez, Birte Hernandez; Kessler, Horst; Fischer, Gunter; Rahfeld, Jens-Ulrich; Gemmecker, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2378-2387</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">E. coli Par10 is a peptidyl-prolyl cis/trans isomerase (PPIase) from Escherichia coli catalyzing the isomerization of Xaa-Pro bonds in oligopeptides with a broad substrate specificity.  The structure of E. coli Par10 has been detd. by multidimensional soln.-state NMR spectroscopy based on 1207 conformational constraints (1067 NOE-derived distances, 42 vicinal coupling-const. restraints, 30 hydrogen-bond restraints, and 68 σ/ψ restraints derived from the Chem. Shift Index).  Simulated-annealing calcns. with the program ARIA and subsequent refinement with XPLOR yielded a set of 18 convergent structures with an av. backbone RMSD from mean at. coordinates of 0.50 Å within the well-defined secondary structure elements.  E. coli Par10 is the smallest known PPIase so far, with a high catalytic efficiency comparable to that of FKBPs and cyclophilins.  The secondary structure of E. coli Par10 consists of four helical regions and a four-stranded antiparallel β-sheet.  The N terminus forms a β-strand, followed by a large stretch comprising three α-helixes.  A loop region contg. a short β-strand separates these helixes from a fourth α-helix.  The C terminus consists of two more β-strands completing the four-stranded antiparallel β-sheet with strand order 2143.  Interestingly, the third β-strand includes a Gly-Pro cis peptide bond.  The curved β-strand forms a hydrophobic binding pocket together with α-helix 4, which also contains a no. of highly conserved residues.  The three-dimensional structure of Par10 closely resembles that of the human proteins hPin1 and hPar14 and the plant protein Pin1At, belonging to the same family of highly homologous proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkYnAREVfwRrVg90H21EOLACvtfcHk0lgS7m0DJW4vfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1eltbg%253D&md5=e3f52cb727cef1d32a2058c99112173d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1110%2Fps.04756704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.04756704%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25BChlewein%26aufirst%3DA.%26aulast%3DVoll%26aufirst%3DG.%26aulast%3DHernandez%2BAlvarez%26aufirst%3DB.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DGemmecker%26aufirst%3DG.%26atitle%3DSolution%2520Structure%2520of%2520Escherichia%2520coli%2520Par10%253A%2520The%2520Prototypic%2520Member%2520of%2520the%2520Parvulin%2520Family%2520of%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%26jtitle%3DProtein%2520Sci.%26date%3D2004%26volume%3D13%26issue%3D9%26spage%3D2378%26epage%3D2387%26doi%3D10.1110%2Fps.04756704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arévalo-Rodríguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardenas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin A and Ess1 Interact with and Regulate Silencing by the Sin3–Rpd3 Histone Deacetylase</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3739</span>– <span class="NLM_lpage">3749</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.14.3739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F19.14.3739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10899127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=3739-3749&issue=14&author=M.+Ar%C3%A9valo-Rodr%C3%ADguezauthor=M.+E.+Cardenasauthor=X.+Wuauthor=S.+D.+Hanesauthor=J.+Heitman&title=Cyclophilin+A+and+Ess1+Interact+with+and+Regulate+Silencing+by+the+Sin3%E2%80%93Rpd3+Histone+Deacetylase&doi=10.1093%2Femboj%2F19.14.3739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase</span></div><div class="casAuthors">Arevalo-Rodriguez, Miguel; Cardenas, Maria E.; Wu, Xiaoyun; Hanes, Steven D.; Heitman, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3739-3749</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Three families of prolyl isomerases have been identified: cyclophilins, FK506-binding proteins (FKBPs) and parvulins.  All 12 cyclophilins and FKBPs are dispensable for growth in yeast, whereas the one parvulin homolog, Ess1, is essential.  We report here that cyclophilin A becomes essential when Ess1 function is compromised.  Overexpression of cyclophilin A suppresses ess1 conditional and null mutations, and that cyclophilin A enzymic activity is required for suppression.  Cyclophilin A and Ess1 function in parallel pathways and act on common targets by a mechanism that requires prolyl isomerization.  Using genetic and biochem. approaches, we found that one of these targets is the Sin3-Rpd3 histone deacetylase complex, and that cyclophilin A increases and Ess1 decreases disruption of gene silencing by this complex.  Conditions that favor acetylation over deacetylation suppress ess1 mutations.  Our findings support a model in which Ess1 and cyclophilin A modulate the activity of the Sin3-Rpd3 complex, and excess histone deacetylation causes mitotic arrest in ess1 mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIrKL0kyLOfbVg90H21EOLACvtfcHk0lgS7m0DJW4vfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7c%253D&md5=ea8489b48b1a3841ba0557b1cee735ed</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.14.3739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.14.3739%26sid%3Dliteratum%253Aachs%26aulast%3DAr%25C3%25A9valo-Rodr%25C3%25ADguez%26aufirst%3DM.%26aulast%3DCardenas%26aufirst%3DM.%2BE.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHanes%26aufirst%3DS.%2BD.%26aulast%3DHeitman%26aufirst%3DJ.%26atitle%3DCyclophilin%2520A%2520and%2520Ess1%2520Interact%2520with%2520and%2520Regulate%2520Silencing%2520by%2520the%2520Sin3%25E2%2580%2593Rpd3%2520Histone%2520Deacetylase%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D14%26spage%3D3739%26epage%3D3749%26doi%3D10.1093%2Femboj%2F19.14.3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devasahayam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arévalo-Rodríguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardenas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, S. D.</span></span> <span> </span><span class="NLM_article-title">The Ess1 Prolyl Isomerase is Linked to Chromatin Remodeling Complexes and the General Transcription Machinery</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3727</span>– <span class="NLM_lpage">3738</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.14.3727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F19.14.3727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10899126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=3727-3738&issue=14&author=X.+Wuauthor=C.+B.+Wilcoxauthor=G.+Devasahayamauthor=R.+L.+Hackettauthor=M.+Ar%C3%A9valo-Rodr%C3%ADguezauthor=M.+E.+Cardenasauthor=J.+Heitmanauthor=S.+D.+Hanes&title=The+Ess1+Prolyl+Isomerase+is+Linked+to+Chromatin+Remodeling+Complexes+and+the+General+Transcription+Machinery&doi=10.1093%2Femboj%2F19.14.3727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery</span></div><div class="casAuthors">Wu, Xiaoyun; Wilcox, Cathy B.; Devasahayam, Gina; Hackett, Robin L.; Arevalo-Rodriguez, Miguel; Cardenas, Maria E.; Heitman, Joseph; Hanes, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3727-3738</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Ess1/Pin1 peptidyl-prolyl isomerase (PPIase) is thought to control mitosis by binding to cell cycle regulatory proteins and altering their activity.  Here we isolate temp.-sensitive ess1 mutants and identify six multi-copy suppressors that rescue their mitotic-lethal phenotype.  None are cell cycle regulators.  Instead, five encode proteins involved in transcription that bind DNA, modify chromatin structure or are regulatory subunits of RNA polymerase II.  A sixth suppressor, cyclophilin A, is a member of a distinct family of PPIases that are targets of immunosuppressive drugs.  We show that the expression of some but not all genes is decreased in ess1 mutants, and that Ess1 interacts with the C-terminal domain (CTD) of RNA polymerase II in vitro and in vivo.  The results forge a strong link between PPIases and the transcription machinery and suggest a new model for how Ess1/Pin1 controls mitosis.  In this model, Ess1 binds and isomerizes the CTD of RNA polymerase II, thus altering its interaction with proteins required for transcription of essential cell cycle genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqerNTHSjgJ67Vg90H21EOLACvtfcHk0liwdfaNqm2gzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7Y%253D&md5=03d5a9c9fc41ff6a1a92fce16ca56490</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.14.3727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.14.3727%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWilcox%26aufirst%3DC.%2BB.%26aulast%3DDevasahayam%26aufirst%3DG.%26aulast%3DHackett%26aufirst%3DR.%2BL.%26aulast%3DAr%25C3%25A9valo-Rodr%25C3%25ADguez%26aufirst%3DM.%26aulast%3DCardenas%26aufirst%3DM.%2BE.%26aulast%3DHeitman%26aufirst%3DJ.%26aulast%3DHanes%26aufirst%3DS.%2BD.%26atitle%3DThe%2520Ess1%2520Prolyl%2520Isomerase%2520is%2520Linked%2520to%2520Chromatin%2520Remodeling%2520Complexes%2520and%2520the%2520General%2520Transcription%2520Machinery%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D14%26spage%3D3727%26epage%3D3738%26doi%3D10.1093%2Femboj%2F19.14.3727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">A Human Peptidyl–Prolyl Isomerase Essential for Regulation of Mitosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>380</i></span> (<span class="NLM_issue">6574</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1038/380544a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2F380544a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8606777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28Xit1OlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=1996&pages=544-547&issue=6574&author=K.+P.+Luauthor=S.+D.+Hanesauthor=T.+Hunter&title=A+Human+Peptidyl%E2%80%93Prolyl+Isomerase+Essential+for+Regulation+of+Mitosis&doi=10.1038%2F380544a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A human peptidyl-prolyl isomerase essential for regulation of mitosis</span></div><div class="casAuthors">Lu, Kun Ping; Hanes, Steven D.; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">6574</span>),
    <span class="NLM_cas:pages">544-47</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The NIMA kinase is essential for progression through mitosis in Aspergillus nidulans, and there is evidence for a similar pathway in other eukaryotic cells.  Here we describe the human protein Pin1, a peptidyl-prolyl cis/trans isomerase (PPIase) that interacts with NIMA.  PPIases are important in protein folding, assembly and/or transport, but none has so far been shown to be required for cell viability.  Pin1 is a nuclear PPIase contg. a WW protein interaction domain, and is structurally and functionally related to Ess1/Ptf1, an essential protein in budding yeast.  PPIase activity is necessary for Ess1/Pin1 function in yeast.  Depletion of Pin1/Ess1 from yeast or HeLa cells induces mitotic arrest, whereas HeLa cells overexpressing Pin1 arrest in the G2 phase of the cell cycle.  Pin1 is thus an essential PPIase that regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0nwXEw0tdW7Vg90H21EOLACvtfcHk0liwdfaNqm2gzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit1OlsLo%253D&md5=8201ab5160fa87f0401a42524b0ea735</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F380544a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F380544a0%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DHanes%26aufirst%3DS.%2BD.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DA%2520Human%2520Peptidyl%25E2%2580%2593Prolyl%2520Isomerase%2520Essential%2520for%2520Regulation%2520of%2520Mitosis%26jtitle%3DNature%26date%3D1996%26volume%3D380%26issue%3D6574%26spage%3D544%26epage%3D547%26doi%3D10.1038%2F380544a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornbluth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Means, A. R.</span></span> <span> </span><span class="NLM_article-title">Requirement of the Prolyl Isomerase Pin1 for the Replication Checkpoint</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">5458</span>),  <span class="NLM_fpage">1644</span>– <span class="NLM_lpage">1647</span>, <span class="refDoi"> DOI: 10.1126/science.287.5458.1644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.287.5458.1644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10698738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhs1Oqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1644-1647&issue=5458&author=K.+E.+Winklerauthor=K.+I.+Swensonauthor=S.+Kornbluthauthor=A.+R.+Means&title=Requirement+of+the+Prolyl+Isomerase+Pin1+for+the+Replication+Checkpoint&doi=10.1126%2Fscience.287.5458.1644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of the prolyl isomerase Pin 1 for the replication checkpoint</span></div><div class="casAuthors">Winkler, Katharine E.; Swenson, Katherine I.; Kornbluth, Sally; Means, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">5458</span>),
    <span class="NLM_cas:pages">1644-1647</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The peptidyl-prolyl isomerase Pin 1 has been implicated in regulating cell cycle progression.  Pin 1 was found to be required for the DNA replication checkpoint in Xenopus laevis.  Egg exts. depleted in Pin 1 inappropriately transited from the G2 to the M phase of the cell cycle in the presence of the DNA replication inhibitor aphidicolin.  This defect in replication checkpoint function was reversed after the addn. of recombinant wild-type Pin 1, but not an isomerase-inactive mutant, to the depleted ext.  Premature mitotic entry in the absence of Pin 1 was accompanied by hyperphosphorylation of Cdc25, activation of Cdc2/cyclin B, and generation of epitopes recognized by the mitotic phosphoprotein antibody, MPM-2.  Therefore, Pin 1 appears to be required for the checkpoint delaying the onset of mitosis in response to incomplete replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpXYoKixAdXLVg90H21EOLACvtfcHk0liwdfaNqm2gzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhs1Oqsb0%253D&md5=2144fa569345deff1797149105ffc999</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.287.5458.1644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.287.5458.1644%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DK.%2BE.%26aulast%3DSwenson%26aufirst%3DK.%2BI.%26aulast%3DKornbluth%26aufirst%3DS.%26aulast%3DMeans%26aufirst%3DA.%2BR.%26atitle%3DRequirement%2520of%2520the%2520Prolyl%2520Isomerase%2520Pin1%2520for%2520the%2520Replication%2520Checkpoint%26jtitle%3DScience%26date%3D2000%26volume%3D287%26issue%3D5458%26spage%3D1644%26epage%3D1647%26doi%3D10.1126%2Fscience.287.5458.1644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suizu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrem, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottapel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1413</span>– <span class="NLM_lpage">1426</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(03)00490-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS1097-2765%2803%2900490-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14690596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1413-1426&issue=6&author=A.+Ryoauthor=F.+Suizuauthor=Y.+Yoshidaauthor=K.+Perremauthor=Y.-C.+Liouauthor=G.+Wulfauthor=R.+Rottapelauthor=S.+Yamaokaauthor=K.+P.+Lu&title=Regulation+of+NF-%CE%BAB+Signaling+by+Pin1-Dependent+Prolyl+Isomerization+and+Ubiquitin-Mediated+Proteolysis+of+p65%2FRelA&doi=10.1016%2FS1097-2765%2803%2900490-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of NF-κB signaling by pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA</span></div><div class="casAuthors">Ryo, Akihide; Suizu, Futoshi; Yoshida, Yasuhiro; Perrem, Kilian; Liou, Yih-cherng; Wulf, Gerburg; Rottapel, Robert; Yamaoka, Shoji; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1413-1426</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The transcription factor NF-κB is activated by the degrdn. of its inhibitor IκBα, resulting in its nuclear translocation.  However, the mechanism by which nuclear NF-κB is subsequently regulated is not clear.  Here we demonstrate that NF-κB function is regulated by Pin1-mediated prolyl isomerization and ubiquitin-mediated proteolysis of its p65/RelA subunit.  Upon cytokine treatment, Pin1 binds to the pThr254-Pro motif in p65 and inhibits p65 binding to IκBα, resulting in increased nuclear accumulation and protein stability of p65 and enhanced NF-κB activity.  Significantly, Pin1-deficient mice and cells are refractory to NF-κB activation by cytokine signals.  Moreover, the stability of p65 is controlled by ubiquitin-mediated proteolysis, facilitated by a cytokine signal inhibitor, SOCS-1, acting as a ubiquitin ligase.  These findings uncover two important mechanisms of regulating NF-κB signaling and offer new insight into the pathogenesis and treatment of some human diseases such as cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrGVvGft_Ph7Vg90H21EOLACvtfcHk0ljwiljVIBMx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVOlsw%253D%253D&md5=e073ddc40259d3397fd54394e186a8d8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900490-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900490-8%26sid%3Dliteratum%253Aachs%26aulast%3DRyo%26aufirst%3DA.%26aulast%3DSuizu%26aufirst%3DF.%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DPerrem%26aufirst%3DK.%26aulast%3DLiou%26aufirst%3DY.-C.%26aulast%3DWulf%26aufirst%3DG.%26aulast%3DRottapel%26aufirst%3DR.%26aulast%3DYamaoka%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DRegulation%2520of%2520NF-%25CE%25BAB%2520Signaling%2520by%2520Pin1-Dependent%2520Prolyl%2520Isomerization%2520and%2520Ubiquitin-Mediated%2520Proteolysis%2520of%2520p65%252FRelA%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26issue%3D6%26spage%3D1413%26epage%3D1426%26doi%3D10.1016%2FS1097-2765%2803%2900490-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Prolyl isomerase Pin1 as a Molecular Target for Cancer Diagnostics and Therapeutics</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00218-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS1535-6108%2803%2900218-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14522251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=175-180&issue=3&author=K.+P.+Lu&title=Prolyl+isomerase+Pin1+as+a+Molecular+Target+for+Cancer+Diagnostics+and+Therapeutics&doi=10.1016%2FS1535-6108%2803%2900218-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics</span></div><div class="casAuthors">Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-180</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review on the features of prolyl isomerase (Pin1) as a mol. target for cancer diagnostics and therapeutics.  Pin1 may function as a crit. catalyst that potentiates multiple oncogenic signaling mechanisms during cancer development.  As a result, Pin1 inhibitors should simultaneously inhibit multiple oncogenic signaling pathways, which may circumvent the characteristics genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbiLNVGyY43bVg90H21EOLACvtfcHk0ljwiljVIBMx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKlsro%253D&md5=61949fee4140e48464256aa7025b5733</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900218-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900218-6%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DProlyl%2520isomerase%2520Pin1%2520as%2520a%2520Molecular%2520Target%2520for%2520Cancer%2520Diagnostics%2520and%2520Therapeutics%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26issue%3D3%26spage%3D175%26epage%3D180%26doi%3D10.1016%2FS1535-6108%2803%2900218-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dartigalongue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, S.</span></span> <span> </span><span class="NLM_article-title">A New Heat-Shock Gene, ppiD, Encodes a Peptidyl–Prolyl Isomerase Required for Folding of Outer Membrane Proteins in Escherichia coli</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3968</span>– <span class="NLM_lpage">3980</span>, <span class="refDoi"> DOI: 10.1093/emboj/17.14.3968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F17.14.3968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9670013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXltFygt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=3968-3980&issue=14&author=C.+Dartigalongueauthor=S.+Raina&title=A+New+Heat-Shock+Gene%2C+ppiD%2C+Encodes+a+Peptidyl%E2%80%93Prolyl+Isomerase+Required+for+Folding+of+Outer+Membrane+Proteins+in+Escherichia+coli&doi=10.1093%2Femboj%2F17.14.3968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A new heat-shock gene, ppiD, encodes a peptidylprolyl isomerase required for folding of outer membrane proteins in Escherichia coli</span></div><div class="casAuthors">Dartigalongue, Claire; Raina, Satish</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3968-3980</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We have identified a new folding catalyst, PpiD, in the periplasm of Escherichia coli.  The gene encoding PpiD was isolated as a multicopy suppressor of surA, a mutation which severely impairs the folding of outer membrane proteins (OMPs).  The ppiD gene was also identified based on its ability to be transcribed by the two-component system CpxR-CpxA.  PpiD was purified to homogeneity and shown to have peptidyl-prolyl isomerase (PPIase) activity in vitro.  The protein is anchored to the inner membrane via a single transmembrane segment, and its catalytic domain faces the periplasm.  In addn., we have identified by site-directed mutagenesis some of the residues essential for its PPIase activity.  A null mutation in ppiD leads to an overall redn. in the level and folding of OMPs and to the induction of the periplasmic stress response.  The combination of ppiD and surA null mutations is lethal.  This is the first time two periplasmic folding catalysts have been shown to be essential.  Another unique aspect of PpiD is that its gene is regulated by both the Cpx two-component system and the σ32 heat shock factor, known to regulate the expression of cytoplasmic chaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYL8G1DMSHGrVg90H21EOLACvtfcHk0ljwiljVIBMx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFygt7Y%253D&md5=cd9ec23d3d04d5f75330410d084ebd55</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.14.3968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.14.3968%26sid%3Dliteratum%253Aachs%26aulast%3DDartigalongue%26aufirst%3DC.%26aulast%3DRaina%26aufirst%3DS.%26atitle%3DA%2520New%2520Heat-Shock%2520Gene%252C%2520ppiD%252C%2520Encodes%2520a%2520Peptidyl%25E2%2580%2593Prolyl%2520Isomerase%2520Required%2520for%2520Folding%2520of%2520Outer%2520Membrane%2520Proteins%2520in%2520Escherichia%2520coli%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26issue%3D14%26spage%3D3968%26epage%3D3980%26doi%3D10.1093%2Femboj%2F17.14.3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howard, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme-Johnson, W.</span></span> <span> </span><span class="NLM_article-title">Klebsiella pneumoniae nifM Gene Product is Required for Stabilization and Activation of Nitrogenase Iron Protein in Escherichia coli</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>261</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=3001082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL28XhtVemsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=772-778&issue=2&author=K.+S.+Howardauthor=P.+McLeanauthor=F.+Hansenauthor=P.+Lemleyauthor=K.+Koblanauthor=W.+Orme-Johnson&title=Klebsiella+pneumoniae+nifM+Gene+Product+is+Required+for+Stabilization+and+Activation+of+Nitrogenase+Iron+Protein+in+Escherichia+coli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Klebsiella pneumoniae nifM gene product is required for stabilization and activation of nitrogenase iron protein in Escherichia coli</span></div><div class="casAuthors">Howard, Karen S.; McLean, Paul A.; Hansen, Finn B.; Lemley, Paul V.; Koblan, Kenneth S.; Orme-Johnson, W. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">772-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A series of plasmids encoding various K. pneumoniae nif (N fixation) genes was constructed to det. which were required to produce active Fe protein in Escherichia coli, a species which does not normally fix N.  The greatest success was achieved with binary plasmid systems that produced nifA regulatory protein under the control of a tac promoter on 1 plasmid, which then induced synthesis of nifH and nifM proteins from their native promoter sites on a 2nd plasmid.  The nifH protein, the monomeric subunit of Fe protein, produced in the presence of nifM, constituted nearly 10% of the whole cell protein and exhibited the corresponding amt. of C2H2-reducing activity in nitrogenase assays conducted in vitro.  The nifH protein formed in the absence of nifM constituted 4.7% of the whole cell protein and exhibited no detectable activity in assays of whole cell exts.  The plasmid-encoded Fe protein was purified to homogeneity and was found to be indistinguishable from that isolated from derepressed wild-type K. pneumoniae, having a similar specific activity, ∼4 Fe/dimer of 68 kilodaltons, and similar EPR features.  Although these expts. do not exclude the participation of other E. coli gene products in the maturation of nifH protein, they limit the nif-specific genes required for active Fe protein prodn. to nifA, nifH, and nifM.  Since nifA is thought to be the required activator protein involved in nif operon transcription, the simplest explanation for these observations is that nifH codes for the peptide of the Fe protein, whereas nifM acts to convert this nifH peptide to the functioning Fe protein of nitrogenase [9013-04-1].  In the absence of nifM, only an inactive nifH polypeptide is produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3HHGVn-2IMrVg90H21EOLACvtfcHk0ljwiljVIBMx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhtVemsrc%253D&md5=aa314b8c63c442bcdea0a6b9ef79ff29</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DK.%2BS.%26aulast%3DMcLean%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DF.%26aulast%3DLemley%26aufirst%3DP.%26aulast%3DKoblan%26aufirst%3DK.%26aulast%3DOrme-Johnson%26aufirst%3DW.%26atitle%3DKlebsiella%2520pneumoniae%2520nifM%2520Gene%2520Product%2520is%2520Required%2520for%2520Stabilization%2520and%2520Activation%2520of%2520Nitrogenase%2520Iron%2520Protein%2520in%2520Escherichia%2520coli%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26issue%3D2%26spage%3D772%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D.</span></span> <span> </span><span class="NLM_article-title">The nifH, nifM and nifN Genes of Azotobacter vinelandii: Characterisation by Tn5 Mutagenesis and Isolation from pLAFR1 Gene Banks</span>. <i>Mol. Gen. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1007/BF00430445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2FBF00430445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2sXmtF2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1986&pages=318-325&issue=2&author=C.+Kennedyauthor=R.+Gamalauthor=R.+Humphreyauthor=J.+Ramosauthor=K.+Brigleauthor=D.+Dean&title=The+nifH%2C+nifM+and+nifN+Genes+of+Azotobacter+vinelandii%3A+Characterisation+by+Tn5+Mutagenesis+and+Isolation+from+pLAFR1+Gene+Banks&doi=10.1007%2FBF00430445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The nifH, nifM and nifN genes of Azotobacter vinelandii:  characterization by Tn5 mutagenesis and isolation from pLAFR1 gene banks</span></div><div class="casAuthors">Kennedy, Christina; Gamal, Rawia; Humphrey, Richard; Ramos, Juan; Brigle, Kevin; Dean, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and General Genetics</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-25</span>CODEN:
                <span class="NLM_cas:coden">MGGEAE</span>;
        ISSN:<span class="NLM_cas:issn">0026-8925</span>.
    </div><div class="casAbstract">Tn5 was introduced into A. vinelandii on a suicide vector, pGS9.  Three Nif- mutants were found to carry Tn5 in nifH (MV6), in nifN (MV22), and in or near nifM (MV21), from the results of hybridization expts.  For MV21 and MV22 this was also shown by complementation with the nif genes of Klebsiella pneumoniae on pRD1.  MV6 failed to synthesis the nifH, D, and K gene products.  MV6 and MV22 fixed nitrogen in the absence of supplied molybdenum while mutant MV21 did not, suggesting that the nifM gene product may be required for the alternative nitrogenase system synthesized in azotobacteria under conditions of molybdenum deprivation.  Reconstitution expts. with mutant exts. showed that MV22 (nifN-) lacked the FeMo cofactor and that MV21 (NifM-) synthesized inactive Fe protein.  These biochem. phenotypes are identical to those of the K. pneumoniae nifN and nifM mutants, resp., demonstrating that these genes have the same function in both K. pneumoniae and A. vinelandii.  Complementation of the A. vinelandii mutants with pLAFR1 gene banks of A. vinelandii or A. chroococcum yielded 3 cosmids of interest.  Plasmid pLV10 complemented UW91, a nifH mutant, and cor. the defect in MV6 after recombination with the mutant genome.  It also carried nifD (but not nifK) and ∼18 kb of DNA upstream from nifH.  Plasmid pLV1 from the A. vinelandii gene bank complemented both MV21 and MV22 as did pLC11, isolated from the A. chroococcum gene bank.  Both pLV1 and pLC11 carried part of the nif cluster downstream of nifHDK which also includes nifEN and nifMVS on ∼22 kb of DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSeVxbQJH7b7Vg90H21EOLACvtfcHk0ljs5ajtj1rpbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtF2msw%253D%253D&md5=7a8adde7c5d1045fc59ac7578a5471d2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF00430445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00430445%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DC.%26aulast%3DGamal%26aufirst%3DR.%26aulast%3DHumphrey%26aufirst%3DR.%26aulast%3DRamos%26aufirst%3DJ.%26aulast%3DBrigle%26aufirst%3DK.%26aulast%3DDean%26aufirst%3DD.%26atitle%3DThe%2520nifH%252C%2520nifM%2520and%2520nifN%2520Genes%2520of%2520Azotobacter%2520vinelandii%253A%2520Characterisation%2520by%2520Tn5%2520Mutagenesis%2520and%2520Isolation%2520from%2520pLAFR1%2520Gene%2520Banks%26jtitle%3DMol.%2520Gen.%2520Genet.%26date%3D1986%26volume%3D205%26issue%3D2%26spage%3D318%26epage%3D325%26doi%3D10.1007%2FBF00430445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helbig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lück, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, M.</span></span> <span> </span><span class="NLM_article-title">Immunolocalization of the Mip Protein of Intracellularly and Extracellularly Grown Legionella pneumophila</span>. <i>Lett. Appl. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1046/j.1472-765x.2001.00861.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1472-765x.2001.00861.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11169048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=83-88&issue=2&author=J.+Helbigauthor=P.+L%C3%BCckauthor=M.+Steinertauthor=E.+Jacobsauthor=M.+Witt&title=Immunolocalization+of+the+Mip+Protein+of+Intracellularly+and+Extracellularly+Grown+Legionella+pneumophila&doi=10.1046%2Fj.1472-765x.2001.00861.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Immunolocalization of the Mip protein of intracellularly and extracellularly grown Legionella pneumophila</span></div><div class="casAuthors">Helbig, J. H.; Luck, P. C.; Steinert, M.; Jacobs, E.; Witt, M.</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Applied Microbiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-88</span>CODEN:
                <span class="NLM_cas:coden">LAMIE7</span>;
        ISSN:<span class="NLM_cas:issn">0266-8254</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The macrophage infectivity potentiator (Mip) protein is an important factor in the optimal intracellular survival of Legionella pneumophila in protozoa and human cell lines.  In this study we have localized the Mip protein in Legionella grown on buffered charcoal yeast ext. (BCYE) agar as well as in Legionella which were ingested by Acanthamoeba castellanii.  Immunogold techniques have shown that Mip is exposed on the cell surface of extracellularly grown bacteria.  In A. castellanii infected with Legionella the Mip protein was also detected on host membranes which exhibited a multilamellar structure.  The morphol. of these structures is similar to that of respirable vesicles of amoebas by which live legionellas may be transmitted to humans.  It can be assumed that the accumulation of Mip protein in the multilamellar host membranes increases the infection potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxibigTEEGabVg90H21EOLACvtfcHk0ljs5ajtj1rpbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFGrsLg%253D&md5=36e9521150af886ce164df8c1b7a9db7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-765x.2001.00861.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-765x.2001.00861.x%26sid%3Dliteratum%253Aachs%26aulast%3DHelbig%26aufirst%3DJ.%26aulast%3DL%25C3%25BCck%26aufirst%3DP.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DE.%26aulast%3DWitt%26aufirst%3DM.%26atitle%3DImmunolocalization%2520of%2520the%2520Mip%2520Protein%2520of%2520Intracellularly%2520and%2520Extracellularly%2520Grown%2520Legionella%2520pneumophila%26jtitle%3DLett.%2520Appl.%2520Microbiol.%26date%3D2001%26volume%3D32%26issue%3D2%26spage%3D83%26epage%3D88%26doi%3D10.1046%2Fj.1472-765x.2001.00861.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leuzzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarselli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taddei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappuoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizza, M.</span></span> <span> </span><span class="NLM_article-title">Ng-MIP, a Surface-Exposed Lipoprotein of Neisseria gonorrhoeae, has a Peptidyl-Prolyl Cis/Trans Isomerase (PPIase) Activity and is Involved in Persistence in Macrophages</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2005.04859.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2005.04859.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16238618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WrtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=669-681&issue=3&author=R.+Leuzziauthor=L.+Serinoauthor=M.+Scarselliauthor=S.+Savinoauthor=M.+R.+Fontanaauthor=E.+Monaciauthor=A.+Taddeiauthor=G.+Fischerauthor=R.+Rappuoliauthor=M.+Pizza&title=Ng-MIP%2C+a+Surface-Exposed+Lipoprotein+of+Neisseria+gonorrhoeae%2C+has+a+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+%28PPIase%29+Activity+and+is+Involved+in+Persistence+in+Macrophages&doi=10.1111%2Fj.1365-2958.2005.04859.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages</span></div><div class="casAuthors">Leuzzi, Rosanna; Serino, Laura; Scarselli, Maria; Savino, Silvana; Fontana, Maria Rita; Monaci, Elisabetta; Taddei, Annarita; Fischer, Gunter; Rappuoli, Rino; Pizza, Mariagrazia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Macrophage infectivity potentiators (MIPs) are a family of surface-exposed virulence factors of intracellular microorganisms such as Legionella, Chlamydia and Trypanosoma.  These proteins display peptidylprolyl cis/trans isomerase (PPIase) activity that is inhibited by immunosuppressants FK506 and rapamycin.  Here the authors describe the identification and characterization in Neisseria gonorrhoeae of Ng-MIP, a surface-exposed lipoprotein with high homol. to MIPs.  The protein is an homodimer with rapamycin-inhibited PPIase activity confirming that it is a functional member of the MIP family.  A knock-out strain, generated by deletion of the mip gene in N. gonorrhoeae F62 strain, was evaluated for its role in infection of mouse and human macrophages.  The authors show that Ng-MIP promotes the intracellular survival of N. gonorrhoeae in macrophages, highlighting a possible role of this protein in promoting the persistence of gonococcal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkygiAM7vglLVg90H21EOLACvtfcHk0ljs5ajtj1rpbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WrtbfL&md5=e37a59a476523bbef44b560e5a31e24e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2005.04859.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2005.04859.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeuzzi%26aufirst%3DR.%26aulast%3DSerino%26aufirst%3DL.%26aulast%3DScarselli%26aufirst%3DM.%26aulast%3DSavino%26aufirst%3DS.%26aulast%3DFontana%26aufirst%3DM.%2BR.%26aulast%3DMonaci%26aufirst%3DE.%26aulast%3DTaddei%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DRappuoli%26aufirst%3DR.%26aulast%3DPizza%26aufirst%3DM.%26atitle%3DNg-MIP%252C%2520a%2520Surface-Exposed%2520Lipoprotein%2520of%2520Neisseria%2520gonorrhoeae%252C%2520has%2520a%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520%2528PPIase%2529%2520Activity%2520and%2520is%2520Involved%2520in%2520Persistence%2520in%2520Macrophages%26jtitle%3DMol.%2520Microbiol.%26date%3D2005%26volume%3D58%26issue%3D3%26spage%3D669%26epage%3D681%26doi%3D10.1111%2Fj.1365-2958.2005.04859.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, G.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Molecular Chaperone Trigger Factor</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2010.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bbamcr.2010.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20132842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVens7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=650-661&issue=6&author=A.+Hoffmannauthor=B.+Bukauauthor=G.+Kramer&title=Structure+and+Function+of+the+Molecular+Chaperone+Trigger+Factor&doi=10.1016%2Fj.bbamcr.2010.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the molecular chaperone Trigger Factor</span></div><div class="casAuthors">Hoffmann, Anja; Bukau, Bernd; Kramer, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">650-661</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Newly synthesized proteins often require the assistance of mol. chaperones to efficiently fold into functional 3-dimensional structures.  At first, ribosome-assocd. chaperones guide the initial folding steps and protect growing polypeptide chains from misfolding and aggregation.  After that, folding into the native structure may occur spontaneously or require support by addnl. chaperones which do not bind to the ribosome, such as DnaK and GroEL.  Here, the authors review current knowledge on the best-characterized ribosome-assocd. chaperone at present, Escherichia coli trigger factor (TF).  The authors describe recent progress on structural and dynamic aspects of TF's interactions with the ribosome and substrates and discuss how these interactions affect co-translational protein folding.  In addn., the authors discuss the newly proposed ribosome-independent function of TF as an assembly factor of multi-subunit protein complexes.  Finally, the authors cover the functional cooperation between TF, DnaK, and GroEL in folding of cytosolic proteins and the interplay between TF and other ribosome-assocd. factors acting in enzymic processing and translocation of nascent polypeptide chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMvdHFDeXct7Vg90H21EOLACvtfcHk0lih3jMrBk09oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVens7g%253D&md5=27dd6d09a043adcf32c9b3f4fbb6453c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2010.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2010.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DA.%26aulast%3DBukau%26aufirst%3DB.%26aulast%3DKramer%26aufirst%3DG.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Molecular%2520Chaperone%2520Trigger%2520Factor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D6%26spage%3D650%26epage%3D661%26doi%3D10.1016%2Fj.bbamcr.2010.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knappe, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaarschmidt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span> <span> </span><span class="NLM_article-title">Insertion of a Chaperone Domain Converts FKBP12 into a Powerful Catalyst of Protein Folding</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1458</span>– <span class="NLM_lpage">1468</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2007.02.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jmb.2007.02.097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17397867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2007&pages=1458-1468&issue=5&author=T.+A.+Knappeauthor=B.+Eckertauthor=P.+Schaarschmidtauthor=C.+Scholzauthor=F.+X.+Schmid&title=Insertion+of+a+Chaperone+Domain+Converts+FKBP12+into+a+Powerful+Catalyst+of+Protein+Folding&doi=10.1016%2Fj.jmb.2007.02.097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Insertion of a Chaperone Domain Converts FKBP12 into a Powerful Catalyst of Protein Folding</span></div><div class="casAuthors">Knappe, Thomas A.; Eckert, Barbara; Schaarschmidt, Peter; Scholz, Christian; Schmid, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1458-1468</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The catalytic activity of human FKBP12 as a prolyl isomerase is high towards short peptides, but very low in proline-limited protein folding reactions.  In contrast, the SlyD proteins, which are members of the FKBP family, are highly active as folding enzymes.  They contain an extra "insert-in-flap" or IF domain near the prolyl isomerase active site.  The excision of this domain did not affect the prolyl isomerase activity of SlyD from Escherichia coli towards short peptide substrates but abolished its catalytic activity in proline-limited protein folding reactions.  The reciprocal insertion of the IF domain of SlyD into human FKBP12 increased its folding activity 200-fold and generated a folding catalyst that is more active than SlyD itself.  The IF domain binds to refolding protein chains and thus functions as a chaperone module.  A prolyl isomerase catalytic site and a sep. chaperone site with an adapted affinity for refolding protein chains are the key elements for a productive coupling between the catalysis of prolyl isomerization and conformational folding in the enzymic mechanisms of SlyD and other prolyl isomerases, such as trigger factor and FkpA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJLaFV4Jgy_7Vg90H21EOLACvtfcHk0lih3jMrBk09oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCmsLk%253D&md5=cdb9e7e6b0b388bbe4a97d1180de01b1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.02.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.02.097%26sid%3Dliteratum%253Aachs%26aulast%3DKnappe%26aufirst%3DT.%2BA.%26aulast%3DEckert%26aufirst%3DB.%26aulast%3DSchaarschmidt%26aufirst%3DP.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26atitle%3DInsertion%2520of%2520a%2520Chaperone%2520Domain%2520Converts%2520FKBP12%2520into%2520a%2520Powerful%2520Catalyst%2520of%2520Protein%2520Folding%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D368%26issue%3D5%26spage%3D1458%26epage%3D1468%26doi%3D10.1016%2Fj.jmb.2007.02.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baars, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ytterberg, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klussmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nord, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygren, P.-Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Wijk, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gier, J.-W.</span></span> <span> </span><span class="NLM_article-title">Consequences of Membrane Protein Overexpression in Escherichia coli</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1550</span>, <span class="refDoi"> DOI: 10.1074/mcp.M600431-MCP200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fmcp.M600431-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17446557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGqsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1527-1550&issue=9&author=S.+Wagnerauthor=L.+Baarsauthor=A.+J.+Ytterbergauthor=A.+Klussmeierauthor=C.+S.+Wagnerauthor=O.+Nordauthor=P.-%C3%85.+Nygrenauthor=K.+J.+van+Wijkauthor=J.-W.+de+Gier&title=Consequences+of+Membrane+Protein+Overexpression+in+Escherichia+coli&doi=10.1074%2Fmcp.M600431-MCP200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Consequences of membrane protein overexpression in Escherichia coli</span></div><div class="casAuthors">Wagner, Samuel; Baars, Louise; Ytterberg, A. Jimmy; Klussmeier, Anja; Wagner, Claudia S.; Nord, Olof; Nygren, Per-Aake; van Wijk, Klaas J.; de Gier, Jan-Willem</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1527-1550</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Overexpression of membrane proteins is often essential for structural and functional studies, but yields are frequently too low.  An understanding of the physiol. response to overexpression is needed to improve such yields.  Therefore, the authors analyzed the consequences of overexpression of three different membrane proteins (YidC, YedZ, and LepI) fused to green fluorescent protein (GFP) in the bacterium Escherichia coli and compared this with overexpression of a sol. protein, GST-GFP.  Proteomes of total lysates, purified aggregates, and cytoplasmic membranes were analyzed by one- and two-dimensional gel electrophoresis and mass spectrometry complemented with flow cytometry, microscopy, Western blotting, and pulse labeling expts.  Compn. and accumulation levels of protein complexes in the cytoplasmic membrane were analyzed with improved two-dimensional blue native PAGE.  Overexpression of the three membrane proteins, but not sol. GST-GFP, resulted in accumulation of cytoplasmic aggregates contg. the overexpressed proteins, chaperones (DnaK/J and GroEL/S), and sol. proteases (HslUV and ClpXP) as well as many precursors of periplasmic and outer membrane proteins.  This was consistent with lowered accumulation levels of secreted proteins in the three membrane protein overexpressors and is likely to be a direct consequence of satn. of the cytoplasmic membrane protein translocation machinery.  Importantly, accumulation levels of respiratory chain complexes in the cytoplasmic membrane were strongly reduced.  Induction of the acetate-phosphotransacetylase pathway for ATP prodn. and a downregulated tricarboxylic acid cycle indicated the activation of the Arc two-component system, which mediates adaptive responses to changing respiratory states.  This study provides a basis for designing rational strategies to improve yields of membrane protein overexpression in E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkXSmxqZ6aT7Vg90H21EOLACvtfcHk0lih3jMrBk09oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGqsrzI&md5=cd2d2aa77d971faa7b44278cf4503598</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M600431-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M600431-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBaars%26aufirst%3DL.%26aulast%3DYtterberg%26aufirst%3DA.%2BJ.%26aulast%3DKlussmeier%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DC.%2BS.%26aulast%3DNord%26aufirst%3DO.%26aulast%3DNygren%26aufirst%3DP.-%25C3%2585.%26aulast%3Dvan%2BWijk%26aufirst%3DK.%2BJ.%26aulast%3Dde%2BGier%26aufirst%3DJ.-W.%26atitle%3DConsequences%2520of%2520Membrane%2520Protein%2520Overexpression%2520in%2520Escherichia%2520coli%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2007%26volume%3D6%26issue%3D9%26spage%3D1527%26epage%3D1550%26doi%3D10.1074%2Fmcp.M600431-MCP200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecht, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raddatz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scior, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solbach, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahl, A.</span></span> <span> </span><span class="NLM_article-title">Prolyl Isomerases in a Minimal Cell: Catalysis of Protein Folding by Trigger Factor from Mycoplasma genitalium</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3270</span>– <span class="NLM_lpage">3280</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2000.01355.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1432-1327.2000.01355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10824113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=3270-3280&issue=11&author=H.+Bangauthor=A.+Pechtauthor=G.+Raddatzauthor=T.+Sciorauthor=W.+Solbachauthor=K.+Bruneauthor=A.+Pahl&title=Prolyl+Isomerases+in+a+Minimal+Cell%3A+Catalysis+of+Protein+Folding+by+Trigger+Factor+from+Mycoplasma+genitalium&doi=10.1046%2Fj.1432-1327.2000.01355.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium</span></div><div class="casAuthors">Bang, Holger; Pecht, Anja; Raddatz, Guenter; Scior, Tom; Solbach, Werner; Brune, Kay; Pahl, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3270-3280</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Peptidyl-prolyl cis/trans isomerases (PPIases) catalyze the isomerization of prolyl peptide bonds.  Distinct families of this class of enzymes are involved in protein folding in vitro, whereas their significance in free living organisms is not known.  Previously, we inspected the smallest known genome of a self-replicating organism and found that Mycoplasma genitalium is devoid of all known PPIases except the trigger factor.  Despite the extensive sequence information becoming available, most genes remain hypothetical and enzyme activities in many species have not been assigned to an open reading frame.  Therefore, we studied the PPIase activity in crude exts. of M. genitalium.  We showed that this is solely attributed to a single enzyme activity, the trigger factor.  Characterization of this enzyme revealed that its PPIase activity resides in a central 12-kDa domain.  Only the complete trigger factor is able to cis/trans isomerize extended peptide substrates, while the PPIase domain alone can not.  The N- and the C-terminal domains of the trigger factor seem to function in binding of proteins as substrates, as demonstrated by protein refolding expts., in which the complete trigger factor catalyzed protein refolding towards a model protein 500-fold more efficiently than the isolated central PPIase domain.  Protein modeling studies suggest that the PPIase domain can fold in a similar way as the PPIase domain of FK506 binding proteins (FKBPs), one class of PPIases, despite only very limited sequence homol.  Differences at the active site explain why this enzyme is not inhibited by FK506 in contrast with FKBPs.  Trigger factor expressed in Escherichia coli confirms its addnl. chaperone functions, as shown by its assocn. with chaperones GroEL and GroES after induction of misfolding.  In contrast, the isolated PPIase-domain lacks any assocn. with chaperones from E. coli.  In summary, trigger factor of M. genitalium is the single folding isomerase of this organism, which harbors an enzymically active PPIase domain with structural homol. to FKBPs.  Its addnl. domains confer its ability to be an efficient catalyst of protein folding.  The protein folding machinery is conserved and shows a dual function as a chaperone and a prolyl isomerase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6UZobm4M_ALVg90H21EOLACvtfcHk0lhSMbsSTdq4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFymt7g%253D&md5=5f8d535a4427881ef9fb4928843590e8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01355.x%26sid%3Dliteratum%253Aachs%26aulast%3DBang%26aufirst%3DH.%26aulast%3DPecht%26aufirst%3DA.%26aulast%3DRaddatz%26aufirst%3DG.%26aulast%3DScior%26aufirst%3DT.%26aulast%3DSolbach%26aufirst%3DW.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DPahl%26aufirst%3DA.%26atitle%3DProlyl%2520Isomerases%2520in%2520a%2520Minimal%2520Cell%253A%2520Catalysis%2520of%2520Protein%2520Folding%2520by%2520Trigger%2520Factor%2520from%2520Mycoplasma%2520genitalium%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26issue%3D11%26spage%3D3270%26epage%3D3280%26doi%3D10.1046%2Fj.1432-1327.2000.01355.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Göthel, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin and Trigger Factor from Bacillus subtilis Catalyze in Vitro Protein Folding and are Necessary for Viability under Starvation Conditions</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">13392</span>– <span class="NLM_lpage">13399</span>, <span class="refDoi"> DOI: 10.1021/bi981253w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi981253w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADyaK1cvit1aqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=13392-13399&issue=38&author=S.+F.+G%C3%B6thelauthor=C.+Scholzauthor=F.+X.+Schmidauthor=M.+A.+Marahiel&title=Cyclophilin+and+Trigger+Factor+from+Bacillus+subtilis+Catalyze+in+Vitro+Protein+Folding+and+are+Necessary+for+Viability+under+Starvation+Conditions&doi=10.1021%2Fbi981253w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions</span></div><div class="casAuthors">Gothel S F; Scholz C; Schmid F X; Marahiel M A</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13392-9</span>
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Cyclophilin (the product of the ppiB gene) and the trigger factor (the product of the tig gene) are the only cytosolic peptidyl-prolyl cis-trans isomerases that are known in Bacillus subtilis.  Both enzymes catalyze the in vitro refolding of ribonuclease T1, a reaction that is limited in rate by a prolyl cis/trans isomerization.  The efficiency of cyclophilin as a folding catalyst is only modest with a kcat/KM value of 3.8 x 10(4) M-1 s-1, but the trigger factor shows an almost 40-fold higher specific activity with a kcat/KM value of 1.4 x 10(6) M-1 s-1.  This high catalytic activity originates from the tight binding to the protein substrate as reflected in both the low KM value of 0.5 microM and in the strong inhibition of the trigger factor by unfolded proteins.  By use of a protein-folding assay, the concentrations of cyclophilin and the trigger factor in the cytosol of B. subtilis could be determined as 26 and 35 microM, respectively.  Together they account for the entire folding activity that is detectable in crude extracts of wild-type B. subtilis cells.  The genes encoding cyclophilin and the trigger factor in the B. subtilis chromosome were disrupted individually and simultaneously.  Even in combination, these disruptions had no effect on cell viability in rich medium or under several stress conditions, such as heat, osmotic, or oxidative stress.  However, in poor medium and, in particular, in the absence of amino acids, the growth of the double mutant strain was strongly decelerated, indicating that the prolyl isomerases become essential for growth under starvation conditions.  It is not yet known whether this function relates to the catalysis of the proline-limited folding of essential proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQw3ZUjd2Nt2NTiMd2aNQVUfW6udTcc2eaX7m5PsFo4Pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvit1aqsQ%253D%253D&md5=ba98ee517d8b4365d3879de8afd6bbb1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi981253w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981253w%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6thel%26aufirst%3DS.%2BF.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DCyclophilin%2520and%2520Trigger%2520Factor%2520from%2520Bacillus%2520subtilis%2520Catalyze%2520in%2520Vitro%2520Protein%2520Folding%2520and%2520are%2520Necessary%2520for%2520Viability%2520under%2520Starvation%2520Conditions%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D38%26spage%3D13392%26epage%3D13399%26doi%3D10.1021%2Fbi981253w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caparon, M. G.</span></span> <span> </span><span class="NLM_article-title">A Role for Trigger Factor and an Rgg-Like Regulator in the Transcription, Secretion and Processing of the Cysteine Proteinase of Streptococcus pyogenes</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6263</span>– <span class="NLM_lpage">6275</span>, <span class="refDoi"> DOI: 10.1093/emboj/17.21.6263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F17.21.6263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9799235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXnsVKht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=6263-6275&issue=21&author=W.+R.+Lyonauthor=C.+M.+Gibsonauthor=M.+G.+Caparon&title=A+Role+for+Trigger+Factor+and+an+Rgg-Like+Regulator+in+the+Transcription%2C+Secretion+and+Processing+of+the+Cysteine+Proteinase+of+Streptococcus+pyogenes&doi=10.1093%2Femboj%2F17.21.6263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A role for Trigger Factor and an Rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes</span></div><div class="casAuthors">Lyon, William R.; Gibson, Carmela M.; Caparon, Michael G.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6263-6275</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The ability of numerous microorganisms to cause disease relies upon the highly regulated expression of secreted proteinases.  In this study, mutagenesis with a novel deriv. of Tn4001 was used to identify genes required for the expression of the secreted cysteine proteinase (SCP) of the pathogenic Gram-pos. bacterium Streptococcus pyogenes.  Designated as Rop loci (regulation of proteinase), ropB is a rgg-like transcriptional activator required for transcription of the gene which encodes the proteinase.  In contrast, ropA contributes post-transcriptionally to the secretion and processing of SCP and encodes a homolog of Trigger Factor, a peptidyl-prolyl isomerase and putative chaparone which is highly conserved in most bacterial species, but of unknown function.  Anal. of addnl. ropA mutants demonstrated that RopA acts both to assist in targeting SCP to the secretory pathway and to promote the ability of the proprotein to establish an active conformation upon secretion.  This latter function was dependent upon the peptidyl-prolyl isomerase domain of RopA and mutants that lacked this domain exhibited a bipartite deficiency manifested as a kinetic defect in autologous processing of the proprotein to the mature proteinase, and as a catalytic defect in the mature proteinase.  These results provide insight into the function of Trigger Factor, the regulation of proteinase activity and the mechanism of secretion in Gram-pos. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCboFd1S5kbVg90H21EOLACvtfcHk0lhSMbsSTdq4MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsVKht7k%253D&md5=ec8dfada402fd771c346ac09404d6e6f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.21.6263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.21.6263%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DW.%2BR.%26aulast%3DGibson%26aufirst%3DC.%2BM.%26aulast%3DCaparon%26aufirst%3DM.%2BG.%26atitle%3DA%2520Role%2520for%2520Trigger%2520Factor%2520and%2520an%2520Rgg-Like%2520Regulator%2520in%2520the%2520Transcription%252C%2520Secretion%2520and%2520Processing%2520of%2520the%2520Cysteine%2520Proteinase%2520of%2520Streptococcus%2520pyogenes%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26issue%3D21%26spage%3D6263%26epage%3D6275%26doi%3D10.1093%2Femboj%2F17.21.6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubail, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbit, A.</span></span> <span> </span><span class="NLM_article-title">A Homolog of Bacillus subtilis Trigger Factor in Listeria monocytogenes is Involved in Stress Tolerance and Bacterial Virulence</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">6623</span>– <span class="NLM_lpage">6631</span>, <span class="refDoi"> DOI: 10.1128/AEM.00624-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAEM.00624-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17021213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFalsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=6623-6631&issue=10&author=A.+Bigotauthor=E.+Bottonauthor=I.+Dubailauthor=A.+Charbit&title=A+Homolog+of+Bacillus+subtilis+Trigger+Factor+in+Listeria+monocytogenes+is+Involved+in+Stress+Tolerance+and+Bacterial+Virulence&doi=10.1128%2FAEM.00624-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A homolog of Bacillus subtilis trigger factor in Listeria monocytogenes is involved in stress tolerance and bacterial virulence</span></div><div class="casAuthors">Bigot, Armelle; Botton, Eleonore; Dubail, Iharilalao; Charbit, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6623-6631</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mol. chaperones play an essential role in the folding of nascent chain polypeptides, as well as in the refolding and degrdn. of misfolded or aggregated proteins.  They also assist in protein translocation and participate in stress functions.  We identified a gene, designated tig, encoding a protein homologous to trigger factor (TF), a cytosolic ribosome-assocd. chaperone, in the genome of Listeria monocytogenes.  We constructed a chromosomal Δtig deletion and evaluated the impact of the mutation on bacterial growth in broth under various stress conditions and on pathogenesis.  The Δtig deletion did not affect cell viability but impaired survival in the presence of heat and ethanol stresses.  We also identified the ffh gene, encoding a protein homologous to the SRP54 eukaryotic component of the signal recognition particle.  However, a Δffh deletion was not tolerated, suggesting that Ffh is essential, as it is in Bacillus subtilis and Escherichia coli.  Thus, although dispensable for growth, TF is involved in the stress response of L. monocytogenes.  The Δtig mutant showed no or very modest intracellular survival defects in eukaryotic cells.  However, in vivo it showed a reduced capacity to persist in the spleens and livers of infected mice, revealing that TF has a role in the pathogenicity of L. monocytogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbIjwuIwjcTrVg90H21EOLACvtfcHk0ljScNztHejCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFalsLvP&md5=6378e57c478efec10e697d1241d156b6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FAEM.00624-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.00624-06%26sid%3Dliteratum%253Aachs%26aulast%3DBigot%26aufirst%3DA.%26aulast%3DBotton%26aufirst%3DE.%26aulast%3DDubail%26aufirst%3DI.%26aulast%3DCharbit%26aufirst%3DA.%26atitle%3DA%2520Homolog%2520of%2520Bacillus%2520subtilis%2520Trigger%2520Factor%2520in%2520Listeria%2520monocytogenes%2520is%2520Involved%2520in%2520Stress%2520Tolerance%2520and%2520Bacterial%2520Virulence%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2006%26volume%3D72%26issue%3D10%26spage%3D6623%26epage%3D6631%26doi%3D10.1128%2FAEM.00624-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caparon, M. G.</span></span> <span> </span><span class="NLM_article-title">Trigger Factor-Mediated Prolyl Isomerization Influences Maturation of the Streptococcus pyogenes Cysteine Protease</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>185</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3661</span>– <span class="NLM_lpage">3667</span>, <span class="refDoi"> DOI: 10.1128/JB.185.12.3661-3667.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.185.12.3661-3667.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12775704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1KgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2003&pages=3661-3667&issue=12&author=W.+R.+Lyonauthor=M.+G.+Caparon&title=Trigger+Factor-Mediated+Prolyl+Isomerization+Influences+Maturation+of+the+Streptococcus+pyogenes+Cysteine+Protease&doi=10.1128%2FJB.185.12.3661-3667.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Trigger factor-mediated prolyl isomerization influences maturation of the Streptococcus pyogenes cysteine protease</span></div><div class="casAuthors">Lyon, William R.; Caparon, Michael G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3661-3667</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Trigger factor, a ribosome-assocd. chaperone and peptidyl-prolyl cis-trans isomerase (PPIase), is essential for the secretion and maturation of the cysteine protease of the pathogenic gram-pos. bacterium Streptococcus pyogenes.  In the absence of trigger factor, the nascent protease polypeptide is not targeted to the secretory pathway.  Some partial-function mutations restore targeting.  However, the secreted protease does not efficiently mature into an enzymically active form, suggesting that trigger factor has an addnl. role in protease biogenesis.  Here, we show that, while not required for targeting, the PPIase activity of trigger factor is essential for maturation of the protease following its secretion from the bacterial cell.  Site-specific mutations introduced into ropA, the gene which encodes trigger factor in S. pyogenes, produced mutant proteins deficient in PPIase activity.  When these mutant alleles were used to replace the wild-type gene on the streptococcal chromosome, anal. of protease biogenesis revealed that, although the protease was secreted normally, it did not efficiently mature to an active form.  Furthermore, mutation of a single proline residue in the protease prodomain suppressed the requirement for PPIase activity, suggesting that this residue is the target of trigger factor.  These data support a model in which trigger factor-mediated prolyl isomerization influences the conformation of the prodomain, which in turn directs the protease into one of several alternative folding pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppsewS--N7c7Vg90H21EOLACvtfcHk0ljScNztHejCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1KgsL4%253D&md5=606ce148f5881ab1f37eb449f1caf47b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FJB.185.12.3661-3667.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.185.12.3661-3667.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DW.%2BR.%26aulast%3DCaparon%26aufirst%3DM.%2BG.%26atitle%3DTrigger%2520Factor-Mediated%2520Prolyl%2520Isomerization%2520Influences%2520Maturation%2520of%2520the%2520Streptococcus%2520pyogenes%2520Cysteine%2520Protease%26jtitle%3DJ.%2520Bacteriol.%26date%3D2003%26volume%3D185%26issue%3D12%26spage%3D3661%26epage%3D3667%26doi%3D10.1128%2FJB.185.12.3661-3667.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eske-Pogodda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titball, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, I.</span></span> <span> </span><span class="NLM_article-title">A Novel FK-506-Binding-Like Protein that Lacks Peptidyl-Prolyl Isomerase Activity is Involved in Intracellular Infection and In Vivo Virulence of Burkholderia pseudomallei</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>157</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2629</span>– <span class="NLM_lpage">2638</span>, <span class="refDoi"> DOI: 10.1099/mic.0.049163-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2Fmic.0.049163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21680634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yktr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2011&pages=2629-2638&issue=9&author=I.+H.+Norvilleauthor=K.+Breitbachauthor=K.+Eske-Pogoddaauthor=N.+J.+Harmerauthor=M.+Sarkar-Tysonauthor=R.+W.+Titballauthor=I.+Steinmetz&title=A+Novel+FK-506-Binding-Like+Protein+that+Lacks+Peptidyl-Prolyl+Isomerase+Activity+is+Involved+in+Intracellular+Infection+and+In+Vivo+Virulence+of+Burkholderia+pseudomallei&doi=10.1099%2Fmic.0.049163-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei</span></div><div class="casAuthors">Norville, Isobel H.; Breitbach, Katrin; Eske-Pogodda, Kristin; Harmer, Nicholas J.; Sarkar-Tyson, Mitali; Titball, Richard W.; Steinmetz, Ivo</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2629-2638</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Burkholderia pseudomallei is a facultative intracellular bacterial pathogen causing melioidosis, an often fatal infectious disease that is endemic in several tropical and subtropical areas around the world.  The authors previously described a Ptk2 cell-based plaque assay screening system of B. pseudomallei transposon mutants that led to the identification of several novel virulence determinants.  Using this approach, they identified a mutant with reduced plaque formation in which the BPSL0918 gene was disrupted.  BPSL0918 encodes a putative FK-506-binding protein (FKBP) representing a family of proteins that typically possess peptidyl-prolyl isomerase (PPIase) activity.  A B. pseudomallei ΔBPSL0918 mutant showed a severely impaired ability to resist intracellular killing and to replicate within primary macrophages.  Complementation of the mutant fully restored its ability to grow intracellularly.  Moreover, B. pseudomallei ΔBPSL0918 was significantly attenuated in a murine model of infection.  Structural modeling confirmed a modified FKBP fold of the BPSL0918-encoded protein but unlike virulence-assocd. FKBPs from other pathogenic bacteria, recombinant BPSL0918 protein did not possess PPIase activity in vitro.  In accordance with this observation BPSL0918 exhibits several mutations in residues that have been proposed to mediate PPIase activity in other FKBPs.  Apparently, B. pseudomallei FKBP represents the first example of this protein family which lacks PPIase activity but is important in intracellular infection of a bacterial pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnC_vMlQTESLVg90H21EOLACvtfcHk0ljScNztHejCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yktr7M&md5=8c1894b88aa4325641a0eba2f42ee72a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.049163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.049163-0%26sid%3Dliteratum%253Aachs%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DBreitbach%26aufirst%3DK.%26aulast%3DEske-Pogodda%26aufirst%3DK.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DTitball%26aufirst%3DR.%2BW.%26aulast%3DSteinmetz%26aufirst%3DI.%26atitle%3DA%2520Novel%2520FK-506-Binding-Like%2520Protein%2520that%2520Lacks%2520Peptidyl-Prolyl%2520Isomerase%2520Activity%2520is%2520Involved%2520in%2520Intracellular%2520Infection%2520and%2520In%2520Vivo%2520Virulence%2520of%2520Burkholderia%2520pseudomallei%26jtitle%3DMicrobiology%26date%3D2011%26volume%3D157%26issue%3D9%26spage%3D2629%26epage%3D2638%26doi%3D10.1099%2Fmic.0.049163-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Echenique-Rivera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Tordello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seib, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappuoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serruto, D.</span></span> <span> </span><span class="NLM_article-title">Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e1002027</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1002027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.ppat.1002027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21589640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVKku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002027&issue=5&author=H.+Echenique-Riveraauthor=A.+Muzziauthor=E.+Del+Tordelloauthor=K.+L.+Seibauthor=P.+Francoisauthor=R.+Rappuoliauthor=M.+Pizzaauthor=D.+Serruto&title=Transcriptome+Analysis+of+Neisseria+meningitidis+in+Human+Whole+Blood+and+Mutagenesis+Studies+Identify+Virulence+Factors+Involved+in+Blood+Survival&doi=10.1371%2Fjournal.ppat.1002027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival</span></div><div class="casAuthors">Echenique-Rivera, Hebert; Muzzi, Alessandro; Del Tordello, Elena; Seib, Kate L.; Francois, Patrice; Rappuoli, Rino; Pizza, Mariagrazia; Serruto, Davide</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1002027</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">During infection Neisseria meningitidis (Nm) encounters multiple environments within the host, which makes rapid adaptation a crucial factor for meningococcal survival.  Despite the importance of invasion into the bloodstream in the meningococcal disease process, little is known about how Nm adapts to permit survival and growth in blood.  The authors performed a time-course transcriptome anal. using an ex vivo model of human whole blood infection.  They obsd. that Nm alters the expression of ≈30% of ORFs of the genome and major dynamic changes were obsd. in the expression of transcriptional regulators, transport and binding proteins, energy metab., and surface-exposed virulence factors.  In particular, they found that the gene encoding the regulator Fur, as well as all genes encoding iron uptake systems, were significantly up-regulated.  Anal. of regulated genes encoding for surface-exposed proteins involved in Nm pathogenesis allowed us to better understand mechanisms used to circumvent host defenses.  During blood infection, Nm activates genes encoding for the factor H binding proteins, fHbp and NspA, genes encoding for detoxifying enzymes such as SodC, Kat and AniA, as well as several less characterized surface-exposed proteins that might have a role in blood survival.  Through mutagenesis studies of a subset of up-regulated genes we were able to identify new proteins important for survival in human blood and also to identify addnl. roles of previously known virulence factors in aiding survival in blood.  Nm mutant strains lacking the genes encoding the hypothetical protein NMB1483 and the surface-exposed proteins NalP, Mip and NspA, the Fur regulator, the transferrin binding protein TbpB, and the -lactate permease LctP were sensitive to killing by human blood.  This increased knowledge of how Nm responds to adaptation in blood could also be helpful to develop diagnostic and therapeutic strategies to control the devastating disease cause by this microorganism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq29YO6kwTGPbVg90H21EOLACvtfcHk0liDFdfEkgxj_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVKku7Y%253D&md5=c0f136d767c57ca911e60ff46dd6ac55</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002027%26sid%3Dliteratum%253Aachs%26aulast%3DEchenique-Rivera%26aufirst%3DH.%26aulast%3DMuzzi%26aufirst%3DA.%26aulast%3DDel%2BTordello%26aufirst%3DE.%26aulast%3DSeib%26aufirst%3DK.%2BL.%26aulast%3DFrancois%26aufirst%3DP.%26aulast%3DRappuoli%26aufirst%3DR.%26aulast%3DPizza%26aufirst%3DM.%26aulast%3DSerruto%26aufirst%3DD.%26atitle%3DTranscriptome%2520Analysis%2520of%2520Neisseria%2520meningitidis%2520in%2520Human%2520Whole%2520Blood%2520and%2520Mutagenesis%2520Studies%2520Identify%2520Virulence%2520Factors%2520Involved%2520in%2520Blood%2520Survival%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26issue%3D5%26spage%3De1002027%26doi%3D10.1371%2Fjournal.ppat.1002027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salim, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckels, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christodoulides, M.</span></span> <span> </span><span class="NLM_article-title">The Neisseria meningitidis Macrophage Infectivity Potentiator Protein Induces Cross-Strain Serum Bactericidal Activity and is a Potential Serogroup B Vaccine Candidate</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3784</span>– <span class="NLM_lpage">3791</span>, <span class="refDoi"> DOI: 10.1128/IAI.05019-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.05019-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21708989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSqt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=3784-3791&issue=9&author=M.-C.+Hungauthor=O.+Salimauthor=J.+N.+Williamsauthor=J.+E.+Heckelsauthor=M.+Christodoulides&title=The+Neisseria+meningitidis+Macrophage+Infectivity+Potentiator+Protein+Induces+Cross-Strain+Serum+Bactericidal+Activity+and+is+a+Potential+Serogroup+B+Vaccine+Candidate&doi=10.1128%2FIAI.05019-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate</span></div><div class="casAuthors">Hung, Miao-Chiu; Salim, Omar; Williams, Jeannette N.; Heckels, John E.; Christodoulides, Myron</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3784-3791</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A gene encoding a 29-kDa protein from Neisseria meningitidis serogroup B strain MC58 with homol. to the macrophage infectivity potentiator (MIP) protein of Legionella pneumophila was cloned and expressed in Escherichia coli, and the purified sol. recombinant protein (rMIP) was used for immunization studies.  Anal. of the predicted amino acid sequences of MIP from 13 well-characterized meningococcal strains, isolated from carriers or patients and differing in serogroup, serotype, and subtype, showed that the protein was highly conserved (98 to 100%), with only three distinct sequence types (designated I, II, and III) found.  Western blotting showed that the MIP protein was expressed at similar levels by all of these strains.  Immunization of mice with type I MC58 rMIP in detergent micelles and liposomes contg. monophosphoryl lipid A (MPLA) induced high levels of surface-reactive antibodies with serum bactericidal activity (SBA) titers of 1/1,024 against the homologous strain.  Bactericidal antibodies, were also induced with the protein in saline alone and liposomes alone (titers, 1/128) but not following adsorption to Al(OH)3.  Significantly, antisera raised against type I rMIP administered in saline or liposomes killed strains of heterologous sequence types II and III with similar SBA titers (1/128 to 1/256).  Taken together, these findings suggest that rMIP can provide cross-strain protection against meningococci and should be considered a potential antigen for inclusion in new vaccines against meningococcal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2VheavvIsLVg90H21EOLACvtfcHk0liDFdfEkgxj_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSqt73M&md5=f3eee9820e1a168b9db0ca64b93c0205</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FIAI.05019-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05019-11%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DSalim%26aufirst%3DO.%26aulast%3DWilliams%26aufirst%3DJ.%2BN.%26aulast%3DHeckels%26aufirst%3DJ.%2BE.%26aulast%3DChristodoulides%26aufirst%3DM.%26atitle%3DThe%2520Neisseria%2520meningitidis%2520Macrophage%2520Infectivity%2520Potentiator%2520Protein%2520Induces%2520Cross-Strain%2520Serum%2520Bactericidal%2520Activity%2520and%2520is%2520a%2520Potential%2520Serogroup%2520B%2520Vaccine%2520Candidate%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26issue%3D9%26spage%3D3784%26epage%3D3791%26doi%3D10.1128%2FIAI.05019-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundemose, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, J. H.</span></span> <span> </span><span class="NLM_article-title">Chlamydia trachomatis Mip-Like Protein has Peptidylprolyl Cis/Trans Isomerase Activity that is Inhibited by FK506 and Rapamycin and is Implicated in Initiation of Chlamydial Infection</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">783</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01168.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1993.tb01168.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7682281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXitlWns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=777-783&issue=5&author=A.+G.+Lundemoseauthor=J.+E.+Kayauthor=J.+H.+Pearce&title=Chlamydia+trachomatis+Mip-Like+Protein+has+Peptidylprolyl+Cis%2FTrans+Isomerase+Activity+that+is+Inhibited+by+FK506+and+Rapamycin+and+is+Implicated+in+Initiation+of+Chlamydial+Infection&doi=10.1111%2Fj.1365-2958.1993.tb01168.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection</span></div><div class="casAuthors">Lundemose, Anker G.; Kay, John E.; Pearce, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">777-83</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">The Mip-like protein of C. trachomatis has sequence similarity with both the Mip protein of Legionella pneumophila, a virulence factor necessary for optimal intracellular infection, and FK506-binding proteins (FKBPs) of both prokaryotic and eukaryotic origin.  FKBPs contain a site for peptidyl-prolyl cis/trans isomerase activity, which is blocked upon binding of the drugs, FK506 or rapamycin.  This paper reports that the recombinant chlamydial Mip-like protein exhibits a peptidyl-prolyl cis/trans isomerase activity which is inhibited by either rapamycin or FK506.  In order to assess the role of the Mip-like protein in chlamydial infection, rapamycin or FK506 (25 μM), were used in either treatment of chlamydial organisms prior to inoculation, or were present at different intervals through the infection.  Pretreatment of organisms alone reduced infectivity for McCoy cells by 30%, with inhibition rising to 80% on more prolonged exposure from 0 to 8 h and 8 to 16 h post-inoculation and declining thereafter.  When drug was present during the developmental cycle at intervals from 0 to 24 h post-inoculation abnormal chlamydia were induced in residual inclusions.  Apparently, inhibition of the isomerase of the Mip-like protein interferes with ≥1 early events in the infective process that det. productive intracellular infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ4oV2yJ3RwrVg90H21EOLACvtfcHk0liDFdfEkgxj_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitlWns7c%253D&md5=63cacc187596bf28356817aa653ab14e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01168.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01168.x%26sid%3Dliteratum%253Aachs%26aulast%3DLundemose%26aufirst%3DA.%2BG.%26aulast%3DKay%26aufirst%3DJ.%2BE.%26aulast%3DPearce%26aufirst%3DJ.%2BH.%26atitle%3DChlamydia%2520trachomatis%2520Mip-Like%2520Protein%2520has%2520Peptidylprolyl%2520Cis%252FTrans%2520Isomerase%2520Activity%2520that%2520is%2520Inhibited%2520by%2520FK506%2520and%2520Rapamycin%2520and%2520is%2520Implicated%2520in%2520Initiation%2520of%2520Chlamydial%2520Infection%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D7%26issue%3D5%26spage%3D777%26epage%3D783%26doi%3D10.1111%2Fj.1365-2958.1993.tb01168.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundemose, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouch, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkelund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, J. H.</span></span> <span> </span><span class="NLM_article-title">Chlamydia trachomatis Mip-Like Protein</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2539</span>– <span class="NLM_lpage">2548</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1992.tb01430.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1992.tb01430.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1406289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXksVemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=2539-2548&issue=17&author=A.+G.+Lundemoseauthor=D.+A.+Rouchauthor=S.+Birkelundauthor=G.+Christiansenauthor=J.+H.+Pearce&title=Chlamydia+trachomatis+Mip-Like+Protein&doi=10.1111%2Fj.1365-2958.1992.tb01430.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Chlamydia trachomatis Mip-like protein</span></div><div class="casAuthors">Lundemose, Anker G.; Rouch, Duncan A.; Birkelund, Svend; Christiansen, Gunaa; Pearce, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2539-48</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">A 27 kDa Chlamydia trachomatis Mip-like protein with homol. to a 175-amino-acid C-terminal fragment of the surface-exposed Legionella pneumophila mip-gene product has previously been described.  In this paper the entire chlamydia Mip-like sequence of C. trachomatis serovar L2 [lymphogranuloma venereum (LGV) biovar] is presented.  The sequence shows high similarity to the legionella Mip protein and its C-terminal region, like that of the legionella Mip, has high amino acid similarity to eukaryotic and prokaryotic FK506-binding proteins.  The chlamydial mip-like gene was defected by polymerase chain reaction (PCR) in other C. trachomatis serovars and by sequencing of the mip-like genes of serovars B and E (trachoma biovar) was shown to be highly conserved within the two majors biovars of C. trachomatis.  Monoclonal and polyclonal antibodies raised against the recombinant Mip-like protein failed to demonstrate surface-exposed epitopes on infectious elementary bodies or reproductive reticulate body forms either by immunofluorescence or immuno-gold electron microscopy.  However, a complement-dependent inhibition of up to 91% of infectivity for cell cultures was obsd. with antibodies to the N-terminal fragment of the Mip-like protein suggesting that antibody-accessible epitopes are present on infectious EBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6UGB4lBQOq7Vg90H21EOLACvtfcHk0lhS3CO0wb7Bzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVemtLw%253D&md5=c10150ef1a4d281ada5df0c7eb350c40</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1992.tb01430.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1992.tb01430.x%26sid%3Dliteratum%253Aachs%26aulast%3DLundemose%26aufirst%3DA.%2BG.%26aulast%3DRouch%26aufirst%3DD.%2BA.%26aulast%3DBirkelund%26aufirst%3DS.%26aulast%3DChristiansen%26aufirst%3DG.%26aulast%3DPearce%26aufirst%3DJ.%2BH.%26atitle%3DChlamydia%2520trachomatis%2520Mip-Like%2520Protein%26jtitle%3DMol.%2520Microbiol.%26date%3D1992%26volume%3D6%26issue%3D17%26spage%3D2539%26epage%3D2548%26doi%3D10.1111%2Fj.1365-2958.1992.tb01430.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianciotto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mody, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toews, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engleberg, N.</span></span> <span> </span><span class="NLM_article-title">A Legionella pneumophila Gene Encoding a Species-Specific Surface Protein Potentiates Initiation of Intracellular infection</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1128/IAI.57.4.1255-1262.1989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.57.4.1255-1262.1989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=2925251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL1MXktVWltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1989&pages=1255-1262&issue=4&author=N.+Cianciottoauthor=B.+Eisensteinauthor=C.+Modyauthor=G.+Toewsauthor=N.+Engleberg&title=A+Legionella+pneumophila+Gene+Encoding+a+Species-Specific+Surface+Protein+Potentiates+Initiation+of+Intracellular+infection&doi=10.1128%2FIAI.57.4.1255-1262.1989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection</span></div><div class="casAuthors">Cianciotto, Nicholas P.; Eisenstein, Barry I.; Mody, Christopher H.; Toews, Galen B.; Engleberg, N. Cary</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1255-62</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">To investigate the pathogenesis of Legionnaires disease at a mol. level, directed allelic exchange was used to mutate a gene encoding a L. pneumophila-specific 24,000-dalton (Da) surface protein.  Southern hybridization and immunoblot analyses demonstrated that the predicted DNA rearrangement occurred in L. pneumophila with a specific loss of 24-kDa antigen expression.  Compared with its isogenic parent, the mutant was significantly impaired in its ability to infect transformed U937 cells, a human macrophage-like cell line; i.e., the bacterial inoculum of the mutant strain that was required to initiate infection of the macrophage monolayer was ∼80-fold greater than that of the isogenic parent strain.  The mutant strain regained full infectivity on reintroduction of a cloned 24-kDa protein gene, indicating that the reduced infectivity was due specifically to the mutation in that gene.  Compared with the parent strain, the mutant strain was recovered at titers that were ∼10-fold lower shortly after infection, but it exhibited a similar intracellular growth rate over the next 40 h, indicating that the mutant was defective in its ability to initiate macrophage infection rather than in its ability to replicate intracellularly.  When opsonized, the mutant strain was still significantly less infectious than the parent strain, despite equiv. macrophage assocn., suggesting that the mutant was not merely missing a ligand for macrophage attachment.  The mutant also exhibited reduced infectivity in explanted human alveolar macrophages, demonstrating the relevance of the U937 cell model for analyzing this mutant phenotype.  These results represent the first identification of a cloned L. pneumophila gene that is necessary for optimal intracellular infection; this gene was designated mip, for macrophage infectivity potentiator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVLhinnsAzd7Vg90H21EOLACvtfcHk0lhS3CO0wb7Bzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVWltLs%253D&md5=3ff954c0ebe6f4514a658e4d4ab6a151</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1128%2FIAI.57.4.1255-1262.1989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.57.4.1255-1262.1989%26sid%3Dliteratum%253Aachs%26aulast%3DCianciotto%26aufirst%3DN.%26aulast%3DEisenstein%26aufirst%3DB.%26aulast%3DMody%26aufirst%3DC.%26aulast%3DToews%26aufirst%3DG.%26aulast%3DEngleberg%26aufirst%3DN.%26atitle%3DA%2520Legionella%2520pneumophila%2520Gene%2520Encoding%2520a%2520Species-Specific%2520Surface%2520Protein%2520Potentiates%2520Initiation%2520of%2520Intracellular%2520infection%26jtitle%3DInfect.%2520Immun.%26date%3D1989%26volume%3D57%26issue%3D4%26spage%3D1255%26epage%3D1262%26doi%3D10.1128%2FIAI.57.4.1255-1262.1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamphausen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmausser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Collagen Binding Protein Mip Enables Legionella pneumophila to Transmigrate Through a Barrier of NCI-H292 Lung Epithelial Cells and Extracellular Matrix</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2006.00802.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1462-5822.2006.00802.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16953800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=450-462&issue=2&author=C.+Wagnerauthor=A.+S.+Khanauthor=T.+Kamphausenauthor=B.+Schmausserauthor=C.+%C3%9Cnalauthor=U.+Lorenzauthor=G.+Fischerauthor=J.+Hackerauthor=M.+Steinert&title=Collagen+Binding+Protein+Mip+Enables+Legionella+pneumophila+to+Transmigrate+Through+a+Barrier+of+NCI-H292+Lung+Epithelial+Cells+and+Extracellular+Matrix&doi=10.1111%2Fj.1462-5822.2006.00802.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix</span></div><div class="casAuthors">Wagner, Carina; Khan, Abdul Salam; Kamphausen, Thilo; Schmausser, Bernd; Uenal, Can; Lorenz, Udo; Fischer, Gunter; Hacker, Joerg; Steinert, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">450-462</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Guinea pigs are highly susceptible to Legionella pneumophila infection and therefore have been the preferred animal model for studies of legionellosis.  In this study guinea pig infections revealed that the Legionella virulence factor Mip (macrophage infectivity potentiator) contributes to the bacterial dissemination within the lung tissue and the spread of Legionella to the spleen.  Histopathol. of infected animals, binding assays with components of the extracellular matrix (ECM), bacterial transmigration expts. across an artificial lung epithelium barrier, inhibitor studies and ECM degrdn. assays were used to elucidate the underlying mechanism of the in vivo observation.  The Mip protein, which belongs to the enzyme family of FK506-binding proteins (FKBP), was shown to bind to the ECM protein collagen (type I, II, III, IV, V, VI).  Transwell assays with L. pneumophila and recombinant Escherichia coli HB101 strains revealed that Mip enables these bacteria to transmigrate across a barrier of NCI-H292 lung epithelial cells and ECM (NCI-H292/ECM barrier).  Mip-specific monoclonal antibodies and the immunosuppressants rapamycin and FK506, which inhibit the peptidyl prolyl cis/trans isomerase (PPIase) activity of Mip, were able to inhibit this transmigration.  By using protease inhibitors we found that the penetration of the NCI-H292/ECM barrier addnl. requires a serine protease activity.  Degrdn. assays with 35S-labeled ECM proteins supported the finding of a concerted action of Mip and a serine protease.  The described synergism between the activity of the collagen binding Mip protein and the serine protease activity represents an entirely new mechanism for bacterial penetration of the lung epithelial barrier and has implications for other prokaryotic and eukaryotic pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIYGrSd_irLVg90H21EOLACvtfcHk0lhS3CO0wb7Bzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslGqsL4%253D&md5=ecf2254e493c64acbb41c2a3bac70c29</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2006.00802.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2006.00802.x%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DC.%26aulast%3DKhan%26aufirst%3DA.%2BS.%26aulast%3DKamphausen%26aufirst%3DT.%26aulast%3DSchmausser%26aufirst%3DB.%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%26aulast%3DLorenz%26aufirst%3DU.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DCollagen%2520Binding%2520Protein%2520Mip%2520Enables%2520Legionella%2520pneumophila%2520to%2520Transmigrate%2520Through%2520a%2520Barrier%2520of%2520NCI-H292%2520Lung%2520Epithelial%2520Cells%2520and%2520Extracellular%2520Matrix%26jtitle%3DCell.%2520Microbiol.%26date%3D2007%26volume%3D9%26issue%3D2%26spage%3D450%26epage%3D462%26doi%3D10.1111%2Fj.1462-5822.2006.00802.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klages, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinsohn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Prolyl-Cis/Trans-Isomerases Mip and PpiB of Legionella pneumophila Contribute to Surface Translocation, Growth at Suboptimal Temperature, and Infection</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">e00939-17</span>, <span class="refDoi"> DOI: 10.1128/IAI.00939-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00939-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30323027" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=e00939-17&issue=1&author=J.+Raschauthor=C.+M.+Unalauthor=A.+Klagesauthor=U.+Karsliauthor=N.+Heinsohnauthor=R.+Brouwerauthor=M.+Richterauthor=A.+Dellmannauthor=M.+Steinert&title=Peptidyl-Prolyl-Cis%2FTrans-Isomerases+Mip+and+PpiB+of+Legionella+pneumophila+Contribute+to+Surface+Translocation%2C+Growth+at+Suboptimal+Temperature%2C+and+Infection&doi=10.1128%2FIAI.00939-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FIAI.00939-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00939-17%26sid%3Dliteratum%253Aachs%26aulast%3DRasch%26aufirst%3DJ.%26aulast%3DUnal%26aufirst%3DC.%2BM.%26aulast%3DKlages%26aufirst%3DA.%26aulast%3DKarsli%26aufirst%3DU.%26aulast%3DHeinsohn%26aufirst%3DN.%26aulast%3DBrouwer%26aufirst%3DR.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DDellmann%26aufirst%3DA.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DPeptidyl-Prolyl-Cis%252FTrans-Isomerases%2520Mip%2520and%2520PpiB%2520of%2520Legionella%2520pneumophila%2520Contribute%2520to%2520Surface%2520Translocation%252C%2520Growth%2520at%2520Suboptimal%2520Temperature%252C%2520and%2520Infection%26jtitle%3DInfect.%2520Immun.%26date%3D2019%26volume%3D87%26issue%3D1%26spage%3De00939-17%26doi%3D10.1128%2FIAI.00939-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arakaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, A.</span></span> <span> </span><span class="NLM_article-title">Induction of Apoptosis of Human Macrophages in Vitro by Legionella longbeachae Through Activation of the Caspase Pathway</span>. <i>J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1099/0022-1317-51-2-159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2F0022-1317-51-2-159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11863267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1eksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=159-168&issue=2&author=N.+Arakakiauthor=F.+Higaauthor=M.+Koideauthor=M.+Tateyamaauthor=A.+Saito&title=Induction+of+Apoptosis+of+Human+Macrophages+in+Vitro+by+Legionella+longbeachae+Through+Activation+of+the+Caspase+Pathway&doi=10.1099%2F0022-1317-51-2-159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis of human macrophages in vitro by Legionella longbeachae through activation of the caspase pathway</span></div><div class="casAuthors">Arakaki, Noriko; Higa, Futoshi; Koide, Michio; Tateyama, Masao; Saito, Atushi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-168</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The cytotoxicity of the facultative intracellular bacterium, Legionella longbeachae, an important cause of legionellosis, was characterized.  Apoptosis was induced in HL-60 cells, a human macrophage-like cell line, during the early stages of infection and induction of apoptosis correlated with cytotoxicity.  Apoptosis was confirmed by agarose gel electrophoresis of fragmented DNA, surface exposure of phosphatidylserine and propidium iodide labeling of host cell nuclei.  The involvement of macrophage infectivity potentiator (Mip) protein, a known virulence factor of L. longbeachae, was also examd.  A mip mutant of L. longbeachae induced apoptosis of HL-60 cells but failed to multiply intracellularly, suggesting that intracellular replication of L. longbeachae is not essential for the induction of apoptosis of HL-60 cells.  Furthermore, induction of apoptosis of L. longbeachae-infected macrophages was mediated by activation of the caspase pathway but might be independent of tumor necrosis factor-α- and Fas mediated signal transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRfQzLYY0-x7Vg90H21EOLACvtfcHk0lg3IBQxx2pKFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1eksLo%253D&md5=19d01b29b291ea7205cbdf2e2a8af663</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-51-2-159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-51-2-159%26sid%3Dliteratum%253Aachs%26aulast%3DArakaki%26aufirst%3DN.%26aulast%3DHiga%26aufirst%3DF.%26aulast%3DKoide%26aufirst%3DM.%26aulast%3DTateyama%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DA.%26atitle%3DInduction%2520of%2520Apoptosis%2520of%2520Human%2520Macrophages%2520in%2520Vitro%2520by%2520Legionella%2520longbeachae%2520Through%2520Activation%2520of%2520the%2520Caspase%2520Pathway%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2002%26volume%3D51%26issue%3D2%26spage%3D159%26epage%3D168%26doi%3D10.1099%2F0022-1317-51-2-159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLennan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuzenroeder, M. W.</span></span> <span> </span><span class="NLM_article-title">Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1492</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1128/IAI.66.4.1492-1499.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.66.4.1492-1499.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9529072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXitFCisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1998&pages=1492-1499&issue=4&author=R.+M.+Doyleauthor=T.+W.+Steeleauthor=A.+M.+McLennanauthor=I.+H.+Parkinsonauthor=P.+A.+Manningauthor=M.+W.+Heuzenroeder&title=Sequence+Analysis+of+the+mip+Gene+of+the+Soilborne+Pathogen+Legionella+longbeachae&doi=10.1128%2FIAI.66.4.1492-1499.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence analysis of the mip gene of the soilborne pathogen Legionella longbeachae</span></div><div class="casAuthors">Doyle, Robyn M.; Steele, Trevor W.; Mclennan, Alan M.; Parkinson, Ian H.; Manning, Paul A.; Heuzenroeder, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1492-1499</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">To understand the basis of pathogenesis by Legionella longbeachae serogroup 1, the importance of the Mip protein in this species was examd.  Amino-terminal anal. of the purified, cloned L. longbeachae serogroup 1 ATCC 33462 Mip protein confirmed that the cloned gene protein was expressed and processed in an Escherichia coli background.  DNA sequence anal. of plasmid pIMVS27, contg. the entire L. longbeachae serogroup 1 mip gene, revealed a high degree of homol. to the mip gene of Legionella pneumophila serogroup 1, 76% homol. at the DNA level and 87% identity at the amino acid level.  Primer extension anal. detd. that the start site of transcription was the same for both species, with some differences obsd. for the -10 and -35 promoter regions.  Primers designed from the mip gene sequence obtained for L. longbeachae serogroup 1 ATCC 33462 were used to amplify the mip genes from L. longbeachae serogroup 2 ATCC 33484 and an Australian clin. isolate of L. longbeachae serogroup 1 A5H5.  The mip gene from A5H5 was 100% identical to the type strain sequence.  The serogroup 2 strain of L. longbeachae differed by 2 base pairs in third-codon positions.  Allelic exchange mutagenesis was used to generate an isogenic mip mutant in ATCC 33462 and strain A5H5.  The ATCC mip mutant was unable to infect a strain of Acanthamoebae sp. both in liq. and in a potting mix coculture system, while the A5H5 mip mutant behaved in a manner similar to that of L. pneumophila serogroup 1, i.e., it displayed a reduced capacity to infect and multiply within Acanthamoebae.  To det. if this mutation resulted in reduced virulence in the guinea pig animal model, the A5H5 mip mutant and its parent strain were assessed for their abilities to establish an infection after aerosol exposure.  Unlike the virulent parent strain, the mutant strain did not kill any animals under two different dose regimes.  The data indicate that the Mip protein plays an important role in the intracellular life cycle of L. longbeachae serogroup 1 species and is required for full virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmCO4UiQAWNrVg90H21EOLACvtfcHk0lg3IBQxx2pKFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFCisLY%253D&md5=add4933eef7c021b9dde67357d7fd83d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1128%2FIAI.66.4.1492-1499.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.66.4.1492-1499.1998%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DR.%2BM.%26aulast%3DSteele%26aufirst%3DT.%2BW.%26aulast%3DMcLennan%26aufirst%3DA.%2BM.%26aulast%3DParkinson%26aufirst%3DI.%2BH.%26aulast%3DManning%26aufirst%3DP.%2BA.%26aulast%3DHeuzenroeder%26aufirst%3DM.%2BW.%26atitle%3DSequence%2520Analysis%2520of%2520the%2520mip%2520Gene%2520of%2520the%2520Soilborne%2520Pathogen%2520Legionella%2520longbeachae%26jtitle%3DInfect.%2520Immun.%26date%3D1998%26volume%3D66%26issue%3D4%26spage%3D1492%26epage%3D1499%26doi%3D10.1128%2FIAI.66.4.1492-1499.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangsborg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianciotto, N. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of a Legionella micdadei mip Mutant</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2840</span>– <span class="NLM_lpage">2845</span>, <span class="refDoi"> DOI: 10.1128/IAI.63.8.2840-2845.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.63.8.2840-2845.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7622203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXntFyqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1995&pages=2840-2845&issue=8&author=W.+A.+O%E2%80%99Connellauthor=J.+M.+Bangsborgauthor=N.+P.+Cianciotto&title=Characterization+of+a+Legionella+micdadei+mip+Mutant&doi=10.1128%2FIAI.63.8.2840-2845.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Legionella micdadei mip mutant</span></div><div class="casAuthors">O'Connell, William A.; Bangsborg, Jette M.; Cianciotto, Nicholas P.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2840-5</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The pathogenesis of Legionella micdadei is dependent upon its ability to infect alveolar phagocytes.  To better understand the basis of intracellular infection by this organism, we examd. the importance of its Mip surface protein.  In Legionella pneumophila, Mip promotes infection of both human macrophages and freshwater protozoa.  Southern hybridization and immunoblot analyses demonstrated that mip sequences were present and expressed within a panel of virulent L. micdadei strains.  Using allelic exchange mutagenesis, we then constructed an L. micdadei strain that completely and specifically lacked Mip.  Although unimpaired in its ability to grow in bacteriol. media, this Mip mutant was defective in its capacity to infect U937 cells, a human macrophage-like cell line.  Most significantly, the Mip- organism displayed a 24-old redn. in survivability immediately after its entry into the phagocyte.  Similarly, the mutant was less able to parasitize Hartmannella amoebae.  Taken together, these data argue that Mip specifically potentiates intracellular growth by L. micdadei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKFfNW3rEq2bVg90H21EOLACvtfcHk0lg3IBQxx2pKFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFyqsbw%253D&md5=40e8dd8c4d86537cf07bfb163bbb28ff</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FIAI.63.8.2840-2845.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.63.8.2840-2845.1995%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DW.%2BA.%26aulast%3DBangsborg%26aufirst%3DJ.%2BM.%26aulast%3DCianciotto%26aufirst%3DN.%2BP.%26atitle%3DCharacterization%2520of%2520a%2520Legionella%2520micdadei%2520mip%2520Mutant%26jtitle%3DInfect.%2520Immun.%26date%3D1995%26volume%3D63%26issue%3D8%26spage%3D2840%26epage%3D2845%26doi%3D10.1128%2FIAI.63.8.2840-2845.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saul, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arie, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulliez-le Normand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betton, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, G.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Studies of FkpA from Escherichia coli, a Cis/Trans Peptidyl-Prolyl Isomerase with Chaperone Activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>335</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2003.10.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jmb.2003.10.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14672666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BD3srpt1Wjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2004&pages=595-608&issue=2&author=F.+Saulauthor=J.-P.+Arieauthor=B.+Vulliez-le+Normandauthor=R.+Kahnauthor=J.-M.+Bettonauthor=G.+Bentley&title=Structural+and+Functional+Studies+of+FkpA+from+Escherichia+coli%2C+a+Cis%2FTrans+Peptidyl-Prolyl+Isomerase+with+Chaperone+Activity&doi=10.1016%2Fj.jmb.2003.10.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity</span></div><div class="casAuthors">Saul F A; Arie J-P; Vulliez-le Normand B; Kahn R; Betton J-M; Bentley G A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">595-608</span>
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The protein FkpA from the periplasm of Escherichia coli exhibits both cis/trans peptidyl-prolyl isomerase (PPIase) and chaperone activities.  The crystal structure of the protein has been determined in three different forms: as the full-length native molecule, as a truncated form lacking the last 21 residues, and as the same truncated form in complex with the immunosuppressant ligand, FK506.  FkpA is a dimeric molecule in which the 245-residue subunit is divided into two domains.  The N-terminal domain includes three helices that are interlaced with those of the other subunit to provide all inter-subunit contacts maintaining the dimeric species.  The C-terminal domain, which belongs to the FK506-binding protein (FKBP) family, binds the FK506 ligand.  The overall form of the dimer is V-shaped, and the different crystal structures reveal a flexibility in the relative orientation of the two C-terminal domains located at the extremities of the V.  The deletion mutant FkpNL, comprising the N-terminal domain only, exists in solution as a mixture of monomeric and dimeric species, and exhibits chaperone activity.  By contrast, a deletion mutant comprising the C-terminal domain only is monomeric, and although it shows PPIase activity, it is devoid of chaperone function.  These results suggest that the chaperone and catalytic activities reside in the N and C-terminal domains, respectively.  Accordingly, the observed mobility of the C-terminal domains of the dimeric molecule could effectively adapt these two independent folding functions of FkpA to polypeptide substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1nDP7lyirx2mbXvSEQle5fW6udTcc2eaM7ri9wCOJsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srpt1Wjtw%253D%253D&md5=727207017b817eea5c9b093626162424</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2003.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2003.10.056%26sid%3Dliteratum%253Aachs%26aulast%3DSaul%26aufirst%3DF.%26aulast%3DArie%26aufirst%3DJ.-P.%26aulast%3DVulliez-le%2BNormand%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DR.%26aulast%3DBetton%26aufirst%3DJ.-M.%26aulast%3DBentley%26aufirst%3DG.%26atitle%3DStructural%2520and%2520Functional%2520Studies%2520of%2520FkpA%2520from%2520Escherichia%2520coli%252C%2520a%2520Cis%252FTrans%2520Peptidyl-Prolyl%2520Isomerase%2520with%2520Chaperone%2520Activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D335%26issue%3D2%26spage%3D595%26epage%3D608%26doi%3D10.1016%2Fj.jmb.2003.10.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hullmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patzer, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Römer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hantke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, V.</span></span> <span> </span><span class="NLM_article-title">Periplasmic Chaperone FkpA is Essential for Imported Colicin M Toxicity</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2008.06327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2008.06327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18554332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVehur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=926-937&issue=4&author=J.+Hullmannauthor=S.+I.+Patzerauthor=C.+R%C3%B6merauthor=K.+Hantkeauthor=V.+Braun&title=Periplasmic+Chaperone+FkpA+is+Essential+for+Imported+Colicin+M+Toxicity&doi=10.1111%2Fj.1365-2958.2008.06327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Periplasmic chaperone FkpA is essential for imported colicin M toxicity</span></div><div class="casAuthors">Hullmann, Julia; Patzer, Silke I.; Roemer, Christin; Hantke, Klaus; Braun, Volkmar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">926-937</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chaperones facilitate correct folding of newly synthesized proteins.  We show here that the periplasmic FkpA chaperone is required for killing Escherichia coli by colicin M entering cells from the outside.  Highly active colicin M prepns. were inactive against fkpA mutant cells; 104-fold dilns. killed fkpA+ cells.  Three previously isolated spontaneous mutants tolerant to colicin M carried a stop codon or an IS1 insertion in the peptidyl-prolyl-cis-trans-isomerase (PPIase) domain (C-domain) of FkpA, which resulted in deletion of the domain.  A randomly generated mutant carried a G148D mutation in the C-domain.  A temp.-sensitive mutant tolerant to colicin M carried a Y25N mutation in the FkpA N-domain.  Mutants transformed with wild-type fkpA were colicin M-sensitive.  Isolated FkpA-His reduced colicin M-His cleavage by proteinase K and renatured denatured colicin M-His in vitro; renaturation was prevented by the PPIase inhibitor FK506.  In both assays, periplasmic SurA-His had no effect.  No other tested periplasmic chaperone could activate colicin M.  Among the tested colicins, only colicin M required FkpA for activity.  Colicin M bound to cells via FhuA was inactivated by trypsin; unbound colicin M retained activity.  We propose that colicin M unfolds during import across the outer membrane, FkpA specifically assists in folding colicin M into an active toxin in the periplasm and PPIase is essential for colicin M activity.  Colicin M is a suitable tool for the isolation of FkpA mutants used to elucidate the functions of the FkpA N- and C-domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-oQcNNYmLbVg90H21EOLACvtfcHk0lglpRgKZ5JkxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVehur3I&md5=ee0dc88cd16213f63613ebaf15a829e5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2008.06327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2008.06327.x%26sid%3Dliteratum%253Aachs%26aulast%3DHullmann%26aufirst%3DJ.%26aulast%3DPatzer%26aufirst%3DS.%2BI.%26aulast%3DR%25C3%25B6mer%26aufirst%3DC.%26aulast%3DHantke%26aufirst%3DK.%26aulast%3DBraun%26aufirst%3DV.%26atitle%3DPeriplasmic%2520Chaperone%2520FkpA%2520is%2520Essential%2520for%2520Imported%2520Colicin%2520M%2520Toxicity%26jtitle%3DMol.%2520Microbiol.%26date%3D2008%26volume%3D69%26issue%3D4%26spage%3D926%26epage%3D937%26doi%3D10.1111%2Fj.1365-2958.2008.06327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Missiakas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, S.</span></span> <span> </span><span class="NLM_article-title">New Components of Protein Folding in Extracytoplasmic Compartments of Escherichia coli SurA, FkpA and Skp/OmpH</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.1996.561412.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1365-2958.1996.561412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8878048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28XlsFyqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=871-884&issue=4&author=D.+Missiakasauthor=J.+M.+Bettonauthor=S.+Raina&title=New+Components+of+Protein+Folding+in+Extracytoplasmic+Compartments+of+Escherichia+coli+SurA%2C+FkpA+and+Skp%2FOmpH&doi=10.1046%2Fj.1365-2958.1996.561412.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">New components of protein folding in extracytoplasmic compartments of Escherichia coli SurA, FkpA and Skp/OmpH</span></div><div class="casAuthors">Missiakas, Dominique; Betton, Jean-Michel; Raina, Satish</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">871-884</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">A global search for extracytoplasmic folding catalysts in Escherichia coli was undertaken using different genetic systems that produce unstable or misfolded proteins in the periplasm.  The extent of misfolding was monitored by the increased activity of the σE regulon that is specifically induced by misfolded proteins in the periplasm.  Using multicopy libraries, the authors cloned two genes, surA and fkpA, that decreased the σE-dependent response constitutively induced by misfolded proteins.  According to their sequences and their biochem. activities, SurA and FkpA belong to two different peptidyl prolyl isomerase (PPI) families.  SurA was also selected as a multicopy suppressor of a defined htrM (rfaD) null mutation.  Such mutants produce a defective lipopolysaccharide that is unable to protect outer membrane proteins from degrdn. during folding.  The SurA multicopy suppression effect in htrM (rfaD) mutant bacteria was directly assocd. with its ability to catalyze the folding of outer membrane proteins immediately after export.  Finally, Tn10 insertions were isolated, which led to an increased activity of the σE regulon.  Such insertions were mapped to the dsb genes encoding catalysts of the protein disulfide isomerase (PDI) family, as well as to the surA, fkpA and ompH/skp genes.  The authors propose that these three proteins (SurA, FkpA and OmpH/Skp) play an active role either as folding catalysts or as chaperones in extracytoplasmic compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7R1O_Reo3VrVg90H21EOLACvtfcHk0lglpRgKZ5JkxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFyqtL0%253D&md5=9c2bcabb801f4e31995daafc65301dd7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1996.561412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1996.561412.x%26sid%3Dliteratum%253Aachs%26aulast%3DMissiakas%26aufirst%3DD.%26aulast%3DBetton%26aufirst%3DJ.%2BM.%26aulast%3DRaina%26aufirst%3DS.%26atitle%3DNew%2520Components%2520of%2520Protein%2520Folding%2520in%2520Extracytoplasmic%2520Compartments%2520of%2520Escherichia%2520coli%2520SurA%252C%2520FkpA%2520and%2520Skp%252FOmpH%26jtitle%3DMol.%2520Microbiol.%26date%3D1996%26volume%3D21%26issue%3D4%26spage%3D871%26epage%3D884%26doi%3D10.1046%2Fj.1365-2958.1996.561412.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. D.</span></span> <span> </span><span class="NLM_article-title">Escherichia coli and Other Species of the Enterobacteriaceae Encode a Protein Similar to the Family of Mip-Like FK506-Binding Proteins</span>. <i>Arch. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>163</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1007/BF00404209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2FBF00404209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7540828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXmtVKjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1995&pages=357-365&issue=5&author=S.+M.+Horneauthor=K.+D.+Young&title=Escherichia+coli+and+Other+Species+of+the+Enterobacteriaceae+Encode+a+Protein+Similar+to+the+Family+of+Mip-Like+FK506-Binding+Proteins&doi=10.1007%2FBF00404209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins</span></div><div class="casAuthors">Horne, Shelley M.; Young, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Microbiology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-65</span>CODEN:
                <span class="NLM_cas:coden">AMICCW</span>;
        ISSN:<span class="NLM_cas:issn">0302-8933</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A newly identified gene in Escherichia coli, fkpA, encodes a protein with extensive similarity to the macrophage infectivity potentiator (Mip) proteins of Legionalla pneumophila and Chlamydia trachomatis.  The FkpA protein may be a new member of the family of FK506-binding motif in 40 of 48 positions, including those amino acids at the active site that form hydrogen bonds with the drug FK506.  The amino acid sequence of the 29 kDa FkpA protein is 30-35% identical to the Mip proteins of L. pneumophila, L. micdadei, and C. trachomatis.  Of the 270 amino acids of FkpA, 113 (42%) are identical to the sequence of one or another of these Mip proteins.  Overexpression of FkpA or deletion of fkpA from the E. coli chromosome had no detrimental effect on bacterial growth, indicating that fkpA is not an essential gene.  Hybridization of fkpA-specific DNA probes to genomic blots revealed that similar genes exist in several representatives of the Enterobacteriaceae.  Thus, mip-like genes are not found exclusively in bacteria having a predominately intracellular life style, but instead appear to be a new FKBP subfamily that is a common constituent of many bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIS66AI1pNnrVg90H21EOLACvtfcHk0ljU1gpj7HXRhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtVKjsrs%253D&md5=74f4c39bb1d66c00a2792b0eca2be975</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2FBF00404209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00404209%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DS.%2BM.%26aulast%3DYoung%26aufirst%3DK.%2BD.%26atitle%3DEscherichia%2520coli%2520and%2520Other%2520Species%2520of%2520the%2520Enterobacteriaceae%2520Encode%2520a%2520Protein%2520Similar%2520to%2520the%2520Family%2520of%2520Mip-Like%2520FK506-Binding%2520Proteins%26jtitle%3DArch.%2520Microbiol.%26date%3D1995%26volume%3D163%26issue%3D5%26spage%3D357%26epage%3D365%26doi%3D10.1007%2FBF00404209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deuerling, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Specking, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoyasu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukau, B.</span></span> <span> </span><span class="NLM_article-title">Trigger Factor and DnaK Cooperate in Folding of Newly Synthesized Proteins</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>400</i></span> (<span class="NLM_issue">6745</span>),  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1038/23301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2F23301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10458167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=693-696&issue=6745&author=E.+Deuerlingauthor=A.+Schulze-Speckingauthor=T.+Tomoyasuauthor=A.+Mogkauthor=B.+Bukau&title=Trigger+Factor+and+DnaK+Cooperate+in+Folding+of+Newly+Synthesized+Proteins&doi=10.1038%2F23301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Trigger factor and DnaK cooperate in folding of newly synthesized proteins</span></div><div class="casAuthors">Deuerling, Elke; Schulze-Specking, Agnes; Tomoyasu, Toshifumi; Mogk, Axel; Bukau, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">6745</span>),
    <span class="NLM_cas:pages">693-696</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The role of mol. chaperones in assisting the folding of newly synthesized proteins in the cytosol is poorly understood.  In Escherichia coli, GroEL assists folding of only a minority of proteins and the Hsp70 homolog DnaK is not essential for protein folding or cell viability at intermediate growth temps.  The major protein assocd. with nascent polypeptides is ribosome-bound trigger factor, which displays chaperone and prolyl isomerase activities in vitro.  Here we show that Δtig::kan mutants lacking trigger factor have no defects in growth or protein folding.  However, combined Δtig::kan and ΔdnaK mutations cause synthetic lethality.  Depletion of DnaK in the Δtig::kan mutant results in massive aggregation of cytosolic proteins.  In Δtig::kan cells, an increased amt. of newly synthesized proteins assocd. transiently with DnaK.  These findings show in vivo activity for a ribosome-assocd. chaperone, trigger factor, in general protein folding, and functional cooperation of this protein with a cytosolic Hsp70.  Trigger factor and DnaK cooperate to promote proper folding of a variety of E. coli proteins, but neither is essential for folding and viability at intermediate growth temps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOlDHU7mH6hbVg90H21EOLACvtfcHk0ljU1gpj7HXRhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVCrs7k%253D&md5=f3d42334f2cd7597dcb298efbfe4d7bd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F23301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F23301%26sid%3Dliteratum%253Aachs%26aulast%3DDeuerling%26aufirst%3DE.%26aulast%3DSchulze-Specking%26aufirst%3DA.%26aulast%3DTomoyasu%26aufirst%3DT.%26aulast%3DMogk%26aufirst%3DA.%26aulast%3DBukau%26aufirst%3DB.%26atitle%3DTrigger%2520Factor%2520and%2520DnaK%2520Cooperate%2520in%2520Folding%2520of%2520Newly%2520Synthesized%2520Proteins%26jtitle%3DNature%26date%3D1999%26volume%3D400%26issue%3D6745%26spage%3D693%26epage%3D696%26doi%3D10.1038%2F23301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teter, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houry, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tradler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockabrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. U.</span></span> <span> </span><span class="NLM_article-title">Polypeptide Flux Through Bacterial Hsp70: DnaK Cooperates with Trigger Factor in Chaperoning Nascent Chains</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80787-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0092-8674%2800%2980787-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10380927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1999&pages=755-765&issue=6&author=S.+A.+Teterauthor=W.+A.+Houryauthor=D.+Angauthor=T.+Tradlerauthor=D.+Rockabrandauthor=G.+Fischerauthor=P.+Blumauthor=C.+Georgopoulosauthor=F.+U.+Hartl&title=Polypeptide+Flux+Through+Bacterial+Hsp70%3A+DnaK+Cooperates+with+Trigger+Factor+in+Chaperoning+Nascent+Chains&doi=10.1016%2FS0092-8674%2800%2980787-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Polypeptide flux through bacterial Hsp70: DnaK cooperates with trigger factor in chaperoning nascent chains</span></div><div class="casAuthors">Teter, Sarah A.; Houry, Walid A.; Ang, Debbie; Tradler, Thomas; Rockabrand, David; Fischer, Gunter; Blum, Paul; Georgopoulos, Costa; Hartl, F. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-765</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A role for DnaK, the major E. coli Hsp70, in chaperoning de novo protein folding has remained elusive.  Here we show that under nonstress conditions DnaK transiently assocs. with a wide variety of nascent and newly synthesized polypeptides, with a preference for chains larger than 30 kDa.  Deletion of the nonessential gene encoding trigger factor, a ribosome-assocd. chaperone, results in a doubling of the fraction of nascent polypeptides interacting with DnaK.  Combined deletion of the trigger factor and DnaK genes is lethal under normal growth conditions.  These findings indicate important, partially overlapping functions of DnaK and trigger factor in de novo protein folding and explain why the loss of either chaperone can be tolerated by E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlnP04Cv-OzrVg90H21EOLACvtfcHk0liRG86-F97p5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOju7s%253D&md5=46fbfbb8a5fc8406029acaf6035845a4</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980787-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980787-4%26sid%3Dliteratum%253Aachs%26aulast%3DTeter%26aufirst%3DS.%2BA.%26aulast%3DHoury%26aufirst%3DW.%2BA.%26aulast%3DAng%26aufirst%3DD.%26aulast%3DTradler%26aufirst%3DT.%26aulast%3DRockabrand%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DBlum%26aufirst%3DP.%26aulast%3DGeorgopoulos%26aufirst%3DC.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DPolypeptide%2520Flux%2520Through%2520Bacterial%2520Hsp70%253A%2520DnaK%2520Cooperates%2520with%2520Trigger%2520Factor%2520in%2520Chaperoning%2520Nascent%2520Chains%26jtitle%3DCell%26date%3D1999%26volume%3D97%26issue%3D6%26spage%3D755%26epage%3D765%26doi%3D10.1016%2FS0092-8674%2800%2980787-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roof, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span> <span> </span><span class="NLM_article-title">The Escherichia coli FKBP-Type PPIase SlyD is Required for the Stabilization of the E Lysis Protein of Bacteriophage φX174</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02984.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1365-2958.2002.02984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12100551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslKlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=99-108&issue=1&author=T.+G.+Bernhardtauthor=W.+D.+Roofauthor=R.+Young&title=The+Escherichia+coli+FKBP-Type+PPIase+SlyD+is+Required+for+the+Stabilization+of+the+E+Lysis+Protein+of+Bacteriophage+%CF%86X174&doi=10.1046%2Fj.1365-2958.2002.02984.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The Escherichia coli FKBP-type PPIase SlyD is required for the stabilization of the E lysis protein of bacteriophage .vphi.X174</span></div><div class="casAuthors">Bernhardt, Thomas G.; Roof, William D.; Young, Ry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-108</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Most bacteriophages abruptly terminate their vegetative cycle by causing lysis of the host cell.  The ssDNA phage .vphi.X174 uses a single lysis gene, E, encoding a 91-amino-acid membrane protein that causes lysis of Escherichia coli by inhibiting MraY, a conserved enzyme of murein biosynthesis.  Recessive mutations in the host gene slyD (sensitivity to lysis) absolutely block E-mediated lysis and .vphi.X174 plaque formation.  The slyD gene encodes a FKBP-type peptidyl-prolyl cis-trans isomerase (PPIase).  To investigate the mol. basis of this unique FKBP-dependence, spontaneous plaque-forming mutants of .vphi.X174 were isolated on a slyD lawn.  All of these Epos (plates on slyD) suppressors encode proteins with either a R3H or L19F change.  The double mutant was also isolated and generated the largest plaques on the slyD lawn.  A c-myc epitope tag sequence was incorporated into the parental E and Epos genes without effect on lytic function.  Western blots and pulse-chase labeling expts. showed that both Epos and E are highly unstable in a slyD background; however, Epos is synthesized at a higher rate, allowing a lysis-sufficient level of Epos to accumulate.  Our results indicate that SlyD is required for stabilizing the E protein and allowing it to accumulate to the levels required to exert its lytic effect.  These data are discussed in terms of a model for the specific role of the SlyD PPIase in E folding, and of the use of the very strict SlyD-dependence phenotype for identifying elements of PPIase selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_9MaRdhqDlbVg90H21EOLACvtfcHk0liRG86-F97p5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslKlu70%253D&md5=7d32cee8e8ee3863feb19cd280ec6601</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02984.x%26sid%3Dliteratum%253Aachs%26aulast%3DBernhardt%26aufirst%3DT.%2BG.%26aulast%3DRoof%26aufirst%3DW.%2BD.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DThe%2520Escherichia%2520coli%2520FKBP-Type%2520PPIase%2520SlyD%2520is%2520Required%2520for%2520the%2520Stabilization%2520of%2520the%2520E%2520Lysis%2520Protein%2520of%2520Bacteriophage%2520%25CF%2586X174%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D45%26issue%3D1%26spage%3D99%26epage%3D108%26doi%3D10.1046%2Fj.1365-2958.2002.02984.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bispham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maskell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, T. S.</span></span> <span> </span><span class="NLM_article-title">Identification of Host-Specific Colonization Factors of Salmonella enterica Serovar Typhimurium</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04323.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2004.04323.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15522082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=994-1010&issue=4&author=E.+Morganauthor=J.+D.+Campbellauthor=S.+C.+Roweauthor=J.+Bisphamauthor=M.+P.+Stevensauthor=A.+J.+Bowenauthor=P.+A.+Barrowauthor=D.+J.+Maskellauthor=T.+S.+Wallis&title=Identification+of+Host-Specific+Colonization+Factors+of+Salmonella+enterica+Serovar+Typhimurium&doi=10.1111%2Fj.1365-2958.2004.04323.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of host-specific colonization factors of Salmonella enterica serovar typhimurium</span></div><div class="casAuthors">Morgan, Eirwen; Campbell, June D.; Rowe, Sonya C.; Bispham, Jennie; Stevens, Mark P.; Bowen, Alison J.; Barrow, Paul A.; Maskell, Duncan J.; Wallis, Timothy S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">994-1010</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The severity of infections caused by Salmonella enterica serovar typhimurium varies depending on the host species.  Numerous virulence genes have been identified in S. typhimurium, largely from studies in mice, but their roles in infections of other species remain unclear.  In the most comprehensive survey of its kind, through the use of signature-tagged mutagenesis of S. typhimurium, we have identified mutants that were unable to colonize calf intestines, mutants unable to colonize chick intestines and mutants unable to colonize both species.  The type three secretion systems encoded on Salmonella pathogenicity islands (SPIs) 1 and 2 were required for efficient colonization of cattle.  However, disruption of these secretion systems only caused a minor defect in S. typhimurium colonization of chicks.  Transposon insertions in SPI-4 compromised S. typhimurium colonization of cattle, but not chicks.  This is the 1st data confirming a role for SPI-4 in pathogenesis.  We have also been able to ascribe a role in colonization for cell surface polysaccharides, cell envelope proteins, and many 'housekeeping' genes and genes of unknown function.  We conclude that S. typhimurium uses different strategies to colonize calves and chicks.  This has major implications for vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH7sNyXLtaArVg90H21EOLACvtfcHk0liRG86-F97p5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsbzL&md5=39f33930dc26ee6ca3921a4657f97b87</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04323.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04323.x%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DJ.%2BD.%26aulast%3DRowe%26aufirst%3DS.%2BC.%26aulast%3DBispham%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DM.%2BP.%26aulast%3DBowen%26aufirst%3DA.%2BJ.%26aulast%3DBarrow%26aufirst%3DP.%2BA.%26aulast%3DMaskell%26aufirst%3DD.%2BJ.%26aulast%3DWallis%26aufirst%3DT.%2BS.%26atitle%3DIdentification%2520of%2520Host-Specific%2520Colonization%2520Factors%2520of%2520Salmonella%2520enterica%2520Serovar%2520Typhimurium%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D54%26issue%3D4%26spage%3D994%26epage%3D1010%26doi%3D10.1111%2Fj.1365-2958.2004.04323.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, X.</span></span> <span> </span><span class="NLM_article-title">Deletion-Mutant Construction, Prokaryotic Expression and Characterization of Peptidyl-Prolyl Cis-Trans Isomerase SlyD from Salmonella enteritidis</span>. <i>Acta Microbiol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29738198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1MfgvFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1282-1290&issue=8&author=R.+Guoauthor=S.+Zhuauthor=Y.+Jiaoauthor=S.+Anauthor=Y.+Xueauthor=X.+Feiauthor=S.+Gengauthor=Z.+Panauthor=X.+Jiao&title=Deletion-Mutant+Construction%2C+Prokaryotic+Expression+and+Characterization+of+Peptidyl-Prolyl+Cis-Trans+Isomerase+SlyD+from+Salmonella+enteritidis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion-mutant construction, prokaryotic expression and characterization of peptidal-prolyl cis-trans isomerase SlyD from Salmonella enteritidis</span></div><div class="casAuthors">Guo Rongxian; Zhu Shanshan; Jiao Yang; An Shumin; Xue Ying; Fei Xiao; Geng Shizhong; Pan Zhiming; Jiao Xin'an</div><div class="citationInfo"><span class="NLM_cas:title">Wei sheng wu xue bao = Acta microbiologica Sinica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1282-90</span>
        ISSN:<span class="NLM_cas:issn">0001-6209</span>.
    </div><div class="casAbstract">Objective:  Salmonella enterica serovar enteritidis is an important food-borne pathogen of human and animal.  To further study the function of SlyD associated with virulence and regulation in stress responses of Salmonella Enteritidis, we constructed slyD gene-deletion mutant,, expressed it in E. coli, and characterized the PPIase enzyme obtained.  Methods:  The slyD gene-deletion mutant of Salmonella enteritidis C50041 was constructed by suicide plasmid mediated homologous recombination.  Salmonella enteritidis slyD prokaryotic expression vector was carried out in E. coli, and PPIase activity of recombination SlyD was measured in protease-coupling assay with chymotrypsin.  For amino acids conservation studies, functional domain searches and secondary structure predictions, the BLAST, SMART, TMHMM, SignalP, PHD and SWISS MODEL were used.  Results:  Salmonella enteritidis C50041 ΔslyD mutant strain was successfully constructed.  The growth rate of slyD-deleted strain was identified consistent with its parent strain C50041.  A soluble recombinant SlyD protein was expressed in Escherichia coli BL21(DE3) cells and confirmed by SDS-PAGE.  Catalytic activity confirmed that the SlyD protein was biologically active.  Bioinformatic analysis showed that Salmonella Enteritidis SlyD as a multifaceted protein including three separated domains, the FKBP type peptidal-prolyl cis-trans isomerase domain, the IF chaperone domain and the metal-binding domain.  Conclusion:  Salmonella enteritidis C50041 ΔslyD mutant strain and soluble SlyD protein was obtained, and the present study may provide a basis for further study of the role of SlyD in Salmonella enteritidis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLwET0LaJOkHtlzo9xastyfW6udTcc2eaW5SBJ_0O2Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfgvFKqtg%253D%253D&md5=0e8a6d2be8e8016ccd7161b3b857c7d6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DFei%26aufirst%3DX.%26aulast%3DGeng%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DJiao%26aufirst%3DX.%26atitle%3DDeletion-Mutant%2520Construction%252C%2520Prokaryotic%2520Expression%2520and%2520Characterization%2520of%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520SlyD%2520from%2520Salmonella%2520enteritidis%26jtitle%3DActa%2520Microbiol.%2520Sin.%26date%3D2016%26volume%3D56%26issue%3D8%26spage%3D1282%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottom, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. D.</span></span> <span> </span><span class="NLM_article-title">Decreased Intracellular Survival of an FkpA Mutant of Salmonella typhimurium Copenhagen</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1128/IAI.65.2.806-810.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.65.2.806-810.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9009347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2sXpvVWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1997&pages=806-810&issue=2&author=S.+M.+Horneauthor=T.+J.+Kottomauthor=L.+K.+Nolanauthor=K.+D.+Young&title=Decreased+Intracellular+Survival+of+an+FkpA+Mutant+of+Salmonella+typhimurium+Copenhagen&doi=10.1128%2FIAI.65.2.806-810.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased intracellular survival of an fkpA mutant of Salmonella typhimurium Copenhagen</span></div><div class="casAuthors">Horne, Shelley M.; Kottom, Theodore J.; Nolan, Lisa K.; Young, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">806-810</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The fkpA gene of S. typhimurium encodes a protein similar to the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Chlamydia trachomatis.  Because Mip proteins enhance the ability of these intracellular pathogens to survive within macrophages and epithelial cells, the authors tested whether the product of the fkpA gene would not have the same effect on the intracellular growth of a virulent strain of S. typhimurium.  By a series of P22 transductions, the fkpA gene of S. typhimurium Copenhagen was replaced with the inactive fkpA::Ω-Cm gene from Escherichia coli, creating the mutant S. typhimurium KY32H1.  The Copenhagen and KY32H1 strains were equally able to enter Caco-2 cells (an epithelial cell line) and J774.A1 cells (a macrophage-like cell line).  However, compared to the parent, the fkpA mutant survived less well in both types of cells during the 1st 6 h after infection.  The no. of viable intracellular S. typhimurium Copenhagen bacteria remained const. 6 h after infection of Caco-2 cells, but the viability of S. typhimurium KY32H1 decreased significantly by 4 h postinfection.  The fkpA mutant also exhibited a reduced ability to survive intracellularly in J774.A1 cells as little as 2 h postinfection.  Complementation of the fkpA mutation by a plasmid-borne wild-type fkpA gene from E. coli restored the ability of S. typhimurium KY32H1 to grow normally in J774.A1 cells.  Thus, expression of the mip-like fkpA gene confers on S. typhimurium Copenhagen properties analogous to those mediated by the Mip proteins in other intracellular pathogens, suggesting that this mechanism may play a role in the virulence and/or intracellular growth of numerous bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF4YL9HZ8gJbVg90H21EOLACvtfcHk0lhvn7LK964h6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXpvVWhtQ%253D%253D&md5=75a8dc99dd9e83f3a3054b0230551894</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1128%2FIAI.65.2.806-810.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.65.2.806-810.1997%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DS.%2BM.%26aulast%3DKottom%26aufirst%3DT.%2BJ.%26aulast%3DNolan%26aufirst%3DL.%2BK.%26aulast%3DYoung%26aufirst%3DK.%2BD.%26atitle%3DDecreased%2520Intracellular%2520Survival%2520of%2520an%2520FkpA%2520Mutant%2520of%2520Salmonella%2520typhimurium%2520Copenhagen%26jtitle%3DInfect.%2520Immun.%26date%3D1997%26volume%3D65%26issue%3D2%26spage%3D806%26epage%3D810%26doi%3D10.1128%2FIAI.65.2.806-810.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuzenroeder, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flower, R.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of Two Immunophilin-Like Genes, ilpA and fkpA, on a Single 3.9-kilobase Fragment of Aeromonas hydrophila Genomic DNA</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>179</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3397</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1128/JB.179.11.3397-3403.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.179.11.3397-3403.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9171380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2sXjsF2jtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1997&pages=3397-3403&issue=11&author=C.+Wongauthor=M.+W.+Heuzenroederauthor=D.+M.+Quinnauthor=R.+Flower&title=Cloning+and+Characterization+of+Two+Immunophilin-Like+Genes%2C+ilpA+and+fkpA%2C+on+a+Single+3.9-kilobase+Fragment+of+Aeromonas+hydrophila+Genomic+DNA&doi=10.1128%2FJB.179.11.3397-3403.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of two immunophilin-like genes, ilpA and fkpA, on a single 3.9-kilobase fragment of Aeromonas hydrophila genomic DNA</span></div><div class="casAuthors">Wong, Christopher Y. F.; Heuzenroeder, Michael W.; Quinn, Diana M.; Flower, Robert L. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3397-3403</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Antiserum to Aeromonas hydrophila A6 cell envelopes was shown in a previous study (C. Y. F. Wong, G. Mayrhofer, M. W. Heuzenroeder, H. M. Atkinson, D. M. Quinn, and R. L. P. Flower, FEMS Immunol. Med. Microbiol. 15:233-241, 1996) to protect mice against lethal infection by this organism.  In this study, colony blot anal. of an A. hydrophila genomic library using antiserum to A. hydrophila A6 cell envelopes revealed a cosmid clone expressing a 30-kDa protein which has not been described previously in aeromonads.  The nucleotide sequence of a 3.9-kb fragment derived from this cosmid which expressed the 30-kDa protein revealed two potential open reading frames (ORFs) with homol. to known immunophilin proteins.  ORF1 encoded a 212-amino-acid protein (mol. mass, 22.4 kDa) with 56% identity to the immunophilin SlyD protein of Escherichia coli.  ORF1 was subsequently designated ilpA (immunophilin-like protein).  ORF3 encoded a potential gene product of 268 amino acids with a typical signal sequence and a predicted mol. size of 28.7 kDa.  The inferred amino acid sequence showed 46% identity with the sequence of the FkpA protein of E. coli and 40% identity with the sequence of the macrophage infectivity potentiator (Mip) protein of Legionella pneumophila.  ORF3 was designated fkpA (FK506 binding protein) by analogy with the E. coli FkpA protein.  Expression of the FkpA protein was confirmed by Western blot (immunoblot) anal., which detected a 30-kDa protein, with antiserum to the Mip protein of Legionella longbeachae and a specific antiserum to an A. hydrophila 30-kDa membrane protein.  PCR and Southern anal. showed that a DNA sequence encoding FkpA was found in all 178 aeromonads of diverse origins tested.  A nonpolar insertion mutation in the fkpA gene did not attenuate virulence in a suckling mouse model nor did it affect the expression of hemolysins or DNase.  This suggests that either the fkpA gene is not essential in the virulence of A. hydrophila under these conditions or there are other genes in A. hydrophila coding for proteins with similar functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonG0mpONHCnbVg90H21EOLACvtfcHk0lhvn7LK964h6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsF2jtb4%253D&md5=9b33a4d1161436a0c45df913a9c1582b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1128%2FJB.179.11.3397-3403.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.179.11.3397-3403.1997%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DC.%26aulast%3DHeuzenroeder%26aufirst%3DM.%2BW.%26aulast%3DQuinn%26aufirst%3DD.%2BM.%26aulast%3DFlower%26aufirst%3DR.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520Two%2520Immunophilin-Like%2520Genes%252C%2520ilpA%2520and%2520fkpA%252C%2520on%2520a%2520Single%25203.9-kilobase%2520Fragment%2520of%2520Aeromonas%2520hydrophila%2520Genomic%2520DNA%26jtitle%3DJ.%2520Bacteriol.%26date%3D1997%26volume%3D179%26issue%3D11%26spage%3D3397%26epage%3D3403%26doi%3D10.1128%2FJB.179.11.3397-3403.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mineshiba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naruishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokeguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashiba, S.</span></span> <span> </span><span class="NLM_article-title">Highly Expressed Genes in a Rough-Colony-Forming Phenotype of Aggregatibacter actinomycetemcomitans: Implication of a mip-Like Gene for the Invasion of Host Tissue</span>. <i>FEMS Immunol. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1111/j.1574-695X.2009.00624.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1574-695X.2009.00624.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19903198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=226-236&issue=2&author=T.+Maedaauthor=H.+Maedaauthor=K.+Yamabeauthor=J.+Mineshibaauthor=I.+Tanimotoauthor=T.+Yamamotoauthor=K.+Naruishiauthor=S.+Kokeguchiauthor=S.+Takashiba&title=Highly+Expressed+Genes+in+a+Rough-Colony-Forming+Phenotype+of+Aggregatibacter+actinomycetemcomitans%3A+Implication+of+a+mip-Like+Gene+for+the+Invasion+of+Host+Tissue&doi=10.1111%2Fj.1574-695X.2009.00624.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Highly expressed genes in a rough-colony-forming phenotype of Aggregatibacter actinomycetemcomitans: implication of a mip-like gene for the invasion of host tissue</span></div><div class="casAuthors">Maeda, Takemasa; Maeda, Hiroshi; Yamabe, Kokoro; Mineshiba, Junji; Tanimoto, Ichiro; Yamamoto, Tadashi; Naruishi, Koji; Kokeguchi, Susumu; Takashiba, Shogo</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Immunology and Medical Microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-236</span>CODEN:
                <span class="NLM_cas:coden">FIMIEV</span>;
        ISSN:<span class="NLM_cas:issn">0928-8244</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aggregatibacter actinomycetemcomitans, a potent pathogen of periodontitis, typically grows as a rough and adherent colony on primary isolated cultures.  The colony transforms into a smooth phenotype during repeated subculture.  In this study, we aimed to identify highly expressed genes in the rough-colony-forming phenotype for isolation of host-induced genes.  Using a cDNA-subtractive hybridization technique, three genes, homologous to a macrophage infectivity potentiator gene (mip), peroxiredoxin gene (prx) and outer membrane protein gene (ompA), were identified.  The expression levels of these genes in the rough-colony-forming phenotype were 4-10-fold higher as compared with the smooth-colony-forming phenotype.  Attention was focused on the mip-like gene, and a recombinant protein and a deficient mutant were constructed.  The recombinant protein reacted with sera from patients with periodontitis, suggesting the prodn. of the Mip-like protein in periodontal lesions.  Viable quant. invasion assay demonstrated that the viable cell counts of the wild-type strain that invaded HeLa cells were more than fourfold as compared with the mip-deficient mutant.  The expression of the mip-like gene, prx-like gene and ompA-like gene may be enhanced in the host, and the mip-like gene may play an important role in the infection of A. actinomycetemcomitans, esp. in its invasion of the epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryuHzqu5ol1LVg90H21EOLACvtfcHk0lhnIvi8DhGk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVCisLs%253D&md5=2a50419da6808b1231d50cb5ad0f87a9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-695X.2009.00624.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-695X.2009.00624.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DYamabe%26aufirst%3DK.%26aulast%3DMineshiba%26aufirst%3DJ.%26aulast%3DTanimoto%26aufirst%3DI.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNaruishi%26aufirst%3DK.%26aulast%3DKokeguchi%26aufirst%3DS.%26aulast%3DTakashiba%26aufirst%3DS.%26atitle%3DHighly%2520Expressed%2520Genes%2520in%2520a%2520Rough-Colony-Forming%2520Phenotype%2520of%2520Aggregatibacter%2520actinomycetemcomitans%253A%2520Implication%2520of%2520a%2520mip-Like%2520Gene%2520for%2520the%2520Invasion%2520of%2520Host%2520Tissue%26jtitle%3DFEMS%2520Immunol.%2520Med.%2520Microbiol.%26date%3D2010%26volume%3D58%26issue%3D2%26spage%3D226%26epage%3D236%26doi%3D10.1111%2Fj.1574-695X.2009.00624.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abendroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muruthi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safford, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moen, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorimer, D. D.</span></span> <span> </span><span class="NLM_article-title">A Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial Immunophilins</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1458</span>– <span class="NLM_lpage">1467</span>, <span class="refDoi"> DOI: 10.1128/AAC.01875-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.01875-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=24366729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFyjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1458-1467&issue=3&author=D.+W.+Begleyauthor=D.+Foxauthor=D.+Jennerauthor=C.+Juliauthor=P.+G.+Pierceauthor=J.+Abendrothauthor=M.+Muruthiauthor=K.+Saffordauthor=V.+Andersonauthor=K.+Atkinsauthor=S.+R.+Barnesauthor=S.+O.+Moenauthor=A.+C.+Raymondauthor=R.+Stacyauthor=P.+J.+Mylerauthor=B.+L.+Stakerauthor=N.+J.+Harmerauthor=I.+H.+Norvilleauthor=U.+Holzgrabeauthor=M.+Sarkar-Tysonauthor=T.+E.+Edwardsauthor=D.+D.+Lorimer&title=A+Structural+Biology+Approach+Enables+the+Development+of+Antimicrobials+Targeting+Bacterial+Immunophilins&doi=10.1128%2FAAC.01875-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins</span></div><div class="casAuthors">Begley, Darren W.; Fox, David; Jenner, Dominic; Juli, Christina; Pierce, Phillip G.; Abendroth, Jan; Muruthi, Muigai; Safford, Kris; Anderson, Vanessa; Atkins, Kateri; Barnes, Steve R.; Moen, Spencer O.; Raymond, Amy C.; Stacy, Robin; Myler, Peter J.; Staker, Bart L.; Harmer, Nicholas J.; Norville, Isobel H.; Holzgrabe, Ulrike; Sarkar-Tyson, Mitali; Edwards, Thomas E.; Lorimer, Donald D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1458-1467, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Macrophage infectivity potentiators (Mips) are immunophilin proteins and essential virulence factors for a range of pathogenic organisms.  We applied a structural biol. approach to characterize a Mip from Burkholderia pseudomallei (BpML1), the causative agent of melioidosis.  Crystal structure and NMR analyses of BpML1 in complex with known macrocyclics and other derivs. led to the identification of a key chem. scaffold.  This scaffold possesses inhibitory potency for BpML1 without the immunosuppressive components of related macrocyclic agents.  Biophys. characterization of a compd. series with this scaffold allowed binding site specificity in soln. and potency detns. for rank ordering the set.  The best compds. in this series possessed a low-micromolar affinity for BpML1, bound at the site of enzymic activity, and inhibited a panel of homologous Mip proteins from other pathogenic bacteria, without demonstrating toxicity in human macrophages.  Importantly, the in vitro activity of BpML1 was reduced by these compds., leading to decreased macrophage infectivity and intracellular growth of Burkholderia pseudomallei.  These compds. offer the potential for activity against a new class of antimicrobial targets and present the utility of a structure-based approach for novel antimicrobial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX6Ocol4-wGrVg90H21EOLACvtfcHk0lhnIvi8DhGk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFyjsLs%253D&md5=30b1b8b8dee0a14575d44118f21eb6f5</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1128%2FAAC.01875-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01875-13%26sid%3Dliteratum%253Aachs%26aulast%3DBegley%26aufirst%3DD.%2BW.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DJenner%26aufirst%3DD.%26aulast%3DJuli%26aufirst%3DC.%26aulast%3DPierce%26aufirst%3DP.%2BG.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DMuruthi%26aufirst%3DM.%26aulast%3DSafford%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DV.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DBarnes%26aufirst%3DS.%2BR.%26aulast%3DMoen%26aufirst%3DS.%2BO.%26aulast%3DRaymond%26aufirst%3DA.%2BC.%26aulast%3DStacy%26aufirst%3DR.%26aulast%3DMyler%26aufirst%3DP.%2BJ.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DT.%2BE.%26aulast%3DLorimer%26aufirst%3DD.%2BD.%26atitle%3DA%2520Structural%2520Biology%2520Approach%2520Enables%2520the%2520Development%2520of%2520Antimicrobials%2520Targeting%2520Bacterial%2520Immunophilins%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D3%26spage%3D1458%26epage%3D1467%26doi%3D10.1128%2FAAC.01875-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jäger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweimer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rösch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">Pipecolic Acid Derivatives as Small-Molecule Inhibitors of the Legionella MIP Protein</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1021/jm101156y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101156y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=277-283&issue=1&author=C.+Juliauthor=M.+Sippelauthor=J.+J%C3%A4gerauthor=A.+Thieleauthor=M.+Weiwadauthor=K.+Schweimerauthor=P.+R%C3%B6schauthor=M.+Steinertauthor=C.+A.+Sotrifferauthor=U.+Holzgrabe&title=Pipecolic+Acid+Derivatives+as+Small-Molecule+Inhibitors+of+the+Legionella+MIP+Protein&doi=10.1021%2Fjm101156y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Pipecolic Acid Derivatives As Small-Molecule Inhibitors of the Legionella MIP Protein</span></div><div class="casAuthors">Juli, Christina; Sippel, Martin; Jaeger, Jens; Thiele, Alexandra; Weiwad, Matthias; Schweimer, Kristian; Roesch, Paul; Steinert, Michael; Sotriffer, Christoph A.; Holzgrabe, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The macrophage infectivity potentiator (MIP) protein is a major virulence factor of Legionella pneumophila, the causative agent of Legionnaires' disease. MIP belongs to the FK506-binding proteins (FKBP) and is necessary for optimal intracellular survival and lung tissue dissemination of L. pneumophila.  We aimed to identify new small-mol. inhibitors of MIP by starting from known FKBP12 ligands.  Computational anal., synthesis, and biol. testing of pipecolic acid derivs. revealed a promising scaffold for new MIP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9jZwK850-Q7Vg90H21EOLACvtfcHk0lhnIvi8DhGk5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL7N&md5=bfe0d0ae70dc777f63e03e0ab24ee8cc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm101156y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101156y%26sid%3Dliteratum%253Aachs%26aulast%3DJuli%26aufirst%3DC.%26aulast%3DSippel%26aufirst%3DM.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DJ.%26aulast%3DThiele%26aufirst%3DA.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DSchweimer%26aufirst%3DK.%26aulast%3DR%25C3%25B6sch%26aufirst%3DP.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DPipecolic%2520Acid%2520Derivatives%2520as%2520Small-Molecule%2520Inhibitors%2520of%2520the%2520Legionella%2520MIP%2520Protein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D277%26epage%3D283%26doi%3D10.1021%2Fjm101156y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seufert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bzdyl, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozjak-Pavlovic, V.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Macrophage Infectivity Potentiator-Like PPIases Affect Neisserial and Chlamydial Pathogenicity</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2016.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.ijantimicag.2016.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27516227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1OktbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=401-408&issue=4&author=A.+Reimerauthor=F.+Seufertauthor=M.+Weiwadauthor=J.+Ebertauthor=N.+M.+Bzdylauthor=C.+M.+Kahlerauthor=M.+Sarkar-Tysonauthor=U.+Holzgrabeauthor=T.+Rudelauthor=V.+Kozjak-Pavlovic&title=Inhibitors+of+Macrophage+Infectivity+Potentiator-Like+PPIases+Affect+Neisserial+and+Chlamydial+Pathogenicity&doi=10.1016%2Fj.ijantimicag.2016.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity</span></div><div class="casAuthors">Reimer, Anastasija; Seufert, Florian; Weiwad, Matthias; Ebert, Jutta; Bzdyl, Nicole M.; Kahler, Charlene M.; Sarkar-Tyson, Mitali; Holzgrabe, Ulrike; Rudel, Thomas; Kozjak-Pavlovic, Vera</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pathogenic bacteria Chlamydia trachomatis, Neisseria gonorrhoeae and Neisseria meningitidis express the surface-exposed macrophage infectivity potentiator (MIP)-like protein, which plays a role in their pathogenicity.  MIP exhibits a peptidyl-prolyl isomerase (PPIase) activity that is inhibited by rapamycin and FK506.  In this study, pipecolic acid derivs. were tested for their activity against the chlamydial and neisserial MIP.  Two MIP inhibitors were identified, PipN3 and PipN4, that affected the developmental cycle of C. trachomatis in HeLa cells.  Furthermore, the authors could show that deletion of neisserial MIP or addn. of the two MIP inhibitors affected the survival of N. gonorrhoeae in the presence of neutrophils.  Furthermore, both compds. inhibited the adherence, invasion and/or survival of N. meningitidis in epithelial cells.  These results confirm the importance of MIP-like proteins in infection and indicate the relevance of pipecolic acid derivs. as antimicrobials against C. trachomatis, N. gonorrhoeae and N. meningitidis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_3bh-FhY0zrVg90H21EOLACvtfcHk0li9nhhRQv3dLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1OktbbF&md5=7b0ae2a3b9fd3174d0e17dd0d2cb3611</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2016.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2016.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DReimer%26aufirst%3DA.%26aulast%3DSeufert%26aufirst%3DF.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DEbert%26aufirst%3DJ.%26aulast%3DBzdyl%26aufirst%3DN.%2BM.%26aulast%3DKahler%26aufirst%3DC.%2BM.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DRudel%26aufirst%3DT.%26aulast%3DKozjak-Pavlovic%26aufirst%3DV.%26atitle%3DInhibitors%2520of%2520Macrophage%2520Infectivity%2520Potentiator-Like%2520PPIases%2520Affect%2520Neisserial%2520and%2520Chlamydial%2520Pathogenicity%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2016%26volume%3D48%26issue%3D4%26spage%3D401%26epage%3D408%26doi%3D10.1016%2Fj.ijantimicag.2016.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seufert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweimer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruhn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rösch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">Development, Synthesis and Structure–Activity-Relationships of Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Legionella pneumophila and Burkholderia pseudomallei</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5134</span>– <span class="NLM_lpage">5147</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmc.2016.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27591009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5134-5147&issue=21&author=F.+Seufertauthor=M.+Kuhnauthor=M.+Heinauthor=M.+Weiwadauthor=M.+Vivoliauthor=I.+H.+Norvilleauthor=M.+Sarkar-Tysonauthor=L.+E.+Marshallauthor=K.+Schweimerauthor=H.+Bruhnauthor=P.+R%C3%B6schauthor=N.+J.+Harmerauthor=C.+A.+Sotrifferauthor=U.+Holzgrabe&title=Development%2C+Synthesis+and+Structure%E2%80%93Activity-Relationships+of+Inhibitors+of+the+Macrophage+Infectivity+Potentiator+%28Mip%29+Proteins+of+Legionella+pneumophila+and+Burkholderia+pseudomallei&doi=10.1016%2Fj.bmc.2016.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Development, synthesis and structure-activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei</span></div><div class="casAuthors">Seufert, Florian; Kuhn, Maximilian; Hein, Michael; Weiwad, Matthias; Vivoli, Mirella; Norville, Isobel H.; Sarkar-Tyson, Mitali; Marshall, Laura E.; Schweimer, Kristian; Bruhn, Heike; Roesch, Paul; Harmer, Nicholas J.; Sotriffer, Christoph A.; Holzgrabe, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5134-5147</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bacteria Burkholderia pseudomallei and Legionella pneumophila cause severe diseases like melioidosis and Legionnaire's disease with high mortality rates despite antibiotic treatment.  Due to increasing antibiotic resistances against these and other Gram-neg. bacteria, alternative therapeutical strategies are in urgent demand.  As a virulence factor, the macrophage infectivity potentiator (Mip) protein constitutes an attractive target.  The Mip proteins of B. pseudomallei and L. pneumophila exhibit peptidyl-prolyl cis/trans isomerase (PPIase) activity and belong to the PPIase superfamily.  In previous studies, the pipecolic acid moiety proved to be a valuable scaffold for inhibiting this PPIase activity.  Thus, a library of pipecolic acid derivs. was established guided by structural information and computational analyses of the binding site and possible binding modes.  Stability and toxicity considerations were taken into account in iterative extensions of the library.  Synthesis and evaluation of the compds. in PPIase assays resulted in highly active inhibitors.  The activities can be interpreted in terms of a common binding mode obtained by docking calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqCr2sKUqiHbVg90H21EOLACvtfcHk0li9nhhRQv3dLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrbK&md5=4bbc17527edeab318e8764becc065648</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DSeufert%26aufirst%3DF.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DHein%26aufirst%3DM.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DVivoli%26aufirst%3DM.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DL.%2BE.%26aulast%3DSchweimer%26aufirst%3DK.%26aulast%3DBruhn%26aufirst%3DH.%26aulast%3DR%25C3%25B6sch%26aufirst%3DP.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DDevelopment%252C%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity-Relationships%2520of%2520Inhibitors%2520of%2520the%2520Macrophage%2520Infectivity%2520Potentiator%2520%2528Mip%2529%2520Proteins%2520of%2520Legionella%2520pneumophila%2520and%2520Burkholderia%2520pseudomallei%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5134%26epage%3D5147%26doi%3D10.1016%2Fj.bmc.2016.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swindells, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Findlay, J. A.</span></span> <span> </span><span class="NLM_article-title">The X-ray Crystal Structure of Rapamycin, C51H79NO13</span>. <i>Can. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2491</span>– <span class="NLM_lpage">2492</span>, <span class="refDoi"> DOI: 10.1139/v78-407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1139%2Fv78-407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaE1MXit1ymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1978&pages=2491-2492&issue=18&author=D.+N.+Swindellsauthor=P.+S.+Whiteauthor=J.+A.+Findlay&title=The+X-ray+Crystal+Structure+of+Rapamycin%2C+C51H79NO13&doi=10.1139%2Fv78-407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The x-ray crystal structure of rapamycin, C51H79NO13</span></div><div class="casAuthors">Swindells, D. C. Neil; White, Peter S.; Findlay, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2491-2</span>CODEN:
                <span class="NLM_cas:coden">CJCHAG</span>;
        ISSN:<span class="NLM_cas:issn">0008-4042</span>.
    </div><div class="casAbstract">The x-ray crystallog. of antifungal antibiotic rapamycin (I) indicates that it is a completely new type of macrolide antibiotic of formula C51H79NO13.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUQjEBO0HV_rVg90H21EOLACvtfcHk0lgnlbWmEKHwIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXit1ymtA%253D%253D&md5=acd80b2ed2d2b32049b7fa0cbfb9069f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1139%2Fv78-407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv78-407%26sid%3Dliteratum%253Aachs%26aulast%3DSwindells%26aufirst%3DD.%2BN.%26aulast%3DWhite%26aufirst%3DP.%2BS.%26aulast%3DFindlay%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520X-ray%2520Crystal%2520Structure%2520of%2520Rapamycin%252C%2520C51H79NO13%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1978%26volume%3D56%26issue%3D18%26spage%3D2491%26epage%3D2492%26doi%3D10.1139%2Fv78-407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marusawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taga, T.</span></span> <span> </span><span class="NLM_article-title">Structure of FK506, a Novel Immunosuppressant Isolated from Streptomyces</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5033</span>, <span class="refDoi"> DOI: 10.1021/ja00250a050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00250a050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2sXlslGktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5031-5033&issue=16&author=H.+Tanakaauthor=A.+Kurodaauthor=H.+Marusawaauthor=H.+Hatanakaauthor=T.+Kinoauthor=T.+Gotoauthor=M.+Hashimotoauthor=T.+Taga&title=Structure+of+FK506%2C+a+Novel+Immunosuppressant+Isolated+from+Streptomyces&doi=10.1021%2Fja00250a050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of FK506, a novel immunosuppressant isolated from Streptomyces</span></div><div class="casAuthors">Tanaka, Hirokazu; Kuroda, Akio; Marusawa, Hiroshi; Hatanaka, Hiroshi; Kino, Toru; Goto, Toshio; Hashimoto, Masashi; Taga, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5031-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The structure I of FK506, a novel macrocyclic lactone isolated from Streptomyces tsukubaensis No. 9993 and which has immunosuppressant activity, was deduced on the basis of chem. and spectroscopic evidence.  The relative configuration was detd. by an x-ray crystal anal. of I and the abs. configuration was established by the fact that hydrolysis of I gave L-pipecolic acid.  The structure is unique in respect of contg. a hemiketal-masked α,β-diketoamide functionality incorporated in a 23-membered ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxGkL2OY6uD7Vg90H21EOLACvtfcHk0lgnlbWmEKHwIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlslGktr8%253D&md5=ca5492f7d8762dffc2e507d0345fa943</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja00250a050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00250a050%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DKuroda%26aufirst%3DA.%26aulast%3DMarusawa%26aufirst%3DH.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DKino%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DStructure%2520of%2520FK506%252C%2520a%2520Novel%2520Immunosuppressant%2520Isolated%2520from%2520Streptomyces%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26issue%3D16%26spage%3D5031%26epage%3D5033%26doi%3D10.1021%2Fja00250a050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondragon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Calcineurin–Cyclophilin–Cyclosporin Shows Common but Distinct Recognition of Immunophilin–Drug Complexes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">12037</span>– <span class="NLM_lpage">12042</span>, <span class="refDoi"> DOI: 10.1073/pnas.192206699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1073%2Fpnas.192206699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12218175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=12037-12042&issue=19&author=Q.+Huaiauthor=H.-Y.+Kimauthor=Y.+Liuauthor=Y.+Zhaoauthor=A.+Mondragonauthor=J.+O.+Liuauthor=H.+Ke&title=Crystal+Structure+of+Calcineurin%E2%80%93Cyclophilin%E2%80%93Cyclosporin+Shows+Common+but+Distinct+Recognition+of+Immunophilin%E2%80%93Drug+Complexes&doi=10.1073%2Fpnas.192206699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes</span></div><div class="casAuthors">Huai, Qing; Kim, Hwa-Young; Liu, Yudong; Zhao, Yingdong; Mondragon, Angelo; Liu, Jun O.; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12037-12042</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the common target for two immunophilin-immunosuppressant complexes, cyclophilin A-cyclosporin A (CyPA-CsA) and FKBP-FK506.  How the two structurally distinct immunophilin-drug complexes bind the same target has remained unknown.  We report the crystal structure of calcineurin (CN) in complex with CyPA-CsA at 2.8-Å resoln.  The CyPA-CsA complex binds to a composite surface formed by the catalytic and regulatory subunits of CN, where the complex of FK506 and its binding protein FKBP also binds.  While the majority of the CN residues involved in the binding are common for both immunophilin-immunosuppressant complexes, a significant no. of the residues are distinct.  Unlike FKBP-FK506, CyPA-CsA interacts with Arg-122 at the active site of CN, implying direct involvement of CyPA-CsA in the regulation of CN catalysis.  The simultaneous interaction of CyPA with both the composite surface and the active site of CN suggests that the composite surface may serve as a substrate recognition site responsible for the narrow substrate specificity of CN.  The comparison of CyPA-CsA-CN with FKBP-FK506-CN significantly contributes to understanding the mol. basis of regulation of CN activity by the immunophilin-immunosuppressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSjhnlTGw4urVg90H21EOLACvtfcHk0lgd7bBvJvMjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D&md5=9cc518ce524b0e84963cc891a9d1415d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192206699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192206699%26sid%3Dliteratum%253Aachs%26aulast%3DHuai%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DH.-Y.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMondragon%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DCrystal%2520Structure%2520of%2520Calcineurin%25E2%2580%2593Cyclophilin%25E2%2580%2593Cyclosporin%2520Shows%2520Common%2520but%2520Distinct%2520Recognition%2520of%2520Immunophilin%25E2%2580%2593Drug%2520Complexes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D19%26spage%3D12037%26epage%3D12042%26doi%3D10.1073%2Fpnas.192206699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span> <span> </span><span class="NLM_article-title">Structures of Calcineurin and its Complexes with Immunophilins–Immunosuppressants</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>311</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1095</span>– <span class="NLM_lpage">1102</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)01537-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0006-291X%2803%2901537-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14623295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVeit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2003&pages=1095-1102&issue=4&author=H.+Keauthor=Q.+Huai&title=Structures+of+Calcineurin+and+its+Complexes+with+Immunophilins%E2%80%93Immunosuppressants&doi=10.1016%2FS0006-291X%2803%2901537-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of calcineurin and its complexes with immunophilins-immunosuppressants</span></div><div class="casAuthors">Ke, Hengming; Huai, Qing</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1095-1102</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review.  Calcineurin (CN) is a Ca2+/calmodulin-dependent serine/threonine protein phosphatase and is involved in many physiol. processes such as T-cell activation and cardiac hypertrophy.  The crystal structures of CN and its complexes with FKBP12-FK506 and cyclophilin-cyclosporin showed that the two structurally unrelated immunophilins-immunosuppressants bind to a common composite surface made up of the residues from both catalytic subunit and regulatory subunit of CN.  The recognition of the immunophilins and immunosuppressive drugs is achieved by common but few distinct CN residues.  However, the binding pattern of FKBP12-FK506 such as hydrogen bonding is significantly different from that of CyPA-CsA.  This common but distinct recognition may indicate capacity of the compn. surface for binding of other inhibitory proteins.  The recognition site and the active site are adjacent and form an "L" shaped cleft.  This implies that the immunophilin recognition site may also serve as a recognition site to define the narrow substrate specificity of calcineurin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVJZtsbMaambVg90H21EOLACvtfcHk0lgd7bBvJvMjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVeit74%253D&md5=ff7d8adae67e24833ea631d834930d18</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901537-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901537-7%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DH.%26aulast%3DHuai%26aufirst%3DQ.%26atitle%3DStructures%2520of%2520Calcineurin%2520and%2520its%2520Complexes%2520with%2520Immunophilins%25E2%2580%2593Immunosuppressants%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D311%26issue%3D4%26spage%3D1095%26epage%3D1102%26doi%3D10.1016%2FS0006-291X%2803%2901537-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehajpal, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suthanthiran, M.</span></span> <span> </span><span class="NLM_article-title">Which Way for Drug-Mediated Immunosuppression?</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1016/0952-7915(94)90085-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0952-7915%2894%2990085-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7826535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=784-790&issue=5&author=V.+K.+Sharmaauthor=B.+Liauthor=A.+Khannaauthor=P.+K.+Sehajpalauthor=M.+Suthanthiran&title=Which+Way+for+Drug-Mediated+Immunosuppression%3F&doi=10.1016%2F0952-7915%2894%2990085-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Which way for drug-mediated immunosuppression?</span></div><div class="casAuthors">Sharma, Vijay K.; Li, Baogui; Khanna, Ashwani; Sehajpal, Prabodh K.; Suthanthiran, Manikkam</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">784-90</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">A review with 53 refs.  The basic immunosuppressive protocol involves the use of multiple drugs, each directed at a discrete site in the T-cell activation cascade.  The prevailing paradigm regarding the mechanisms of action of immunosuppressants is that they function to prevent allograft rejection of preventing cell activation, proliferation and/or cytokine prodn.  A new hypothesis is that some of the immunosuppressants might function by stimulating the expression of immunosuppressive mols. and/or cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfUUybKNwQALVg90H21EOLACvtfcHk0lgd7bBvJvMjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWju74%253D&md5=453b309c0d3a30bbdc79a1ccea582cdd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0952-7915%2894%2990085-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0952-7915%252894%252990085-X%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DV.%2BK.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DSehajpal%26aufirst%3DP.%2BK.%26aulast%3DSuthanthiran%26aufirst%3DM.%26atitle%3DWhich%2520Way%2520for%2520Drug-Mediated%2520Immunosuppression%253F%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1994%26volume%3D6%26issue%3D5%26spage%3D784%26epage%3D790%26doi%3D10.1016%2F0952-7915%2894%2990085-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span> <span> </span><span class="NLM_article-title">FKBP Family Proteins: Immunophilins with Versatile Biological Functions</span>. <i>Neurosignals</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1159/000123041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1159%2F000123041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18635947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=318-325&issue=4&author=C.+B.+Kangauthor=Y.+Hongauthor=S.+Dhe-Paganonauthor=H.+S.+Yoon&title=FKBP+Family+Proteins%3A+Immunophilins+with+Versatile+Biological+Functions&doi=10.1159%2F000123041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP Family Proteins: Immunophilins with Versatile Biological Functions</span></div><div class="casAuthors">Kang, Cong Bao; Hong, Ye; Dhe-Paganon, Sirano; Yoon, Ho Sup</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Immunophilins consist of a family of highly conserved proteins binding with immunosuppressive drugs such as FK506, rapamycin and cyclosporin A. FK506-binding protein (FKBP) is one of two major immunophilins and most of FKBP family members bind FK506 and show peptidylprolyl cis/trans isomerase (PPIase) activity.  Small size FKBP family members contain only FK506-binding domain, while FKBPs with large mol. wts. possess extra domains such as tetratricopeptide repeat domains, calmodulin binding and transmembrane motifs.  FKBPs are involved in several biochem. processes including protein folding, receptor signaling, protein trafficking and transcription.  FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands.  The roles of immunophilins in protein transportation and apoptosis through their mol. interactions with receptors or proteins have emerged recently.  Moreover, therapeutic implications of immunophilin ligands in treating neurodegenerative disorders have been accumulating.  FK506 and its derivs. with no immunosuppressive activities bind to the conserved active sites of the canonical FKBP members such as FKBP12, which shows PPIase activity.  These immunophilin ligands show variable efficacy in animal models for Parkinson's disease, dementia, and spinal cord injury, where the canonical immunophilins function as chaperones and are assoc. with the protein folding and modulation of oxidative stress.  On the other hand, in the noncanonical FKBP members such as FKBP38, FK506-binding site is not conserved and shows neither PPIase activity nor affinity to FK506.  Interestingly, the small mol.-mediated inhibition of the noncanonical member of FKBP family appears to cause neuronal protection and induce proliferation of neuronal stem cells in a rat focal cerebral ischemia model.  Currently, the mechanisms of actions remain unclear.  This review focuses on mol. characteristics of the canonical and noncanonical FKBP family members and the biol. functions of their ligands in performing neuroprotective and neurotrophic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQb9fhZ9y9bVg90H21EOLACvtfcHk0lgd7bBvJvMjEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegu7jN&md5=817eb2315f334f15b7aad9a9f1124c13</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1159%2F000123041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000123041%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DC.%2BB.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26atitle%3DFKBP%2520Family%2520Proteins%253A%2520Immunophilins%2520with%2520Versatile%2520Biological%2520Functions%26jtitle%3DNeurosignals%26date%3D2008%26volume%3D16%26issue%3D4%26spage%3D318%26epage%3D325%26doi%3D10.1159%2F000123041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandless, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burakoff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>250</i></span> (<span class="NLM_issue">4980</span>),  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1126/science.1700475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.1700475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1700475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXhslaltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1990&pages=556-559&issue=4980&author=B.+E.+Biererauthor=P.+K.+Somersauthor=T.+J.+Wandlessauthor=S.+J.+Burakoffauthor=S.+L.+Schreiber&title=Probing+Immunosuppressant+Action+with+a+Nonnatural+Immunophilin+Ligand&doi=10.1126%2Fscience.1700475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Probing immunosuppressant action with a nonnatural immunophilin ligand</span></div><div class="casAuthors">Bierer, Barbara E.; Somers, Patricia K.; Wandless, Thomas J.; Burakoff, Steven J.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">4980</span>),
    <span class="NLM_cas:pages">556-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The immunosuppressants FK506 and rapamycin bind to the same immunophilin, FK506 binding protein (FKBP), and inhibit distinct signal transduction pathways in T lymphocytes.  A nonnatural immunophilin ligand, 506BD, which contains only the common structural elements of FK506 and rapamycin, was synthesized and found to be a high-affinity ligand of FKBP and a potent inhibitor of FKBP rotamase activity.  Whereas 506BD does not interfere with T cell activation, it does block the immunosuppressive effects of both FK506 and rapamycin.  Thus, the common immunophilin binding element of these immunosuppressants, which is responsible for rotamase inhibition, is fused to different effector elements, resulting in the inhibition of different signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9rkttxhLXKLVg90H21EOLACvtfcHk0ligHzGY9vQzWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslaltA%253D%253D&md5=f9a1b701c5cd04c06b65bc0e701565be</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1126%2Fscience.1700475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1700475%26sid%3Dliteratum%253Aachs%26aulast%3DBierer%26aufirst%3DB.%2BE.%26aulast%3DSomers%26aufirst%3DP.%2BK.%26aulast%3DWandless%26aufirst%3DT.%2BJ.%26aulast%3DBurakoff%26aufirst%3DS.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DProbing%2520Immunosuppressant%2520Action%2520with%2520a%2520Nonnatural%2520Immunophilin%2520Ligand%26jtitle%3DScience%26date%3D1990%26volume%3D250%26issue%3D4980%26spage%3D556%26epage%3D559%26doi%3D10.1126%2Fscience.1700475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Chemistry and Biology of the Immunophilins and their Immunosuppressive Ligands</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>251</i></span> (<span class="NLM_issue">4991</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1126/science.1702904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.1702904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1702904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXhsVWjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1991&pages=283-287&issue=4991&author=S.+L.+Schreiber&title=Chemistry+and+Biology+of+the+Immunophilins+and+their+Immunosuppressive+Ligands&doi=10.1126%2Fscience.1702904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of the immunophilins and their immunosuppressive ligands</span></div><div class="casAuthors">Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">4991</span>),
    <span class="NLM_cas:pages">283-7</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review and discussion with 57 refs.  Cyclosporin A, FK506, and rapamycin are inhibitors of specific signal transduction pathways that lead to T lymphocyte activation.  These immunosuppressive agents bind with high affinity to cytoplasmic receptors termed immunophilins (immunosuppressant binding proteins).  Studies in this area have focused on the structural basis for the mol. recognition of immunosuppressants by immunophilins and the biol. consequences of their interactions.  Defining the biol. roles of this emerging family of receptors and their ligands may illuminate the process of protein trafficking in cells and the mechanisms of signal transmission through the cytoplasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMdTsEre1d3rVg90H21EOLACvtfcHk0ligHzGY9vQzWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsVWjs7w%253D&md5=b69959b27d3f361863dcb6c2f0de9289</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1126%2Fscience.1702904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1702904%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DChemistry%2520and%2520Biology%2520of%2520the%2520Immunophilins%2520and%2520their%2520Immunosuppressive%2520Ligands%26jtitle%3DScience%26date%3D1991%26volume%3D251%26issue%3D4991%26spage%3D283%26epage%3D287%26doi%3D10.1126%2Fscience.1702904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>273</i></span> (<span class="NLM_issue">5272</span>),  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1126/science.273.5272.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.273.5272.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8662507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1Crs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=239-242&issue=5272&author=J.+Choiauthor=J.+Chenauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Structure+of+the+FKBP12-Rapamycin+Complex+Interacting+with+Binding+Domain+of+Human+FRAP&doi=10.1126%2Fscience.273.5272.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP</span></div><div class="casAuthors">Choi, Jungwon; Chen, Jie; Schreiber, Stuart L.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">5272</span>),
    <span class="NLM_cas:pages">239-242</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Rapamycin, a potent immunosuppressive agent, binds two proteins: the FK506-binding protein (FKBP12) and the FKBP-rapamycin-assocd. protein (FRAP).  A crystal structure of the ternary complex of human FKBP12, rapamycin, and the FKBP12-rapamycin-binding (FRB) domain of human FRAP at a resoln. of 2.7 angstroms revealed the two proteins bound together as a result of the ability of rapamycin to occupy two different hydrophobic binding pockets simultaneously.  The structure shows extensive interactions between rapamycin and both proteins, but fewer interactions between the proteins.  The structure of the FRB domain of FRAP clarifies both rapamycin-independent and -dependent effects obsd. for mutants of FRAP and its homologs in the family of proteins related to the ataxia-telangiectasis mutant gene product, and it illustrates how a small cell-permeable mol. can mediate protein dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwBLM2PsItYLVg90H21EOLACvtfcHk0ligHzGY9vQzWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1Crs7k%253D&md5=c72a82e14c09d9a705215b4ac0525336</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscience.273.5272.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.273.5272.239%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520FKBP12-Rapamycin%2520Complex%2520Interacting%2520with%2520Binding%2520Domain%2520of%2520Human%2520FRAP%26jtitle%3DScience%26date%3D1996%26volume%3D273%26issue%3D5272%26spage%3D239%26epage%3D242%26doi%3D10.1126%2Fscience.273.5272.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standaert, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Atomic Structures of the Human Immunophilin FKBP-12 Complexes with FK506 and Rapamycin</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>229</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1993.1012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1006%2Fjmbi.1993.1012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7678431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1993&pages=105-124&issue=1&author=G.+D.+Van%0ADuyneauthor=R.+F.+Standaertauthor=P.+A.+Karplusauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Atomic+Structures+of+the+Human+Immunophilin+FKBP-12+Complexes+with+FK506+and+Rapamycin&doi=10.1006%2Fjmbi.1993.1012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin</span></div><div class="casAuthors">Van Duyne, Gregory D.; Standaert, Robert F.; Karplus, P. Andrew; Schreiber, Stuart L.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-24</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">High resoln. structures for the complexes formed by the immunosuppressive agents FK506 and rapamycin with the human immunophilin FKBP-12 have been detd. by X-ray diffraction.  FKBP-12 has a novel fold comprised of a five-stranded β-sheet wrapping around a short α-helix with an overall conical shape.  Both FK506 and rapamycin bind in the cavity defined by the β-sheet, α-helix and three loops.  Both FK506 and rapamycin bind in similar fashion with a set of hydrogen bonds and an unusual carbonyl binding pocket.  Bound FK506 has a different conformation than free (cryst.) FK506 while rapamycin's bound conformation is virtually identical to that of unbound rapamycin.  FKBP-12 is a peptidyl-prolyl isomerase (PPIase), and the structures of the complexes suggest ways in which this catalytic activity could operate.  The different complexes are active in suppressing different steps of T cell activation, an activity seemingly unconnected with the PPIase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo3bBH2sCbrVg90H21EOLACvtfcHk0lg7k08EO6Iw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKnsr4%253D&md5=6500d557923abae9cf3ca4d103cc145e</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1993.1012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1993.1012%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DStandaert%26aufirst%3DR.%2BF.%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DAtomic%2520Structures%2520of%2520the%2520Human%2520Immunophilin%2520FKBP-12%2520Complexes%2520with%2520FK506%2520and%2520Rapamycin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D229%26issue%3D1%26spage%3D105%26epage%3D124%26doi%3D10.1006%2Fjmbi.1993.1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mech, C.</span></span> <span> </span><span class="NLM_article-title">Determination of Enzymatic Catalysis for the Cis-Trans-Isomerization of Peptide Binding in Proline-Containing Peptides</span>. <i>Biomed. Biochim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=6395866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2MXhtVymtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1984&pages=1101-1111&author=G.+Fischerauthor=H.+Bangauthor=C.+Mech&title=Determination+of+Enzymatic+Catalysis+for+the+Cis-Trans-Isomerization+of+Peptide+Binding+in+Proline-Containing+Peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of enzyme catalysis for cis-trans-isomerization of peptide bonds using proline-containing peptides</span></div><div class="casAuthors">Fischer, G.; Bang, H.; Mech, C.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedica Biochimica Acta</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1101-11</span>CODEN:
                <span class="NLM_cas:coden">BBIADT</span>;
        ISSN:<span class="NLM_cas:issn">0232-766X</span>.
    </div><div class="casAbstract">The rates of cis to trans interconversion of Glt-(Ala)n-Pro-Phe-4-nitroanilines (n = 1-3, Glt = glutaryl) were estd. by a 2-step process with chymotrypsin as the trans-substrate cleaving activity.  Pig kidney and several other tissues contained demonstrable catalytic activity for the cis to trans interconversion of proline-contg. peptides.  The active protein fraction was purified 38-fold from pig kidney cortex by (NH4)2SO4 pptn. and a series of column chromatog. techniques.  Activity was detected against the cis to trans interconversion of Glt-Ala-Pro-Phe-4-nitroanilide, Glt-Ala-Ala-Pro-Phe-4-nitroanilide, and Glt-Ala-Ala-Ala-Pro-Phe-4-nitroanilide to different extents.  No activity was found with Phe-Pro-4-nitroanilide.  With respect to the substrate specificity, this enzyme must be classified as a peptidyl-prolyl cis-trans-isomerase.  The enzyme was strongly inactivated by p-chloromercuribenzoate, SDS, Hg2+, and Cu2+ ions, but was not inhibited by metal chelators, diisopropylphosphorofluoridate, and chlorotosylamidophenylbutane.  The activity is abolished by incubation with trypsin.  The enzyme is heat sensitive at 50°.  A new type of enzyme which catalyze conformational interconversions is thus proposed.  The possible location of the enzyme on ribosomal particles is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3rEtrJSA3JLVg90H21EOLACvtfcHk0lg7k08EO6Iw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtVymtLw%253D&md5=b90e923a65cf08661587cd4572afdeeb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DBang%26aufirst%3DH.%26aulast%3DMech%26aufirst%3DC.%26atitle%3DDetermination%2520of%2520Enzymatic%2520Catalysis%2520for%2520the%2520Cis-Trans-Isomerization%2520of%2520Peptide%2520Binding%2520in%2520Proline-Containing%2520Peptides%26jtitle%3DBiomed.%2520Biochim.%2520Acta%26date%3D1984%26volume%3D43%26spage%3D1101%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span> <span> </span><span class="NLM_article-title">A Miniaturized Peptidyl-Prolyl Isomerase Enzyme Assay</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>536</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.ab.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28803887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2nsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=536&publication_year=2017&pages=59-68&author=M.+Vivoliauthor=J.+Renouauthor=A.+Chevalierauthor=I.+H.+Norvilleauthor=S.+Diazauthor=C.+Juliauthor=H.+Atkinsauthor=U.+Holzgrabeauthor=P.-Y.+Renardauthor=M.+Sarkar-Tysonauthor=N.+J.+Harmer&title=A+Miniaturized+Peptidyl-Prolyl+Isomerase+Enzyme+Assay&doi=10.1016%2Fj.ab.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A miniaturized peptidyl-prolyl isomerase enzyme assay</span></div><div class="casAuthors">Vivoli, Mirella; Renou, Julien; Chevalier, Arnaud; Norville, Isobel H.; Diaz, Suraya; Juli, Christina; Atkins, Helen; Holzgrabe, Ulrike; Renard, Pierre-Yves; Sarkar-Tyson, Mitali; Harmer, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">536</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prolyl-peptidyl isomerases (PPIases) are enzymes that are found in all living organisms.  They form an essential part of the cellular protein folding homeostasis machinery.  PPIases are assocd. with many important human diseases, e.g. cardiovascular disease, cancer and Alzheimer's.  The development of novel PPIase inhibitors has been limited by the lack of a rapid, lab.-based assay for these enzymes, as their substrates and products are challenging to distinguish.  A well described continuous assay, coupled with the hydrolysis of a peptide by chymotrypsin is highly effective, but comparatively slow.  To address this, we developed an improved version of the traditional assay using a temp. controlled plate reader.  This assay allows semi-automated medium throughput assays in an academic lab. for 84 samples per day.  The assay shows lower errors, with an av. Z' of 0.72.  We further developed the assay using a fluorogenic peptide-based FRET probe.  This provides an extremely sensitive PPIase assay using substrate at 200 nM, which approaches single turnover conditions.  The fluorescent probe achieves an excellent quenching efficiency of 98.6%, and initial expts. showed acceptable Z' of 0.31 and 0.30 for cyclophilin A and hFKBP12 resp.  The assays provide an improved toolset for the quant., biochem. anal. of PPIases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1P0AZy-FPdLVg90H21EOLACvtfcHk0lg7k08EO6Iw3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2nsr%252FE&md5=c91498089b309e1ca1f0941752ec1324</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DVivoli%26aufirst%3DM.%26aulast%3DRenou%26aufirst%3DJ.%26aulast%3DChevalier%26aufirst%3DA.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DDiaz%26aufirst%3DS.%26aulast%3DJuli%26aufirst%3DC.%26aulast%3DAtkins%26aufirst%3DH.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DRenard%26aufirst%3DP.-Y.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26atitle%3DA%2520Miniaturized%2520Peptidyl-Prolyl%2520Isomerase%2520Enzyme%2520Assay%26jtitle%3DAnal.%2520Biochem.%26date%3D2017%26volume%3D536%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.ab.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luengo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konialian, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozamus, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Kinetic Evlauation of High-Affinity FKBP Ligands and the X-Ray Crystal Structures of Their Complexes with FKBP12</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9925</span>– <span class="NLM_lpage">9938</span>, <span class="refDoi"> DOI: 10.1021/ja00075a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00075a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXhtlCju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=9925-9938&author=D.+A.+Holtauthor=J.+I.+Luengoauthor=D.+S.+Yamashitaauthor=H.+J.+Ohauthor=A.+L.+Konialianauthor=H.+K.+Yenauthor=L.+W.+Rozamusauthor=M.+Brandtauthor=M.+J.+Bossardauthor=M.+A.+Levyauthor=D.+S.+Egglestonauthor=J.+Liangauthor=W.+Schultzauthor=T.+J.+Stoutauthor=J.+Clardy&title=Design%2C+Synthesis+and+Kinetic+Evlauation+of+High-Affinity+FKBP+Ligands+and+the+X-Ray+Crystal+Structures+of+Their+Complexes+with+FKBP12&doi=10.1021%2Fja00075a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12</span></div><div class="casAuthors">Holt, Dennis A.; Luengo, Juan I.; Yamashita, Dennis S.; Oh, Hye Ja; Konialian, Arda L.; Yen, Hwa Kwo; Rozamus, Leonard W.; Brandt, Martin; Bossard, Mary J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9925-38</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The high-affinity FKBP12 ligands I [R = Et, R1 = 1-hydroxycyclohexyl, cyclohexyl, CMe2Et; R = 3-cyclohexylpropyl, (CH2)3Ph, (CH2)3C6H2(OMe)3-3,4,5, (R)-CH(CMe2CH:CH2)CH2CH2Ph, (R)- and (S)-CHPhCH2CH2Ph, (R)- and (S)-1-cyclohexyl-3-phenyl-1-propyl] and II [X = (CH2)3, (CH2)5, (R)- and (S)-CH(CH2CH2Ph)C6H4O-m] were prepd.  These compds. potently inhibit the cis-trans-peptidylprolyl isomerase (rotamase) activity catalyzed by FKBP12 with inhibition consts. (Ki,app) as low as 1 nM, yet they possess remarkable structural simplicity relative to FK506 and rapamycin, from which they are conceptually derived.  The at. structures of three FKBP12-ligand complexes and of one unbound ligand were detd. by X-ray crystallog. and are compared to the FKBP12-FK506 and FKBP12-rapamycin complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMo4l1GweibVg90H21EOLACvtfcHk0ljZrHxu6UGhdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtlCju7c%253D&md5=5dfa7a210f55bbaddeadc14a90ab28ab</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fja00075a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00075a008%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DOh%26aufirst%3DH.%2BJ.%26aulast%3DKonialian%26aufirst%3DA.%2BL.%26aulast%3DYen%26aufirst%3DH.%2BK.%26aulast%3DRozamus%26aufirst%3DL.%2BW.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DLevy%26aufirst%3DM.%2BA.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DSchultz%26aufirst%3DW.%26aulast%3DStout%26aufirst%3DT.%2BJ.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Kinetic%2520Evlauation%2520of%2520High-Affinity%2520FKBP%2520Ligands%2520and%2520the%2520X-Ray%2520Crystal%2520Structures%2520of%2520Their%2520Complexes%2520with%2520FKBP12%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D9925%26epage%3D9938%26doi%3D10.1021%2Fja00075a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Microbial Peptidyl-Prolyl Cis/Trans Isomerases (PPIases): Virulence Factors and Potential Alternative Drug Targets</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00015-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FMMBR.00015-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=25184565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWqsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=544-571&issue=3&author=C.+M.+%C3%9Cnalauthor=M.+Steinert&title=Microbial+Peptidyl-Prolyl+Cis%2FTrans+Isomerases+%28PPIases%29%3A+Virulence+Factors+and+Potential+Alternative+Drug+Targets&doi=10.1128%2FMMBR.00015-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets</span></div><div class="casAuthors">Uenal, Can M.; Steinert, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">544-571, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1098-5557</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Initially discovered in the context of immunomodulation, peptidyl-prolyl cis/trans isomerases (PPIases) were soon identified as enzymes catalyzing the rate-limiting protein folding step at peptidyl bonds preceding proline residues.  Intense searches revealed that PPIases are a superfamily of proteins consisting of three structurally distinguishable families with representatives in every described species of prokaryote and eukaryote and, recently, even in some giant viruses.  Despite the clear-cut enzymic activity and ubiquitous distribution of PPIases, reports on solely PPIase-dependent biol. roles remain scarce.  Nevertheless, they have been found to be involved in a plethora of biol. processes, such as gene expression, signal transduction, protein secretion, development, and tissue regeneration, underscoring their general importance.  Hence, it is not surprising that PPIases have also been identified as virulence-assocd. proteins.  The extent of contribution to virulence is highly variable and dependent on the pleiotropic roles of a single PPIase in the resp. pathogen.  The main objective of this review is to discuss this variety in virulence-related bacterial and protozoan PPIases as well as the involvement of host PPIases in infectious processes.  Moreover, a special focus is given to Legionella pneumophila macrophage infectivity potentiator (Mip) and Mip-like PPIases of other pathogens, as the bestcharacterized virulence-related representatives of this family.  Finally, the potential of PPIases as alternative drug targets and first tangible results are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4SmfajVI9PrVg90H21EOLACvtfcHk0ljZrHxu6UGhdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWqsbrI&md5=220c39860c9411024ccac4ef5df1a3b0</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00015-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00015-14%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%2BM.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DMicrobial%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%2520%2528PPIases%2529%253A%2520Virulence%2520Factors%2520and%2520Potential%2520Alternative%2520Drug%2520Targets%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2014%26volume%3D78%26issue%3D3%26spage%3D544%26epage%3D571%26doi%3D10.1128%2FMMBR.00015-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babine, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleckman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moomaw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and X-Ray Crystallographic Studies of Novel FKBP-12 Ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00290-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0960-894X%2895%2900290-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFGksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=1719-1724&issue=15&author=R.+E.+Babineauthor=T.+Bleckmanauthor=C.+Kissingerauthor=R.+Showalterauthor=L.+Pelletierauthor=C.+Lewisauthor=K.+Tuckerauthor=E.+Moomawauthor=H.+Pargeauthor=J.+E.+Villafranca&title=Design%2C+Synthesis+and+X-Ray+Crystallographic+Studies+of+Novel+FKBP-12+Ligands&doi=10.1016%2F0960-894X%2895%2900290-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and x-ray crystallographic studies of novel FKBP-12 ligands</span></div><div class="casAuthors">Babine, Robert E.; Bleckman, T. M.; Kissinger, C. R.; Showalter, R.; Pelletier, L. A.; Lewis, C.; Tucker, Kathleen; Moomaw, Ellen; Parge, H. E.; Villafranca, J. Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1719-24</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">By using the crystal structure of FKBP-12, a novel class of ligands I (X = O, NMe, S, SO2; R = Ph, substituted Ph, CH2Ph, 2-imidazolyl, 4-pyridyl) was designed, prepd., and evaluated.  The crystal structure of the complex between I (X = S; R = 4-pyridyl) and FKBP-12 is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtzuQsLHM0ErVg90H21EOLACvtfcHk0ljZrHxu6UGhdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFGksbg%253D&md5=a27165989214e2b7a1fc028ccb7d1aba</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900290-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900290-A%26sid%3Dliteratum%253Aachs%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DBleckman%26aufirst%3DT.%26aulast%3DKissinger%26aufirst%3DC.%26aulast%3DShowalter%26aufirst%3DR.%26aulast%3DPelletier%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DTucker%26aufirst%3DK.%26aulast%3DMoomaw%26aufirst%3DE.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520X-Ray%2520Crystallographic%2520Studies%2520of%2520Novel%2520FKBP-12%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26issue%3D15%26spage%3D1719%26epage%3D1724%26doi%3D10.1016%2F0960-894X%2895%2900290-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theuerkorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinsohn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila</span>. <i>Front. Bioeng. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">41</span>, <span class="refDoi"> DOI: 10.3389/fbioe.2015.00041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffbioe.2015.00041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=25870856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC2MjktVSjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=41&author=J.+Raschauthor=M.+Theuerkornauthor=C.+%C3%9Cnalauthor=N.+Heinsohnauthor=S.+Tranauthor=G.+Fischerauthor=M.+Weiwadauthor=M.+Steinert&title=Novel+Cycloheximide+Derivatives+Targeting+the+Moonlighting+Protein+Mip+Exhibit+Specific+Antimicrobial+Activity+Against+Legionella+pneumophila&doi=10.3389%2Ffbioe.2015.00041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila</span></div><div class="casAuthors">Rasch Janine; Heinsohn Natascha; Tran Stefan; Theuerkorn Martin; Unal Can; Fischer Gunter; Weiwad Matthias; Steinert Michael</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in bioengineering and biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41</span>
        ISSN:<span class="NLM_cas:issn">2296-4185</span>.
    </div><div class="casAbstract">Macrophage infectivity potentiator (Mip) and Mip-like proteins are virulence factors in a wide range of pathogens including Legionella pneumophila.  These proteins belong to the FK506 binding protein (FKBP) family of peptidyl-prolyl-cis/trans-isomerases (PPIases).  In L. pneumophila, the PPIase activity of Mip is required for invasion of macrophages, transmigration through an in vitro lung-epithelial barrier, and full virulence in the guinea pig infection model.  Additionally, Mip is a moonlighting protein that binds to collagen IV in the extracellular matrix.  Here, we describe the development and synthesis of cycloheximide derivatives with adamantyl moieties as novel FKBP ligands, and analyze their effect on the viability of L. pneumophila and other bacteria.  All compounds efficiently inhibited PPIase activity of the prototypic human FKBP12 as well as Mip with IC50-values as low as 180 nM and 1.7 μM, respectively.  Five of these derivatives inhibited the growth of L. pneumophila at concentrations of 30-40 μM, but exhibited no effect on other tested bacterial species indicating a specific spectrum of antibacterial activity.  The derivatives carrying a 3,5-dimethyladamantan-1-[yl]acetamide substitution (MT_30.32), and a 3-ethyladamantan-1-[yl]acetamide substitution (MT_30.51) had the strongest effects in PPIase- and liquid growth assays.  MT_30.32 and MT_30.51 were also inhibitory in macrophage infection studies without being cytotoxic.  Accordingly, by applying a combinatorial approach, we were able to generate novel, hybrid inhibitors consisting of cycloheximide and adamantane, two known FKBP inhibitors that interact with different parts of the PPIase domain, respectively.  Interestingly, despite the proven Mip-inhibitory activity, the viability of a Mip-deficient strain was affected to the same degree as its wild type.  Hence, we also propose that cycloheximide derivatives with adamantyl moieties are potent PPIase inhibitors with multiple targets in L. pneumophila.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaqxR1PPJECacY7HFp97qMfW6udTcc2ea9JzKgAQEmlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjktVSjsw%253D%253D&md5=37534335b0428a948ec06e9fd8626c59</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3389%2Ffbioe.2015.00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffbioe.2015.00041%26sid%3Dliteratum%253Aachs%26aulast%3DRasch%26aufirst%3DJ.%26aulast%3DTheuerkorn%26aufirst%3DM.%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%26aulast%3DHeinsohn%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DNovel%2520Cycloheximide%2520Derivatives%2520Targeting%2520the%2520Moonlighting%2520Protein%2520Mip%2520Exhibit%2520Specific%2520Antimicrobial%2520Activity%2520Against%2520Legionella%2520pneumophila%26jtitle%3DFront.%2520Bioeng.%2520Biotechnol.%26date%3D2015%26volume%3D3%26spage%3D41%26doi%3D10.3389%2Ffbioe.2015.00041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyrwa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Küllertz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiericke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Cytotoxic Evaluation of Cycloheximide Derivatives as Potential Inhibitors of FKBP12 with Neuroregenerative Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3615</span>– <span class="NLM_lpage">3622</span>, <span class="refDoi"> DOI: 10.1021/jm991038t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991038t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXltV2lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3615-3622&issue=18&author=C.+Christnerauthor=R.+Wyrwaauthor=S.+Marschauthor=G.+K%C3%BCllertzauthor=R.+Thierickeauthor=S.+Grableyauthor=D.+Schumannauthor=G.+Fischer&title=Synthesis+and+Cytotoxic+Evaluation+of+Cycloheximide+Derivatives+as+Potential+Inhibitors+of+FKBP12+with+Neuroregenerative+Properties&doi=10.1021%2Fjm991038t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Cytotoxic Evaluation of Cycloheximide Derivatives as Potential Inhibitors of FKBP12 with Neuroregenerative Properties</span></div><div class="casAuthors">Christner, Claudia; Wyrwa, Ralf; Marsch, Silvia; Kuellertz, Gerhard; Thiericke, Ralf; Grabley, Susanne; Schumann, Dieter; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3615-3622</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the new finding that the protein synthesis inhibitor cycloheximide I (R = H) is able to competitively inhibit hFKBP12 (Ki = 3.4 μM) and homologous enzymes, a series of derivs. has been synthesized.  The effect of the compds. on the activity of hFKBP12 and their cytotoxicity against eukaryotic cell lines (mouse L-929 fibroblasts, K-562 leukemic cells) were detd.  As a result, several less toxic or nontoxic cycloheximide derivs. were identified by N-substitution of the glutarimide moiety and exhibit IC50 values in the range of 22.0-4.4 μM for inhibition of hFKBP12.  Among these compds. cycloheximide ethanoate I [R = EtOCOCH2 (II), Ki = 4.1 μM], which exerted FKBP12 inhibition to an extent comparable to that of cycloheximide I, was found to cause an approx. 1000-fold weaker inhibitory effect on eukaryotic protein synthesis (IC50 = 115 μM).  II was able to significantly speed nerve regeneration in a rat sciatic nerve neurotomy model at dosages of 30 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zPyFcJwQ9LVg90H21EOLACvtfcHk0ljrfu8cMmgYEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltV2lsLs%253D&md5=08eebb8f803cee09a895f1ae0a333d43</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm991038t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991038t%26sid%3Dliteratum%253Aachs%26aulast%3DChristner%26aufirst%3DC.%26aulast%3DWyrwa%26aufirst%3DR.%26aulast%3DMarsch%26aufirst%3DS.%26aulast%3DK%25C3%25BCllertz%26aufirst%3DG.%26aulast%3DThiericke%26aufirst%3DR.%26aulast%3DGrabley%26aufirst%3DS.%26aulast%3DSchumann%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Cytotoxic%2520Evaluation%2520of%2520Cycloheximide%2520Derivatives%2520as%2520Potential%2520Inhibitors%2520of%2520FKBP12%2520with%2520Neuroregenerative%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D18%26spage%3D3615%26epage%3D3622%26doi%3D10.1021%2Fjm991038t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titball, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span> <span> </span><span class="NLM_article-title">The Structure of a Burkholderia pseudomallei Immunophilin–Inhibitor Complex Reveals New Approaches to Antimicrobial Development</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>437</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1042/BJ20110345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1042%2FBJ20110345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21574961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVektro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2011&pages=413-422&issue=3&author=I.+H.+Norvilleauthor=K.+O%E2%80%99Sheaauthor=M.+Sarkar-Tysonauthor=S.+Zhengauthor=R.+W.+Titballauthor=G.+Varaniauthor=N.+J.+Harmer&title=The+Structure+of+a+Burkholderia+pseudomallei+Immunophilin%E2%80%93Inhibitor+Complex+Reveals+New+Approaches+to+Antimicrobial+Development&doi=10.1042%2FBJ20110345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development</span></div><div class="casAuthors">Norville, Isobel H.; O'Shea, Katherine; Sarkar-Tyson, Mitali; Zheng, Su-Xin; Titball, Richard W.; Varani, Gabriele; Harmer, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-422</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Mips (macrophage infectivity potentiators) are a subset of immunophilins assocd. with virulence in a range of micro-organisms.  These proteins possess peptidylprolyl isomerase activity and are inhibited by drugs including rapamycin and tacrolimus.  We detd. the structure of the Mip homolog [BpML1 (Burkholderia pseudomallei Mip-like protein 1)] from the human pathogen and biowarfare threat B. pseudomallei by NMR and x-ray crystallog.  The crystal structure suggests that key catalytic residues in the BpML1 active site have unexpected conformational flexibility consistent with a role in catalysis.  The structure further revealed BpML1 binding to a helical peptide, in a manner resembling the physiol. interaction of human TGFβRI (transforming growth factor β receptor I) with the human immunophilin FKBP12 (FK506-binding protein 12).  Furthermore, the structure of BpML1 bound to the class inhibitor cycloheximide N-ethylethanoate showed that this inhibitor mimics such a helical peptide, in contrast with the extended prolyl-peptide mimicking shown by inhibitors such as tacrolimus.  We suggest that Mips, and potentially other bacterial immunophilins, participate in protein-protein interactions in addn. to their peptidylprolyl isomerase activity, and that some roles of Mip proteins in virulence are independent of their peptidylprolyl isomerase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkl3Cu0LAflbVg90H21EOLACvtfcHk0ljrfu8cMmgYEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVektro%253D&md5=54f78e3c153d3fa7126e4256ae3b4127</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1042%2FBJ20110345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110345%26sid%3Dliteratum%253Aachs%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DTitball%26aufirst%3DR.%2BW.%26aulast%3DVarani%26aufirst%3DG.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520Structure%2520of%2520a%2520Burkholderia%2520pseudomallei%2520Immunophilin%25E2%2580%2593Inhibitor%2520Complex%2520Reveals%2520New%2520Approaches%2520to%2520Antimicrobial%2520Development%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D437%26issue%3D3%26spage%3D413%26epage%3D422%26doi%3D10.1042%2FBJ20110345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konialian-Beck, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozamus, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krog, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erhard, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luengo, J. I.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Studies of Synthetic FKBP Ligands as Peptidyl-Prolyl Isomerase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80135-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0960-894X%2801%2980135-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXktVShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=315-320&issue=2&author=D.+A.+Holtauthor=A.+L.+Konialian-Beckauthor=H.-J.+Ohauthor=H.-K.+Yenauthor=L.+W.+Rozamusauthor=A.+J.+Krogauthor=K.+F.+Erhardauthor=E.+Ortizauthor=M.+A.+Levyauthor=M.+Brandtauthor=M.+J.+Bossardauthor=J.+I.+Luengo&title=Structure-Activity+Studies+of+Synthetic+FKBP+Ligands+as+Peptidyl-Prolyl+Isomerase+Inhibitors&doi=10.1016%2FS0960-894X%2801%2980135-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies of synthetic FKBP ligands as peptidyl-prolyl isomerase inhibitors</span></div><div class="casAuthors">Holt, Dennis A.; Konialian-Beck, Arda L.; Oh, Hye-Ja; Yen, Hwa-Kwo; Rozamus, Leonard W.; Krog, Arnold J.; Erhard, Karl F.; Ortiz, Elizabeth; Levy, Mark A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-20</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">A series of non-macrocyclic pipecolyl α-ketoamides were prepd. and evaluated as FKBP cis-trans peptidyl-prolyl isomerase inhibitors.  These compds. exhibited inhibition consts. as low as 2 nM.  Their design was based on a consideration of the common FKBP-binding elements of FK506 and rapamycin.  Structure-activity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_06XFe8kOFLVg90H21EOLACvtfcHk0ljsjEBNL6fbog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVShsLo%253D&md5=0219535a44a4ce656b1a974fcf355dfd</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980135-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980135-9%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DKonialian-Beck%26aufirst%3DA.%2BL.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DYen%26aufirst%3DH.-K.%26aulast%3DRozamus%26aufirst%3DL.%2BW.%26aulast%3DKrog%26aufirst%3DA.%2BJ.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DOrtiz%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DM.%2BA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26atitle%3DStructure-Activity%2520Studies%2520of%2520Synthetic%2520FKBP%2520Ligands%2520as%2520Peptidyl-Prolyl%2520Isomerase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26issue%3D2%26spage%3D315%26epage%3D320%26doi%3D10.1016%2FS0960-894X%2801%2980135-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wintermeyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span> <span> </span><span class="NLM_article-title">Influence of Site Specifically Altered Mip Proteins on Intracellular Survival of Legionella pneumophila in Eukaryotic Cells</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4576</span>– <span class="NLM_lpage">4583</span>, <span class="refDoi"> DOI: 10.1128/IAI.63.12.4576-4583.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.63.12.4576-4583.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7591108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXpslClsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1995&pages=4576-4583&issue=12&author=E.+Wintermeyerauthor=B.+Ludwigauthor=M.+Steinertauthor=B.+Schmidtauthor=G.+Fischerauthor=J.+Hacker&title=Influence+of+Site+Specifically+Altered+Mip+Proteins+on+Intracellular+Survival+of+Legionella+pneumophila+in+Eukaryotic+Cells&doi=10.1128%2FIAI.63.12.4576-4583.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells</span></div><div class="casAuthors">Wintermeyer, Eva; Ludwig, Birgit; Steinert, Michael; Schmidt, Bettina; Fischer, Gunter; Hacker, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4576-83</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">L. pneumophila, the causative agent of Legionnaires' disease, is able to survive intracellularly in eukaryotic cells such as monocytes, macrophages, and protozoan organisms.  The Mip (macrophage infectivity potentiator) protein represents a factor of L. pneumophila necessary for optimal intracellular survival.  Interestingly, Mip belongs to the substance class of FK 506-binding proteins and exhibits peptidyl-prolyl cis/trans isomerase (PPIase) activity that can be inhibited by the immunosuppressant FK 506.  In order to identify amino acids most likely to be involved in the enzymic activity of Mip, site-directed mutagenized Mip proteins were constructed and characterized.  An Asp-142 to Leu-142 mutation and a Tyr-185 to Ala-185 substitution resulted in strongly reduced PPIase activity of the recombinant Mip proteins (5.3 and 0.6% of the activity of the wild-type Mip, resp.).  Genes coding for the wild-type and for site-directed-mutagenized Mip proteins were used to complement 3 different Mip-neg. mutants of L. pneumophila.  While Mip protein expression could be restored in the corresponding complementants, significant Mip-specific PPIase activity could be detected only in Mip mutants complemented with wild-type mip genes.  To investigate the influence of the PPIase activity of Mip on intracellular survival of L. pneumophila, invasion assays were performed using the macrophage-like cell line U937, human blood monocytes, and Acanthamoeba castellanii.  The Mip-neg. mutants were approx. 50- to 100-fold less infective for A. castellanii and for human mononuclear phagocytes in vitro than their isogenic Mip-pos. parental strains.  The wild-type invasion rate could be restored by introducing an intact copy of the mip gene into Mip-neg. strains.  In addn., no differences in intracellular survival were obsd. between the wild-type isolates and the Legionella strains exhibiting strongly reduced PPIase activity.  These data indicate that the enzymic activity of Mip does not contribute to intracellular survival of L. pneumophila.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXCfawlvswNrVg90H21EOLACvtfcHk0ljsjEBNL6fbog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslClsrk%253D&md5=61bbec0b0229d0ad465dc97b994020cb</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1128%2FIAI.63.12.4576-4583.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.63.12.4576-4583.1995%26sid%3Dliteratum%253Aachs%26aulast%3DWintermeyer%26aufirst%3DE.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26atitle%3DInfluence%2520of%2520Site%2520Specifically%2520Altered%2520Mip%2520Proteins%2520on%2520Intracellular%2520Survival%2520of%2520Legionella%2520pneumophila%2520in%2520Eukaryotic%2520Cells%26jtitle%3DInfect.%2520Immun.%26date%3D1995%26volume%3D63%26issue%3D12%26spage%3D4576%26epage%3D4583%26doi%3D10.1128%2FIAI.63.12.4576-4583.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marks, A. R.</span></span> <span> </span><span class="NLM_article-title">Cellular Functions of Immunophilins</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1152/physrev.1996.76.3.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1152%2Fphysrev.1996.76.3.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8757784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28XltVagsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1996&pages=631-649&issue=3&author=A.+R.+Marks&title=Cellular+Functions+of+Immunophilins&doi=10.1152%2Fphysrev.1996.76.3.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular functions of immunophilins</span></div><div class="casAuthors">Marks, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-649</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 161 refs.  Immunophilins are members of a highly conserved family of proteins all of which are cis-trans peptidylprolyl isomerases.  The prototypic members of the immunophilin family, cyclophilin A and FKBP12, were discovered on the basis of their ability to bind and mediate the immunosuppressive effects of the drugs, cyclosporin, FK506, and rapamycin.  However, the prolyl isomerase activity of these proteins is not involved in any of the immunosuppressive effects.  Indeed, despite the fact that all members of the family are prolyl isomerases, the cellular role of this enzymic function has not been clearly defined.  In many cases, immunophilins are widely expressed and are present at high levels in some tissues.  Moreover, whereas the no. of proteins that belong to the immunophilin family continues to grow, the natural cellular functions of all but a few remain obscure.  An example where immunophilins do appear to have a defined cellular role, in the absence of immunosuppressive ligands, is the modulation of intracellular Ca2+ release channel function by FKBP12 and FKBP12.6.  In this case, FKBPs are integral parts of 3 types of Ca2+ release channel complexes, skeletal and cardiac ryanodine receptors and the inositol 1,4,5-trisphosphate receptor.  In each case, FKBPs modulate channel function possibly by enhancing the cooperativity between subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHPBkjksRz8bVg90H21EOLACvtfcHk0lhK412RKuHAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVagsrY%253D&md5=251fabbea8ddd15e12876de18c1d68b1</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1996.76.3.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1996.76.3.631%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DA.%2BR.%26atitle%3DCellular%2520Functions%2520of%2520Immunophilins%26jtitle%3DPhysiol.%2520Rev.%26date%3D1996%26volume%3D76%26issue%3D3%26spage%3D631%26epage%3D649%26doi%3D10.1152%2Fphysrev.1996.76.3.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">FKBP Ligands—Where We Are and Where to Go?</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1425</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffphar.2018.01425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30568592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1425&author=J.+M.+Kolosauthor=A.+M.+Vollauthor=M.+Bauderauthor=F.+Hausch&title=FKBP+Ligands%E2%80%94Where+We+Are+and+Where+to+Go%3F&doi=10.3389%2Ffphar.2018.01425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP Ligands-where we are and where to go?</span></div><div class="casAuthors">Kolos, Juergen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1425</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  In recent years, many members of the FK506-binding protein (FKBP) family were increasingly linked to various diseases.  The binding domain of FKBPs differs only in a few amino acid residues, but their biol. roles are versatile.  High-affinity ligands with selectivity between close homologs are scarce.  This review will give an overview of the most prominent ligands developed for FKBPs and highlight a perspective for future developments.  More precisely, human FKBPs and correlated diseases will be discussed as well as microbial FKBPs in the context of anti-bacterial and anti-fungal therapeutics.  The last section gives insights into high-affinity ligands as chem. tools and dimerizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBr9H6aE3nrVg90H21EOLACvtfcHk0lhK412RKuHAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK&md5=72403a782e5d7e96352188f9e88821d9</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01425%26sid%3Dliteratum%253Aachs%26aulast%3DKolos%26aufirst%3DJ.%2BM.%26aulast%3DVoll%26aufirst%3DA.%2BM.%26aulast%3DBauder%26aufirst%3DM.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DFKBP%2520Ligands%25E2%2580%2594Where%2520We%2520Are%2520and%2520Where%2520to%2520Go%253F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D1425%26doi%3D10.3389%2Ffphar.2018.01425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pomplun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hähle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klages, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieß, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toh, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3660</span>– <span class="NLM_lpage">3673</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3660-3673&issue=8&author=S.+Pomplunauthor=C.+Sippelauthor=A.+H%C3%A4hleauthor=D.+Tayauthor=K.+Shimaauthor=A.+Klagesauthor=C.+M.+%C3%9Cnalauthor=B.+Rie%C3%9Fauthor=H.+T.+Tohauthor=G.+Hansenauthor=H.+S.+Yoonauthor=A.+Bracherauthor=P.+Preiserauthor=J.+Ruppauthor=M.+Steinertauthor=F.+Hausch&title=Chemogenomic+Profiling+of+Human+and+Microbial+FK506-Binding+Proteins&doi=10.1021%2Facs.jmedchem.8b00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins</span></div><div class="casAuthors">Pomplun, Sebastian; Sippel, Claudia; Haehle, Andreas; Tay, Donald; Shima, Kensuke; Klages, Alina; Uenal, Can Murat; Riess, Benedikt; Toh, Hui Ting; Hansen, Guido; Yoon, Ho Sup; Bracher, Andreas; Preiser, Peter; Rupp, Jan; Steinert, Michael; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3660-3673</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl isomerase activities and act as coreceptors for immunosuppressants.  Microbial macrophage-infectivity-potentiator (Mip)-type FKBPs can enhance infectivity.  However, developing druglike ligands for FKBPs or Mips has proven difficult, and many FKBPs and Mips still lack biol. useful ligands.  To explore the scope and potential of C5-substituted [4.3.1]-aza-bicyclic sulfonamides as a broadly applicable class of FKBP inhibitors, we developed a new synthesis method for the bicyclic core scaffold and used it to prep. an FKBP- and Mip-focused library.  This allowed us to perform a systematic structure-activity-relationship anal. across key human FKBPs and microbial Mips, yielding highly improved inhibitors for all the FKBPs studied.  A cocrystal structure confirmed the mol.-binding mode of the core structure and explained the affinity gained as a result of the preferred substituents.  The best FKBP and Mip ligands showed promising antimalarial, antileginonellal, and antichlamydial properties in cellular models of infectivity, suggesting that substituted [4.3.1]-aza-bicyclic sulfonamides could be a novel class of anti-infectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_KYmjlu3wrrVg90H21EOLACvtfcHk0lhK412RKuHAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWru7o%253D&md5=1961bd1a6f7aa868b5dd58319600b840</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00137%26sid%3Dliteratum%253Aachs%26aulast%3DPomplun%26aufirst%3DS.%26aulast%3DSippel%26aufirst%3DC.%26aulast%3DH%25C3%25A4hle%26aufirst%3DA.%26aulast%3DTay%26aufirst%3DD.%26aulast%3DShima%26aufirst%3DK.%26aulast%3DKlages%26aufirst%3DA.%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%2BM.%26aulast%3DRie%25C3%259F%26aufirst%3DB.%26aulast%3DToh%26aufirst%3DH.%2BT.%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DBracher%26aufirst%3DA.%26aulast%3DPreiser%26aufirst%3DP.%26aulast%3DRupp%26aufirst%3DJ.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DChemogenomic%2520Profiling%2520of%2520Human%2520and%2520Microbial%2520FK506-Binding%2520Proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D8%26spage%3D3660%26epage%3D3673%26doi%3D10.1021%2Facs.jmedchem.8b00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">Human and Escherichia coli Cyclophilins: Sensitivity to Inhibition by the Immunosuppressant Cyclosporin A Correlates with a Specific Tryptophan Residue</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2306</span>– <span class="NLM_lpage">2310</span>, <span class="refDoi"> DOI: 10.1021/bi00223a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00223a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXhtFCkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=2306-2310&issue=9&author=J.+Liuauthor=C.+M.+Chenauthor=C.+T.+Walsh&title=Human+and+Escherichia+coli+Cyclophilins%3A+Sensitivity+to+Inhibition+by+the+Immunosuppressant+Cyclosporin+A+Correlates+with+a+Specific+Tryptophan+Residue&doi=10.1021%2Fbi00223a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Human and Escherichia coli cyclophilins:  sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue</span></div><div class="casAuthors">Liu, Jun; Chen, Chih Ming; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2306-10</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The human T-cell protein cyclophilin shows high affinity for and is the proposed target of the major immunosuppressant drug cyclosporin A (CsA).  Cyclophilin also has peptidyl prolyl cis-trans isomerase (PPIase) activity that is inhibited by CsA with an IC50 of 6 nM, while by contrast a homologous PPIase from Escherichia coli has been found to be much less sensitive to CsA, shown here to be 500-fold less potent at an IC50 of 3000 nM.  This E. coli rotamase lacks the single highly conserved tryptophan residue of eukaryotic cyclophilins, and it is shown here that mutation of the natural F112 to W112 enhances E. coli rotamase susceptibility to CsA inhibition by 23-fold.  Correspondingly, the human W121 mutations to F121 or A121 yield cyclophilins with 75- and 200-fold decreased sensitivity to CsA, while kcat/Km values of rotamase activity in a tetrapeptide assay drop only 2- and 13-fold, resp.  This complementary gain and loss of CsA sensitivity to mutation to or from tryptophan validate the indole side chain as a major determinant in immunosuppressant drug recognition and the sepn. of PPIase catalytic efficiency from CsA affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe28ffDNC8ebVg90H21EOLACvtfcHk0lh5gqQYjcNXPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtFCkt7w%253D&md5=aa75576c6569680c3f2214536149dbbf</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fbi00223a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00223a003%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BM.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DHuman%2520and%2520Escherichia%2520coli%2520Cyclophilins%253A%2520Sensitivity%2520to%2520Inhibition%2520by%2520the%2520Immunosuppressant%2520Cyclosporin%2520A%2520Correlates%2520with%2520a%2520Specific%2520Tryptophan%2520Residue%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26issue%3D9%26spage%3D2306%26epage%3D2310%26doi%3D10.1021%2Fbi00223a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Prolyl Cis-Trans Isomerase from Bacillus subtilis. A Prokaryotic Enzyme that is Highly Sensitive to Cyclosporin A</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>309</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(92)80779-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0014-5793%2892%2980779-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1516692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXnsF2guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1992&pages=231-234&issue=3&author=M.+Herrlerauthor=H.+Bangauthor=K.+Bruneauthor=G.+Fischerauthor=M.+A.+Marahiel&title=Peptidyl-Prolyl+Cis-Trans+Isomerase+from+Bacillus+subtilis.+A+Prokaryotic+Enzyme+that+is+Highly+Sensitive+to+Cyclosporin+A&doi=10.1016%2F0014-5793%2892%2980779-G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl-prolyl cis-trans isomerase from Bacillus subtilis.  A prokaryotic enzyme that is highly sensitive to cyclosporin A</span></div><div class="casAuthors">Herrler, Michael; Bang, Holger; Brune, Kay; Fischer, Gunter; Marahiel, Mohamed A.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Cyclophilins are members of a class of proteins with peptidyl-prolyl cis-trans isomerase (PPIase) activity.  These enzymes bind the immunosuppressive agent, cyclosporin A (CsA), which acts as a competitive inhibitor.  The peptidyl-prolyl cis-trans isomerase from Bacillus subtilis was purified to homogeneity in a 4-step purifn. procedure, which resulted in a 100-fold protein purifn. with a yield of 5%.  Coomassie blue-stained SDS-PAGE revealed a single band of about 18 kDa.  PPIase activity was detd. using synthetic peptides as substrates in a 2-step reaction coupled to chymotrypsin.  Treatment of B. subtilis PPIase with CsA revealed an inhibition const. of 175 nM, which differs from cyclophilin of enterobacteria such as Escherichia coli or Salmonella typhimurium and is in the range of human enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYAkhgKQ76gbVg90H21EOLACvtfcHk0lh5gqQYjcNXPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXnsF2guw%253D%253D&md5=77f1115f84e2083425d19ab3b3fcedcd</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2892%2980779-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252892%252980779-G%26sid%3Dliteratum%253Aachs%26aulast%3DHerrler%26aufirst%3DM.%26aulast%3DBang%26aufirst%3DH.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DPeptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520from%2520Bacillus%2520subtilis.%2520A%2520Prokaryotic%2520Enzyme%2520that%2520is%2520Highly%2520Sensitive%2520to%2520Cyclosporin%2520A%26jtitle%3DFEBS%2520Lett.%26date%3D1992%26volume%3D309%26issue%3D3%26spage%3D231%26epage%3D234%26doi%3D10.1016%2F0014-5793%2892%2980779-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of ppiB, a Bacillus subtilis Gene which Encodes a Cyclosporine A-Sensitive Peptidyl-Prolyl Cis-Trans Isomerase</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1994.tb00384.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1994.tb00384.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8022278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADyaK2c3ptlOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1994&pages=1073-1083&issue=6&author=M.+Herrlerauthor=H.+Bangauthor=M.+A.+Marahiel&title=Cloning+and+Characterization+of+ppiB%2C+a+Bacillus+subtilis+Gene+which+Encodes+a+Cyclosporine+A-Sensitive+Peptidyl-Prolyl+Cis-Trans+Isomerase&doi=10.1111%2Fj.1365-2958.1994.tb00384.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of ppiB, a Bacillus subtilis gene which encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase</span></div><div class="casAuthors">Herrler M; Bang H; Marahiel M A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular microbiology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1073-83</span>
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">Sequencing of N-terminal and internal peptide fragments of the purified 17 kDa Bacillus subtilis peptidyl-prolyl cis-trans isomerase (PPIase) revealed sequence identity to conserved regions of a number of eukaryotic and prokaryotic cyclophilins.  Using two oligonucleotide primers corresponding to the N-terminus and a highly conserved internal amino acid sequence, polymerase chain reactions (PCR) with B. subtilis genomic DNA were carried out.  The resultant PCR fragment of 335 bp was cloned, sequenced and subsequently used as a probe for screening a lambda Zap II gene library of B. subtilis.  Two overlapping positive clones of 5 and 7 kb containing the B. subtilis PPIase gene (ppiB), which is 432 bp in length and encodes a protein of 144 amino acid residues, were identified and two distinct transcriptional initiation sites at the 5' end of ppiB were mapped.  The entire region (35 kb) between spoVA and serA was recently sequenced in B. subtilis, and an open reading frame (ORF) that encodes a putative peptidyl-prolyl cis-trans isomerase at about 210 degrees on the B. subtilis genetic map was located.  This putative PPIase is identical to PPiB.  We have overexpressed the ppiB gene in Escherichia coli, purified the encoded protein to apparent homology and shown that it exhibits PPIase activity.  In addition, the recombinant PPiB shows a significant inhibition of PPIase activity by cyclosporin A (CsA) at a level comparable to that observed for the B. subtilis enzyme.  Interestingly the B. subtilis PPIase shows about 40% identity to eukaryotic PPIases and less similarity to those of Gram-negative bacteria (27-32% identity).  Like other interruption mutants of yeast and Neurospora, which lack a functional cyclophilin gene, a B. subtilis mutant containing ppiB::cat, a cat-interrupted copy of ppiB in the chromosome, is viable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJywNOE7R26QHqQV89nF-2fW6udTcc2eYYhc5b2z1ftbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3ptlOktA%253D%253D&md5=3dffba0b3d5d229854961380e9f84b30</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1994.tb00384.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1994.tb00384.x%26sid%3Dliteratum%253Aachs%26aulast%3DHerrler%26aufirst%3DM.%26aulast%3DBang%26aufirst%3DH.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520ppiB%252C%2520a%2520Bacillus%2520subtilis%2520Gene%2520which%2520Encodes%2520a%2520Cyclosporine%2520A-Sensitive%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%26jtitle%3DMol.%2520Microbiol.%26date%3D1994%26volume%3D11%26issue%3D6%26spage%3D1073%26epage%3D1083%26doi%3D10.1111%2Fj.1365-2958.1994.tb00384.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galat, A.</span></span> <span> </span><span class="NLM_article-title">Compression of Large Sets of Sequence Data Reveals Fine Diversification of Functional Profiles in Multigene Families of Proteins: A Study for Peptidyl-Prolyl Cis/Trans Isomerases (PPIase)</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">59</span>, <span class="refDoi"> DOI: 10.3390/biom9020059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Fbiom9020059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=59&issue=2&author=A.+Galat&title=Compression+of+Large+Sets+of+Sequence+Data+Reveals+Fine+Diversification+of+Functional+Profiles+in+Multigene+Families+of+Proteins%3A+A+Study+for+Peptidyl-Prolyl+Cis%2FTrans+Isomerases+%28PPIase%29&doi=10.3390%2Fbiom9020059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Compression of large sets of sequence data reveals fine diversification of functional profiles in multigene families of proteins: a study for peptidyl-prolyl cis/trans isomerases (PPIase)</span></div><div class="casAuthors">Galat, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59/1-59/15</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In this tech. note, we describe analyzes of more than 15,000 sequences of FK506- binding proteins (FKBP) and cyclophilins, also known as peptidyl-prolyl cis/trans isomerases (PPIases).  We have developed a novel way of displaying relative changes of amino acid (AA)- residues at a given sequence position by using heat-maps.  This type of representation allows simultaneous estn. of conservation level in a given sequence position in the entire group of functionally-related paralogues (multigene family of proteins).  We have also proposed that at least two FKBPs, namely FKBP36, encoded by the gene and FKBP51, encoded by the Fkbp5 gene, can form dimers bound via a disulfide bridge in the nucleus.  This type of dimer may have some crucial function in the regulation of some nuclear complexes at different stages of the cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFKnWkYjvMWbVg90H21EOLACvtfcHk0lgVkcABZtIzzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvVehtrY%253D&md5=8edf6c9d469d7fac571a5a5ec3fcafa5</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.3390%2Fbiom9020059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9020059%26sid%3Dliteratum%253Aachs%26aulast%3DGalat%26aufirst%3DA.%26atitle%3DCompression%2520of%2520Large%2520Sets%2520of%2520Sequence%2520Data%2520Reveals%2520Fine%2520Diversification%2520of%2520Functional%2520Profiles%2520in%2520Multigene%2520Families%2520of%2520Proteins%253A%2520A%2520Study%2520for%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%2520%2528PPIase%2529%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26issue%3D2%26spage%3D59%26doi%3D10.3390%2Fbiom9020059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna-Slater, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finerty, P. J.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenmesser, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span> <span> </span><span class="NLM_article-title">Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">e1000439</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1000439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pbio.1000439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20676357" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=e1000439&issue=7&author=T.+L.+Davisauthor=J.+R.+Walkerauthor=V.+Campagna-Slaterauthor=P.+J.+Finertyauthor=R.+Paramanathanauthor=G.+Bernsteinauthor=F.+MacKenzieauthor=W.+Tempelauthor=H.+Ouyangauthor=W.+H.+Leeauthor=E.+Z.+Eisenmesserauthor=S.+Dhe-Paganon&title=Structural+and+Biochemical+Characterization+of+the+Human+Cyclophilin+Family+of+Peptidyl-Prolyl+Isomerases&doi=10.1371%2Fjournal.pbio.1000439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000439%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DCampagna-Slater%26aufirst%3DV.%26aulast%3DFinerty%26aufirst%3DP.%2BJ.%26aulast%3DParamanathan%26aufirst%3DR.%26aulast%3DBernstein%26aufirst%3DG.%26aulast%3DMacKenzie%26aufirst%3DF.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DOuyang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DEisenmesser%26aufirst%3DE.%2BZ.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26atitle%3DStructural%2520and%2520Biochemical%2520Characterization%2520of%2520the%2520Human%2520Cyclophilin%2520Family%2520of%2520Peptidyl-Prolyl%2520Isomerases%26jtitle%3DPLoS%2520Biol.%26date%3D2010%26volume%3D8%26issue%3D7%26spage%3De1000439%26doi%3D10.1371%2Fjournal.pbio.1000439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagöz, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berges, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priebe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Acuña, J. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänsch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic Clostridioides difficile Cyclophilin PpiB Controls Cysteine-Tolerance, Toxin Production, the Central Metabolism and Multiple Stress Responses</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">340</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffphar.2019.00340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=31024308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGlsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=340&author=C.+M.+%C3%9Cnalauthor=M.+S.+Karag%C3%B6zauthor=M.+Bergesauthor=C.+Priebeauthor=J.+M.+B.+de+Acu%C3%B1aauthor=J.+Wissingauthor=L.+J%C3%A4nschauthor=D.+Jahnauthor=M.+Steinert&title=Pleiotropic+Clostridioides+difficile+Cyclophilin+PpiB+Controls+Cysteine-Tolerance%2C+Toxin+Production%2C+the+Central+Metabolism+and+Multiple+Stress+Responses&doi=10.3389%2Ffphar.2019.00340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic Clostridioides difficile cyclophilin PpiB controls cysteine- tolerance, toxin production, the central metabolism and multiple stress responses</span></div><div class="casAuthors">Uenal, Can Murat; Karagoz, Mustafa Safa; Berges, Mareike; Priebe, Christina; Borrero de Acuna, Jose Manuel; Wissing, Josef; Jaensch, Lothar; Jahn, Dieter; Steinert, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">340</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The Gram-pos. pathogen Clostridioides difficile is the main bacterial agent of nosocomial antibiotic assocd. diarrhea.  Bacterial peptidyl-prolyl-cis/trans-isomerases (PPIases) are well established modulators of virulence that influence the outcome of human pathologies during infections.  Here, we present the first interactomic network of the sole cyclophilin-type PPIase of C. difficile (CdPpiB) and show that it has diverse interaction partners including major enzymes of the amino acid-dependent energy (LdhA, EtfAB, Had, Acd) and the glucose-derived (Fba, GapA, Pfo, Pyk, Pyc) central metab.  Proteins of the general (UspA), oxidative (Rbr1,2,3, Dsr), alk. (YloU, YphY) and cold shock (CspB) response were found bound to CdPpiB.  The transcriptional (Lrp), translational (InfC, RFF) and folding (GroS, DnaK) control proteins were also found attached.  For a crucial enzyme of cysteine metab., O-acetylserine sulfhydrylase (CysK), the global transcription regulator Lrp and the flagellar subunit FliC, these interactions were independently confirmed using a bacterial two hybrid system.  The active site residues F50, F109, and F110 of CdPpiB were shown to be important for the interaction with the residue P87 of Lrp.  CysK activity after heat denaturation was restored by interaction with CdPpiB.  In accordance, tolerance toward cell wall stress caused by the exposure to amoxicillin was reduced.  In the absence of CdPpiB, C. difficile was more susceptible toward L-cysteine.  At the same time, the cysteinemediated suppression of toxin prodn. ceased resulting in higher cytotoxicity.  In summary, the cyclophilin-type PPIase of C. difficile (CdPpiB) coordinates major cellular processes via its interaction with major regulators of transcription, translation, protein folding, stress response and the central metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgF5HU3xSW0rVg90H21EOLACvtfcHk0lgVkGdp_nY_ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGlsLbL&md5=90d1ada2393012eb1596f12f6b6323f8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00340%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%2BM.%26aulast%3DKarag%25C3%25B6z%26aufirst%3DM.%2BS.%26aulast%3DBerges%26aufirst%3DM.%26aulast%3DPriebe%26aufirst%3DC.%26aulast%3Dde%2BAcu%25C3%25B1a%26aufirst%3DJ.%2BM.%2BB.%26aulast%3DWissing%26aufirst%3DJ.%26aulast%3DJ%25C3%25A4nsch%26aufirst%3DL.%26aulast%3DJahn%26aufirst%3DD.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DPleiotropic%2520Clostridioides%2520difficile%2520Cyclophilin%2520PpiB%2520Controls%2520Cysteine-Tolerance%252C%2520Toxin%2520Production%252C%2520the%2520Central%2520Metabolism%2520and%2520Multiple%2520Stress%2520Responses%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D340%26doi%3D10.3389%2Ffphar.2019.00340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göthel, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Histidine 109 in Peptidyl-Prolyl Cis-Trans Isomerase of Bacillus subtilis Plays an Important Role in Catalysis and in Cyclosporin A Binding</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.1574-6968.1997.tb12635.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1574-6968.1997.tb12635.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9297832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVKnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1997&pages=139-144&issue=1&author=T.+V.+Achenbachauthor=S.+F.+G%C3%B6thelauthor=M.+A.+Marahiel&title=Histidine+109+in+Peptidyl-Prolyl+Cis-Trans+Isomerase+of+Bacillus+subtilis+Plays+an+Important+Role+in+Catalysis+and+in+Cyclosporin+A+Binding&doi=10.1111%2Fj.1574-6968.1997.tb12635.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Histidine 109 in peptidyl-prolyl cis-trans isomerase of Bacillus subtilis plays an important role in catalysis and in cyclosporin A binding</span></div><div class="casAuthors">Achenbach, Tatjana V.; Goethel, Sven F.; Marahiel, Mohamed A.</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-144</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Peptidylprolyl isomerase (PPI)/cyclophilin of B. subtilis has a moderate affinity to cyclosporin A (IC50: 120 nM) and low catalytic activity (kcat/Km: 1.1 μM-1 s-1) when compared to other ubiquitous PPIs.  The active site residues (Val-52, His-90, and His-109), which are not conserved within other PPIs, were found to play an important role in cyclosporin A binding and catalytic activity.  Here, the authors report on double mutations of these residues, which greatly improved cyclosporin A affinity and catalytic activity.  The H90N/H109W mutation displayed an IC50 value of 46 nM, whereas the V52M/H109F mutation exhibited >18-fold higher catalytic activity than that detected for wild-type PPI.  Mutations H109W and H109F of B. subtilis PPI showed no change in cyclosporin A affinity and catalytic activity between pH 6 and 8.  In contrast, wild-type PPI (H109) showed up to 10-fold redn. below pH 7.5, both in cyclosporin A affinity and in catalytic activity.  These findings clearly underline the importance of the unique His-109 residue in the B. subtilis enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkLENAcRxvk7Vg90H21EOLACvtfcHk0liR1kv6CHWdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVKnt7o%253D&md5=ee09822374e83fab7ae28e3a7858875a</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-6968.1997.tb12635.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-6968.1997.tb12635.x%26sid%3Dliteratum%253Aachs%26aulast%3DAchenbach%26aufirst%3DT.%2BV.%26aulast%3DG%25C3%25B6thel%26aufirst%3DS.%2BF.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DHistidine%2520109%2520in%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520of%2520Bacillus%2520subtilis%2520Plays%2520an%2520Important%2520Role%2520in%2520Catalysis%2520and%2520in%2520Cyclosporin%2520A%2520Binding%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D1997%26volume%3D154%26issue%3D1%26spage%3D139%26epage%3D144%26doi%3D10.1111%2Fj.1574-6968.1997.tb12635.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reffuveille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leneveu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auffray, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rincé, A.</span></span> <span> </span><span class="NLM_article-title">Lipoproteins of Enterococcus faecalis: Bioinformatic Identification, Expression Analysis and Relation to Virulence</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>157</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3001</span>– <span class="NLM_lpage">3013</span>, <span class="refDoi"> DOI: 10.1099/mic.0.053314-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2Fmic.0.053314-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21903750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2011&pages=3001-3013&issue=11&author=F.+Reffuveilleauthor=C.+Leneveuauthor=S.+Chevalierauthor=Y.+Auffrayauthor=A.+Rinc%C3%A9&title=Lipoproteins+of+Enterococcus+faecalis%3A+Bioinformatic+Identification%2C+Expression+Analysis+and+Relation+to+Virulence&doi=10.1099%2Fmic.0.053314-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoproteins of Enterococcus faecalis: bioinformatic identification, expression analysis and relation to virulence</span></div><div class="casAuthors">Reffuveille, Fany; Leneveu, Charlene; Chevalier, Sylvie; Auffray, Yanick; Rince, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3001-3013</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  Enterococcus faecalis is a ubiquitous bacterium that is capable of surviving in a broad range of natural environments, including the human host, as either a natural commensal or an opportunistic pathogen involved in severe hospital-acquired infections.  How such opportunistic pathogens cause fatal infections is largely unknown but it is likely that they are equipped with sophisticated systems to perceive external signals and interact with eukaryotic cells.  Accordingly, being partially exposed at the cell exterior, some surface-assocd. proteins are involved in several steps of the infection process.  Among them are lipoproteins, representing about 25 % of the surface-assocd. proteins, which could play a major role in bacterial virulence processes.  This review focuses on the identification of 90 lipoprotein-encoding genes in the genome of the E. faecalis V583 clin. strain and their putative roles, and provides a transcriptional comparison of microarray data performed in environmental conditions including blood and urine.  Thus, these data suggest a potential involvement of lipoproteins in E. faecalis virulence, making them serious candidates for vaccine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9uMIqARK_m7Vg90H21EOLACvtfcHk0liR1kv6CHWdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtL%252FI&md5=2303a4b2a75b0215a1e820d3bff43463</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.053314-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.053314-0%26sid%3Dliteratum%253Aachs%26aulast%3DReffuveille%26aufirst%3DF.%26aulast%3DLeneveu%26aufirst%3DC.%26aulast%3DChevalier%26aufirst%3DS.%26aulast%3DAuffray%26aufirst%3DY.%26aulast%3DRinc%25C3%25A9%26aufirst%3DA.%26atitle%3DLipoproteins%2520of%2520Enterococcus%2520faecalis%253A%2520Bioinformatic%2520Identification%252C%2520Expression%2520Analysis%2520and%2520Relation%2520to%2520Virulence%26jtitle%3DMicrobiology%26date%3D2011%26volume%3D157%26issue%3D11%26spage%3D3001%26epage%3D3013%26doi%3D10.1099%2Fmic.0.053314-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reffuveille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanguinetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posteraro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auffray, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rince, A.</span></span> <span> </span><span class="NLM_article-title">Involvement of Peptidylprolyl Cis/Trans Isomerases in Enterococcus faecalis Virulence</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1728</span>– <span class="NLM_lpage">1735</span>, <span class="refDoi"> DOI: 10.1128/IAI.06251-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.06251-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22331431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=1728-1735&issue=5&author=F.+Reffuveilleauthor=N.+Connilauthor=M.+Sanguinettiauthor=B.+Posteraroauthor=S.+Chevalierauthor=Y.+Auffrayauthor=A.+Rince&title=Involvement+of+Peptidylprolyl+Cis%2FTrans+Isomerases+in+Enterococcus+faecalis+Virulence&doi=10.1128%2FIAI.06251-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of peptidylprolyl cis/trans isomerases in Enterococcus faecalis virulence</span></div><div class="casAuthors">Reffuveille, Fany; Connil, Nathalie; Sanguinetti, Maurizio; Posteraro, Brunella; Chevalier, Sylvie; Auffray, Yanick; Rince, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1728-1735</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Peptidylprolyl cis/trans isomerases (PPIases) are enzymes involved in protein folding.  Anal. of the genome sequence of Enterococcus faecalis V583 allowed for identification of 3 PPIases carrying genes.  Ef2898 encodes an intracellular PPIase which was not shown to be important for the E. faecalis stress response or virulence.  The other two PPIases, the parvulin family rotamase EF0685 and the cyclophilin family member EF1534, are expected to be surface-exposed proteins.  They were shown to be important for virulence and resistance to NaCl.  A Δef0685 Δef1534 mutant was also more resistant to oxidative stress, was able to grow under a high manganese concn., and showed altered resistance to ampicillin and quinolone antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_KJ9ktOV_mLVg90H21EOLACvtfcHk0ljmi2wOhUCMKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKms7g%253D&md5=90b303d59a740f92ae884252a95f097f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1128%2FIAI.06251-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.06251-11%26sid%3Dliteratum%253Aachs%26aulast%3DReffuveille%26aufirst%3DF.%26aulast%3DConnil%26aufirst%3DN.%26aulast%3DSanguinetti%26aufirst%3DM.%26aulast%3DPosteraro%26aufirst%3DB.%26aulast%3DChevalier%26aufirst%3DS.%26aulast%3DAuffray%26aufirst%3DY.%26aulast%3DRince%26aufirst%3DA.%26atitle%3DInvolvement%2520of%2520Peptidylprolyl%2520Cis%252FTrans%2520Isomerases%2520in%2520Enterococcus%2520faecalis%2520Virulence%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26issue%3D5%26spage%3D1728%26epage%3D1735%26doi%3D10.1128%2FIAI.06251-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukouhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, T.</span></span> <span> </span><span class="NLM_article-title">Surface Lipoprotein PpiA of Streptococcus mutans Suppresses Scavenger Receptor MARCO-Dependent Phagocytosis by Macrophages</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4933</span>– <span class="NLM_lpage">4940</span>, <span class="refDoi"> DOI: 10.1128/IAI.05693-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.05693-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21986627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=4933-4940&issue=12&author=T.+Mukouharaauthor=T.+Arimotoauthor=K.+Choauthor=M.+Yamamotoauthor=T.+Igarashi&title=Surface+Lipoprotein+PpiA+of+Streptococcus+mutans+Suppresses+Scavenger+Receptor+MARCO-Dependent+Phagocytosis+by+Macrophages&doi=10.1128%2FIAI.05693-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Surface lipoprotein PpiA of Streptococcus mutans suppresses scavenger receptor MARCO-dependent phagocytosis by macrophages</span></div><div class="casAuthors">Mukouhara, Tadashi; Arimoto, Takafumi; Cho, Kasei; Yamamoto, Matsuo; Igarashi, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4933-4940</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Streptococcus mutans is assocd. with the initiation and progression of human dental caries and is occasionally isolated from the blood of patients with bacteremia and infective endocarditis.  For the pathogen to survive in the infected host, surface lipoproteins of S. mutans are likely to play important roles in interactions with the innate immune system.  To clarify the role that a putative lipoprotein, peptidyl-prolyl cis/trans-isomerase (PpiA), of S. mutans plays in the macrophage response, we investigated the response of THP-1-derived macrophages to S. mutans challenge.  The deletion of the gene encoding Lgt eliminated PpiA on the cell surface of S. mutans, which implies that PpiA is a lipoprotein that is lipid anchored in the cell membrane by Lgt.  Human and murine peritoneal macrophages both showed higher phagocytic activities for the ppiA and lgt mutants than the wild type, which indicates that the presence of PpiA reduces S. mutans phagocytosis.  In addn., infection with S. mutans markedly induced mRNAs of macrophage receptor with collagenous structure (MARCO) and scavenger receptor A (SR-A) in human macrophages.  In particular, transcriptional and translational levels of MARCO in human macrophages infected with the ppiA mutant were higher than those in macrophages infected with the wild type.  Phagocytosis of S. mutans by human macrophages markedly decreased after treatment with anti-MARCO IgG.  These results demonstrate that the S. mutans lipoprotein PpiA contributes to suppression of MARCO-mediated phagocytosis of this bacterium by macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvMX358Sb6NbVg90H21EOLACvtfcHk0ljbIoKGr6yEDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksrvJ&md5=9f4ae47e422e04d6ad53b1c9575c9516</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1128%2FIAI.05693-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05693-11%26sid%3Dliteratum%253Aachs%26aulast%3DMukouhara%26aufirst%3DT.%26aulast%3DArimoto%26aufirst%3DT.%26aulast%3DCho%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DIgarashi%26aufirst%3DT.%26atitle%3DSurface%2520Lipoprotein%2520PpiA%2520of%2520Streptococcus%2520mutans%2520Suppresses%2520Scavenger%2520Receptor%2520MARCO-Dependent%2520Phagocytosis%2520by%2520Macrophages%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26issue%3D12%26spage%3D4933%26epage%3D4940%26doi%3D10.1128%2FIAI.05693-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estevão, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogenboezem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luijendijk, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamphausen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmidt, S.</span></span> <span> </span><span class="NLM_article-title">The Streptococcal Lipoprotein Rotamase A (SlrA) is a Functional Peptidyl-Prolyl Isomerase Involved in Pneumococcal Colonization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1074/jbc.M510014200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M510014200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16260779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Whsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=968-976&issue=2&author=P.+W.+Hermansauthor=P.+V.+Adrianauthor=C.+Albertauthor=S.+Estev%C3%A3oauthor=T.+Hoogenboezemauthor=I.+H.+Luijendijkauthor=T.+Kamphausenauthor=S.+Hammerschmidt&title=The+Streptococcal+Lipoprotein+Rotamase+A+%28SlrA%29+is+a+Functional+Peptidyl-Prolyl+Isomerase+Involved+in+Pneumococcal+Colonization&doi=10.1074%2Fjbc.M510014200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The Streptococcal Lipoprotein Rotamase A (SlrA) Is a Functional Peptidyl-prolyl Isomerase Involved in Pneumococcal Colonization</span></div><div class="casAuthors">Hermans, Peter W. M.; Adrian, Peter V.; Albert, Christa; Estevao, Silvia; Hoogenboezem, Theo; Luijendijk, Ingrid H. T.; Kamphausen, Thilo; Hammerschmidt, Sven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">968-976</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Streptococcus pneumoniae expresses two surface-exposed lipoproteins, PpmA and SlrA, which share homol. with distinct families of peptidyl-prolyl isomerases (PPIases).  In this study, we demonstrated for the first time that the lipoprotein cyclophilin, SlrA, can catalyze the cis-trans isomerization of proline contg. tetrapeptides and that SlrA contributes to pneumococcal colonization.  The substrate specificity of SlrA is typical for prokaryotic and eukaryotic cyclophilins, with Suc-Ala-Ala-Pro-Phe-p-nitroanilide (pNA) being the most rapidly catalyzed substrate.  In a mouse pneumonia model the slrA knock-out D39ΔslrA did not cause significant differences in the survival times of mice compared with the isogenic wild-type strain.  In contrast, a detailed anal. of bacterial outgrowth over time in the nasopharynx, airways, lungs, blood, and spleen showed a rapid elimination of slrA mutants from the upper airways but did not reveal significant differences in the lungs, blood, and spleen.  These results suggested that SlrA is involved in colonization but does not contribute significantly to invasive pneumococcal disease.  In cell culture infection expts., the absence of SlrA impaired adherence to pneumococcal disease-specific epithelial and endothelial non-professional cell lines.  Adherence of the slrA mutant could not be restored by exogenously added SlrA.  Strikingly, deficiency in SlrA did not reduce binding activity to host target proteins, but resulted in enhanced uptake by professional phagocytes.  In conclusion, SlrA is a functional, cyclophilin-type PPIase and contributes to pneumococcal virulence in the first stage of infection, namely, colonization of the upper airways, most likely by modulating the biol. function of important virulence proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1KvmGV8V4ILVg90H21EOLACvtfcHk0lhz92aP2SFlIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Whsg%253D%253D&md5=690761952d72a069876eb859e0d022eb</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M510014200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M510014200%26sid%3Dliteratum%253Aachs%26aulast%3DHermans%26aufirst%3DP.%2BW.%26aulast%3DAdrian%26aufirst%3DP.%2BV.%26aulast%3DAlbert%26aufirst%3DC.%26aulast%3DEstev%25C3%25A3o%26aufirst%3DS.%26aulast%3DHoogenboezem%26aufirst%3DT.%26aulast%3DLuijendijk%26aufirst%3DI.%2BH.%26aulast%3DKamphausen%26aufirst%3DT.%26aulast%3DHammerschmidt%26aufirst%3DS.%26atitle%3DThe%2520Streptococcal%2520Lipoprotein%2520Rotamase%2520A%2520%2528SlrA%2529%2520is%2520a%2520Functional%2520Peptidyl-Prolyl%2520Isomerase%2520Involved%2520in%2520Pneumococcal%2520Colonization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D2%26spage%3D968%26epage%3D976%26doi%3D10.1074%2Fjbc.M510014200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Involvement of Lipoprotein PpiA of Streptococcus gordonii in Evasion of Phagocytosis by Macrophages</span>. <i>Mol. Oral Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1111/omi.12031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fomi.12031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23734737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlensbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=379-391&issue=5&author=K.+Choauthor=T.+Arimotoauthor=T.+Igarashiauthor=M.+Yamamoto&title=Involvement+of+Lipoprotein+PpiA+of+Streptococcus+gordonii+in+Evasion+of+Phagocytosis+by+Macrophages&doi=10.1111%2Fomi.12031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of lipoprotein PpiA of Streptococcus gordonii in evasion of phagocytosis by macrophages</span></div><div class="casAuthors">Cho, K.; Arimoto, T.; Igarashi, T.; Yamamoto, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oral Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-391</span>CODEN:
                <span class="NLM_cas:coden">MOMOBT</span>;
        ISSN:<span class="NLM_cas:issn">2041-1006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Streptococcus gordonii is a commensal gram-pos. bacterium that resides in the human oral cavity, and is one of the most common causes of infective endocarditis (IE).  Bacterial surface mols. play an important role in establishing IE, and several S. gordonii proteins have been implicated in binding to host cells during the establishment of IE.  In this study, we identified a putative lipoprotein, peptidyl-prolyl cis/trans isomerase (PpiA), and clarified its role in evasion of phagocytosis by macrophages.  Attenuation of the gene encoding prolipoprotein diacylglyceryl transferase (Lgt) altered the localization of PpiA from the cell surface to the culture supernatant, indicating that PpiA is lipid-anchored in the cell membrane by Lgt.  Both human and murine macrophages showed higher phagocytic activity towards ppiA and lgt mutants than the wild-type, indicating that the presence of PpiA suppresses phagocytosis of S. gordonii.  Human macrophages treated with dextran sulfate had significantly impaired phagocytosis of S. gordonii, suggesting that class A scavenger receptors in human macrophages are involved in the phagocytosis of S. gordonii.  These results provide evidence that S. gordonii lipoprotein PpiA plays an important role in inhibiting phagocytic engulfment and in evasion of the host immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2IdAONQbWPLVg90H21EOLACvtfcHk0lhz92aP2SFlIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlensbvE&md5=bf32b412d5aef209fd17484afc9705ec</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1111%2Fomi.12031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fomi.12031%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DK.%26aulast%3DArimoto%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DInvolvement%2520of%2520Lipoprotein%2520PpiA%2520of%2520Streptococcus%2520gordonii%2520in%2520Evasion%2520of%2520Phagocytosis%2520by%2520Macrophages%26jtitle%3DMol.%2520Oral%2520Microbiol.%26date%3D2013%26volume%3D28%26issue%3D5%26spage%3D379%26epage%3D391%26doi%3D10.1111%2Fomi.12031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keogh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzeciak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Null, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. K.</span></span> <span> </span><span class="NLM_article-title">Novel Regulation of Alpha-Toxin and the Phenol-Soluble Modulins by Peptidyl-Prolyl Cis/Trans Isomerase Enzymes in Staphylococcus aureus</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">343</span>, <span class="refDoi"> DOI: 10.3390/toxins11060343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Ftoxins11060343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlCi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=343&issue=6&author=R.+A.+Keoghauthor=R.+L.+Zapfauthor=E.+Trzeciakauthor=G.+G.+Nullauthor=R.+E.+Wiemelsauthor=R.+K.+Carroll&title=Novel+Regulation+of+Alpha-Toxin+and+the+Phenol-Soluble+Modulins+by+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+Enzymes+in+Staphylococcus+aureus&doi=10.3390%2Ftoxins11060343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel regulation of alpha-toxin and the phenol-soluble modulins by peptidyl-prolyl cis/trans isomerase enzymes in Staphylococcus aureus</span></div><div class="casAuthors">Keogh, Rebecca A.; Zapf, Rachel L.; Trzeciak, Emily; Null, Gillian G.; Wiemels, Richard E.; Carroll, Ronan K.</div><div class="citationInfo"><span class="NLM_cas:title">Toxins</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">343</span>CODEN:
                <span class="NLM_cas:coden">TOXIB7</span>;
        ISSN:<span class="NLM_cas:issn">2072-6651</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Peptidyl-prolyl cis/trans isomerases (PPIases) are enzymes that catalyze the cis-to-trans isomerization around proline bonds, allowing proteins to fold into their correct confirmation.  Previously, we identified two PPIase enzymes in Staphylococcus aureus (PpiB and PrsA) that are involved in the regulation of virulence determinants and have shown that PpiB contributes to S. aureus virulence in a murine abscessmodel of infection.  Here, we further examine the role of these PPIases in S. aureus virulence and, in particular, their regulation of hemolytic toxins.  Using murine abscess and systemic models of infection, we show that a ppiB mutant in a USA300 background is attenuated for virulence but that a prsA mutant is not.  Deletion of the ppiB gene leads to decreased bacterial survival in macrophages and nasal epithelial cells, while there is no significant difference when prsA is deleted.  Anal. of culture supernatants reveals that a ppiBmutant strain has reduced levels of the phenol-sol. modulins and that both ppiB and prsA mutants have reduced alpha-toxin activity.  Finally, we perform immunopptn. to identify cellular targets of PpiB and PrsA.  Results suggest a novel role for PpiB in S. aureus protein secretion.  Collectively, our results demonstrate that PpiB and PrsA influence S. aureus toxins via distinct mechanisms, and that PpiB but not PrsA contributes to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsBQkc3xRCrVg90H21EOLACvtfcHk0lhzvOMhx1MGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlCi&md5=debb88e7649795cdbd4c7aee725e7a87</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.3390%2Ftoxins11060343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins11060343%26sid%3Dliteratum%253Aachs%26aulast%3DKeogh%26aufirst%3DR.%2BA.%26aulast%3DZapf%26aufirst%3DR.%2BL.%26aulast%3DTrzeciak%26aufirst%3DE.%26aulast%3DNull%26aufirst%3DG.%2BG.%26aulast%3DWiemels%26aufirst%3DR.%2BE.%26aulast%3DCarroll%26aufirst%3DR.%2BK.%26atitle%3DNovel%2520Regulation%2520of%2520Alpha-Toxin%2520and%2520the%2520Phenol-Soluble%2520Modulins%2520by%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520Enzymes%2520in%2520Staphylococcus%2520aureus%26jtitle%3DToxins%26date%3D2019%26volume%3D11%26issue%3D6%26spage%3D343%26doi%3D10.3390%2Ftoxins11060343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keogh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittekind, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. K.</span></span> <span> </span><span class="NLM_article-title">The Intracellular Cyclophilin PpiB Contributes to the Virulence of Staphylococcus aureus Independently of its Peptidyl-Prolyl Cis/Trans Isomerase Activity</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">e00379</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1128/IAI.00379-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00379-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30104214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVeiu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=e00379-18&issue=11&author=R.+A.+Keoghauthor=R.+L.+Zapfauthor=R.+E.+Wiemelsauthor=M.+A.+Wittekindauthor=R.+K.+Carroll&title=The+Intracellular+Cyclophilin+PpiB+Contributes+to+the+Virulence+of+Staphylococcus+aureus+Independently+of+its+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+Activity&doi=10.1128%2FIAI.00379-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The intracellular cyclophilin PpiB contributes to the virulence of Staphylococcus aureus independently of its peptidyl-prolyl cis/trans isomerase activity</span></div><div class="casAuthors">Keogh, Rebecca A.; Zapf, Rachel L.; Wiemels, Richard E.; Wittekind, Marcus A.; Carroll, Ronan K.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e00379-18/1-e00379-18/13</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Staphylococcus aureus cyclophilin PpiB is an intracellular peptidyl prolyl cis/trans isomerase (PPIase) that has previously been shown to contribute to secreted nuclease and hemolytic activity.  In this study, we investigated the contribution of PpiB to S. aureus virulence.  Using a murine abscess model of infection, we demonstrated that a ppiB mutant is attenuated for virulence.  We went on to investigate the mechanism through which PpiB protein contributes to virulence, in particular the contribution of PpiB PPIase activity.  We detd. the amino acid residues that are important for PpiB PPIase activity and showed that a single amino acid substitution (F64A) completely abrogates PPIase activity.  Using purified PpiB F64A protein in vitro, we showed that PPIase activity only partially contributes to Nuc refolding and that PpiB also possesses PPIase-independent activity.  Using allelic exchange, we introduced the F64A substitution onto the S. aureus chromosome, generating a strain that produces enzymically inactive PpiB.  Anal. of the PpiB F64A strain revealed that PPIase activity is not required for hemolysis of human blood or virulence in a mouse.  Together, these results demonstrate that PpiB contributes to S. aureus virulence via a mechanism unrelated to prolyl isomerase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVF2_6Eaxiv7Vg90H21EOLACvtfcHk0lhzvOMhx1MGMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVeiu7vN&md5=f1cf08c4382ba3c7f0b99a17b4046ee8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1128%2FIAI.00379-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00379-18%26sid%3Dliteratum%253Aachs%26aulast%3DKeogh%26aufirst%3DR.%2BA.%26aulast%3DZapf%26aufirst%3DR.%2BL.%26aulast%3DWiemels%26aufirst%3DR.%2BE.%26aulast%3DWittekind%26aufirst%3DM.%2BA.%26aulast%3DCarroll%26aufirst%3DR.%2BK.%26atitle%3DThe%2520Intracellular%2520Cyclophilin%2520PpiB%2520Contributes%2520to%2520the%2520Virulence%2520of%2520Staphylococcus%2520aureus%2520Independently%2520of%2520its%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520Activity%26jtitle%3DInfect.%2520Immun.%26date%3D2018%26volume%3D86%26issue%3D11%26spage%3De00379%26epage%3D18%26doi%3D10.1128%2FIAI.00379-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cech, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. K.</span></span> <span> </span><span class="NLM_article-title">An Intracellular Peptidyl-Prolyl Cis/Trans Isomerase is Required for Folding and Activity of the Staphylococcus aureus Secreted Virulence Factor Nuclease</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>199</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">e00453</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1128/JB.00453-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.00453-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27795319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVaqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2017&pages=e00453-16&issue=1&author=R.+E.+Wiemelsauthor=S.+M.+Cechauthor=N.+M.+Meyerauthor=C.+A.+Burkeauthor=A.+Weissauthor=A.+R.+Parksauthor=L.+N.+Shawauthor=R.+K.+Carroll&title=An+Intracellular+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+is+Required+for+Folding+and+Activity+of+the+Staphylococcus+aureus+Secreted+Virulence+Factor+Nuclease&doi=10.1128%2FJB.00453-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">An intracellular peptidyl-prolyl cis/trans isomerase is required for folding and activity of the Staphylococcus aureus secreted virulence factor nuclease</span></div><div class="casAuthors">Wiemels, Richard E.; Cech, Stephanie M.; Meyer, Nikki M.; Burke, Caleb A.; Weiss, Andy; Parks, Anastacia R.; Shaw, Lindsey N.; Carroll, Ronan K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e00453-16/1-e00453-16/15</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">1098-5530</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Staphylococcus aureus is an important human pathogen that relies on a large repertoire of secreted and cell wall-assocd. proteins for pathogenesis.  Consequently, the ability of the organism to cause disease is absolutely dependent on its ability to synthesize and successfully secrete these proteins.  In this study, we investigate the role of peptidyl-prolyl cis/trans isomerases (PPIases) on the activity of the S. aureus secreted virulence factor nuclease (Nuc).  We identify a staphylococcal cyclophilin-type PPIase (PpiB) that is required for optimal activity of Nuc.  Disruption of ppiB results in decreased nuclease activity in culture supernatants; however, the levels of Nuc protein are not altered, suggesting that the decrease in activity results from misfolding of Nuc in the absence of PpiB.  We go on to demonstrate that PpiB exhibits PPIase activity in vitro, is localized to the bacterial cytosol, and directly interacts with Nuc in vitro to accelerate the rate of Nuc refolding.  Finally, we demonstrate an addnl. role for PpiB in S. aureus hemolysis and demonstrate that the S. aureus parvulin-type PPIase PrsA also plays a role in the activity of secreted virulence factors.  The deletion of prsA leads to a decrease in secreted protease and phospholipase activity, similar to that obsd. in other Gram-pos. pathogens.  Together, these results demonstrate, for the 1st time to our knowledge, that PPIases play an important role in the secretion of virulence factors in S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozfz6iW4I13LVg90H21EOLACvtfcHk0lhUD--Lv6KS8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVaqtLk%253D&md5=d91a6643575cf71d48cd50a9f5d662ff</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1128%2FJB.00453-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00453-16%26sid%3Dliteratum%253Aachs%26aulast%3DWiemels%26aufirst%3DR.%2BE.%26aulast%3DCech%26aufirst%3DS.%2BM.%26aulast%3DMeyer%26aufirst%3DN.%2BM.%26aulast%3DBurke%26aufirst%3DC.%2BA.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DParks%26aufirst%3DA.%2BR.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26aulast%3DCarroll%26aufirst%3DR.%2BK.%26atitle%3DAn%2520Intracellular%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520is%2520Required%2520for%2520Folding%2520and%2520Activity%2520of%2520the%2520Staphylococcus%2520aureus%2520Secreted%2520Virulence%2520Factor%2520Nuclease%26jtitle%3DJ.%2520Bacteriol.%26date%3D2017%26volume%3D199%26issue%3D1%26spage%3De00453%26epage%3D16%26doi%3D10.1128%2FJB.00453-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bzdyl, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarovich, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, T. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Prolyl Isomerase ppiB Is Essential for Proteome Homeostasis and Virulence in Burkholderia pseudomallei</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">e00528</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1128/IAI.00528-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00528-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=31331957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Gjt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=e00528-19&issue=10&author=N.+M.+Bzdylauthor=N.+E.+Scottauthor=I.+H.+Norvilleauthor=A.+E.+Scottauthor=T.+Atkinsauthor=S.+Pangauthor=D.+S.+Sarovichauthor=G.+Coombsauthor=T.+J.+J.+Inglisauthor=C.+M.+Kahlerauthor=M.+Sarkar-Tyson&title=Peptidyl-Prolyl+Isomerase+ppiB+Is+Essential+for+Proteome+Homeostasis+and+Virulence+in+Burkholderia+pseudomallei&doi=10.1128%2FIAI.00528-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl-prolyl isomerase ppiB is essential for proteome homeostasis and virulence in Burkholderia pseudomallei</span></div><div class="casAuthors">Bzdyl, Nicole M.; Scott, Nichollas E.; Norville, Isobel H.; Scott, Andrew E.; Atkins, Timothy; Pang, Stanley; Sarovich, Derek S.; Coombs, Geoffrey; Inglis, Timothy J. J.; Kahler, Charlene M.; Sarkar-Tyson, Mitali</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e00528-19</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Burkholderia pseudomallei is the causative agent of melioidosis, a disease endemic to Southeast Asia and northern Australia.  Mortality rates in these areas are high even with antimicrobial treatment, and there are few options for effective therapy.  Therefore, there is a need to identify antibacterial targets for the development of novel treatments.  Cyclophilins are a family of highly conserved enzymes important in multiple cellular processes.  Cyclophilins catalyze the cis-trans isomerization of xaa-proline bonds, a rate-limiting step in protein folding which has been shown to be important for bacterial virulence.  B. pseudomallei carries a putative cyclophilin B gene, ppiB, the role of which was investigated.  A B. pseudomallei ΔppiB (BpsΔppiB) mutant strain demonstrates impaired biofilm formation and reduced motility.  Macrophage invasion and survival assays showed that although the BpsΔppiB strain retained the ability to infect macrophages, it had reduced survival and lacked the ability to spread cell to cell, indicating ppiB is essential for B. pseudomallei virulence.  This is reflected in the BALB/c mouse infection model, demonstrating the requirement of ppiB for in vivo disease dissemination and progression.  Proteomic anal. demonstrates that the loss of PpiB leads to pleiotropic effects, supporting the role of PpiB in maintaining proteome homeostasis.  The loss of PpiB leads to decreased abundance of multiple virulence determinants, including flagellar machinery and alterations in type VI secretion system proteins.  In addn., the loss of ppiB leads to increased sensitivity toward multiple antibiotics, including meropenem and doxycycline, highlighting ppiB inhibition as a promising antivirulence target to both treat B. pseudomallei infections and increase antibiotic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrANn15KCVVMbVg90H21EOLACvtfcHk0ljjj0KUVyalPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Gjt7fL&md5=4d03005df3774c826a617cfd923593f3</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1128%2FIAI.00528-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00528-19%26sid%3Dliteratum%253Aachs%26aulast%3DBzdyl%26aufirst%3DN.%2BM.%26aulast%3DScott%26aufirst%3DN.%2BE.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DScott%26aufirst%3DA.%2BE.%26aulast%3DAtkins%26aufirst%3DT.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DSarovich%26aufirst%3DD.%2BS.%26aulast%3DCoombs%26aufirst%3DG.%26aulast%3DInglis%26aufirst%3DT.%2BJ.%2BJ.%26aulast%3DKahler%26aufirst%3DC.%2BM.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26atitle%3DPeptidyl-Prolyl%2520Isomerase%2520ppiB%2520Is%2520Essential%2520for%2520Proteome%2520Homeostasis%2520and%2520Virulence%2520in%2520Burkholderia%2520pseudomallei%26jtitle%3DInfect.%2520Immun.%26date%3D2019%26volume%3D87%26issue%3D10%26spage%3De00528%26epage%3D19%26doi%3D10.1128%2FIAI.00528-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Söderberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianciotto, N. P.</span></span> <span> </span><span class="NLM_article-title">A Legionella pneumophila Peptidyl-Prolyl Cis-Trans Isomerase Present in Culture Supernatants is Necessary for Optimal Growth at Low Temperatures</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1634</span>– <span class="NLM_lpage">1638</span>, <span class="refDoi"> DOI: 10.1128/AEM.02512-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAEM.02512-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18165359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1akurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1634-1638&issue=5&author=M.+A.+S%C3%B6derbergauthor=N.+P.+Cianciotto&title=A+Legionella+pneumophila+Peptidyl-Prolyl+Cis-Trans+Isomerase+Present+in+Culture+Supernatants+is+Necessary+for+Optimal+Growth+at+Low+Temperatures&doi=10.1128%2FAEM.02512-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">A Legionella pneumophila peptidyl-prolyl cis-trans isomerase present in culture supernatants is necessary for optimal growth at low temperatures</span></div><div class="casAuthors">Soderberg, Maria A.; Cianciotto, Nicholas P.</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1634-1638</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Several Legionella pneumophila proteins were highly expressed in low-temp. supernatants.  One of these proteins was the peptidyl-prolyl isomerase PpiB.  Mutants lacking ppiB exhibited reduced growth at 17°C.  Since PpiB lacked a signal sequence and was present in 17°C supernatants of type II and type IV secretion mutants, this protein may be secreted by a novel mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfpvnnqApoAbVg90H21EOLACvtfcHk0lgnmTi0i2DjdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1akurg%253D&md5=e09e23cbdcc7f5cc963ab64a67088448</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1128%2FAEM.02512-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.02512-07%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B6derberg%26aufirst%3DM.%2BA.%26aulast%3DCianciotto%26aufirst%3DN.%2BP.%26atitle%3DA%2520Legionella%2520pneumophila%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520Present%2520in%2520Culture%2520Supernatants%2520is%2520Necessary%2520for%2520Optimal%2520Growth%2520at%2520Low%2520Temperatures%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2008%26volume%3D74%26issue%3D5%26spage%3D1634%26epage%3D1638%26doi%3D10.1128%2FAEM.02512-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tradler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücknagel, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schierhorn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Küllertz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">A Cyclophilin-Like Peptidyl-Prolyl Cis/Trans Isomerase from Legionella pneumophila–Characterization, Molecular Cloning and Overexpression</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1160</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.1996.00061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1365-2958.1996.00061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8898384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28XmtVKit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=1147-1160&issue=6&author=B.+Schmidtauthor=T.+Tradlerauthor=J.+U.+Rahfeldauthor=B.+Ludwigauthor=B.+Jainauthor=K.+Mannauthor=K.+P.+R%C3%BCcknagelauthor=B.+Janowskiauthor=A.+Schierhornauthor=G.+K%C3%BCllertzauthor=J.+Hackerauthor=G.+Fischer&title=A+Cyclophilin-Like+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+from+Legionella+pneumophila%E2%80%93Characterization%2C+Molecular+Cloning+and+Overexpression&doi=10.1046%2Fj.1365-2958.1996.00061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">A cyclophilin-like peptidyl-prolyl cis/trans isomerase from Legionella pneumophila - characterization, molecular cloning and overexpression</span></div><div class="casAuthors">Schmidt, Bettina; Tradler, Thomas; Rahfeld, Jens-U.; Ludwig, Birgit; Jain, Bunty; Mann, Karlheinz; Ruecknagel, K. Peter; Janowski, Bernhard; Schlierhorn, Angelika; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1147-1160</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Legionella pneumophila is the causative agent of a severe form of pneumonia in humans (Legionnaires' disease).  A major virulence factor, the Mip protein (FK506-binding protein, FKBP25mem), belongs to the enzyme family of peptidyl-prolyl cis/trans isomerases (PPlases).  This study shows that L. pneumophila Philadelphia I possesses an addnl. cytoplasmic PPlase at a level of enzyme activity comparable to that of FKBP25mem.  The N-terminal amino acid sequence of the purified protein was obtained by Edman degrdn. and showed that the protein is a member of the cyclophilin family of PPlases.  The lcy gene (Legionella cyclophilin) was cloned and sequenced.  It encodes a putative 164-amino-acid protein with a mol. mass of 17,968 Da called L. pneumophila cyclophilin 18 (L.p. Cyp18).  Amino acid sequence comparison displays considerable similarity to the cytoplasmic and the periplasmic cyclophilins of Escherichia coli with 60.5 and 51.5% identity, resp.  The substrate specificity and inhibition by cyclosporin A revealed a pattern that is typically found for other bacterial cyclophilins.  An L. pneumophila Cyp18 deriv. with a 19-amino-acid polypeptide extension including a 6-histidine tag and an enterokinase cleavage site exhibits PPlase activity when produced at high levels in E. coli K-12.  After removal of the extension by enterokinase, the properties of the recombinant Cyp18 were indistinguishable from those of the authentic enzyme.  In order to investigate the influence of Cyp18 on intracellular survival of L. pneumophila an lcy-neg. L. pneumophila strain was constructed.  Compared with the wild-type strain, the mutant did not exhibit a significant phenotype but was 10-fold less invasive for Acanthamoeba castellanii.  Like human cyclophilin, the L. p. Cyp18 exhibits nuclease activity, but this enzymic activity does not appear to be linked with the native structure of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTsRprkgYjLVg90H21EOLACvtfcHk0liaNc3M2B3ZiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVKit7s%253D&md5=042cf0dd9b4116803ae3ae5a7e6677b5</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1996.00061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1996.00061.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DTradler%26aufirst%3DT.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DJain%26aufirst%3DB.%26aulast%3DMann%26aufirst%3DK.%26aulast%3DR%25C3%25BCcknagel%26aufirst%3DK.%2BP.%26aulast%3DJanowski%26aufirst%3DB.%26aulast%3DSchierhorn%26aufirst%3DA.%26aulast%3DK%25C3%25BCllertz%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DA%2520Cyclophilin-Like%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520from%2520Legionella%2520pneumophila%25E2%2580%2593Characterization%252C%2520Molecular%2520Cloning%2520and%2520Overexpression%26jtitle%3DMol.%2520Microbiol.%26date%3D1996%26volume%3D21%26issue%3D6%26spage%3D1147%26epage%3D1160%26doi%3D10.1046%2Fj.1365-2958.1996.00061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezyri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grados, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpusas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Structure-Function Analysis of the Periplasmic Escherichia coli Cyclophilin PpiA in Relation to Biofilm Formation</span>. <i>J. Mol. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1159/000478858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1159%2F000478858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28889121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1cbmsVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=228-236&issue=4&author=A.+Skagiaauthor=E.+Vezyriauthor=K.+Gradosauthor=A.+Venierakiauthor=M.+Karpusasauthor=P.+Katinakisauthor=M.+Dimou&title=Structure-Function+Analysis+of+the+Periplasmic+Escherichia+coli+Cyclophilin+PpiA+in+Relation+to+Biofilm+Formation&doi=10.1159%2F000478858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Function Analysis of the Periplasmic Escherichia coli Cyclophilin PpiA in Relation to Biofilm Formation</span></div><div class="casAuthors">Skagia Aggeliki; Vezyri Eleni; Grados Konstantinos; Venieraki Anastasia; Karpusas Michael; Katinakis Panagiotis; Dimou Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular microbiology and biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">228-236</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The presence of peptidyl-prolyl cis/trans isomerases (PPIases, EC: 5.2.1.8) in all domains of life indicates their biological importance.  Cyclophilin PpiA, present in the periplasm of gram-negative bacteria, possesses PPIase activity but its physiological functions are still not clearly defined.  Here, we demonstrate that the ΔppiA deletion strain from Escherichia coli exhibits an increased ability for biofilm formation and enhanced swimming motility compared to the wild-type strain.  To identify structural features of PpiA which are necessary for the negative modulation of biofilm formation, we constructed a series of mutant PpiA proteins using a combination of error-prone and site-directed mutagenesis approaches.  We show that the negative effect of PpiA on biofilm formation is not dependent on its PPIase activity, since PpiA mutants with a reduced PPIase activity are able to complement the ΔppiA strain during biofilm growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLErnixfNh_K69lAbTj9rGfW6udTcc2eZOZC5VOhB6Qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbmsVamtQ%253D%253D&md5=f59a0c726562b37d82ce871592284b00</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1159%2F000478858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000478858%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DVezyri%26aufirst%3DE.%26aulast%3DGrados%26aufirst%3DK.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DStructure-Function%2520Analysis%2520of%2520the%2520Periplasmic%2520Escherichia%2520coli%2520Cyclophilin%2520PpiA%2520in%2520Relation%2520to%2520Biofilm%2520Formation%26jtitle%3DJ.%2520Mol.%2520Microbiol.%2520Biotechnol.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D228%26epage%3D236%26doi%3D10.1159%2F000478858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezyri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkinou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpusas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Analysis of Cyclophilin PpiB Mutants Supports an In Vivo Function not Limited to Prolyl Isomerization Activity</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1111/gtc.12452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fgtc.12452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27868330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVymt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=32-44&issue=1&author=A.+Skagiaauthor=E.+Vezyriauthor=M.+Sigalaauthor=A.+Kokkinouauthor=M.+Karpusasauthor=A.+Venierakiauthor=P.+Katinakisauthor=M.+Dimou&title=Structural+and+Functional+Analysis+of+Cyclophilin+PpiB+Mutants+Supports+an+In+Vivo+Function+not+Limited+to+Prolyl+Isomerization+Activity&doi=10.1111%2Fgtc.12452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analysis of cyclophilin PpiB mutants supports an in vivo function not limited to prolyl isomerization activity</span></div><div class="casAuthors">Skagia, Aggeliki; Vezyri, Eleni; Sigala, Markezina; Kokkinou, Areti; Karpusas, Michael; Venieraki, Anastasia; Katinakis, Panagiotis; Dimou, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-44</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1365-2443</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Escherichia coli cyclophilin PpiB is a peptidyl-prolyl cis/trans isomerase (PPIase, EC: 5.2.1.8), involved in the neg. modulation of various bacterial processes, such as swimming and swarming motility and biofilm formation ability.  In this study, we show that PpiB possesses also a chaperone function as it can prevent the thermal denaturation of citrate synthase even with essentially eliminated PPIase activity.  We demonstrate, using active site mutations, that the PPIase activity of PpiB is required in all processes, except for the neg. effect on swimming, indicating a possible isomerase-independent function.  Addnl., we show that the reduced PPIase activity of PpiB does not prevent the assocn. with all prey proteins tested and that the PPIase active site is not involved necessarily in each assocn.  We also used a random mutagenesis approach, to identify amino acid residues apart from the catalytic site, which are necessary for PpiB function.  The combination of enzymic studies concerning the PPIase and chaperone activities of each mutant protein, with structural analyses based on 3D models, provided further insights into the effects of the mutations on the function of PpiB and showed the importance of structural features in addn. to the catalytic site, for its in vivo role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr52EEu8UdYfrVg90H21EOLACvtfcHk0lgnvdZgD6IV3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVymt7fL&md5=5bac8a7e7eda22eeef4ce3770a0d15e9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12452%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DVezyri%26aufirst%3DE.%26aulast%3DSigala%26aufirst%3DM.%26aulast%3DKokkinou%26aufirst%3DA.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DStructural%2520and%2520Functional%2520Analysis%2520of%2520Cyclophilin%2520PpiB%2520Mutants%2520Supports%2520an%2520In%2520Vivo%2520Function%2520not%2520Limited%2520to%2520Prolyl%2520Isomerization%2520Activity%26jtitle%3DGenes%2520Cells%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D32%26epage%3D44%26doi%3D10.1111%2Fgtc.12452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zografou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasseas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Functional Analysis of the Cyclophilin PpiB Role in Bacterial Cell Division</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1111/gtc.12514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fgtc.12514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28752912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1enu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=810-824&issue=9&author=A.+Skagiaauthor=C.+Zografouauthor=A.+Venierakiauthor=C.+Fasseasauthor=P.+Katinakisauthor=M.+Dimou&title=Functional+Analysis+of+the+Cyclophilin+PpiB+Role+in+Bacterial+Cell+Division&doi=10.1111%2Fgtc.12514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of the cyclophilin PpiB role in bacterial cell division</span></div><div class="casAuthors">Skagia, Aggeliki; Zografou, Chrysoula; Venieraki, Anastasia; Fasseas, Costas; Katinakis, Panagiotis; Dimou, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">810-824</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1365-2443</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Escherichia coli PpiB is a peptidyl-prolyl cis/trans isomerase (PPIase, EC: 5.2.1.8) with chaperone activity.  Here, we show that the ΔppiB deletion strain and the PpiB over-expression wild-type strain are both characterized by defects in cell division involving milder or severe cell filamentation, resp.  Using various PpiB mutants, we show that the PPIase activity of PpiB is necessary for the obsd. cell filamentation, whereas other structural features apart from the active site are also important for this phenotype.  Early divisome components zipA and ftsZ showed decreased expression in ΔppiB cells, whereas the corresponding proteins partially suppressed the division phenotype of ΔppiB cells as well.  Although PpiB itself has no obvious specific affinity for the septal ring as a GFP translational fusion showed a diffuse cytoplasmic localization, it interacts with FtsZ employing the C-terminal FtsZ domain, decreases its GTPase activity and when over-expressed shows an inhibitory effect on the proper FtsZ localization at future division sites.  Furthermore, addnl. putative PpiB prey proteins are able to partially restore the ΔppiB phenotype indicating that PpiB is able to control bacterial cell division by probably modulating the function of various other proteins which are indirectly assocd. with the process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMWEMzAgrZlrVg90H21EOLACvtfcHk0li6Kfo6G18UoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1enu7%252FI&md5=422107ead1f61f7b56e0502da96c7247</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12514%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DZografou%26aufirst%3DC.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DFasseas%26aufirst%3DC.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DFunctional%2520Analysis%2520of%2520the%2520Cyclophilin%2520PpiB%2520Role%2520in%2520Bacterial%2520Cell%2520Division%26jtitle%3DGenes%2520Cells%26date%3D2017%26volume%3D22%26issue%3D9%26spage%3D810%26epage%3D824%26doi%3D10.1111%2Fgtc.12514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zografou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezyri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin PpiB is Involved in Motility and Biofilm Formation Via its Functional Association with Certain Proteins</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1111/gtc.12383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fgtc.12383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27306110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFChsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=833-851&issue=8&author=A.+Skagiaauthor=C.+Zografouauthor=E.+Vezyriauthor=A.+Venierakiauthor=P.+Katinakisauthor=M.+Dimou&title=Cyclophilin+PpiB+is+Involved+in+Motility+and+Biofilm+Formation+Via+its+Functional+Association+with+Certain+Proteins&doi=10.1111%2Fgtc.12383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin PpiB is involved in motility and biofilm formation via its functional association with certain proteins</span></div><div class="casAuthors">Skagia, Aggeliki; Zografou, Chrysoula; Vezyri, Eleni; Venieraki, Anastasia; Katinakis, Panagiotis; Dimou, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">833-851</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1365-2443</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PpiB belongs to the superfamily of peptidyl-prolyl cis/trans isomerases (PPIases, EC: 5.2.1.8), which catalyze the rate-limiting protein folding step at peptidyl-prolyl bonds and control several biol. processes.  In this study, we show that PpiB acts as a neg. effector of motility and biofilm formation ability of Escherichia coli.  We identify multicopy suppressors of each ΔppiB phenotype among putative PpiB prey proteins which upon deletion are often characterized by analogous phenotypes.  Many putative preys show similar gene expression in wild-type and ΔppiB genetic backgrounds implying possible post-translational modifications by PpiB.  We further conducted in vivo and in vitro interaction screens to det. which of them represent true preys.  For DnaK, acetyl-CoA carboxylase, biotin carboxylase subunit (AccC) and phosphate acetyltransferase (Pta) we also showed a direct role of PpiB in the functional control of these proteins because it increased the measured enzyme activity of each protein and further interfered with DnaK localization and the correct folding of AccC.  Taken together, these results indicate that PpiB is involved in diverse regulatory mechanisms to neg. modulate motility and biofilm formation via its functional assocn. with certain protein substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreAIkEq-kAZbVg90H21EOLACvtfcHk0li6Kfo6G18UoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFChsLs%253D&md5=2e07db56eacf569220ed40afd5b66480</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12383%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DZografou%26aufirst%3DC.%26aulast%3DVezyri%26aufirst%3DE.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DCyclophilin%2520PpiB%2520is%2520Involved%2520in%2520Motility%2520and%2520Biofilm%2520Formation%2520Via%2520its%2520Functional%2520Association%2520with%2520Certain%2520Proteins%26jtitle%3DGenes%2520Cells%26date%3D2016%26volume%3D21%26issue%3D8%26spage%3D833%26epage%3D851%26doi%3D10.1111%2Fgtc.12383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kok, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffels, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellingwerf, K. J.</span></span> <span> </span><span class="NLM_article-title">A Gene of Acinetobacter calcoaceticus BD413 Encodes a Periplasmic Peptidyl-Prolyl Cis-Trans Isomerase of the Cyclophilin Sub-Class that is not Essential for Growth</span>. <i>Biochim. Biophys. Acta, Gene Struct. Expression</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>1219</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1016/0167-4781(94)90218-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0167-4781%2894%2990218-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7948017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXitlWlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1219&publication_year=1994&pages=601-606&issue=3&author=R.+G.+Kokauthor=V.+M.+Christoffelsauthor=B.+Vosmanauthor=K.+J.+Hellingwerf&title=A+Gene+of+Acinetobacter+calcoaceticus+BD413+Encodes+a+Periplasmic+Peptidyl-Prolyl+Cis-Trans+Isomerase+of+the+Cyclophilin+Sub-Class+that+is+not+Essential+for+Growth&doi=10.1016%2F0167-4781%2894%2990218-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A gene of Acinetobacter calcoaceticus BD413 encodes a periplasmic peptidyl-prolyl cis-trans isomerase of the cyclophilin sub-class that is not essential for growth</span></div><div class="casAuthors">Kok, Ruben G.; Christoffels, Vincent M.; Vosman, Ben; Hellingwerf, Klaas J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Structure and Expression</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">1219</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-6</span>CODEN:
                <span class="NLM_cas:coden">BBGSD5</span>;
        ISSN:<span class="NLM_cas:issn">0167-4781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Downstream of the Acinetobacter calcoaceticus estA gene, encoding a cell-bound esterase, an open reading frame (orf) was identified, which may encode a protein with a mass of 20.4 kDa.  This protein shows extensive similarity to both prokaryotic and eukaryotic peptidyl-prolyl cis-trans isomerases (PPIases) of the cyclophilin sub-class, esp. to the periplasmic rotamase (RotA) of Escherichia coli.  A putative signal sequence suggests that the product of the Acinetobacter gene, the authors termed rotA, is located outside the cytoplasm.  Transcription of the gene is initiated from a promoter, just upstream of the rotA orf.  The observation that two A. calcoaceticus rotA deletion mutants display no apparent mutant phenotype, suggests that this PPIase is not essential for growth of the organism.  These mutants, to the knowledge, are the first prokaryotic PPIase mutants reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmVrVw1llxa7Vg90H21EOLACvtfcHk0lilrZJjMnLO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlWlsbw%253D&md5=74a4daedb4caaa044f5ebe5dce97a6a7</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0167-4781%2894%2990218-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4781%252894%252990218-6%26sid%3Dliteratum%253Aachs%26aulast%3DKok%26aufirst%3DR.%2BG.%26aulast%3DChristoffels%26aufirst%3DV.%2BM.%26aulast%3DVosman%26aufirst%3DB.%26aulast%3DHellingwerf%26aufirst%3DK.%2BJ.%26atitle%3DA%2520Gene%2520of%2520Acinetobacter%2520calcoaceticus%2520BD413%2520Encodes%2520a%2520Periplasmic%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520of%2520the%2520Cyclophilin%2520Sub-Class%2520that%2520is%2520not%2520Essential%2520for%2520Growth%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Struct.%2520Expression%26date%3D1994%26volume%3D1219%26issue%3D3%26spage%3D601%26epage%3D606%26doi%3D10.1016%2F0167-4781%2894%2990218-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roset, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia Fernandez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DelVecchio, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, G.</span></span> <span> </span><span class="NLM_article-title">Intracellularly Induced Cyclophilins Play an Important Role in Stress Adaptation and Virulence of Brucella abortus</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1128/IAI.01125-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.01125-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23230297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Snt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=521-530&issue=2&author=M.+S.+Rosetauthor=L.+Garcia+Fernandezauthor=V.+G.+DelVecchioauthor=G.+Briones&title=Intracellularly+Induced+Cyclophilins+Play+an+Important+Role+in+Stress+Adaptation+and+Virulence+of+Brucella+abortus&doi=10.1128%2FIAI.01125-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellularly induced cyclophilins play an important role in stress adaptation and virulence of Brucella abortus</span></div><div class="casAuthors">Roset, Mara S.; Fernandez, Lucia Garcia; DelVecchio, Vito G.; Briones, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">521-530</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brucella is an intracellular bacterial pathogen that causes the worldwide zoonotic disease brucellosis.  Brucella virulence relies on its ability to transition to an intracellular lifestyle within host cells.  Thus, this pathogen must sense its intracellular localization and then reprogram gene expression for survival within the host cell.  A comparative proteomic investigation was performed to identify differentially expressed proteins potentially relevant for Brucella intracellular adaptation.  Two proteins identified as cyclophilins (CypA and CypB) were overexpressed in the intracellular environment of the host cell in comparison to lab.-grown Brucella.  To define the potential role of cyclophilins in Brucella virulence, a double-deletion mutant was constructed and its resulting phenotype was characterized.  The Brucella abortus ΔcypAB mutant displayed increased sensitivity to environmental stressors, such as oxidative stress, pH, and detergents.  In addn., the B. abortus ΔcypAB mutant strain had a reduced growth rate at lower temp., a phenotype assocd. with defective expression of cyclophilins in other microorganisms.  The B. abortus ΔcypAB mutant also displays reduced virulence in BALB/c mice and defective intracellular survival in HeLa cells.  These findings suggest that cyclophilins are important for Brucella virulence and survival in the host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHTvW-tE1lsrVg90H21EOLACvtfcHk0lilrZJjMnLO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Snt7k%253D&md5=482ebc52cfe73b60862c277a2a9a925b</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1128%2FIAI.01125-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.01125-12%26sid%3Dliteratum%253Aachs%26aulast%3DRoset%26aufirst%3DM.%2BS.%26aulast%3DGarcia%2BFernandez%26aufirst%3DL.%26aulast%3DDelVecchio%26aufirst%3DV.%2BG.%26aulast%3DBriones%26aufirst%3DG.%26atitle%3DIntracellularly%2520Induced%2520Cyclophilins%2520Play%2520an%2520Important%2520Role%2520in%2520Stress%2520Adaptation%2520and%2520Virulence%2520of%2520Brucella%2520abortus%26jtitle%3DInfect.%2520Immun.%26date%3D2013%26volume%3D81%26issue%3D2%26spage%3D521%26epage%3D530%26doi%3D10.1128%2FIAI.01125-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhaduri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhetaria, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhasmana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virdi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, Y.</span></span> <span> </span><span class="NLM_article-title">Mycobacterium tuberculosis Cyclophilin A Uses Novel Signal Sequence for Secretion and Mimics Eukaryotic Cyclophilins for Interaction with Host Protein Repertoire</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">e88090</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0088090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pone.0088090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=24505389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWgsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e88090&issue=2&author=A.+Bhaduriauthor=R.+Misraauthor=A.+Majiauthor=P.+J.+Bhetariaauthor=S.+Mishraauthor=G.+Aroraauthor=L.+K.+Singhauthor=N.+Dhasmanaauthor=N.+Dubeyauthor=J.+S.+Virdiauthor=Y.+Singh&title=Mycobacterium+tuberculosis+Cyclophilin+A+Uses+Novel+Signal+Sequence+for+Secretion+and+Mimics+Eukaryotic+Cyclophilins+for+Interaction+with+Host+Protein+Repertoire&doi=10.1371%2Fjournal.pone.0088090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Mycobacterium tuberculosis cyclophilin a uses novel signal sequence for secretion and mimics eukaryotic cyclophilins for interaction with host protein repertoire</span></div><div class="casAuthors">Bhaduri, Asani; Misra, Richa; Maji, Abhijit; Bhetaria, Preetida J.; Mishra, Sonakshi; Arora, Gunjan; Singh, Lalit Kumar; Dhasmana, Neha; Dubey, Neha; Virdi, Jugsharan Singh; Singh, Yogendra</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e88090/1-e88090/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cyclophilins are prolyl isomerases with multitude of functions in different cellular processes and pathol. conditions.  Cyclophilin A (PpiA) of Mycobacterium tuberculosis is secreted during infection in intraphagosomal niche.  However, our understanding about the evolutionary origin, secretory mechanism or the interactome of M. tuberculosis PpiA is limited.  This study demonstrates through phylogenetic and structural analyses that PpiA has more proximity to human cyclophilins than the prokaryotic counterparts.  The authors report a unique N-terminal sequence (MADCDSVTNSP) present in pathogenic mycobacterial PpiA and absent in non-pathogenic strains.  This sequence stretch was shown to be essential for PpiA secretion.  The overexpression of full-length PpiA from M. tuberculosis in non-pathogenic Mycobacterium smegmatis resulted in PpiA secretion while truncation of the N-terminal stretch obstructed the secretion.  In addn., presence of an ESX pathway substrate motif in M. tuberculosis PpiA suggested possible involvement of Type VII secretion system.  Site-directed mutagenesis of key residues in this motif in full-length PpiA also hindered the secretion in M. smegmatis.  Bacterial two-hybrid screens with human lung cDNA library as target were utilized to identify interaction partners of PpiA from host repertoire, and a no. of substrates with functional representation in iron storage, signal transduction and immune responses were detected.  The extensive host interactome coupled with the sequence and structural similarity to human cyclophilins is strongly suggestive of PpiA being deployed by M. tuberculosis as an effector mimic against the host cyclophilins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUUjNhQOIArVg90H21EOLACvtfcHk0lilrZJjMnLO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWgsLfJ&md5=8967929be39d7dbc30a9cd63af67efc6</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0088090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0088090%26sid%3Dliteratum%253Aachs%26aulast%3DBhaduri%26aufirst%3DA.%26aulast%3DMisra%26aufirst%3DR.%26aulast%3DMaji%26aufirst%3DA.%26aulast%3DBhetaria%26aufirst%3DP.%2BJ.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DArora%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DL.%2BK.%26aulast%3DDhasmana%26aufirst%3DN.%26aulast%3DDubey%26aufirst%3DN.%26aulast%3DVirdi%26aufirst%3DJ.%2BS.%26aulast%3DSingh%26aufirst%3DY.%26atitle%3DMycobacterium%2520tuberculosis%2520Cyclophilin%2520A%2520Uses%2520Novel%2520Signal%2520Sequence%2520for%2520Secretion%2520and%2520Mimics%2520Eukaryotic%2520Cyclophilins%2520for%2520Interaction%2520with%2520Host%2520Protein%2520Repertoire%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3De88090%26doi%3D10.1371%2Fjournal.pone.0088090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammirati, E.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine in Transplantation—A History of Converging Timelines</span>. <i>J. Biol. Regul. Homeostatic Agents</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22217983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XislCitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=493-504&author=D.+Colomboauthor=E.+Ammirati&title=Cyclosporine+in+Transplantation%E2%80%94A+History+of+Converging+Timelines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine in transplantation - a history of converging timelines</span></div><div class="casAuthors">Colombo, D.; Ammirati, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Regulators and Homeostatic Agents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">JBRAER</span>;
        ISSN:<span class="NLM_cas:issn">0393-974X</span>.
    
            (<span class="NLM_cas:orgname">BIOLIFE, s.a.s.</span>)
        </div><div class="casAbstract">A review.  Discovery and pharmacol. development of cyclosporine was conducted by Jean Borel and colleagues in the 1970s.  Cyclosporine is the first compd. to inhibit the lymphocytes specifically and reversibly, and represents the prototype of a new generation of immunosuppressive drugs: the calcineurine inhibitors.  Historical chronol. of successes in clin. application of cyclosporine and development of solid-organ transplantation are retraced here, underscoring the converging timelines of this drug and these interventions.  In 1978-79 the first successful results of the use of cyclosporine in kidney were reported.  Cyclosporine was the first single drug able to control rejection.  In 1982-83 first trials demonstrated the benefit from treatment with cyclosporine in kidney recipients compared to azathioprine and steroids.  In the 1980s solid-organ transplantation entered the "cyclosporine era" with unhoped-for results in heart transplantation.  The present review focuses also on cyclosporine-based regimen of immunosuppression, adverse side effects and safety in pregnancy in subjects under treatment with cyclosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1YSwrBWVwKLVg90H21EOLACvtfcHk0ljlliyAtr5PHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XislCitb8%253D&md5=8cca6bbb53cec167f387c069ce484bcb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DD.%26aulast%3DAmmirati%26aufirst%3DE.%26atitle%3DCyclosporine%2520in%2520Transplantation%25E2%2580%2594A%2520History%2520of%2520Converging%2520Timelines%26jtitle%3DJ.%2520Biol.%2520Regul.%2520Homeostatic%2520Agents%26date%3D2011%26volume%3D25%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyasu, S.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Action of Cyclosporine</span>. <i>Immunopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/S0162-3109(00)00192-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0162-3109%2800%2900192-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10878286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlKkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2000&pages=119-125&issue=2%E2%80%933&author=S.+Matsudaauthor=S.+Koyasu&title=Mechanisms+of+Action+of+Cyclosporine&doi=10.1016%2FS0162-3109%2800%2900192-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of cyclosporine</span></div><div class="casAuthors">Matsuda, S.; Koyasu, S.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">119-125</span>CODEN:
                <span class="NLM_cas:coden">IMMUDP</span>;
        ISSN:<span class="NLM_cas:issn">0162-3109</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with ∼90 refs.  Cyclosporine (cyclosporin A, CsA) has potent immunosuppressive properties, reflecting its ability to block the transcription of cytokine genes in activated T cells.  It is well established that CsA through formation of a complex with cyclophilin inhibits the phosphatase activity of calcineurin, which regulates nuclear translocation and subsequent activation of NFAT transcription factors.  In addn. to the calcineurin/NFAT pathway, recent studies indicate that CsA also blocks the activation of JNK and p38 signaling pathways triggered by antigen recognition, making CsA a highly specific inhibitor of T cell activation.  Here we discuss the action of CsA on JNK and p38 activation pathways.  We also argue the potential of CsA and its natural counterparts as pharmacol. probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Y0c5-UmKabVg90H21EOLACvtfcHk0ljlliyAtr5PHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlKkt7s%253D&md5=756ce95c9104825ad1050b9d43114837</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2800%2900192-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252800%252900192-2%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DS.%26aulast%3DKoyasu%26aufirst%3DS.%26atitle%3DMechanisms%2520of%2520Action%2520of%2520Cyclosporine%26jtitle%3DImmunopharmacology%26date%3D2000%26volume%3D47%26issue%3D2%25E2%2580%25933%26spage%3D119%26epage%3D125%26doi%3D10.1016%2FS0162-3109%2800%2900192-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, G. R.</span></span> <span> </span><span class="NLM_article-title">The Mechanism of Action of Cyclosporin A and FK506</span>. <i>Immunol. Today</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/0167-5699(92)90111-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0167-5699%2892%2990111-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1374612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK38XisVOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=136-142&issue=4&author=S.+L.+Schreiberauthor=G.+R.+Crabtree&title=The+Mechanism+of+Action+of+Cyclosporin+A+and+FK506&doi=10.1016%2F0167-5699%2892%2990111-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of action of cyclosporin A and FK506</span></div><div class="casAuthors">Schreiber, Stuart L.; Crabtree, Gerald R.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">136-42</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    </div><div class="casAbstract">A review with 80 refs.  Cyclosporin A (CsA) and FK506 are powerful suppressors of the immune system, most notably of T cells.  They act at a point in activation that lies between receptor ligation and the transcription of early genes.  Recent findings that indicate CsA and FK506 operate as prodrugs are discussed: they bind endogenous intracellular receptors, the immunophilins, and the resulting complex targets the protein phosphatase, calcineurin, to exert the immunosuppressive effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFf8-CJpSiYrVg90H21EOLACvtfcHk0ljlliyAtr5PHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisVOksb8%253D&md5=faacba90d38767f48f8d0c343c8b8aa8</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2F0167-5699%2892%2990111-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-5699%252892%252990111-J%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCrabtree%26aufirst%3DG.%2BR.%26atitle%3DThe%2520Mechanism%2520of%2520Action%2520of%2520Cyclosporin%2520A%2520and%2520FK506%26jtitle%3DImmunol.%2520Today%26date%3D1992%26volume%3D13%26issue%3D4%26spage%3D136%26epage%3D142%26doi%3D10.1016%2F0167-5699%2892%2990111-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paeshuyse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalfaro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span> <span> </span><span class="NLM_article-title">The Non-Immunosuppressive Cyclosporin DEBIO-025 is a Potent Inhibitor of Hepatitis C Virus Replication In Vitro</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1002/hep.21102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fhep.21102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16557546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvV2is70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=761-770&issue=4&author=J.+Paeshuyseauthor=A.+Kaulauthor=E.+De+Clercqauthor=B.+Rosenwirthauthor=J.+M.+Dumontauthor=P.+Scalfaroauthor=R.+Bartenschlagerauthor=J.+Neyts&title=The+Non-Immunosuppressive+Cyclosporin+DEBIO-025+is+a+Potent+Inhibitor+of+Hepatitis+C+Virus+Replication+In+Vitro&doi=10.1002%2Fhep.21102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro</span></div><div class="casAuthors">Paeshuyse, Jan; Kaul, Artur; De Clercq, Erik; Rosenwirth, Brigitte; Dumont, Jean-Maurice; Scalfaro, Pietro; Bartenchlager, Ralf; Neyts, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-770</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Cyclosporin A (CsA) inhibits the in vitro replication of HCV subgenomic replicons.  We here report on the potent anti-HCV activity of the non-immunosuppressive cyclosporin DEBIO-025.  The 50% effective concn. for inhibition of HCV subgenomic replicon replication in Huh 5-2 cells (luciferase assay) by DEBIO-025 was 0.27 ± 0.03 μg/mL and for CsA 2.8 ± 0.4 μg/mL.  The concn. that reduced the growth of exponentially proliferating Huh 5-2 cells by 50% was greater than 27 μg/mL for DEBIO-025 and 12 ± 6 μg/mL for CsA, resulting in a selectivity index of approx. 900 for DEBIO-025 and 40 for CsA.  The superior activity of DEBIO-025, as compared with CsA, was corroborated by monitoring HCV RNA levels in Huh 5-2, two other HCV subgenomic replicon-contg. cell lines, and by monitoring the luciferase signal and viral antigen prodn. in hepatoma cells that had been infected with an infectious full-length chimeric HCV construct.  The combination of interferon alpha 2a with either CsA or DEBIO-025 resulted in an additive to slightly synergistic antiviral activity.  DEBIO-025, at concns. of 0.5 and 1 μg/mL, was able to clear cells from their HCV replicon within three to four passages, whereas treatment with CsA at the same concns. for seven consecutive passages did not result in clearance of the HCV replicon.  In conclusion, DEBIO-025, a compd. that is also endowed with potent anti-HIV activity and is well tolerated in animals and humans, may form an attractive new option for the therapy of HCV infections, particularly in HCV/HIV co-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm7ye6ckOcSbVg90H21EOLACvtfcHk0lgXTx_jZK7KlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvV2is70%253D&md5=4d6822134e90969a7251204eefc954ed</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2Fhep.21102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.21102%26sid%3Dliteratum%253Aachs%26aulast%3DPaeshuyse%26aufirst%3DJ.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DDumont%26aufirst%3DJ.%2BM.%26aulast%3DScalfaro%26aufirst%3DP.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DNeyts%26aufirst%3DJ.%26atitle%3DThe%2520Non-Immunosuppressive%2520Cyclosporin%2520DEBIO-025%2520is%2520a%2520Potent%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%2520In%2520Vitro%26jtitle%3DHepatology%26date%3D2006%26volume%3D43%26issue%3D4%26spage%3D761%26epage%3D770%26doi%3D10.1002%2Fhep.21102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quesniaux, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreier, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Regenmortel, M. H.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin Binds to the Region of Cyclosporine Involved in its Immunosuppressive Activity</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1359</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1002/eji.1830170921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Feji.1830170921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=3308488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL1cXhsVejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=1359-1365&issue=9&author=V.+F.+Quesniauxauthor=M.+H.+Schreierauthor=R.+M.+Wengerauthor=P.+C.+Hiestandauthor=M.+W.+Hardingauthor=M.+H.+Van+Regenmortel&title=Cyclophilin+Binds+to+the+Region+of+Cyclosporine+Involved+in+its+Immunosuppressive+Activity&doi=10.1002%2Feji.1830170921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity</span></div><div class="casAuthors">Quesniaux, Valerie F. J.; Schreier, Max H.; Wenger, Roland M.; Hiestand, Peter C.; Harding, Matthew W.; Van Regenmortel, Marc H. V.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Immunology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1359-65</span>CODEN:
                <span class="NLM_cas:coden">EJIMAF</span>;
        ISSN:<span class="NLM_cas:issn">0014-2980</span>.
    </div><div class="casAbstract">In the present study, a quant. immunoassay for cyclophilin was developed which made it possible to compare its relative affinity for cyclosporine and any of its analogs.  The binding of cyclophilin to cyclosporine coated on a solid phase was revealed by anticyclophilin rabbit antiserum followed by antiglobulin-enzyme conjugate.  This reaction was inhibited by addn. of free cyclosporine or certain cyclosporine analogs.  By studying the binding of cyclophilin to more than 50 cyclosporine derivs. modified singly on each of the 11 amino acid residues, it was shown that cyclophilin binds to the residues of cyclosporine known to be crit. for its immunosuppressive activity.  Thus, cyclophilin as a highly discriminating stereospecific binding protein for cyclosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriVEkBdt0P_rVg90H21EOLACvtfcHk0lgXTx_jZK7KlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhsVejsLc%253D&md5=67f1289e9393d4c2e0e61cda02b9c190</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Feji.1830170921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.1830170921%26sid%3Dliteratum%253Aachs%26aulast%3DQuesniaux%26aufirst%3DV.%2BF.%26aulast%3DSchreier%26aufirst%3DM.%2BH.%26aulast%3DWenger%26aufirst%3DR.%2BM.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DHarding%26aufirst%3DM.%2BW.%26aulast%3DVan%2BRegenmortel%26aufirst%3DM.%2BH.%26atitle%3DCyclophilin%2520Binds%2520to%2520the%2520Region%2520of%2520Cyclosporine%2520Involved%2520in%2520its%2520Immunosuppressive%2520Activity%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D1987%26volume%3D17%26issue%3D9%26spage%3D1359%26epage%3D1365%26doi%3D10.1002%2Feji.1830170921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7145</span>– <span class="NLM_lpage">7159</span>, <span class="refDoi"> DOI: 10.1021/jm500223x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500223x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7145-7159&issue=17&author=Z.+K.+Sweeneyauthor=J.+Fuauthor=B.+Wiedmann&title=From+Chemical+Tools+to+Clinical+Medicines%3A+Nonimmunosuppressive+Cyclophilin+Inhibitors+Derived+from+the+Cyclosporin+and+Sanglifehrin+Scaffolds&doi=10.1021%2Fjm500223x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds</span></div><div class="casAuthors">Sweeney, Zachary K.; Fu, Jiping; Wiedmann, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7145-7159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cyclophilins are widely expressed enzymes that catalyze the interconversion of the cis and trans peptide bonds of prolines.  The immunosuppressive natural products cyclosporine A and sanglifehrin A inhibit the enzymic activity of the cyclophilins.  Chem. modification of both the cyclosporine and sanglifehrin scaffolds has produced many analogs that inhibit cyclophilins in vitro but have reduced immunosuppressive properties.  Three nonimmunosuppressive cyclophilin inhibitors (alisporivir, SCY-635, and NIM811) have demonstrated clin. efficacy for the treatment of hepatitis C infection.  Addnl. candidates are in various stages of preclin. development for the treatment of hepatitis C or myocardial reperfusion injury.  Recent publications suggest that cyclophilin inhibitors may have utility for the treatment of diverse viral infections, inflammatory indications, and cancer.  In this review, we document the structure-activity relationships of the nonimmunosuppressive cyclosporins and sanglifehrins in clin. and preclin. development.  Aspects of the pharmacokinetic behavior and chem. biol. of these drug candidates are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX8HG6odes7Vg90H21EOLACvtfcHk0liZklTnwMvFOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D&md5=c011a3ad8d4db9481fb5f99c1e917759</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm500223x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500223x%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DFrom%2520Chemical%2520Tools%2520to%2520Clinical%2520Medicines%253A%2520Nonimmunosuppressive%2520Cyclophilin%2520Inhibitors%2520Derived%2520from%2520the%2520Cyclosporin%2520and%2520Sanglifehrin%2520Scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D17%26spage%3D7145%26epage%3D7159%26doi%3D10.1021%2Fjm500223x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furegati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprzyk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yifru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Potent Nonimmunosuppressive Cyclophilin Inhibitors with Improved Pharmaceutical Properties and Decreased Transporter Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8503</span>– <span class="NLM_lpage">8516</span>, <span class="refDoi"> DOI: 10.1021/jm500862r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500862r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8503-8516&issue=20&author=J.+Fuauthor=M.+Tjandraauthor=C.+Beckerauthor=D.+Bednarczykauthor=M.+Capparelliauthor=R.+Ellingauthor=I.+Hannaauthor=R.+Fujimotoauthor=M.+Furegatiauthor=S.+Karurauthor=T.+Kasprzykauthor=M.+Knappauthor=K.+Leungauthor=X.+Liauthor=P.+Luauthor=W.+Mergoauthor=C.+Miaultauthor=S.+Ngauthor=D.+Parkerauthor=Y.+Pengauthor=S.+Roggoauthor=A.+Rivkinauthor=R.+L.+Simmonsauthor=M.+Wangauthor=B.+Wiedmannauthor=A.+H.+Weissauthor=L.+Xiaoauthor=L.+Xieauthor=W.+Xuauthor=A.+Yifruauthor=S.+Yangauthor=B.+Zhouauthor=Z.+K.+Sweeney&title=Potent+Nonimmunosuppressive+Cyclophilin+Inhibitors+with+Improved+Pharmaceutical+Properties+and+Decreased+Transporter+Inhibition&doi=10.1021%2Fjm500862r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition</span></div><div class="casAuthors">Fu, Jiping; Tjandra, Meiliana; Becker, Christopher; Bednarczyk, Dallas; Capparelli, Michael; Elling, Robert; Hanna, Imad; Fujimoto, Roger; Furegati, Markus; Karur, Subramanian; Kasprzyk, Theresa; Knapp, Mark; Leung, Kwan; Li, Xiaolin; Lu, Peichao; Mergo, Wosenu; Miault, Charlotte; Ng, Simon; Parker, David; Peng, Yunshan; Roggo, Silvio; Rivkin, Alexey; Simmons, Robert L.; Wang, Michael; Wiedmann, Brigitte; Weiss, Andrew H.; Xiao, Linda; Xie, Lili; Xu, Wenjian; Yifru, Aregahegn; Yang, Shengtian; Zhou, Bo; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8503-8516</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonimmunosuppressive cyclophilin inhibitors have demonstrated efficacy for the treatment of hepatitis C infection (HCV).  However, alisporivir, cyclosporin A, and most other cyclosporins are potent inhibitors of OATP1B1, MRP2, MDR1, and other important drug transporters.  Redn. of the side chain hydrophobicity of the P4 residue preserves cyclophilin binding and antiviral potency while decreasing transporter inhibition.  Representative inhibitor 33 (NIM258) is a less potent transporter inhibitor relative to previously described cyclosporins, retains anti-HCV activity in cell culture, and has an acceptable pharmacokinetic profile in rats and dogs.  An X-ray structure of 33 bound to rat cyclophilin D is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJTTMugCPY6bVg90H21EOLACvtfcHk0liZklTnwMvFOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L&md5=80688933869bade9ce2684db9ca82cb6</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm500862r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500862r%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DTjandra%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBednarczyk%26aufirst%3DD.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DHanna%26aufirst%3DI.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DFuregati%26aufirst%3DM.%26aulast%3DKarur%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DT.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DMiault%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWiedmann%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DPotent%2520Nonimmunosuppressive%2520Cyclophilin%2520Inhibitors%2520with%2520Improved%2520Pharmaceutical%2520Properties%2520and%2520Decreased%2520Transporter%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8503%26epage%3D8516%26doi%3D10.1021%2Fjm500862r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepanier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ure, D. R.</span></span> <span> </span><span class="NLM_article-title">A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>371</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.261099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1124%2Fjpet.119.261099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=31406003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2019&pages=231-241&issue=2&author=J.+Kuoauthor=M.+Bobardtauthor=U.+Chatterjiauthor=P.+R.+Mayoauthor=D.+J.+Trepanierauthor=R.+T.+Fosterauthor=P.+Gallayauthor=D.+R.+Ure&title=A+Pan-Cyclophilin+Inhibitor%2C+CRV431%2C+Decreases+Fibrosis+and+Tumor+Development+in+Chronic+Liver+Disease+Models&doi=10.1124%2Fjpet.119.261099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">A pan-cyclophilin inhibitor, CRV431, decreases fibrosis and tumor development in chronic liver disease modelss</span></div><div class="casAuthors">Kuo, Joseph; Bobardt, Michael; Chatterji, Udayan; Mayo, Patrick R.; Trepanier, Daniel J.; Foster, Robert T.; Gallay, Philippe; Ure, Daren R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-241</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous studies show that cyclophilins contribute to many pathol. processes, and cyclophilin inhibitors demonstrate therapeutic activities in many exptl. models.  However, no drug with cyclophilin inhibition as the primary mode of action has advanced completely through clin. development to market.  In this study, we present findings on the cyclophilin inhibitor, CRV431, that highlight its potential as a drug candidate for chronic liver diseases.  CRV431 was found to potently inhibit all cyclophilin isoforms tested-A, B, D, and G.  Inhibitory const. or IC50 values ranged from 1 to 7 nM, which was up to 13 times more potent than the parent compd., cyclosporine A (CsA), from which CRV431 was derived.  Other CRV431 advantages over CsA as a nontransplant drug candidate were significantly diminished immunosuppressive activity, less drug transporter inhibition, and reduced cytotoxicity potential.  Oral dosing to mice and rats led to good blood exposures and a 5- to 15-fold accumulation of CRV431 in liver compared with blood concns. across a wide range of CRV431 dosing levels.  Most importantly, CRV431 decreased liver fibrosis in a 6-wk carbon tetrachloride model and in a mouse model of nonalcoholic steatohepatitis (NASH).  Addnl., CRV431 administration during a late, oncogenic stage of the NASH disease model resulted in a 50% redn. in the no. and size of liver tumors.  These findings are consistent with CRV431 targeting fibrosis and cancer through multiple, cyclophilin-mediated mechanisms and support the development of CRV431 as a safe and effective drug candidate for liver diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY9VqpwJ0rObVg90H21EOLACvtfcHk0ljC9U9vseU-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmtrfM&md5=808c7817c15ed6c84393f0f4bced2485</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.261099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.261099%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DMayo%26aufirst%3DP.%2BR.%26aulast%3DTrepanier%26aufirst%3DD.%2BJ.%26aulast%3DFoster%26aufirst%3DR.%2BT.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DUre%26aufirst%3DD.%2BR.%26atitle%3DA%2520Pan-Cyclophilin%2520Inhibitor%252C%2520CRV431%252C%2520Decreases%2520Fibrosis%2520and%2520Tumor%2520Development%2520in%2520Chronic%2520Liver%2520Disease%2520Models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26volume%3D371%26issue%3D2%26spage%3D231%26epage%3D241%26doi%3D10.1124%2Fjpet.119.261099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmid, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaksche, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peichl, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Human Immunodeficiency Virus Type 1 Replication by SDZ NIM 811, a Nonimmunosuppressive Cyclosporine Analog</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1763</span>– <span class="NLM_lpage">1772</span>, <span class="refDoi"> DOI: 10.1128/AAC.38.8.1763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.38.8.1763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7527198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=1763-1772&issue=8&author=B.+Rosenwirthauthor=A.+Billichauthor=R.+Datemaauthor=P.+Donatschauthor=F.+Hammerschmidauthor=R.+Harrisonauthor=P.+Hiestandauthor=H.+Jakscheauthor=P.+Mayerauthor=P.+Peichl&title=Inhibition+of+Human+Immunodeficiency+Virus+Type+1+Replication+by+SDZ+NIM+811%2C+a+Nonimmunosuppressive+Cyclosporine+Analog&doi=10.1128%2FAAC.38.8.1763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppresive cyclosporine analog</span></div><div class="casAuthors">Rosenwirth, Brigitte; Billich, Andreas; Datema, Roelf; Donatsch, Peter; Hammerschmid, Franz; Harrison, Richard; Hiestand, Peter; Jaksche, Herbert; Mayer, Peter; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1763-72</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">(Me-Ile-4)cyclosporin (SDZ NIM 811) is a 4-substituted cyclosporin which is devoid of immunosuppressive activity but retains full capacity for binding to cyclophilin and exhibits potent anti-human immunodeficiency virus type 1 (HIV-1) activity.  SDZ NIM 811 selectively inhibits HIV-1 replication in T4 lymphocyte cell lines, in a monocytic cell line, and in HeLa T4 cells.  Furthermore, its antiviral activity against lab. strains and against clin. isolates from geog. distinct regions in primary T4 lymphocytes and in primary monocytes (50 inhibitory concn. = 0.011 to 0.057 μg/mL) was demonstrated.  SDZ NIM 811 does not inhibit proviral gene expression or virus-specific enzyme functions, either free or bound to cyclophilin.  The compd. does not influence CD4 expression or inhibit fusion between virus-infected ad uninfected cells.  SDZ NIM 811 was, however, found to block formation of infectious particles from chronically infected cells.  Oral administration to mice, rats, dogs and monkeys resulted in levels in blood considerably exceeding the drug concn., which completely blocked virus replication in primary cells.  SDZ NIM 811 caused changes of toxicity parameters in rats to a smaller degree than cyclosporine (formerly cyclosporin A).  Thus, the potent and selective anti-HIV-1 activity of SDZ NIM 811 and its favorable pharmacokinetic behavior together with its lower nephrotoxicity than that of cyclosporine make this compd. a promising candidate for development as an anti-HIV drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXexjevqslpLVg90H21EOLACvtfcHk0ljC9U9vseU-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGjtrY%253D&md5=bcd9550aed98340fc820e7ef9dc5bd77</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1128%2FAAC.38.8.1763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.38.8.1763%26sid%3Dliteratum%253Aachs%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DDatema%26aufirst%3DR.%26aulast%3DDonatsch%26aufirst%3DP.%26aulast%3DHammerschmid%26aufirst%3DF.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJaksche%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DPeichl%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520Replication%2520by%2520SDZ%2520NIM%2520811%252C%2520a%2520Nonimmunosuppressive%2520Cyclosporine%2520Analog%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1994%26volume%3D38%26issue%3D8%26spage%3D1763%26epage%3D1772%26doi%3D10.1128%2FAAC.38.8.1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosli, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">[Melle4]Cyclosporin, a Novel Natural Cyclosporin with Anti-HIV Activity: Structural Elucidation, Biosynthesis and Biological Properties</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1177/095632029400500507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1177%2F095632029400500507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=331-339&issue=5&author=R.+Traberauthor=H.+Kobelauthor=H.+R.+Loosliauthor=H.+Sennauthor=B.+Rosenwirthauthor=A.+Lawen&title=%5BMelle4%5DCyclosporin%2C+a+Novel+Natural+Cyclosporin+with+Anti-HIV+Activity%3A+Structural+Elucidation%2C+Biosynthesis+and+Biological+Properties&doi=10.1177%2F095632029400500507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">[Melle4]Cyclosporin, a novel natural cyclosporin with anti-HIV activity: structural elucidation, biosynthesis and biological properties</span></div><div class="casAuthors">Traber, R.; Kobel, H.; Loosli, H.-R.; Senn, H.; Rosenwirth, B.; Lawen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">331-9</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    </div><div class="casAbstract">From fermns. of Tolypocladium niveum supplemented with D-threonine, a novel natural cyclosporin, [Melle4]cyclosporin, was isolated.  Its structural elucidation is based on amino acid anal. and spectroscopic data; the amino acid sequence was deduced from two-dimensional NMR investigations applied to the iso-deriv. of [Melle4]cyclosporin which, in contrast to the natural product, is present as one homogeneous conformation in soln.  We show that one of the four N-methyl-L-leucine units of cyclosporin A, namely that in position 4, is replaced by N-methyl-L-isoleucine.  The putative mechanism by which D-threonine induces in vivo biosynthesis of [Melle4]cyclosporin was achieved using the previously described enzymic system, thereby demonstrating the high affinity of cyclosporin synthetase for isoleucine in position 4.  In a long series of cyclosporins obtained by in vitro and in vivo biosynthesis, [Melle4]cyclosporin represents the first example that is devoid of immunosuppressive efficacy while retaining strong binding to cyclophilin.  It exerts potent in vitro anti-HIV-1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrew2_oamlMRrVg90H21EOLACvtfcHk0ljC9U9vseU-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWgtro%253D&md5=4fcf3c537311da87b4a32e14301135c7</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1177%2F095632029400500507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F095632029400500507%26sid%3Dliteratum%253Aachs%26aulast%3DTraber%26aufirst%3DR.%26aulast%3DKobel%26aufirst%3DH.%26aulast%3DLoosli%26aufirst%3DH.%2BR.%26aulast%3DSenn%26aufirst%3DH.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3D%255BMelle4%255DCyclosporin%252C%2520a%2520Novel%2520Natural%2520Cyclosporin%2520with%2520Anti-HIV%2520Activity%253A%2520Structural%2520Elucidation%252C%2520Biosynthesis%2520and%2520Biological%2520Properties%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D1994%26volume%3D5%26issue%3D5%26spage%3D331%26epage%3D339%26doi%3D10.1177%2F095632029400500507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poullennec, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlWrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1000-1017&issue=3&author=V.+A.+Steadmanauthor=S.+B.+Pettitauthor=K.+G.+Poullennecauthor=L.+Lazaridesauthor=A.+J.+Keatsauthor=D.+K.+Deanauthor=S.+J.+Stanwayauthor=C.+A.+Austinauthor=J.+A.+Sanvoisinauthor=G.+M.+Wattauthor=H.+G.+Fliriauthor=A.+C.+Liclicanauthor=D.+Jinauthor=M.+H.+Wongauthor=S.+A.+Leavittauthor=Y.+J.+Leeauthor=Y.+Tianauthor=C.+R.+Freyauthor=T.+C.+Applebyauthor=U.+Schmitzauthor=P.+Jansaauthor=R.+L.+Mackmanauthor=B.+E.+Schultz&title=Discovery+of+Potent+Cyclophilin+Inhibitors+Based+on+the+Structural+Simplification+of+Sanglifehrin+A&doi=10.1021%2Facs.jmedchem.6b01329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A</span></div><div class="casAuthors">Steadman, Victoria A.; Pettit, Simon B.; Poullennec, Karine G.; Lazarides, Linos; Keats, Andrew J.; Dean, David K.; Stanway, Steven J.; Austin, Carol A.; Sanvoisin, Jonathan A.; Watt, Gregory M.; Fliri, Hans G.; Liclican, Albert C.; Jin, Debi; Wong, Melanie H.; Leavitt, Stephanie A.; Lee, Yu-Jen; Tian, Yang; Frey, Christian R.; Appleby, Todd C.; Schmitz, Uli; Jansa, Petr; Mackman, Richard L.; Schultz, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1000-1017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclophilin inhibition has been a target for the treatment of hepatitis C and other diseases, but the generation of potent, drug-like mols. through chem. synthesis has been challenging.  In this study, a set of macrocyclic cyclophilin inhibitors was synthesized based on the core structure of the natural product sanglifehrin A.  Initial compd. optimization identified the valine-m-tyrosine-piperazic acid tripeptide (Val-m-Tyr-Pip) in the sanglifehrin core, stereocenters at C14 and C15, and the hydroxyl group of the m-tyrosine (m-Tyr) residue as key contributors to compd. potency.  Replacing the C18-C21 diene unit of sanglifehrin with a styryl group led to potent compds. that displayed a novel binding mode in which the styrene moiety engaged in a π-stacking interaction with Arg55 of cyclophilin A (Cyp A), and the m-Tyr residue was displaced into solvent.  This observation allowed further simplifications of the scaffold to generate new lead compds. in the search for orally bioavailable cyclophilin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorJXRBXLoC-rVg90H21EOLACvtfcHk0ljs2LRpiVWFuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlWrsg%253D%253D&md5=7b3c1ccee76ff6da98064783c0710fd6</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01329%26sid%3Dliteratum%253Aachs%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DPettit%26aufirst%3DS.%2BB.%26aulast%3DPoullennec%26aufirst%3DK.%2BG.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DA.%2BJ.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26aulast%3DSanvoisin%26aufirst%3DJ.%2BA.%26aulast%3DWatt%26aufirst%3DG.%2BM.%26aulast%3DFliri%26aufirst%3DH.%2BG.%26aulast%3DLiclican%26aufirst%3DA.%2BC.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DAppleby%26aufirst%3DT.%2BC.%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520Potent%2520Cyclophilin%2520Inhibitors%2520Based%2520on%2520the%2520Structural%2520Simplification%2520of%2520Sanglifehrin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D3%26spage%3D1000%26epage%3D1017%26doi%3D10.1021%2Facs.jmedchem.6b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span> <span> </span><span class="NLM_article-title">Profile of Alisporivir and its Potential in the Treatment of Hepatitis C</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S30946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.2147%2FDDDT.S30946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23440335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslCitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=105-115&author=P.+A.+Gallayauthor=K.+Lin&title=Profile+of+Alisporivir+and+its+Potential+in+the+Treatment+of+Hepatitis+C&doi=10.2147%2FDDDT.S30946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Profile of alisporivir and its potential in the treatment of hepatitis C</span></div><div class="casAuthors">Gallay, Philippe A.; Lin, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-115</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Two classes of hepatitis C antiviral agents currently exist, i.e., direct-acting antivirals and host-targeting antivirals.  Direct-acting antivirals target viral proteins including NS3/NS4A protease, NS5B polymerase and NS5A protein, while host-targeting antivirals target various host proteins crit. for replication of the hepatitis C virus (HCV).  Alisporivir is the most advanced host-targeting antiviral in clin. development.  Alisporivir blocks HCV replication by neutralizing the peptidyl-prolyl isomerase activity of the abundant host cytosolic protein, cyclophilin A.  Due to its unique mechanism of antiviral action, alisporivir is pangenotypic, provides a high barrier for development of viral resistance, and does not permit cross-resistance to direct-acting antivirals.  Alisporivir has an excellent pharmacokinetic and safety profile.  Phase I and II clin. studies have demonstrated that alisporivir causes a dramatic redn. in viral loads in HCV-infected patients.  Alisporivir was shown to be highly potent in treatment-naive and treatment-experienced patients with genotype 1 as well as in those with genotypes 2 or 3.  Low viral breakthrough rates were obsd. and the most frequent clin. and lab. adverse events assocd. with alisporivir in combination with pegylated interferon-alpha and ribavirin were similar to those assocd. with pegylated interferon-alpha and ribavirin used alone.  A lab. abnormality obsd. in some patients receiving alisporivir is hyperbilirubinemia, which is related to transporter inhibition and not to liver toxicity.  The most recent clin. results suggest that alisporivir plus other direct-acting antivirals should provide a successful treatment option for difficult-to-treat populations, such as nonresponders to prior interferon-alpha therapy and patients with cirrhosis.  In conclusion, alisporivir represents an attractive candidate component of future interferon-free regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-CPcaDXEJbVg90H21EOLACvtfcHk0ljs2LRpiVWFuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslCitrY%253D&md5=e1f3a8dc6bdbd47b845bcc3f6af5381d</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S30946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S30946%26sid%3Dliteratum%253Aachs%26aulast%3DGallay%26aufirst%3DP.%2BA.%26aulast%3DLin%26aufirst%3DK.%26atitle%3DProfile%2520of%2520Alisporivir%2520and%2520its%2520Potential%2520in%2520the%2520Treatment%2520of%2520Hepatitis%2520C%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2013%26volume%3D7%26spage%3D105%26epage%3D115%26doi%3D10.2147%2FDDDT.S30946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poullennec, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannizzaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiva, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highton, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9473</span>– <span class="NLM_lpage">9499</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVChtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9473-9499&issue=21&author=R.+L.+Mackmanauthor=V.+A.+Steadmanauthor=D.+K.+Deanauthor=P.+Jansaauthor=K.+G.+Poullennecauthor=T.+Applebyauthor=C.+Austinauthor=C.+A.+Blakemoreauthor=R.+Caiauthor=C.+Cannizzaroauthor=G.+Chinauthor=J.+C.+Chivaauthor=N.+A.+Dunbarauthor=H.+Fliriauthor=A.+J.+Hightonauthor=H.+Huiauthor=M.+Jiauthor=H.+Jinauthor=K.+Karkiauthor=A.+J.+Keatsauthor=L.+Lazaridesauthor=Y.+J.+Leeauthor=A.+Liclicanauthor=M.+Mishauthor=B.+Murrayauthor=S.+B.+Pettitauthor=P.+Pyunauthor=M.+Sangiauthor=R.+Santosauthor=J.+Sanvoisinauthor=U.+Schmitzauthor=A.+Schrierauthor=D.+Siegelauthor=D.+Sperandioauthor=G.+Stepanauthor=Y.+Tianauthor=G.+M.+Wattauthor=H.+Yangauthor=B.+E.+Schultz&title=Discovery+of+a+Potent+and+Orally+Bioavailable+Cyclophilin+Inhibitor+Derived+from+the+Sanglifehrin+Macrocycle&doi=10.1021%2Facs.jmedchem.8b00802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and orally bioavailable cyclophilin inhibitor derived from the sanglifehrin macrocycle</span></div><div class="casAuthors">Mackman, Richard L.; Steadman, Victoria A.; Dean, David K.; Jansa, Petr; Poullennec, Karine G.; Appleby, Todd; Austin, Carol; Blakemore, Caroline A.; Cai, Ruby; Cannizzaro, Carina; Chin, Gregory; Chiva, Jean-Yves C.; Dunbar, Neil A.; Fliri, Hans; Highton, Adrian J.; Hui, Hon; Ji, Mingzhe; Jin, Haolun; Karki, Kapil; Keats, Andrew J.; Lazarides, Linos; Lee, Yu-Jen; Liclican, Albert; Mish, Michael; Murray, Bernard; Pettit, Simon B.; Pyun, Peter; Sangi, Michael; Santos, Rex; Sanvoisin, Jonathan; Schmitz, Uli; Schrier, Adam; Siegel, Dustin; Sperandio, David; Stepan, George; Tian, Yang; Watt, Gregory M.; Yang, Hai; Schultz, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9473-9499</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C.  Our aim was to discover through total synthesis an orally bioavailable, non-immunosuppressive cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus (HCV) activity that could serve as part of an all oral antiviral combination therapy.  An initial lead (I) derived from the sanglifehrin A macrocycle was optimized using structure based design to produce a potent and orally bioavailable inhibitor (II).  The macrocycle ring size was reduced by one atom, and an internal hydrogen bond drove improved permeability and drug-like properties. II demonstrates potent Cyp inhibition (Kd = 5 nM), potent anti-HCV 2a activity (EC50 = 98 nM), and high oral bioavailability in rat (100%) and dog (55%).  The synthetic accessibility and properties of II support its potential as an anti-HCV agent and for interrogating the role of Cyp inhibition in a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEpEZcwXK8z7Vg90H21EOLACvtfcHk0ljs2LRpiVWFuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVChtbrI&md5=616cf72e0d2766e159769166c98a9e86</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00802%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DPoullennec%26aufirst%3DK.%2BG.%26aulast%3DAppleby%26aufirst%3DT.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBlakemore%26aufirst%3DC.%2BA.%26aulast%3DCai%26aufirst%3DR.%26aulast%3DCannizzaro%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DG.%26aulast%3DChiva%26aufirst%3DJ.%2BC.%26aulast%3DDunbar%26aufirst%3DN.%2BA.%26aulast%3DFliri%26aufirst%3DH.%26aulast%3DHighton%26aufirst%3DA.%2BJ.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DKeats%26aufirst%3DA.%2BJ.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DMish%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DPettit%26aufirst%3DS.%2BB.%26aulast%3DPyun%26aufirst%3DP.%26aulast%3DSangi%26aufirst%3DM.%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DSanvoisin%26aufirst%3DJ.%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DSchrier%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DD.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWatt%26aufirst%3DG.%2BM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Orally%2520Bioavailable%2520Cyclophilin%2520Inhibitor%2520Derived%2520from%2520the%2520Sanglifehrin%2520Macrocycle%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D21%26spage%3D9473%26epage%3D9499%26doi%3D10.1021%2Facs.jmedchem.8b00802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallansch, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalfaro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besseghir, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span> <span> </span><span class="NLM_article-title">Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-Cyclophilin-Resistant in Owl Monkey Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">40293</span>– <span class="NLM_lpage">40300</span>, <span class="refDoi"> DOI: 10.1074/jbc.M506314200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M506314200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16199531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Gjs7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=40293-40300&issue=48&author=U.+Chatterjiauthor=M.+D.+Bobardtauthor=R.+Stanfieldauthor=R.+G.+Ptakauthor=L.+A.+Pallanschauthor=P.+A.+Wardauthor=M.+J.+Jonesauthor=C.+A.+Stoddartauthor=P.+Scalfaroauthor=J.+M.+Dumontauthor=K.+Besseghirauthor=B.+Rosenwirthauthor=P.+A.+Gallay&title=Naturally+Occurring+Capsid+Substitutions+Render+HIV-1+Cyclophilin+A+Independent+in+Human+Cells+and+TRIM-Cyclophilin-Resistant+in+Owl+Monkey+Cells&doi=10.1074%2Fjbc.M506314200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells</span></div><div class="casAuthors">Chatterji, Udayan; Bobardt, Michael D.; Stanfield, Robyn; Ptak, Roger G.; Pallansch, Luke A.; Ward, Priscilla A.; Jones, Maureen J.; Stoddart, Cheryl A.; Scalfaro, Pietro; Dumont, Jean-Maurice; Besseghir, Kamel; Rosenwirth, Brigitte; Gallay, Philippe A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">40293-40300</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">In this study, we asked if a naturally occurring HIV-1 variant exists that circumvents CypA dependence in human cells.  To address this issue, we sought viruses for CypA independence using Debio-025, a cyclosporine A (CsA) analog that disrupts CypA-capsid interaction.  Surprisingly, viral variants from the Main group replicate even in the presence of the drug.  Sequencing analyses revealed that these viruses encode capsid substitutions within the CypA-binding site (V86P/H87Q/I91V/M96I).  When we introduced these substitutions into viruses that normally rely on CypA for replication, these mutants no longer depended on CypA, suggesting that naturally occurring capsid substitutions obviate the need for CypA.  This is the first demonstration that isolates from the Main group naturally develop CypA-independent strategies to replicate in human cells.  Surprisingly, we found that these capsid substitutions render HIV-1 capable of infecting Owl monkey (OMK) cells that highly restrict HIV-1.  OMK cell resistance to HIV-1 is mediated via TRIM-Cyp, which arose from a retrotransposition of CypA into the TRIM5 α gene.  Interestingly, satn. expts. suggest that the Pro86/Gln87/Val91/Ile96 capsid core is "invisible" to TRIM-Cyp.  This study demonstrates that specific capsid substitutions can release HIV-1 from both CypA dependence in human cells and TRIM-Cyp restriction in monkey cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojVkKwpMEydbVg90H21EOLACvtfcHk0lj5APbEhScnKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Gjs7vN&md5=9fa9607b2ba33c28d7f82e2ef7afc101</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M506314200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M506314200%26sid%3Dliteratum%253Aachs%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DBobardt%26aufirst%3DM.%2BD.%26aulast%3DStanfield%26aufirst%3DR.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DPallansch%26aufirst%3DL.%2BA.%26aulast%3DWard%26aufirst%3DP.%2BA.%26aulast%3DJones%26aufirst%3DM.%2BJ.%26aulast%3DStoddart%26aufirst%3DC.%2BA.%26aulast%3DScalfaro%26aufirst%3DP.%26aulast%3DDumont%26aufirst%3DJ.%2BM.%26aulast%3DBesseghir%26aufirst%3DK.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DGallay%26aufirst%3DP.%2BA.%26atitle%3DNaturally%2520Occurring%2520Capsid%2520Substitutions%2520Render%2520HIV-1%2520Cyclophilin%2520A%2520Independent%2520in%2520Human%2520Cells%2520and%2520TRIM-Cyclophilin-Resistant%2520in%2520Owl%2520Monkey%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D48%26spage%3D40293%26epage%3D40300%26doi%3D10.1074%2Fjbc.M506314200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godofsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praestgaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. G.</span></span> <span> </span><span class="NLM_article-title">Safety, Pharmacokinetics, and Antiviral Activity of the Cyclophilin Inhibitor NIM811 Alone or in Combination with Pegylated Interferon in HCV-Infected Patients Receiving 14 Days of Therapy</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2011.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.antiviral.2011.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21255610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVymtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=238-245&issue=3&author=E.+Lawitzauthor=E.+Godofskyauthor=R.+Rouzierauthor=T.+Marburyauthor=T.+Nguyenauthor=J.+Keauthor=M.+Huangauthor=J.+Praestgaardauthor=D.+Serraauthor=T.+G.+Evans&title=Safety%2C+Pharmacokinetics%2C+and+Antiviral+Activity+of+the+Cyclophilin+Inhibitor+NIM811+Alone+or+in+Combination+with+Pegylated+Interferon+in+HCV-Infected+Patients+Receiving+14+Days+of+Therapy&doi=10.1016%2Fj.antiviral.2011.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy</span></div><div class="casAuthors">Lawitz, Eric; Godofsky, Eliot; Rouzier, Regine; Marbury, Thomas; Nguyen, Tuan; Ke, June; Huang, Mei Mei; Praestgaard, Jens; Serra, Denise; Evans, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-245</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: Cyclophilin inhibitors have shown activity against a variety of viruses, including HCV.  NIM811, a novel, non-immunosuppressive cyclophilin inhibitor was studied in ascending doses in a randomized, double-blind, placebo-controlled 14-day trial in genotype 1 HCV patients.  Doses of 10 up to 600 mg were given orally once or twice daily as monotherapy (9:3 randomization of NIM811:placebo). 600 mg or placebo bid for 14 days was then co-administered with pegylated interferon α (PEG-IFN-α) administered on days 1 and 8 to genotype 1 relapsers.  Results: NIM811 was well tolerated at all doses.  Although lack of antiviral effect was noted in the monotherapy arms, liver transaminase normalization occurred at doses over 75 mg.  Mild, clin. non-significant elevations of bilirubin, and significant declines in platelet nos. were obsd. in the 400 and 600 mg bid groups.  In the combination group, the mean HCV RNA decline was 2.85 log, compared to a 0.56 log in the PEG-IFN alone arm.  The mean ALT (alanine transaminase) declined significantly by day 14 in the combination, but was unchanged in the PEG-IFN alone group.  In the combination therapy group, the mean platelets were 203 × 109/L at baseline and fell to 105 × 109/L by day 14; for patients treated with PEG-IFN the values were 177 × 109 and 139 × 109/L.  There was a significant increase in bilirubin, although this did not reach clin. concerning levels.  There were no severe or serious adverse events.  The pharmacokinetics in both monotherapy and combination arms were dose linear and not affected by PEG-INF.  Conclusion: NIM811 monotherapy resulted in a normalization of liver transaminases in the absence of significant virol. response.  The combination of NIM811 and pegylated interferon-α showed significant antiviral activity compared to interferon alone in genotype 1 HCV relapsers.  The use of oral cyclophilin inhibitors as part of a combination regime for treatment of hepatitis C, esp. to deter resistance, holds promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfmLT5LneqM7Vg90H21EOLACvtfcHk0liMCtMmOdshzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVymtL0%253D&md5=a11997c788ef8b85f345fb2230ddbc60</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2011.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2011.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DGodofsky%26aufirst%3DE.%26aulast%3DRouzier%26aufirst%3DR.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DKe%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DPraestgaard%26aufirst%3DJ.%26aulast%3DSerra%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DT.%2BG.%26atitle%3DSafety%252C%2520Pharmacokinetics%252C%2520and%2520Antiviral%2520Activity%2520of%2520the%2520Cyclophilin%2520Inhibitor%2520NIM811%2520Alone%2520or%2520in%2520Combination%2520with%2520Pegylated%2520Interferon%2520in%2520HCV-Infected%2520Patients%2520Receiving%252014%2520Days%2520of%2520Therapy%26jtitle%3DAntiviral%2520Res.%26date%3D2011%26volume%3D89%26issue%3D3%26spage%3D238%26epage%3D245%26doi%3D10.1016%2Fj.antiviral.2011.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin Inhibitors: an Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2558</span>– <span class="NLM_lpage">2577</span>, <span class="refDoi"> DOI: 10.3390/v4112558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Fv4112558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23202494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=2558-2577&issue=11&author=S.+Hopkinsauthor=P.+Gallay&title=Cyclophilin+Inhibitors%3A+an+Emerging+Class+of+Therapeutics+for+the+Treatment+of+Chronic+Hepatitis+C+Infection&doi=10.3390%2Fv4112558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection</span></div><div class="casAuthors">Hopkins, Sam; Gallay, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2558-2577</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The advent of the replicon system together with advances in cell culture have contributed significantly to our understanding of the function of virally-encoded structural and nonstructural proteins in the replication cycle of the hepatitis C virus.  In addn., in vitro systems have been used to identify several host proteins whose expression is crit. for supporting such diverse activities as viral entry, RNA replication, particle assembly and the release of infectious virions.  Among all known host proteins that participate in the HCV replication cycle, cyclophilins are unique because they constitute the only host target that has formed the basis of pharmaceutical drug discovery and drug development programs.  The introduction of the nonimmunosuppressive cyclophilin inhibitors into clin. testing has confirmed the clin. utility of CsA-based inhibitors for the treatment of individuals with chronic hepatitis C infection and has yielded new insights into their mechanism(s) of action.  This review describes the biochem. evidence for the potential roles played by cyclophilins in supporting HCV RNA replication and summarizes clin. trial results obtained with the first generation of nonimmunosuppressive cyclophilin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZzgAJ1L1MN7Vg90H21EOLACvtfcHk0liMCtMmOdshzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrrE&md5=ec08cd3fcb01f3d38ee8a04e98c9195a</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.3390%2Fv4112558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv4112558%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DGallay%26aufirst%3DP.%26atitle%3DCyclophilin%2520Inhibitors%253A%2520an%2520Emerging%2520Class%2520of%2520Therapeutics%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Hepatitis%2520C%2520Infection%26jtitle%3DViruses%26date%3D2012%26volume%3D4%26issue%3D11%26spage%3D2558%26epage%3D2577%26doi%3D10.3390%2Fv4112558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flisiak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaroszewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flisiak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapinski, T.</span></span> <span> </span><span class="NLM_article-title">Update on Alisporivir in Treatment of Viral Hepatitis C</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1517/13543784.2012.658641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1517%2F13543784.2012.658641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22316207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFSrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=375-382&issue=3&author=R.+Flisiakauthor=J.+Jaroszewiczauthor=I.+Flisiakauthor=T.+Lapinski&title=Update+on+Alisporivir+in+Treatment+of+Viral+Hepatitis+C&doi=10.1517%2F13543784.2012.658641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Update on in treatment of viral hepatitis C</span></div><div class="casAuthors">Flisiak, Robert; Jaroszewicz, Jerzy; Flisiak, Iwona; Lapinnski, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-382</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: There are two classes of anti-hepatitis C virus (HCV) agents currently in development: direct-acting antivirals (DAA) and host-targeting antivirals (HTA).  Cyclophilin inhibitor , previously known as Debio-025 is the most advanced HTA in development.Areas covered: Exptl. and clin. studies demonstrated that ALV has high genetic barrier and no cross-resistance to DAA.  Pharmacokinetic studies showed a profile suitable for once-daily administration.  Phase I and II studies confirmed strong HCV suppression and that addn. of ALV to pegylated IFNα (PegIFNα) and ribavirin (RBV) can improve their efficacy significantly.  ALV was well tolerated and prevalence of the most frequent clin. and lab. adverse events was similar to PegIFNα/RBV.  Hyperbilirubinemia was the only significant adverse event related to ALV, but it was transient, reversible and not assocd. with hepatotoxicity or cholestasis.Expert opinion: ALV is pangenotypic, with once-daily administration and safe, therefore medication can be easy and flexible.  There is still a need of data in difficult-to-treat populations and genetic studies allowing selection of possible non-responders.  Registration of ALV for IFN-based treatment is expected within 3 years, but ALV is also a good candidate for IFN-sparing combinations with DAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBrbSV1cltlLVg90H21EOLACvtfcHk0lgtsZnWtuf0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFSrt7c%253D&md5=7431ebf29cbe1e8fdbe2c48235292213</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1517%2F13543784.2012.658641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2012.658641%26sid%3Dliteratum%253Aachs%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DJaroszewicz%26aufirst%3DJ.%26aulast%3DFlisiak%26aufirst%3DI.%26aulast%3DLapinski%26aufirst%3DT.%26atitle%3DUpdate%2520on%2520Alisporivir%2520in%2520Treatment%2520of%2520Viral%2520Hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26issue%3D3%26spage%3D375%26epage%3D382%26doi%3D10.1517%2F13543784.2012.658641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lochmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luneau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuerch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yifru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurcher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallou, F.</span></span> <span> </span><span class="NLM_article-title">Development of a Cyclosporin A Derivative with Excellent Anti-Hepatitis C Virus Potency</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmc.2017.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28919180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFSrs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=957-969&issue=4&author=J.+Fuauthor=C.+Beckerauthor=L.+Caoauthor=M.+Capparelliauthor=R.+Denayauthor=R.+Fujimotoauthor=Y.+Gaiauthor=Z.+Gaoauthor=C.+Guenatauthor=S.+Karurauthor=H.+Kimauthor=W.+Liauthor=X.+Liauthor=W.+Liauthor=T.+Lochmannauthor=A.+Luauthor=P.+Luauthor=A.+Luneauauthor=N.+Meierauthor=W.+Mergoauthor=S.+Ngauthor=D.+Parkerauthor=Y.+Pengauthor=B.+Rissauthor=A.+Rivkinauthor=S.+Roggoauthor=H.+Schroederauthor=F.+Schuerchauthor=R.+L.+Simmonsauthor=F.+Sunauthor=Z.+K.+Sweeneyauthor=M.+Tjandraauthor=M.+Wangauthor=R.+Wangauthor=A.+H.+Weissauthor=N.+Wengerauthor=Q.+Wuauthor=X.+Xiongauthor=S.+Xuauthor=W.+Xuauthor=A.+Yifruauthor=J.+Zhaoauthor=J.+Zhouauthor=C.+Zurcherauthor=F.+Gallou&title=Development+of+a+Cyclosporin+A+Derivative+with+Excellent+Anti-Hepatitis+C+Virus+Potency&doi=10.1016%2Fj.bmc.2017.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potency</span></div><div class="casAuthors">Fu, Jiping; Becker, Christopher; Cao, Li; Capparelli, Michael; Denay, Regis; Fujimoto, Roger; Gai, Yu; Gao, Zhaobo; Guenat, Christian; Karur, Subramanian; Kim, Hongyong; Li, Weikuan; Li, Xiaolin; Li, Wei; Lochmann, Thomas; Lu, Amy; Lu, Peichao; Luneau, Alexandre; Meier, Nicole; Mergo, Wosenu; Ng, Simon; Parker, David; Peng, Yunshan; Riss, Bernard; Rivkin, Alexey; Roggo, Silvio; Schroeder, Harald; Schuerch, Friedrich; Simmons, Robert L.; Sun, Feng; Sweeney, Zachary K.; Tjandra, Meiliana; Wang, Michael; Wang, Ruidong; Weiss, Andrew H.; Wenger, Nicolas; Wu, Quanbing; Xiong, Xin; Xu, Su; Xu, Wenjian; Yifru, Aregahegn; Zhao, Jibin; Zhou, Jianguang; Zurcher, Christian; Gallou, Fabrice</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">957-969</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic modification of cyclosporin A at P3-P4 positions led to the discovery of NIM258, a next generation cyclophilin inhibitor with excellent anti-hepatitis C virus potency, with decreased transporter inhibition, and pharmacokinetics suitable for coadministration with other drugs.  Herein is disclosed the evolution of the synthetic strategy to from the original medicinal chem. route, designed for late diversification, to a convergent and robust development synthesis.  The chiral centers in the P4 fragment were constructed by an asym. chelated Claisen rearrangement in the presence of quinidine as the chiral ligand.  Identification of advanced cryst. intermediates enabled practical supply of key intermediates.  Finally, macrocyclization was carried out at 10% wt. concn. by a general and unconventional "slow release" concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiv_fCt-rcP7Vg90H21EOLACvtfcHk0lgtsZnWtuf0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFSrs7jL&md5=e9c4d273d2c88444436a3050a77a2589</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DDenay%26aufirst%3DR.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DGai%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DGuenat%26aufirst%3DC.%26aulast%3DKarur%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLochmann%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DLuneau%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DN.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DRiss%26aufirst%3DB.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DSchroeder%26aufirst%3DH.%26aulast%3DSchuerch%26aufirst%3DF.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTjandra%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DWenger%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DZurcher%26aufirst%3DC.%26aulast%3DGallou%26aufirst%3DF.%26atitle%3DDevelopment%2520of%2520a%2520Cyclosporin%2520A%2520Derivative%2520with%2520Excellent%2520Anti-Hepatitis%2520C%2520Virus%2520Potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D4%26spage%3D957%26epage%3D969%26doi%3D10.1016%2Fj.bmc.2017.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin Cabrejas, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutzi Eme, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Sanglifehrin-Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-Ray Crystal Structure, and Binding Data</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3849</span>– <span class="NLM_lpage">3859</span>, <span class="refDoi"> DOI: 10.1021/ja021327y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja021327y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Oqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=3849-3859&issue=13&author=R.+Sedraniauthor=J.+Kallenauthor=L.+M.+Martin+Cabrejasauthor=C.+D.+Papageorgiouauthor=F.+Seniaauthor=S.+Rohrbachauthor=D.+Wagnerauthor=B.+Thaiauthor=A.+M.+Jutzi+Emeauthor=J.+Franceauthor=L.+Obererauthor=G.+Rihsauthor=G.+Zenkeauthor=J.+Wagner&title=Sanglifehrin-Cyclophilin+Interaction%3A+Degradation+Work%2C+Synthetic+Macrocyclic+Analogues%2C+X-Ray+Crystal+Structure%2C+and+Binding+Data&doi=10.1021%2Fja021327y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Sanglifehrin-Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray Crystal Structure, and Binding Data</span></div><div class="casAuthors">Sedrani, Richard; Kallen, Joerg; Cabrejas, Luisa M. Martin; Papageorgiou, Charles D.; Senia, Francesco; Rohrbach, Stefan; Wagner, Dieter; Thai, Binh; Eme, Anne-Marie Jutzi; France, Julien; Oberer, Lukas; Rihs, Grety; Zenke, Gerhard; Wagner, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3849-3859</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sanglifehrin A (SFA) is a novel immunosuppressive natural product isolated from Streptomyces sp. A92-308110.  SFA has a very strong affinity for cyclophilin A (IC50 = 6.9±0.9 nM) but is structurally different from cyclosporin A (CsA) and exerts its immunosuppressive activity via a novel mechanism.  SFA has a complex mol. structure consisting of a 22-membered macrocycle, bearing in position 23 a nine-carbon tether terminated by a highly substituted spirobicyclic moiety.  Selective oxidative cleavage of the C26:C27 exocyclic double bond affords the spirolactam contg. fragment (I) and macrolide (II).  The affinity of II for cyclophilin (IC50 = 29±2.1 nM) is essentially identical to SFA, which indicates that the interaction between SFA and cyclophilin A is mediated exclusively by the macrocyclic portion of the mol.  This observation was confirmed by the x-ray crystal structure resolved at 2.1 Å of cyclophilin A complexed to macrolide (III), a close analog of II.  The x-ray crystal structure showed that macrolide III binds to the same deep hydrophobic pocket of cyclophilin A as CsA.  Addnl. valuable details of the structure-activity relation were obtained by two different chem. approaches: (1) degrdn. work on macrolide II or (2) synthesis of a library of macrolide analogs using the ring-closing metathesis reaction as the key step.  Altogether, it appears that the complex macrocyclic fragment of SFA is a highly optimized combination of multiple functionalities including an (E,E)-diene, a short polypropionate fragment, and an unusual tripeptide unit, which together provide an extremely strong affinity for cyclophilin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC0LnYEI6dN7Vg90H21EOLACvtfcHk0lhZsfSL4OwJeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Oqsbo%253D&md5=4e474f008fc663b5ceefb3f8a027d81f</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fja021327y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja021327y%26sid%3Dliteratum%253Aachs%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMartin%2BCabrejas%26aufirst%3DL.%2BM.%26aulast%3DPapageorgiou%26aufirst%3DC.%2BD.%26aulast%3DSenia%26aufirst%3DF.%26aulast%3DRohrbach%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DThai%26aufirst%3DB.%26aulast%3DJutzi%2BEme%26aufirst%3DA.%2BM.%26aulast%3DFrance%26aufirst%3DJ.%26aulast%3DOberer%26aufirst%3DL.%26aulast%3DRihs%26aufirst%3DG.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DSanglifehrin-Cyclophilin%2520Interaction%253A%2520Degradation%2520Work%252C%2520Synthetic%2520Macrocyclic%2520Analogues%252C%2520X-Ray%2520Crystal%2520Structure%252C%2520and%2520Binding%2520Data%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26issue%3D13%26spage%3D3849%26epage%3D3859%26doi%3D10.1021%2Fja021327y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 A Resolution</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">21965</span>– <span class="NLM_lpage">21971</span>, <span class="refDoi"> DOI: 10.1074/jbc.M501623200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M501623200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15772070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksl2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=21965-21971&issue=23&author=J.+Kallenauthor=R.+Sedraniauthor=G.+Zenkeauthor=J.+Wagner&title=Structure+of+Human+Cyclophilin+A+in+Complex+with+the+Novel+Immunosuppressant+Sanglifehrin+A+at+1.6+A+Resolution&doi=10.1074%2Fjbc.M501623200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 Å Resolution</span></div><div class="casAuthors">Kallen, Joerg; Sedrani, Richard; Zenke, Gerhard; Wagner, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">21965-21971</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sanglifehrin A (SFA) is a novel immunosuppressant isolated from Streptomyces sp. that binds strongly to the human immunophilin cyclophilin A (CypA).  SFA exerts its immunosuppressive activity through a mode of action different from that of all other known immunophilin-binding substances, namely cyclosporine A (CsA), FK506, and rapamycin.  The authors have detd. the crystal structure of human CypA in complex with SFA at 1.6 Å resoln.  The high resoln. of the structure revealed the abs. configuration at all 17 chiral centers of SFA as well as the details of the CypA/SFA interactions.  In particular, it was shown that the 22-membered macrocycle of SFA is deeply embedded in the same binding site as CsA and forms six direct hydrogen bonds with CypA.  The effector domain of SFA, on the other hand, has a chem. and three-dimensional structure very different from CsA, already strongly suggesting different immunosuppressive mechanisms.  Furthermore, two CypA·SFA complexes form a dimer in the crystal as well as in soln. as shown by light scattering and size exclusion chromatog. expts.  This observation raises the possibility that the dimer of CypA·SFA complexes is the mol. species mediating the immunosuppressive effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQPAV1em05LVg90H21EOLACvtfcHk0lhZsfSL4OwJeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksl2hs7s%253D&md5=252fd4e34c59eefa8276fda3c61012db</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501623200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501623200%26sid%3Dliteratum%253Aachs%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520Human%2520Cyclophilin%2520A%2520in%2520Complex%2520with%2520the%2520Novel%2520Immunosuppressant%2520Sanglifehrin%2520A%2520at%25201.6%2520A%2520Resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D23%26spage%3D21965%26epage%3D21971%26doi%3D10.1074%2Fjbc.M501623200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Immecke, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechtel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoche, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackstein, H.</span></span> <span> </span><span class="NLM_article-title">The Cyclophilin-Binding Agent Sanglifehrin A is a Dendritic Cell Chemokine and Migration Inhibitor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e18406</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0018406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pone.0018406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21483789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVeltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18406&issue=3&author=S.+N.+Immeckeauthor=N.+Baalauthor=J.+Wilhelmauthor=J.+Bechtelauthor=A.+Knocheauthor=G.+Beinauthor=H.+Hackstein&title=The+Cyclophilin-Binding+Agent+Sanglifehrin+A+is+a+Dendritic+Cell+Chemokine+and+Migration+Inhibitor&doi=10.1371%2Fjournal.pone.0018406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor</span></div><div class="casAuthors">Immecke, Sabrina N.; Baal, Nelli; Wilhelm, Jochen; Bechtel, Juliane; Knoche, Angela; Bein, Gregor; Hackstein, Holger</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e18406</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Sanglifehrin A (SFA) is a cyclophilin-binding immunosuppressant but the immunobiol. of action is poorly understood.  We and others have reported that SFA inhibits IL-12 prodn. and antigen uptake in dendritic cells (DC) and exhibits lower activity against lymphocytes.  Here we show that SFA suppresses DC chemokine prodn. and migration.  Gene expression anal. and subsequent protein level confirmation revealed that SFA suppressed CCL5, CCL17, CCL19, CXCL9 and CXCL10 expression in human monocyte-derived DC (moDC).  A systems biol. anal., Onto Express, confirmed that SFA interferes with chemokine-chemokine receptor gene expression with the highest impact.  Direct comparison with the related agent cyclosporine A (CsA) and dexamethasone indicated that SFA uniquely suppresses moDC chemokine expression.  Competitive expts. with a 100-fold molar excess of CsA and with N-methyl-val-4-cyclosporin, representing a nonimmunosuppressive deriv. of CsA indicated chemokine suppression through a cyclophilin-A independent pathway.  Functional assays confirmed reduced migration of CD4+ Tcells and moDCs to supernatant of SFA-exposed moDCs.  Vice versa, SFA-exposed moDC exhibited reduced migration against CCL19.  Moreover, SFA suppressed expression of the ectoenzyme CD38 that was reported to regulate DC migration and cytokine prodn.  These results identify SFA as a DC chemokine and migration inhibitor and provide novel insight into the immunobiol. of SFA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob5W8lLIjWLLVg90H21EOLACvtfcHk0lj_EvNKhftCCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVeltLY%253D&md5=ecb412e2f51e18127acb196d74983123</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0018406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0018406%26sid%3Dliteratum%253Aachs%26aulast%3DImmecke%26aufirst%3DS.%2BN.%26aulast%3DBaal%26aufirst%3DN.%26aulast%3DWilhelm%26aufirst%3DJ.%26aulast%3DBechtel%26aufirst%3DJ.%26aulast%3DKnoche%26aufirst%3DA.%26aulast%3DBein%26aufirst%3DG.%26aulast%3DHackstein%26aufirst%3DH.%26atitle%3DThe%2520Cyclophilin-Binding%2520Agent%2520Sanglifehrin%2520A%2520is%2520a%2520Dendritic%2520Cell%2520Chemokine%2520and%2520Migration%2520Inhibitor%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3De18406%26doi%3D10.1371%2Fjournal.pone.0018406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strittmatter, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesniaux, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanglier, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehr, T.</span></span> <span> </span><span class="NLM_article-title">Sanglifehrin A, a Novel Cyclophilin-Binding Compound Showing Immunosuppressive Activity with a New Mechanism of Action</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>166</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">7165</span>– <span class="NLM_lpage">7171</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.166.12.7165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.4049%2Fjimmunol.166.12.7165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11390463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=7165-7171&issue=12&author=G.+Zenkeauthor=U.+Strittmatterauthor=S.+Fuchsauthor=V.+F.+Quesniauxauthor=V.+Brinkmannauthor=W.+Schulerauthor=M.+Zuriniauthor=A.+Enzauthor=A.+Billichauthor=J.+J.+Sanglierauthor=T.+Fehr&title=Sanglifehrin+A%2C+a+Novel+Cyclophilin-Binding+Compound+Showing+Immunosuppressive+Activity+with+a+New+Mechanism+of+Action&doi=10.4049%2Fjimmunol.166.12.7165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action</span></div><div class="casAuthors">Zenke, Gerhard; Strittmatter, Ulrike; Fuchs, Serge; Quesniaux, Valerie F. J.; Brinkmann, Volker; Schuler, Walter; Zurini, Mauro; Enz, Albert; Billich, Andreas; Sanglier, Jean-Jacques; Fehr, Theo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7165-7171</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The authors report here on the characterization of the novel immunosuppressant Sanglifehrin A (SFA).  SFA is a representative of a class of macrolides produced by actinomycetes that bind to cyclophilin A (CypA), the binding protein of the fungal cyclic peptide cyclosporin A (CsA).  SFA interacts with high affinity with the CsA binding side of CypA and inhibits its peptidyl-prolyl isomerase activity.  The mode of action of SFA is different from known immunosuppressive drugs.  It has no effect on the phosphatase activity of calcineurin, the target of the immunosuppressants CsA and FK506 when complexed to their binding proteins CypA and FK binding protein, resp.  Moreover, its effects are independent of binding of cyclophilin.  SFA inhibits alloantigen-stimulated T cell proliferation but acts at a later stage than CsA and FK506.  In contrast to these drugs, SFA does not affect IL-2 transcription or secretion.  However, it blocks IL-2-dependent proliferation and cytokine prodn. of T cells, in this respect resembling rapamycin.  SFA inhibits the proliferation of mitogen-activated B cells, but, unlike rapamycin, it has no effect on CD154/IL-4-induced Ab synthesis.  The activity of SFA is also different from that of other known late-acting immunosuppressants, e.g., mycophenolate mofetil or brequinar, as it does not affect de novo purine and pyrimidine biosynthesis.  In summary, the authors have identified a novel immunosuppressant, which represents, in addn. to CsA, FK506 and rapamycin, a fourth class of immunophilin-binding metabolites with a new, yet undefined mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0KrU7iDIlLLVg90H21EOLACvtfcHk0lj_EvNKhftCCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOntb0%253D&md5=b792dd757a17b1aa62e422080d27a6a3</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.166.12.7165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.166.12.7165%26sid%3Dliteratum%253Aachs%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DStrittmatter%26aufirst%3DU.%26aulast%3DFuchs%26aufirst%3DS.%26aulast%3DQuesniaux%26aufirst%3DV.%2BF.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DSchuler%26aufirst%3DW.%26aulast%3DZurini%26aufirst%3DM.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DSanglier%26aufirst%3DJ.%2BJ.%26aulast%3DFehr%26aufirst%3DT.%26atitle%3DSanglifehrin%2520A%252C%2520a%2520Novel%2520Cyclophilin-Binding%2520Compound%2520Showing%2520Immunosuppressive%2520Activity%2520with%2520a%2520New%2520Mechanism%2520of%2520Action%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D166%26issue%3D12%26spage%3D7165%26epage%3D7171%26doi%3D10.4049%2Fjimmunol.166.12.7165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaither, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabanis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joberty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baryza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">Multiple Cyclophilins Involved in Different Cellular Pathways Mediate HCV Replication</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>397</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2009.10.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.virol.2009.10.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19932913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2010&pages=43-55&issue=1&author=L.+A.+Gaitherauthor=J.+Borawskiauthor=L.+J.+Andersonauthor=K.+A.+Balabanisauthor=P.+Devayauthor=G.+Jobertyauthor=C.+Rauauthor=M.+Schirleauthor=T.+Bouwmeesterauthor=C.+Mickaninauthor=S.+Zhaoauthor=C.+Vickersauthor=L.+Leeauthor=G.+Dengauthor=J.+Baryzaauthor=R.+A.+Fujimotoauthor=K.+Linauthor=T.+Comptonauthor=B.+Wiedmann&title=Multiple+Cyclophilins+Involved+in+Different+Cellular+Pathways+Mediate+HCV+Replication&doi=10.1016%2Fj.virol.2009.10.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple cyclophilins involved in different cellular pathways mediate HCV replication</span></div><div class="casAuthors">Gaither, L. Alex; Borawski, Jason; Anderson, Leah J.; Balabanis, Kara A.; Devay, Piroska; Joberty, Gerard; Rau, Christina; Schirle, Markus; Bouwmeester, Tewis; Mickanin, Craig; Zhao, Shan Chuan; Vickers, Chad; Lee, Lac; Deng, Gejing; Baryza, Jeremy; Fujimoto, Roger A.; Lin, Kai; Compton, Teresa; Wiedmann, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-55</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three cyclophilin inhibitors (DEBIO-025, SCY635, and NIM811) are currently in clin. trials for hepatitis C therapy.  The mechanism of action of these, however, is not completely understood.  There are at least 16 cyclophilins expressed in human cells which are involved in a diverse set of cellular processes.  Large-scale siRNA expts., chemoproteomic assays with cyclophilin binding compds., and mRNA profiling of HCV replicon contg. cells were used to identify the cyclophilins that are instrumental to HCV replication.  The previously reported cyclophilin A was confirmed and addnl. cyclophilin contg. pathways were identified.  Together, the expts. provide strong evidence that NIM811 reduces viral replication by inhibition of multiple cyclophilins and pathways with protein trafficking as the most strongly and persistently affected pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNp3ZT5AY_lrVg90H21EOLACvtfcHk0lic-EKUgfuc8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFejtw%253D%253D&md5=1c440922dff7d216599718deec0cdee2</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2009.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2009.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DGaither%26aufirst%3DL.%2BA.%26aulast%3DBorawski%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DBalabanis%26aufirst%3DK.%2BA.%26aulast%3DDevay%26aufirst%3DP.%26aulast%3DJoberty%26aufirst%3DG.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DVickers%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DBaryza%26aufirst%3DJ.%26aulast%3DFujimoto%26aufirst%3DR.%2BA.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DCompton%26aufirst%3DT.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DMultiple%2520Cyclophilins%2520Involved%2520in%2520Different%2520Cellular%2520Pathways%2520Mediate%2520HCV%2520Replication%26jtitle%3DVirology%26date%3D2010%26volume%3D397%26issue%3D1%26spage%3D43%26epage%3D55%26doi%3D10.1016%2Fj.virol.2009.10.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-e-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paeshuyse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piraee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suthar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warneck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B.</span></span> <span> </span><span class="NLM_article-title">Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin Family</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1975</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.1128/AAC.01627-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.01627-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21383094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCls7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=1975-1981&issue=5&author=M.+A.+Gregoryauthor=M.+Bobardtauthor=S.+Obeidauthor=U.+Chatterjiauthor=N.+J.+Coatesauthor=T.+Fosterauthor=P.+Gallayauthor=P.+Leyssenauthor=S.+J.+Mossauthor=J.+Neytsauthor=M.+Nur-e-Alamauthor=J.+Paeshuyseauthor=M.+Piraeeauthor=D.+Sutharauthor=T.+Warneckauthor=M.+Q.+Zhangauthor=B.+Wilkinson&title=Preclinical+Characterization+of+Naturally+Occurring+Polyketide+Cyclophilin+Inhibitors+from+the+Sanglifehrin+Family&doi=10.1128%2FAAC.01627-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family</span></div><div class="casAuthors">Gregory, Matthew A.; Bobardt, Michael; Obeid, Susan; Chatterji, Udayan; Coates, Nigel J.; Foster, Teresa; Gallay, Philippe; Leyssen, Pieter; Moss, Steven J.; Neyts, Johan; Nur-e-Alam, Mohammad; Paeshuyse, Jan; Piraee, Mahmood; Suthar, Dipen; Warneck, Tony; Zhang, Ming-Qiang; Wilkinson, Barrie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1975-1981</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cyclophilin inhibitors currently in clin. trials for hepatitis C virus (HCV) are all analogs of cyclosporine (CsA).  Sanglifehrins are a group of naturally occurring cyclophilin binding polyketides that are structurally distinct from the cyclosporines and are produced by a microorganism amenable to biosynthetic engineering for lead optimization and large-scale prodn. by fermn.  Preclin. characterization of the potential utility of this class of compds. for the treatment of HCV revealed that the natural sanglifehrins A to D are all more potent than CsA at disrupting formation of the NS5A-CypA, -CypB, and -CypD complexes and at inhibition of CypA, CypB, and CypD isomerase activity.  In particular, sanglifehrin B (SfB) was 30- to 50-fold more potent at inhibiting the isomerase activity of all Cyps tested than CsA and was also shown to be a more potent inhibitor of the 1b subgenomic replicon (50% effective concns. [EC50s] of 0.070 μM and 0.16 μM in Huh 5-2 and Huh 9-13 cells, resp.).  Physicochem. and mouse pharmacokinetic analyses revealed low oral bioavailability (F < 4%) and low soly. (<25 μM), although the half-lives (t1/2) of SfA and SfB in mouse blood after i.v. (i.v.) dosing were long (t1/2 > 5 h).  These data demonstrate that naturally occurring sanglifehrins are suitable lead compds. for the development of novel analogs that are less immunosuppressive and that have improved metab. and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp40pGLgUiK7Vg90H21EOLACvtfcHk0lh_jpd0sW-I4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCls7fN&md5=e17c16ba8040d20c3ff835274a4c1016</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1128%2FAAC.01627-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01627-10%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DM.%2BA.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DObeid%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DCoates%26aufirst%3DN.%2BJ.%26aulast%3DFoster%26aufirst%3DT.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DPaeshuyse%26aufirst%3DJ.%26aulast%3DPiraee%26aufirst%3DM.%26aulast%3DSuthar%26aufirst%3DD.%26aulast%3DWarneck%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DWilkinson%26aufirst%3DB.%26atitle%3DPreclinical%2520Characterization%2520of%2520Naturally%2520Occurring%2520Polyketide%2520Cyclophilin%2520Inhibitors%2520from%2520the%2520Sanglifehrin%2520Family%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26issue%3D5%26spage%3D1975%26epage%3D1981%26doi%3D10.1128%2FAAC.01627-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-e-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suthar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yongsheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warneck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, M. A.</span></span> <span> </span><span class="NLM_article-title">Sangamides, a New Class of Cyclophilin-Inhibiting Host-Targeted Antivirals for Treatment of HCV Infection</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1039/C1MD00227A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1039%2FC1MD00227A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSlt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=944-949&issue=8&author=S.+J.+Mossauthor=M.+Bobardtauthor=P.+Leyssenauthor=N.+Coatesauthor=U.+Chatterjiauthor=X.+Dejianauthor=T.+Fosterauthor=J.+Liuauthor=M.+Nur-e-Alamauthor=D.+Sutharauthor=C.+Yongshengauthor=T.+Warneckauthor=M.-Q.+Zhangauthor=J.+Neytsauthor=P.+Gallayauthor=B.+Wilkinsonauthor=M.+A.+Gregory&title=Sangamides%2C+a+New+Class+of+Cyclophilin-Inhibiting+Host-Targeted+Antivirals+for+Treatment+of+HCV+Infection&doi=10.1039%2FC1MD00227A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection</span></div><div class="casAuthors">Moss, Steven J.; Bobardt, Michael; Leyssen, Pieter; Coates, Nigel; Chatterji, Udayan; Xie, Dejian; Foster, Teresa; Liu, Jinlun; Nur-e-Alam, Mohammad; Suthar, Dipen; Chen, Yongsheng; Warneck, Tony; Zhang, Ming-Qiang; Neyts, Johan; Gallay, Philippe; Wilkinson, Barrie; Gregory, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">944-949</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sangamides are amide derivs. of sanglifehrin A, a cyclophilin-binding polyketide natural product which is structurally distinct from cyclosporine A. Cyclosporine A is the starting point for the synthesis of cyclophilin inhibitors such as alisporivir, currently in development for the treatment of HCV infection.  We report here initial results of the optimization program which led to identification of the sangamides, compds. that exhibit significantly improved potential for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f6CS9dAItbVg90H21EOLACvtfcHk0lh_jpd0sW-I4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSlt7zN&md5=79871e6747c3bc22c875f64b8f6b5ebb</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC1MD00227A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1MD00227A%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DCoates%26aufirst%3DN.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DDejian%26aufirst%3DX.%26aulast%3DFoster%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DSuthar%26aufirst%3DD.%26aulast%3DYongsheng%26aufirst%3DC.%26aulast%3DWarneck%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.-Q.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DGregory%26aufirst%3DM.%2BA.%26atitle%3DSangamides%252C%2520a%2520New%2520Class%2520of%2520Cyclophilin-Inhibiting%2520Host-Targeted%2520Antivirals%2520for%2520Treatment%2520of%2520HCV%2520Infection%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D8%26spage%3D944%26epage%3D949%26doi%3D10.1039%2FC1MD00227A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Belkacem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevers, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cala, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douguet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlotsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J. F.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of a New Family of Non-Peptidic Small-Molecule Cyclophilin Inhibitors with Potent Antiviral Activities</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12777</span>, <span class="refDoi"> DOI: 10.1038/ncomms12777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fncomms12777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27652979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12777&author=A.+Ahmed-Belkacemauthor=L.+Colliandreauthor=N.+Ahnouauthor=Q.+Neversauthor=M.+Gelinauthor=Y.+Bessinauthor=R.+Brilletauthor=O.+Calaauthor=D.+Douguetauthor=W.+Bourguetauthor=I.+Krimmauthor=J.+M.+Pawlotskyauthor=J.+F.+Guichou&title=Fragment-Based+Discovery+of+a+New+Family+of+Non-Peptidic+Small-Molecule+Cyclophilin+Inhibitors+with+Potent+Antiviral+Activities&doi=10.1038%2Fncomms12777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span></div><div class="casAuthors">Ahmed-Belkacem, Abdelhakim; Colliandre, Lionel; Ahnou, Nazim; Nevers, Quentin; Gelin, Muriel; Bessin, Yannick; Brillet, Rozenn; Cala, Olivier; Douguet, Dominique; Bourguet, William; Krimm, Isabelle; Pawlotsky, Jean-Michel; Guichou, Jean- Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12777</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilins are peptidyl-prolyl cis/trans isomerases (PPIase) that catalyze the interconversion of the peptide bond at proline residues.  Several cyclophilins play a pivotal role in the life cycle of a no. of viruses.  The existing cyclophilin inhibitors, all derived from cyclosporine A or sanglifehrin A, have disadvantages, including their size, potential for side effects unrelated to cyclophilin inhibition and drug-drug interactions, unclear antiviral spectrum and manufg. issues.  Here we use a fragment-based drug discovery approach using nucleic magnetic resonance, X-ray crystallog. and structure-based compd. optimization to generate a new family of non-peptidic, small-mol. cyclophilin inhibitors with potent in vitro PPIase inhibitory activity and antiviral activity against hepatitis C virus, human immunodeficiency virus and coronaviruses.  This family of compds. has the potential for broad-spectrum, high-barrier-to-resistance treatment of viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyow1ByjcKUbVg90H21EOLACvtfcHk0ljGqd0LY9N_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO&md5=f984a686b75eea86431cd048f82f11c5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fncomms12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12777%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed-Belkacem%26aufirst%3DA.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DAhnou%26aufirst%3DN.%26aulast%3DNevers%26aufirst%3DQ.%26aulast%3DGelin%26aufirst%3DM.%26aulast%3DBessin%26aufirst%3DY.%26aulast%3DBrillet%26aufirst%3DR.%26aulast%3DCala%26aufirst%3DO.%26aulast%3DDouguet%26aufirst%3DD.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DPawlotsky%26aufirst%3DJ.%2BM.%26aulast%3DGuichou%26aufirst%3DJ.%2BF.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520New%2520Family%2520of%2520Non-Peptidic%2520Small-Molecule%2520Cyclophilin%2520Inhibitors%2520with%2520Potent%2520Antiviral%2520Activities%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12777%26doi%3D10.1038%2Fncomms12777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1007/s11095-011-0564-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2Fs11095-011-0564-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21861202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=411-426&issue=2&author=M.+Karlgrenauthor=G.+Ahlinauthor=C.+A.+Bergstromauthor=R.+Svenssonauthor=J.+Palmauthor=P.+Artursson&title=In+Vitro+and+In+Silico+Strategies+to+Identify+OATP1B1+Inhibitors+and+Predict+Clinical+Drug-Drug+Interactions&doi=10.1007%2Fs11095-011-0564-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions</span></div><div class="casAuthors">Karlgren, Maria; Ahlin, Gustav; Bergstroem, Christel A. S.; Svensson, Richard; Palm, Johan; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">411-426</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To establish in vitro and in silico models that predict clin. drug-drug interactions (DDIs) with the OATP1B1 (SLCO1B1) transporter.  Methods: The inhibitory effect of 146 drugs and drug-like compds. on OATP1B1-mediated transport was studied in HEK293 cells.  A computational model was developed to predict OATP1B1 inhibition.  Concn.-dependent effects were investigated for six compds.; clin. DDIs were predicted by calcg. change in exposure (i.e. R-values) in eight different ways.  Results: Sixty-five compds. were identified as OATP1B1 inhibitors at 20 μM.  The computational model predicted the test set with 80% accuracy for inhibitors and 91% for non-inhibitors.  In vitro-in vivo comparisons underscored the importance of using drugs with known clin. effects as refs.  Thus, ref. drugs, cyclosporin A, gemfibrozil, and fenofibrate, provided an inhibition interval to which three antiviral drugs, atazanavir, lopinavir, and amprenavir, could be compared and their clin. DDIs with OATP1B1 classified.  Conclusions: Twenty-two new OATP1B1 inhibitors were identified, a predictive OATP1B1 inhibition in silico model was developed, and successful predictions of clin. DDIs were obtained with OATP1B1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZVO33bM9iobVg90H21EOLACvtfcHk0lgKZYxEhxm5Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKitrrK&md5=e688f0827c6c046dfe5e6532a17bdc47</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs11095-011-0564-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-011-0564-9%26sid%3Dliteratum%253Aachs%26aulast%3DKarlgren%26aufirst%3DM.%26aulast%3DAhlin%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DC.%2BA.%26aulast%3DSvensson%26aufirst%3DR.%26aulast%3DPalm%26aufirst%3DJ.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Silico%2520Strategies%2520to%2520Identify%2520OATP1B1%2520Inhibitors%2520and%2520Predict%2520Clinical%2520Drug-Drug%2520Interactions%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26issue%3D2%26spage%3D411%26epage%3D426%26doi%3D10.1007%2Fs11095-011-0564-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shore, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandalaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latawiec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javed, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criddle, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, R.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2596</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01801</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01801" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs12jsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2596-2611&issue=6&author=E.+R.+Shoreauthor=M.+Awaisauthor=N.+M.+Kershawauthor=R.+R.+Gibsonauthor=S.+Pandalaneniauthor=D.+Latawiecauthor=L.+Wenauthor=M.+A.+Javedauthor=D.+N.+Criddleauthor=N.+Berryauthor=P.+M.+O%E2%80%99Neillauthor=L.+Y.+Lianauthor=R.+Sutton&title=Small+Molecule+Inhibitors+of+Cyclophilin+D+To+Protect+Mitochondrial+Function+as+a+Potential+Treatment+for+Acute+Pancreatitis&doi=10.1021%2Facs.jmedchem.5b01801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis</span></div><div class="casAuthors">Shore, Emma R.; Awais, Muhammad; Kershaw, Neil M.; Gibson, Robert R.; Pandalaneni, Sravan; Latawiec, Diane; Wen, Li; Javed, Muhammad A.; Criddle, David N.; Berry, Neil; O'Neill, Paul M.; Lian, Lu-Yun; Sutton, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2596-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Opening of the mitochondrial permeability transition pore (MPTP) causes mitochondrial dysfunction and necrosis in acute pancreatitis (AP), a condition without specific drug treatment.  Cyclophilin D (CypD) is a mitochondrial matrix peptidyl-prolyl isomerase that regulates the MPTP and is a drug target for AP.  We have synthesized urea-based small mol. inhibitors of cyclophilins and tested them against CypD using binding and isomerase activity assays.  Thermodn. profiles of the CypD/inhibitor interactions were detd. by isothermal titrn. calorimetry.  Seven new high-resoln. crystal structures of CypD-inhibitor complexes were obtained to guide compd. optimization.  Compds. 4, 13, 14, and 19 were tested in freshly isolated murine pancreatic acinar cells (PACs) to det. inhibition of toxin-induced loss of mitochondrial membrane potential (ΔΨm) and necrotic cell death pathway activation.  Compd. 19 was found to have a Kd of 410 nM and a favorable thermodn. profile, and it showed significant protection of ΔΨm and reduced necrosis of murine as well as human PACs.  Compd. 19 holds significant promise for future lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOALCctyBii7Vg90H21EOLACvtfcHk0lh0AGlvhm9rrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs12jsLg%253D&md5=fb9489a647a3f30978a9be44ea36a9fe</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01801%26sid%3Dliteratum%253Aachs%26aulast%3DShore%26aufirst%3DE.%2BR.%26aulast%3DAwais%26aufirst%3DM.%26aulast%3DKershaw%26aufirst%3DN.%2BM.%26aulast%3DGibson%26aufirst%3DR.%2BR.%26aulast%3DPandalaneni%26aufirst%3DS.%26aulast%3DLatawiec%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DJaved%26aufirst%3DM.%2BA.%26aulast%3DCriddle%26aufirst%3DD.%2BN.%26aulast%3DBerry%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DLian%26aufirst%3DL.%2BY.%26aulast%3DSutton%26aufirst%3DR.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Cyclophilin%2520D%2520To%2520Protect%2520Mitochondrial%2520Function%2520as%2520a%2520Potential%2520Treatment%2520for%2520Acute%2520Pancreatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2596%26epage%3D2611%26doi%3D10.1021%2Facs.jmedchem.5b01801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malone, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wear, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florance, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barran, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkinshaw, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, N. J.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Conformationally Constrained Cyclophilin Inhibitors Showing a Cyclosporin-A Phenotype in C. elegans</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1002/cbic.201000413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fcbic.201000413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21337480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=802-810&issue=5&author=C.+J.+Dunsmoreauthor=K.+J.+Maloneauthor=K.+R.+Baileyauthor=M.+A.+Wearauthor=H.+Floranceauthor=S.+Shirranauthor=P.+E.+Barranauthor=A.+P.+Pageauthor=M.+D.+Walkinshawauthor=N.+J.+Turner&title=Design+and+Synthesis+of+Conformationally+Constrained+Cyclophilin+Inhibitors+Showing+a+Cyclosporin-A+Phenotype+in+C.+elegans&doi=10.1002%2Fcbic.201000413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Conformationally Constrained Cyclophilin Inhibitors Showing a Cyclosporin-A Phenotype in C. elegans</span></div><div class="casAuthors">Dunsmore, Colin J.; Malone, Kirk J.; Bailey, Kevin R.; Wear, Martin A.; Florance, Hannah; Shirran, Sally; Barran, Perdita E.; Page, Antony P.; Walkinshaw, Malcolm D.; Turner, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">802-810</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cyclophilin A (CypA) is a member of the immunophilin family of proteins and receptor for the immunosuppressant drug cyclosporin A (CsA).  Here we describe the design and synthesis of a new class of small-mol. inhibitors for CypA that are based upon a dimedone template.  Electrospray mass spectrometry is utilized as an initial screen to quantify the protein affinity of the ligands.  Active inhibitors and fluorescently labeled derivs. are then used as chem. probes for investigating the biol. role of cyclophilins in the nematode Caenorhabditis elegans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd10HS1yxA9bVg90H21EOLACvtfcHk0lh0AGlvhm9rrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGgs7c%253D&md5=adf1ec2723731749ded3d233295354c0</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201000413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201000413%26sid%3Dliteratum%253Aachs%26aulast%3DDunsmore%26aufirst%3DC.%2BJ.%26aulast%3DMalone%26aufirst%3DK.%2BJ.%26aulast%3DBailey%26aufirst%3DK.%2BR.%26aulast%3DWear%26aufirst%3DM.%2BA.%26aulast%3DFlorance%26aufirst%3DH.%26aulast%3DShirran%26aufirst%3DS.%26aulast%3DBarran%26aufirst%3DP.%2BE.%26aulast%3DPage%26aufirst%3DA.%2BP.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DTurner%26aufirst%3DN.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Conformationally%2520Constrained%2520Cyclophilin%2520Inhibitors%2520Showing%2520a%2520Cyclosporin-A%2520Phenotype%2520in%2520C.%2520elegans%26jtitle%3DChemBioChem%26date%3D2011%26volume%3D12%26issue%3D5%26spage%3D802%26epage%3D810%26doi%3D10.1002%2Fcbic.201000413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavanieu, A.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design, Synthesis, and Biological Evaluation of Novel Inhibitors of Human Cyclophilin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">900</span>– <span class="NLM_lpage">910</span>, <span class="refDoi"> DOI: 10.1021/jm050716a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050716a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=900-910&issue=3&author=J.+F.+Guichouauthor=J.+Viaudauthor=C.+Mettlingauthor=G.+Subraauthor=Y.+L.+Linauthor=A.+Chavanieu&title=Structure-Based+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+Inhibitors+of+Human+Cyclophilin+A&doi=10.1021%2Fjm050716a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A</span></div><div class="casAuthors">Guichou, Jean-Francois; Viaud, Julien; Mettling, Clement; Subra, Guy; Lin, Yea-Lih; Chavanieu, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">900-910</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclophilin A is involved in many cellular processes, including protein folding and intracellular transports.  Because cyclophilin A has been shown to interact with HIV-1 gag proteins and to enhance the viral infectivity, nonimmunosuppressive cyclophilin A ligands may represent a new class of therapeutic agents against HIV.  In this paper, a virtual screening using structure- and pharmacophore-based design to identify original nonpeptidic cyclophilin ligands is reported.  Following a lead identification of compds. 1-(3-benzyloxypyridin-2-yl)-3-(3-chlorophenyl)urea [I; R1 = H, R2 = Cl (II)] and 1-(3-benzyloxypyridin-2-yl)-3-(3-trifluoromethylphenyl)urea [I; R1 = H, R2 = CF3 (III)] (IC50 = 0.3 μM), a series of mols. were synthesized from a diarylurea scaffold and evaluated for their in vitro ability to inhibit the cis-trans isomerase activity of cyclophilin A.  Mol. modifications provided several more potent compds., in particular analogs I (R1 = NO2, R2 = H) and I (R1 = CO2Et, R2 = H) with IC50 of 14 and 20 nM, resp.  Then, the effect of analogs II and III (R1 = H, R2 = CF3) on HIV virion infectivity in both immortalized and primary cells was evaluated.  Both II and III reduced virion infectivity in the replication-defective one-round infection assay, but only II impaired wild-type HIV infection in human peripheral blood mononuclear cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2EkYyZ2-5HbVg90H21EOLACvtfcHk0ljcHBr6iN7T8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGnsw%253D%253D&md5=c8afc21956e023e7950007e7a06da51e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm050716a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050716a%26sid%3Dliteratum%253Aachs%26aulast%3DGuichou%26aufirst%3DJ.%2BF.%26aulast%3DViaud%26aufirst%3DJ.%26aulast%3DMettling%26aufirst%3DC.%26aulast%3DSubra%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DY.%2BL.%26aulast%3DChavanieu%26aufirst%3DA.%26atitle%3DStructure-Based%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Inhibitors%2520of%2520Human%2520Cyclophilin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D3%26spage%3D900%26epage%3D910%26doi%3D10.1021%2Fjm050716a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using De Novo Drug Design Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5295</span>– <span class="NLM_lpage">5298</span>, <span class="refDoi"> DOI: 10.1021/jm9008295</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9008295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5295-5298&issue=17&author=S.+Niauthor=Y.+Yuanauthor=J.+Huangauthor=X.+Maoauthor=M.+Lvauthor=J.+Zhuauthor=X.+Shenauthor=J.+Peiauthor=L.+Laiauthor=H.+Jiangauthor=J.+Li&title=Discovering+Potent+Small+Molecule+Inhibitors+of+Cyclophilin+A+Using+De+Novo+Drug+Design+Approach&doi=10.1021%2Fjm9008295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach</span></div><div class="casAuthors">Ni, Shuaishuai; Yuan, Yaxia; Huang, Jin; Mao, Xiaona; Lv, Maosheng; Zhu, Jin; Shen, Xu; Pei, Jianfeng; Lai, Luhua; Jiang, Hualiang; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5295-5298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work describes an integrated approach of de novo drug design, chem. synthesis, and bioassay for quick identification of a series of novel small mol. cyclophilin A (CypA) inhibitors (1-3).  The activities of the two most potent CypA inhibitors, 3h and 3i (I) are 2.59 and 1.52 nM, resp., which are about 16 and 27 times more potent than that of cyclosporin A.  This study clearly demonstrates the power of our de novo drug design strategy and the related program LigBuilder 2.0 in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8NECkXQBFc7Vg90H21EOLACvtfcHk0ljcHBr6iN7T8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3K&md5=efed32e984fc74810f9d110dbeb94616</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm9008295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008295%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovering%2520Potent%2520Small%2520Molecule%2520Inhibitors%2520of%2520Cyclophilin%2520A%2520Using%2520De%2520Novo%2520Drug%2520Design%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D17%26spage%3D5295%26epage%3D5298%26doi%3D10.1021%2Fjm9008295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücknagel, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Confirmation of the Existence of a Third Family Among Peptidyl-Prolyl Cis/Trans Isomerases. Amino Acid Sequence and Recombinant Production of Parvulin</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>352</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(94)00932-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0014-5793%2894%2900932-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7925971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXhtFKhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1994&pages=180-184&issue=2&author=J.-U.+Rahfeldauthor=K.+P.+R%C3%BCcknagelauthor=B.+Schelbertauthor=B.+Ludwigauthor=J.+Hackerauthor=K.+Mannauthor=G.+Fischer&title=Confirmation+of+the+Existence+of+a+Third+Family+Among+Peptidyl-Prolyl+Cis%2FTrans+Isomerases.+Amino+Acid+Sequence+and+Recombinant+Production+of+Parvulin&doi=10.1016%2F0014-5793%2894%2900932-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin</span></div><div class="casAuthors">Rahfeld, Jens-U.; Ruecknagel, Karl Peter; Schelbert, Birte; Ludwig, Birgit; Hacker, Joerg; Mann, Karlheinz; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">In addn. to the major cyclophilin-like peptidyl-prolyl cis/trans isomerases (PPIases) of Escherichia coli, an enzyme of very low relative mol. mass (10.1 kDa) was discovered in this organism which gave first indication of the existence of a novel family in this enzyme class.  In the present report, the chem. detd. amino acid sequence was detd. of 4 peptides derived from the 10.1-kDa protein by the treatment with either CNBr or endoproteinase Lys-C.  Together with a continuous run of 75 amino acids starting N-terminally, the sequence of the mature enzyme, 92 residues in length, was elucidated.  Cloning and detn. of the primary structure of a DNA fragment encoding this enzyme were also performed.  Overexpression of the enzyme by using multicopies of plasmid pSEP38 in E. coli and detecting an enhanced PPIase activity attributed to the 10.1-kDa enzyme provided addnl. proof that the 92 amino acid protein was a PPIase.  The enzyme was called parvulin (lat.: parvulus, very small).  Homol. analyses indicated that several parvulin-like proteins could be found in the database screened.  To further elucidate the functional role of PPIases it might be of some importance that homologous proteins like the PrtM protein of Lactococcus lactis and the PrsA lipoprotein of Bacillus subtilis are known to be involved in the protein export and maturation machinery of the bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc9vnyB0ZGpLVg90H21EOLACvtfcHk0ljcHBr6iN7T8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtFKhtbg%253D&md5=55ab2bfff124990da4341b27d76f453a</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900932-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900932-5%26sid%3Dliteratum%253Aachs%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26aulast%3DR%25C3%25BCcknagel%26aufirst%3DK.%2BP.%26aulast%3DSchelbert%26aufirst%3DB.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DMann%26aufirst%3DK.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DConfirmation%2520of%2520the%2520Existence%2520of%2520a%2520Third%2520Family%2520Among%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases.%2520Amino%2520Acid%2520Sequence%2520and%2520Recombinant%2520Production%2520of%2520Parvulin%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D352%26issue%3D2%26spage%3D180%26epage%3D184%26doi%3D10.1016%2F0014-5793%2894%2900932-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matern, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barion, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens-Kneip, S.</span></span> <span> </span><span class="NLM_article-title">PpiD is a Player in the Network of Periplasmic Chaperones in Escherichia coli</span>. <i>BMC Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">251</span>, <span class="refDoi"> DOI: 10.1186/1471-2180-10-251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1186%2F1471-2180-10-251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20920237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC3cbgt1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=251&issue=1&author=Y.+Maternauthor=B.+Barionauthor=S.+Behrens-Kneip&title=PpiD+is+a+Player+in+the+Network+of+Periplasmic+Chaperones+in+Escherichia+coli&doi=10.1186%2F1471-2180-10-251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">PpiD is a player in the network of periplasmic chaperones in Escherichia coli</span></div><div class="casAuthors">Matern Yvonne; Barion Birgitta; Behrens-Kneip Susanne</div><div class="citationInfo"><span class="NLM_cas:title">BMC microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">251</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The inner membrane-anchored periplasmic folding factor PpiD is described as a parvulin-like peptidyl prolyl isomerase (PPIase) that assists in the maturation of the major beta-barrel outer membrane proteins (OMPs) of Escherichia coli.  More recent work however, calls these findings into question.  Here, we re-examined the role of PpiD in the E. coli periplasm by analyzing its functional interplay with other folding factors that influence OMP maturation as well as general protein folding in the periplasmic compartment of the cell, such as SurA, Skp, and DegP.  RESULTS:  The analysis of the effects of both deletion and overexpression of ppiD on cell envelope phenotypes revealed that PpiD in contrast to prior observations plays only a minor role, if any, in the maturation of OMPs and cannot compensate for the lack of SurA in the periplasm.  On the other hand, our results show that overproduction of PpiD rescues a surA skp double mutant from lethality.  In the presence of increased PpiD levels surA skp cells show reduced activities of both the SigmaE-dependent and the Cpx envelope stress responses, and contain increased amounts of folded species of the major OMP OmpA.  These effects require the anchoring of PpiD in the inner membrane but are independent of its parvulin-like PPIase domain.  Moreover, a PpiD protein lacking the PPIase domain also complements the growth defects of an fkpA ppiD surA triple PPIase mutant and exhibits chaperone activity in vitro.  In addition, PpiD appears to collaborate with DegP, as deletion of ppiD confers a temperature-dependent conditional synthetic phenotype in a degP mutant.  CONCLUSIONS:  This study provides first direct evidence that PpiD functions as a chaperone and contributes to the network of periplasmic chaperone activities without being specifically involved in OMP maturation.  Consistent with previous work, our data support a model in which the chaperone function of PpiD is used to aid in the early periplasmic folding of many newly translocated proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqfTKufo_Bisve_zCu79I8fW6udTcc2eb4mpQW_aFr2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbgt1KhsQ%253D%253D&md5=4a2d9e385c12d3adace9c7153b5b4be8</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1186%2F1471-2180-10-251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2180-10-251%26sid%3Dliteratum%253Aachs%26aulast%3DMatern%26aufirst%3DY.%26aulast%3DBarion%26aufirst%3DB.%26aulast%3DBehrens-Kneip%26aufirst%3DS.%26atitle%3DPpiD%2520is%2520a%2520Player%2520in%2520the%2520Network%2520of%2520Periplasmic%2520Chaperones%2520in%2520Escherichia%2520coli%26jtitle%3DBMC%2520Microbiol.%26date%3D2010%26volume%3D10%26issue%3D1%26spage%3D251%26doi%3D10.1186%2F1471-2180-10-251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volokhina, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grijpstra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stork, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilders, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommassen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M. P.</span></span> <span> </span><span class="NLM_article-title">Role of the Periplasmic Chaperones Skp, SurA, and DegQ in Outer Membrane Protein Biogenesis in Neisseria meningitidis</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1621</span>, <span class="refDoi"> DOI: 10.1128/JB.00532-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.00532-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21296967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVyrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2011&pages=1612-1621&issue=7&author=E.+B.+Volokhinaauthor=J.+Grijpstraauthor=M.+Storkauthor=I.+Schildersauthor=J.+Tommassenauthor=M.+P.+Bos&title=Role+of+the+Periplasmic+Chaperones+Skp%2C+SurA%2C+and+DegQ+in+Outer+Membrane+Protein+Biogenesis+in+Neisseria+meningitidis&doi=10.1128%2FJB.00532-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the periplasmic chaperones Skp, SurA, and DegO in outer membrane protein biogenesis in Neisseria meningitidis</span></div><div class="casAuthors">Volokhina, Elena B.; Grijpstra, Jan; Stork, Michel; Schilders, Ingrid; Tommassen, Jan; Bos, Martine P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1612-1621</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The periplasmic chaperones Skp, SurA, and DegP are implicated in the biogenesis of outer membrane proteins (OMPs) in Escherichia coli.  Here, the authors investigated whether these chaperones exert similar functions in Neisseria meningitidis.  Although N. meningitidis does not contain a homolog of the protease/chaperone DegP, it does possess a homolog of another E. coli protein, DegQ, which can functionally replace DegP when overproduced.  Hence, the authors examd. whether in N. meningitidis, DegQ acts as a functional homolog of DegP.  Single skp, surA, and degQ mutants were easily obtained, showing that none of these chaperones is essential in N. meningitidis.  Furthermore, all combinations of double mutants were generated and no synthetic lethality was obsd.  The absence of SurA or DegQ did not affect OMP biogenesis.  In contrast, the absence of Skp resulted in severely lower levels of the porins PorA and PorB but not of other OMPs.  These decreased levels were not due to proteolytic activity of DegQ, since porin levels remained low in a skp degQ double mutant, indicating that neisserial DegQ is not a functional homolog of E. coli DegP.  The absence of Skp resulted in lower expression of the porB gene, as shown by using a PporBM-lacZ fusion.  The authors found no cross-species complementation when Skp of E. coli or N. meningitidis was heterologously expressed in skp mutants, indicating that Skp functions in a species-specific manner.  The results demonstrate an important role for Skp but not for SurA or DegQ in OMP biogenesis in N. meningitidis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoakBGDj6SWMLVg90H21EOLACvtfcHk0ljtGumnqjIQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVyrtLc%253D&md5=d6de9b7e4b54bbb6af00d71483d713aa</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1128%2FJB.00532-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00532-10%26sid%3Dliteratum%253Aachs%26aulast%3DVolokhina%26aufirst%3DE.%2BB.%26aulast%3DGrijpstra%26aufirst%3DJ.%26aulast%3DStork%26aufirst%3DM.%26aulast%3DSchilders%26aufirst%3DI.%26aulast%3DTommassen%26aufirst%3DJ.%26aulast%3DBos%26aufirst%3DM.%2BP.%26atitle%3DRole%2520of%2520the%2520Periplasmic%2520Chaperones%2520Skp%252C%2520SurA%252C%2520and%2520DegQ%2520in%2520Outer%2520Membrane%2520Protein%2520Biogenesis%2520in%2520Neisseria%2520meningitidis%26jtitle%3DJ.%2520Bacteriol.%26date%3D2011%26volume%3D193%26issue%3D7%26spage%3D1612%26epage%3D1621%26doi%3D10.1128%2FJB.00532-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jousselin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosato, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renzoni, A.</span></span> <span> </span><span class="NLM_article-title">The Staphylococcus aureus Chaperone PrsA is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1656</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1128/AAC.02333-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.02333-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVylsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1656-1666&issue=3&author=A.+Jousselinauthor=C.+Manzanoauthor=A.+Bietteauthor=P.+Reedauthor=M.+G.+Pinhoauthor=A.+E.+Rosatoauthor=W.+L.+Kelleyauthor=A.+Renzoni&title=The+Staphylococcus+aureus+Chaperone+PrsA+is+a+New+Auxiliary+Factor+of+Oxacillin+Resistance+Affecting+Penicillin-Binding+Protein+2A&doi=10.1128%2FAAC.02333-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A</span></div><div class="casAuthors">Jousselin, Ambre; Manzano, Caroline; Biette, Alexandra; Reed, Patricia; Pinho, Mariana G.; Rosato, Adriana E.; Kelley, William L.; Renzoni, Adriana</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1656-1666</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Expression of the methicillin-resistant S. aureus (MRSA) phenotype results from the expression of the extra penicillin-binding protein 2A (PBP2A), which is encoded by mecA and acquired horizontally on part of the SCCmec cassette.  PBP2A can catalyze dd-transpeptidation of peptidoglycan (PG) because of its low affinity for β-lactam antibiotics and can functionally cooperate with the PBP2 transglycosylase in the biosynthesis of PG.  Here, we focus upon the role of the membrane-bound PrsA foldase protein as a regulator of β-lactam resistance expression.  Deletion of prsA altered oxacillin resistance in 3 different SCCmec backgrounds and, more importantly, caused a decrease in PBP2A membrane amts. without affecting mecA mRNA levels.  The N- and C-terminal domains of PrsA were found to be crit. features for PBP2A protein membrane levels and oxacillin resistance.  We propose that PrsA has a role in posttranscriptional maturation of PBP2A, possibly in the export and(or) folding of newly synthesized PBP2A.  This addnl. level of control in the expression of the mecA-dependent MRSA phenotype constitutes an opportunity to expand the strategies to design anti-infective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKSE_MfdXsP7Vg90H21EOLACvtfcHk0ljtGumnqjIQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVylsLc%253D&md5=faafbead601eaa7f6b703f0bf44913e4</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1128%2FAAC.02333-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02333-15%26sid%3Dliteratum%253Aachs%26aulast%3DJousselin%26aufirst%3DA.%26aulast%3DManzano%26aufirst%3DC.%26aulast%3DBiette%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DP.%26aulast%3DPinho%26aufirst%3DM.%2BG.%26aulast%3DRosato%26aufirst%3DA.%2BE.%26aulast%3DKelley%26aufirst%3DW.%2BL.%26aulast%3DRenzoni%26aufirst%3DA.%26atitle%3DThe%2520Staphylococcus%2520aureus%2520Chaperone%2520PrsA%2520is%2520a%2520New%2520Auxiliary%2520Factor%2520of%2520Oxacillin%2520Resistance%2520Affecting%2520Penicillin-Binding%2520Protein%25202A%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26issue%3D3%26spage%3D1656%26epage%3D1666%26doi%3D10.1128%2FAAC.02333-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jousselin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renzoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrey, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monod, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, W. L.</span></span> <span> </span><span class="NLM_article-title">The Posttranslocational Chaperone Lipoprotein PrsA is Involved in Both Glycopeptide and Oxacillin Resistance in Staphylococcus aureus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3629</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1128/AAC.06264-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.06264-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22526301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3629-3640&issue=7&author=A.+Jousselinauthor=A.+Renzoniauthor=D.+O.+Andreyauthor=A.+Monodauthor=D.+P.+Lewauthor=W.+L.+Kelley&title=The+Posttranslocational+Chaperone+Lipoprotein+PrsA+is+Involved+in+Both+Glycopeptide+and+Oxacillin+Resistance+in+Staphylococcus+aureus&doi=10.1128%2FAAC.06264-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Jousselin, Ambre; Renzoni, Adriana; Andrey, Diego O.; Monod, Antoinette; Lew, Daniel P.; Kelley, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3629-3640</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Understanding in detail the factors which permit Staphylococcus aureus to counteract cell wall-active antibiotics is a prerequisite to elaborating effective strategies to prolong the usefulness of these drugs and define new targets for pharmacol. intervention.  Methicillin-resistant S. aureus (MRSA) strains are major pathogens of hospital-acquired and community-acquired infections and are most often treated with glycopeptides (vancomycin and teicoplanin) because of their resistance to most penicillins and a limited arsenal of clin. proven alternatives.  In this study, we examd. PrsA, a lipid-anchored protein of the parvulin PPIase family (peptidyl-prolyl cis/trans isomerase) found ubiquitously in all Gram-pos. species, in which it assists posttranslocational folding at the outer surface of the cytoplasmic membrane.  We show by both genetic and biochem. assays that prsA is directly regulated by the VraRS two-component sentinel system of cell wall stress.  Disruption of prsA is tolerated by S. aureus, and its loss results in no detectable overt macroscopic changes in cell wall architecture or growth rate under nonstressed growth conditions.  Disruption of prsA leads, however, to notable alterations in the sensitivity to glycopeptides and dramatically decreases the resistance of COL (MRSA) to oxacillin.  Quant. transcriptional anal. reveals that prsA and vraR are coordinately upregulated in a panel of stable lab. and clin. glycopeptide-intermediate S. aureus (GISA) strains compared to their susceptible parents.  Collectively, our results point to a role for prsA as a facultative facilitator of protein secretion or extracellular folding and provide a framework for understanding why prsA is a key element of the VraRS-mediated cell wall stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpShVC4DfeGg7Vg90H21EOLACvtfcHk0lg_ANu7HHNnPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2is74%253D&md5=ddd8851423d51c9e0b7d3c8a419ecbd0</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1128%2FAAC.06264-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06264-11%26sid%3Dliteratum%253Aachs%26aulast%3DJousselin%26aufirst%3DA.%26aulast%3DRenzoni%26aufirst%3DA.%26aulast%3DAndrey%26aufirst%3DD.%2BO.%26aulast%3DMonod%26aufirst%3DA.%26aulast%3DLew%26aufirst%3DD.%2BP.%26aulast%3DKelley%26aufirst%3DW.%2BL.%26atitle%3DThe%2520Posttranslocational%2520Chaperone%2520Lipoprotein%2520PrsA%2520is%2520Involved%2520in%2520Both%2520Glycopeptide%2520and%2520Oxacillin%2520Resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26issue%3D7%26spage%3D3629%26epage%3D3640%26doi%3D10.1128%2FAAC.06264-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span> <span> </span><span class="NLM_article-title">Exoproteome Profiling Reveals the Involvement of the Foldase PrsA in the Cell Surface Properties and Pathogenesis of Staphylococcus aureus</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5–6</span>),  <span class="NLM_fpage">1700195</span>, <span class="refDoi"> DOI: 10.1002/pmic.201700195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fpmic.201700195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29334195" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=1700195&issue=5%E2%80%936&author=M.+H.+Linauthor=C.+C.+Liauthor=J.+C.+Shuauthor=H.+W.+Chuauthor=C.+C.+Liuauthor=C.+C.+Wu&title=Exoproteome+Profiling+Reveals+the+Involvement+of+the+Foldase+PrsA+in+the+Cell+Surface+Properties+and+Pathogenesis+of+Staphylococcus+aureus&doi=10.1002%2Fpmic.201700195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1002%2Fpmic.201700195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.201700195%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BC.%26aulast%3DShu%26aufirst%3DJ.%2BC.%26aulast%3DChu%26aufirst%3DH.%2BW.%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DExoproteome%2520Profiling%2520Reveals%2520the%2520Involvement%2520of%2520the%2520Foldase%2520PrsA%2520in%2520the%2520Cell%2520Surface%2520Properties%2520and%2520Pathogenesis%2520of%2520Staphylococcus%2520aureus%26jtitle%3DProteomics%26date%3D2018%26volume%3D18%26issue%3D5%25E2%2580%25936%26spage%3D1700195%26doi%3D10.1002%2Fpmic.201700195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyyryläinen, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciniak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahncke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietiäinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seppala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapot-Chartier, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuipers, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span> <span> </span><span class="NLM_article-title">Penicillin-Binding Protein Folding is Dependent on the PrsA Peptidyl-Prolyl Cis-Trans Isomerase in Bacillus subtilis</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2010.07188.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2010.07188.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20487272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Citrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=108-127&issue=1&author=H.+L.+Hyyryl%C3%A4inenauthor=B.+C.+Marciniakauthor=K.+Dahnckeauthor=M.+Pieti%C3%A4inenauthor=P.+Courtinauthor=M.+Vitikainenauthor=R.+Seppalaauthor=A.+Ottoauthor=D.+Becherauthor=M.+P.+Chapot-Chartierauthor=O.+P.+Kuipersauthor=V.+P.+Kontinen&title=Penicillin-Binding+Protein+Folding+is+Dependent+on+the+PrsA+Peptidyl-Prolyl+Cis-Trans+Isomerase+in+Bacillus+subtilis&doi=10.1111%2Fj.1365-2958.2010.07188.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Penicillin-binding protein folding is dependent on the PrsA peptidyl-prolyl cis-trans isomerase in Bacillus subtilis</span></div><div class="casAuthors">Hyyrylainen, Hanne-Leena; Marciniak, Bogumila C.; Dahncke, Kathleen; Pietiainen, Milla; Courtin, Pascal; Vitikainen, Marika; Seppala, Raili; Otto, Andreas; Becher, Dorte; Chapot-Chartier, Marie-Pierre; Kuipers, Oscar P.; Kontinen, Vesa P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-127</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The PrsA protein is a membrane-anchored peptidylprolyl cis-trans isomerase in Bacillus subtilis and most other Gram-pos. bacteria.  It catalyzes the post-translocational folding of exported proteins and is essential for normal growth of B. subtilis.  The authors studied the mechanism behind this indispensability.  They constructed a viable prsA null mutant in the presence of a high concn. of magnesium.  Various changes in cell morphol. in the absence of PrsA suggested that PrsA is involved in the biosynthesis of the cylindrical lateral wall.  Consistently, four penicillin-binding proteins (PBP2a, PBP2b, PBP3 and PBP4) were unstable in the absence of PrsA, while muropeptide anal. revealed a 2% decrease in the peptidoglycan cross-linkage index.  Misfolded PBP2a was detected in PrsA-depleted cells, indicating that PrsA is required for the folding of this PBP either directly or indirectly.  Furthermore, strongly increased uniform staining of cell wall with a fluorescent vancomycin was obsd. in the absence of PrsA.  The authors also demonstrated that PrsA is a dimeric or oligomeric protein which is localized at distinct spots organized in a helical pattern along the cell membrane.  These results suggest that PrsA is essential for normal growth most probably as PBP folding is dependent on this PPlase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWDiEz3UXHV7Vg90H21EOLACvtfcHk0lg_ANu7HHNnPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Citrs%253D&md5=1fd49d453540c96424006e4b3e203808</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2010.07188.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2010.07188.x%26sid%3Dliteratum%253Aachs%26aulast%3DHyyryl%25C3%25A4inen%26aufirst%3DH.%2BL.%26aulast%3DMarciniak%26aufirst%3DB.%2BC.%26aulast%3DDahncke%26aufirst%3DK.%26aulast%3DPieti%25C3%25A4inen%26aufirst%3DM.%26aulast%3DCourtin%26aufirst%3DP.%26aulast%3DVitikainen%26aufirst%3DM.%26aulast%3DSeppala%26aufirst%3DR.%26aulast%3DOtto%26aufirst%3DA.%26aulast%3DBecher%26aufirst%3DD.%26aulast%3DChapot-Chartier%26aufirst%3DM.%2BP.%26aulast%3DKuipers%26aufirst%3DO.%2BP.%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26atitle%3DPenicillin-Binding%2520Protein%2520Folding%2520is%2520Dependent%2520on%2520the%2520PrsA%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520in%2520Bacillus%2520subtilis%26jtitle%3DMol.%2520Microbiol.%26date%3D2010%26volume%3D77%26issue%3D1%26spage%3D108%26epage%3D127%26doi%3D10.1111%2Fj.1365-2958.2010.07188.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">Bacillus subtilis PrsA is Required In Vivo as an Extracytoplasmic Chaperone for Secretion of Active Enzymes Synthesized Either With or Without Pro-Sequences</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01640.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1993.tb01640.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8102773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFWjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=957-966&issue=5&author=M.+Jacobsauthor=J.+B.+Andersenauthor=V.+Kontinenauthor=M.+Sarvas&title=Bacillus+subtilis+PrsA+is+Required+In+Vivo+as+an+Extracytoplasmic+Chaperone+for+Secretion+of+Active+Enzymes+Synthesized+Either+With+or+Without+Pro-Sequences&doi=10.1111%2Fj.1365-2958.1993.tb01640.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Bacillus subtilis PrsA is required in vivo as an extracytoplasmic chaperone for secretion of active enzymes synthesized either with or without prosequences</span></div><div class="casAuthors">Jacobs, M.; Andersen, J. B.; Kontinen, V.; Sarvas, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">957-66</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">In prsA (protein secretion) mutants of Bacillus subtilis, decreased levels of exoproteins, including α-amylase and subtilisins, are found extracellularly.  The effect of prsA on subtilisin secretion is elaborated here.  Extracytoplasmic folding and secretion of active subtilisin is assisted by the N-terminal pro-sequence of its precursor.  The product of the prsA gene is addnl. required for these processes in vivo.  Inducible expression of different subtilisin-alk. phosphatase fusion genes in the prsA3 mutant was examd.  There was massive degrdn. of the fusion proteins, and a lack of enzymic activity in the protein secreted.  Apparently, PrsA is a novel chaperone with a predicted extracytoplasmic location, and is important in vivo for the proper conformation of various exoproteins, including those with pro-sequence (like subtilisin) and those without (like α-amylase).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofwmvO7IB3crVg90H21EOLACvtfcHk0ljM5Assq_1BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFWjsrc%253D&md5=82e9771d71bc5f4c7af94b215b5d09a4</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01640.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01640.x%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DJ.%2BB.%26aulast%3DKontinen%26aufirst%3DV.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DBacillus%2520subtilis%2520PrsA%2520is%2520Required%2520In%2520Vivo%2520as%2520an%2520Extracytoplasmic%2520Chaperone%2520for%2520Secretion%2520of%2520Active%2520Enzymes%2520Synthesized%2520Either%2520With%2520or%2520Without%2520Pro-Sequences%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D8%26issue%3D5%26spage%3D957%26epage%3D966%26doi%3D10.1111%2Fj.1365-2958.1993.tb01640.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">A Gene (prsA) of Bacillus subtilis Involved in a Novel, Late Stage of Protein Export</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1283</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1991.tb01901.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1991.tb01901.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1956302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK38Xht1aisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=1273-1283&issue=5&author=V.+Kontinenauthor=P.+Sarisauthor=M.+Sarvas&title=A+Gene+%28prsA%29+of+Bacillus+subtilis+Involved+in+a+Novel%2C+Late+Stage+of+Protein+Export&doi=10.1111%2Fj.1365-2958.1991.tb01901.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A gene (prsA) of Bacillus subtilis involved in a novel, late stage of protein export</span></div><div class="casAuthors">Kontinen, V. P.; Saris, P.; Sarvas, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1273-83</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">A gene locus of B. subtilis identified by mutations (prs) conferring a defect in protein secretion was closed from a lambdaGEM-11 expression library.  The sites of 3 closely linked prs mutations (prs-3, prs-29, and prs-40) were found to reside in a 5.3 kb DNA fragment, which also complemented the secretion defect in prs-3 and prs-29 mutants.  Partial sequencing of the fragment showed that these 3 mutations affect 1 distinct gene (prsA) encoding a putative protein of 292 amino acids (33 kDa).  Sequence anal. indicated the PrsA protein to be a lipoprotein located outside the cytoplasmic membrane.  Thirty percent identity was shown to the PrtM protein of Lactococcus lactis, which is involved in the maturation of an exported proteinase.  The phenotypes of prsA mutants and the structural similarity of PrsA with PrtM suggest that PrsA may have a novel function at a late phase in protein export.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruflf2gvc5k7Vg90H21EOLACvtfcHk0ljM5Assq_1BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1aisr0%253D&md5=ab1e6dcef093fb9a74ff60b78ddcd77d</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1991.tb01901.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1991.tb01901.x%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%26aulast%3DSaris%26aufirst%3DP.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DA%2520Gene%2520%2528prsA%2529%2520of%2520Bacillus%2520subtilis%2520Involved%2520in%2520a%2520Novel%252C%2520Late%2520Stage%2520of%2520Protein%2520Export%26jtitle%3DMol.%2520Microbiol.%26date%3D1991%26volume%3D5%26issue%3D5%26spage%3D1273%26epage%3D1283%26doi%3D10.1111%2Fj.1365-2958.1991.tb01901.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">The PrsA Lipoprotein is Essential for Protein Secretion in Bacillus subtilis and Sets a Limit for High-Level Secretion</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01616.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1993.tb01616.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8332065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Oktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=727-737&issue=4&author=V.+P.+Kontinenauthor=M.+Sarvas&title=The+PrsA+Lipoprotein+is+Essential+for+Protein+Secretion+in+Bacillus+subtilis+and+Sets+a+Limit+for+High-Level+Secretion&doi=10.1111%2Fj.1365-2958.1993.tb01616.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">The PrsA lipoprotein is essential for protein secretion in Bacillus subtilis and sets a limit for high-level secretion</span></div><div class="casAuthors">Kontinen, Vesa P.; Sarvas, Matti</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">727-37</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">Mutations of the prsA gene of B. subtilis have indicated that the gene is involved in protein secretion and it encodes a novel component of the cellular secretion machinery.  It is now demonstrated that the gene product is a membrane-assocd. lipoprotein, presumably bound to the outer face of the cytoplasmic membrane.  Expts. to inactivate the prsA gene with insertions indicated that it is indispensable for viability.  The cellular level of PrsA protein was decreased in prsA mutants with decreased level of exoproteins, consistent with an essential function in protein secretion.  An increased amt. of cellular PrsA protein was introduced by increasing the copy no. of prsA in B. subtilis.  This enhanced, from 6- to 2-fold, the secretion of α-amylases and a protease in strains that expressed high levels of these exoenzymes.  This suggests that PrsA protein is the rate-limiting component of the secretion machinery, a finding that is of considerable biotechnol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr25y5Vb0kX5LVg90H21EOLACvtfcHk0ljM5Assq_1BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Oktr0%253D&md5=cd957ade93fc108e75b0206461d2293a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01616.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01616.x%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DThe%2520PrsA%2520Lipoprotein%2520is%2520Essential%2520for%2520Protein%2520Secretion%2520in%2520Bacillus%2520subtilis%2520and%2520Sets%2520a%2520Limit%2520for%2520High-Level%2520Secretion%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D8%26issue%3D4%26spage%3D727%26epage%3D737%26doi%3D10.1111%2Fj.1365-2958.1993.tb01616.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappalainen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seppala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antelmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savilahti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span> <span> </span><span class="NLM_article-title">Structure-Function Analysis of PrsA Reveals Roles for the Parvulin-Like and Flanking N-and C-Terminal Domains in Protein Folding and Secretion in Bacillus subtilis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">19302</span>– <span class="NLM_lpage">19314</span>, <span class="refDoi"> DOI: 10.1074/jbc.M400861200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M400861200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14976191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVKmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=19302-19314&issue=18&author=M.+Vitikainenauthor=I.+Lappalainenauthor=R.+Seppalaauthor=H.+Antelmannauthor=H.+Boerauthor=S.+Tairaauthor=H.+Savilahtiauthor=M.+Heckerauthor=M.+Vihinenauthor=M.+Sarvasauthor=V.+P.+Kontinen&title=Structure-Function+Analysis+of+PrsA+Reveals+Roles+for+the+Parvulin-Like+and+Flanking+N-and+C-Terminal+Domains+in+Protein+Folding+and+Secretion+in+Bacillus+subtilis&doi=10.1074%2Fjbc.M400861200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function analysis of PrsA reveals roles for the parvulin-like and flanking N- and C-terminal domains in protein folding and secretion in Bacillus subtilis</span></div><div class="casAuthors">Vitikainen, Marika; Lappalainen, Ilkka; Seppala, Raili; Antelmann, Haike; Boer, Harry; Taira, Suvi; Savilahti, Harri; Hecker, Michael; Vihinen, Mauno; Sarvas, Matti; Kontinen, Vesa P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">19302-19314</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The PrsA protein of B. subtilis is an essential membrane-bound lipoprotein that is assumed to assist post-translocational folding of exported proteins and stabilize them in the compartment between the cytoplasmic membrane and cell wall.  This folding activity is consistent with the homol. of a segment of PrsA with parvulin-type peptidylprolyl cis/trans isomerases (PPIases).  Here, mol. modeling showed that the parvulin-like region could adopt a parvulin-type fold with structurally conserved active site residues.  PrsA exhibited PPIase activity in a manner dependent on the parvulin-like domain.  The authors constructed deletion, peptide insertion, and amino acid substitution mutations and demonstrated that the parvulin-like domain as well as flanking N- and C-terminal domains were essential for in vivo PrsA function in protein secretion and growth.  Surprisingly, none of the predicted active site residues of the parvulin-like domain was essential for growth and protein secretion, although several active site mutations reduced or abolished the PPIase activity or the ability of PrsA to catalyze proline-limited protein folding in vitro.  These results indicate that PrsA is a PPIase, but the essential role in vivo seems to depend on some non-PPIase activity of both the parvulin-like and flanking domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRzQuvLMbDLVg90H21EOLACvtfcHk0li_AGzKxNA1tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVKmurY%253D&md5=84cfabdeddb956c7f4e705bd80afa4db</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M400861200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M400861200%26sid%3Dliteratum%253Aachs%26aulast%3DVitikainen%26aufirst%3DM.%26aulast%3DLappalainen%26aufirst%3DI.%26aulast%3DSeppala%26aufirst%3DR.%26aulast%3DAntelmann%26aufirst%3DH.%26aulast%3DBoer%26aufirst%3DH.%26aulast%3DTaira%26aufirst%3DS.%26aulast%3DSavilahti%26aufirst%3DH.%26aulast%3DHecker%26aufirst%3DM.%26aulast%3DVihinen%26aufirst%3DM.%26aulast%3DSarvas%26aufirst%3DM.%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26atitle%3DStructure-Function%2520Analysis%2520of%2520PrsA%2520Reveals%2520Roles%2520for%2520the%2520Parvulin-Like%2520and%2520Flanking%2520N-and%2520C-Terminal%2520Domains%2520in%2520Protein%2520Folding%2520and%2520Secretion%2520in%2520Bacillus%2520subtilis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D18%26spage%3D19302%26epage%3D19314%26doi%3D10.1074%2Fjbc.M400861200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pummi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airaksinen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahlström, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span> <span> </span><span class="NLM_article-title">Quantitation of the Capacity of the Secretion Apparatus and Requirement for PrsA in Growth and Secretion of α-Amylase in Bacillus subtilis</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>183</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1881</span>– <span class="NLM_lpage">1890</span>, <span class="refDoi"> DOI: 10.1128/JB.183.6.1881-1890.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.183.6.1881-1890.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11222585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVeksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2001&pages=1881-1890&issue=6&author=M.+Vitikainenauthor=T.+Pummiauthor=U.+Airaksinenauthor=E.+Wahlstr%C3%B6mauthor=H.+Wuauthor=M.+Sarvasauthor=V.+P.+Kontinen&title=Quantitation+of+the+Capacity+of+the+Secretion+Apparatus+and+Requirement+for+PrsA+in+Growth+and+Secretion+of+%CE%B1-Amylase+in+Bacillus+subtilis&doi=10.1128%2FJB.183.6.1881-1890.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of α-amylase in Bacillus subtilis</span></div><div class="casAuthors">Vitikainen, Marika; Pummi, Tiina; Airaksinen, Ulla; Wahlstrom, Eva; Wu, Hongyan; Sarvas, Matti; Kontinen, Vesa P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1881-1890</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Regulated expression of AmyQ α-amylase of Bacillus amyloliquefaciens was used to examine the capacity of the protein secretion app. of B. subtilis.  One B. subtilis cell was found to secrete maximally 10 fg of AmyQ per h.  The signal peptidase SipT limits the rate of processing of the signal peptide.  Another limit is set by PrsA lipoprotein.  The wild-type level of PrsA was 2 × 104 mols. per cell.  Decreasing the cellular level of PrsA did not decrease the capacity of the protein translocation or signal peptide processing steps but dramatically affected secretion in a posttranslocational step.  There was a linear correlation between the no. of cellular PrsA mols. and the no. of secreted AmyQ mols. over a wide range of prsA and amyQ expression levels.  Significantly, even when amyQ was expressed at low levels, overprodn. of PrsA enhanced its secretion.  The finding is consistent with a reversible interaction between PrsA and AmyQ.  The high cellular level of PrsA suggests a chaperone-like function.  PrsA was also found to be essential for the viability of B. subtilis.  Drastic depletion of PrsA resulted in altered cellular morphol. and ultimately in cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxlIKq1l3xJLVg90H21EOLACvtfcHk0li_AGzKxNA1tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVeksL4%253D&md5=ce922b228a47bcd57ea4df0467bb50de</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1128%2FJB.183.6.1881-1890.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.183.6.1881-1890.2001%26sid%3Dliteratum%253Aachs%26aulast%3DVitikainen%26aufirst%3DM.%26aulast%3DPummi%26aufirst%3DT.%26aulast%3DAiraksinen%26aufirst%3DU.%26aulast%3DWahlstr%25C3%25B6m%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSarvas%26aufirst%3DM.%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26atitle%3DQuantitation%2520of%2520the%2520Capacity%2520of%2520the%2520Secretion%2520Apparatus%2520and%2520Requirement%2520for%2520PrsA%2520in%2520Growth%2520and%2520Secretion%2520of%2520%25CE%25B1-Amylase%2520in%2520Bacillus%2520subtilis%26jtitle%3DJ.%2520Bacteriol.%26date%3D2001%26volume%3D183%26issue%3D6%26spage%3D1881%26epage%3D1890%26doi%3D10.1128%2FJB.183.6.1881-1890.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">Mutants of Bacillus subtilis Defective in Protein Export</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2333</span>– <span class="NLM_lpage">2344</span>, <span class="refDoi"> DOI: 10.1099/00221287-134-8-2333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2F00221287-134-8-2333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL1cXlsVKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1988&pages=2333-2344&issue=8&author=V.+P.+Kontinenauthor=M.+Sarvas&title=Mutants+of+Bacillus+subtilis+Defective+in+Protein+Export&doi=10.1099%2F00221287-134-8-2333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Mutants of Bacillus subtilis defective in protein export</span></div><div class="casAuthors">Kontinen, Vesa P.; Sarvas, Matti</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Microbiology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2333-44</span>CODEN:
                <span class="NLM_cas:coden">JGMIAN</span>;
        ISSN:<span class="NLM_cas:issn">0022-1287</span>.
    </div><div class="casAbstract">Bacillus Strains were isolated that have mutations (designated prs) that decrease secretion of α-amylase and have a pleiotropic effect on the secretion of other exoproteins.  The seven mutants were selected in a strain of B. subtilis which overproduces α-amylase due to the presence of an α-amylase gene on a multicopy plasmid.  The mutations were mapped to four different chromosomal loci.  The phenotype of the mutants, esp. their pleiotropic effects and the accumulation of α-amylase precursor, indicated that they have defects in the mechanism of protein export.  Double mutants with certain pairwise combinations of mutations in different loci had additive effects of secretion, suggesting that these prs genes encode different components of the secretion pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouFNZxu9MXP7Vg90H21EOLACvtfcHk0li_AGzKxNA1tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsVKis7s%253D&md5=8a91afcb0cd7b17f3b3111cd6b161914</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1099%2F00221287-134-8-2333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F00221287-134-8-2333%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DMutants%2520of%2520Bacillus%2520subtilis%2520Defective%2520in%2520Protein%2520Export%26jtitle%3DMicrobiology%26date%3D1988%26volume%3D134%26issue%3D8%26spage%3D2333%26epage%3D2344%26doi%3D10.1099%2F00221287-134-8-2333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag, N. E.</span></span> <span> </span><span class="NLM_article-title">Listeria monocytogenes PrsA2 is Required for Virulence Factor Secretion and Bacterial Viability Within the Host Cell Cytosol</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4944</span>– <span class="NLM_lpage">4957</span>, <span class="refDoi"> DOI: 10.1128/IAI.00532-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00532-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20823208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSntbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=4944-4957&issue=11&author=F.+Alonzoauthor=N.+E.+Freitag&title=Listeria+monocytogenes+PrsA2+is+Required+for+Virulence+Factor+Secretion+and+Bacterial+Viability+Within+the+Host+Cell+Cytosol&doi=10.1128%2FIAI.00532-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Listeria monocytogenes PrsA2 is required for virulence factor secretion and bacterial viability within the host cell cytosol</span></div><div class="casAuthors">Alonzo, Francis, III; Freitag, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4944-4957</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In the course of establishing its replication niche within the cytosol of infected host cells, the facultative intracellular bacterial pathogen Listeria monocytogenes must efficiently regulate the secretion and activity of multiple virulence factors.  L. monocytogenes encodes two predicted posttranslocation secretion chaperones, PrsA1 and PrsA2, and evidence suggests that PrsA2 has been specifically adapted for bacterial pathogenesis.  PrsA-like chaperones have been identified in a no. of Gram-pos. bacteria, where they are reported to function at the bacterial membrane-cell wall interface to assist in the folding of proteins translocated across the membrane; in some cases, these proteins have been found to be essential for bacterial viability.  In this study, the contributions of PrsA2 and PrsA1 to L. monocytogenes growth and protein secretion were investigated in vitro and in vivo.  Neither PrsA2 nor PrsA1 was found to be essential for L. monocytogenes growth in broth culture; however, optimal bacterial viability was found to be dependent upon PrsA2 for L. monocytogenes located within the cytosol of host cells.  Proteomic analyses of prsA2 mutant strains in the presence of a mutationally activated allele of the virulence regulator PrfA revealed a crit. requirement for PrsA activity under conditions of PrfA activation, an event which normally takes place within the host cell cytosol.  Despite a high degree of amino acid similarity, no detectable degree of functional overlap was obsd. between PrsA2 and PrsA1.  The results indicate a crit. requirement for PrsA2 under conditions relevant to host cell infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdCZHXpLnCX7Vg90H21EOLACvtfcHk0ljDSn0Wc52gIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSntbjK&md5=4d90775e0d8d7083a18ed91b16a6cc8b</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1128%2FIAI.00532-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00532-10%26sid%3Dliteratum%253Aachs%26aulast%3DAlonzo%26aufirst%3DF.%26aulast%3DFreitag%26aufirst%3DN.%2BE.%26atitle%3DListeria%2520monocytogenes%2520PrsA2%2520is%2520Required%2520for%2520Virulence%2520Factor%2520Secretion%2520and%2520Bacterial%2520Viability%2520Within%2520the%2520Host%2520Cell%2520Cytosol%26jtitle%3DInfect.%2520Immun.%26date%3D2010%26volume%3D78%26issue%3D11%26spage%3D4944%26epage%3D4957%26doi%3D10.1128%2FIAI.00532-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag, N. E.</span></span> <span> </span><span class="NLM_article-title">The Posttranslocation Chaperone PrsA2 Contributes to Multiple Facets of Listeria monocytogenes Pathogenesis</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2612</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1128/IAI.00280-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00280-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19451247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFams7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=2612-2623&issue=7&author=F.+Alonzoauthor=G.+C.+Portauthor=M.+Caoauthor=N.+E.+Freitag&title=The+Posttranslocation+Chaperone+PrsA2+Contributes+to+Multiple+Facets+of+Listeria+monocytogenes+Pathogenesis&doi=10.1128%2FIAI.00280-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The posttranslocation chaperone PrsA2 contributes to multiple facets of Listeria monocytogenes pathogenesis</span></div><div class="casAuthors">Alonzo, Francis, III; Port, Gary C.; Cao, Min; Freitag, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2612-2623</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Listeria monocytogenes is an intracellular bacterial pathogen whose virulence depends on the regulated expression of numerous secreted bacterial factors.  As for other gram-pos. bacteria, many proteins secreted by L. monocytogenes are translocated across the bacterial membrane in an unfolded state to the compartment existing between the membrane and the cell wall.  This compartment presents a challenging environment for protein folding due to its high d. of neg. charge, high concns. of cations, and low pH.  We recently identified PrsA2 as a gene product required for L. monocytogenes virulence.  PrsA2 was identified based on its increased secretion by strains contg. a mutationally activated form of prfA, the key regulator of L. monocytogenes virulence gene expression.  The prsA2 gene product is one of at least two predicted peptidyl-prolyl cis/trans-isomerases encoded by L. monocytogenes; these proteins function as posttranslocation protein chaperones and/or foldases.  In this study, we demonstrate that PrsA2 plays a unique and important role in L. monocytogenes pathogenesis by promoting the activity and stability of at least two crit. secreted virulence factors: listeriolysin O (LLO) and a broad-specificity phospholipase.  Loss of PrsA2 activity severely attenuated virulence in mice and impaired bacterial cell-to-cell spread in host cells.  In contrast, mutants lacking prsA1 resembled wild-type bacteria with respect to intracellular growth and cell-to-cell spread as well as virulence in mice.  PrsA2 is thus distinct from PrsA1 in its unique requirement for the stability and full activity of L. monocytogenes-secreted factors that contribute to host infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Uqivqm2RyrVg90H21EOLACvtfcHk0ljDSn0Wc52gIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFams7g%253D&md5=08f0a879cad6595791c2ed12ff8e8545</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1128%2FIAI.00280-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00280-09%26sid%3Dliteratum%253Aachs%26aulast%3DAlonzo%26aufirst%3DF.%26aulast%3DPort%26aufirst%3DG.%2BC.%26aulast%3DCao%26aufirst%3DM.%26aulast%3DFreitag%26aufirst%3DN.%2BE.%26atitle%3DThe%2520Posttranslocation%2520Chaperone%2520PrsA2%2520Contributes%2520to%2520Multiple%2520Facets%2520of%2520Listeria%2520monocytogenes%2520Pathogenesis%26jtitle%3DInfect.%2520Immun.%26date%3D2009%26volume%3D77%26issue%3D7%26spage%3D2612%26epage%3D2623%26doi%3D10.1128%2FIAI.00280-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, F.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xayarath, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag, N. E.</span></span> <span> </span><span class="NLM_article-title">Functional Analysis of the Listeria monocytogenes Secretion Chaperone PrsA2 and its Multiple Contributions to Bacterial Virulence</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1530</span>– <span class="NLM_lpage">1548</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2011.07665.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2011.07665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21545417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVChsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=1530-1548&issue=6&author=F.+Alonzoauthor=B.+Xayarathauthor=J.+C.+Whisstockauthor=N.+E.+Freitag&title=Functional+Analysis+of+the+Listeria+monocytogenes+Secretion+Chaperone+PrsA2+and+its+Multiple+Contributions+to+Bacterial+Virulence&doi=10.1111%2Fj.1365-2958.2011.07665.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of the Listeria monocytogenes secretion chaperone PrsA2 and its multiple contributions to bacterial virulence</span></div><div class="casAuthors">Alonzo, Francis, III; Xayarath, Bobbi; Whisstock, James C.; Freitag, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1530-1548</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">As an organism that has evolved to live in environments ranging from soil to the cytosol of mammalian cells, Listeria monocytogenes must regulate the secretion and activity of protein products that promote survival within these habitats.  The post-translocation chaperone PrsA2 has been adapted to assist in the folding and activity of L. monocytogenes secreted proteins required for bacterial replication within host cells.  Here we present the first structure/function investigation of the contributions of PrsA2 to protein secretion and activity as well as to bacterial virulence.  Domain swap expts. with the closely related L. monocytogenes PrsA1 protein combined with targeted mutagenesis indicate distinct functional roles for the PrsA2 peptidyl-prolyl isomerase (PPIase) and the N- and C-terminal domains in pathogenesis.  In contrast to other PrsA-like proteins described thus far in the literature, an abs. in vivo requirement for PrsA2 PPIase activity is evident in mouse infection models.  This work illustrates the diversity of function assocd. with L. monocytogenes PrsA2 that serves to promote bacterial life within the infected host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTOnHO-9lQrVg90H21EOLACvtfcHk0ljDSn0Wc52gIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVChsbg%253D&md5=c66965727987f384646afb85098626d4</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2011.07665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2011.07665.x%26sid%3Dliteratum%253Aachs%26aulast%3DAlonzo%26aufirst%3DF.%26aulast%3DXayarath%26aufirst%3DB.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DFreitag%26aufirst%3DN.%2BE.%26atitle%3DFunctional%2520Analysis%2520of%2520the%2520Listeria%2520monocytogenes%2520Secretion%2520Chaperone%2520PrsA2%2520and%2520its%2520Multiple%2520Contributions%2520to%2520Bacterial%2520Virulence%26jtitle%3DMol.%2520Microbiol.%26date%3D2011%26volume%3D80%26issue%3D6%26spage%3D1530%26epage%3D1548%26doi%3D10.1111%2Fj.1365-2958.2011.07665.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cron, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bootsma, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghout, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, P. W.</span></span> <span> </span><span class="NLM_article-title">Surface-Associated Lipoprotein PpmA of Streptococcus pneumoniae is Involved in Colonization in a Strain-Specific Manner</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">2401</span>– <span class="NLM_lpage">2410</span>, <span class="refDoi"> DOI: 10.1099/mic.0.026765-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2Fmic.0.026765-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19389773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFemsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2009&pages=2401-2410&author=L.+E.+Cronauthor=H.+J.+Bootsmaauthor=N.+Noskeauthor=P.+Burghoutauthor=S.+Hammerschmidtauthor=P.+W.+Hermans&title=Surface-Associated+Lipoprotein+PpmA+of+Streptococcus+pneumoniae+is+Involved+in+Colonization+in+a+Strain-Specific+Manner&doi=10.1099%2Fmic.0.026765-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Surface-associated lipoprotein PpmA of Streptococcus pneumoniae is involved in colonization in a strain-specific manner</span></div><div class="casAuthors">Cron, L. E.; Bootsma, H. J.; Noske, N.; Burghout, P.; Hammerschmidt, S.; Hermans, P. W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2401-2410</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Streptococcus pneumoniae produces two surface-assocd. lipoproteins that share homol., with two distinct families of peptidyl-prolyl isomerases (PPlases), the streptococcal lipoprotein rotamase A (SlrA) and the putative proteinase maturation protein A (PpmA).  Previously, the authors have demonstrated that SlrA has PPlase activity, and that the enzyme plays a role in pneumococcal virulence.  Here, they investigated the contribution of PpmA to pneumococcal pathogenesis.  Pneumococcal mutants of D39 and TIGR4 lacking the gene encoding PpmA were less capable of persisting in the nasopharynx of mice, demonstrating the contribution of PpmA to pneumococcal colonization.  This observation was partially confirmed in vitro, as the pneumococcal mutants NCTC10319ΔppmA and TIGR4ΔcpsΔppmA, but not D39ΔcpsΔppmA, were impaired in adherence to Detroit 562 pharyngeal cells.  This suggests that the contribution of PpmA to pneumococcal colonization is not solely the result of its role in adherence to epithelial cells.  Deficiency in PpmA did not result in reduced binding to various extracellular matrix and serum proteins.  Similar to SlrA, we obsd. that PpmA was involved in immune evasion.  Uptake of PpmA-deficient D39Δcps and NCTC10319 by human polymorphonuclear leukocytes was significantly enhanced compared to the isogenic wild-types.  In addn., ingestion of D39ΔppmA, but not that of either NCTC10319ΔppmA or TIGR4ΔppmA, by murine macrophage cell line J774 was also enhanced, whereas intracellular killing remained unaffected.  We conclude that PpmA contributes to the early stages of infection, i.e. colonization.  The contribution of PpmA to virulence can be explained by its strain-specific role in adherence to epithelial cells and contribution to the evasion of phagocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs22mkYITPNLVg90H21EOLACvtfcHk0lhtXh27ywf3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFemsL4%253D&md5=844d8e65c5cc591d930e4a598b4a4f46</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.026765-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.026765-0%26sid%3Dliteratum%253Aachs%26aulast%3DCron%26aufirst%3DL.%2BE.%26aulast%3DBootsma%26aufirst%3DH.%2BJ.%26aulast%3DNoske%26aufirst%3DN.%26aulast%3DBurghout%26aufirst%3DP.%26aulast%3DHammerschmidt%26aufirst%3DS.%26aulast%3DHermans%26aufirst%3DP.%2BW.%26atitle%3DSurface-Associated%2520Lipoprotein%2520PpmA%2520of%2520Streptococcus%2520pneumoniae%2520is%2520Involved%2520in%2520Colonization%2520in%2520a%2520Strain-Specific%2520Manner%26jtitle%3DMicrobiology%26date%3D2009%26volume%3D155%26spage%3D2401%26epage%3D2410%26doi%3D10.1099%2Fmic.0.026765-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Justice, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunstad, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duguay, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Periplasmic Peptidyl Prolyl Cis-Trans Isomerases are not Essential for Viability, but SurA is Required for Pilus Biogenesis in Escherichia coli</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>187</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">7680</span>– <span class="NLM_lpage">7686</span>, <span class="refDoi"> DOI: 10.1128/JB.187.22.7680-7686.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.187.22.7680-7686.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16267292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WnurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2005&pages=7680-7686&issue=22&author=S.+S.+Justiceauthor=D.+A.+Hunstadauthor=J.+R.+Harperauthor=A.+R.+Duguayauthor=J.+S.+Pinknerauthor=J.+Bannauthor=C.+Friedenauthor=T.+J.+Silhavyauthor=S.+J.+Hultgren&title=Periplasmic+Peptidyl+Prolyl+Cis-Trans+Isomerases+are+not+Essential+for+Viability%2C+but+SurA+is+Required+for+Pilus+Biogenesis+in+Escherichia+coli&doi=10.1128%2FJB.187.22.7680-7686.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli</span></div><div class="casAuthors">Justice, Sheryl S.; Hunstad, David A.; Harper, Jill Reiss; Duguay, Amy R.; Pinkner, Jerome S.; Bann, James; Frieden, Carl; Silhavy, Thomas J.; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7680-7686</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In Escherichia coli, FkpA, PpiA, PpiD, and SurA are the four known periplasmic cis-trans prolyl isomerases.  These isomerases facilitate proper protein folding by increasing the rate of transition of proline residues between the cis and trans states.  Genetic inactivation of all four periplasmic isomerases resulted in a viable strain that exhibited a decreased growth rate and increased susceptibility to certain antibiotics.  Levels of the outer membrane proteins LamB and OmpA in the quadruple mutant were indistinguishable from those in the surA single mutant.  In addn., expression of P and type 1 pili (adhesive organelles produced by uropathogenic strains of E. coli and assembled by the chaperone/usher pathway) were severely diminished in the absence of the four periplasmic isomerases.  Maturation of the usher was significantly impaired in the outer membranes of strains devoid of all four periplasmic isomerases, resulting in a defect in pilus assembly.  Moreover, this defect in pilus assembly and usher stability could be attributed to the absence of SurA.  The data presented here suggest that the four periplasmic isomerases are not essential for growth under lab. conditions but may have significant roles in survival in environmental and pathogenic niches, as indicated by the effect on pilus prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDCqVaua1PGbVg90H21EOLACvtfcHk0lhtXh27ywf3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WnurbE&md5=3a5e65b1cf908ba8bf553fb546773941</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1128%2FJB.187.22.7680-7686.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.187.22.7680-7686.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJustice%26aufirst%3DS.%2BS.%26aulast%3DHunstad%26aufirst%3DD.%2BA.%26aulast%3DHarper%26aufirst%3DJ.%2BR.%26aulast%3DDuguay%26aufirst%3DA.%2BR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DBann%26aufirst%3DJ.%26aulast%3DFrieden%26aufirst%3DC.%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DPeriplasmic%2520Peptidyl%2520Prolyl%2520Cis-Trans%2520Isomerases%2520are%2520not%2520Essential%2520for%2520Viability%252C%2520but%2520SurA%2520is%2520Required%2520for%2520Pilus%2520Biogenesis%2520in%2520Escherichia%2520coli%26jtitle%3DJ.%2520Bacteriol.%26date%3D2005%26volume%3D187%26issue%3D22%26spage%3D7680%26epage%3D7686%26doi%3D10.1128%2FJB.187.22.7680-7686.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tormo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almiron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolter, R.</span></span> <span> </span><span class="NLM_article-title">surA, an Escherichia coli Gene Essential for Survival in Stationary Phase</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4339</span>– <span class="NLM_lpage">4347</span>, <span class="refDoi"> DOI: 10.1128/JB.172.8.4339-4347.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.172.8.4339-4347.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=2165476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFahsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1990&pages=4339-4347&issue=8&author=A.+Tormoauthor=M.+Almironauthor=R.+Kolter&title=surA%2C+an+Escherichia+coli+Gene+Essential+for+Survival+in+Stationary+Phase&doi=10.1128%2FJB.172.8.4339-4347.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">surA, an Escherichia coli gene essential for survival in stationary phase</span></div><div class="casAuthors">Tormo, Antonio; Almiron, Marta; Kolter, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4339-47</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    </div><div class="casAbstract">Mutations in genes not required for exponential growth but essential for survival in stationary phase were isolated in an effort to understand the ability of wild-type E. coli cells to remain viable during prolonged periods of nutritional deprivation.  The phenotype of these mutations is referred to as Sur- (survival) and the genes are designated sur.  The detailed anal. of one of these mutations is presented here.  The mutation (surA1) caused by insertion of a mini-Tn10 element defined a new gene located near 1 min on the E. coli chromosome.  It was located directly upstream of pdxA and formed part of a complex operon.  Evidence is presented supporting the interpretation that cells harboring the surA1 mutation die during stationary phase while similar insertion mutations in other genes of the operon do not lead to a Sur- phenotype.  Strains harboring surA1 had a normal doubling time in both rich and minimal medium, but cultures lost viability after several days in stationary phase.  Anal. of revertants and suppressors of surA1, which arose after prolonged incubation in stationary phase, indicates that DNA rearrangements (excisions and duplications) occurred in cultures of this strain even when the viable-cell counts were below 102 cells per mL.  Cells contg. suppressing mutations then grew in the same culture to 108 cells per mL, taking over the population.  The implications of these observations to the understanding of stationary-phase mutagenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriKnkNZfGaNLVg90H21EOLACvtfcHk0lhtXh27ywf3CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFahsb4%253D&md5=fcc9b0375c8ace55372d116022f6be7c</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1128%2FJB.172.8.4339-4347.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.172.8.4339-4347.1990%26sid%3Dliteratum%253Aachs%26aulast%3DTormo%26aufirst%3DA.%26aulast%3DAlmiron%26aufirst%3DM.%26aulast%3DKolter%26aufirst%3DR.%26atitle%3DsurA%252C%2520an%2520Escherichia%2520coli%2520Gene%2520Essential%2520for%2520Survival%2520in%2520Stationary%2520Phase%26jtitle%3DJ.%2520Bacteriol.%26date%3D1990%26volume%3D172%26issue%3D8%26spage%3D4339%26epage%3D4347%26doi%3D10.1128%2FJB.172.8.4339-4347.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunstad, D. A.</span></span> <span> </span><span class="NLM_article-title">Components of SurA Required for Outer Membrane Biogenesis in Uropathogenic Escherichia coli</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">e3359</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0003359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pone.0003359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18836534" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e3359&issue=10&author=K.+M.+Wattsauthor=D.+A.+Hunstad&title=Components+of+SurA+Required+for+Outer+Membrane+Biogenesis+in+Uropathogenic+Escherichia+coli&doi=10.1371%2Fjournal.pone.0003359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0003359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0003359%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DK.%2BM.%26aulast%3DHunstad%26aufirst%3DD.%2BA.%26atitle%3DComponents%2520of%2520SurA%2520Required%2520for%2520Outer%2520Membrane%2520Biogenesis%2520in%2520Uropathogenic%2520Escherichia%2520coli%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26issue%3D10%26spage%3De3359%26doi%3D10.1371%2Fjournal.pone.0003359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sydenham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatfield, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, G.</span></span> <span> </span><span class="NLM_article-title">Salmonella enterica Serovar Typhimurium SurA Mutants are Attenuated and Effective Live Oral Vaccines</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1128/IAI.68.3.1109-1115.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.68.3.1109-1115.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10678914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVKktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=1109-1115&issue=3&author=M.+Sydenhamauthor=G.+Douceauthor=F.+Boweauthor=S.+Ahmedauthor=S.+Chatfieldauthor=G.+Dougan&title=Salmonella+enterica+Serovar+Typhimurium+SurA+Mutants+are+Attenuated+and+Effective+Live+Oral+Vaccines&doi=10.1128%2FIAI.68.3.1109-1115.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines</span></div><div class="casAuthors">Sydenham, Mark; Douce, Gillian; Bowe, Frances; Ahmed, Saddif; Chatfield, Steve; Dougan, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1109-1115</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A previously described attenuated TnphoA mutant (BRD441) of Salmonella enterica serovar Typhimurium C5 was characterized, and the transposon was shown to be inserted in surA, a gene which encodes a peptidylprolyl-cis,trans-isomerase.  A defined surA deletion mutation was introduced into S. enterica serovar Typhimurium C5 and the mutant strain, named S. enterica serovar Typhimurium BRD1115, was extensively characterized both in vitro and in vivo.  S. enterica serovar Typhimurium BRD1115 was defective in the ability to adhere to and invade eukaryotic cells.  Furthermore, S. enterica serovar Typhimurium BRD1115 was attenuated by at least 3 log units when administered orally or i.v. to BALB/c mice.  Complementation of the mutation with a plasmid carrying the intact surA gene almost completely restored the virulence of BRD1115.  In addn., S. enterica serovar Typhimurium BRD1115 demonstrated potential as a vaccine candidate, since mice immunized with BRD1115 were protected against subsequent challenge with S. enterica serovar Typhimurium C5.  S. enterica serovar Typhimurium BRD1115 also showed potential as a vehicle for the effective delivery of heterologous antigens, such as the nontoxic, protective fragment C domain of tetanus toxin, to the murine immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc6JbUPczPMrVg90H21EOLACvtfcHk0lhRfbCH9lEALQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVKktb4%253D&md5=87bba53011961505cb8548ecffdc187c</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1128%2FIAI.68.3.1109-1115.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.68.3.1109-1115.2000%26sid%3Dliteratum%253Aachs%26aulast%3DSydenham%26aufirst%3DM.%26aulast%3DDouce%26aufirst%3DG.%26aulast%3DBowe%26aufirst%3DF.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DChatfield%26aufirst%3DS.%26aulast%3DDougan%26aufirst%3DG.%26atitle%3DSalmonella%2520enterica%2520Serovar%2520Typhimurium%2520SurA%2520Mutants%2520are%2520Attenuated%2520and%2520Effective%2520Live%2520Oral%2520Vaccines%26jtitle%3DInfect.%2520Immun.%26date%3D2000%26volume%3D68%26issue%3D3%26spage%3D1109%26epage%3D1115%26doi%3D10.1128%2FIAI.68.3.1109-1115.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purdy, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, S. M.</span></span> <span> </span><span class="NLM_article-title">IcsA Surface Presentation in Shigella flexneri Requires the Periplasmic Chaperones DegP, Skp, and SurA</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>189</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5566</span>– <span class="NLM_lpage">5573</span>, <span class="refDoi"> DOI: 10.1128/JB.00483-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.00483-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17526712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos1Crtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2007&pages=5566-5573&issue=15&author=G.+E.+Purdyauthor=C.+R.+Fisherauthor=S.+M.+Payne&title=IcsA+Surface+Presentation+in+Shigella+flexneri+Requires+the+Periplasmic+Chaperones+DegP%2C+Skp%2C+and+SurA&doi=10.1128%2FJB.00483-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">IcsA surface presentation in Shigella flexneri requires the periplasmic chaperones DegP, Skp, and SurA</span></div><div class="casAuthors">Purdy, Georgiana E.; Fisher, Carolyn R.; Payne, Shelley M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5566-5573</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A Shigella flexneri degP mutant, which was defective for plaque formation in Henle cell monolayers, had a reduced amt. of IcsA detectable on the bacterial surface with antibody.  However, the mutant secreted IcsA to the outer membrane at wild-type levels.  This suggests that IcsA adopts an altered conformation in the outer membrane of the degP mutant with reduced exposure on the cell surface.  IcsA is, therefore, unlikely to be accessible to actin-nucleating proteins within the eukaryotic cell cytoplasm, which is required for bacterial movement within the host cell and cell-to-cell spread.  The degP mutant was somewhat more sensitive to detergents, antibiotics, and the antimicrobial peptide magainin, indicating that the degP phenotype was not limited to IcsA surface presentation.  The plaque defect of the degP mutant, which is independent of DegP protease activity, was suppressed by overexpression of the periplasmic chaperone Skp but not by SurA.  S. flexneri skp and surA mutants failed to form plaques in Henle cell monolayers and were defective in cell surface presentation and polar localization of IcsA.  Therefore, the three periplasmic folding factors DegP, Skp, and SurA were all required for IcsA localization and plaque formation by S. flexneri.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVbgylfG0V2bVg90H21EOLACvtfcHk0lhRfbCH9lEALQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos1Crtbk%253D&md5=3ebe33db3d88897c848fd700e73b4be7</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1128%2FJB.00483-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00483-07%26sid%3Dliteratum%253Aachs%26aulast%3DPurdy%26aufirst%3DG.%2BE.%26aulast%3DFisher%26aufirst%3DC.%2BR.%26aulast%3DPayne%26aufirst%3DS.%2BM.%26atitle%3DIcsA%2520Surface%2520Presentation%2520in%2520Shigella%2520flexneri%2520Requires%2520the%2520Periplasmic%2520Chaperones%2520DegP%252C%2520Skp%252C%2520and%2520SurA%26jtitle%3DJ.%2520Bacteriol.%26date%3D2007%26volume%3D189%26issue%3D15%26spage%3D5566%26epage%3D5573%26doi%3D10.1128%2FJB.00483-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkönig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smet-Nocca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobecq, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieruszeski, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sénéchal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landrieu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob-Dubuisson, F.</span></span> <span> </span><span class="NLM_article-title">The Peptidyl–Prolyl Isomerase and Chaperone Par27 of Bordetella pertussis as the Prototype for a New Group of Parvulins</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2007.10.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jmb.2007.10.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18164725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2ns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2008&pages=414-426&issue=2&author=H.+Hodakauthor=A.+Wohlk%C3%B6nigauthor=C.+Smet-Noccaauthor=H.+Drobecqauthor=J.-M.+Wieruszeskiauthor=M.+S%C3%A9n%C3%A9chalauthor=I.+Landrieuauthor=C.+Lochtauthor=M.+Jaminauthor=F.+Jacob-Dubuisson&title=The+Peptidyl%E2%80%93Prolyl+Isomerase+and+Chaperone+Par27+of+Bordetella+pertussis+as+the+Prototype+for+a+New+Group+of+Parvulins&doi=10.1016%2Fj.jmb.2007.10.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The Peptidyl-Prolyl Isomerase and Chaperone Par27 of Bordetella pertussis as the Prototype for a New Group of Parvulins</span></div><div class="casAuthors">Hodak, Helene; Wohlkonig, Alexandre; Smet-Nocca, Caroline; Drobecq, Herve; Wieruszeski, Jean-Michel; Senechal, Magalie; Landrieu, Isabelle; Locht, Camille; Jamin, Marc; Jacob-Dubuisson, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">414-426</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Proteins that pass through the periplasm in an unfolded state are highly sensitive to proteolysis and aggregation and, therefore, often require protection by chaperone-like proteins.  The periplasm of Gram-neg. bacteria is well equipped with ATP-independent chaperones and folding catalysts, including peptidyl-prolyl isomerases (PPIases).  The filamentous hemagglutinin of Bordetella pertussis, which is secreted by the two-partner secretion pathway, crosses the periplasm in an unfolded conformation.  By affinity chromatog., we identified a new periplasmic PPIase of the parvulin family, Par27, which binds to an unfolded filamentous hemagglutinin fragment.  Par27 differs from previously characterized bacterial and eukaryotic parvulins.  Its central parvulin-like domain is flanked by atypical N- and C-terminal extensions that are found in a no. of putative PPIases present mostly in β proteobacteria.  Par27 displays both PPIase and chaperone activities in vitro.  In vivo, Par27 might function as a general periplasmic chaperone in B. pertussis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQrGescYP8h7Vg90H21EOLACvtfcHk0lhRfbCH9lEALQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2ns7k%253D&md5=11bc155dad78c5024d42aac56fc560c6</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.10.088%26sid%3Dliteratum%253Aachs%26aulast%3DHodak%26aufirst%3DH.%26aulast%3DWohlk%25C3%25B6nig%26aufirst%3DA.%26aulast%3DSmet-Nocca%26aufirst%3DC.%26aulast%3DDrobecq%26aufirst%3DH.%26aulast%3DWieruszeski%26aufirst%3DJ.-M.%26aulast%3DS%25C3%25A9n%25C3%25A9chal%26aufirst%3DM.%26aulast%3DLandrieu%26aufirst%3DI.%26aulast%3DLocht%26aufirst%3DC.%26aulast%3DJamin%26aufirst%3DM.%26aulast%3DJacob-Dubuisson%26aufirst%3DF.%26atitle%3DThe%2520Peptidyl%25E2%2580%2593Prolyl%2520Isomerase%2520and%2520Chaperone%2520Par27%2520of%2520Bordetella%2520pertussis%2520as%2520the%2520Prototype%2520for%2520a%2520New%2520Group%2520of%2520Parvulins%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D376%26issue%3D2%26spage%3D414%26epage%3D426%26doi%3D10.1016%2Fj.jmb.2007.10.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obi, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, M. S.</span></span> <span> </span><span class="NLM_article-title">Demarcating SurA Activities Required for Outer Membrane Targeting of Yersinia pseudotuberculosis Adhesins</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2308</span>, <span class="refDoi"> DOI: 10.1128/IAI.01208-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.01208-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23589578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=2296-2308&issue=7&author=I.+R.+Obiauthor=M.+S.+Francis&title=Demarcating+SurA+Activities+Required+for+Outer+Membrane+Targeting+of+Yersinia+pseudotuberculosis+Adhesins&doi=10.1128%2FIAI.01208-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Demarcating SurA activities required for outer membrane targeting of Yersinia pseudotuberculosis adhesins</span></div><div class="casAuthors">Obi, Ikenna R.; Francis, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2296-2308</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">SurA is a periplasmic protein folding factor involved in chaperoning and trafficking of outer membrane proteins across the Gram-neg. bacterial periplasm.  In addn., SurA also possesses peptidyl-prolyl cis/trans isomerase activity.  The authors have previously reported that in enteropathogenic Yersinia pseudotuberculosis, SurA is needed for bacterial virulence and envelope integrity.  The authors studied the role of SurA in the assembly of important Yersinia adhesins.  Using genetic mutation, biochem. characterization, and an in vitro-based bacterial host cell assocn. assay, surface localization of the invasin adhesin was shown to be dependent on SurA.  As a surA deletion also has some impact on the levels of individual components of the BAM complex in the Yersinia outer membrane, abolished invasin surface assembly could reflect both a direct loss of SurA-dependent periplasmic targeting and a potentially compromised BAM complex assembly platform in the outer membrane.  To various degrees, the assembly of two other adhesins, Ail and the pH 6 antigen fibrillum PsaA, also depends on SurA.  Consequently, loss of SurA leads to a dramatic redn. in Yersinia attachment to eukaryotic host cells.  Genetic complementation of surA deletion mutants indicated a prominent role for SurA chaperone function in outer membrane protein assembly.  Significantly, the N terminus of SurA contributed most of this SurA chaperone function.  Despite a dominant chaperoning role, it was also evident that SurA isomerization activity did make a modest contribution to this assembly process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob6A1qQqv4ubVg90H21EOLACvtfcHk0lhKF6dUpUx3-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsLzP&md5=9fbf158bad73ce0a0a0dbc5186492c95</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1128%2FIAI.01208-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.01208-12%26sid%3Dliteratum%253Aachs%26aulast%3DObi%26aufirst%3DI.%2BR.%26aulast%3DFrancis%26aufirst%3DM.%2BS.%26atitle%3DDemarcating%2520SurA%2520Activities%2520Required%2520for%2520Outer%2520Membrane%2520Targeting%2520of%2520Yersinia%2520pseudotuberculosis%2520Adhesins%26jtitle%3DInfect.%2520Immun.%26date%3D2013%26volume%3D81%26issue%3D7%26spage%3D2296%26epage%3D2308%26doi%3D10.1128%2FIAI.01208-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obi, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordfelth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, M. S.</span></span> <span> </span><span class="NLM_article-title">Varying Dependency of Periplasmic Peptidyl-Prolyl Cis–Trans Isomerases in Promoting Yersinia pseudotuberculosis Stress Tolerance and Pathogenicity</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>439</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1042/BJ20110767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1042%2FBJ20110767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21726196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yku77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2011&pages=321-332&issue=2&author=I.+R.+Obiauthor=R.+Nordfelthauthor=M.+S.+Francis&title=Varying+Dependency+of+Periplasmic+Peptidyl-Prolyl+Cis%E2%80%93Trans+Isomerases+in+Promoting+Yersinia+pseudotuberculosis+Stress+Tolerance+and+Pathogenicity&doi=10.1042%2FBJ20110767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Varying dependency of periplasmic peptidylprolyl cis-trans isomerases in promoting Yersinia pseudotuberculosis stress tolerance and pathogenicity</span></div><div class="casAuthors">Obi, Ikenna R.; Nordfelth, Roland; Francis, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-332</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Periplasmic PPIases (peptidylprolyl cis-trans isomerases) catalyze the cis-trans isomerization of peptidyl-prolyl bonds, which is a rate-limiting step during protein folding.  We demonstrate that the surA, ppiA, ppiD, fkpA and fklB alleles each encode a periplasmic PPIase in the bacterial pathogen Yersinia pseudotuberculosis.  Of these, four were purified to homogeneity.  Purified SurA, FkpA and FklB, but not PpiD, displayed detectable PPIase activity in vitro.  Significantly, only Y. pseudotuberculosis lacking surA caused drastic alterations to the outer membrane protein profile and FA (fatty acid) compn.  They also exhibited aberrant cellular morphol., leaking LPS (lipopolysaccharide) into the extracellular environment.  The SurA PPIase is therefore most crit. for maintaining Y. pseudotuberculosis envelope integrity during routine culturing.  On the other hand, bacteria lacking either surA or all of the genes ppiA, ppiD, fkpA and fklB were sensitive to hydrogen peroxide and were attenuated in mice infections.  Thus Y. pseudotuberculosis exhibits both SurA-dependent and -independent requirements for periplasmic PPIase activity to ensure in vivo survival and a full virulence effect in a mammalian host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv4gdZ-spK6LVg90H21EOLACvtfcHk0lhKF6dUpUx3-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yku77E&md5=2953215f282f7e89ebab3395cda746fb</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1042%2FBJ20110767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110767%26sid%3Dliteratum%253Aachs%26aulast%3DObi%26aufirst%3DI.%2BR.%26aulast%3DNordfelth%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DM.%2BS.%26atitle%3DVarying%2520Dependency%2520of%2520Periplasmic%2520Peptidyl-Prolyl%2520Cis%25E2%2580%2593Trans%2520Isomerases%2520in%2520Promoting%2520Yersinia%2520pseudotuberculosis%2520Stress%2520Tolerance%2520and%2520Pathogenicity%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D439%26issue%3D2%26spage%3D321%26epage%3D332%26doi%3D10.1042%2FBJ20110767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazemian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourmand, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siadat, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahdavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazdi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majelan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afshar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaseri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getso, M. I.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Immunogenicity Evaluation of PpiC, GeLE, and VS87_01105 Proteins of Enterococcus faecalis as Vaccine Candidates</span>. <i>Iran. Biomed. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.29252/ibj.23.5.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.29252%2Fibj.23.5.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=343-353&issue=5&author=H.+Kazemianauthor=M.+R.+Pourmandauthor=S.+D.+Siadatauthor=M.+Mahdaviauthor=M.+H.+Yazdiauthor=P.+A.+Majelanauthor=D.+Afsharauthor=M.+Yaseriauthor=M.+Davariauthor=M.+I.+Getso&title=Molecular+Cloning+and+Immunogenicity+Evaluation+of+PpiC%2C+GeLE%2C+and+VS87_01105+Proteins+of+Enterococcus+faecalis+as+Vaccine+Candidates&doi=10.29252%2Fibj.23.5.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.29252%2Fibj.23.5.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.29252%252Fibj.23.5.6%26sid%3Dliteratum%253Aachs%26aulast%3DKazemian%26aufirst%3DH.%26aulast%3DPourmand%26aufirst%3DM.%2BR.%26aulast%3DSiadat%26aufirst%3DS.%2BD.%26aulast%3DMahdavi%26aufirst%3DM.%26aulast%3DYazdi%26aufirst%3DM.%2BH.%26aulast%3DMajelan%26aufirst%3DP.%2BA.%26aulast%3DAfshar%26aufirst%3DD.%26aulast%3DYaseri%26aufirst%3DM.%26aulast%3DDavari%26aufirst%3DM.%26aulast%3DGetso%26aufirst%3DM.%2BI.%26atitle%3DMolecular%2520Cloning%2520and%2520Immunogenicity%2520Evaluation%2520of%2520PpiC%252C%2520GeLE%252C%2520and%2520VS87_01105%2520Proteins%2520of%2520Enterococcus%2520faecalis%2520as%2520Vaccine%2520Candidates%26jtitle%3DIran.%2520Biomed.%2520J.%26date%3D2019%26volume%3D23%26issue%3D5%26spage%3D343%26epage%3D353%26doi%3D10.29252%2Fibj.23.5.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datsenko, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Construction of Escherichia coli K-12 In-Frame, Single-Gene Knockout Mutants: the Keio Collection</span>. <i>Mol. Syst. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2006.0008</span>, <span class="refDoi"> DOI: 10.1038/msb4100050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fmsb4100050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16738554" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=2006.0008&issue=1&author=T.+Babaauthor=T.+Araauthor=M.+Hasegawaauthor=Y.+Takaiauthor=Y.+Okumuraauthor=M.+Babaauthor=K.+A.+Datsenkoauthor=M.+Tomitaauthor=B.+L.+Wannerauthor=H.+Mori&title=Construction+of+Escherichia+coli+K-12+In-Frame%2C+Single-Gene+Knockout+Mutants%3A+the+Keio+Collection&doi=10.1038%2Fmsb4100050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fmsb4100050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmsb4100050%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DAra%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTakai%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDatsenko%26aufirst%3DK.%2BA.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DWanner%26aufirst%3DB.%2BL.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DConstruction%2520of%2520Escherichia%2520coli%2520K-12%2520In-Frame%252C%2520Single-Gene%2520Knockout%2520Mutants%253A%2520the%2520Keio%2520Collection%26jtitle%3DMol.%2520Syst.%2520Biol.%26date%3D2006%26volume%3D2%26issue%3D1%26spage%3D2006.0008%26doi%3D10.1038%2Fmsb4100050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span> <span> </span><span class="NLM_article-title">Defining the Roles of the Periplasmic Chaperones SurA, Skp, and DegP in Escherichia coli</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2473</span>– <span class="NLM_lpage">2484</span>, <span class="refDoi"> DOI: 10.1101/gad.1581007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1101%2Fgad.1581007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17908933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKrtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2473-2484&issue=19&author=J.+G.+Sklarauthor=T.+Wuauthor=D.+Kahneauthor=T.+J.+Silhavy&title=Defining+the+Roles+of+the+Periplasmic+Chaperones+SurA%2C+Skp%2C+and+DegP+in+Escherichia+coli&doi=10.1101%2Fgad.1581007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli</span></div><div class="casAuthors">Sklar, Joseph G.; Wu, Tao; Kahne, Daniel; Silhavy, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2473-2484</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Integral β-barrel proteins (OMPs) are a major class of outer membrane proteins in Gram-neg. bacteria.  In Escherichia coli, these proteins are synthesized in the cytoplasm, translocated across the inner membrane via the Sec machinery, and assembled in the outer membrane through an unknown mechanism that requires the outer membrane YaeT complex and the periplasmic chaperones SurA, DegP, and Skp.  Here, we have established the relationship between these three chaperones providing insight into the mechanism of OMP biogenesis using depletion anal.  Depletion of SurA alone results in a marked decrease in outer membrane d., while the loss of DegP and Skp has no effect on outer membrane compn.  Furthermore, we demonstrate that SurA and YaeT interact directly in vivo.  Based on these results, we suggest that SurA is the primary chaperone responsible for the periplasmic transit of the bulk mass of OMPs to the YaeT complex.  The role of Skp and DegP is amplified in the absence of SurA.  Evidence presented suggests that DegP/Skp function to rescue OMPs that fall off the SurA pathway.  The seemingly redundant periplasmic chaperones do function in parallel, but the relative importance of the primary function of each pathway depends on whether or not cells are under stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2opsuBX_ju7Vg90H21EOLACvtfcHk0lhmFg2MnAxirQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKrtL3I&md5=52149f8fdbdf7251ce0b5e2f3dec5e11</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1101%2Fgad.1581007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1581007%26sid%3Dliteratum%253Aachs%26aulast%3DSklar%26aufirst%3DJ.%2BG.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26atitle%3DDefining%2520the%2520Roles%2520of%2520the%2520Periplasmic%2520Chaperones%2520SurA%252C%2520Skp%252C%2520and%2520DegP%2520in%2520Escherichia%2520coli%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26issue%3D19%26spage%3D2473%26epage%3D2484%26doi%3D10.1101%2Fgad.1581007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vertommen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverrier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collet, J. F.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Role of the Escherichia coli Periplasmic Chaperone SurA using Differential Proteomics</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2432</span>– <span class="NLM_lpage">2443</span>, <span class="refDoi"> DOI: 10.1002/pmic.200800794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fpmic.200800794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19343722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=2432-2443&issue=9&author=D.+Vertommenauthor=N.+Ruizauthor=P.+Leverrierauthor=T.+J.+Silhavyauthor=J.+F.+Collet&title=Characterization+of+the+Role+of+the+Escherichia+coli+Periplasmic+Chaperone+SurA+using+Differential+Proteomics&doi=10.1002%2Fpmic.200800794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the role of the Escherichia coli periplasmic chaperone SurA using differential proteomics</span></div><div class="casAuthors">Vertommen, Didier; Ruiz, Natividad; Leverrier, Pauline; Silhavy, Thomas J.; Collet, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2432-2443</span>CODEN:
                <span class="NLM_cas:coden">PROTC7</span>;
        ISSN:<span class="NLM_cas:issn">1615-9853</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Little is known on how β-barrel proteins are assembled in the outer membrane (OM) of Gram-neg. bacteria.  SurA has been proposed to be the primary chaperone escorting the bulk mass of OM proteins across the periplasm.  However, the impact of SurA deletion on the global OM proteome has not been detd., thereby limiting our understanding of the function of SurA.  By using a differential proteomics approach based on 2-D LC-MSn, we compared the relative abundance of 64 OM proteins, including 23 β-barrel proteins, in wild-type and surA strains.  Unexpectedly, we found that the loss of SurA affects the abundance of eight β-barrel proteins.  Of all the decreased proteins, FhuA and LptD are the only two for which the decreased protein abundance cannot be attributed, at least in part, to decreased mRNA levels in the surA strain.  In the case of LptD, an essential protein involved in OM biogenesis, our data support a role for SurA in the assembly of this protein and suggest that LptD is a true SurA substrate.  Based on our results, we propose a revised model in which only a subset of OM proteins depends on SurA for proper folding and insertion in the OM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2VqT_VriKarVg90H21EOLACvtfcHk0lhmFg2MnAxirQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVChsLk%253D&md5=e4f2e1fe49b881c320430bb190f8cc75</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fpmic.200800794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.200800794%26sid%3Dliteratum%253Aachs%26aulast%3DVertommen%26aufirst%3DD.%26aulast%3DRuiz%26aufirst%3DN.%26aulast%3DLeverrier%26aufirst%3DP.%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26aulast%3DCollet%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520Role%2520of%2520the%2520Escherichia%2520coli%2520Periplasmic%2520Chaperone%2520SurA%2520using%2520Differential%2520Proteomics%26jtitle%3DProteomics%26date%3D2009%26volume%3D9%26issue%3D9%26spage%3D2432%26epage%3D2443%26doi%3D10.1002%2Fpmic.200800794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Baño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcalá, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisneros, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horcajada, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tórtola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirelis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peña, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llanos, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, A.</span></span> <span> </span><span class="NLM_article-title">Community Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli</span>. <i>Arch. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1897</span>– <span class="NLM_lpage">1902</span>, <span class="refDoi"> DOI: 10.1001/archinte.168.17.1897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1001%2Farchinte.168.17.1897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18809817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2rur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2008&pages=1897-1902&issue=17&author=J.+Rodr%C3%ADguez-Ba%C3%B1oauthor=J.+C.+Alcal%C3%A1author=J.+M.+Cisnerosauthor=F.+Grillauthor=A.+Oliverauthor=J.+P.+Horcajadaauthor=T.+T%C3%B3rtolaauthor=B.+Mirelisauthor=G.+Navarroauthor=M.+Cuencaauthor=M.+Esteveauthor=C.+Pe%C3%B1aauthor=A.+C.+Llanosauthor=R.+Cant%C3%B3nauthor=A.+Pascual&title=Community+Infections+Caused+by+Extended-Spectrum+%CE%B2-Lactamase-Producing+Escherichia+coli&doi=10.1001%2Farchinte.168.17.1897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli</span></div><div class="casAuthors">Rodriguez-Bano, Jesus; Alcala, Juan C.; Cisneros, Jose M.; Grill, Fabio; Oliver, Antonio; Horcajada, Juan P.; Tortola, Teresa; Mirelis, Beatriz; Navarro, Gemma; Cuenca, Maria; Esteve, Maria; Pena, Carmen; Llanos, Ana C.; Canton, Rafael; Pascual, Alvaro</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Internal Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1897-1902</span>CODEN:
                <span class="NLM_cas:coden">AIMDAP</span>;
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is an increasingly important group of community pathogens worldwide.  These organisms are frequently resistant to many of the antimicrobial agents usually recommended for the treatment of infections caused by E coli, such as penicillins, cephalosporins, fluoroquinolones, and trimethoprim-sulfamethoxazole.  Data concerning risk factors, clin. features, and therapeutic options for such infections are scarce.  A case-control study was performed to investigate the risk factors for all types of community-acquired infections caused by ESBL-producing E coli in 11 Spanish hospitals from Feb. 2002 to May 2003.  Controls were randomly chosen from among outpatients with a clin. sample not yielding ESBL-producing E coli.  The clin. features of these infections were investigated in the case patients.  The efficacy of fosfomycin tromethamine and amoxicillin-clavulanate potassium was observationally studied in patients with cystitis.  A total of 122 cases were included.  Risk factors selected by multivariate anal. included the following: age older than 60 years; female sex; diabetes mellitus; recurrent urinary tract infections (UTIs); previous invasive procedures of the urinary tract; follow-up in outpatient clinic; and previous receipt of aminopenicillins, cephalosporins, and fluoroquinolones.  Urinary tract infections accounted for 93% of the cases; 6% of the patients were bacteremic and 10% needed hospitalization.  The cure rate of patients with cystitis was 93% with fosfomycin therapy (all isolates were susceptible); among patients treated with amoxicillin-clavulanate, cure rates were 93% for those with susceptible isolates (min. inhibitory concn. ≤8 μg/mL) and 56% for those with intermediate or resistant isolates (min. inhibitory concn. ≥16 μg/mL) (P = .02).  In predisposed patients, ESBL-producing E coli is a notable cause of community-acquired infection, and particularly UTI.  Fosfomycin and amoxicillin-clavulanate appear to be effective for cystitis caused by susceptible isolates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6OXF87GbT4LVg90H21EOLACvtfcHk0lhmFg2MnAxirQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2rur7F&md5=8ccad2fd624eab92c60df972f9f655bb</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1001%2Farchinte.168.17.1897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.168.17.1897%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Ba%25C3%25B1o%26aufirst%3DJ.%26aulast%3DAlcal%25C3%25A1%26aufirst%3DJ.%2BC.%26aulast%3DCisneros%26aufirst%3DJ.%2BM.%26aulast%3DGrill%26aufirst%3DF.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DHorcajada%26aufirst%3DJ.%2BP.%26aulast%3DT%25C3%25B3rtola%26aufirst%3DT.%26aulast%3DMirelis%26aufirst%3DB.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DCuenca%26aufirst%3DM.%26aulast%3DEsteve%26aufirst%3DM.%26aulast%3DPe%25C3%25B1a%26aufirst%3DC.%26aulast%3DLlanos%26aufirst%3DA.%2BC.%26aulast%3DCant%25C3%25B3n%26aufirst%3DR.%26aulast%3DPascual%26aufirst%3DA.%26atitle%3DCommunity%2520Infections%2520Caused%2520by%2520Extended-Spectrum%2520%25CE%25B2-Lactamase-Producing%2520Escherichia%2520coli%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2008%26volume%3D168%26issue%3D17%26spage%3D1897%26epage%3D1902%26doi%3D10.1001%2Farchinte.168.17.1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rottier, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammerlaan, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, M. J.</span></span> <span> </span><span class="NLM_article-title">Effects of Confounders and Intermediates on the Association of Bacteraemia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae and Patient Outcome: a Meta-Analysis</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1093/jac/dks065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Fjac%2Fdks065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22396430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1311-1320&issue=6&author=W.+C.+Rottierauthor=H.+S.+Ammerlaanauthor=M.+J.+Bonten&title=Effects+of+Confounders+and+Intermediates+on+the+Association+of+Bacteraemia+Caused+by+Extended-Spectrum+%CE%B2-Lactamase-Producing+Enterobacteriaceae+and+Patient+Outcome%3A+a+Meta-Analysis&doi=10.1093%2Fjac%2Fdks065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of confounders and intermediates on the association of bacteremia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis</span></div><div class="casAuthors">Rottier, Wouter C.; Ammerlaan, Heidi S. M.; Bonten, Marc J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1311-1320</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Bacteremia caused by Enterobacteriaceae (EB) producing extended-spectrum β-lactamase (ESBL+) has been assocd. with higher mortality compared with non-ESBL-producing (ESBL-) EB bacteremia in observational studies.  We conducted a systematic review and meta-anal. of these studies to assess how adjusting for confounding in multivariate analyses affects the pooled est., and whether multivariate analyses that include intermediates in the causal pathway of outcome (sepsis severity and inadequate empirical therapy) have lower ests. of attributable mortality.  PubMed search on 23 Nov. 2010 followed by manually searching ref. lists of included studies.  Study eligibility criteria Cohort studies published in English with sep. mortality rates for ESBL+ and ESBL- EB bacteremia.  Random-effects pooling of unadjusted and adjusted ORs followed by subgroup analyses to explore effects of adjustment procedures on adjusted ORs.  The pooled OR for the unadjusted mortality assocd. with ESBL prodn. was 2.35 (95% CI 1.90-2.91, I2 = 42%, 32 studies).  The pooled adjusted OR was 1.52 (95% CI 1.15-2.01, I2 = 32%, 15 studies).  Adjustment for more intermediates was assocd. with decreasing ORs.  The pooled OR for the analyses adjusting for inadequate empirical therapy was 1.37 (95% CI 1.04-1.82).  Conclusions ESBL prodn. in EB bacteremia is assocd. with a higher mortality compared with bacteremia with ESBL- EB, although the est. of this assocn. is affected by adjustment procedures.  Adjustment for inadequate empirical therapy leads to a redn. in ORs, indicating that higher mortality is likely to be mediated through this phenomenon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbndAdIkiqAbVg90H21EOLACvtfcHk0ljbJb8lqKSuMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2qt74%253D&md5=e2db4e94813a9addfb61eb3b80b0b939</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks065%26sid%3Dliteratum%253Aachs%26aulast%3DRottier%26aufirst%3DW.%2BC.%26aulast%3DAmmerlaan%26aufirst%3DH.%2BS.%26aulast%3DBonten%26aufirst%3DM.%2BJ.%26atitle%3DEffects%2520of%2520Confounders%2520and%2520Intermediates%2520on%2520the%2520Association%2520of%2520Bacteraemia%2520Caused%2520by%2520Extended-Spectrum%2520%25CE%25B2-Lactamase-Producing%2520Enterobacteriaceae%2520and%2520Patient%2520Outcome%253A%2520a%2520Meta-Analysis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26issue%3D6%26spage%3D1311%26epage%3D1320%26doi%3D10.1093%2Fjac%2Fdks065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">The Isomerase PIN1 Controls Numerous Cancer-Driving Pathways and is a Unique Drug Target</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnrc.2016.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27256007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XptV2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=463-478&issue=7&author=X.+Z.+Zhouauthor=K.+P.+Lu&title=The+Isomerase+PIN1+Controls+Numerous+Cancer-Driving+Pathways+and+is+a+Unique+Drug+Target&doi=10.1038%2Fnrc.2016.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</span></div><div class="casAuthors">Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">463-478</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeted drugs have changed cancer treatment but are often ineffective in the long term against solid tumors, largely because of the activation of heterogeneous oncogenic pathways.  A central common signalling mechanism in many of these pathways is proline-directed phosphorylation, which is regulated by many kinases and phosphatases.  The structure and function of these phosphorylated proteins are further controlled by a single proline isomerase: PIN1.  PIN1 is overactivated in cancers and it promotes cancer and cancer stem cells by disrupting the balance of oncogenes and tumor suppressors.  This review discusses the roles of PIN1 in cancer and the potential of PIN1 inhibitors to restore this balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUoqPfQTmR7Vg90H21EOLACvtfcHk0ljbJb8lqKSuMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptV2isLo%253D&md5=d43428a5099591624980fede9c91fbab</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.49%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DThe%2520Isomerase%2520PIN1%2520Controls%2520Numerous%2520Cancer-Driving%2520Pathways%2520and%2520is%2520a%2520Unique%2520Drug%2520Target%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26issue%3D7%26spage%3D463%26epage%3D478%26doi%3D10.1038%2Fnrc.2016.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A.</span></span> <span> </span><span class="NLM_article-title">Pin1 Inhibitors: Pitfalls, Progress and Cellular Pharmacology</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4283</span>– <span class="NLM_lpage">4291</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2013.05.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23796453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVShsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4283-4291&issue=15&author=J.+D.+Mooreauthor=A.+Potter&title=Pin1+Inhibitors%3A+Pitfalls%2C+Progress+and+Cellular+Pharmacology&doi=10.1016%2Fj.bmcl.2013.05.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 inhibitors: Pitfalls, progress and cellular pharmacology</span></div><div class="casAuthors">Moore, Jonathan D.; Potter, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4283-4291</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Compelling data supports the hypothesis that Pin1 inhibitors will be useful for the therapy of cancer: Pin1 deficient mice resist the induction of breast cancers normally evoked by expression of MMTV-driven Ras or Erb2 alleles.  While Pin1 poses challenges for drug discovery, several groups have identified potent antagonists by structure based drug design, significant progress has been made designing peptidic inhibitors and a no. of natural products have been found that blockade Pin1, notably epigallocatchechin gallate (EGCG), a major flavonoid in green tea.  Here we critically discuss the modes of action and likely specificity of these compds., concluding that a suitable chem. biol. tool for probing the function of Pin1 has yet to be found.  We conclude by outlining some open questions regarding the target validation of Pin1 and the prospects for identification of improved inhibitors in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8su1BMHiwErVg90H21EOLACvtfcHk0ljbJb8lqKSuMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVShsbfP&md5=d078f5975ede469ad74619eb7e6de031</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.088%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DPin1%2520Inhibitors%253A%2520Pitfalls%252C%2520Progress%2520and%2520Cellular%2520Pharmacology%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4283%26epage%3D4291%26doi%3D10.1016%2Fj.bmcl.2013.05.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunyak, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestwicki, J. E.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9622</span>– <span class="NLM_lpage">9644</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKms73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9622-9644&issue=21&author=B.+M.+Dunyakauthor=J.+E.+Gestwicki&title=Peptidyl-Proline+Isomerases+%28PPIases%29%3A+Targets+for+Natural+Products+and+Natural+Product-Inspired+Compounds&doi=10.1021%2Facs.jmedchem.6b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds</span></div><div class="casAuthors">Dunyak, Bryan M.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9622-9644</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptidyl-proline isomerases (PPIases) are a chaperone superfamily comprising the FK506-binding proteins (FKBPs), cyclophilins, and parvulins.  PPIases catalyze the cis/trans isomerization of proline, acting as a regulatory switch during folding, activation, and/or degrdn. of many proteins.  These "clients" include proteins with key roles in cancer, neurodegeneration, and psychiatric disorders, suggesting that PPIase inhibitors could be important therapeutics.  However, the active site of PPIases is shallow, solvent-exposed, and well conserved between family members, making selective inhibitor design challenging.  Despite these hurdles, macrocyclic natural products, including FK506, rapamycin, and cyclosporin, bind PPIases with nanomolar or better affinity.  De novo attempts to derive new classes of inhibitors have been somewhat less successful, often showcasing the "undruggable" features of PPIases.  Interestingly, the most potent of these next-generation mols. tend to integrate features of the natural products, including macrocyclization or proline mimicry strategies.  Here, we review recent developments and ongoing challenges in the inhibition of PPIases, with a focus on how natural products might inform the creation of potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz44xLeDGfhLVg90H21EOLACvtfcHk0lhwx_B-nLTw0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKms73J&md5=b4c6336096f9558926d965d73fb6b7da</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00411%26sid%3Dliteratum%253Aachs%26aulast%3DDunyak%26aufirst%3DB.%2BM.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DPeptidyl-Proline%2520Isomerases%2520%2528PPIases%2529%253A%2520Targets%2520for%2520Natural%2520Products%2520and%2520Natural%2520Product-Inspired%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D21%26spage%3D9622%26epage%3D9644%26doi%3D10.1021%2Facs.jmedchem.6b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campaner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustighi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zannini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalid, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valsasina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippione, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giabbai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carloni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Incalci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappuzzello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Sal, G.</span></span> <span> </span><span class="NLM_article-title">A Covalent PIN1 Inhibitor Selectively Targets Cancer Cells by a Dual Mechanism of Action</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15772</span>, <span class="refDoi"> DOI: 10.1038/ncomms15772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fncomms15772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28598431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmslSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15772&author=E.+Campanerauthor=A.+Rustighiauthor=A.+Zanniniauthor=A.+Cristianiauthor=S.+Piazzaauthor=Y.+Cianiauthor=O.+Kalidauthor=G.+Golanauthor=E.+Balogluauthor=S.+Shachamauthor=B.+Valsasinaauthor=U.+Cucchiauthor=A.+C.+Pippioneauthor=M.+L.+Lolliauthor=B.+Giabbaiauthor=P.+Storiciauthor=P.+Carloniauthor=G.+Rossettiauthor=F.+Benvenutiauthor=E.+Belloauthor=M.+D%E2%80%99Incalciauthor=E.+Cappuzzelloauthor=A.+Rosatoauthor=G.+Del+Sal&title=A+Covalent+PIN1+Inhibitor+Selectively+Targets+Cancer+Cells+by+a+Dual+Mechanism+of+Action&doi=10.1038%2Fncomms15772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action</span></div><div class="casAuthors">Campaner Elena; Rustighi Alessandra; Zannini Alessandro; Cristiani Alberto; Piazza Silvano; Ciani Yari; Del Sal Giannino; Campaner Elena; Zannini Alessandro; Del Sal Giannino; Kalid Ori; Golan Gali; Baloglu Erkan; Shacham Sharon; Valsasina Barbara; Cucchi Ulisse; Pippione Agnese Chiara; Lolli Marco Lucio; Giabbai Barbara; Storici Paola; Carloni Paolo; Rossetti Giulia; Rossetti Giulia; Rossetti Giulia; Benvenuti Federica; Bello Ezia; D'Incalci Maurizio; Cappuzzello Elisa; Rosato Antonio; Rosato Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15772</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The prolyl isomerase PIN1, a critical modifier of multiple signalling pathways, is overexpressed in the majority of cancers and its activity strongly contributes to tumour initiation and progression.  Inactivation of PIN1 function conversely curbs tumour growth and cancer stem cell expansion, restores chemosensitivity and blocks metastatic spread, thus providing the rationale for a therapeutic strategy based on PIN1 inhibition.  Notwithstanding, potent PIN1 inhibitors are still missing from the arsenal of anti-cancer drugs.  By a mechanism-based screening, we have identified a novel covalent PIN1 inhibitor, KPT-6566, able to selectively inhibit PIN1 and target it for degradation.  We demonstrate that KPT-6566 covalently binds to the catalytic site of PIN1.  This interaction results in the release of a quinone-mimicking drug that generates reactive oxygen species and DNA damage, inducing cell death specifically in cancer cells.  Accordingly, KPT-6566 treatment impairs PIN1-dependent cancer phenotypes in vitro and growth of lung metastasis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeCgKMDdtGrcULxIEhxUjPfW6udTcc2eYpnY-mcIdA5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmslSgtA%253D%253D&md5=36747881bb866fc653478916352b6f96</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1038%2Fncomms15772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15772%26sid%3Dliteratum%253Aachs%26aulast%3DCampaner%26aufirst%3DE.%26aulast%3DRustighi%26aufirst%3DA.%26aulast%3DZannini%26aufirst%3DA.%26aulast%3DCristiani%26aufirst%3DA.%26aulast%3DPiazza%26aufirst%3DS.%26aulast%3DCiani%26aufirst%3DY.%26aulast%3DKalid%26aufirst%3DO.%26aulast%3DGolan%26aufirst%3DG.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DPippione%26aufirst%3DA.%2BC.%26aulast%3DLolli%26aufirst%3DM.%2BL.%26aulast%3DGiabbai%26aufirst%3DB.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DCarloni%26aufirst%3DP.%26aulast%3DRossetti%26aufirst%3DG.%26aulast%3DBenvenuti%26aufirst%3DF.%26aulast%3DBello%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Incalci%26aufirst%3DM.%26aulast%3DCappuzzello%26aufirst%3DE.%26aulast%3DRosato%26aufirst%3DA.%26aulast%3DDel%2BSal%26aufirst%3DG.%26atitle%3DA%2520Covalent%2520PIN1%2520Inhibitor%2520Selectively%2520Targets%2520Cancer%2520Cells%2520by%2520a%2520Dual%2520Mechanism%2520of%2520Action%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15772%26doi%3D10.1038%2Fncomms15772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, P.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Human Parvulins Pin1 and Par14/17</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>399</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1515/hsz-2017-0137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1515%2Fhsz-2017-0137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29040060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=2018&pages=101-125&issue=2&author=A.+Matenaauthor=E.+Rehicauthor=D.+Honigauthor=B.+Kambaauthor=P.+Bayer&title=Structure+and+Function+of+the+Human+Parvulins+Pin1+and+Par14%2F17&doi=10.1515%2Fhsz-2017-0137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the human parvulins Pin1 and Par14/17</span></div><div class="casAuthors">Matena, Anja; Rehic, Edisa; Hoenig, Dana; Kamba, Bianca; Bayer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-125</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Parvulins belong to the family of peptidyl-prolyl cis/trans isomerases (PPIases) assisting in protein folding and in regulating the function of a broad variety of proteins in all branches of life.  The human representatives Pin1 and Par14/17 are directly involved in processes influencing cellular maintenance and cell fate decisions such as cell-cycle progression, metabolic pathways and ribosome biogenesis.  This review on human parvulins summarizes the current knowledge of these enzymes and intends to oppose the well-studied Pin1 to its less well-examd. homolog human Par14/17 with respect to structure, catalytic and cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV720QKhIJMLVg90H21EOLACvtfcHk0lhwx_B-nLTw0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSju7o%253D&md5=f86512448b520d5a23d6ab965661b4e0</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2017-0137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2017-0137%26sid%3Dliteratum%253Aachs%26aulast%3DMatena%26aufirst%3DA.%26aulast%3DRehic%26aufirst%3DE.%26aulast%3DHonig%26aufirst%3DD.%26aulast%3DKamba%26aufirst%3DB.%26aulast%3DBayer%26aufirst%3DP.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Human%2520Parvulins%2520Pin1%2520and%2520Par14%252F17%26jtitle%3DBiol.%2520Chem.%26date%3D2018%26volume%3D399%26issue%3D2%26spage%3D101%26epage%3D125%26doi%3D10.1515%2Fhsz-2017-0137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Sluijs, P.</span></span> <span> </span><span class="NLM_article-title">Juglone Inactivates Cysteine-Rich Proteins Required for Progression Through Mitosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">21714</span>– <span class="NLM_lpage">21724</span>, <span class="refDoi"> DOI: 10.1074/jbc.M710264200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M710264200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18539601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21714-21724&issue=31&author=C.+Filaauthor=C.+Metzauthor=P.+van+der+Sluijs&title=Juglone+Inactivates+Cysteine-Rich+Proteins+Required+for+Progression+Through+Mitosis&doi=10.1074%2Fjbc.M710264200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis</span></div><div class="casAuthors">Fila, Claudia; Metz, Corina; van der Sluijs, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">21714-21724</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The parvulin peptidyl-prolyl isomerase Pin1 catalyzes cis-trans isomerization of p(S/T)-P bonds and might alter conformation and function of client proteins.  Since the trans conformation of p(S/T)-P bonds is preferred by protein phosphatase 2A (PP2A), Pin1 may facilitate PP2A-mediated dephosphorylation.  Juglone irreversibly inhibits parvulins and is often used to study the function of Pin1 in vivo.  The drug prevents dephosphorylation of mitotic phosphoproteins, perhaps because they bind Pin1 and are dephosphorylated by PP2A.  We show here however that juglone inhibited post-mitotic dephosphorylation and the exit of mitosis, independent of Pin1.  This effect involved covalent modification of sulfhydryl groups in proteins essential for metaphase/anaphase transition.  Particularly cytoplasmic proteins with a high cysteine content were vulnerable to the drug.  Alkylation of sulfhydryl groups altered the conformation of such proteins, as evidenced by the disappearance of antibody epitopes on tubulin and the mitotic checkpoint component BubR1.  The latter activates the anaphase-promoting complex/cyclosome, which degrades regulatory proteins, such as cyclin B1 and securins, and is required for mitotic exit.  Indeed, juglone-treated cells failed to assemble a mitotic spindle, which correlated with perturbed microtubule dynamics, loss of immunodetectable tubulin, and formation of tubulin aggregates.  Juglone also prevented degrdn. of cyclin B1, independently of the Mps1-controlled mitotic spindle checkpoint.  Since juglone affected cell cycle progression at several levels, more specific drugs need to be developed for studies of Pin1 function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_CYTjs-XCaLVg90H21EOLACvtfcHk0lgZ2ZVqg1ulTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWrtr0%253D&md5=5c6ef075f4129b155a67420f7db2ae91</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M710264200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M710264200%26sid%3Dliteratum%253Aachs%26aulast%3DFila%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BSluijs%26aufirst%3DP.%26atitle%3DJuglone%2520Inactivates%2520Cysteine-Rich%2520Proteins%2520Required%2520for%2520Progression%2520Through%2520Mitosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D31%26spage%3D21714%26epage%3D21724%26doi%3D10.1074%2Fjbc.M710264200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wildemann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanghanel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Nanomolar Inhibitors of the Peptidyl Prolyl Cis/Trans Isomerase Pin1 from Combinatorial Peptide Libraries</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2147</span>– <span class="NLM_lpage">2150</span>, <span class="refDoi"> DOI: 10.1021/jm060036n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060036n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitl2itLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2147-2150&issue=7&author=D.+Wildemannauthor=F.+Erdmannauthor=B.+H.+Alvarezauthor=G.+Stollerauthor=X.+Z.+Zhouauthor=J.+Fanghanelauthor=M.+Schutkowskiauthor=K.+P.+Luauthor=G.+Fischer&title=Nanomolar+Inhibitors+of+the+Peptidyl+Prolyl+Cis%2FTrans+Isomerase+Pin1+from+Combinatorial+Peptide+Libraries&doi=10.1021%2Fjm060036n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomolar Inhibitors of the Peptidyl Prolyl Cis/Trans Isomerase Pin1 from Combinatorial Peptide Libraries</span></div><div class="casAuthors">Wildemann, Dirk; Erdmann, Frank; Hernandez Alvarez, Birte; Stoller, Gerlind; Zhou, Xiao Z.; Fanghaenel, Joerg; Schutkowski, Mike; Lu, Kun P.; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2147-2150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The peptidyl prolyl cis/trans isomerase Pin1 has been implicated in the development of cancer, Alzheimer's disease and asthma, but highly specific and potent Pin1 inhibitors remain to be identified.  Here, by screening a combinatorial peptide library, we identified a series of nanomolar peptidic inhibitors.  Nonproteinogenic amino acids, incorporated into 5-mer to 8-mer oligopeptides contg. a D-phosphothreonine as a central template, yielded selective inhibitors that blocked cell cycle progression in HeLa cells in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDg0JZfbs9RbVg90H21EOLACvtfcHk0lgZ2ZVqg1ulTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitl2itLg%253D&md5=1b6e0c69ced4c6bff5a0680f77d0a763</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Fjm060036n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060036n%26sid%3Dliteratum%253Aachs%26aulast%3DWildemann%26aufirst%3DD.%26aulast%3DErdmann%26aufirst%3DF.%26aulast%3DAlvarez%26aufirst%3DB.%2BH.%26aulast%3DStoller%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DFanghanel%26aufirst%3DJ.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DNanomolar%2520Inhibitors%2520of%2520the%2520Peptidyl%2520Prolyl%2520Cis%252FTrans%2520Isomerase%2520Pin1%2520from%2520Combinatorial%2520Peptide%2520Libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D7%26spage%3D2147%26epage%3D2150%26doi%3D10.1021%2Fjm060036n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildemann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdecia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for High-Affinity Peptide Inhibition of Human Pin1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1021/cb7000044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb7000044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFSltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=320-328&issue=5&author=Y.+Zhangauthor=S.+Daumauthor=D.+Wildemannauthor=X.+Z.+Zhouauthor=M.+A.+Verdeciaauthor=M.+E.+Bowmanauthor=C.+Luckeauthor=T.+Hunterauthor=K.+P.+Luauthor=G.+Fischerauthor=J.+P.+Noel&title=Structural+Basis+for+High-Affinity+Peptide+Inhibition+of+Human+Pin1&doi=10.1021%2Fcb7000044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for high-affinity peptide inhibition of human Pin1</span></div><div class="casAuthors">Zhang, Yan; Daum, Sebastian; Wildemann, Dirk; Zhou, Xiao Zhen; Verdecia, Mark A.; Bowman, Marianne E.; Lucke, Christian; Hunter, Tony; Lu, Kun-Ping; Fischer, Gunter; Noel, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">320-328</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human Pin1 is a key regulator of cell-cycle progression and plays growth-promoting roles in human cancers.  High-affinity inhibitors of Pin1 may provide a unique opportunity for disrupting oncogenic pathways.  Here the authors report two high-resoln. x-ray crystal structures of human Pin1 bound to nonnatural peptide inhibitors.  The structures of the bound high-affinity peptides identify a type-1 β-turn conformation for Pin1 prolyl peptide isomerase domain-peptide binding and an extensive mol. interface for high-affinity recognition.  Moreover, these structures suggest chem. elements that may further improve the affinity and pharmacol. properties of future peptide-based Pin inhibitors.  Finally, an intramol. hydrogen bond obsd. in both peptide complexes mimics the cyclic conformation of FK506 and rapamycin.  Both FK506 and rapamycin are clin. important inhibitors of other peptidyl-prolyl cis-trans isomerases.  This comparative discovery suggests that a cyclic peptide polyketide bridge, like that found in FK506 and rapamycin or a similar linkage, may significantly improve the binding affinity of structure-based Pin1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLtJ1MDtcTcbVg90H21EOLACvtfcHk0lgZ2ZVqg1ulTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFSltLY%253D&md5=597094a0bfb5d80583a21dadeadc7c60</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fcb7000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb7000044%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DWildemann%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DVerdecia%26aufirst%3DM.%2BA.%26aulast%3DBowman%26aufirst%3DM.%2BE.%26aulast%3DLucke%26aufirst%3DC.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520Basis%2520for%2520High-Affinity%2520Peptide%2520Inhibition%2520of%2520Human%2520Pin1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26issue%3D5%26spage%3D320%26epage%3D328%26doi%3D10.1021%2Fcb7000044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Membrane Permeable Cyclic Peptidyl Inhibitors Against Human Peptidyl-Prolyl Isomerase Pin1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2494</span>– <span class="NLM_lpage">2501</span>, <span class="refDoi"> DOI: 10.1021/jm901778v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901778v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlKiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2494-2501&issue=6&author=T.+Liuauthor=Y.+Liuauthor=H.+Y.+Kaoauthor=D.+Pei&title=Membrane+Permeable+Cyclic+Peptidyl+Inhibitors+Against+Human+Peptidyl-Prolyl+Isomerase+Pin1&doi=10.1021%2Fjm901778v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Permeable Cyclic Peptidyl Inhibitors against Human Peptidylprolyl Isomerase Pin1</span></div><div class="casAuthors">Liu, Tao; Liu, Yu; Kao, Hung-Ying; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2494-2501</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptidylprolyl isomerase Pin1 regulates the function and/or stability of phosphoproteins by altering the conformation of specific pSer/pThr-Pro peptide bonds.  In this work, a cyclic peptide library was synthesized and screened against the catalytic domain of human Pin1.  The selected inhibitors contained a consensus motif of D-pThr-Pip-Nal (where Pip is L-piperidine-2-carboxylic acid and Nal is L-2-naphthylalanine).  Representative compds. were tested for binding to Pin1 by isothermal titrn. calorimetry and inhibition of Pin1 activity, and the most potent inhibitors had KD (and KI) values in the low nanomolar range.  Treatment of breast cancer cells with the inhibitors, which were rendered membrane permeable by attachment of an octaarginine sequence, inhibited cell proliferation and increased the protein levels of two previously established Pin1 substrates, PML and SMRT.  Finally, a second generation of cell permeable Pin1 inhibitors was designed by replacing the noncrit. residues within the cyclic peptide ring with arginine residues and shown to have antiproliferative activity against the cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHy73i3_6BkLVg90H21EOLACvtfcHk0lgRrltK3RTk3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlKiurc%253D&md5=2af6a30c6399cb98689e3c0cdc7879cf</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1021%2Fjm901778v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901778v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKao%26aufirst%3DH.%2BY.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DMembrane%2520Permeable%2520Cyclic%2520Peptidyl%2520Inhibitors%2520Against%2520Human%2520Peptidyl-Prolyl%2520Isomerase%2520Pin1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D6%26spage%3D2494%26epage%3D2501%26doi%3D10.1021%2Fjm901778v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briesewitz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrios, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhiang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1021/cb3005275</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb3005275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1akur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=423-431&issue=2&author=Z.+Qianauthor=T.+Liuauthor=Y.+Y.+Liuauthor=R.+Briesewitzauthor=A.+M.+Barriosauthor=S.+M.+Jhiangauthor=D.+Pei&title=Efficient+Delivery+of+Cyclic+Peptides+into+Mammalian+Cells+with+Short+Sequence+Motifs&doi=10.1021%2Fcb3005275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs</span></div><div class="casAuthors">Qian, Ziqing; Liu, Tao; Liu, Yu-Yu; Briesewitz, Roger; Barrios, Amy M.; Jhiang, Sissy M.; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">423-431</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptides hold great potential as therapeutic agents and research tools, but their broad application has been limited by poor membrane permeability.  Here, we report a potentially general approach for intracellular delivery of cyclic peptides.  Short peptide motifs rich in arginine and hydrophobic residues (e.g., FΦRRRR, where Φ is l-2-naphthylalanine), when embedded into small- to medium-sized cyclic peptides (7-13 amino acids), bound to the plasma membrane of mammalian cultured cells and were subsequently internalized by the cells.  Confocal microscopy and a newly developed peptide internalization assay demonstrated that cyclic peptides contg. these transporter motifs were translocated into the cytoplasm and nucleus at efficiencies 2-5-fold higher than that of nonaarginine (R9).  Furthermore, incorporation of the FΦRRRR motif into a cyclic peptide contg. a phosphocoumaryl aminopropionic acid (pCAP) residue generated a cell permeable, fluorogenic probe for detecting intracellular protein tyrosine phosphatase activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUMFM_wJk9bVg90H21EOLACvtfcHk0lgRrltK3RTk3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1akur%252FO&md5=80f723598b2afcf4503bbb026a7290e9</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Fcb3005275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3005275%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DBriesewitz%26aufirst%3DR.%26aulast%3DBarrios%26aufirst%3DA.%2BM.%26aulast%3DJhiang%26aufirst%3DS.%2BM.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DEfficient%2520Delivery%2520of%2520Cyclic%2520Peptides%2520into%2520Mammalian%2520Cells%2520with%2520Short%2520Sequence%2520Motifs%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3D423%26epage%3D431%26doi%3D10.1021%2Fcb3005275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedewy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abou-Taleb, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammad, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Generation of a Cell-Permeable Cycloheptapeptidyl Inhibitor Against the Peptidyl-Prolyl Isomerase Pin1</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4540</span>– <span class="NLM_lpage">4543</span>, <span class="refDoi"> DOI: 10.1039/C7OB00430C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1039%2FC7OB00430C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28517007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotValu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=4540-4543&issue=21&author=W.+Bedewyauthor=H.+Liaoauthor=N.+A.+Abou-Talebauthor=S.+F.+Hammadauthor=T.+Nasrauthor=D.+Pei&title=Generation+of+a+Cell-Permeable+Cycloheptapeptidyl+Inhibitor+Against+the+Peptidyl-Prolyl+Isomerase+Pin1&doi=10.1039%2FC7OB00430C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1</span></div><div class="casAuthors">Bedewy, Walaa; Liao, Hui; Abou-Taleb, Nageh A.; Hammad, Sherif F.; Nasr, Tamer; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4540-4543</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cyclic peptides are capable of binding and modulating challenging drug targets including protein-protein interactions.  However, their lack of membrane permeability prevents their application against intracellular targets.  In this study, we show that it is possible to design a cell-permeable and biol. active cycloheptapeptide inhibitor against the intracellular enzyme peptidyl-prolyl isomerase Pin1 by integrating cell-penetrating and target-binding sequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DJxspjoHyrVg90H21EOLACvtfcHk0lgRrltK3RTk3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotValu78%253D&md5=7ba307be4f57d40b73767e98b16db9eb</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1039%2FC7OB00430C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB00430C%26sid%3Dliteratum%253Aachs%26aulast%3DBedewy%26aufirst%3DW.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DAbou-Taleb%26aufirst%3DN.%2BA.%26aulast%3DHammad%26aufirst%3DS.%2BF.%26aulast%3DNasr%26aufirst%3DT.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DGeneration%2520of%2520a%2520Cell-Permeable%2520Cycloheptapeptidyl%2520Inhibitor%2520Against%2520the%2520Peptidyl-Prolyl%2520Isomerase%2520Pin1%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26issue%3D21%26spage%3D4540%26epage%3D4543%26doi%3D10.1039%2FC7OB00430C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Cell-Permeable Bicyclic Peptide Inhibitors Against Intracellular Proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">9830</span>– <span class="NLM_lpage">9833</span>, <span class="refDoi"> DOI: 10.1021/ja503710n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja503710n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9830-9833&issue=28&author=W.+Lianauthor=B.+Jiangauthor=Z.+Qianauthor=D.+Pei&title=Cell-Permeable+Bicyclic+Peptide+Inhibitors+Against+Intracellular+Proteins&doi=10.1021%2Fja503710n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-Permeable Bicyclic Peptide Inhibitors against Intracellular Proteins</span></div><div class="casAuthors">Lian, Wenlong; Jiang, Bisheng; Qian, Ziqing; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9830-9833</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptides have great potential as therapeutic agents and research tools but are generally impermeable to the cell membrane.  Fusion of cyclic peptides with a cyclic cell-penetrating peptide produces bicyclic peptides that are cell-permeable and retain the ability to recognize specific intracellular targets.  Application of this strategy to protein tyrosine phosphatase 1B (PTP1B) and a peptidyl-prolyl cis-trans isomerase (Pin1) isomerase resulted in potent, selective, proteolytically stable, and biol. active inhibitors against the enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRmCZ_CIlJirVg90H21EOLACvtfcHk0ljjrONZG1vJvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbrN&md5=a8f8e1f0344958dbfeaefef43741d589</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Fja503710n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja503710n%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DZ.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DCell-Permeable%2520Bicyclic%2520Peptide%2520Inhibitors%2520Against%2520Intracellular%2520Proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D28%26spage%3D9830%26epage%3D9833%26doi%3D10.1021%2Fja503710n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor Against Peptidyl-Prolyl Isomerase Pin1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6306</span>– <span class="NLM_lpage">6312</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6306-6312&issue=15&author=B.+Jiangauthor=D.+Pei&title=A+Selective%2C+Cell-Permeable+Nonphosphorylated+Bicyclic+Peptidyl+Inhibitor+Against+Peptidyl-Prolyl+Isomerase+Pin1&doi=10.1021%2Facs.jmedchem.5b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1</span></div><div class="casAuthors">Jiang, Bisheng; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6306-6312</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pin1 regulates the levels and functions of phosphoproteins by catalyzing phosphorylation-dependent cis/trans isomerization of peptidyl-prolyl bonds.  Previous Pin1 inhibitors contained phosphoamino acids, which are metabolically unstable and have poor membrane permeability.  In this work, the authors report a cell-permeable and metabolically stable nonphosphorylated bicyclic peptide as a potent and selective Pin1 inhibitor, which inhibited the intracellular Pin1 activity in cultured mammalian cells but had little effect on other isomerases such as Pin4, FKBP12, or cyclophilin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK8No2ty2NM7Vg90H21EOLACvtfcHk0ljjrONZG1vJvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77P&md5=735a73f73d5aa05ab7f046e7e693b135</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00411%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DA%2520Selective%252C%2520Cell-Permeable%2520Nonphosphorylated%2520Bicyclic%2520Peptidyl%2520Inhibitor%2520Against%2520Peptidyl-Prolyl%2520Isomerase%2520Pin1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D15%26spage%3D6306%26epage%3D6312%26doi%3D10.1021%2Facs.jmedchem.5b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Understanding Cell Penetration of Cyclic Peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">10241</span>– <span class="NLM_lpage">10287</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.9b00008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.9b00008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=10241-10287&issue=17&author=P.+G.+Doughertyauthor=A.+Sahniauthor=D.+Pei&title=Understanding+Cell+Penetration+of+Cyclic+Peptides&doi=10.1021%2Facs.chemrev.9b00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Cell Penetration of Cyclic Peptides</span></div><div class="casAuthors">Dougherty, Patrick G.; Sahni, Ashweta; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10241-10287</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Approx. 75% of all disease-relevant human proteins, including those involved in intracellular protein-protein interactions (PPIs), are undruggable with the current drug modalities (i.e., small mols. and biologics).  Macrocyclic peptides provide a potential soln. to these undruggable targets because their larger sizes (relative to conventional small mols.) endow them the capability of binding to flat PPI interfaces with antibody-like affinity and specificity.  Powerful combinatorial library technologies have been developed to routinely identify cyclic peptides as potent, specific inhibitors against proteins including PPI targets.  However, with the exception of a very small set of sequences, the vast majority of cyclic peptides are impermeable to the cell membrane, preventing their application against intracellular targets.  This Review examines common structural features that render most cyclic peptides membrane impermeable, as well as the unique features that allow the minority of sequences to enter the cell interior by passive diffusion, endocytosis/endosomal escape, or other mechanisms.  We also present the current state of knowledge about the mol. mechanisms of cell penetration, the various strategies for designing cell-permeable, biol. active cyclic peptides against intracellular targets, and the assay methods available to quantify their cell-permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0NDA9U7-1YrVg90H21EOLACvtfcHk0ljjrONZG1vJvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D&md5=65f68a9b69f3f7f33641b6a91835b1dd</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.9b00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.9b00008%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DP.%2BG.%26aulast%3DSahni%26aufirst%3DA.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DUnderstanding%2520Cell%2520Penetration%2520of%2520Cyclic%2520Peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26issue%3D17%26spage%3D10241%26epage%3D10287%26doi%3D10.1021%2Facs.chemrev.9b00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiler, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etzkorn, F. A.</span></span> <span> </span><span class="NLM_article-title">Conformationally Locked Isostere of PhosphoSer-Cis-Pro Inhibits Pin1 23-fold Better than PhosphoSer-Trans-Pro Isostere</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">15533</span>– <span class="NLM_lpage">15542</span>, <span class="refDoi"> DOI: 10.1021/ja046396m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja046396m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15533-15542&issue=47&author=X.+J.+Wangauthor=B.+Xuauthor=A.+B.+Mullinsauthor=F.+K.+Neilerauthor=F.+A.+Etzkorn&title=Conformationally+Locked+Isostere+of+PhosphoSer-Cis-Pro+Inhibits+Pin1+23-fold+Better+than+PhosphoSer-Trans-Pro+Isostere&doi=10.1021%2Fja046396m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally Locked Isostere of PhosphoSer-cis-Pro Inhibits Pin1 23-Fold Better than PhosphoSer-trans-Pro Isostere</span></div><div class="casAuthors">Wang, Xiaodong J.; Xu, Bailing; Mullins, Ashley B.; Neiler, Freda K.; Etzkorn, Felicia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15533-15542</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stereoisomeric cis and trans substrate analogs for Pin1 were designed and synthesized.  The central phosphoSer-Pro core of the Pin1 substrate was replaced by cis and trans amide isosteres in Ac-Phe-Phe-pSer-ψ[(Z and E)CH:C]-Pro-Arg-NH2, 1 and 2, peptidomimetics.  They were synthesized on solid phase in 17% yield for the cis analog 1, and 16% yield for the trans analog 2.  A second trans amide isostere with a C-terminal N-methylamide 3 was synthesized in 7% yield.  The protease-coupled Pin1 assay showed that all three compds. inhibited the Pin1 peptidyl-prolyl isomerase (PPIase) enzymic activity.  The cis isostere 1 was 23 times more potent (Ki = 1.74±0.08 μM) than its trans counterpart 2 (Ki = 40±2 μM) in competitive inhibition of Pin1.  These results suggest that the catalytic site of Pin1 binds cis substrates more tightly in aq. soln.  Antiproliferative activity toward the A2780 human ovarian cancer cell line by the cis and trans analogs correlates with Pin1 inhibition results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR69CE2ChtL7Vg90H21EOLACvtfcHk0lhJEy1gc2pT1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOisLs%253D&md5=f6032101e5c92c159d3cee993b704654</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1021%2Fja046396m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046396m%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DMullins%26aufirst%3DA.%2BB.%26aulast%3DNeiler%26aufirst%3DF.%2BK.%26aulast%3DEtzkorn%26aufirst%3DF.%2BA.%26atitle%3DConformationally%2520Locked%2520Isostere%2520of%2520PhosphoSer-Cis-Pro%2520Inhibits%2520Pin1%252023-fold%2520Better%2520than%2520PhosphoSer-Trans-Pro%2520Isostere%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D47%26spage%3D15533%26epage%3D15542%26doi%3D10.1021%2Fja046396m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etzkorn, F. A.</span></span> <span> </span><span class="NLM_article-title">Pin1 as an Anticancer Drug Target</span>. <i>Drug News Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1358/dnp.2009.22.7.1414594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1358%2Fdnp.2009.22.7.1414594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19890497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOmt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=399-407&issue=7&author=G.+G.+Xuauthor=F.+A.+Etzkorn&title=Pin1+as+an+Anticancer+Drug+Target&doi=10.1358%2Fdnp.2009.22.7.1414594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 as an anticancer drug target</span></div><div class="casAuthors">Xu, Guoyan G.; Etzkorn, Felicia A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Pin1 specifically catalyzes the cis/trans isomerization of phospho-Ser/Thr-Pro bonds and plays an important role in many cellular events through the effects of conformational change on the function of its biol. substrates, including cell division cycle 25 C (Cdc25C), c-Jun and p53.  Pin1 is overexpressed in many human cancer tissues, including breast, prostate and lung cancer.  Its expression correlates with cyclin D1 levels, which contribute to cell transformation.  Overexpression of Pin1 promotes tumor growth, while inhibition of Pin1 causes tumor cell apoptosis.  Pin1 plays an important role in oncogenesis and therefore may serve as an effective anticancer target.  Many inhibitors of Pin1 have been discovered, including several classes of designed inhibitors (alkene isosteres, reduced amides, indanyl ketones) and natural products (juglone, pepticinnamin E analogs, PiB and its derivs. obtained from a library screen).  Pin1 inhibitors could be used as a novel type of anticancer drug by blocking cell cycle progression.  Therefore, Pin1 represents a new diagnostic and therapeutic anticancer drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokZhI1yjKrcLVg90H21EOLACvtfcHk0lhJEy1gc2pT1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOmt73N&md5=bc132881bbbfd7810a485188178b15b9</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2009.22.7.1414594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2009.22.7.1414594%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DG.%2BG.%26aulast%3DEtzkorn%26aufirst%3DF.%2BA.%26atitle%3DPin1%2520as%2520an%2520Anticancer%2520Drug%2520Target%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2009%26volume%3D22%26issue%3D7%26spage%3D399%26epage%3D407%26doi%3D10.1358%2Fdnp.2009.22.7.1414594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagostino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marakovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mroczkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanarsdale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popoff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piraino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margosiak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Los, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Novel Human Pin1 Inhibitors (I)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5613</span>– <span class="NLM_lpage">5616</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2009.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19729306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5613-5616&issue=19&author=C.+Guoauthor=X.+Houauthor=L.+Dongauthor=E.+Dagostinoauthor=S.+Greasleyauthor=R.+Ferreauthor=J.+Marakovitsauthor=M.+C.+Johnsonauthor=D.+Matthewsauthor=B.+Mroczkowskiauthor=H.+Pargeauthor=T.+Vanarsdaleauthor=I.+Popoffauthor=J.+Pirainoauthor=S.+Margosiakauthor=J.+Thomsonauthor=G.+Losauthor=B.+W.+Murray&title=Structure-Based+Design+of+Novel+Human+Pin1+Inhibitors+%28I%29&doi=10.1016%2Fj.bmcl.2009.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel human Pin1 inhibitors (I)</span></div><div class="casAuthors">Guo, Chuangxing; Hou, Xinjun; Dong, Liming; Dagostino, Eleanor; Greasley, Samantha; Ferre, RoseAnn; Marakovits, Joseph; Johnson, M. Catherine; Matthews, David; Mroczkowski, Barbara; Parge, Hans; Van Arsdale, Todd; Popoff, Ian; Piraino, Joseph; Margosiak, Stephen; Thomson, James; Los, Gerrit; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5613-5616</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pin1 is a member of the cis-trans peptidyl-prolyl isomerase family with potential anti-cancer therapeutic value.  Structure-based de novo design and optimization of novel Pin1 inhibitors, e.g., I, are reported.  Without a viable lead from internal screenings, a series of novel Pin1 inhibitors by interrogating and exploring a protein crystal structure of Pin1 is designed.  The ligand efficiency of the initial concept mol. was optimized with integrated SBDD and parallel chem. approaches, resulting in a more attractive lead series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy51a1X9SYC7Vg90H21EOLACvtfcHk0lhJEy1gc2pT1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur%252FM&md5=6fbb8e918fd39293dc419dfa0747a937</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DDagostino%26aufirst%3DE.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DMarakovits%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BC.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DVanarsdale%26aufirst%3DT.%26aulast%3DPopoff%26aufirst%3DI.%26aulast%3DPiraino%26aufirst%3DJ.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DThomson%26aufirst%3DJ.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Human%2520Pin1%2520Inhibitors%2520%2528I%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5613%26epage%3D5616%26doi%3D10.1016%2Fj.bmcl.2009.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marakovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagostino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraynov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Novel Human Pin1 Inhibitors (II)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2010.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20207139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslGmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2210-2214&issue=7&author=L.+Dongauthor=J.+Marakovitsauthor=X.+Houauthor=C.+Guoauthor=S.+Greasleyauthor=E.+Dagostinoauthor=R.+Ferreauthor=M.+C.+Johnsonauthor=E.+Kraynovauthor=J.+Thomsonauthor=V.+Pathakauthor=B.+W.+Murray&title=Structure-Based+Design+of+Novel+Human+Pin1+Inhibitors+%28II%29&doi=10.1016%2Fj.bmcl.2010.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel human Pin1 inhibitors (II)</span></div><div class="casAuthors">Dong, Liming; Marakovits, Joseph; Hou, Xinjun; Guo, Chuangxing; Greasley, Samantha; Dagostino, Eleanor; Ferre, RoseAnn; Johnson, M. Catherine; Kraynov, Eugenia; Thomson, James; Pathak, Ved; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2210-2214</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Following the discovery of a novel series of phosphate-contg. small mol. Pin1 inhibitors, the drug design strategy shifted to replacement of the phosphate group with an isostere with potential better pharmaceutical properties.  The initial loss in potency of carboxylate analogs was likely due to weaker charge-charge interactions in the putative phosphate binding pocket and was subsequently recovered by structure-based optimization of ligand-protein interactions in the proline binding site, leading to the discovery of a sub-micromolar non-phosphate small mol. Pin1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgilRHkGBuYbVg90H21EOLACvtfcHk0lhdETSUWK-KgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmt7s%253D&md5=d16f5beec12a17a38bca7e84e09ddb0d</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DL.%26aulast%3DMarakovits%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DDagostino%26aufirst%3DE.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DM.%2BC.%26aulast%3DKraynov%26aufirst%3DE.%26aulast%3DThomson%26aufirst%3DJ.%26aulast%3DPathak%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Human%2520Pin1%2520Inhibitors%2520%2528II%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2210%26epage%3D2214%26doi%3D10.1016%2Fj.bmcl.2010.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunns, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrace, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matossova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Cell-Active Phenyl-Imidazole Pin1 Inhibitors by Structure-Guided Fragment Evolution</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6483</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2010.09.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20932746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6483-6488&issue=22&author=A.+Potterauthor=V.+Oldfieldauthor=C.+Nunnsauthor=C.+Fromontauthor=S.+Rayauthor=C.+J.+Northfieldauthor=C.+J.+Bryantauthor=S.+F.+Scraceauthor=D.+Robinsonauthor=N.+Matossovaauthor=L.+Bakerauthor=P.+Dokurnoauthor=A.+E.+Surgenorauthor=B.+Davisauthor=C.+M.+Richardsonauthor=J.+B.+Murrayauthor=J.+D.+Moore&title=Discovery+of+Cell-Active+Phenyl-Imidazole+Pin1+Inhibitors+by+Structure-Guided+Fragment+Evolution&doi=10.1016%2Fj.bmcl.2010.09.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution</span></div><div class="casAuthors">Potter, Andrew; Oldfield, Victoria; Nunns, Claire; Fromont, Christophe; Ray, Stuart; Northfield, Christopher J.; Bryant, Christopher J.; Scrace, Simon F.; Robinson, David; Matossova, Natalia; Baker, Lisa; Dokurno, Pawel; Surgenor, Allan E.; Davis, Ben; Richardson, Christine M.; Murray, James B.; Moore, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6483-6488</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pin1 is an emerging oncol. target strongly implicated in Ras and ErbB2-mediated tumorigenesis.  Pin1 isomerizes bonds linking phospho-serine/threonine moieties to proline enabling it to play a key role in proline-directed kinase signalling.  Here we report a novel series of Pin1 inhibitors based on a Ph imidazole acid core that contains sub-μM inhibitors.  Compds. have been identified that block prostate cancer cell growth under conditions where Pin1 is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6tUxclpvVtLVg90H21EOLACvtfcHk0lhdETSUWK-KgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7bN&md5=ee4cd613389f2933ea806c617eaf1769</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.063%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DOldfield%26aufirst%3DV.%26aulast%3DNunns%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DBryant%26aufirst%3DC.%2BJ.%26aulast%3DScrace%26aufirst%3DS.%2BF.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DMatossova%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520of%2520Cell-Active%2520Phenyl-Imidazole%2520Pin1%2520Inhibitors%2520by%2520Structure-Guided%2520Fragment%2520Evolution%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6483%26epage%3D6488%26doi%3D10.1016%2Fj.bmcl.2010.09.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueritz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunns, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrace, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Design of Alpha-Amino Acid-Derived Pin1 Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2009.11.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19969456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=586-590&issue=2&author=A.+J.+Potterauthor=S.+Rayauthor=L.+Gueritzauthor=C.+L.+Nunnsauthor=C.+J.+Bryantauthor=S.+F.+Scraceauthor=N.+Matassovaauthor=L.+Bakerauthor=P.+Dokurnoauthor=D.+A.+Robinsonauthor=A.+E.+Surgenorauthor=B.+Davisauthor=J.+B.+Murrayauthor=C.+M.+Richardsonauthor=J.+D.+Moore&title=Structure-Guided+Design+of+Alpha-Amino+Acid-Derived+Pin1+Inhibitors&doi=10.1016%2Fj.bmcl.2009.11.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of α-amino acid-derived Pin1 inhibitors</span></div><div class="casAuthors">Potter, Andrew J.; Ray, Stuart; Gueritz, Louisa; Nunns, Claire L.; Bryant, Christopher J.; Scrace, Simon F.; Matassova, Natalia; Baker, Lisa; Dokurno, Pawel; Robinson, David A.; Surgenor, Allan E.; Davis, Ben; Murray, James B.; Richardson, Christine M.; Moore, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">586-590</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The peptidyl prolyl cis/trans isomerase Pin1 is a promising mol. target for anti-cancer therapeutics.  Here we report the structure-guided evolution of an indole 2-carboxylic acid fragment hit into a series of α-benzimidazolyl-substituted amino acids.  Examples inhibited Pin1 activity with IC50 <100 nM, but were inactive on cells.  Replacement of the benzimidazole ring with a naphthyl group resulted in a 10-50-fold loss in ligand potency, but these examples downregulated biomarkers of Pin1 activity and blocked proliferation of PC3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaxl5WF47R9LVg90H21EOLACvtfcHk0lhdETSUWK-KgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbjF&md5=3006dad4fda09dffe5bd6be7ede1ecb7</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.090%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DA.%2BJ.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DGueritz%26aufirst%3DL.%26aulast%3DNunns%26aufirst%3DC.%2BL.%26aulast%3DBryant%26aufirst%3DC.%2BJ.%26aulast%3DScrace%26aufirst%3DS.%2BF.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26atitle%3DStructure-Guided%2520Design%2520of%2520Alpha-Amino%2520Acid-Derived%2520Pin1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D586%26epage%3D590%26doi%3D10.1016%2Fj.bmcl.2009.11.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Pin1 and Par14 Peptidyl Prolyl Isomerase Inhibitors Block Cell Proliferation</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(02)00310-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS1074-5521%2802%2900310-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12573694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1SmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=15-24&issue=1&author=T.+Uchidaauthor=M.+Takamiyaauthor=M.+Takahashiauthor=H.+Miyashitaauthor=H.+Ikedaauthor=T.+Teradaauthor=Y.+Matsuoauthor=M.+Shirouzuauthor=S.+Yokoyamaauthor=F.+Fujimoriauthor=T.+Hunter&title=Pin1+and+Par14+Peptidyl+Prolyl+Isomerase+Inhibitors+Block+Cell+Proliferation&doi=10.1016%2FS1074-5521%2802%2900310-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 and Par14 Peptidyl Prolyl Isomerase Inhibitors Block Cell Proliferation</span></div><div class="casAuthors">Uchida, Takafumi; Takamiya, Mari; Takahashi, Morito; Miyashita, Hitoshi; Ikeda, Hisafumi; Terada, Toru; Matsuo, Yo; Shirouzu, Mikako; Yokoyama, Shigeyuki; Fujimori, Fumihiro; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Disruption of the parvulin family peptidyl prolyl isomerase (PPIase) Pin1 gene delays reentry into the cell cycle when quiescent primary mouse embryo fibroblasts are stimulated with serum.  Since Pin1 regulates cell cycle progression, a Pin1 inhibitor would be expected to block cell proliferation.  To identify such inhibitors, we screened a chem. compd. library for mols. that inhibited human Pin1 PPIase activity in vitro.  We found a set of compds. that inhibited Pin1 PPIase activity in vitro with low μM IC50s and inhibited the growth of several cancer lines.  Among the inhibitors, PiB, diethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo[lmn] phenanthroline-2,7-diacetate Et 1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn] phenanthroline-(2H,7H)-diacetate, had the least nonspecific toxicity.  These results suggest that Pin1 inhibitors could be used as a novel type of anticancer drug that acts by blocking cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV0Do36G7blbVg90H21EOLACvtfcHk0lh2Ugtc4K4_vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1SmtQ%253D%253D&md5=65a6d7e955f32ec1231c012d49cbe0d1</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900310-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900310-1%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DT.%26aulast%3DTakamiya%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DFujimori%26aufirst%3DF.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DPin1%2520and%2520Par14%2520Peptidyl%2520Prolyl%2520Isomerase%2520Inhibitors%2520Block%2520Cell%2520Proliferation%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D1%26spage%3D15%26epage%3D24%26doi%3D10.1016%2FS1074-5521%2802%2900310-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, T.</span></span> <span> </span><span class="NLM_article-title">Dipentamethylene Thiuram Monosulfide is a Novel Inhibitor of Pin1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>384</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2009.04.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bbrc.2009.04.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19422802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVCqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2009&pages=394-398&issue=3&author=Y.+Tataraauthor=Y.+C.+Linauthor=Y.+Bambaauthor=T.+Moriauthor=T.+Uchida&title=Dipentamethylene+Thiuram+Monosulfide+is+a+Novel+Inhibitor+of+Pin1&doi=10.1016%2Fj.bbrc.2009.04.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1</span></div><div class="casAuthors">Tatara, Yota; Lin, Yi-Chin; Bamba, Yoshimasa; Mori, Tadashi; Uchida, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">394-398</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pin1 is involved in eukaryotic cell proliferation by changing the structure and function of phosphorylated proteins.  PiB, the Pin1 specific inhibitor, blocks cancer cell proliferation.  However, low soly. of PiB in DMSO has limited studies of its effectiveness.  We screened for addnl. Pin1 inhibitors and identified the DMSO-sol. compd. dipentamethylene thiuram monosulfide (DTM) that inhibits Pin1 activity with an EC50 value of 4.1 μM.  Mol. modeling and enzyme kinetic anal. indicated that DTM competitively inhibits Pin1 activity, with a Ki value of 0.05 μM.  The KD value of DTM with Pin1 was detd. to be 0.06 μM by SPR technol.  Moreover, DTM specifically inhibited peptidyl-prolyl cis/trans isomerase activity in HeLa cells.  FACS anal. showed that DTM induced G0 arrest of the HCT116 cells.  Our results suggest that DTM has the potential to guide the development of novel antifungal and/or anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKyR6-TAv7h7Vg90H21EOLACvtfcHk0lh2Ugtc4K4_vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVCqs78%253D&md5=638a29e63c73abc7a4fd6e769d0d6a75</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.04.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.04.144%26sid%3Dliteratum%253Aachs%26aulast%3DTatara%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DBamba%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DUchida%26aufirst%3DT.%26atitle%3DDipentamethylene%2520Thiuram%2520Monosulfide%2520is%2520a%2520Novel%2520Inhibitor%2520of%2520Pin1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D384%26issue%3D3%26spage%3D394%26epage%3D398%26doi%3D10.1016%2Fj.bbrc.2009.04.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kats, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nechama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarnerio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozkurt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moerke, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rego, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Coco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Active Pin1 is a Key Target of All-Trans Retinoic Acid in Acute Promyelocytic Leukemia and Breast Cancer</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1038/nm.3839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnm.3839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=25849135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=457-466&issue=5&author=S.+Weiauthor=S.+Kozonoauthor=L.+Katsauthor=M.+Nechamaauthor=W.+Liauthor=J.+Guarnerioauthor=M.+Luoauthor=M.+H.+Youauthor=Y.+Yaoauthor=A.+Kondoauthor=H.+Huauthor=G.+Bozkurtauthor=N.+J.+Moerkeauthor=S.+Caoauthor=M.+Reschkeauthor=C.+H.+Chenauthor=E.+M.+Regoauthor=F.+Lo-Cocoauthor=L.+C.+Cantleyauthor=T.+H.+Leeauthor=H.+Wuauthor=Y.+Zhangauthor=P.+P.+Pandolfiauthor=X.+Z.+Zhouauthor=K.+P.+Lu&title=Active+Pin1+is+a+Key+Target+of+All-Trans+Retinoic+Acid+in+Acute+Promyelocytic+Leukemia+and+Breast+Cancer&doi=10.1038%2Fnm.3839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</span></div><div class="casAuthors">Wei, Shuo; Kozono, Shingo; Kats, Lev; Nechama, Morris; Li, Wenzong; Guarnerio, Jlenia; Luo, Manli; You, Mi-Hyeon; Yao, Yandan; Kondo, Asami; Hu, Hai; Bozkurt, Gunes; Moerke, Nathan J.; Cao, Shugeng; Reschke, Markus; Chen, Chun-Hau; Rego, Eduardo M.; Lo-Coco, Francesco; Cantley, Lewis C.; Lee, Tae Ho; Wu, Hao; Zhang, Yan; Pandolfi, Pier Paolo; Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">457-466</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A common key regulator of oncogenic signaling pathways in multiple tumor types is the unique isomerase Pin1.  However, available Pin1 inhibitors lack the required specificity and potency for inhibiting Pin1 function in vivo.  By using mechanism-based screening, here we find that all-trans retinoic acid (ATRA)-a therapy for acute promyelocytic leukemia (APL) that is considered the first example of targeted therapy in cancer, but whose drug target remains elusive-inhibits and degrades active Pin1 selectively in cancer cells by directly binding to the substrate phosphate- and proline-binding pockets in the Pin1 active site.  ATRA-induced Pin1 ablation degrades the protein encoded by the fusion oncogene PML-RARA and treats APL in APL cell and animal models as well as in human patients.  ATRA-induced Pin1 ablation also potently inhibits triple-neg. breast cancer cell growth in human cells and in animal models by acting on many Pin1 substrate oncogenes and tumor suppressors.  Thus, ATRA simultaneously blocks multiple Pin1-regulated cancer-driving pathways, an attractive property for treating aggressive and drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc0ia_X46okbVg90H21EOLACvtfcHk0lh2Ugtc4K4_vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurg%253D&md5=03ded9956ae56f280e2c1bfee7672444</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1038%2Fnm.3839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3839%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%26aulast%3DKozono%26aufirst%3DS.%26aulast%3DKats%26aufirst%3DL.%26aulast%3DNechama%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGuarnerio%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DM.%2BH.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DBozkurt%26aufirst%3DG.%26aulast%3DMoerke%26aufirst%3DN.%2BJ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DReschke%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DRego%26aufirst%3DE.%2BM.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DActive%2520Pin1%2520is%2520a%2520Key%2520Target%2520of%2520All-Trans%2520Retinoic%2520Acid%2520in%2520Acute%2520Promyelocytic%2520Leukemia%2520and%2520Breast%2520Cancer%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26issue%3D5%26spage%3D457%26epage%3D466%26doi%3D10.1038%2Fnm.3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balis, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feusner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reaman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, R. M.</span></span> <span> </span><span class="NLM_article-title">Phase I and Pharmacokinetic Evaluation of All-Trans-Retinoic Acid in Pediatric Patients with Cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1673</span>, <span class="refDoi"> DOI: 10.1200/JCO.1992.10.11.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1200%2FJCO.1992.10.11.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1403049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADyaK3s%252FhvFChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1992&pages=1666-1673&issue=11&author=M.+A.+Smithauthor=P.+C.+Adamsonauthor=F.+M.+Balisauthor=J.+Feusnerauthor=L.+Aronsonauthor=R.+F.+Murphyauthor=M.+E.+Horowitzauthor=G.+Reamanauthor=G.+D.+Hammondauthor=R.+M.+Fenton&title=Phase+I+and+Pharmacokinetic+Evaluation+of+All-Trans-Retinoic+Acid+in+Pediatric+Patients+with+Cancer&doi=10.1200%2FJCO.1992.10.11.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer</span></div><div class="casAuthors">Smith M A; Adamson P C; Balis F M; Feusner J; Aronson L; Murphy R F; Horowitz M E; Reaman G; Hammond G D; Fenton R M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1666-73</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Recent reports of the dramatic antitumor effect of all-trans-retinoic acid (RA) in patients with acute promyelocytic leukemia (APL) have renewed interest in the oncologic indications for retinoids.  Furthermore, a variety of pediatric tumors are responsive to RA in vitro, which provides additional rationale for a phase I evaluation of RA in children with cancer that is refractory to standard therapy.  PATIENTS AND METHODS:  A phase I trial of RA administered orally twice daily for 28-day treatment courses was performed.  Cohorts of at least three pediatric cancer patients were entered at successive RA dose levels (from 45 to 80 mg/m2/d) until dose-limiting toxicity (DLT) was consistently observed.  RESULTS:  The maximum-tolerated dose (MTD) of RA was 60 mg/m2/d.  Three of eight patients at the 80-mg/m2/d dose level developed reversible pseudotumor cerebri that necessitated discontinuation of the agent.  Both patients with APL achieved complete remission (CR), whereas no patients with solid tumors had objective responses.  Pharmacokinetic studies demonstrated a relatively short terminal half-life for RA (45 minutes), with diminution in plasma levels after chronic dosing.  CONCLUSIONS:  The MTD and recommended phase II dose for RA in children is 60 mg/m2/d given twice daily.  Reversible CNS toxicity related to RA-induced pseudotumor cerebri is dose-limiting.  Two children with APL achieved a CR to RA, which supports the inclusion of pediatric patients in clinical trials that evaluate the use of RA for patients with APL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiJ2bQIpU6kMzK395ZObgVfW6udTcc2ebyQ83mgSlySLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FhvFChtA%253D%253D&md5=55d46bb190262170c778e6e4cf64b9ff</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1200%2FJCO.1992.10.11.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.1992.10.11.1666%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26aulast%3DFeusner%26aufirst%3DJ.%26aulast%3DAronson%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DR.%2BF.%26aulast%3DHorowitz%26aufirst%3DM.%2BE.%26aulast%3DReaman%26aufirst%3DG.%26aulast%3DHammond%26aufirst%3DG.%2BD.%26aulast%3DFenton%26aufirst%3DR.%2BM.%26atitle%3DPhase%2520I%2520and%2520Pharmacokinetic%2520Evaluation%2520of%2520All-Trans-Retinoic%2520Acid%2520in%2520Pediatric%2520Patients%2520with%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1992%26volume%3D10%26issue%3D11%26spage%3D1666%26epage%3D1673%26doi%3D10.1200%2FJCO.1992.10.11.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">A Novel Controlled Release Formulation of the Pin1 Inhibitor ATRA to Improve Liver Cancer Therapy by Simultaneously Blocking Multiple Cancer Pathways</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2017.11.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jconrel.2017.11.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29170140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFajsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2018&pages=405-422&author=D.+Yangauthor=W.+Luoauthor=J.+Wangauthor=M.+Zhengauthor=X.+H.+Liaoauthor=N.+Zhangauthor=W.+Luauthor=L.+Wangauthor=A.+Z.+Chenauthor=W.+G.+Wuauthor=H.+Liuauthor=S.+B.+Wangauthor=X.+Z.+Zhouauthor=K.+P.+Lu&title=A+Novel+Controlled+Release+Formulation+of+the+Pin1+Inhibitor+ATRA+to+Improve+Liver+Cancer+Therapy+by+Simultaneously+Blocking+Multiple+Cancer+Pathways&doi=10.1016%2Fj.jconrel.2017.11.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways</span></div><div class="casAuthors">Yang, Dayun; Luo, Wensong; Wang, Jichuang; Zheng, Min; Liao, Xin-Hua; Zhang, Nan; Lu, Wenxian; Wang, Long; Chen, Ai-Zheng; Wu, Wen-Guo; Liu, Hekun; Wang, Shi-Bin; Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">405-422</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths worldwide largely due to lack of effective targeted drugs to simultaneously block multiple cancer-driving pathways.  The identification of all-trans retinoic acid (ATRA) as a potent Pin1 inhibitor provides a promising candidate for HCC targeted therapy because Pin1 is overexpressed in most HCC and activates numerous cancer-driving pathways.  However, the efficacy of ATRA against solid tumors is limited due to its short half-life of 45 min in humans.  A slow-releasing ATRA formulation inhibits solid tumors such as HCC, but can be used only in animals.  Here, we developed a one-step, cost-effective route to produce a novel biocompatible, biodegradable, and non-toxic controlled release formulation of ATRA for effective HCC therapy.  We used supercrit. carbon dioxide process to encapsulate ATRA in largely uniform poly L-lactic acid (PLLA) microparticles, with the efficiency of 91.4% and yield of 68.3%, and ∼ 4-fold higher Cmax and AUC over the slow-releasing ATRA formulation.  ATRA-PLLA microparticles had good biocompatibility, and significantly enhanced the inhibitory potency of ATRA on HCC cell growth, improving IC50 by over 3-fold.  ATRA-PLLA microparticles exerted its efficacy likely through degrading Pin1 and inhibiting multiple Pin1-regulated cancer pathways and cell cycle progression.  Indeed, Pin1 knock-down abolished ATRA inhibitory effects on HCC cells and ATRA-PLLA did not inhibit normal liver cells, as expected because ATRA selectively inhibits active Pin1 in cancer cells.  Moreover ATRA-PLLA microparticles significantly enhanced the efficacy of ATRA against HCC tumor growth in mice through reducing Pin1, with a better potency than the slow-releasing ATRA formulation, consistent with its improved pharmacokinetic profiles.  This study illustrates an effective platform to produce controlled release formulation of anti-cancer drugs, and ATRA-PLLA microparticles might be a promising targeted drug for HCC therapy as PLLA is biocompatible, biodegradable and nontoxic to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QOesAHAoq7Vg90H21EOLACvtfcHk0liiIPq800-x_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFajsLfL&md5=f6b89850089afed918ec8d68264dcb4b</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2017.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2017.11.031%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DX.%2BH.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DA.%2BZ.%26aulast%3DWu%26aufirst%3DW.%2BG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%2BB.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DA%2520Novel%2520Controlled%2520Release%2520Formulation%2520of%2520the%2520Pin1%2520Inhibitor%2520ATRA%2520to%2520Improve%2520Liver%2520Cancer%2520Therapy%2520by%2520Simultaneously%2520Blocking%2520Multiple%2520Cancer%2520Pathways%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2018%26volume%3D269%26spage%3D405%26epage%3D422%26doi%3D10.1016%2Fj.jconrel.2017.11.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massefski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doctor, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span> <span> </span><span class="NLM_article-title">Arsenic Targets Pin1 and Cooperates with Retinoic Acid to Inhibit Cancer-Driving Pathways and Tumor-Initiating Cells</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3069</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05402-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fs41467-018-05402-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30093655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ms12nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3069&issue=1&author=S.+Kozonoauthor=Y.+M.+Linauthor=H.+S.+Seoauthor=B.+Pinchauthor=X.+Lianauthor=C.+Qiuauthor=M.+K.+Herbertauthor=C.+H.+Chenauthor=L.+Tanauthor=Z.+J.+Gaoauthor=W.+Massefskiauthor=Z.+M.+Doctorauthor=B.+P.+Jacksonauthor=Y.+Chenauthor=S.+Dhe-Paganonauthor=K.+P.+Luauthor=X.+Z.+Zhou&title=Arsenic+Targets+Pin1+and+Cooperates+with+Retinoic+Acid+to+Inhibit+Cancer-Driving+Pathways+and+Tumor-Initiating+Cells&doi=10.1038%2Fs41467-018-05402-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</span></div><div class="casAuthors">Kozono Shingo; Lin Yu-Min; Lian Xiaolan; Qiu Chenxi; Herbert Megan K; Chen Chun-Hau; Gao Ziang Jeff; Lu Kun Ping; Zhou Xiao Zhen; Kozono Shingo; Lin Yu-Min; Lian Xiaolan; Qiu Chenxi; Herbert Megan K; Chen Chun-Hau; Gao Ziang Jeff; Lu Kun Ping; Zhou Xiao Zhen; Seo Hyuk-Soo; Pinch Benika; Tan Li; Massefski Walter; Doctor Zainab M; Dhe-Paganon Sirano; Pinch Benika; Lian Xiaolan; Lian Xiaolan; Chen Yuanzhong; Lu Kun Ping; Qiu Chenxi; Lu Kun Ping; Zhou Xiao Zhen; Jackson Brian P</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3069</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) combination safely cures fatal acute promyelocytic leukemia, but their mechanisms of action and efficacy are not fully understood.  ATRA inhibits leukemia, breast, and liver cancer by targeting isomerase Pin1, a master regulator of oncogenic signaling networks.  Here we show that ATO targets Pin1 and cooperates with ATRA to exert potent anticancer activity.  ATO inhibits and degrades Pin1, and suppresses its oncogenic function by noncovalent binding to Pin1's active site.  ATRA increases cellular ATO uptake through upregulating aquaporin-9.  ATO and ATRA, at clinically safe doses, cooperatively ablate Pin1 to block numerous cancer-driving pathways and inhibit the growth of triple-negative breast cancer cells and tumor-initiating cells in cell and animal models including patient-derived orthotopic xenografts, like Pin1 knockout, which is substantiated by comprehensive protein and microRNA analyses.  Thus, synergistic targeting of Pin1 by ATO and ATRA offers an attractive approach to combating breast and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIUnXfwZaCRg5nADWVYHg1fW6udTcc2eY0ypuOVZaBirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ms12nsQ%253D%253D&md5=3f6b63a8f502af29d2d0526dcb17352d</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05402-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05402-2%26sid%3Dliteratum%253Aachs%26aulast%3DKozono%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DY.%2BM.%26aulast%3DSeo%26aufirst%3DH.%2BS.%26aulast%3DPinch%26aufirst%3DB.%26aulast%3DLian%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DHerbert%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DZ.%2BJ.%26aulast%3DMassefski%26aufirst%3DW.%26aulast%3DDoctor%26aufirst%3DZ.%2BM.%26aulast%3DJackson%26aufirst%3DB.%2BP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26atitle%3DArsenic%2520Targets%2520Pin1%2520and%2520Cooperates%2520with%2520Retinoic%2520Acid%2520to%2520Inhibit%2520Cancer-Driving%2520Pathways%2520and%2520Tumor-Initiating%2520Cells%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D3069%26doi%3D10.1038%2Fs41467-018-05402-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urusova, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zykova, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">Epigallocatechin-Gallate Suppresses Tumorigenesis by Directly Targeting Pin1</span>. <i>Cancer Prev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1366</span>– <span class="NLM_lpage">1377</span>, <span class="refDoi"> DOI: 10.1158/1940-6207.CAPR-11-0301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1158%2F1940-6207.CAPR-11-0301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21750208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12ktbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=1366-1377&issue=9&author=D.+V.+Urusovaauthor=J.+H.+Shimauthor=D.+J.+Kimauthor=S.+K.+Jungauthor=T.+A.+Zykovaauthor=A.+Carperauthor=A.+M.+Bodeauthor=Z.+Dong&title=Epigallocatechin-Gallate+Suppresses+Tumorigenesis+by+Directly+Targeting+Pin1&doi=10.1158%2F1940-6207.CAPR-11-0301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1</span></div><div class="casAuthors">Urusova, Darya V.; Shim, Jung-Hyun; Kim, Dong Joon; Jung, Sung Keun; Zykova, Tatyana A.; Carper, Andria; Bode, Ann M.; Dong, Zigang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1366-1377</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The most active anticancer component in green tea is epigallocatechin-3-gallate (EGCG).  The human peptidyl prolyl cis/trans isomerase (Pin1) plays a crit. role in oncogenic signaling.  Herein, we report the X-ray crystal structure of the Pin1/EGCG complex resolved at 1.9 Å resoln.  Notably, the structure revealed the presence of EGCG in both the WW and PPIase domains of Pin1.  The direct binding of EGCG with Pin1 was confirmed and the interaction inhibited Pin1 PPIase activity.  In addn., proliferation of cells expressing Pin1 was inhibited and tumor growth in a xenograft mouse model was suppressed.  The binding of EGCG with Arg17 in the WW domain prevented the binding of c-Jun, a well-known Pin1 substrate.  EGCG treatment corresponded with a decreased abundance of cyclin D1 and diminution of 12-O-tetradecanoylphorbol-l3-acetate-induced AP-1 or NF-κB promoter activity in cells expressing Pin1.  Overall, these results showed that EGCG directly suppresses the tumor-promoting effect of Pin1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRULfb5orgLVg90H21EOLACvtfcHk0lisDGUMHdR2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12ktbzF&md5=c0ec8e7b93fa4e925e5df83d542ef340</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-11-0301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-11-0301%26sid%3Dliteratum%253Aachs%26aulast%3DUrusova%26aufirst%3DD.%2BV.%26aulast%3DShim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DJung%26aufirst%3DS.%2BK.%26aulast%3DZykova%26aufirst%3DT.%2BA.%26aulast%3DCarper%26aufirst%3DA.%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DEpigallocatechin-Gallate%2520Suppresses%2520Tumorigenesis%2520by%2520Directly%2520Targeting%2520Pin1%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2011%26volume%3D4%26issue%3D9%26spage%3D1366%26epage%3D1377%26doi%3D10.1158%2F1940-6207.CAPR-11-0301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span> <span> </span><span class="NLM_article-title">Interaction Between Pin1 and its Natural Product Inhibitor Epigallocatechin-3-Gallate by Spectroscopy and Molecular Dynamics Simulations</span>. <i>Spectrochim. Acta, Part A</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1016/j.saa.2016.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.saa.2016.06.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27372509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSgu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2016&pages=134-143&author=L.+Xiauthor=Y.+Wangauthor=Q.+Heauthor=Q.+Zhangauthor=L.+Du&title=Interaction+Between+Pin1+and+its+Natural+Product+Inhibitor+Epigallocatechin-3-Gallate+by+Spectroscopy+and+Molecular+Dynamics+Simulations&doi=10.1016%2Fj.saa.2016.06.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between Pin1 and its natural product inhibitor epigallocatechin-3-gallate by spectroscopy and molecular dynamics simulations</span></div><div class="casAuthors">Xi, Lei; Wang, Yu; He, Qing; Zhang, Qingyan; Du, Linfang</div><div class="citationInfo"><span class="NLM_cas:title">Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134-143</span>CODEN:
                <span class="NLM_cas:coden">SAMCAS</span>;
        ISSN:<span class="NLM_cas:issn">1386-1425</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The binding of epigallocatechin 3-gallate (EGCG) to wild-type peptidylprolyl isomerase Pin1 in soln. was studied by spectroscopic methods and mol. dynamics simulations to explore the binding mode and inhibition mechanism.  The binding consts. and no. of binding sites per Pin1 for EGCG were calcd. through the Stern-Volmer equation.  The values of binding free energy and thermodn. parameters were calcd. and indicated that H-bonds, electrostatic interactions, and van der Waals interactions played major roles in the binding process.  The alterations of Pin1 secondary structure in the presence of EGCG were confirmed by far-UV CD spectroscopy.  The binding model at the at.-level revealed that EGCG was bound by Glu-12, Lys-13, Arg-14, Met-15, and Arg-17 in the Pin1 WW domain.  Furthermore, EGCG could also interact with Arg-69, Asp-112, Cys-113, and Ser-114 in the Pin1 isomerase domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbZkpXyj1vPLVg90H21EOLACvtfcHk0lg0H18PePrW2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSgu7rF&md5=e474f5ffbb769a7fce28642ba8f455d3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2Fj.saa.2016.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.saa.2016.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DL.%26atitle%3DInteraction%2520Between%2520Pin1%2520and%2520its%2520Natural%2520Product%2520Inhibitor%2520Epigallocatechin-3-Gallate%2520by%2520Spectroscopy%2520and%2520Molecular%2520Dynamics%2520Simulations%26jtitle%3DSpectrochim.%2520Acta%252C%2520Part%2520A%26date%3D2016%26volume%3D169%26spage%3D134%26epage%3D143%26doi%3D10.1016%2Fj.saa.2016.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ready, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span> <span> </span><span class="NLM_article-title">Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">19673</span>– <span class="NLM_lpage">19684</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.443895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M112.443895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23671287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKmsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=19673-19684&issue=27&author=J.+A.+Kilgoreauthor=X.+Duauthor=L.+Melitoauthor=S.+Weiauthor=C.+Wangauthor=H.+G.+Chinauthor=B.+Posnerauthor=S.+Pradhanauthor=J.+M.+Readyauthor=N.+S.+Williams&title=Identification+of+DNMT1+Selective+Antagonists+Using+a+Novel+Scintillation+Proximity+Assay&doi=10.1074%2Fjbc.M112.443895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay</span></div><div class="casAuthors">Kilgore, Jessica A.; Du, Xinlin; Melito, Lisa; Wei, Shuguang; Wang, Changguang; Chin, Hang Gyeong; Posner, Bruce; Pradhan, Sriharsa; Ready, Joseph M.; Williams, Noelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">19673-19684</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A novel scintillation proximity high throughput assay (SPA) to identify inhibitors of DNA methyltransferase was developed and used to screen over 180,000 compds.  The majority of the validated hits shared a quinone core and several were found to generate the reactive oxygen species, H2O2.  Inhibition of the prodn. of H2O2 by the addn. of catalase blocked the ability of this group of compds. to inhibit DNA methyltransferase (DNMT) activity.  However, a related compd., SW155246, was identified that existed in an already reduced form of the quinone.  This compd. did not generate H2O2, and catalase did not block its ability to inhibit DNA methyltransferase.  SW155246 showed a 30-fold preference for inhibition of human DNMT1 vs. human or murine DNMT3A or -3B, inhibited global methylation in HeLa cells, and reactivated expression of the tumor suppressor gene RASSF1A in A549 cells.  To the authors' knowledge, this work represents the first description of selective chem. inhibitors of the DNMT1 enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodp6ODITC6hLVg90H21EOLACvtfcHk0lg0H18PePrW2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKmsLjP&md5=45e90f8b7d6c458a45ce4bd7103819e7</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.443895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.443895%26sid%3Dliteratum%253Aachs%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DMelito%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DH.%2BG.%26aulast%3DPosner%26aufirst%3DB.%26aulast%3DPradhan%26aufirst%3DS.%26aulast%3DReady%26aufirst%3DJ.%2BM.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26atitle%3DIdentification%2520of%2520DNMT1%2520Selective%2520Antagonists%2520Using%2520a%2520Novel%2520Scintillation%2520Proximity%2520Assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D27%26spage%3D19673%26epage%3D19684%26doi%3D10.1074%2Fjbc.M112.443895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balam Muñoz, B.</span>; <span class="NLM_string-name">Albores, A.</span></span> <span> </span><span class="NLM_article-title">DNA Damage Caused by Polycyclic Aromatic Hydrocarbons: Mechanisms and Markers, Selected Topics in DNA Repair</span>. In  <i>Selected Topics in DNA Repair</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. C.</span></span>, Ed.; <span class="NLM_publisher-name">IntechOpen</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.5772/22527</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.5772%2F22527" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=125-144&author=B.+Balam+Mu%C3%B1oz&author=A.+Alboresauthor=C.+C.+Chen&title=Selected+Topics+in+DNA+Repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.5772%2F22527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F22527%26sid%3Dliteratum%253Aachs%26aulast%3DBalam%2BMu%25C3%25B1oz%26aufirst%3DB.%26atitle%3DDNA%2520Damage%2520Caused%2520by%2520Polycyclic%2520Aromatic%2520Hydrocarbons%253A%2520Mechanisms%2520and%2520Markers%252C%2520Selected%2520Topics%2520in%2520DNA%2520Repair%26btitle%3DSelected%2520Topics%2520in%2520DNA%2520Repair%26aulast%3DChen%26aufirst%3DC.%2BC.%26pub%3DIntechOpen%26date%3D2011%26spage%3D125%26epage%3D144%26doi%3D10.5772%2F22527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun-Kyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soohoo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balastik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Essential role of Pin1 in the regulation of TRF1 Stability and Telomere Maintenance</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/ncb1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fncb1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19060891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=97-105&issue=1&author=T.+H.+Leeauthor=A.+Tun-Kyiauthor=R.+Shiauthor=J.+Limauthor=C.+Soohooauthor=G.+Finnauthor=M.+Balastikauthor=L.+Pastorinoauthor=G.+Wulfauthor=X.+Z.+Zhouauthor=K.+P.+Lu&title=Essential+role+of+Pin1+in+the+regulation+of+TRF1+Stability+and+Telomere+Maintenance&doi=10.1038%2Fncb1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance</span></div><div class="casAuthors">Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Telomeres are essential for maintaining cellular proliferative capacity and their loss has been implicated in ageing.  A key regulator in telomere maintenance is the telomeric protein TRF1, which was also identified as Pin2 in a screen for Pin1.  Pin1 is a unique prolyl isomerase that regulates protein conformation and function after phosphorylation.  However, little is known about the role of Pin1 in telomere regulation or the modulation of TRF1 by upstream signals.  Here we identify TRF1 as a major conserved substrate for Pin1 during telomere maintenance and ageing.  Pin1 inhibition renders TRF1 resistant to protein degrdn., enhances TRF1 binding to telomeres, and leads to gradual telomere loss in human cells and in mice.  Pin1-deficient mice also show widespread premature ageing phenotypes within just one generation, similar to those in telomerase-deficient mice after 4-5 consecutive generations.  Thus, Pin1 is an essential regulator of TRF1 stability, telomere maintenance and ageing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv8l7UyzuPNbVg90H21EOLACvtfcHk0lieGXpCjG0bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGqsg%253D%253D&md5=984cbc06e38dfdb3332d029a3cbbfd3e</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fncb1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1818%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DTun-Kyi%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DSoohoo%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DG.%26aulast%3DBalastik%26aufirst%3DM.%26aulast%3DPastorino%26aufirst%3DL.%26aulast%3DWulf%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DEssential%2520role%2520of%2520Pin1%2520in%2520the%2520regulation%2520of%2520TRF1%2520Stability%2520and%2520Telomere%2520Maintenance%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2009%26volume%3D11%26issue%3D1%26spage%3D97%26epage%3D105%26doi%3D10.1038%2Fncb1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Means, A. R.</span></span> <span> </span><span class="NLM_article-title">Pin1 Regulates the Timing of Mammalian Primordial Germ Cell Proliferation</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3579</span>– <span class="NLM_lpage">3586</span>, <span class="refDoi"> DOI: 10.1242/dev.00584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1242%2Fdev.00584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12810604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Whuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2003&pages=3579-3586&issue=15&author=F.+W.+Atchisonauthor=B.+Capelauthor=A.+R.+Means&title=Pin1+Regulates+the+Timing+of+Mammalian+Primordial+Germ+Cell+Proliferation&doi=10.1242%2Fdev.00584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 regulates the timing of mammalian primordial germ cell proliferation</span></div><div class="casAuthors">Atchison, Fawn W.; Capel, Blanche; Means, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3579-3586</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Primordial germ cells (PGCs) give rise to male and female germ cells to transmit the genome from generation to generation.  Defects in PGC development often result in infertility.  In the mouse embryo, PGCs undergo proliferation and expansion during and after their migration to the gonads from 8.5 to 13.5 days post coitum (dpc).  We show that a peptidyl-prolyl isomerase, Pin1, is involved in the regulation of mammalian PGC proliferation.  We discovered that both the male and female Pin1-/- mice had profound fertility defects.  Investigation of the reproductive organs revealed significantly fewer germ cells in the adult Pin1-/- testes and ovaries than in wild type or heterozygotes, which resulted from Pin1-/- males and females being born with severely reduced no. of gonocytes and oocytes.  Further studies in 8.5 to 13.5 dpc Pin1-/- embryos showed that PGCs were allocated properly at the base of the allantois, but their cell expansion was progressively impaired, resulting in a markedly reduced no. of PGCs at 13.5 dpc.  Analyses using markers of cell cycle parameters and apoptosis revealed that Pin1-/- PGCs did not undergo cell cycle arrest or apoptosis.  Instead, Pin1-/- PGCs had a lower BrdU labeling index compared with wild-type PGCs.  We conclude that PGCs have a prolonged cell cycle in the absence of Pin1, which translates into fewer cell divisions and strikingly fewer Pin1-/- PGCs by the end of the proliferative phase.  These results indicate that Pin1 regulates the timing of PGC proliferation during mouse embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRf3Q-lWuZzLVg90H21EOLACvtfcHk0lieGXpCjG0bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Whuro%253D&md5=e7747ac0b78c645bc3c3d7715311faee</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1242%2Fdev.00584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.00584%26sid%3Dliteratum%253Aachs%26aulast%3DAtchison%26aufirst%3DF.%2BW.%26aulast%3DCapel%26aufirst%3DB.%26aulast%3DMeans%26aufirst%3DA.%2BR.%26atitle%3DPin1%2520Regulates%2520the%2520Timing%2520of%2520Mammalian%2520Primordial%2520Germ%2520Cell%2520Proliferation%26jtitle%3DDevelopment%26date%3D2003%26volume%3D130%26issue%3D15%26spage%3D3579%26epage%3D3586%26doi%3D10.1242%2Fdev.00584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weininger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span> <span> </span><span class="NLM_article-title">The Prolyl Isomerase Domain of PpiD from Escherichia coli Shows a Parvulin Fold but is Devoid of Catalytic Activity</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1002/pro.277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fpro.277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19866485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=6-18&issue=1&author=U.+Weiningerauthor=R.+P.+Jakobauthor=M.+Kovermannauthor=J.+Balbachauthor=F.+X.+Schmid&title=The+Prolyl+Isomerase+Domain+of+PpiD+from+Escherichia+coli+Shows+a+Parvulin+Fold+but+is+Devoid+of+Catalytic+Activity&doi=10.1002%2Fpro.277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">The prolyl isomerase domain of PpiD from Escherichia coli shows a parvulin fold but is devoid of catalytic activity</span></div><div class="casAuthors">Weininger, Ulrich; Jakob, Roman P.; Kovermann, Michael; Balbach, Jochen; Schmid, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-18</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PpiD is a periplasmic folding helper protein of Escherichia coli.  It consists of an N-terminal helix that anchors PpiD in the inner membrane near the SecYEG translocon, followed by three periplasmic domains.  The second domain (residues 264-357) shows homol. to parvulin-like prolyl isomerases.  This domain is a well-folded, stable protein and follows a simple two-state folding mechanism.  In its soln. structure, as detd. by NMR spectroscopy, it resembles most closely the first parvulin domain of the SurA protein, which resides in the periplasm of E. coli as well.  A previously reported prolyl isomerase activity of PpiD could not be reproduced when using improved protease-free peptide assays or assays with refolding proteins as substrates.  However, the parvulin domain of PpiD interacts with a proline-contg. tetrapeptide, and as identified by NMR resonance shift anal., the binding site colocalized with the catalytic sites of other parvulins.  In its structure, the parvulin domain of PpiD resembles most closely the inactive first parvulin domain of SurA, which is part of the chaperone unit of this protein and presumably involved in substrate recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU_a6w_xNIkrVg90H21EOLACvtfcHk0lieGXpCjG0bvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGgtg%253D%253D&md5=bfa80d9f330215efd375286788ec47b8</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1002%2Fpro.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.277%26sid%3Dliteratum%253Aachs%26aulast%3DWeininger%26aufirst%3DU.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DKovermann%26aufirst%3DM.%26aulast%3DBalbach%26aufirst%3DJ.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26atitle%3DThe%2520Prolyl%2520Isomerase%2520Domain%2520of%2520PpiD%2520from%2520Escherichia%2520coli%2520Shows%2520a%2520Parvulin%2520Fold%2520but%2520is%2520Devoid%2520of%2520Catalytic%2520Activity%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26issue%3D1%26spage%3D6%26epage%3D18%26doi%3D10.1002%2Fpro.277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0035.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the anticancer drug 5-fluorouracil (<b>1</b>, left), which has been shown to prevent biofilm formation on catheters<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and the halogenated furanone-derivative (<b>2</b>, right), which has been shown to interfere with quorum sensing and preventing biofilm formation in <i>P. aeruginosa</i>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The PPIase activity of the immunophilins, such as the macrophage infectivity potentiator (Mip) protein, catalyzes the <i>cis</i>–<i>trans</i> isomerization of the peptide bonds preceding a proline residue in a polypeptide chain; P<sup>1</sup> = peptide chain 1 and P<sup>2</sup> = peptide chain 2. Due to steric hindrance, most amino acids have a strong energetic preference for the <i>trans</i> peptide bond conformation, but proline’s unusual structure stabilizes the <i>cis</i> form so that both isomers are populated under biologically relevant conditions, allowing the correct folding of polypeptide chains into correctly structured proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of the natural products rapamycin (<b>4</b>) and FK506 (<b>3</b>). The common pipecoline substructure is marked red. Blue dashed lines show approximate limits of the binding domain, which depend on the respective FKBP and the effector domains, which interact with mTOR in the case of rapamycin or with calcineurin in the case of FK506. The numbers are indicating the atom number of the longest ring structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the cognate inhibitor of cyclophilins, cyclosporin A (CsA) (<b>5</b>, left), and of parvulins, juglone (<b>6</b>, right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Detailed FKBP12 interactions with rapamycin (<b>4</b>), representative for other FKBPs. Black dashed lines indicate hydrogen bonds. Green amino acids show points of contact deep in the binding pocket and blue amino acids on its surface.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Illustration of the absorption spectra during the protease-coupled reaction (with and without PPIase or rapamycin). Mip PPIase activity catalyzes the conversion from <i>cis</i> to <i>trans</i> of the substrate, and the absorption increases rapidly, while rapamycin, as a Mip inhibitor, prevents this effect. The reaction reaches equilibrium as all substrate is turned over to a <i>trans</i> state. (B) Residual activity curve of compounds. In the PPIase assay the catalytic efficiency of the unbound enzyme (without inhibitor) was assumed to be 100% of the enzyme activity, and all other efficiency values (with inhibitor) were compared. The residual activity of the enzyme could thus be maintained at different inhibitor concentrations, and therefore, the IC<sub>50</sub> value for each compound can be determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Starting point for investigations were two FKPB12 inhibitors were tested for LpMip inhibition. Affinities of ligand <b>7</b> (<i>K</i><sub>i</sub> = 0.010 μM)<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> and ligand <b>8</b> (<i>K</i><sub>i</sub> = 0.230 μM) to FKBP12 were described before.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Top-binding mode of ligand <b>8</b> in LpMip justifies its selection as first lead structure. The pipecoline ring is placed deep in the active-site pocket, whereas the phenyl ring of the sulfonamide moiety occupies a subpocket and the trimethoxyphenyl moiety lies on the surface.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Reproduced with permission from <i>Journal of Medicinal Chemistry</i>, Juli et al.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of the sulfonamide residue shows that the benzyl moiety in <b>10</b> is superior to phenyl (<b>9</b>) for Mip inhibition, and substitution B in meta position is possible and was also investigated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Optimization of the R″ residue showed that bulky trimethoxyphenyl (<b>11</b>) or pyridine rings (<b>12</b>) are moieties of choice in terms of Mip inhibition. Additionally, a pyridine residue promises an improved solubility of the compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Hit compounds of the nonimmunosuppressive FKBP ligand screening: cycloheximide (<b>13</b>, left) and adamantane (<b>14</b>, right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Several hybrids, highest to lowest activity. Hit compound <b>16</b> had 10-fold lower IC<sub>50</sub> values for LpMip than for FKBP12; the hydroxylation decreased the affinity especially for LpMip. The weakest compound <b>15</b> (<i>tert</i>-butyl instead of adamantane and N-methylation) significantly worsens the affinity, especially for FKBP12.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Cocrystallization trials with BpML1 were carried out with several pipecolic acids. Compounds <b>20</b>–<b>23</b> delivered crystals with sufficient X-ray data for structure determination. Compound <b>22</b> represents the <i>S</i>-enantiomer of compound <b>21</b>, while all others were introduced as racemates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Structure ensemble for pipecolic acids binding to BpML1. Four crystallographic poses were observed for compound <b>21</b> (pink), while two poses each were obtained for compounds <b>20</b> (green), <b>22</b> (blue), and <b>23</b> (yellow). A full model complex for compound <b>23</b> is postulated (gray) and is based on NMR data and available space in the crystal structure. Non-carbon atoms for each compound are colored as follows: red, oxygen; blue, nitrogen; gold, sulfur.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Reproduced with permission from   <cite><i>Antimicrobial
Agents and Chemotherapy</i></cite>, <contrib-group>Begley</contrib-group> , Volume <em>58</em>, Issue 3, pp 1458–1467, Copyright <span class="NLM_year">2014</span> American Society for Microbiology, DOI: <pub-id pub-id-type="doi" type="simple">10.1128/aac.01875-13</pub-id>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Crystal structures of BpML1 bound to FK-506 (<b>3</b>, brown; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UQB">3UQB</a>) and compound <b>22</b> (cyan; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G50">4G50</a>). The conformational change within the R92-I98 loop accommodates the terminal phenyl group of compound <b>22</b> (bottom), relative to the FK-506-bound structure (top). The R92 side chain is not modeled in the FK-506 structure (top) due to insufficient electron density.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Reproduced with permission from   <cite><i>Antimicrobial Agents and Chemotherapy</i></cite>, <contrib-group>Begley</contrib-group> , Volume <em>58</em>,
Issue 3, pp 1458–1467, Copyright <span class="NLM_year">2014</span> American Society for Microbiology,
DOI: <pub-id pub-id-type="doi" type="simple">10.1128/aac.01875-13</pub-id>.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. For BpML1 inhibition the new lead structure <b>S-24</b> could be identified and was a starting point for further optimization.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. In a screening campaign potent human FKBP inhibitors were tested against several pathogens to find new hits for the respective microbial Mips. The common framework of this series of compounds offers three regions to modify (R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>). Hit compound <b>32</b> for human FKBP inhibition was the starting point of microbial investigations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. New hit compounds for microbial Mip inhibition were found by the screening of known human FKBP inhibitors. Compound <b>33</b> represents an exclusive inhibitor of the <i>Chlamydia</i> Mip protein, whereas compound <b>34</b> combines many advantageous structural elements for a broad spectrum of microbial Mip proteins and, with some modification, becomes a potent inhibitor of <i>Plasmodium</i> and <i>Legionella</i> Mip.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Sangliferin <b>41</b> derived Cyp A inhibiting macrocycles <b>43</b> and <b>44</b> were turned to the highly orally bioavailable macrocycle <b>45</b> by structure guided optimization by Mackman et al.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structures of small molecule cyclophilin inhibitors <b>46</b>, <b>47</b>, and <b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structures of the antibiotics oxacillin (<b>49</b>) and the glycopeptides teicoplanin (<b>50</b>) and vancomycin (<b>51</b>) to which an increased susceptibility was observed in the <i>S. aureus</i> prsA mutant.<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152,153)</a> The antibiotic ampicillin (<b>52</b>) was also found to have an increased efficacy against <i>E. faecalis</i>Δ<i>ef0685</i>Δef1534.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The antibiotic, penicillin G (<b>53</b>), displayed increased efficacy in the PrsA2 mutant, indicating that PrsA2 was involved in PBP folding, thus mediating penicillin G resistance.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures of antimicrobials novobiocin (<b>54</b>) and bacitracin (<b>55</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Peptide PIN1 inhibitor <b>56</b> by Wildemann et al., which was discovered by screening a cellulose-bound peptide library of 5-mer acetylated peptides containing nonproteinogenic amino acids surrounding a <span class="smallcaps smallerCapital">d</span>-phosphothreonine.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Shown is a comparison of the active sites of human PIN1 and FKBP complexes. (a) Chemical structure of peptide <b>56</b>. The <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-stereoisomers differ on the marked carbon atom C*. (b) Comparative binding modes of the <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-stereoisomer of peptide <b>56</b> to human PIN1 shown as superimposed images. The <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-isomer-bound structures of PIN1 are identical to each other. The PIN1 amino acid side chains involved in peptide recognition are shown as half-colored bonds with carbon shown in brown for the <span class="smallcaps smallerCapital">d</span>-isomer complex and yellow for the <span class="smallcaps smallerCapital">l</span>-isomer complex. <span class="smallcaps smallerCapital">d</span>- and <span class="smallcaps smallerCapital">l</span>-isomers are depicted as half-colored bonds with carbon colored light gray for the <span class="smallcaps smallerCapital">d</span>-isomer and cyan for the <span class="smallcaps smallerCapital">l</span>-form. (c) A close-up view rendered in a slightly different orientation than panel a. (d) Surface of PIN1 complexed with the <span class="smallcaps smallerCapital">d</span>-isomer of <b>56</b>. The intramolecular hydrogen bond (dashed red cylinders) between the carbonyl oxygen of Phe1 and the amide nitrogen of Nal4 defines a bound peptide conformation that closely resembles the conformation and binding mode of rapamycin bound to FKBP depicted in panel d (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKB">1FKB</a>). (e) Rendered 3D structure of the FKBP12/rapamycin complex. In PIN1, the Pip residue forms several hydrophobic interactions with Phe134 and Leu122 in the PIN1 active site. In the FKBP–rapamycin complex this interaction is spatially conserved with Phe46 and Trp59 in human FKBP12 sequestering the Pip moiety of rapamycin.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Reproduced with permission from <i>ACS Chemical Biology</i>, Zhang et al.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Top: First generation, cyclic peptide PIN1 inhibitor <b>57</b> by Bedewy et al.,<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> attached to an octaarginine sequence using a disulfide linker, which is reduced in the cytosol.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Left: Cell-permeable and biologically active cycloheptapeptide <b>58</b>.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Right: Cell-permeable and metabolically stable nonphosphorylated bicyclic peptide <b>59</b>.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Small molecule, phosphate or carboxylate containing PIN1 inhibitors <b>60</b>, <b>61</b>, and <b>62</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Structures of the small molecule PIN1 inhibitors PiB (<b>63</b>),<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> DTM (<b>64</b>),<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> and ATRA (<b>65</b>).<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> ATRA (<b>65</b>) is already being used for the medical treatment of acne and acute promyelocytic leukemia (APL).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/medium/jm0c00911_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Structures of the small molecule PIN1 inhibitors EGCG (<b>67</b>) and KPT-6566 (<b>68A</b>) and its byproduct KPT-6566-B (<b>68B</b>).<a onclick="showRef(event, 'ref183 ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref183 ref206 ref207">(183,206,207)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00911/20201120/images/large/jm0c00911_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00911&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 212 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, I. M.</span></span> <span> </span><span class="NLM_article-title">Antibiotic Stewardship: Overcoming Implementation Barriers</span>. <i>Curr. Opin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1097/QCO.0b013e3283483262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1097%2FQCO.0b013e3283483262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21587070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC3MnktValsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=357-362&issue=4&author=A.+M.+Balauthor=I.+M.+Gould&title=Antibiotic+Stewardship%3A+Overcoming+Implementation+Barriers&doi=10.1097%2FQCO.0b013e3283483262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic stewardship: overcoming implementation barriers</span></div><div class="casAuthors">Bal Abhijit M; Gould Ian M</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Antimicrobial stewardship is now recognized as a formal strategy for curbing the upward trend in antibiotic resistance.  Literature on antimicrobial stewardship has focused on areas of strategic importance and operational delivery.  A number of barriers have been recognized in the implementation of successful programs.  These include lack of physician participation, lack of diagnostic facility, absence of formal mechanism of data collection, variation between countries, and lack of cooperative strategies.  In this review, we suggest strategies to overcome these barriers.  RECENT FINDINGS:  In the last few years, it has been recognized that an executive program is necessary for successful implementation of strategies to control the growing antibiotic resistance.  Efforts have been made at higher levels of government through organizations such as the European Centre for Disease Prevention and Control.  The need for community healthcare involvement has also been recognized.  At a local level, strategies to promote cooperation between various committees (e.g. infection control and antimicrobial management teams) have been proposed and adopting antibiotic care bundles as part of patient safety and healthcare is being explored.  SUMMARY:  We suggest that executive level planning, local cooperation, sustained education, emphasis on de-escalation, and use of care bundles could stem the tide of growing resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrfVLBD0YLIFw2ofyr07jXfW6udTcc2ebp1muKNGseRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnktValsw%253D%253D&md5=f8fbd35b19db35b90c92ab78775de075</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e3283483262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e3283483262%26sid%3Dliteratum%253Aachs%26aulast%3DBal%26aufirst%3DA.%2BM.%26aulast%3DGould%26aufirst%3DI.%2BM.%26atitle%3DAntibiotic%2520Stewardship%253A%2520Overcoming%2520Implementation%2520Barriers%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D24%26issue%3D4%26spage%3D357%26epage%3D362%26doi%3D10.1097%2FQCO.0b013e3283483262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasko, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, V.</span></span> <span> </span><span class="NLM_article-title">Anti-Virulence Strategies to Combat Bacteria-Mediated Disease</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1038/nrd3013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnrd3013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20081869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=117-128&issue=2&author=D.+A.+Raskoauthor=V.+Sperandio&title=Anti-Virulence+Strategies+to+Combat+Bacteria-Mediated+Disease&doi=10.1038%2Fnrd3013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-virulence strategies to combat bacteria-mediated disease</span></div><div class="casAuthors">Rasko, David A.; Sperandio, Vanessa</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibiotic resistance is one of the greatest challenges of the twenty-first century.  However, the increasing understanding of bacterial pathogenesis and intercellular communication has revealed many potential strategies to develop novel drugs to treat bacteria-mediated disease.  Interference with bacterial virulence and/or cell-to-cell signaling pathways is an esp. compelling approach, as it is thought to apply less selective pressure for the development of bacterial resistance than traditional strategies, which are aimed at killing bacteria or preventing their growth.  Here, we discuss the mechanisms of bacterial virulence and present promising anti-virulence strategies and compds. for the future treatment of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_XHw8YsfL7Vg90H21EOLACvtfcHk0lhjBw6M7T5pnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D&md5=e46d5501a1a28a3deb2e3b2432dff66a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd3013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3013%26sid%3Dliteratum%253Aachs%26aulast%3DRasko%26aufirst%3DD.%2BA.%26aulast%3DSperandio%26aufirst%3DV.%26atitle%3DAnti-Virulence%2520Strategies%2520to%2520Combat%2520Bacteria-Mediated%2520Disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26issue%3D2%26spage%3D117%26epage%3D128%26doi%3D10.1038%2Fnrd3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cegelski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldridge, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">The Biology and Future Prospects of Antivirulence Therapies</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnrmicro1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18079741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVaqt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=17-27&issue=1&author=L.+Cegelskiauthor=G.+R.+Marshallauthor=G.+R.+Eldridgeauthor=S.+J.+Hultgren&title=The+Biology+and+Future+Prospects+of+Antivirulence+Therapies&doi=10.1038%2Fnrmicro1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The biology and future prospects of antivirulence therapies</span></div><div class="casAuthors">Cegelski, Lynette; Marshall, Garland R.; Eldridge, Gary R.; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-27</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting bacterial virulence is an alternative approach to antimicrobial therapy.  This Review considers recent efforts towards antivirulence-based drug discovery in the framework of marketable drugs, and discusses what challenges remain and the factors that are crucial to developing the antivirulence therapeutic approach.  The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches.  Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium.  Certain virulence factors have been shown to be potential targets for drug design and therapeutic intervention, whereas new insights are crucial for exploiting others.  Targeting virulence represents a new paradigm to empower the clinician to prevent and treat infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOBVkXUSVSbVg90H21EOLACvtfcHk0lhjBw6M7T5pnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVaqt7vF&md5=42b72b7a52f5b83c0c1c949ee73f03ef</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1818%26sid%3Dliteratum%253Aachs%26aulast%3DCegelski%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26aulast%3DEldridge%26aufirst%3DG.%2BR.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520Biology%2520and%2520Future%2520Prospects%2520of%2520Antivirulence%2520Therapies%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2008%26volume%3D6%26issue%3D1%26spage%3D17%26epage%3D27%26doi%3D10.1038%2Fnrmicro1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avelar, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longtine, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mermel, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heard, S. O.</span></span> <span> </span><span class="NLM_article-title">Anti-Infective External Coating of Central Venous Catheters: a Randomized, Noninferiority Trial Comparing 5-Fluorouracil with Chlorhexidine/Silver Sulfadiazine in Preventing Catheter Colonization</span>. <i>Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2095</span>– <span class="NLM_lpage">2102</span>, <span class="refDoi"> DOI: 10.1097/CCM.0b013e3181f265ba</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1097%2FCCM.0b013e3181f265ba" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20711070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSqur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2095-2102&issue=11&author=J.+M.+Walzauthor=R.+L.+Avelarauthor=K.+J.+Longtineauthor=K.+L.+Carterauthor=L.+A.+Mermelauthor=S.+O.+Heard&title=Anti-Infective+External+Coating+of+Central+Venous+Catheters%3A+a+Randomized%2C+Noninferiority+Trial+Comparing+5-Fluorouracil+with+Chlorhexidine%2FSilver+Sulfadiazine+in+Preventing+Catheter+Colonization&doi=10.1097%2FCCM.0b013e3181f265ba"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-infective external coating of central venous catheters: A randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization</span></div><div class="casAuthors">Walz, J. Matthias; Avelar, Rui L.; Longtine, Karen J.; Carter, Kent L.; Mermel, Leonard A.; Heard, Stephen O.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Care Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2095-2102</span>CODEN:
                <span class="NLM_cas:coden">CCMDC7</span>;
        ISSN:<span class="NLM_cas:issn">0090-3493</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: The antimetabolite drug, 5-fluorouracil, inhibits microbial growth.  Coating of central venous catheters with 5-fluorouracil may reduce the risk of catheter infection.  Our objective was to compare the safety and efficacy of central venous catheters externally coated with 5-fluorouracil with those coated with chlorhexidine and silver sulfadiazine.  Design: Prospective, single-blind, randomized, active-controlled, multicentered, noninferiority trial.  Setting: Twenty-five US medical center intensive care units.  Patients: A total of 960 adult patients requiring central venous catheterization for up to 28 days.  Interventions: Patients were randomized to receive a central venous catheter externally coated with either 5-fluorouracil (n = 480) or chlorhexidine and silver sulfadiazine (n = 480).  Measurements and main results: The primary antimicrobial outcome was a dichotomous measure (<15 colony-forming units or ≥15 colony-forming units) for catheter colonization detd. by the roll plate method.  Secondary antimicrobial outcomes included local site infection and catheter-related bloodstream infection.  Central venous catheters coated with 5-fluorouracil were noninferior to chlorhexidine and silver sulfadiazine coated central venous catheters with respect to the incidence of catheter colonization (2.9% vs. 5.3%, resp.).  Local site infection occurred in 1.4% of the 5-fluorouracil group and 0.9% of the chlorhexidine and silver sulfadiazine group.  No episode of catheter-related bloodstream infection occurred in the 5-fluorouracil group, whereas two episodes were noted in the chlorhexidine and silver sulfadiazine group.  Only Gram-pos. organisms were cultured from 5-fluorouracil catheters, whereas Gram-pos. bacteria, Gram-neg. bacteria, and Candida were cultured from the chlorhexidine and silver sulfadiazine central venous catheters.  Adverse events were comparable between the two central venous catheter coatings.  Conclusions: Our results suggest that central venous catheters externally coated with 5-fluorouracil are a safe and effective alternative to catheters externally coated with chlorhexidine and silver sulfadiazine when used in critically ill patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3C3LeljOZCbVg90H21EOLACvtfcHk0ljiHqlFXxD5Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSqur7L&md5=c06a2463e7fa255e8b1547d80918b0c2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2FCCM.0b013e3181f265ba&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCCM.0b013e3181f265ba%26sid%3Dliteratum%253Aachs%26aulast%3DWalz%26aufirst%3DJ.%2BM.%26aulast%3DAvelar%26aufirst%3DR.%2BL.%26aulast%3DLongtine%26aufirst%3DK.%2BJ.%26aulast%3DCarter%26aufirst%3DK.%2BL.%26aulast%3DMermel%26aufirst%3DL.%2BA.%26aulast%3DHeard%26aufirst%3DS.%2BO.%26atitle%3DAnti-Infective%2520External%2520Coating%2520of%2520Central%2520Venous%2520Catheters%253A%2520a%2520Randomized%252C%2520Noninferiority%2520Trial%2520Comparing%25205-Fluorouracil%2520with%2520Chlorhexidine%252FSilver%2520Sulfadiazine%2520in%2520Preventing%2520Catheter%2520Colonization%26jtitle%3DCrit.%2520Care%2520Med.%26date%3D2010%26volume%3D38%26issue%3D11%26spage%3D2095%26epage%3D2102%26doi%3D10.1097%2FCCM.0b013e3181f265ba" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hentzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Givskov, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of Quorum Sensing for the Treatment of Chronic Bacterial Infections</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1172/JCI20074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1172%2FJCI20074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14597754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGqsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=1300-1307&issue=9&author=M.+Hentzerauthor=M.+Givskov&title=Pharmacological+Inhibition+of+Quorum+Sensing+for+the+Treatment+of+Chronic+Bacterial+Infections&doi=10.1172%2FJCI20074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections</span></div><div class="casAuthors">Hentzer, Morten; Givskov, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1300-1307</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Traditional treatment of infectious diseases is based on compds. that aim to kill or inhibit bacterial growth.  A major concern with this approach is the frequently obsd. development of resistance to antimicrobial compds.  The discovery of bacterial-communication systems (quorum-sensing systems), which orchestrate important temporal events during the infection process, has afforded a novel opportunity to ameliorate bacterial infection by means other than growth inhibition.  Compds. able to over-ride bacterial signaling are present in Nature.  Here, the authors discuss the known signaling mechanisms and potential antipathogenic drugs that specifically target quorum-sensing systems in a manner unlikely to pose a selective pressure for the development of resistant mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxemnrP5U9EbVg90H21EOLACvtfcHk0ljiHqlFXxD5Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGqsro%253D&md5=c0e525617af51d91070720dbd22e4570</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1172%2FJCI20074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI20074%26sid%3Dliteratum%253Aachs%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DGivskov%26aufirst%3DM.%26atitle%3DPharmacological%2520Inhibition%2520of%2520Quorum%2520Sensing%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Bacterial%2520Infections%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26issue%3D9%26spage%3D1300%26epage%3D1307%26doi%3D10.1172%2FJCI20074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fasciano, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaban, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecsas, J.</span></span> <span> </span><span class="NLM_article-title">Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target</span>. <i>EcoSal Plus.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1128/ecosalplus.ESP-0032-2018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2Fecosalplus.ESP-0032-2018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=261-276&author=A.+C.+Fascianoauthor=L.+Shabanauthor=J.+Mecsas&title=Promises+and+Challenges+of+the+Type+Three+Secretion+System+Injectisome+as+an+Antivirulence+Target&doi=10.1128%2Fecosalplus.ESP-0032-2018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2Fecosalplus.ESP-0032-2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fecosalplus.ESP-0032-2018%26sid%3Dliteratum%253Aachs%26aulast%3DFasciano%26aufirst%3DA.%2BC.%26aulast%3DShaban%26aufirst%3DL.%26aulast%3DMecsas%26aufirst%3DJ.%26atitle%3DPromises%2520and%2520Challenges%2520of%2520the%2520Type%2520Three%2520Secretion%2520System%2520Injectisome%2520as%2520an%2520Antivirulence%2520Target%26jtitle%3DEcoSal%2520Plus.%26date%3D2019%26spage%3D261%26epage%3D276%26doi%3D10.1128%2Fecosalplus.ESP-0032-2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandts, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halvorson, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, M.</span></span> <span> </span><span class="NLM_article-title">Consideration of the Possibility that the Slow Step in Protein Denaturation Reactions is due to Cis-Trans Isomerism of Proline Residues</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4953</span>– <span class="NLM_lpage">4963</span>, <span class="refDoi"> DOI: 10.1021/bi00693a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00693a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaE28XhsVOk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=4953-4963&issue=22&author=J.+F.+Brandtsauthor=H.+R.+Halvorsonauthor=M.+Brennan&title=Consideration+of+the+Possibility+that+the+Slow+Step+in+Protein+Denaturation+Reactions+is+due+to+Cis-Trans+Isomerism+of+Proline+Residues&doi=10.1021%2Fbi00693a026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues</span></div><div class="casAuthors">Brandts, John F.; Halvorson, Herbert R.; Brennan, Maureen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4953-63</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A model is proposed for the apparent 2-phase kinetics in the denaturation of small proteins.  It is suggested that only 1 of these phases, the fast 1, is actually an unfolding process.  The slow phase is assumed to arise from the cis-trans isomerism of proline residues in the denatured protein.  From model compd. data, the expected rate for isomerism was in satisfactory agreement with the rates actually obsd. for protein folding.  A simple model of protein unfolding based on the isomerism concept was very successful in accounting for many known exptl. characteristics of the kinetics and thermodn. of protein denaturation.  Thus, the model is able to predict that 2 kinetic phases will be seen in the transition region while none are seen in the base-line regions, that both the fast and slow refolding phases lead to the native protein as the product, that the fast phase becomes the only observable phase for jumps ending far in the denatured base-line region, that most or all small proteins show a limiting low-temp. activation energy of ∼20,000 cal, and that the relaxation time for the slow phase seen in cytochrome c denaturation is much shorter than for all other small proteins.  By utilizing double-jump expts., it was shown directly that the slow phase is not part of the unfolding process, but corresponds to a transition among ≥2 denatured forms which have identical spectroscopic (286.5 nm) properties.  Thus, the slow relaxation is invisible except in the transition region where it couples to the fast unfolding equil.  Finally, since the present model assumes that only 1 of the major kinetic phases seen in denaturation reactions is concerned with the denaturation process per se, it is in agreement with numerous thermodn. studies which show consistency with the 2-state model for unfolding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUGXF5gCyaC7Vg90H21EOLACvtfcHk0ljiHqlFXxD5Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XhsVOk&md5=8a20b90b6d768ab845f58b48b28e321a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fbi00693a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00693a026%26sid%3Dliteratum%253Aachs%26aulast%3DBrandts%26aufirst%3DJ.%2BF.%26aulast%3DHalvorson%26aufirst%3DH.%2BR.%26aulast%3DBrennan%26aufirst%3DM.%26atitle%3DConsideration%2520of%2520the%2520Possibility%2520that%2520the%2520Slow%2520Step%2520in%2520Protein%2520Denaturation%2520Reactions%2520is%2520due%2520to%2520Cis-Trans%2520Isomerism%2520of%2520Proline%2520Residues%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26issue%3D22%26spage%3D4953%26epage%3D4963%26doi%3D10.1021%2Fbi00693a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Catalysis of Protein Folding by Prolyl Isomerase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>329</i></span> (<span class="NLM_issue">6136</span>),  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1038/329268a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2F329268a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=3306408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2sXmtlajsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=268-270&issue=6136&author=K.+Langauthor=F.+X.+Schmidauthor=G.+Fischer&title=Catalysis+of+Protein+Folding+by+Prolyl+Isomerase&doi=10.1038%2F329268a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Catalysis of protein folding by prolyl isomerase</span></div><div class="casAuthors">Lang, Kurt; Schmid, Franz X.; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">6136</span>),
    <span class="NLM_cas:pages">268-70</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Peptidyl-prolyl cis-trans isomerase (PPIase), from pig kidney, efficiently catalyzes slow steps in the refolding of the Ig light chain from mouse, porcine RNase, and the S-fragment of bovine RNase A.  Refolding of intact bovine RNase A is not catalyzed by PPIase, probably because proline peptide bonds are inaccessible.  The data suggest that proline cis-trans isomerization is rate-limiting in some slow protein folding reactions, where fast- and slow-folding isomers coexist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWfpD4lpp_vrVg90H21EOLACvtfcHk0lj-5N76GdZaEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtlajsLs%253D&md5=c02562503173799e552c2ff058ec7ec2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F329268a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329268a0%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DK.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DCatalysis%2520of%2520Protein%2520Folding%2520by%2520Prolyl%2520Isomerase%26jtitle%3DNature%26date%3D1987%26volume%3D329%26issue%3D6136%26spage%3D268%26epage%3D270%26doi%3D10.1038%2F329268a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiene-Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span> <span> </span><span class="NLM_article-title">Receptor Accessory Folding Helper Enzymes: the Functional Role of Peptidyl Prolyl Cis/Trans Isomerases</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>495</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(01)02326-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0014-5793%2801%2902326-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11322937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFehu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=495&publication_year=2001&pages=1-6&issue=1%E2%80%932&author=C.+Schiene-Fischerauthor=C.+Yu&title=Receptor+Accessory+Folding+Helper+Enzymes%3A+the+Functional+Role+of+Peptidyl+Prolyl+Cis%2FTrans+Isomerases&doi=10.1016%2FS0014-5793%2801%2902326-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases</span></div><div class="casAuthors">Schiene-Fischer, C.; Yu, C.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">495</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 66 refs.  Receptor accessory peptidyl prolyl cis/trans isomerases (PPIases) of the FKBP and cyclophilin types form receptor heterocomplexes with different stabilities.  PPIases have been found to assoc. with other receptor heterocomplex constituents via either proline-directed active sites or addnl. domains of the enzymes.  The single-domain PPIases FKBP12 and FKBP12.6 are shown to interact with receptor protein kinases and calcium channels at their active sites.  In contrast, heterooligomeric nuclear receptors contain multi-domain PPIases like FKBP51, FKBP52 or cyclophilin 40 that directly interact with the chaperone hsp90 via the tetratricopeptide repeat modules of the folding helper enzymes.  PPIases play a crit. role in the functional arrangement of components within receptor heterocomplexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBogMjRhrxTrVg90H21EOLACvtfcHk0lj-5N76GdZaEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFehu7w%253D&md5=4567c349d7371106117ca5c06da29930</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2801%2902326-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252801%252902326-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchiene-Fischer%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26atitle%3DReceptor%2520Accessory%2520Folding%2520Helper%2520Enzymes%253A%2520the%2520Functional%2520Role%2520of%2520Peptidyl%2520Prolyl%2520Cis%252FTrans%2520Isomerases%26jtitle%3DFEBS%2520Lett.%26date%3D2001%26volume%3D495%26issue%3D1%25E2%2580%25932%26spage%3D1%26epage%3D6%26doi%3D10.1016%2FS0014-5793%2801%2902326-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span>; <span class="NLM_string-name">Aumüller, T.</span></span> <span> </span><span class="NLM_article-title">Regulation of Peptide Bond Cis/Trans Isomerization by Enzyme Catalysis and its Implication in Physiological Processes</span>.  <i>Reviews of Physiology, Biochemistry and Pharmacology</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2003</span>; pp  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1007/s10254-003-0011-3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2Fs10254-003-0011-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=105-150&author=G.+Fischer&author=T.+Aum%C3%BCller&title=Reviews+of+Physiology%2C+Biochemistry+and+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10254-003-0011-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252Fs10254-003-0011-3%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DRegulation%2520of%2520Peptide%2520Bond%2520Cis%252FTrans%2520Isomerization%2520by%2520Enzyme%2520Catalysis%2520and%2520its%2520Implication%2520in%2520Physiological%2520Processes%26btitle%3DReviews%2520of%2520Physiology%252C%2520Biochemistry%2520and%2520Pharmacology%26pub%3DSpringer%26date%3D2003%26spage%3D105%26epage%3D150%26doi%3D10.1007%2Fs10254-003-0011-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghartey-Kwansah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of FKBP Family Protein: Evaluation, Structure, and Function in Mammals and Drosophila melanogaster</span>. <i>BMC Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.1186/s12861-018-0167-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1186%2Fs12861-018-0167-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29587629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjsFWrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=7&issue=1&author=G.+Ghartey-Kwansahauthor=Z.+Liauthor=R.+Fengauthor=L.+Wangauthor=X.+Zhouauthor=F.+Z.+Chenauthor=M.+M.+Xuauthor=O.+Jonesauthor=Y.+Muauthor=S.+Chenauthor=J.+Bryantauthor=W.+B.+Isaacsauthor=J.+Maauthor=X.+Xu&title=Comparative+Analysis+of+FKBP+Family+Protein%3A+Evaluation%2C+Structure%2C+and+Function+in+Mammals+and+Drosophila+melanogaster&doi=10.1186%2Fs12861-018-0167-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of FKBP family protein: evaluation, structure, and function in mammals and Drosophila melanogaster</span></div><div class="casAuthors">Ghartey-Kwansah, George; Li, Zhongguang; Feng, Rui; Wang, Liyang; Zhou, Xin; Chen, Frederic Z.; Xu, Meng Meng; Jones, Odell; Mu, Yulian; Chen, Shawn; Bryant, Joseph; Isaacs, Williams B.; Ma, Jianjie; Xu, Xuehong</div><div class="citationInfo"><span class="NLM_cas:title">BMC Developmental Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7/1-7/12</span>CODEN:
                <span class="NLM_cas:coden">BDBMA7</span>;
        ISSN:<span class="NLM_cas:issn">1471-213X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: FK506-binding proteins (FKBPs) have become the subject of considerable interest in several fields, leading to the identification of several cellular and mol. pathways in which FKBPs impact prenatal development and pathogenesis of many human diseases.  Main body: This anal. revealed differences between how mammalian and Drosophila FKBPs mechanisms function in relation to the immunosuppressant drugs, FK506 and rapamycin.  Differences that could be used to design insect-specific pesticides. (1) Mol. phylogenetic anal. of FKBP family proteins revealed that the eight known Drosophila FKBPs share homol. with the human FKBP12.  This indicates a close evolutionary relationship, and possible origination from a common ancestor. (2) The known FKBPs contain FK domains, i.e., a prolyl cis/trans isomerase (PPIase) domain that mediates immune suppression through inhibition of calcineurin.  The dFKBP59, CG4735/ Shutdown, CG1847, and CG5482 have a Tetratricopeptide receptor domain at the C-terminus, which regulates transcription and protein transportation. (3) FKBP51 and FKBP52 (dFKBP59), along with Cyclophilin 40 and protein phosphatase 5, function as Hsp90 immunophilin co-chaperones within steroid receptor-Hsp90 heterocomplexes.  These immunophilins are potential drug targets in pathways assocd. with normal physiol. and may be used to treat a variety of steroid-based diseases by targeting exocytic/endocytic cycling and vesicular trafficking. (4) By assocg. with presinilin, a crit. component of the Notch signaling pathway, FKBP14 is a downstream effector of Notch activation at the membrane.  Meanwhile, Shutdown assocs. with transposons in the PIWI-interacting RNA pathway, playing a crucial role in both germ cells and ovarian somas.  Mutations in or silencing of dFKBPs lead to early embryonic lethality in Drosophila.  Therefore, further understanding the mechanisms of FK506 and rapamycin binding to immunophilin FKBPs in endocrine, cardiovascular, and neurol. function in both mammals and Drosophila would provide prospects in generating unique, insect specific therapeutics targeting the above cellular signaling pathways.  Conclusion: This review will evaluate the functional roles of FKBP family proteins, and systematically summarize the similarities and differences between FKBP proteins in Drosophila and Mammals.  Specific therapeutics targeting cellular signaling pathways will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovBGPdYUHS3LVg90H21EOLACvtfcHk0lihCsYgrKbMgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjsFWrsbk%253D&md5=0268a18ca62377e521cc2f59a6d16e43</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2Fs12861-018-0167-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12861-018-0167-3%26sid%3Dliteratum%253Aachs%26aulast%3DGhartey-Kwansah%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DF.%2BZ.%26aulast%3DXu%26aufirst%3DM.%2BM.%26aulast%3DJones%26aufirst%3DO.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DBryant%26aufirst%3DJ.%26aulast%3DIsaacs%26aufirst%3DW.%2BB.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26atitle%3DComparative%2520Analysis%2520of%2520FKBP%2520Family%2520Protein%253A%2520Evaluation%252C%2520Structure%252C%2520and%2520Function%2520in%2520Mammals%2520and%2520Drosophila%2520melanogaster%26jtitle%3DBMC%2520Dev.%2520Biol.%26date%3D2018%26volume%3D18%26issue%3D1%26spage%3D7%26doi%3D10.1186%2Fs12861-018-0167-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">FKBP Ligands—Where We Are and Where to Go?</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1425</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffphar.2018.01425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30568592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1425&author=J.+M.+Kolosauthor=A.+M.+Vollauthor=M.+Bauderauthor=F.+Hausch&title=FKBP+Ligands%E2%80%94Where+We+Are+and+Where+to+Go%3F&doi=10.3389%2Ffphar.2018.01425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP Ligands-where we are and where to go?</span></div><div class="casAuthors">Kolos, Juergen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1425</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  In recent years, many members of the FK506-binding protein (FKBP) family were increasingly linked to various diseases.  The binding domain of FKBPs differs only in a few amino acid residues, but their biol. roles are versatile.  High-affinity ligands with selectivity between close homologs are scarce.  This review will give an overview of the most prominent ligands developed for FKBPs and highlight a perspective for future developments.  More precisely, human FKBPs and correlated diseases will be discussed as well as microbial FKBPs in the context of anti-bacterial and anti-fungal therapeutics.  The last section gives insights into high-affinity ligands as chem. tools and dimerizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBr9H6aE3nrVg90H21EOLACvtfcHk0lihCsYgrKbMgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK&md5=72403a782e5d7e96352188f9e88821d9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01425%26sid%3Dliteratum%253Aachs%26aulast%3DKolos%26aufirst%3DJ.%2BM.%26aulast%3DVoll%26aufirst%3DA.%2BM.%26aulast%3DBauder%26aufirst%3DM.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DFKBP%2520Ligands%25E2%2580%2594Where%2520We%2520Are%2520and%2520Where%2520to%2520Go%253F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D1425%26doi%3D10.3389%2Ffphar.2018.01425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aghdasi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resnick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">FKBP12, the 12-kDa FK506-Binding Protein, is a Physiologic Regulator of the Cell Cycle</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2425</span>– <span class="NLM_lpage">2430</span>, <span class="refDoi"> DOI: 10.1073/pnas.041614198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1073%2Fpnas.041614198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11226255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslKnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=2425-2430&issue=5&author=B.+Aghdasiauthor=K.+Yeauthor=A.+Resnickauthor=A.+Huangauthor=H.+C.+Haauthor=X.+Guoauthor=T.+M.+Dawsonauthor=V.+L.+Dawsonauthor=S.+H.+Snyder&title=FKBP12%2C+the+12-kDa+FK506-Binding+Protein%2C+is+a+Physiologic+Regulator+of+the+Cell+Cycle&doi=10.1073%2Fpnas.041614198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle</span></div><div class="casAuthors">Aghdasi, Bahman; Ye, Keqiang; Resnick, Adam; Huang, Alex; Ha, Hyo Chol; Guo, Xin; Dawson, Ted M.; Dawson, Valina L.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2425-2430</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type I receptor.  We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection.  This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1.  The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12.  Cell cycle arrest is prevented by transfection with a dominant-neg. TGF-β receptor construct.  TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways.  SMAD signaling is down-regulated in FKBP12-/- cells.  Inhibition of ERK/MAP kinase fails to affect p21 up-regulation.  By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38.  Thus, FKBP12 is a physiol. regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_od66DYf4y7Vg90H21EOLACvtfcHk0lihCsYgrKbMgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslKnu7k%253D&md5=df78bd5811d28ad431c5cf6d003f3326</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.041614198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.041614198%26sid%3Dliteratum%253Aachs%26aulast%3DAghdasi%26aufirst%3DB.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DResnick%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DHa%26aufirst%3DH.%2BC.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DFKBP12%252C%2520the%252012-kDa%2520FK506-Binding%2520Protein%252C%2520is%2520a%2520Physiologic%2520Regulator%2520of%2520the%2520Cell%2520Cycle%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26issue%3D5%26spage%3D2425%26epage%3D2430%26doi%3D10.1073%2Fpnas.041614198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Köhler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanghänel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüneberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Biochemical and Functional Analyses of the Mip Protein: Influence of the N-Terminal Half and of Peptidylprolyl Isomerase Activity on the Virulence of Legionella pneumophila</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4389</span>– <span class="NLM_lpage">4397</span>, <span class="refDoi"> DOI: 10.1128/IAI.71.8.4389-4397.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.71.8.4389-4397.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12874317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BD3szlvFSgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2003&pages=4389-4397&issue=8&author=R.+K%C3%B6hlerauthor=J.+Fangh%C3%A4nelauthor=B.+K%C3%B6nigauthor=E.+L%C3%BCnebergauthor=M.+Froschauthor=J.-U.+Rahfeldauthor=R.+Hilgenfeldauthor=G.+Fischerauthor=J.+Hackerauthor=M.+Steinert&title=Biochemical+and+Functional+Analyses+of+the+Mip+Protein%3A+Influence+of+the+N-Terminal+Half+and+of+Peptidylprolyl+Isomerase+Activity+on+the+Virulence+of+Legionella+pneumophila&doi=10.1128%2FIAI.71.8.4389-4397.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and functional analyses of the Mip protein: influence of the N-terminal half and of peptidylprolyl isomerase activity on the virulence of Legionella pneumophila</span></div><div class="casAuthors">Kohler Rolf; Fanghanel Jorg; Konig Bettina; Luneberg Edeltraud; Frosch Matthias; Rahfeld Jens-Ulrich; Hilgenfeld Rolf; Fischer Gunter; Hacker Jorg; Steinert Michael</div><div class="citationInfo"><span class="NLM_cas:title">Infection and immunity</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4389-97</span>
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The virulence factor Mip (macrophage infectivity potentiator) contributes to the intracellular survival of Legionella pneumophila, the causative agent of Legionnaires' disease.  The protein consists of two domains that are connected via a very long alpha-helix (A.  Riboldi-Tunnicliffe et al., Nat.  Struct.  Biol. 8:779-783, 2001).  The fold of the C-terminal domain (residues 100 to 213) is closely related to human FK506-binding protein (FKBP12), and like FKBP12, Mip exhibits peptidylprolyl cis/trans isomerase (PPIase) activity.  The alpha-helical N-terminal domain is responsible for the formation of very stable Mip homodimers.  In order to determine the importance of the homodimeric state of Mip for its biochemical activities and for infectivity of Legionella, a truncated, monomeric Mip variant [Mip((77-213))] was overexpressed in Escherichia coli and characterized biochemically.  In vitro isomerase activity assays revealed that the altered protein exhibits full isomerase activity towards peptide substrates.  However, the deletion resulted in a dramatic loss in the efficiency of refolding of reduced and carboxy-methylated RNase T(1).  By cis complementation of the Mip-negative mutant strain L. pneumophila JR32-2, we constructed the strain L. pneumophila JR32-2.4, which expresses an N-terminally truncated variant of Mip.  Infection studies with these strains revealed that the N-terminal part and the dimerization of Mip but not its PPIase activity are necessary for full virulence in Acanthamoeba castellanii.  Infection of guinea pigs showed that strains with dimerization-deficient Mip (JR32-2.4) or a very low PPIase activity (JR32-2.2) were significantly attenuated in the animal model.  These results suggest a different role of the PPIase activity and the N-terminally mediated dimeric state of Mip in monocellular systems and during the infection of guinea pigs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRpWFC3n1ojUHdcurJClFcfW6udTcc2ebrFhoIPApeKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szlvFSgsA%253D%253D&md5=d1cc6f210819d5dbadc0d28f12e82cf1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FIAI.71.8.4389-4397.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.71.8.4389-4397.2003%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25B6hler%26aufirst%3DR.%26aulast%3DFangh%25C3%25A4nel%26aufirst%3DJ.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26aulast%3DL%25C3%25BCneberg%26aufirst%3DE.%26aulast%3DFrosch%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26aulast%3DHilgenfeld%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DBiochemical%2520and%2520Functional%2520Analyses%2520of%2520the%2520Mip%2520Protein%253A%2520Influence%2520of%2520the%2520N-Terminal%2520Half%2520and%2520of%2520Peptidylprolyl%2520Isomerase%2520Activity%2520on%2520the%2520Virulence%2520of%2520Legionella%2520pneumophila%26jtitle%3DInfect.%2520Immun.%26date%3D2003%26volume%3D71%26issue%3D8%26spage%3D4389%26epage%3D4397%26doi%3D10.1128%2FIAI.71.8.4389-4397.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titball, R. W.</span></span> <span> </span><span class="NLM_article-title">A Burkholderia pseudomallei Macrophage Infectivity Potentiator-like Protein has Rapamycin-Inhibitable Peptidylprolyl Isomerase Activity and Pleiotropic Effects on Virulence</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4299</span>– <span class="NLM_lpage">4307</span>, <span class="refDoi"> DOI: 10.1128/IAI.00134-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00134-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21859853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=4299-4307&issue=11&author=I.+H.+Norvilleauthor=N.+J.+Harmerauthor=S.+V.+Hardingauthor=G.+Fischerauthor=K.+E.+Keithauthor=K.+A.+Brownauthor=M.+Sarkar-Tysonauthor=R.+W.+Titball&title=A+Burkholderia+pseudomallei+Macrophage+Infectivity+Potentiator-like+Protein+has+Rapamycin-Inhibitable+Peptidylprolyl+Isomerase+Activity+and+Pleiotropic+Effects+on+Virulence&doi=10.1128%2FIAI.00134-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence</span></div><div class="casAuthors">Norville, Isobel H.; Harmer, Nicholas J.; Harding, Sarah V.; Fischer, Gunter; Keith, Karen E.; Brown, Katherine A.; Sarkar-Tyson, Mitali; Titball, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4299-4307</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Macrophage infectivity potentiators (Mips) are a group of virulence factors encoded by pathogenic bacteria such as Legionella, Chlamydia, and Neisseria species.  Mips are part of the FK506-binding protein (FKBP) family, whose members typically exhibit peptidylprolyl cis-trans isomerase (PPIase) activity which is inhibitable by the immunosuppressants FK506 and rapamycin.  Here we describe the identification and characterization of BPSS1823, a Mip-like protein in the intracellular pathogen Burkholderia pseudomallei.  Recombinant BPSS1823 protein has rapamycin-inhibitable PPIase activity, indicating that it is a functional FKBP.  A mutant strain generated by deletion of BPSS1823 in B. pseudomallei exhibited a reduced ability to survive within cells and significant attenuation in vivo, suggesting that BPSS1823 is important for B. pseudomallei virulence.  In addn., pleiotropic effects were obsd. with a redn. in virulence mechanisms, including resistance to host killing mechanisms, swarming motility, and protease prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonwE-0EBbhELVg90H21EOLACvtfcHk0lh26fcMI7lZew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsb3J&md5=e3e843c0b64df456016cac4a01184d80</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FIAI.00134-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00134-11%26sid%3Dliteratum%253Aachs%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DHarding%26aufirst%3DS.%2BV.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DKeith%26aufirst%3DK.%2BE.%26aulast%3DBrown%26aufirst%3DK.%2BA.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DTitball%26aufirst%3DR.%2BW.%26atitle%3DA%2520Burkholderia%2520pseudomallei%2520Macrophage%2520Infectivity%2520Potentiator-like%2520Protein%2520has%2520Rapamycin-Inhibitable%2520Peptidylprolyl%2520Isomerase%2520Activity%2520and%2520Pleiotropic%2520Effects%2520on%2520Virulence%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26issue%3D11%26spage%3D4299%26epage%3D4307%26doi%3D10.1128%2FIAI.00134-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, J. D.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Calcineurin is a Common Target of Cyclophilin-Cyclosporin A and FKBP-FK506 Complexes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">815</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(91)90124-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0092-8674%2891%2990124-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1715244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1991&pages=807-815&issue=4&author=J.+Liuauthor=J.+D.+Farmerauthor=W.+S.+Laneauthor=J.+Friedmanauthor=I.+Weissmanauthor=S.+L.+Schreiber&title=Calcineurin+is+a+Common+Target+of+Cyclophilin-Cyclosporin+A+and+FKBP-FK506+Complexes&doi=10.1016%2F0092-8674%2891%2990124-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</span></div><div class="casAuthors">Liu, Jun; Farmer, Jesse D., Jr.; Lane, Willam S.; Friedman, Jeff; Weissman, Irving; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-15</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">Although the immediate receptors (immunophilins) of the immunosuppressants cyclosporin A (CsA) and FK506 are distinct, their similar mechanisms of inhibition of cell signaling suggest that their assocd. immunophilin complexes interact with a common target.  The authors report that the complexes cyclophilin-CsA and FKBP-FK506 (but not cyclophilin, FKBP, FKBP-rapamycin, or FKBP-506BD) competitively bind to and inhibit the Ca2+- and calmodulin-dependent phosphatase calcineurin, although the binding and inhibition of calcineurin do not require calmodulin.  These results suggest that calcineurin is involved in a common step assocd. with T cell receptor and IgE receptor signaling pathways and that cyclophilin and FKBP mediate the actions of CsA and FK506, resp., by forming drug-dependent complexes with and altering the activity of calcineurin-calmodulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxfN8mg-hNhLVg90H21EOLACvtfcHk0lh26fcMI7lZew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsV2qu7w%253D&md5=00c4883ea86e6b2c554f8f72ed717ac9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990124-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990124-H%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFarmer%26aufirst%3DJ.%2BD.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DWeissman%26aufirst%3DI.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DCalcineurin%2520is%2520a%2520Common%2520Target%2520of%2520Cyclophilin-Cyclosporin%2520A%2520and%2520FKBP-FK506%2520Complexes%26jtitle%3DCell%26date%3D1991%26volume%3D66%26issue%3D4%26spage%3D807%26epage%3D815%26doi%3D10.1016%2F0092-8674%2891%2990124-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span> <span> </span><span class="NLM_article-title">The Cyclophilins</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">226</span>, <span class="refDoi"> DOI: 10.1186/gb-2005-6-7-226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1186%2Fgb-2005-6-7-226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15998457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BD2Mzks1Ohsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=226&issue=7&author=P.+Wangauthor=J.+Heitman&title=The+Cyclophilins&doi=10.1186%2Fgb-2005-6-7-226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilins</span></div><div class="casAuthors">Wang Ping; Heitman Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">226</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclophilins (Enzyme Commission (EC) number 5.1.2.8) belong to a group of proteins that have peptidyl-prolyl cis-trans isomerase activity; such proteins are collectively known as immunophilins and also include the FK-506-binding proteins and the parvulins.  Cyclophilins are found in all cells of all organisms studied, in both prokaryotes and eukaryotes; humans have a total of 16 cyclophilin proteins, Arabidopsis up to 29 and Saccharomyces 8.  The first member of the cyclophilins to be identified in mammals, cyclophilin A, is the major cellular target for, and thus mediates the actions of, the immunosuppressive drug cyclosporin A.  Cyclophilin A forms a ternary complex with cyclosporin A and the calcium-calmodulin-activated serine/threonine-specific protein phosphatase calcineurin; formation of this complex prevents calcineurin from regulating cytokine gene transcription.  Recent studies have implicated a diverse array of additional cellular functions for cyclophilins, including roles as chaperones and in cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS24wrjwlZ9Y4NpW7w2tapOfW6udTcc2eZnTjmHnF2Bm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mzks1Ohsg%253D%253D&md5=eed8b951aea639edbafabd50568d2ac8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2Fgb-2005-6-7-226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2005-6-7-226%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DHeitman%26aufirst%3DJ.%26atitle%3DThe%2520Cyclophilins%26jtitle%3DGenome%2520Biol.%26date%3D2005%26volume%3D6%26issue%3D7%26spage%3D226%26doi%3D10.1186%2Fgb-2005-6-7-226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luban, J.</span></span> <span> </span><span class="NLM_article-title">Isolation, Characterization and Targeted Disruption of Mouse Ppia: Cyclophilin A is not Essential for Mammalian Cell Viability</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1006/geno.2000.6295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1006%2Fgeno.2000.6295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10964515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVaks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=167-178&issue=2&author=J.+Colganauthor=M.+Asmalauthor=J.+Luban&title=Isolation%2C+Characterization+and+Targeted+Disruption+of+Mouse+Ppia%3A+Cyclophilin+A+is+not+Essential+for+Mammalian+Cell+Viability&doi=10.1006%2Fgeno.2000.6295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation, characterization and targeted disruption of mouse Ppia: cyclophilin A is not essential for mammalian cell viability</span></div><div class="casAuthors">Colgan, John; Asmal, Mohammed; Luban, Jeremy</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-178</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Cyclophilins (CyPs) are a family of proteins found in organisms ranging from prokaryotes to humans.  These mols. exhibit peptidyl-prolyl isomerase activity in vitro, suggesting that they influence the conformation of proteins in cells.  CyPs also bind with varying affinities to the immunosuppressive drug cyclosporin A (CsA), a compd. used clin. to prevent allograft rejection.  The founding member of the family, cyclophilin A (CyPA), is an abundant, ubiquitously expressed protein of unknown function that binds with nanomolar affinity to CsA.  Here, we describe the isolation and characterization of mouse Ppia (mPpia), the gene encoding CyPA.  Ppia was isolated using a PCR screen that distinguishes the expressed gene from multiple pseudogenes present in the mouse genome. mPpia consists of 5 exons and 4 introns spanning roughly 4.5 kb and maps to chromosome 11 near the centromere.  Sequence anal. of a 369-bp fragment from the proximal promoter region of mPpia revealed the presence of a TATA box and sites recognized by several transcriptional regulators, including Sp1, AP-2, GATA factors, c-Myb, and NF-IL-6.  This region is sufficient to drive high-level reporter gene expression in transfected cells.  Both copies of Ppia were disrupted in murine embryonic stem (ES) cells via gene targeting.  Ppia-/- ES cells grow normally and differentiate into hematopoietic precursor cells in vitro, indicating that CyPA is not essential for mammalian cell viability.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTk1hMnKpswrVg90H21EOLACvtfcHk0lhi7Z5LXOEakg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVaks74%253D&md5=c8e33a9460afa4e3dd1b02bc420134a2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1006%2Fgeno.2000.6295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.2000.6295%26sid%3Dliteratum%253Aachs%26aulast%3DColgan%26aufirst%3DJ.%26aulast%3DAsmal%26aufirst%3DM.%26aulast%3DLuban%26aufirst%3DJ.%26atitle%3DIsolation%252C%2520Characterization%2520and%2520Targeted%2520Disruption%2520of%2520Mouse%2520Ppia%253A%2520Cyclophilin%2520A%2520is%2520not%2520Essential%2520for%2520Mammalian%2520Cell%2520Viability%26jtitle%3DGenomics%26date%3D2000%26volume%3D68%26issue%3D2%26spage%3D167%26epage%3D178%26doi%3D10.1006%2Fgeno.2000.6295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frausto, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, H.</span></span> <span> </span><span class="NLM_article-title">Cyclophilins as Modulators of Viral Replication</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1684</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.3390/v5071684</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Fv5071684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23852270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Squ7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1684-1701&issue=7&author=S.+D.+Fraustoauthor=E.+Leeauthor=H.+Tang&title=Cyclophilins+as+Modulators+of+Viral+Replication&doi=10.3390%2Fv5071684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilins as modulators of viral replication</span></div><div class="casAuthors">Frausto, Stephen D.; Lee, Emily; Tang, Hengli</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1684-1701</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Cyclophilins are peptidyl-prolyl cis/trans isomerases important in the proper folding of certain proteins.  Mounting evidence supports varied roles of cyclophilins, either pos. or neg., in the life cycles of diverse viruses, but the nature and mechanisms of these roles are yet to be defined.  The potential for cyclophilins to serve as a drug target for antiviral therapy is evidenced by the success of non-immunosuppressive cyclophilin inhibitors (CPIs), including Alisporivir, in clin. trials targeting hepatitis C virus infection.  In addn., as cyclophilins are implicated in the predisposition to, or severity of, various diseases, the ability to specifically and effectively modulate their function will prove increasingly useful for disease intervention.  In this review, we will summarize the evidence of cyclophilins as key mediators of viral infection and prospective drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzkac6M6NnLbVg90H21EOLACvtfcHk0lhi7Z5LXOEakg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Squ7nF&md5=ce32f7f31012ac027240193c31f384d8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3390%2Fv5071684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5071684%26sid%3Dliteratum%253Aachs%26aulast%3DFrausto%26aufirst%3DS.%2BD.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DTang%26aufirst%3DH.%26atitle%3DCyclophilins%2520as%2520Modulators%2520of%2520Viral%2520Replication%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26issue%3D7%26spage%3D1684%26epage%3D1701%26doi%3D10.3390%2Fv5071684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span> <span> </span><span class="NLM_article-title">Microbial Cyclophilins: Specialized Functions in Virulence and Beyond</span>. <i>World J. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">164</span>, <span class="refDoi"> DOI: 10.1007/s11274-017-2330-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2Fs11274-017-2330-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28791545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1cflvFajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2017&pages=164&issue=9&author=M.+Dimouauthor=A.+Venierakiauthor=P.+Katinakis&title=Microbial+Cyclophilins%3A+Specialized+Functions+in+Virulence+and+Beyond&doi=10.1007%2Fs11274-017-2330-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial cyclophilins: specialized functions in virulence and beyond</span></div><div class="casAuthors">Dimou Maria; Venieraki Anastasia; Katinakis Panagiotis</div><div class="citationInfo"><span class="NLM_cas:title">World journal of microbiology & biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">164</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclophilins belong to the superfamily of peptidyl-prolyl cis/trans isomerases (PPIases, EC: 5.2.1.8), the enzymes that catalyze the cis/trans isomerization of peptidyl-prolyl peptide bonds in unfolded and partially folded polypeptide chains and native state proteins.  Cyclophilins have been extensively studied, since they are involved in multiple cellular processes related to human pathologies, such as neurodegenerative disorders, infectious diseases, and cancer.  However, the presence of cyclophilins in all domains of life indicates a broader biological importance.  In this mini-review, we summarize current advances in the study of microbial cyclophilins.  Apart from their anticipated role in protein folding and chaperoning, cyclophilins are involved in several other biological processes, such as cellular signal transduction, adaptation to stress, control of pathogens virulence, and modulation of host immune response.  Since many existing family members do not have well-defined functions and novel ones are being characterized, the requirement for further studies on their biological role and molecular mechanism of action is apparent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH-SHNg_NDmpdYoSR9eyvsfW6udTcc2ebZP4tR-rHmwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cflvFajsw%253D%253D&md5=abd1fbd47eb869f056a8b18b7e383137</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11274-017-2330-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11274-017-2330-6%26sid%3Dliteratum%253Aachs%26aulast%3DDimou%26aufirst%3DM.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKatinakis%26aufirst%3DP.%26atitle%3DMicrobial%2520Cyclophilins%253A%2520Specialized%2520Functions%2520in%2520Virulence%2520and%2520Beyond%26jtitle%3DWorld%2520J.%2520Microbiol.%2520Biotechnol.%26date%3D2017%26volume%3D33%26issue%3D9%26spage%3D164%26doi%3D10.1007%2Fs11274-017-2330-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipping, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucknagel, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kullertz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Selective Inactivation of Parvulin-Like Peptidyl-Prolyl Cis/Trans Isomerases by Juglone</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5953</span>– <span class="NLM_lpage">5960</span>, <span class="refDoi"> DOI: 10.1021/bi973162p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi973162p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXislKksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=5953-5960&issue=17&author=L.+Hennigauthor=C.+Christnerauthor=M.+Kippingauthor=B.+Schelbertauthor=K.+P.+Rucknagelauthor=S.+Grableyauthor=G.+Kullertzauthor=G.+Fischer&title=Selective+Inactivation+of+Parvulin-Like+Peptidyl-Prolyl+Cis%2FTrans+Isomerases+by+Juglone&doi=10.1021%2Fbi973162p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone</span></div><div class="casAuthors">Hennig, Lars; Christner, Claudia; Kipping, Marc; Schelbert, Birte; Rucknagel, Karl Peter; Grabley, Susanne; Kullertz, Gerd; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5953-5960</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In contrast to FK506-binding proteins and cyclophilins, the parvulin family of peptidylprolyl cis/trans-isomerases (PPIases; EC 5.2.1.8) cannot be inhibited by either FK506 or cyclosporin A.  Here, the authors found that juglone (5-hydroxy-1,4-naphthoquinone) (I) irreversibly inhibited the enzymic activity of several parvulin PPIases, like E. coli parvulin, yeast Ess1/Ptf1, and human Pin1 PPIases, in a specific manner, thus allowing selective inactivation of these enzymes in the presence of other PPIases.  The mode of action was studied by analyzing the inactivation kinetics and the nature of products of the reaction of E. coli parvulin and its C69A variant with I.  For all parvulins investigated, complete inactivation was obtained by a slow process that was characterized by pseudo-1st-order rate consts. in the range of 5.3 x 10-4 to 4.5 x 10-3 s-1.  The inactivated parvulin contained 2 I mols. that were covalently bound to the side-chains of Cys-41 and Cys-69 because of Michael addn. of the SH groups to I.  Redox reactions did not contribute to the inactivation process.  Because SH group modification was shown to proceed 5-fold faster than the rate of enzyme inactivation, it was considered as a necessary but not sufficient condition for inactivation.  When measured by far-UV CD, the rate of structural alterations following SH group modification paralleled exactly the rate of inactivation.  Thus, partial unfolding of the active site of the parvulins is thought to be the cause of the deterioration of PPIase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRTKWIkst6ibVg90H21EOLACvtfcHk0lhvLInc1ZnU0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislKksbg%253D&md5=82ced741f4f63486c8c677a9a05915dc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi973162p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi973162p%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DChristner%26aufirst%3DC.%26aulast%3DKipping%26aufirst%3DM.%26aulast%3DSchelbert%26aufirst%3DB.%26aulast%3DRucknagel%26aufirst%3DK.%2BP.%26aulast%3DGrabley%26aufirst%3DS.%26aulast%3DKullertz%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DSelective%2520Inactivation%2520of%2520Parvulin-Like%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%2520by%2520Juglone%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D17%26spage%3D5953%26epage%3D5960%26doi%3D10.1021%2Fbi973162p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tradler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a 14 kDa Human Protein as a Novel Parvulin-Like Peptidyl Prolyl Cis/Trans Isomerase</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>446</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00239-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0014-5793%2899%2900239-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10100858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVCmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=1999&pages=278-282&issue=2%E2%80%933&author=T.+Uchidaauthor=F.+Fujimoriauthor=T.+Tradlerauthor=G.+Fischerauthor=J.-U.+Rahfeld&title=Identification+and+Characterization+of+a+14+kDa+Human+Protein+as+a+Novel+Parvulin-Like+Peptidyl+Prolyl+Cis%2FTrans+Isomerase&doi=10.1016%2FS0014-5793%2899%2900239-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase</span></div><div class="casAuthors">Uchida, Takafumi; Fujimori, Fumihiro; Tradler, Thomas; Fischer, Gunter; Rahfeld, Jens-U.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">2,3</span>),
    <span class="NLM_cas:pages">278-282</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A second member of the parvulin family of peptidyl-prolyl cis/trans isomerases was identified in a human lung cDNA library.  The gene encoded a protein named hPar14 that has 131 amino acid residues and a mol. mass of 13676 Da.  Sequence comparison showed 34.5% identity to E. coli Par10 and 34% identity to human Pin1 (hPar18) within a C-terminal region of 87 or 120 amino acid residues, resp.  In comparison to the E. coli Par10, hPar14 possesses a N-terminal extension of 41 amino acid residues.  This extension does not contain a polyproline II helix-binding motif typical of the known eukaryotic parvulins.  The hPar14 does not accelerate the cis to trans interconversion of oligopeptides with side chain-phosphorylated Ser(Thr)-Pro moieties as hPin1 did.  In contrast, it showed preference of an arginine residue adjacent N-terminal to proline.  Northern blot anal. revealed expression of the gene within various human tissues like heart, placenta, liver, kidney and pancreas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraEVwDIawjfbVg90H21EOLACvtfcHk0lhvLInc1ZnU0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVCmtbo%253D&md5=540534ee06ec8471d467cdd60489beb8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900239-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900239-2%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DT.%26aulast%3DFujimori%26aufirst%3DF.%26aulast%3DTradler%26aufirst%3DT.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%252014%2520kDa%2520Human%2520Protein%2520as%2520a%2520Novel%2520Parvulin-Like%2520Peptidyl%2520Prolyl%2520Cis%252FTrans%2520Isomerase%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D446%26issue%3D2%25E2%2580%25933%26spage%3D278%26epage%3D282%26doi%3D10.1016%2FS0014-5793%2899%2900239-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kühlewein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez Alvarez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemmecker, G.</span></span> <span> </span><span class="NLM_article-title">Solution Structure of Escherichia coli Par10: The Prototypic Member of the Parvulin Family of Peptidyl-Prolyl Cis/Trans Isomerases</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2378</span>– <span class="NLM_lpage">2387</span>, <span class="refDoi"> DOI: 10.1110/ps.04756704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1110%2Fps.04756704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15322281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1eltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=2378-2387&issue=9&author=A.+K%C3%BChleweinauthor=G.+Vollauthor=B.+Hernandez+Alvarezauthor=H.+Kesslerauthor=G.+Fischerauthor=J.+U.+Rahfeldauthor=G.+Gemmecker&title=Solution+Structure+of+Escherichia+coli+Par10%3A+The+Prototypic+Member+of+the+Parvulin+Family+of+Peptidyl-Prolyl+Cis%2FTrans+Isomerases&doi=10.1110%2Fps.04756704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Solution structure of Escherichia coli Par10: The prototypic member of the Parvulin family of peptidyl-prolyl cis/trans isomerases</span></div><div class="casAuthors">Kuehlewein, Angelika; Voll, Georg; Alvarez, Birte Hernandez; Kessler, Horst; Fischer, Gunter; Rahfeld, Jens-Ulrich; Gemmecker, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2378-2387</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">E. coli Par10 is a peptidyl-prolyl cis/trans isomerase (PPIase) from Escherichia coli catalyzing the isomerization of Xaa-Pro bonds in oligopeptides with a broad substrate specificity.  The structure of E. coli Par10 has been detd. by multidimensional soln.-state NMR spectroscopy based on 1207 conformational constraints (1067 NOE-derived distances, 42 vicinal coupling-const. restraints, 30 hydrogen-bond restraints, and 68 σ/ψ restraints derived from the Chem. Shift Index).  Simulated-annealing calcns. with the program ARIA and subsequent refinement with XPLOR yielded a set of 18 convergent structures with an av. backbone RMSD from mean at. coordinates of 0.50 Å within the well-defined secondary structure elements.  E. coli Par10 is the smallest known PPIase so far, with a high catalytic efficiency comparable to that of FKBPs and cyclophilins.  The secondary structure of E. coli Par10 consists of four helical regions and a four-stranded antiparallel β-sheet.  The N terminus forms a β-strand, followed by a large stretch comprising three α-helixes.  A loop region contg. a short β-strand separates these helixes from a fourth α-helix.  The C terminus consists of two more β-strands completing the four-stranded antiparallel β-sheet with strand order 2143.  Interestingly, the third β-strand includes a Gly-Pro cis peptide bond.  The curved β-strand forms a hydrophobic binding pocket together with α-helix 4, which also contains a no. of highly conserved residues.  The three-dimensional structure of Par10 closely resembles that of the human proteins hPin1 and hPar14 and the plant protein Pin1At, belonging to the same family of highly homologous proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkYnAREVfwRrVg90H21EOLACvtfcHk0ljXBNCOzusC1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1eltbg%253D&md5=e3f52cb727cef1d32a2058c99112173d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1110%2Fps.04756704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.04756704%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25BChlewein%26aufirst%3DA.%26aulast%3DVoll%26aufirst%3DG.%26aulast%3DHernandez%2BAlvarez%26aufirst%3DB.%26aulast%3DKessler%26aufirst%3DH.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DGemmecker%26aufirst%3DG.%26atitle%3DSolution%2520Structure%2520of%2520Escherichia%2520coli%2520Par10%253A%2520The%2520Prototypic%2520Member%2520of%2520the%2520Parvulin%2520Family%2520of%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%26jtitle%3DProtein%2520Sci.%26date%3D2004%26volume%3D13%26issue%3D9%26spage%3D2378%26epage%3D2387%26doi%3D10.1110%2Fps.04756704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arévalo-Rodríguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardenas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin A and Ess1 Interact with and Regulate Silencing by the Sin3–Rpd3 Histone Deacetylase</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3739</span>– <span class="NLM_lpage">3749</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.14.3739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F19.14.3739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10899127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=3739-3749&issue=14&author=M.+Ar%C3%A9valo-Rodr%C3%ADguezauthor=M.+E.+Cardenasauthor=X.+Wuauthor=S.+D.+Hanesauthor=J.+Heitman&title=Cyclophilin+A+and+Ess1+Interact+with+and+Regulate+Silencing+by+the+Sin3%E2%80%93Rpd3+Histone+Deacetylase&doi=10.1093%2Femboj%2F19.14.3739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase</span></div><div class="casAuthors">Arevalo-Rodriguez, Miguel; Cardenas, Maria E.; Wu, Xiaoyun; Hanes, Steven D.; Heitman, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3739-3749</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Three families of prolyl isomerases have been identified: cyclophilins, FK506-binding proteins (FKBPs) and parvulins.  All 12 cyclophilins and FKBPs are dispensable for growth in yeast, whereas the one parvulin homolog, Ess1, is essential.  We report here that cyclophilin A becomes essential when Ess1 function is compromised.  Overexpression of cyclophilin A suppresses ess1 conditional and null mutations, and that cyclophilin A enzymic activity is required for suppression.  Cyclophilin A and Ess1 function in parallel pathways and act on common targets by a mechanism that requires prolyl isomerization.  Using genetic and biochem. approaches, we found that one of these targets is the Sin3-Rpd3 histone deacetylase complex, and that cyclophilin A increases and Ess1 decreases disruption of gene silencing by this complex.  Conditions that favor acetylation over deacetylation suppress ess1 mutations.  Our findings support a model in which Ess1 and cyclophilin A modulate the activity of the Sin3-Rpd3 complex, and excess histone deacetylation causes mitotic arrest in ess1 mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIrKL0kyLOfbVg90H21EOLACvtfcHk0ljXBNCOzusC1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7c%253D&md5=ea8489b48b1a3841ba0557b1cee735ed</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.14.3739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.14.3739%26sid%3Dliteratum%253Aachs%26aulast%3DAr%25C3%25A9valo-Rodr%25C3%25ADguez%26aufirst%3DM.%26aulast%3DCardenas%26aufirst%3DM.%2BE.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHanes%26aufirst%3DS.%2BD.%26aulast%3DHeitman%26aufirst%3DJ.%26atitle%3DCyclophilin%2520A%2520and%2520Ess1%2520Interact%2520with%2520and%2520Regulate%2520Silencing%2520by%2520the%2520Sin3%25E2%2580%2593Rpd3%2520Histone%2520Deacetylase%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D14%26spage%3D3739%26epage%3D3749%26doi%3D10.1093%2Femboj%2F19.14.3739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devasahayam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackett, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arévalo-Rodríguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardenas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, S. D.</span></span> <span> </span><span class="NLM_article-title">The Ess1 Prolyl Isomerase is Linked to Chromatin Remodeling Complexes and the General Transcription Machinery</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3727</span>– <span class="NLM_lpage">3738</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.14.3727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F19.14.3727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10899126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=3727-3738&issue=14&author=X.+Wuauthor=C.+B.+Wilcoxauthor=G.+Devasahayamauthor=R.+L.+Hackettauthor=M.+Ar%C3%A9valo-Rodr%C3%ADguezauthor=M.+E.+Cardenasauthor=J.+Heitmanauthor=S.+D.+Hanes&title=The+Ess1+Prolyl+Isomerase+is+Linked+to+Chromatin+Remodeling+Complexes+and+the+General+Transcription+Machinery&doi=10.1093%2Femboj%2F19.14.3727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery</span></div><div class="casAuthors">Wu, Xiaoyun; Wilcox, Cathy B.; Devasahayam, Gina; Hackett, Robin L.; Arevalo-Rodriguez, Miguel; Cardenas, Maria E.; Heitman, Joseph; Hanes, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3727-3738</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Ess1/Pin1 peptidyl-prolyl isomerase (PPIase) is thought to control mitosis by binding to cell cycle regulatory proteins and altering their activity.  Here we isolate temp.-sensitive ess1 mutants and identify six multi-copy suppressors that rescue their mitotic-lethal phenotype.  None are cell cycle regulators.  Instead, five encode proteins involved in transcription that bind DNA, modify chromatin structure or are regulatory subunits of RNA polymerase II.  A sixth suppressor, cyclophilin A, is a member of a distinct family of PPIases that are targets of immunosuppressive drugs.  We show that the expression of some but not all genes is decreased in ess1 mutants, and that Ess1 interacts with the C-terminal domain (CTD) of RNA polymerase II in vitro and in vivo.  The results forge a strong link between PPIases and the transcription machinery and suggest a new model for how Ess1/Pin1 controls mitosis.  In this model, Ess1 binds and isomerizes the CTD of RNA polymerase II, thus altering its interaction with proteins required for transcription of essential cell cycle genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqerNTHSjgJ67Vg90H21EOLACvtfcHk0ljXBNCOzusC1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlegs7Y%253D&md5=03d5a9c9fc41ff6a1a92fce16ca56490</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.14.3727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.14.3727%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWilcox%26aufirst%3DC.%2BB.%26aulast%3DDevasahayam%26aufirst%3DG.%26aulast%3DHackett%26aufirst%3DR.%2BL.%26aulast%3DAr%25C3%25A9valo-Rodr%25C3%25ADguez%26aufirst%3DM.%26aulast%3DCardenas%26aufirst%3DM.%2BE.%26aulast%3DHeitman%26aufirst%3DJ.%26aulast%3DHanes%26aufirst%3DS.%2BD.%26atitle%3DThe%2520Ess1%2520Prolyl%2520Isomerase%2520is%2520Linked%2520to%2520Chromatin%2520Remodeling%2520Complexes%2520and%2520the%2520General%2520Transcription%2520Machinery%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26issue%3D14%26spage%3D3727%26epage%3D3738%26doi%3D10.1093%2Femboj%2F19.14.3727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanes, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">A Human Peptidyl–Prolyl Isomerase Essential for Regulation of Mitosis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>380</i></span> (<span class="NLM_issue">6574</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1038/380544a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2F380544a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8606777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28Xit1OlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=1996&pages=544-547&issue=6574&author=K.+P.+Luauthor=S.+D.+Hanesauthor=T.+Hunter&title=A+Human+Peptidyl%E2%80%93Prolyl+Isomerase+Essential+for+Regulation+of+Mitosis&doi=10.1038%2F380544a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A human peptidyl-prolyl isomerase essential for regulation of mitosis</span></div><div class="casAuthors">Lu, Kun Ping; Hanes, Steven D.; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">6574</span>),
    <span class="NLM_cas:pages">544-47</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The NIMA kinase is essential for progression through mitosis in Aspergillus nidulans, and there is evidence for a similar pathway in other eukaryotic cells.  Here we describe the human protein Pin1, a peptidyl-prolyl cis/trans isomerase (PPIase) that interacts with NIMA.  PPIases are important in protein folding, assembly and/or transport, but none has so far been shown to be required for cell viability.  Pin1 is a nuclear PPIase contg. a WW protein interaction domain, and is structurally and functionally related to Ess1/Ptf1, an essential protein in budding yeast.  PPIase activity is necessary for Ess1/Pin1 function in yeast.  Depletion of Pin1/Ess1 from yeast or HeLa cells induces mitotic arrest, whereas HeLa cells overexpressing Pin1 arrest in the G2 phase of the cell cycle.  Pin1 is thus an essential PPIase that regulates mitosis presumably by interacting with NIMA and attenuating its mitosis-promoting activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0nwXEw0tdW7Vg90H21EOLACvtfcHk0lg7kaO5y_UoyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit1OlsLo%253D&md5=8201ab5160fa87f0401a42524b0ea735</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F380544a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F380544a0%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DHanes%26aufirst%3DS.%2BD.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DA%2520Human%2520Peptidyl%25E2%2580%2593Prolyl%2520Isomerase%2520Essential%2520for%2520Regulation%2520of%2520Mitosis%26jtitle%3DNature%26date%3D1996%26volume%3D380%26issue%3D6574%26spage%3D544%26epage%3D547%26doi%3D10.1038%2F380544a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornbluth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Means, A. R.</span></span> <span> </span><span class="NLM_article-title">Requirement of the Prolyl Isomerase Pin1 for the Replication Checkpoint</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">5458</span>),  <span class="NLM_fpage">1644</span>– <span class="NLM_lpage">1647</span>, <span class="refDoi"> DOI: 10.1126/science.287.5458.1644</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.287.5458.1644" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10698738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhs1Oqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2000&pages=1644-1647&issue=5458&author=K.+E.+Winklerauthor=K.+I.+Swensonauthor=S.+Kornbluthauthor=A.+R.+Means&title=Requirement+of+the+Prolyl+Isomerase+Pin1+for+the+Replication+Checkpoint&doi=10.1126%2Fscience.287.5458.1644"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of the prolyl isomerase Pin 1 for the replication checkpoint</span></div><div class="casAuthors">Winkler, Katharine E.; Swenson, Katherine I.; Kornbluth, Sally; Means, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">5458</span>),
    <span class="NLM_cas:pages">1644-1647</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The peptidyl-prolyl isomerase Pin 1 has been implicated in regulating cell cycle progression.  Pin 1 was found to be required for the DNA replication checkpoint in Xenopus laevis.  Egg exts. depleted in Pin 1 inappropriately transited from the G2 to the M phase of the cell cycle in the presence of the DNA replication inhibitor aphidicolin.  This defect in replication checkpoint function was reversed after the addn. of recombinant wild-type Pin 1, but not an isomerase-inactive mutant, to the depleted ext.  Premature mitotic entry in the absence of Pin 1 was accompanied by hyperphosphorylation of Cdc25, activation of Cdc2/cyclin B, and generation of epitopes recognized by the mitotic phosphoprotein antibody, MPM-2.  Therefore, Pin 1 appears to be required for the checkpoint delaying the onset of mitosis in response to incomplete replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpXYoKixAdXLVg90H21EOLACvtfcHk0lg7kaO5y_UoyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhs1Oqsb0%253D&md5=2144fa569345deff1797149105ffc999</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1126%2Fscience.287.5458.1644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.287.5458.1644%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DK.%2BE.%26aulast%3DSwenson%26aufirst%3DK.%2BI.%26aulast%3DKornbluth%26aufirst%3DS.%26aulast%3DMeans%26aufirst%3DA.%2BR.%26atitle%3DRequirement%2520of%2520the%2520Prolyl%2520Isomerase%2520Pin1%2520for%2520the%2520Replication%2520Checkpoint%26jtitle%3DScience%26date%3D2000%26volume%3D287%26issue%3D5458%26spage%3D1644%26epage%3D1647%26doi%3D10.1126%2Fscience.287.5458.1644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suizu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrem, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottapel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1413</span>– <span class="NLM_lpage">1426</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(03)00490-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS1097-2765%2803%2900490-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14690596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1413-1426&issue=6&author=A.+Ryoauthor=F.+Suizuauthor=Y.+Yoshidaauthor=K.+Perremauthor=Y.-C.+Liouauthor=G.+Wulfauthor=R.+Rottapelauthor=S.+Yamaokaauthor=K.+P.+Lu&title=Regulation+of+NF-%CE%BAB+Signaling+by+Pin1-Dependent+Prolyl+Isomerization+and+Ubiquitin-Mediated+Proteolysis+of+p65%2FRelA&doi=10.1016%2FS1097-2765%2803%2900490-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of NF-κB signaling by pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA</span></div><div class="casAuthors">Ryo, Akihide; Suizu, Futoshi; Yoshida, Yasuhiro; Perrem, Kilian; Liou, Yih-cherng; Wulf, Gerburg; Rottapel, Robert; Yamaoka, Shoji; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1413-1426</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The transcription factor NF-κB is activated by the degrdn. of its inhibitor IκBα, resulting in its nuclear translocation.  However, the mechanism by which nuclear NF-κB is subsequently regulated is not clear.  Here we demonstrate that NF-κB function is regulated by Pin1-mediated prolyl isomerization and ubiquitin-mediated proteolysis of its p65/RelA subunit.  Upon cytokine treatment, Pin1 binds to the pThr254-Pro motif in p65 and inhibits p65 binding to IκBα, resulting in increased nuclear accumulation and protein stability of p65 and enhanced NF-κB activity.  Significantly, Pin1-deficient mice and cells are refractory to NF-κB activation by cytokine signals.  Moreover, the stability of p65 is controlled by ubiquitin-mediated proteolysis, facilitated by a cytokine signal inhibitor, SOCS-1, acting as a ubiquitin ligase.  These findings uncover two important mechanisms of regulating NF-κB signaling and offer new insight into the pathogenesis and treatment of some human diseases such as cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrGVvGft_Ph7Vg90H21EOLACvtfcHk0lg7kaO5y_UoyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVOlsw%253D%253D&md5=e073ddc40259d3397fd54394e186a8d8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900490-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900490-8%26sid%3Dliteratum%253Aachs%26aulast%3DRyo%26aufirst%3DA.%26aulast%3DSuizu%26aufirst%3DF.%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DPerrem%26aufirst%3DK.%26aulast%3DLiou%26aufirst%3DY.-C.%26aulast%3DWulf%26aufirst%3DG.%26aulast%3DRottapel%26aufirst%3DR.%26aulast%3DYamaoka%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DRegulation%2520of%2520NF-%25CE%25BAB%2520Signaling%2520by%2520Pin1-Dependent%2520Prolyl%2520Isomerization%2520and%2520Ubiquitin-Mediated%2520Proteolysis%2520of%2520p65%252FRelA%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D12%26issue%3D6%26spage%3D1413%26epage%3D1426%26doi%3D10.1016%2FS1097-2765%2803%2900490-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Prolyl isomerase Pin1 as a Molecular Target for Cancer Diagnostics and Therapeutics</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00218-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS1535-6108%2803%2900218-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14522251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=175-180&issue=3&author=K.+P.+Lu&title=Prolyl+isomerase+Pin1+as+a+Molecular+Target+for+Cancer+Diagnostics+and+Therapeutics&doi=10.1016%2FS1535-6108%2803%2900218-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics</span></div><div class="casAuthors">Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-180</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review on the features of prolyl isomerase (Pin1) as a mol. target for cancer diagnostics and therapeutics.  Pin1 may function as a crit. catalyst that potentiates multiple oncogenic signaling mechanisms during cancer development.  As a result, Pin1 inhibitors should simultaneously inhibit multiple oncogenic signaling pathways, which may circumvent the characteristics genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbiLNVGyY43bVg90H21EOLACvtfcHk0lg7kaO5y_UoyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKlsro%253D&md5=61949fee4140e48464256aa7025b5733</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900218-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900218-6%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DProlyl%2520isomerase%2520Pin1%2520as%2520a%2520Molecular%2520Target%2520for%2520Cancer%2520Diagnostics%2520and%2520Therapeutics%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26issue%3D3%26spage%3D175%26epage%3D180%26doi%3D10.1016%2FS1535-6108%2803%2900218-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dartigalongue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, S.</span></span> <span> </span><span class="NLM_article-title">A New Heat-Shock Gene, ppiD, Encodes a Peptidyl–Prolyl Isomerase Required for Folding of Outer Membrane Proteins in Escherichia coli</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">3968</span>– <span class="NLM_lpage">3980</span>, <span class="refDoi"> DOI: 10.1093/emboj/17.14.3968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F17.14.3968" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9670013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXltFygt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=3968-3980&issue=14&author=C.+Dartigalongueauthor=S.+Raina&title=A+New+Heat-Shock+Gene%2C+ppiD%2C+Encodes+a+Peptidyl%E2%80%93Prolyl+Isomerase+Required+for+Folding+of+Outer+Membrane+Proteins+in+Escherichia+coli&doi=10.1093%2Femboj%2F17.14.3968"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A new heat-shock gene, ppiD, encodes a peptidylprolyl isomerase required for folding of outer membrane proteins in Escherichia coli</span></div><div class="casAuthors">Dartigalongue, Claire; Raina, Satish</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3968-3980</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We have identified a new folding catalyst, PpiD, in the periplasm of Escherichia coli.  The gene encoding PpiD was isolated as a multicopy suppressor of surA, a mutation which severely impairs the folding of outer membrane proteins (OMPs).  The ppiD gene was also identified based on its ability to be transcribed by the two-component system CpxR-CpxA.  PpiD was purified to homogeneity and shown to have peptidyl-prolyl isomerase (PPIase) activity in vitro.  The protein is anchored to the inner membrane via a single transmembrane segment, and its catalytic domain faces the periplasm.  In addn., we have identified by site-directed mutagenesis some of the residues essential for its PPIase activity.  A null mutation in ppiD leads to an overall redn. in the level and folding of OMPs and to the induction of the periplasmic stress response.  The combination of ppiD and surA null mutations is lethal.  This is the first time two periplasmic folding catalysts have been shown to be essential.  Another unique aspect of PpiD is that its gene is regulated by both the Cpx two-component system and the σ32 heat shock factor, known to regulate the expression of cytoplasmic chaperones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYL8G1DMSHGrVg90H21EOLACvtfcHk0liNivA9z0O6AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFygt7Y%253D&md5=cd9ec23d3d04d5f75330410d084ebd55</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.14.3968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.14.3968%26sid%3Dliteratum%253Aachs%26aulast%3DDartigalongue%26aufirst%3DC.%26aulast%3DRaina%26aufirst%3DS.%26atitle%3DA%2520New%2520Heat-Shock%2520Gene%252C%2520ppiD%252C%2520Encodes%2520a%2520Peptidyl%25E2%2580%2593Prolyl%2520Isomerase%2520Required%2520for%2520Folding%2520of%2520Outer%2520Membrane%2520Proteins%2520in%2520Escherichia%2520coli%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26issue%3D14%26spage%3D3968%26epage%3D3980%26doi%3D10.1093%2Femboj%2F17.14.3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howard, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koblan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme-Johnson, W.</span></span> <span> </span><span class="NLM_article-title">Klebsiella pneumoniae nifM Gene Product is Required for Stabilization and Activation of Nitrogenase Iron Protein in Escherichia coli</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>261</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=3001082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL28XhtVemsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=772-778&issue=2&author=K.+S.+Howardauthor=P.+McLeanauthor=F.+Hansenauthor=P.+Lemleyauthor=K.+Koblanauthor=W.+Orme-Johnson&title=Klebsiella+pneumoniae+nifM+Gene+Product+is+Required+for+Stabilization+and+Activation+of+Nitrogenase+Iron+Protein+in+Escherichia+coli"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Klebsiella pneumoniae nifM gene product is required for stabilization and activation of nitrogenase iron protein in Escherichia coli</span></div><div class="casAuthors">Howard, Karen S.; McLean, Paul A.; Hansen, Finn B.; Lemley, Paul V.; Koblan, Kenneth S.; Orme-Johnson, W. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">261</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">772-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A series of plasmids encoding various K. pneumoniae nif (N fixation) genes was constructed to det. which were required to produce active Fe protein in Escherichia coli, a species which does not normally fix N.  The greatest success was achieved with binary plasmid systems that produced nifA regulatory protein under the control of a tac promoter on 1 plasmid, which then induced synthesis of nifH and nifM proteins from their native promoter sites on a 2nd plasmid.  The nifH protein, the monomeric subunit of Fe protein, produced in the presence of nifM, constituted nearly 10% of the whole cell protein and exhibited the corresponding amt. of C2H2-reducing activity in nitrogenase assays conducted in vitro.  The nifH protein formed in the absence of nifM constituted 4.7% of the whole cell protein and exhibited no detectable activity in assays of whole cell exts.  The plasmid-encoded Fe protein was purified to homogeneity and was found to be indistinguishable from that isolated from derepressed wild-type K. pneumoniae, having a similar specific activity, ∼4 Fe/dimer of 68 kilodaltons, and similar EPR features.  Although these expts. do not exclude the participation of other E. coli gene products in the maturation of nifH protein, they limit the nif-specific genes required for active Fe protein prodn. to nifA, nifH, and nifM.  Since nifA is thought to be the required activator protein involved in nif operon transcription, the simplest explanation for these observations is that nifH codes for the peptide of the Fe protein, whereas nifM acts to convert this nifH peptide to the functioning Fe protein of nitrogenase [9013-04-1].  In the absence of nifM, only an inactive nifH polypeptide is produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3HHGVn-2IMrVg90H21EOLACvtfcHk0liNivA9z0O6AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhtVemsrc%253D&md5=aa314b8c63c442bcdea0a6b9ef79ff29</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DK.%2BS.%26aulast%3DMcLean%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DF.%26aulast%3DLemley%26aufirst%3DP.%26aulast%3DKoblan%26aufirst%3DK.%26aulast%3DOrme-Johnson%26aufirst%3DW.%26atitle%3DKlebsiella%2520pneumoniae%2520nifM%2520Gene%2520Product%2520is%2520Required%2520for%2520Stabilization%2520and%2520Activation%2520of%2520Nitrogenase%2520Iron%2520Protein%2520in%2520Escherichia%2520coli%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26issue%3D2%26spage%3D772%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D.</span></span> <span> </span><span class="NLM_article-title">The nifH, nifM and nifN Genes of Azotobacter vinelandii: Characterisation by Tn5 Mutagenesis and Isolation from pLAFR1 Gene Banks</span>. <i>Mol. Gen. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1007/BF00430445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2FBF00430445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2sXmtF2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1986&pages=318-325&issue=2&author=C.+Kennedyauthor=R.+Gamalauthor=R.+Humphreyauthor=J.+Ramosauthor=K.+Brigleauthor=D.+Dean&title=The+nifH%2C+nifM+and+nifN+Genes+of+Azotobacter+vinelandii%3A+Characterisation+by+Tn5+Mutagenesis+and+Isolation+from+pLAFR1+Gene+Banks&doi=10.1007%2FBF00430445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The nifH, nifM and nifN genes of Azotobacter vinelandii:  characterization by Tn5 mutagenesis and isolation from pLAFR1 gene banks</span></div><div class="casAuthors">Kennedy, Christina; Gamal, Rawia; Humphrey, Richard; Ramos, Juan; Brigle, Kevin; Dean, Dennis</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and General Genetics</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">318-25</span>CODEN:
                <span class="NLM_cas:coden">MGGEAE</span>;
        ISSN:<span class="NLM_cas:issn">0026-8925</span>.
    </div><div class="casAbstract">Tn5 was introduced into A. vinelandii on a suicide vector, pGS9.  Three Nif- mutants were found to carry Tn5 in nifH (MV6), in nifN (MV22), and in or near nifM (MV21), from the results of hybridization expts.  For MV21 and MV22 this was also shown by complementation with the nif genes of Klebsiella pneumoniae on pRD1.  MV6 failed to synthesis the nifH, D, and K gene products.  MV6 and MV22 fixed nitrogen in the absence of supplied molybdenum while mutant MV21 did not, suggesting that the nifM gene product may be required for the alternative nitrogenase system synthesized in azotobacteria under conditions of molybdenum deprivation.  Reconstitution expts. with mutant exts. showed that MV22 (nifN-) lacked the FeMo cofactor and that MV21 (NifM-) synthesized inactive Fe protein.  These biochem. phenotypes are identical to those of the K. pneumoniae nifN and nifM mutants, resp., demonstrating that these genes have the same function in both K. pneumoniae and A. vinelandii.  Complementation of the A. vinelandii mutants with pLAFR1 gene banks of A. vinelandii or A. chroococcum yielded 3 cosmids of interest.  Plasmid pLV10 complemented UW91, a nifH mutant, and cor. the defect in MV6 after recombination with the mutant genome.  It also carried nifD (but not nifK) and ∼18 kb of DNA upstream from nifH.  Plasmid pLV1 from the A. vinelandii gene bank complemented both MV21 and MV22 as did pLC11, isolated from the A. chroococcum gene bank.  Both pLV1 and pLC11 carried part of the nif cluster downstream of nifHDK which also includes nifEN and nifMVS on ∼22 kb of DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSeVxbQJH7b7Vg90H21EOLACvtfcHk0liNivA9z0O6AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtF2msw%253D%253D&md5=7a8adde7c5d1045fc59ac7578a5471d2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF00430445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00430445%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DC.%26aulast%3DGamal%26aufirst%3DR.%26aulast%3DHumphrey%26aufirst%3DR.%26aulast%3DRamos%26aufirst%3DJ.%26aulast%3DBrigle%26aufirst%3DK.%26aulast%3DDean%26aufirst%3DD.%26atitle%3DThe%2520nifH%252C%2520nifM%2520and%2520nifN%2520Genes%2520of%2520Azotobacter%2520vinelandii%253A%2520Characterisation%2520by%2520Tn5%2520Mutagenesis%2520and%2520Isolation%2520from%2520pLAFR1%2520Gene%2520Banks%26jtitle%3DMol.%2520Gen.%2520Genet.%26date%3D1986%26volume%3D205%26issue%3D2%26spage%3D318%26epage%3D325%26doi%3D10.1007%2FBF00430445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Helbig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lück, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, M.</span></span> <span> </span><span class="NLM_article-title">Immunolocalization of the Mip Protein of Intracellularly and Extracellularly Grown Legionella pneumophila</span>. <i>Lett. Appl. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1046/j.1472-765x.2001.00861.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1472-765x.2001.00861.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11169048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFGrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=83-88&issue=2&author=J.+Helbigauthor=P.+L%C3%BCckauthor=M.+Steinertauthor=E.+Jacobsauthor=M.+Witt&title=Immunolocalization+of+the+Mip+Protein+of+Intracellularly+and+Extracellularly+Grown+Legionella+pneumophila&doi=10.1046%2Fj.1472-765x.2001.00861.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Immunolocalization of the Mip protein of intracellularly and extracellularly grown Legionella pneumophila</span></div><div class="casAuthors">Helbig, J. H.; Luck, P. C.; Steinert, M.; Jacobs, E.; Witt, M.</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Applied Microbiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">83-88</span>CODEN:
                <span class="NLM_cas:coden">LAMIE7</span>;
        ISSN:<span class="NLM_cas:issn">0266-8254</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The macrophage infectivity potentiator (Mip) protein is an important factor in the optimal intracellular survival of Legionella pneumophila in protozoa and human cell lines.  In this study we have localized the Mip protein in Legionella grown on buffered charcoal yeast ext. (BCYE) agar as well as in Legionella which were ingested by Acanthamoeba castellanii.  Immunogold techniques have shown that Mip is exposed on the cell surface of extracellularly grown bacteria.  In A. castellanii infected with Legionella the Mip protein was also detected on host membranes which exhibited a multilamellar structure.  The morphol. of these structures is similar to that of respirable vesicles of amoebas by which live legionellas may be transmitted to humans.  It can be assumed that the accumulation of Mip protein in the multilamellar host membranes increases the infection potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxibigTEEGabVg90H21EOLACvtfcHk0lhmMaUZlGtNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFGrsLg%253D&md5=36e9521150af886ce164df8c1b7a9db7</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-765x.2001.00861.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-765x.2001.00861.x%26sid%3Dliteratum%253Aachs%26aulast%3DHelbig%26aufirst%3DJ.%26aulast%3DL%25C3%25BCck%26aufirst%3DP.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DE.%26aulast%3DWitt%26aufirst%3DM.%26atitle%3DImmunolocalization%2520of%2520the%2520Mip%2520Protein%2520of%2520Intracellularly%2520and%2520Extracellularly%2520Grown%2520Legionella%2520pneumophila%26jtitle%3DLett.%2520Appl.%2520Microbiol.%26date%3D2001%26volume%3D32%26issue%3D2%26spage%3D83%26epage%3D88%26doi%3D10.1046%2Fj.1472-765x.2001.00861.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leuzzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarselli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taddei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappuoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizza, M.</span></span> <span> </span><span class="NLM_article-title">Ng-MIP, a Surface-Exposed Lipoprotein of Neisseria gonorrhoeae, has a Peptidyl-Prolyl Cis/Trans Isomerase (PPIase) Activity and is Involved in Persistence in Macrophages</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2005.04859.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2005.04859.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16238618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WrtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2005&pages=669-681&issue=3&author=R.+Leuzziauthor=L.+Serinoauthor=M.+Scarselliauthor=S.+Savinoauthor=M.+R.+Fontanaauthor=E.+Monaciauthor=A.+Taddeiauthor=G.+Fischerauthor=R.+Rappuoliauthor=M.+Pizza&title=Ng-MIP%2C+a+Surface-Exposed+Lipoprotein+of+Neisseria+gonorrhoeae%2C+has+a+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+%28PPIase%29+Activity+and+is+Involved+in+Persistence+in+Macrophages&doi=10.1111%2Fj.1365-2958.2005.04859.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages</span></div><div class="casAuthors">Leuzzi, Rosanna; Serino, Laura; Scarselli, Maria; Savino, Silvana; Fontana, Maria Rita; Monaci, Elisabetta; Taddei, Annarita; Fischer, Gunter; Rappuoli, Rino; Pizza, Mariagrazia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Macrophage infectivity potentiators (MIPs) are a family of surface-exposed virulence factors of intracellular microorganisms such as Legionella, Chlamydia and Trypanosoma.  These proteins display peptidylprolyl cis/trans isomerase (PPIase) activity that is inhibited by immunosuppressants FK506 and rapamycin.  Here the authors describe the identification and characterization in Neisseria gonorrhoeae of Ng-MIP, a surface-exposed lipoprotein with high homol. to MIPs.  The protein is an homodimer with rapamycin-inhibited PPIase activity confirming that it is a functional member of the MIP family.  A knock-out strain, generated by deletion of the mip gene in N. gonorrhoeae F62 strain, was evaluated for its role in infection of mouse and human macrophages.  The authors show that Ng-MIP promotes the intracellular survival of N. gonorrhoeae in macrophages, highlighting a possible role of this protein in promoting the persistence of gonococcal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkygiAM7vglLVg90H21EOLACvtfcHk0lhmMaUZlGtNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WrtbfL&md5=e37a59a476523bbef44b560e5a31e24e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2005.04859.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2005.04859.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeuzzi%26aufirst%3DR.%26aulast%3DSerino%26aufirst%3DL.%26aulast%3DScarselli%26aufirst%3DM.%26aulast%3DSavino%26aufirst%3DS.%26aulast%3DFontana%26aufirst%3DM.%2BR.%26aulast%3DMonaci%26aufirst%3DE.%26aulast%3DTaddei%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DRappuoli%26aufirst%3DR.%26aulast%3DPizza%26aufirst%3DM.%26atitle%3DNg-MIP%252C%2520a%2520Surface-Exposed%2520Lipoprotein%2520of%2520Neisseria%2520gonorrhoeae%252C%2520has%2520a%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520%2528PPIase%2529%2520Activity%2520and%2520is%2520Involved%2520in%2520Persistence%2520in%2520Macrophages%26jtitle%3DMol.%2520Microbiol.%26date%3D2005%26volume%3D58%26issue%3D3%26spage%3D669%26epage%3D681%26doi%3D10.1111%2Fj.1365-2958.2005.04859.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, G.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Molecular Chaperone Trigger Factor</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2010.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bbamcr.2010.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20132842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVens7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=650-661&issue=6&author=A.+Hoffmannauthor=B.+Bukauauthor=G.+Kramer&title=Structure+and+Function+of+the+Molecular+Chaperone+Trigger+Factor&doi=10.1016%2Fj.bbamcr.2010.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the molecular chaperone Trigger Factor</span></div><div class="casAuthors">Hoffmann, Anja; Bukau, Bernd; Kramer, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">650-661</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Newly synthesized proteins often require the assistance of mol. chaperones to efficiently fold into functional 3-dimensional structures.  At first, ribosome-assocd. chaperones guide the initial folding steps and protect growing polypeptide chains from misfolding and aggregation.  After that, folding into the native structure may occur spontaneously or require support by addnl. chaperones which do not bind to the ribosome, such as DnaK and GroEL.  Here, the authors review current knowledge on the best-characterized ribosome-assocd. chaperone at present, Escherichia coli trigger factor (TF).  The authors describe recent progress on structural and dynamic aspects of TF's interactions with the ribosome and substrates and discuss how these interactions affect co-translational protein folding.  In addn., the authors discuss the newly proposed ribosome-independent function of TF as an assembly factor of multi-subunit protein complexes.  Finally, the authors cover the functional cooperation between TF, DnaK, and GroEL in folding of cytosolic proteins and the interplay between TF and other ribosome-assocd. factors acting in enzymic processing and translocation of nascent polypeptide chains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMvdHFDeXct7Vg90H21EOLACvtfcHk0lhmMaUZlGtNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVens7g%253D&md5=27dd6d09a043adcf32c9b3f4fbb6453c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2010.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2010.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DA.%26aulast%3DBukau%26aufirst%3DB.%26aulast%3DKramer%26aufirst%3DG.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Molecular%2520Chaperone%2520Trigger%2520Factor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D6%26spage%3D650%26epage%3D661%26doi%3D10.1016%2Fj.bbamcr.2010.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knappe, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaarschmidt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span> <span> </span><span class="NLM_article-title">Insertion of a Chaperone Domain Converts FKBP12 into a Powerful Catalyst of Protein Folding</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1458</span>– <span class="NLM_lpage">1468</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2007.02.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jmb.2007.02.097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17397867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2007&pages=1458-1468&issue=5&author=T.+A.+Knappeauthor=B.+Eckertauthor=P.+Schaarschmidtauthor=C.+Scholzauthor=F.+X.+Schmid&title=Insertion+of+a+Chaperone+Domain+Converts+FKBP12+into+a+Powerful+Catalyst+of+Protein+Folding&doi=10.1016%2Fj.jmb.2007.02.097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Insertion of a Chaperone Domain Converts FKBP12 into a Powerful Catalyst of Protein Folding</span></div><div class="casAuthors">Knappe, Thomas A.; Eckert, Barbara; Schaarschmidt, Peter; Scholz, Christian; Schmid, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1458-1468</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The catalytic activity of human FKBP12 as a prolyl isomerase is high towards short peptides, but very low in proline-limited protein folding reactions.  In contrast, the SlyD proteins, which are members of the FKBP family, are highly active as folding enzymes.  They contain an extra "insert-in-flap" or IF domain near the prolyl isomerase active site.  The excision of this domain did not affect the prolyl isomerase activity of SlyD from Escherichia coli towards short peptide substrates but abolished its catalytic activity in proline-limited protein folding reactions.  The reciprocal insertion of the IF domain of SlyD into human FKBP12 increased its folding activity 200-fold and generated a folding catalyst that is more active than SlyD itself.  The IF domain binds to refolding protein chains and thus functions as a chaperone module.  A prolyl isomerase catalytic site and a sep. chaperone site with an adapted affinity for refolding protein chains are the key elements for a productive coupling between the catalysis of prolyl isomerization and conformational folding in the enzymic mechanisms of SlyD and other prolyl isomerases, such as trigger factor and FkpA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJLaFV4Jgy_7Vg90H21EOLACvtfcHk0ljn_jSm2_UroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCmsLk%253D&md5=cdb9e7e6b0b388bbe4a97d1180de01b1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.02.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.02.097%26sid%3Dliteratum%253Aachs%26aulast%3DKnappe%26aufirst%3DT.%2BA.%26aulast%3DEckert%26aufirst%3DB.%26aulast%3DSchaarschmidt%26aufirst%3DP.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26atitle%3DInsertion%2520of%2520a%2520Chaperone%2520Domain%2520Converts%2520FKBP12%2520into%2520a%2520Powerful%2520Catalyst%2520of%2520Protein%2520Folding%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D368%26issue%3D5%26spage%3D1458%26epage%3D1468%26doi%3D10.1016%2Fj.jmb.2007.02.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baars, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ytterberg, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klussmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nord, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygren, P.-Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Wijk, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gier, J.-W.</span></span> <span> </span><span class="NLM_article-title">Consequences of Membrane Protein Overexpression in Escherichia coli</span>. <i>Mol. Cell. Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1550</span>, <span class="refDoi"> DOI: 10.1074/mcp.M600431-MCP200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fmcp.M600431-MCP200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17446557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGqsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1527-1550&issue=9&author=S.+Wagnerauthor=L.+Baarsauthor=A.+J.+Ytterbergauthor=A.+Klussmeierauthor=C.+S.+Wagnerauthor=O.+Nordauthor=P.-%C3%85.+Nygrenauthor=K.+J.+van+Wijkauthor=J.-W.+de+Gier&title=Consequences+of+Membrane+Protein+Overexpression+in+Escherichia+coli&doi=10.1074%2Fmcp.M600431-MCP200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Consequences of membrane protein overexpression in Escherichia coli</span></div><div class="casAuthors">Wagner, Samuel; Baars, Louise; Ytterberg, A. Jimmy; Klussmeier, Anja; Wagner, Claudia S.; Nord, Olof; Nygren, Per-Aake; van Wijk, Klaas J.; de Gier, Jan-Willem</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Proteomics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1527-1550</span>CODEN:
                <span class="NLM_cas:coden">MCPOBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-9476</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Overexpression of membrane proteins is often essential for structural and functional studies, but yields are frequently too low.  An understanding of the physiol. response to overexpression is needed to improve such yields.  Therefore, the authors analyzed the consequences of overexpression of three different membrane proteins (YidC, YedZ, and LepI) fused to green fluorescent protein (GFP) in the bacterium Escherichia coli and compared this with overexpression of a sol. protein, GST-GFP.  Proteomes of total lysates, purified aggregates, and cytoplasmic membranes were analyzed by one- and two-dimensional gel electrophoresis and mass spectrometry complemented with flow cytometry, microscopy, Western blotting, and pulse labeling expts.  Compn. and accumulation levels of protein complexes in the cytoplasmic membrane were analyzed with improved two-dimensional blue native PAGE.  Overexpression of the three membrane proteins, but not sol. GST-GFP, resulted in accumulation of cytoplasmic aggregates contg. the overexpressed proteins, chaperones (DnaK/J and GroEL/S), and sol. proteases (HslUV and ClpXP) as well as many precursors of periplasmic and outer membrane proteins.  This was consistent with lowered accumulation levels of secreted proteins in the three membrane protein overexpressors and is likely to be a direct consequence of satn. of the cytoplasmic membrane protein translocation machinery.  Importantly, accumulation levels of respiratory chain complexes in the cytoplasmic membrane were strongly reduced.  Induction of the acetate-phosphotransacetylase pathway for ATP prodn. and a downregulated tricarboxylic acid cycle indicated the activation of the Arc two-component system, which mediates adaptive responses to changing respiratory states.  This study provides a basis for designing rational strategies to improve yields of membrane protein overexpression in E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkXSmxqZ6aT7Vg90H21EOLACvtfcHk0ljn_jSm2_UroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGqsrzI&md5=cd2d2aa77d971faa7b44278cf4503598</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fmcp.M600431-MCP200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fmcp.M600431-MCP200%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DBaars%26aufirst%3DL.%26aulast%3DYtterberg%26aufirst%3DA.%2BJ.%26aulast%3DKlussmeier%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DC.%2BS.%26aulast%3DNord%26aufirst%3DO.%26aulast%3DNygren%26aufirst%3DP.-%25C3%2585.%26aulast%3Dvan%2BWijk%26aufirst%3DK.%2BJ.%26aulast%3Dde%2BGier%26aufirst%3DJ.-W.%26atitle%3DConsequences%2520of%2520Membrane%2520Protein%2520Overexpression%2520in%2520Escherichia%2520coli%26jtitle%3DMol.%2520Cell.%2520Proteomics%26date%3D2007%26volume%3D6%26issue%3D9%26spage%3D1527%26epage%3D1550%26doi%3D10.1074%2Fmcp.M600431-MCP200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecht, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raddatz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scior, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solbach, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahl, A.</span></span> <span> </span><span class="NLM_article-title">Prolyl Isomerases in a Minimal Cell: Catalysis of Protein Folding by Trigger Factor from Mycoplasma genitalium</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3270</span>– <span class="NLM_lpage">3280</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2000.01355.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1432-1327.2000.01355.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10824113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvFymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=3270-3280&issue=11&author=H.+Bangauthor=A.+Pechtauthor=G.+Raddatzauthor=T.+Sciorauthor=W.+Solbachauthor=K.+Bruneauthor=A.+Pahl&title=Prolyl+Isomerases+in+a+Minimal+Cell%3A+Catalysis+of+Protein+Folding+by+Trigger+Factor+from+Mycoplasma+genitalium&doi=10.1046%2Fj.1432-1327.2000.01355.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium</span></div><div class="casAuthors">Bang, Holger; Pecht, Anja; Raddatz, Guenter; Scior, Tom; Solbach, Werner; Brune, Kay; Pahl, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3270-3280</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Peptidyl-prolyl cis/trans isomerases (PPIases) catalyze the isomerization of prolyl peptide bonds.  Distinct families of this class of enzymes are involved in protein folding in vitro, whereas their significance in free living organisms is not known.  Previously, we inspected the smallest known genome of a self-replicating organism and found that Mycoplasma genitalium is devoid of all known PPIases except the trigger factor.  Despite the extensive sequence information becoming available, most genes remain hypothetical and enzyme activities in many species have not been assigned to an open reading frame.  Therefore, we studied the PPIase activity in crude exts. of M. genitalium.  We showed that this is solely attributed to a single enzyme activity, the trigger factor.  Characterization of this enzyme revealed that its PPIase activity resides in a central 12-kDa domain.  Only the complete trigger factor is able to cis/trans isomerize extended peptide substrates, while the PPIase domain alone can not.  The N- and the C-terminal domains of the trigger factor seem to function in binding of proteins as substrates, as demonstrated by protein refolding expts., in which the complete trigger factor catalyzed protein refolding towards a model protein 500-fold more efficiently than the isolated central PPIase domain.  Protein modeling studies suggest that the PPIase domain can fold in a similar way as the PPIase domain of FK506 binding proteins (FKBPs), one class of PPIases, despite only very limited sequence homol.  Differences at the active site explain why this enzyme is not inhibited by FK506 in contrast with FKBPs.  Trigger factor expressed in Escherichia coli confirms its addnl. chaperone functions, as shown by its assocn. with chaperones GroEL and GroES after induction of misfolding.  In contrast, the isolated PPIase-domain lacks any assocn. with chaperones from E. coli.  In summary, trigger factor of M. genitalium is the single folding isomerase of this organism, which harbors an enzymically active PPIase domain with structural homol. to FKBPs.  Its addnl. domains confer its ability to be an efficient catalyst of protein folding.  The protein folding machinery is conserved and shows a dual function as a chaperone and a prolyl isomerase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6UZobm4M_ALVg90H21EOLACvtfcHk0ljn_jSm2_UroA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvFymt7g%253D&md5=5f8d535a4427881ef9fb4928843590e8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01355.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01355.x%26sid%3Dliteratum%253Aachs%26aulast%3DBang%26aufirst%3DH.%26aulast%3DPecht%26aufirst%3DA.%26aulast%3DRaddatz%26aufirst%3DG.%26aulast%3DScior%26aufirst%3DT.%26aulast%3DSolbach%26aufirst%3DW.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DPahl%26aufirst%3DA.%26atitle%3DProlyl%2520Isomerases%2520in%2520a%2520Minimal%2520Cell%253A%2520Catalysis%2520of%2520Protein%2520Folding%2520by%2520Trigger%2520Factor%2520from%2520Mycoplasma%2520genitalium%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26issue%3D11%26spage%3D3270%26epage%3D3280%26doi%3D10.1046%2Fj.1432-1327.2000.01355.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Göthel, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin and Trigger Factor from Bacillus subtilis Catalyze in Vitro Protein Folding and are Necessary for Viability under Starvation Conditions</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">13392</span>– <span class="NLM_lpage">13399</span>, <span class="refDoi"> DOI: 10.1021/bi981253w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi981253w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADyaK1cvit1aqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=13392-13399&issue=38&author=S.+F.+G%C3%B6thelauthor=C.+Scholzauthor=F.+X.+Schmidauthor=M.+A.+Marahiel&title=Cyclophilin+and+Trigger+Factor+from+Bacillus+subtilis+Catalyze+in+Vitro+Protein+Folding+and+are+Necessary+for+Viability+under+Starvation+Conditions&doi=10.1021%2Fbi981253w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions</span></div><div class="casAuthors">Gothel S F; Scholz C; Schmid F X; Marahiel M A</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">13392-9</span>
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Cyclophilin (the product of the ppiB gene) and the trigger factor (the product of the tig gene) are the only cytosolic peptidyl-prolyl cis-trans isomerases that are known in Bacillus subtilis.  Both enzymes catalyze the in vitro refolding of ribonuclease T1, a reaction that is limited in rate by a prolyl cis/trans isomerization.  The efficiency of cyclophilin as a folding catalyst is only modest with a kcat/KM value of 3.8 x 10(4) M-1 s-1, but the trigger factor shows an almost 40-fold higher specific activity with a kcat/KM value of 1.4 x 10(6) M-1 s-1.  This high catalytic activity originates from the tight binding to the protein substrate as reflected in both the low KM value of 0.5 microM and in the strong inhibition of the trigger factor by unfolded proteins.  By use of a protein-folding assay, the concentrations of cyclophilin and the trigger factor in the cytosol of B. subtilis could be determined as 26 and 35 microM, respectively.  Together they account for the entire folding activity that is detectable in crude extracts of wild-type B. subtilis cells.  The genes encoding cyclophilin and the trigger factor in the B. subtilis chromosome were disrupted individually and simultaneously.  Even in combination, these disruptions had no effect on cell viability in rich medium or under several stress conditions, such as heat, osmotic, or oxidative stress.  However, in poor medium and, in particular, in the absence of amino acids, the growth of the double mutant strain was strongly decelerated, indicating that the prolyl isomerases become essential for growth under starvation conditions.  It is not yet known whether this function relates to the catalysis of the proline-limited folding of essential proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQw3ZUjd2Nt2NTiMd2aNQVUfW6udTcc2eYnkB6MYpWpvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvit1aqsQ%253D%253D&md5=ba98ee517d8b4365d3879de8afd6bbb1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi981253w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi981253w%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6thel%26aufirst%3DS.%2BF.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DCyclophilin%2520and%2520Trigger%2520Factor%2520from%2520Bacillus%2520subtilis%2520Catalyze%2520in%2520Vitro%2520Protein%2520Folding%2520and%2520are%2520Necessary%2520for%2520Viability%2520under%2520Starvation%2520Conditions%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26issue%3D38%26spage%3D13392%26epage%3D13399%26doi%3D10.1021%2Fbi981253w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caparon, M. G.</span></span> <span> </span><span class="NLM_article-title">A Role for Trigger Factor and an Rgg-Like Regulator in the Transcription, Secretion and Processing of the Cysteine Proteinase of Streptococcus pyogenes</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6263</span>– <span class="NLM_lpage">6275</span>, <span class="refDoi"> DOI: 10.1093/emboj/17.21.6263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Femboj%2F17.21.6263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9799235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXnsVKht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=6263-6275&issue=21&author=W.+R.+Lyonauthor=C.+M.+Gibsonauthor=M.+G.+Caparon&title=A+Role+for+Trigger+Factor+and+an+Rgg-Like+Regulator+in+the+Transcription%2C+Secretion+and+Processing+of+the+Cysteine+Proteinase+of+Streptococcus+pyogenes&doi=10.1093%2Femboj%2F17.21.6263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">A role for Trigger Factor and an Rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes</span></div><div class="casAuthors">Lyon, William R.; Gibson, Carmela M.; Caparon, Michael G.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6263-6275</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The ability of numerous microorganisms to cause disease relies upon the highly regulated expression of secreted proteinases.  In this study, mutagenesis with a novel deriv. of Tn4001 was used to identify genes required for the expression of the secreted cysteine proteinase (SCP) of the pathogenic Gram-pos. bacterium Streptococcus pyogenes.  Designated as Rop loci (regulation of proteinase), ropB is a rgg-like transcriptional activator required for transcription of the gene which encodes the proteinase.  In contrast, ropA contributes post-transcriptionally to the secretion and processing of SCP and encodes a homolog of Trigger Factor, a peptidyl-prolyl isomerase and putative chaparone which is highly conserved in most bacterial species, but of unknown function.  Anal. of addnl. ropA mutants demonstrated that RopA acts both to assist in targeting SCP to the secretory pathway and to promote the ability of the proprotein to establish an active conformation upon secretion.  This latter function was dependent upon the peptidyl-prolyl isomerase domain of RopA and mutants that lacked this domain exhibited a bipartite deficiency manifested as a kinetic defect in autologous processing of the proprotein to the mature proteinase, and as a catalytic defect in the mature proteinase.  These results provide insight into the function of Trigger Factor, the regulation of proteinase activity and the mechanism of secretion in Gram-pos. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlCboFd1S5kbVg90H21EOLACvtfcHk0lhZevvFzZg6wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsVKht7k%253D&md5=ec8dfada402fd771c346ac09404d6e6f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F17.21.6263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F17.21.6263%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DW.%2BR.%26aulast%3DGibson%26aufirst%3DC.%2BM.%26aulast%3DCaparon%26aufirst%3DM.%2BG.%26atitle%3DA%2520Role%2520for%2520Trigger%2520Factor%2520and%2520an%2520Rgg-Like%2520Regulator%2520in%2520the%2520Transcription%252C%2520Secretion%2520and%2520Processing%2520of%2520the%2520Cysteine%2520Proteinase%2520of%2520Streptococcus%2520pyogenes%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26issue%3D21%26spage%3D6263%26epage%3D6275%26doi%3D10.1093%2Femboj%2F17.21.6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubail, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charbit, A.</span></span> <span> </span><span class="NLM_article-title">A Homolog of Bacillus subtilis Trigger Factor in Listeria monocytogenes is Involved in Stress Tolerance and Bacterial Virulence</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">6623</span>– <span class="NLM_lpage">6631</span>, <span class="refDoi"> DOI: 10.1128/AEM.00624-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAEM.00624-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17021213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFalsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=6623-6631&issue=10&author=A.+Bigotauthor=E.+Bottonauthor=I.+Dubailauthor=A.+Charbit&title=A+Homolog+of+Bacillus+subtilis+Trigger+Factor+in+Listeria+monocytogenes+is+Involved+in+Stress+Tolerance+and+Bacterial+Virulence&doi=10.1128%2FAEM.00624-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A homolog of Bacillus subtilis trigger factor in Listeria monocytogenes is involved in stress tolerance and bacterial virulence</span></div><div class="casAuthors">Bigot, Armelle; Botton, Eleonore; Dubail, Iharilalao; Charbit, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6623-6631</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Mol. chaperones play an essential role in the folding of nascent chain polypeptides, as well as in the refolding and degrdn. of misfolded or aggregated proteins.  They also assist in protein translocation and participate in stress functions.  We identified a gene, designated tig, encoding a protein homologous to trigger factor (TF), a cytosolic ribosome-assocd. chaperone, in the genome of Listeria monocytogenes.  We constructed a chromosomal Δtig deletion and evaluated the impact of the mutation on bacterial growth in broth under various stress conditions and on pathogenesis.  The Δtig deletion did not affect cell viability but impaired survival in the presence of heat and ethanol stresses.  We also identified the ffh gene, encoding a protein homologous to the SRP54 eukaryotic component of the signal recognition particle.  However, a Δffh deletion was not tolerated, suggesting that Ffh is essential, as it is in Bacillus subtilis and Escherichia coli.  Thus, although dispensable for growth, TF is involved in the stress response of L. monocytogenes.  The Δtig mutant showed no or very modest intracellular survival defects in eukaryotic cells.  However, in vivo it showed a reduced capacity to persist in the spleens and livers of infected mice, revealing that TF has a role in the pathogenicity of L. monocytogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbIjwuIwjcTrVg90H21EOLACvtfcHk0lhZevvFzZg6wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFalsLvP&md5=6378e57c478efec10e697d1241d156b6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1128%2FAEM.00624-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.00624-06%26sid%3Dliteratum%253Aachs%26aulast%3DBigot%26aufirst%3DA.%26aulast%3DBotton%26aufirst%3DE.%26aulast%3DDubail%26aufirst%3DI.%26aulast%3DCharbit%26aufirst%3DA.%26atitle%3DA%2520Homolog%2520of%2520Bacillus%2520subtilis%2520Trigger%2520Factor%2520in%2520Listeria%2520monocytogenes%2520is%2520Involved%2520in%2520Stress%2520Tolerance%2520and%2520Bacterial%2520Virulence%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2006%26volume%3D72%26issue%3D10%26spage%3D6623%26epage%3D6631%26doi%3D10.1128%2FAEM.00624-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caparon, M. G.</span></span> <span> </span><span class="NLM_article-title">Trigger Factor-Mediated Prolyl Isomerization Influences Maturation of the Streptococcus pyogenes Cysteine Protease</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>185</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3661</span>– <span class="NLM_lpage">3667</span>, <span class="refDoi"> DOI: 10.1128/JB.185.12.3661-3667.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.185.12.3661-3667.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12775704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1KgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2003&pages=3661-3667&issue=12&author=W.+R.+Lyonauthor=M.+G.+Caparon&title=Trigger+Factor-Mediated+Prolyl+Isomerization+Influences+Maturation+of+the+Streptococcus+pyogenes+Cysteine+Protease&doi=10.1128%2FJB.185.12.3661-3667.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Trigger factor-mediated prolyl isomerization influences maturation of the Streptococcus pyogenes cysteine protease</span></div><div class="casAuthors">Lyon, William R.; Caparon, Michael G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3661-3667</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Trigger factor, a ribosome-assocd. chaperone and peptidyl-prolyl cis-trans isomerase (PPIase), is essential for the secretion and maturation of the cysteine protease of the pathogenic gram-pos. bacterium Streptococcus pyogenes.  In the absence of trigger factor, the nascent protease polypeptide is not targeted to the secretory pathway.  Some partial-function mutations restore targeting.  However, the secreted protease does not efficiently mature into an enzymically active form, suggesting that trigger factor has an addnl. role in protease biogenesis.  Here, we show that, while not required for targeting, the PPIase activity of trigger factor is essential for maturation of the protease following its secretion from the bacterial cell.  Site-specific mutations introduced into ropA, the gene which encodes trigger factor in S. pyogenes, produced mutant proteins deficient in PPIase activity.  When these mutant alleles were used to replace the wild-type gene on the streptococcal chromosome, anal. of protease biogenesis revealed that, although the protease was secreted normally, it did not efficiently mature to an active form.  Furthermore, mutation of a single proline residue in the protease prodomain suppressed the requirement for PPIase activity, suggesting that this residue is the target of trigger factor.  These data support a model in which trigger factor-mediated prolyl isomerization influences the conformation of the prodomain, which in turn directs the protease into one of several alternative folding pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppsewS--N7c7Vg90H21EOLACvtfcHk0lhCzHh4Dup0YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1KgsL4%253D&md5=606ce148f5881ab1f37eb449f1caf47b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FJB.185.12.3661-3667.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.185.12.3661-3667.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLyon%26aufirst%3DW.%2BR.%26aulast%3DCaparon%26aufirst%3DM.%2BG.%26atitle%3DTrigger%2520Factor-Mediated%2520Prolyl%2520Isomerization%2520Influences%2520Maturation%2520of%2520the%2520Streptococcus%2520pyogenes%2520Cysteine%2520Protease%26jtitle%3DJ.%2520Bacteriol.%26date%3D2003%26volume%3D185%26issue%3D12%26spage%3D3661%26epage%3D3667%26doi%3D10.1128%2FJB.185.12.3661-3667.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eske-Pogodda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titball, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetz, I.</span></span> <span> </span><span class="NLM_article-title">A Novel FK-506-Binding-Like Protein that Lacks Peptidyl-Prolyl Isomerase Activity is Involved in Intracellular Infection and In Vivo Virulence of Burkholderia pseudomallei</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>157</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2629</span>– <span class="NLM_lpage">2638</span>, <span class="refDoi"> DOI: 10.1099/mic.0.049163-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2Fmic.0.049163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21680634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yktr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2011&pages=2629-2638&issue=9&author=I.+H.+Norvilleauthor=K.+Breitbachauthor=K.+Eske-Pogoddaauthor=N.+J.+Harmerauthor=M.+Sarkar-Tysonauthor=R.+W.+Titballauthor=I.+Steinmetz&title=A+Novel+FK-506-Binding-Like+Protein+that+Lacks+Peptidyl-Prolyl+Isomerase+Activity+is+Involved+in+Intracellular+Infection+and+In+Vivo+Virulence+of+Burkholderia+pseudomallei&doi=10.1099%2Fmic.0.049163-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei</span></div><div class="casAuthors">Norville, Isobel H.; Breitbach, Katrin; Eske-Pogodda, Kristin; Harmer, Nicholas J.; Sarkar-Tyson, Mitali; Titball, Richard W.; Steinmetz, Ivo</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2629-2638</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Burkholderia pseudomallei is a facultative intracellular bacterial pathogen causing melioidosis, an often fatal infectious disease that is endemic in several tropical and subtropical areas around the world.  The authors previously described a Ptk2 cell-based plaque assay screening system of B. pseudomallei transposon mutants that led to the identification of several novel virulence determinants.  Using this approach, they identified a mutant with reduced plaque formation in which the BPSL0918 gene was disrupted.  BPSL0918 encodes a putative FK-506-binding protein (FKBP) representing a family of proteins that typically possess peptidyl-prolyl isomerase (PPIase) activity.  A B. pseudomallei ΔBPSL0918 mutant showed a severely impaired ability to resist intracellular killing and to replicate within primary macrophages.  Complementation of the mutant fully restored its ability to grow intracellularly.  Moreover, B. pseudomallei ΔBPSL0918 was significantly attenuated in a murine model of infection.  Structural modeling confirmed a modified FKBP fold of the BPSL0918-encoded protein but unlike virulence-assocd. FKBPs from other pathogenic bacteria, recombinant BPSL0918 protein did not possess PPIase activity in vitro.  In accordance with this observation BPSL0918 exhibits several mutations in residues that have been proposed to mediate PPIase activity in other FKBPs.  Apparently, B. pseudomallei FKBP represents the first example of this protein family which lacks PPIase activity but is important in intracellular infection of a bacterial pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnC_vMlQTESLVg90H21EOLACvtfcHk0lhCzHh4Dup0YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yktr7M&md5=8c1894b88aa4325641a0eba2f42ee72a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.049163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.049163-0%26sid%3Dliteratum%253Aachs%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DBreitbach%26aufirst%3DK.%26aulast%3DEske-Pogodda%26aufirst%3DK.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DTitball%26aufirst%3DR.%2BW.%26aulast%3DSteinmetz%26aufirst%3DI.%26atitle%3DA%2520Novel%2520FK-506-Binding-Like%2520Protein%2520that%2520Lacks%2520Peptidyl-Prolyl%2520Isomerase%2520Activity%2520is%2520Involved%2520in%2520Intracellular%2520Infection%2520and%2520In%2520Vivo%2520Virulence%2520of%2520Burkholderia%2520pseudomallei%26jtitle%3DMicrobiology%26date%3D2011%26volume%3D157%26issue%3D9%26spage%3D2629%26epage%3D2638%26doi%3D10.1099%2Fmic.0.049163-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Echenique-Rivera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Tordello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seib, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappuoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serruto, D.</span></span> <span> </span><span class="NLM_article-title">Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e1002027</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1002027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.ppat.1002027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21589640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVKku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=e1002027&issue=5&author=H.+Echenique-Riveraauthor=A.+Muzziauthor=E.+Del+Tordelloauthor=K.+L.+Seibauthor=P.+Francoisauthor=R.+Rappuoliauthor=M.+Pizzaauthor=D.+Serruto&title=Transcriptome+Analysis+of+Neisseria+meningitidis+in+Human+Whole+Blood+and+Mutagenesis+Studies+Identify+Virulence+Factors+Involved+in+Blood+Survival&doi=10.1371%2Fjournal.ppat.1002027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival</span></div><div class="casAuthors">Echenique-Rivera, Hebert; Muzzi, Alessandro; Del Tordello, Elena; Seib, Kate L.; Francois, Patrice; Rappuoli, Rino; Pizza, Mariagrazia; Serruto, Davide</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1002027</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">During infection Neisseria meningitidis (Nm) encounters multiple environments within the host, which makes rapid adaptation a crucial factor for meningococcal survival.  Despite the importance of invasion into the bloodstream in the meningococcal disease process, little is known about how Nm adapts to permit survival and growth in blood.  The authors performed a time-course transcriptome anal. using an ex vivo model of human whole blood infection.  They obsd. that Nm alters the expression of ≈30% of ORFs of the genome and major dynamic changes were obsd. in the expression of transcriptional regulators, transport and binding proteins, energy metab., and surface-exposed virulence factors.  In particular, they found that the gene encoding the regulator Fur, as well as all genes encoding iron uptake systems, were significantly up-regulated.  Anal. of regulated genes encoding for surface-exposed proteins involved in Nm pathogenesis allowed us to better understand mechanisms used to circumvent host defenses.  During blood infection, Nm activates genes encoding for the factor H binding proteins, fHbp and NspA, genes encoding for detoxifying enzymes such as SodC, Kat and AniA, as well as several less characterized surface-exposed proteins that might have a role in blood survival.  Through mutagenesis studies of a subset of up-regulated genes we were able to identify new proteins important for survival in human blood and also to identify addnl. roles of previously known virulence factors in aiding survival in blood.  Nm mutant strains lacking the genes encoding the hypothetical protein NMB1483 and the surface-exposed proteins NalP, Mip and NspA, the Fur regulator, the transferrin binding protein TbpB, and the -lactate permease LctP were sensitive to killing by human blood.  This increased knowledge of how Nm responds to adaptation in blood could also be helpful to develop diagnostic and therapeutic strategies to control the devastating disease cause by this microorganism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq29YO6kwTGPbVg90H21EOLACvtfcHk0lhCzHh4Dup0YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVKku7Y%253D&md5=c0f136d767c57ca911e60ff46dd6ac55</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002027%26sid%3Dliteratum%253Aachs%26aulast%3DEchenique-Rivera%26aufirst%3DH.%26aulast%3DMuzzi%26aufirst%3DA.%26aulast%3DDel%2BTordello%26aufirst%3DE.%26aulast%3DSeib%26aufirst%3DK.%2BL.%26aulast%3DFrancois%26aufirst%3DP.%26aulast%3DRappuoli%26aufirst%3DR.%26aulast%3DPizza%26aufirst%3DM.%26aulast%3DSerruto%26aufirst%3DD.%26atitle%3DTranscriptome%2520Analysis%2520of%2520Neisseria%2520meningitidis%2520in%2520Human%2520Whole%2520Blood%2520and%2520Mutagenesis%2520Studies%2520Identify%2520Virulence%2520Factors%2520Involved%2520in%2520Blood%2520Survival%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26issue%3D5%26spage%3De1002027%26doi%3D10.1371%2Fjournal.ppat.1002027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salim, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckels, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christodoulides, M.</span></span> <span> </span><span class="NLM_article-title">The Neisseria meningitidis Macrophage Infectivity Potentiator Protein Induces Cross-Strain Serum Bactericidal Activity and is a Potential Serogroup B Vaccine Candidate</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3784</span>– <span class="NLM_lpage">3791</span>, <span class="refDoi"> DOI: 10.1128/IAI.05019-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.05019-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21708989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFSqt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=3784-3791&issue=9&author=M.-C.+Hungauthor=O.+Salimauthor=J.+N.+Williamsauthor=J.+E.+Heckelsauthor=M.+Christodoulides&title=The+Neisseria+meningitidis+Macrophage+Infectivity+Potentiator+Protein+Induces+Cross-Strain+Serum+Bactericidal+Activity+and+is+a+Potential+Serogroup+B+Vaccine+Candidate&doi=10.1128%2FIAI.05019-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate</span></div><div class="casAuthors">Hung, Miao-Chiu; Salim, Omar; Williams, Jeannette N.; Heckels, John E.; Christodoulides, Myron</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3784-3791</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A gene encoding a 29-kDa protein from Neisseria meningitidis serogroup B strain MC58 with homol. to the macrophage infectivity potentiator (MIP) protein of Legionella pneumophila was cloned and expressed in Escherichia coli, and the purified sol. recombinant protein (rMIP) was used for immunization studies.  Anal. of the predicted amino acid sequences of MIP from 13 well-characterized meningococcal strains, isolated from carriers or patients and differing in serogroup, serotype, and subtype, showed that the protein was highly conserved (98 to 100%), with only three distinct sequence types (designated I, II, and III) found.  Western blotting showed that the MIP protein was expressed at similar levels by all of these strains.  Immunization of mice with type I MC58 rMIP in detergent micelles and liposomes contg. monophosphoryl lipid A (MPLA) induced high levels of surface-reactive antibodies with serum bactericidal activity (SBA) titers of 1/1,024 against the homologous strain.  Bactericidal antibodies, were also induced with the protein in saline alone and liposomes alone (titers, 1/128) but not following adsorption to Al(OH)3.  Significantly, antisera raised against type I rMIP administered in saline or liposomes killed strains of heterologous sequence types II and III with similar SBA titers (1/128 to 1/256).  Taken together, these findings suggest that rMIP can provide cross-strain protection against meningococci and should be considered a potential antigen for inclusion in new vaccines against meningococcal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2VheavvIsLVg90H21EOLACvtfcHk0lhMtub6IggW9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFSqt73M&md5=f3eee9820e1a168b9db0ca64b93c0205</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FIAI.05019-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05019-11%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DSalim%26aufirst%3DO.%26aulast%3DWilliams%26aufirst%3DJ.%2BN.%26aulast%3DHeckels%26aufirst%3DJ.%2BE.%26aulast%3DChristodoulides%26aufirst%3DM.%26atitle%3DThe%2520Neisseria%2520meningitidis%2520Macrophage%2520Infectivity%2520Potentiator%2520Protein%2520Induces%2520Cross-Strain%2520Serum%2520Bactericidal%2520Activity%2520and%2520is%2520a%2520Potential%2520Serogroup%2520B%2520Vaccine%2520Candidate%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26issue%3D9%26spage%3D3784%26epage%3D3791%26doi%3D10.1128%2FIAI.05019-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundemose, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, J. H.</span></span> <span> </span><span class="NLM_article-title">Chlamydia trachomatis Mip-Like Protein has Peptidylprolyl Cis/Trans Isomerase Activity that is Inhibited by FK506 and Rapamycin and is Implicated in Initiation of Chlamydial Infection</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">777</span>– <span class="NLM_lpage">783</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01168.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1993.tb01168.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7682281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXitlWns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1993&pages=777-783&issue=5&author=A.+G.+Lundemoseauthor=J.+E.+Kayauthor=J.+H.+Pearce&title=Chlamydia+trachomatis+Mip-Like+Protein+has+Peptidylprolyl+Cis%2FTrans+Isomerase+Activity+that+is+Inhibited+by+FK506+and+Rapamycin+and+is+Implicated+in+Initiation+of+Chlamydial+Infection&doi=10.1111%2Fj.1365-2958.1993.tb01168.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection</span></div><div class="casAuthors">Lundemose, Anker G.; Kay, John E.; Pearce, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">777-83</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">The Mip-like protein of C. trachomatis has sequence similarity with both the Mip protein of Legionella pneumophila, a virulence factor necessary for optimal intracellular infection, and FK506-binding proteins (FKBPs) of both prokaryotic and eukaryotic origin.  FKBPs contain a site for peptidyl-prolyl cis/trans isomerase activity, which is blocked upon binding of the drugs, FK506 or rapamycin.  This paper reports that the recombinant chlamydial Mip-like protein exhibits a peptidyl-prolyl cis/trans isomerase activity which is inhibited by either rapamycin or FK506.  In order to assess the role of the Mip-like protein in chlamydial infection, rapamycin or FK506 (25 μM), were used in either treatment of chlamydial organisms prior to inoculation, or were present at different intervals through the infection.  Pretreatment of organisms alone reduced infectivity for McCoy cells by 30%, with inhibition rising to 80% on more prolonged exposure from 0 to 8 h and 8 to 16 h post-inoculation and declining thereafter.  When drug was present during the developmental cycle at intervals from 0 to 24 h post-inoculation abnormal chlamydia were induced in residual inclusions.  Apparently, inhibition of the isomerase of the Mip-like protein interferes with ≥1 early events in the infective process that det. productive intracellular infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ4oV2yJ3RwrVg90H21EOLACvtfcHk0lhMtub6IggW9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitlWns7c%253D&md5=63cacc187596bf28356817aa653ab14e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01168.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01168.x%26sid%3Dliteratum%253Aachs%26aulast%3DLundemose%26aufirst%3DA.%2BG.%26aulast%3DKay%26aufirst%3DJ.%2BE.%26aulast%3DPearce%26aufirst%3DJ.%2BH.%26atitle%3DChlamydia%2520trachomatis%2520Mip-Like%2520Protein%2520has%2520Peptidylprolyl%2520Cis%252FTrans%2520Isomerase%2520Activity%2520that%2520is%2520Inhibited%2520by%2520FK506%2520and%2520Rapamycin%2520and%2520is%2520Implicated%2520in%2520Initiation%2520of%2520Chlamydial%2520Infection%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D7%26issue%3D5%26spage%3D777%26epage%3D783%26doi%3D10.1111%2Fj.1365-2958.1993.tb01168.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundemose, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouch, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkelund, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christiansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, J. H.</span></span> <span> </span><span class="NLM_article-title">Chlamydia trachomatis Mip-Like Protein</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2539</span>– <span class="NLM_lpage">2548</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1992.tb01430.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1992.tb01430.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1406289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXksVemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=2539-2548&issue=17&author=A.+G.+Lundemoseauthor=D.+A.+Rouchauthor=S.+Birkelundauthor=G.+Christiansenauthor=J.+H.+Pearce&title=Chlamydia+trachomatis+Mip-Like+Protein&doi=10.1111%2Fj.1365-2958.1992.tb01430.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Chlamydia trachomatis Mip-like protein</span></div><div class="casAuthors">Lundemose, Anker G.; Rouch, Duncan A.; Birkelund, Svend; Christiansen, Gunaa; Pearce, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2539-48</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">A 27 kDa Chlamydia trachomatis Mip-like protein with homol. to a 175-amino-acid C-terminal fragment of the surface-exposed Legionella pneumophila mip-gene product has previously been described.  In this paper the entire chlamydia Mip-like sequence of C. trachomatis serovar L2 [lymphogranuloma venereum (LGV) biovar] is presented.  The sequence shows high similarity to the legionella Mip protein and its C-terminal region, like that of the legionella Mip, has high amino acid similarity to eukaryotic and prokaryotic FK506-binding proteins.  The chlamydial mip-like gene was defected by polymerase chain reaction (PCR) in other C. trachomatis serovars and by sequencing of the mip-like genes of serovars B and E (trachoma biovar) was shown to be highly conserved within the two majors biovars of C. trachomatis.  Monoclonal and polyclonal antibodies raised against the recombinant Mip-like protein failed to demonstrate surface-exposed epitopes on infectious elementary bodies or reproductive reticulate body forms either by immunofluorescence or immuno-gold electron microscopy.  However, a complement-dependent inhibition of up to 91% of infectivity for cell cultures was obsd. with antibodies to the N-terminal fragment of the Mip-like protein suggesting that antibody-accessible epitopes are present on infectious EBs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6UGB4lBQOq7Vg90H21EOLACvtfcHk0lhMtub6IggW9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVemtLw%253D&md5=c10150ef1a4d281ada5df0c7eb350c40</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1992.tb01430.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1992.tb01430.x%26sid%3Dliteratum%253Aachs%26aulast%3DLundemose%26aufirst%3DA.%2BG.%26aulast%3DRouch%26aufirst%3DD.%2BA.%26aulast%3DBirkelund%26aufirst%3DS.%26aulast%3DChristiansen%26aufirst%3DG.%26aulast%3DPearce%26aufirst%3DJ.%2BH.%26atitle%3DChlamydia%2520trachomatis%2520Mip-Like%2520Protein%26jtitle%3DMol.%2520Microbiol.%26date%3D1992%26volume%3D6%26issue%3D17%26spage%3D2539%26epage%3D2548%26doi%3D10.1111%2Fj.1365-2958.1992.tb01430.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianciotto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mody, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toews, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engleberg, N.</span></span> <span> </span><span class="NLM_article-title">A Legionella pneumophila Gene Encoding a Species-Specific Surface Protein Potentiates Initiation of Intracellular infection</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1262</span>, <span class="refDoi"> DOI: 10.1128/IAI.57.4.1255-1262.1989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.57.4.1255-1262.1989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=2925251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL1MXktVWltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1989&pages=1255-1262&issue=4&author=N.+Cianciottoauthor=B.+Eisensteinauthor=C.+Modyauthor=G.+Toewsauthor=N.+Engleberg&title=A+Legionella+pneumophila+Gene+Encoding+a+Species-Specific+Surface+Protein+Potentiates+Initiation+of+Intracellular+infection&doi=10.1128%2FIAI.57.4.1255-1262.1989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection</span></div><div class="casAuthors">Cianciotto, Nicholas P.; Eisenstein, Barry I.; Mody, Christopher H.; Toews, Galen B.; Engleberg, N. Cary</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1255-62</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">To investigate the pathogenesis of Legionnaires disease at a mol. level, directed allelic exchange was used to mutate a gene encoding a L. pneumophila-specific 24,000-dalton (Da) surface protein.  Southern hybridization and immunoblot analyses demonstrated that the predicted DNA rearrangement occurred in L. pneumophila with a specific loss of 24-kDa antigen expression.  Compared with its isogenic parent, the mutant was significantly impaired in its ability to infect transformed U937 cells, a human macrophage-like cell line; i.e., the bacterial inoculum of the mutant strain that was required to initiate infection of the macrophage monolayer was ∼80-fold greater than that of the isogenic parent strain.  The mutant strain regained full infectivity on reintroduction of a cloned 24-kDa protein gene, indicating that the reduced infectivity was due specifically to the mutation in that gene.  Compared with the parent strain, the mutant strain was recovered at titers that were ∼10-fold lower shortly after infection, but it exhibited a similar intracellular growth rate over the next 40 h, indicating that the mutant was defective in its ability to initiate macrophage infection rather than in its ability to replicate intracellularly.  When opsonized, the mutant strain was still significantly less infectious than the parent strain, despite equiv. macrophage assocn., suggesting that the mutant was not merely missing a ligand for macrophage attachment.  The mutant also exhibited reduced infectivity in explanted human alveolar macrophages, demonstrating the relevance of the U937 cell model for analyzing this mutant phenotype.  These results represent the first identification of a cloned L. pneumophila gene that is necessary for optimal intracellular infection; this gene was designated mip, for macrophage infectivity potentiator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVLhinnsAzd7Vg90H21EOLACvtfcHk0ligJX0qnaSS_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVWltLs%253D&md5=3ff954c0ebe6f4514a658e4d4ab6a151</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1128%2FIAI.57.4.1255-1262.1989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.57.4.1255-1262.1989%26sid%3Dliteratum%253Aachs%26aulast%3DCianciotto%26aufirst%3DN.%26aulast%3DEisenstein%26aufirst%3DB.%26aulast%3DMody%26aufirst%3DC.%26aulast%3DToews%26aufirst%3DG.%26aulast%3DEngleberg%26aufirst%3DN.%26atitle%3DA%2520Legionella%2520pneumophila%2520Gene%2520Encoding%2520a%2520Species-Specific%2520Surface%2520Protein%2520Potentiates%2520Initiation%2520of%2520Intracellular%2520infection%26jtitle%3DInfect.%2520Immun.%26date%3D1989%26volume%3D57%26issue%3D4%26spage%3D1255%26epage%3D1262%26doi%3D10.1128%2FIAI.57.4.1255-1262.1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamphausen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmausser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Collagen Binding Protein Mip Enables Legionella pneumophila to Transmigrate Through a Barrier of NCI-H292 Lung Epithelial Cells and Extracellular Matrix</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2006.00802.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1462-5822.2006.00802.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16953800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhslGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=450-462&issue=2&author=C.+Wagnerauthor=A.+S.+Khanauthor=T.+Kamphausenauthor=B.+Schmausserauthor=C.+%C3%9Cnalauthor=U.+Lorenzauthor=G.+Fischerauthor=J.+Hackerauthor=M.+Steinert&title=Collagen+Binding+Protein+Mip+Enables+Legionella+pneumophila+to+Transmigrate+Through+a+Barrier+of+NCI-H292+Lung+Epithelial+Cells+and+Extracellular+Matrix&doi=10.1111%2Fj.1462-5822.2006.00802.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix</span></div><div class="casAuthors">Wagner, Carina; Khan, Abdul Salam; Kamphausen, Thilo; Schmausser, Bernd; Uenal, Can; Lorenz, Udo; Fischer, Gunter; Hacker, Joerg; Steinert, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">450-462</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Guinea pigs are highly susceptible to Legionella pneumophila infection and therefore have been the preferred animal model for studies of legionellosis.  In this study guinea pig infections revealed that the Legionella virulence factor Mip (macrophage infectivity potentiator) contributes to the bacterial dissemination within the lung tissue and the spread of Legionella to the spleen.  Histopathol. of infected animals, binding assays with components of the extracellular matrix (ECM), bacterial transmigration expts. across an artificial lung epithelium barrier, inhibitor studies and ECM degrdn. assays were used to elucidate the underlying mechanism of the in vivo observation.  The Mip protein, which belongs to the enzyme family of FK506-binding proteins (FKBP), was shown to bind to the ECM protein collagen (type I, II, III, IV, V, VI).  Transwell assays with L. pneumophila and recombinant Escherichia coli HB101 strains revealed that Mip enables these bacteria to transmigrate across a barrier of NCI-H292 lung epithelial cells and ECM (NCI-H292/ECM barrier).  Mip-specific monoclonal antibodies and the immunosuppressants rapamycin and FK506, which inhibit the peptidyl prolyl cis/trans isomerase (PPIase) activity of Mip, were able to inhibit this transmigration.  By using protease inhibitors we found that the penetration of the NCI-H292/ECM barrier addnl. requires a serine protease activity.  Degrdn. assays with 35S-labeled ECM proteins supported the finding of a concerted action of Mip and a serine protease.  The described synergism between the activity of the collagen binding Mip protein and the serine protease activity represents an entirely new mechanism for bacterial penetration of the lung epithelial barrier and has implications for other prokaryotic and eukaryotic pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzIYGrSd_irLVg90H21EOLACvtfcHk0ligJX0qnaSS_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhslGqsL4%253D&md5=ecf2254e493c64acbb41c2a3bac70c29</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2006.00802.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2006.00802.x%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DC.%26aulast%3DKhan%26aufirst%3DA.%2BS.%26aulast%3DKamphausen%26aufirst%3DT.%26aulast%3DSchmausser%26aufirst%3DB.%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%26aulast%3DLorenz%26aufirst%3DU.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DCollagen%2520Binding%2520Protein%2520Mip%2520Enables%2520Legionella%2520pneumophila%2520to%2520Transmigrate%2520Through%2520a%2520Barrier%2520of%2520NCI-H292%2520Lung%2520Epithelial%2520Cells%2520and%2520Extracellular%2520Matrix%26jtitle%3DCell.%2520Microbiol.%26date%3D2007%26volume%3D9%26issue%3D2%26spage%3D450%26epage%3D462%26doi%3D10.1111%2Fj.1462-5822.2006.00802.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klages, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsli, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinsohn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Prolyl-Cis/Trans-Isomerases Mip and PpiB of Legionella pneumophila Contribute to Surface Translocation, Growth at Suboptimal Temperature, and Infection</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">e00939-17</span>, <span class="refDoi"> DOI: 10.1128/IAI.00939-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00939-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30323027" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=e00939-17&issue=1&author=J.+Raschauthor=C.+M.+Unalauthor=A.+Klagesauthor=U.+Karsliauthor=N.+Heinsohnauthor=R.+Brouwerauthor=M.+Richterauthor=A.+Dellmannauthor=M.+Steinert&title=Peptidyl-Prolyl-Cis%2FTrans-Isomerases+Mip+and+PpiB+of+Legionella+pneumophila+Contribute+to+Surface+Translocation%2C+Growth+at+Suboptimal+Temperature%2C+and+Infection&doi=10.1128%2FIAI.00939-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FIAI.00939-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00939-17%26sid%3Dliteratum%253Aachs%26aulast%3DRasch%26aufirst%3DJ.%26aulast%3DUnal%26aufirst%3DC.%2BM.%26aulast%3DKlages%26aufirst%3DA.%26aulast%3DKarsli%26aufirst%3DU.%26aulast%3DHeinsohn%26aufirst%3DN.%26aulast%3DBrouwer%26aufirst%3DR.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DDellmann%26aufirst%3DA.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DPeptidyl-Prolyl-Cis%252FTrans-Isomerases%2520Mip%2520and%2520PpiB%2520of%2520Legionella%2520pneumophila%2520Contribute%2520to%2520Surface%2520Translocation%252C%2520Growth%2520at%2520Suboptimal%2520Temperature%252C%2520and%2520Infection%26jtitle%3DInfect.%2520Immun.%26date%3D2019%26volume%3D87%26issue%3D1%26spage%3De00939-17%26doi%3D10.1128%2FIAI.00939-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arakaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koide, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, A.</span></span> <span> </span><span class="NLM_article-title">Induction of Apoptosis of Human Macrophages in Vitro by Legionella longbeachae Through Activation of the Caspase Pathway</span>. <i>J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1099/0022-1317-51-2-159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2F0022-1317-51-2-159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11863267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1eksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=159-168&issue=2&author=N.+Arakakiauthor=F.+Higaauthor=M.+Koideauthor=M.+Tateyamaauthor=A.+Saito&title=Induction+of+Apoptosis+of+Human+Macrophages+in+Vitro+by+Legionella+longbeachae+Through+Activation+of+the+Caspase+Pathway&doi=10.1099%2F0022-1317-51-2-159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis of human macrophages in vitro by Legionella longbeachae through activation of the caspase pathway</span></div><div class="casAuthors">Arakaki, Noriko; Higa, Futoshi; Koide, Michio; Tateyama, Masao; Saito, Atushi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-168</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The cytotoxicity of the facultative intracellular bacterium, Legionella longbeachae, an important cause of legionellosis, was characterized.  Apoptosis was induced in HL-60 cells, a human macrophage-like cell line, during the early stages of infection and induction of apoptosis correlated with cytotoxicity.  Apoptosis was confirmed by agarose gel electrophoresis of fragmented DNA, surface exposure of phosphatidylserine and propidium iodide labeling of host cell nuclei.  The involvement of macrophage infectivity potentiator (Mip) protein, a known virulence factor of L. longbeachae, was also examd.  A mip mutant of L. longbeachae induced apoptosis of HL-60 cells but failed to multiply intracellularly, suggesting that intracellular replication of L. longbeachae is not essential for the induction of apoptosis of HL-60 cells.  Furthermore, induction of apoptosis of L. longbeachae-infected macrophages was mediated by activation of the caspase pathway but might be independent of tumor necrosis factor-α- and Fas mediated signal transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRfQzLYY0-x7Vg90H21EOLACvtfcHk0ligJX0qnaSS_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1eksLo%253D&md5=19d01b29b291ea7205cbdf2e2a8af663</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-51-2-159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-51-2-159%26sid%3Dliteratum%253Aachs%26aulast%3DArakaki%26aufirst%3DN.%26aulast%3DHiga%26aufirst%3DF.%26aulast%3DKoide%26aufirst%3DM.%26aulast%3DTateyama%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DA.%26atitle%3DInduction%2520of%2520Apoptosis%2520of%2520Human%2520Macrophages%2520in%2520Vitro%2520by%2520Legionella%2520longbeachae%2520Through%2520Activation%2520of%2520the%2520Caspase%2520Pathway%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2002%26volume%3D51%26issue%3D2%26spage%3D159%26epage%3D168%26doi%3D10.1099%2F0022-1317-51-2-159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steele, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLennan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuzenroeder, M. W.</span></span> <span> </span><span class="NLM_article-title">Sequence Analysis of the mip Gene of the Soilborne Pathogen Legionella longbeachae</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1492</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1128/IAI.66.4.1492-1499.1998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.66.4.1492-1499.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9529072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1cXitFCisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1998&pages=1492-1499&issue=4&author=R.+M.+Doyleauthor=T.+W.+Steeleauthor=A.+M.+McLennanauthor=I.+H.+Parkinsonauthor=P.+A.+Manningauthor=M.+W.+Heuzenroeder&title=Sequence+Analysis+of+the+mip+Gene+of+the+Soilborne+Pathogen+Legionella+longbeachae&doi=10.1128%2FIAI.66.4.1492-1499.1998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence analysis of the mip gene of the soilborne pathogen Legionella longbeachae</span></div><div class="casAuthors">Doyle, Robyn M.; Steele, Trevor W.; Mclennan, Alan M.; Parkinson, Ian H.; Manning, Paul A.; Heuzenroeder, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1492-1499</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">To understand the basis of pathogenesis by Legionella longbeachae serogroup 1, the importance of the Mip protein in this species was examd.  Amino-terminal anal. of the purified, cloned L. longbeachae serogroup 1 ATCC 33462 Mip protein confirmed that the cloned gene protein was expressed and processed in an Escherichia coli background.  DNA sequence anal. of plasmid pIMVS27, contg. the entire L. longbeachae serogroup 1 mip gene, revealed a high degree of homol. to the mip gene of Legionella pneumophila serogroup 1, 76% homol. at the DNA level and 87% identity at the amino acid level.  Primer extension anal. detd. that the start site of transcription was the same for both species, with some differences obsd. for the -10 and -35 promoter regions.  Primers designed from the mip gene sequence obtained for L. longbeachae serogroup 1 ATCC 33462 were used to amplify the mip genes from L. longbeachae serogroup 2 ATCC 33484 and an Australian clin. isolate of L. longbeachae serogroup 1 A5H5.  The mip gene from A5H5 was 100% identical to the type strain sequence.  The serogroup 2 strain of L. longbeachae differed by 2 base pairs in third-codon positions.  Allelic exchange mutagenesis was used to generate an isogenic mip mutant in ATCC 33462 and strain A5H5.  The ATCC mip mutant was unable to infect a strain of Acanthamoebae sp. both in liq. and in a potting mix coculture system, while the A5H5 mip mutant behaved in a manner similar to that of L. pneumophila serogroup 1, i.e., it displayed a reduced capacity to infect and multiply within Acanthamoebae.  To det. if this mutation resulted in reduced virulence in the guinea pig animal model, the A5H5 mip mutant and its parent strain were assessed for their abilities to establish an infection after aerosol exposure.  Unlike the virulent parent strain, the mutant strain did not kill any animals under two different dose regimes.  The data indicate that the Mip protein plays an important role in the intracellular life cycle of L. longbeachae serogroup 1 species and is required for full virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmCO4UiQAWNrVg90H21EOLACvtfcHk0lhz4kBSqDuwvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFCisLY%253D&md5=add4933eef7c021b9dde67357d7fd83d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1128%2FIAI.66.4.1492-1499.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.66.4.1492-1499.1998%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DR.%2BM.%26aulast%3DSteele%26aufirst%3DT.%2BW.%26aulast%3DMcLennan%26aufirst%3DA.%2BM.%26aulast%3DParkinson%26aufirst%3DI.%2BH.%26aulast%3DManning%26aufirst%3DP.%2BA.%26aulast%3DHeuzenroeder%26aufirst%3DM.%2BW.%26atitle%3DSequence%2520Analysis%2520of%2520the%2520mip%2520Gene%2520of%2520the%2520Soilborne%2520Pathogen%2520Legionella%2520longbeachae%26jtitle%3DInfect.%2520Immun.%26date%3D1998%26volume%3D66%26issue%3D4%26spage%3D1492%26epage%3D1499%26doi%3D10.1128%2FIAI.66.4.1492-1499.1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangsborg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianciotto, N. P.</span></span> <span> </span><span class="NLM_article-title">Characterization of a Legionella micdadei mip Mutant</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2840</span>– <span class="NLM_lpage">2845</span>, <span class="refDoi"> DOI: 10.1128/IAI.63.8.2840-2845.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.63.8.2840-2845.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7622203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXntFyqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1995&pages=2840-2845&issue=8&author=W.+A.+O%E2%80%99Connellauthor=J.+M.+Bangsborgauthor=N.+P.+Cianciotto&title=Characterization+of+a+Legionella+micdadei+mip+Mutant&doi=10.1128%2FIAI.63.8.2840-2845.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Legionella micdadei mip mutant</span></div><div class="casAuthors">O'Connell, William A.; Bangsborg, Jette M.; Cianciotto, Nicholas P.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2840-5</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The pathogenesis of Legionella micdadei is dependent upon its ability to infect alveolar phagocytes.  To better understand the basis of intracellular infection by this organism, we examd. the importance of its Mip surface protein.  In Legionella pneumophila, Mip promotes infection of both human macrophages and freshwater protozoa.  Southern hybridization and immunoblot analyses demonstrated that mip sequences were present and expressed within a panel of virulent L. micdadei strains.  Using allelic exchange mutagenesis, we then constructed an L. micdadei strain that completely and specifically lacked Mip.  Although unimpaired in its ability to grow in bacteriol. media, this Mip mutant was defective in its capacity to infect U937 cells, a human macrophage-like cell line.  Most significantly, the Mip- organism displayed a 24-old redn. in survivability immediately after its entry into the phagocyte.  Similarly, the mutant was less able to parasitize Hartmannella amoebae.  Taken together, these data argue that Mip specifically potentiates intracellular growth by L. micdadei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKFfNW3rEq2bVg90H21EOLACvtfcHk0lhz4kBSqDuwvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFyqsbw%253D&md5=40e8dd8c4d86537cf07bfb163bbb28ff</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1128%2FIAI.63.8.2840-2845.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.63.8.2840-2845.1995%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DW.%2BA.%26aulast%3DBangsborg%26aufirst%3DJ.%2BM.%26aulast%3DCianciotto%26aufirst%3DN.%2BP.%26atitle%3DCharacterization%2520of%2520a%2520Legionella%2520micdadei%2520mip%2520Mutant%26jtitle%3DInfect.%2520Immun.%26date%3D1995%26volume%3D63%26issue%3D8%26spage%3D2840%26epage%3D2845%26doi%3D10.1128%2FIAI.63.8.2840-2845.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saul, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arie, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulliez-le Normand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betton, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentley, G.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Studies of FkpA from Escherichia coli, a Cis/Trans Peptidyl-Prolyl Isomerase with Chaperone Activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>335</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2003.10.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jmb.2003.10.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14672666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BD3srpt1Wjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2004&pages=595-608&issue=2&author=F.+Saulauthor=J.-P.+Arieauthor=B.+Vulliez-le+Normandauthor=R.+Kahnauthor=J.-M.+Bettonauthor=G.+Bentley&title=Structural+and+Functional+Studies+of+FkpA+from+Escherichia+coli%2C+a+Cis%2FTrans+Peptidyl-Prolyl+Isomerase+with+Chaperone+Activity&doi=10.1016%2Fj.jmb.2003.10.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional studies of FkpA from Escherichia coli, a cis/trans peptidyl-prolyl isomerase with chaperone activity</span></div><div class="casAuthors">Saul F A; Arie J-P; Vulliez-le Normand B; Kahn R; Betton J-M; Bentley G A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">595-608</span>
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The protein FkpA from the periplasm of Escherichia coli exhibits both cis/trans peptidyl-prolyl isomerase (PPIase) and chaperone activities.  The crystal structure of the protein has been determined in three different forms: as the full-length native molecule, as a truncated form lacking the last 21 residues, and as the same truncated form in complex with the immunosuppressant ligand, FK506.  FkpA is a dimeric molecule in which the 245-residue subunit is divided into two domains.  The N-terminal domain includes three helices that are interlaced with those of the other subunit to provide all inter-subunit contacts maintaining the dimeric species.  The C-terminal domain, which belongs to the FK506-binding protein (FKBP) family, binds the FK506 ligand.  The overall form of the dimer is V-shaped, and the different crystal structures reveal a flexibility in the relative orientation of the two C-terminal domains located at the extremities of the V.  The deletion mutant FkpNL, comprising the N-terminal domain only, exists in solution as a mixture of monomeric and dimeric species, and exhibits chaperone activity.  By contrast, a deletion mutant comprising the C-terminal domain only is monomeric, and although it shows PPIase activity, it is devoid of chaperone function.  These results suggest that the chaperone and catalytic activities reside in the N and C-terminal domains, respectively.  Accordingly, the observed mobility of the C-terminal domains of the dimeric molecule could effectively adapt these two independent folding functions of FkpA to polypeptide substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1nDP7lyirx2mbXvSEQle5fW6udTcc2eZzoHadGkSKybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srpt1Wjtw%253D%253D&md5=727207017b817eea5c9b093626162424</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2003.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2003.10.056%26sid%3Dliteratum%253Aachs%26aulast%3DSaul%26aufirst%3DF.%26aulast%3DArie%26aufirst%3DJ.-P.%26aulast%3DVulliez-le%2BNormand%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DR.%26aulast%3DBetton%26aufirst%3DJ.-M.%26aulast%3DBentley%26aufirst%3DG.%26atitle%3DStructural%2520and%2520Functional%2520Studies%2520of%2520FkpA%2520from%2520Escherichia%2520coli%252C%2520a%2520Cis%252FTrans%2520Peptidyl-Prolyl%2520Isomerase%2520with%2520Chaperone%2520Activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D335%26issue%3D2%26spage%3D595%26epage%3D608%26doi%3D10.1016%2Fj.jmb.2003.10.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hullmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patzer, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Römer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hantke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, V.</span></span> <span> </span><span class="NLM_article-title">Periplasmic Chaperone FkpA is Essential for Imported Colicin M Toxicity</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">937</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2008.06327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2008.06327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18554332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVehur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=926-937&issue=4&author=J.+Hullmannauthor=S.+I.+Patzerauthor=C.+R%C3%B6merauthor=K.+Hantkeauthor=V.+Braun&title=Periplasmic+Chaperone+FkpA+is+Essential+for+Imported+Colicin+M+Toxicity&doi=10.1111%2Fj.1365-2958.2008.06327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Periplasmic chaperone FkpA is essential for imported colicin M toxicity</span></div><div class="casAuthors">Hullmann, Julia; Patzer, Silke I.; Roemer, Christin; Hantke, Klaus; Braun, Volkmar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">926-937</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chaperones facilitate correct folding of newly synthesized proteins.  We show here that the periplasmic FkpA chaperone is required for killing Escherichia coli by colicin M entering cells from the outside.  Highly active colicin M prepns. were inactive against fkpA mutant cells; 104-fold dilns. killed fkpA+ cells.  Three previously isolated spontaneous mutants tolerant to colicin M carried a stop codon or an IS1 insertion in the peptidyl-prolyl-cis-trans-isomerase (PPIase) domain (C-domain) of FkpA, which resulted in deletion of the domain.  A randomly generated mutant carried a G148D mutation in the C-domain.  A temp.-sensitive mutant tolerant to colicin M carried a Y25N mutation in the FkpA N-domain.  Mutants transformed with wild-type fkpA were colicin M-sensitive.  Isolated FkpA-His reduced colicin M-His cleavage by proteinase K and renatured denatured colicin M-His in vitro; renaturation was prevented by the PPIase inhibitor FK506.  In both assays, periplasmic SurA-His had no effect.  No other tested periplasmic chaperone could activate colicin M.  Among the tested colicins, only colicin M required FkpA for activity.  Colicin M bound to cells via FhuA was inactivated by trypsin; unbound colicin M retained activity.  We propose that colicin M unfolds during import across the outer membrane, FkpA specifically assists in folding colicin M into an active toxin in the periplasm and PPIase is essential for colicin M activity.  Colicin M is a suitable tool for the isolation of FkpA mutants used to elucidate the functions of the FkpA N- and C-domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob-oQcNNYmLbVg90H21EOLACvtfcHk0lgK1WAOb0_Lsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVehur3I&md5=ee0dc88cd16213f63613ebaf15a829e5</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2008.06327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2008.06327.x%26sid%3Dliteratum%253Aachs%26aulast%3DHullmann%26aufirst%3DJ.%26aulast%3DPatzer%26aufirst%3DS.%2BI.%26aulast%3DR%25C3%25B6mer%26aufirst%3DC.%26aulast%3DHantke%26aufirst%3DK.%26aulast%3DBraun%26aufirst%3DV.%26atitle%3DPeriplasmic%2520Chaperone%2520FkpA%2520is%2520Essential%2520for%2520Imported%2520Colicin%2520M%2520Toxicity%26jtitle%3DMol.%2520Microbiol.%26date%3D2008%26volume%3D69%26issue%3D4%26spage%3D926%26epage%3D937%26doi%3D10.1111%2Fj.1365-2958.2008.06327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Missiakas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betton, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, S.</span></span> <span> </span><span class="NLM_article-title">New Components of Protein Folding in Extracytoplasmic Compartments of Escherichia coli SurA, FkpA and Skp/OmpH</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">871</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.1996.561412.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1365-2958.1996.561412.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8878048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28XlsFyqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=871-884&issue=4&author=D.+Missiakasauthor=J.+M.+Bettonauthor=S.+Raina&title=New+Components+of+Protein+Folding+in+Extracytoplasmic+Compartments+of+Escherichia+coli+SurA%2C+FkpA+and+Skp%2FOmpH&doi=10.1046%2Fj.1365-2958.1996.561412.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">New components of protein folding in extracytoplasmic compartments of Escherichia coli SurA, FkpA and Skp/OmpH</span></div><div class="casAuthors">Missiakas, Dominique; Betton, Jean-Michel; Raina, Satish</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">871-884</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">A global search for extracytoplasmic folding catalysts in Escherichia coli was undertaken using different genetic systems that produce unstable or misfolded proteins in the periplasm.  The extent of misfolding was monitored by the increased activity of the σE regulon that is specifically induced by misfolded proteins in the periplasm.  Using multicopy libraries, the authors cloned two genes, surA and fkpA, that decreased the σE-dependent response constitutively induced by misfolded proteins.  According to their sequences and their biochem. activities, SurA and FkpA belong to two different peptidyl prolyl isomerase (PPI) families.  SurA was also selected as a multicopy suppressor of a defined htrM (rfaD) null mutation.  Such mutants produce a defective lipopolysaccharide that is unable to protect outer membrane proteins from degrdn. during folding.  The SurA multicopy suppression effect in htrM (rfaD) mutant bacteria was directly assocd. with its ability to catalyze the folding of outer membrane proteins immediately after export.  Finally, Tn10 insertions were isolated, which led to an increased activity of the σE regulon.  Such insertions were mapped to the dsb genes encoding catalysts of the protein disulfide isomerase (PDI) family, as well as to the surA, fkpA and ompH/skp genes.  The authors propose that these three proteins (SurA, FkpA and OmpH/Skp) play an active role either as folding catalysts or as chaperones in extracytoplasmic compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7R1O_Reo3VrVg90H21EOLACvtfcHk0lgK1WAOb0_Lsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFyqtL0%253D&md5=9c2bcabb801f4e31995daafc65301dd7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1996.561412.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1996.561412.x%26sid%3Dliteratum%253Aachs%26aulast%3DMissiakas%26aufirst%3DD.%26aulast%3DBetton%26aufirst%3DJ.%2BM.%26aulast%3DRaina%26aufirst%3DS.%26atitle%3DNew%2520Components%2520of%2520Protein%2520Folding%2520in%2520Extracytoplasmic%2520Compartments%2520of%2520Escherichia%2520coli%2520SurA%252C%2520FkpA%2520and%2520Skp%252FOmpH%26jtitle%3DMol.%2520Microbiol.%26date%3D1996%26volume%3D21%26issue%3D4%26spage%3D871%26epage%3D884%26doi%3D10.1046%2Fj.1365-2958.1996.561412.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. D.</span></span> <span> </span><span class="NLM_article-title">Escherichia coli and Other Species of the Enterobacteriaceae Encode a Protein Similar to the Family of Mip-Like FK506-Binding Proteins</span>. <i>Arch. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>163</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1007/BF00404209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2FBF00404209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7540828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXmtVKjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1995&pages=357-365&issue=5&author=S.+M.+Horneauthor=K.+D.+Young&title=Escherichia+coli+and+Other+Species+of+the+Enterobacteriaceae+Encode+a+Protein+Similar+to+the+Family+of+Mip-Like+FK506-Binding+Proteins&doi=10.1007%2FBF00404209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins</span></div><div class="casAuthors">Horne, Shelley M.; Young, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Microbiology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-65</span>CODEN:
                <span class="NLM_cas:coden">AMICCW</span>;
        ISSN:<span class="NLM_cas:issn">0302-8933</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A newly identified gene in Escherichia coli, fkpA, encodes a protein with extensive similarity to the macrophage infectivity potentiator (Mip) proteins of Legionalla pneumophila and Chlamydia trachomatis.  The FkpA protein may be a new member of the family of FK506-binding motif in 40 of 48 positions, including those amino acids at the active site that form hydrogen bonds with the drug FK506.  The amino acid sequence of the 29 kDa FkpA protein is 30-35% identical to the Mip proteins of L. pneumophila, L. micdadei, and C. trachomatis.  Of the 270 amino acids of FkpA, 113 (42%) are identical to the sequence of one or another of these Mip proteins.  Overexpression of FkpA or deletion of fkpA from the E. coli chromosome had no detrimental effect on bacterial growth, indicating that fkpA is not an essential gene.  Hybridization of fkpA-specific DNA probes to genomic blots revealed that similar genes exist in several representatives of the Enterobacteriaceae.  Thus, mip-like genes are not found exclusively in bacteria having a predominately intracellular life style, but instead appear to be a new FKBP subfamily that is a common constituent of many bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIS66AI1pNnrVg90H21EOLACvtfcHk0lgK1WAOb0_Lsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtVKjsrs%253D&md5=74f4c39bb1d66c00a2792b0eca2be975</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2FBF00404209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00404209%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DS.%2BM.%26aulast%3DYoung%26aufirst%3DK.%2BD.%26atitle%3DEscherichia%2520coli%2520and%2520Other%2520Species%2520of%2520the%2520Enterobacteriaceae%2520Encode%2520a%2520Protein%2520Similar%2520to%2520the%2520Family%2520of%2520Mip-Like%2520FK506-Binding%2520Proteins%26jtitle%3DArch.%2520Microbiol.%26date%3D1995%26volume%3D163%26issue%3D5%26spage%3D357%26epage%3D365%26doi%3D10.1007%2FBF00404209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deuerling, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze-Specking, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomoyasu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukau, B.</span></span> <span> </span><span class="NLM_article-title">Trigger Factor and DnaK Cooperate in Folding of Newly Synthesized Proteins</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>400</i></span> (<span class="NLM_issue">6745</span>),  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">696</span>, <span class="refDoi"> DOI: 10.1038/23301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2F23301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10458167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=693-696&issue=6745&author=E.+Deuerlingauthor=A.+Schulze-Speckingauthor=T.+Tomoyasuauthor=A.+Mogkauthor=B.+Bukau&title=Trigger+Factor+and+DnaK+Cooperate+in+Folding+of+Newly+Synthesized+Proteins&doi=10.1038%2F23301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Trigger factor and DnaK cooperate in folding of newly synthesized proteins</span></div><div class="casAuthors">Deuerling, Elke; Schulze-Specking, Agnes; Tomoyasu, Toshifumi; Mogk, Axel; Bukau, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">6745</span>),
    <span class="NLM_cas:pages">693-696</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The role of mol. chaperones in assisting the folding of newly synthesized proteins in the cytosol is poorly understood.  In Escherichia coli, GroEL assists folding of only a minority of proteins and the Hsp70 homolog DnaK is not essential for protein folding or cell viability at intermediate growth temps.  The major protein assocd. with nascent polypeptides is ribosome-bound trigger factor, which displays chaperone and prolyl isomerase activities in vitro.  Here we show that Δtig::kan mutants lacking trigger factor have no defects in growth or protein folding.  However, combined Δtig::kan and ΔdnaK mutations cause synthetic lethality.  Depletion of DnaK in the Δtig::kan mutant results in massive aggregation of cytosolic proteins.  In Δtig::kan cells, an increased amt. of newly synthesized proteins assocd. transiently with DnaK.  These findings show in vivo activity for a ribosome-assocd. chaperone, trigger factor, in general protein folding, and functional cooperation of this protein with a cytosolic Hsp70.  Trigger factor and DnaK cooperate to promote proper folding of a variety of E. coli proteins, but neither is essential for folding and viability at intermediate growth temps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOlDHU7mH6hbVg90H21EOLACvtfcHk0ljlxPY9B4afDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVCrs7k%253D&md5=f3d42334f2cd7597dcb298efbfe4d7bd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F23301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F23301%26sid%3Dliteratum%253Aachs%26aulast%3DDeuerling%26aufirst%3DE.%26aulast%3DSchulze-Specking%26aufirst%3DA.%26aulast%3DTomoyasu%26aufirst%3DT.%26aulast%3DMogk%26aufirst%3DA.%26aulast%3DBukau%26aufirst%3DB.%26atitle%3DTrigger%2520Factor%2520and%2520DnaK%2520Cooperate%2520in%2520Folding%2520of%2520Newly%2520Synthesized%2520Proteins%26jtitle%3DNature%26date%3D1999%26volume%3D400%26issue%3D6745%26spage%3D693%26epage%3D696%26doi%3D10.1038%2F23301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teter, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houry, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tradler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockabrand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. U.</span></span> <span> </span><span class="NLM_article-title">Polypeptide Flux Through Bacterial Hsp70: DnaK Cooperates with Trigger Factor in Chaperoning Nascent Chains</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80787-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0092-8674%2800%2980787-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10380927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1999&pages=755-765&issue=6&author=S.+A.+Teterauthor=W.+A.+Houryauthor=D.+Angauthor=T.+Tradlerauthor=D.+Rockabrandauthor=G.+Fischerauthor=P.+Blumauthor=C.+Georgopoulosauthor=F.+U.+Hartl&title=Polypeptide+Flux+Through+Bacterial+Hsp70%3A+DnaK+Cooperates+with+Trigger+Factor+in+Chaperoning+Nascent+Chains&doi=10.1016%2FS0092-8674%2800%2980787-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Polypeptide flux through bacterial Hsp70: DnaK cooperates with trigger factor in chaperoning nascent chains</span></div><div class="casAuthors">Teter, Sarah A.; Houry, Walid A.; Ang, Debbie; Tradler, Thomas; Rockabrand, David; Fischer, Gunter; Blum, Paul; Georgopoulos, Costa; Hartl, F. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-765</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A role for DnaK, the major E. coli Hsp70, in chaperoning de novo protein folding has remained elusive.  Here we show that under nonstress conditions DnaK transiently assocs. with a wide variety of nascent and newly synthesized polypeptides, with a preference for chains larger than 30 kDa.  Deletion of the nonessential gene encoding trigger factor, a ribosome-assocd. chaperone, results in a doubling of the fraction of nascent polypeptides interacting with DnaK.  Combined deletion of the trigger factor and DnaK genes is lethal under normal growth conditions.  These findings indicate important, partially overlapping functions of DnaK and trigger factor in de novo protein folding and explain why the loss of either chaperone can be tolerated by E. coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlnP04Cv-OzrVg90H21EOLACvtfcHk0ljlxPY9B4afDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOju7s%253D&md5=46fbfbb8a5fc8406029acaf6035845a4</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980787-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980787-4%26sid%3Dliteratum%253Aachs%26aulast%3DTeter%26aufirst%3DS.%2BA.%26aulast%3DHoury%26aufirst%3DW.%2BA.%26aulast%3DAng%26aufirst%3DD.%26aulast%3DTradler%26aufirst%3DT.%26aulast%3DRockabrand%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DBlum%26aufirst%3DP.%26aulast%3DGeorgopoulos%26aufirst%3DC.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DPolypeptide%2520Flux%2520Through%2520Bacterial%2520Hsp70%253A%2520DnaK%2520Cooperates%2520with%2520Trigger%2520Factor%2520in%2520Chaperoning%2520Nascent%2520Chains%26jtitle%3DCell%26date%3D1999%26volume%3D97%26issue%3D6%26spage%3D755%26epage%3D765%26doi%3D10.1016%2FS0092-8674%2800%2980787-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roof, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span> <span> </span><span class="NLM_article-title">The Escherichia coli FKBP-Type PPIase SlyD is Required for the Stabilization of the E Lysis Protein of Bacteriophage φX174</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02984.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1365-2958.2002.02984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12100551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslKlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=99-108&issue=1&author=T.+G.+Bernhardtauthor=W.+D.+Roofauthor=R.+Young&title=The+Escherichia+coli+FKBP-Type+PPIase+SlyD+is+Required+for+the+Stabilization+of+the+E+Lysis+Protein+of+Bacteriophage+%CF%86X174&doi=10.1046%2Fj.1365-2958.2002.02984.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The Escherichia coli FKBP-type PPIase SlyD is required for the stabilization of the E lysis protein of bacteriophage .vphi.X174</span></div><div class="casAuthors">Bernhardt, Thomas G.; Roof, William D.; Young, Ry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-108</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Most bacteriophages abruptly terminate their vegetative cycle by causing lysis of the host cell.  The ssDNA phage .vphi.X174 uses a single lysis gene, E, encoding a 91-amino-acid membrane protein that causes lysis of Escherichia coli by inhibiting MraY, a conserved enzyme of murein biosynthesis.  Recessive mutations in the host gene slyD (sensitivity to lysis) absolutely block E-mediated lysis and .vphi.X174 plaque formation.  The slyD gene encodes a FKBP-type peptidyl-prolyl cis-trans isomerase (PPIase).  To investigate the mol. basis of this unique FKBP-dependence, spontaneous plaque-forming mutants of .vphi.X174 were isolated on a slyD lawn.  All of these Epos (plates on slyD) suppressors encode proteins with either a R3H or L19F change.  The double mutant was also isolated and generated the largest plaques on the slyD lawn.  A c-myc epitope tag sequence was incorporated into the parental E and Epos genes without effect on lytic function.  Western blots and pulse-chase labeling expts. showed that both Epos and E are highly unstable in a slyD background; however, Epos is synthesized at a higher rate, allowing a lysis-sufficient level of Epos to accumulate.  Our results indicate that SlyD is required for stabilizing the E protein and allowing it to accumulate to the levels required to exert its lytic effect.  These data are discussed in terms of a model for the specific role of the SlyD PPIase in E folding, and of the use of the very strict SlyD-dependence phenotype for identifying elements of PPIase selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_9MaRdhqDlbVg90H21EOLACvtfcHk0ljlxPY9B4afDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslKlu70%253D&md5=7d32cee8e8ee3863feb19cd280ec6601</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02984.x%26sid%3Dliteratum%253Aachs%26aulast%3DBernhardt%26aufirst%3DT.%2BG.%26aulast%3DRoof%26aufirst%3DW.%2BD.%26aulast%3DYoung%26aufirst%3DR.%26atitle%3DThe%2520Escherichia%2520coli%2520FKBP-Type%2520PPIase%2520SlyD%2520is%2520Required%2520for%2520the%2520Stabilization%2520of%2520the%2520E%2520Lysis%2520Protein%2520of%2520Bacteriophage%2520%25CF%2586X174%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D45%26issue%3D1%26spage%3D99%26epage%3D108%26doi%3D10.1046%2Fj.1365-2958.2002.02984.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bispham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maskell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, T. S.</span></span> <span> </span><span class="NLM_article-title">Identification of Host-Specific Colonization Factors of Salmonella enterica Serovar Typhimurium</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04323.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2004.04323.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15522082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=994-1010&issue=4&author=E.+Morganauthor=J.+D.+Campbellauthor=S.+C.+Roweauthor=J.+Bisphamauthor=M.+P.+Stevensauthor=A.+J.+Bowenauthor=P.+A.+Barrowauthor=D.+J.+Maskellauthor=T.+S.+Wallis&title=Identification+of+Host-Specific+Colonization+Factors+of+Salmonella+enterica+Serovar+Typhimurium&doi=10.1111%2Fj.1365-2958.2004.04323.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of host-specific colonization factors of Salmonella enterica serovar typhimurium</span></div><div class="casAuthors">Morgan, Eirwen; Campbell, June D.; Rowe, Sonya C.; Bispham, Jennie; Stevens, Mark P.; Bowen, Alison J.; Barrow, Paul A.; Maskell, Duncan J.; Wallis, Timothy S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">994-1010</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The severity of infections caused by Salmonella enterica serovar typhimurium varies depending on the host species.  Numerous virulence genes have been identified in S. typhimurium, largely from studies in mice, but their roles in infections of other species remain unclear.  In the most comprehensive survey of its kind, through the use of signature-tagged mutagenesis of S. typhimurium, we have identified mutants that were unable to colonize calf intestines, mutants unable to colonize chick intestines and mutants unable to colonize both species.  The type three secretion systems encoded on Salmonella pathogenicity islands (SPIs) 1 and 2 were required for efficient colonization of cattle.  However, disruption of these secretion systems only caused a minor defect in S. typhimurium colonization of chicks.  Transposon insertions in SPI-4 compromised S. typhimurium colonization of cattle, but not chicks.  This is the 1st data confirming a role for SPI-4 in pathogenesis.  We have also been able to ascribe a role in colonization for cell surface polysaccharides, cell envelope proteins, and many 'housekeeping' genes and genes of unknown function.  We conclude that S. typhimurium uses different strategies to colonize calves and chicks.  This has major implications for vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH7sNyXLtaArVg90H21EOLACvtfcHk0ljTHktCzQMyKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWgsbzL&md5=39f33930dc26ee6ca3921a4657f97b87</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04323.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04323.x%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DJ.%2BD.%26aulast%3DRowe%26aufirst%3DS.%2BC.%26aulast%3DBispham%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DM.%2BP.%26aulast%3DBowen%26aufirst%3DA.%2BJ.%26aulast%3DBarrow%26aufirst%3DP.%2BA.%26aulast%3DMaskell%26aufirst%3DD.%2BJ.%26aulast%3DWallis%26aufirst%3DT.%2BS.%26atitle%3DIdentification%2520of%2520Host-Specific%2520Colonization%2520Factors%2520of%2520Salmonella%2520enterica%2520Serovar%2520Typhimurium%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D54%26issue%3D4%26spage%3D994%26epage%3D1010%26doi%3D10.1111%2Fj.1365-2958.2004.04323.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, X.</span></span> <span> </span><span class="NLM_article-title">Deletion-Mutant Construction, Prokaryotic Expression and Characterization of Peptidyl-Prolyl Cis-Trans Isomerase SlyD from Salmonella enteritidis</span>. <i>Acta Microbiol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1282</span>– <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29738198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1MfgvFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1282-1290&issue=8&author=R.+Guoauthor=S.+Zhuauthor=Y.+Jiaoauthor=S.+Anauthor=Y.+Xueauthor=X.+Feiauthor=S.+Gengauthor=Z.+Panauthor=X.+Jiao&title=Deletion-Mutant+Construction%2C+Prokaryotic+Expression+and+Characterization+of+Peptidyl-Prolyl+Cis-Trans+Isomerase+SlyD+from+Salmonella+enteritidis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion-mutant construction, prokaryotic expression and characterization of peptidal-prolyl cis-trans isomerase SlyD from Salmonella enteritidis</span></div><div class="casAuthors">Guo Rongxian; Zhu Shanshan; Jiao Yang; An Shumin; Xue Ying; Fei Xiao; Geng Shizhong; Pan Zhiming; Jiao Xin'an</div><div class="citationInfo"><span class="NLM_cas:title">Wei sheng wu xue bao = Acta microbiologica Sinica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1282-90</span>
        ISSN:<span class="NLM_cas:issn">0001-6209</span>.
    </div><div class="casAbstract">Objective:  Salmonella enterica serovar enteritidis is an important food-borne pathogen of human and animal.  To further study the function of SlyD associated with virulence and regulation in stress responses of Salmonella Enteritidis, we constructed slyD gene-deletion mutant,, expressed it in E. coli, and characterized the PPIase enzyme obtained.  Methods:  The slyD gene-deletion mutant of Salmonella enteritidis C50041 was constructed by suicide plasmid mediated homologous recombination.  Salmonella enteritidis slyD prokaryotic expression vector was carried out in E. coli, and PPIase activity of recombination SlyD was measured in protease-coupling assay with chymotrypsin.  For amino acids conservation studies, functional domain searches and secondary structure predictions, the BLAST, SMART, TMHMM, SignalP, PHD and SWISS MODEL were used.  Results:  Salmonella enteritidis C50041 ΔslyD mutant strain was successfully constructed.  The growth rate of slyD-deleted strain was identified consistent with its parent strain C50041.  A soluble recombinant SlyD protein was expressed in Escherichia coli BL21(DE3) cells and confirmed by SDS-PAGE.  Catalytic activity confirmed that the SlyD protein was biologically active.  Bioinformatic analysis showed that Salmonella Enteritidis SlyD as a multifaceted protein including three separated domains, the FKBP type peptidal-prolyl cis-trans isomerase domain, the IF chaperone domain and the metal-binding domain.  Conclusion:  Salmonella enteritidis C50041 ΔslyD mutant strain and soluble SlyD protein was obtained, and the present study may provide a basis for further study of the role of SlyD in Salmonella enteritidis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLwET0LaJOkHtlzo9xastyfW6udTcc2eakcoAkQHaoLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfgvFKqtg%253D%253D&md5=0e8a6d2be8e8016ccd7161b3b857c7d6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DFei%26aufirst%3DX.%26aulast%3DGeng%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DJiao%26aufirst%3DX.%26atitle%3DDeletion-Mutant%2520Construction%252C%2520Prokaryotic%2520Expression%2520and%2520Characterization%2520of%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520SlyD%2520from%2520Salmonella%2520enteritidis%26jtitle%3DActa%2520Microbiol.%2520Sin.%26date%3D2016%26volume%3D56%26issue%3D8%26spage%3D1282%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kottom, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, K. D.</span></span> <span> </span><span class="NLM_article-title">Decreased Intracellular Survival of an FkpA Mutant of Salmonella typhimurium Copenhagen</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1128/IAI.65.2.806-810.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.65.2.806-810.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9009347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2sXpvVWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1997&pages=806-810&issue=2&author=S.+M.+Horneauthor=T.+J.+Kottomauthor=L.+K.+Nolanauthor=K.+D.+Young&title=Decreased+Intracellular+Survival+of+an+FkpA+Mutant+of+Salmonella+typhimurium+Copenhagen&doi=10.1128%2FIAI.65.2.806-810.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased intracellular survival of an fkpA mutant of Salmonella typhimurium Copenhagen</span></div><div class="casAuthors">Horne, Shelley M.; Kottom, Theodore J.; Nolan, Lisa K.; Young, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">806-810</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The fkpA gene of S. typhimurium encodes a protein similar to the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Chlamydia trachomatis.  Because Mip proteins enhance the ability of these intracellular pathogens to survive within macrophages and epithelial cells, the authors tested whether the product of the fkpA gene would not have the same effect on the intracellular growth of a virulent strain of S. typhimurium.  By a series of P22 transductions, the fkpA gene of S. typhimurium Copenhagen was replaced with the inactive fkpA::Ω-Cm gene from Escherichia coli, creating the mutant S. typhimurium KY32H1.  The Copenhagen and KY32H1 strains were equally able to enter Caco-2 cells (an epithelial cell line) and J774.A1 cells (a macrophage-like cell line).  However, compared to the parent, the fkpA mutant survived less well in both types of cells during the 1st 6 h after infection.  The no. of viable intracellular S. typhimurium Copenhagen bacteria remained const. 6 h after infection of Caco-2 cells, but the viability of S. typhimurium KY32H1 decreased significantly by 4 h postinfection.  The fkpA mutant also exhibited a reduced ability to survive intracellularly in J774.A1 cells as little as 2 h postinfection.  Complementation of the fkpA mutation by a plasmid-borne wild-type fkpA gene from E. coli restored the ability of S. typhimurium KY32H1 to grow normally in J774.A1 cells.  Thus, expression of the mip-like fkpA gene confers on S. typhimurium Copenhagen properties analogous to those mediated by the Mip proteins in other intracellular pathogens, suggesting that this mechanism may play a role in the virulence and/or intracellular growth of numerous bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF4YL9HZ8gJbVg90H21EOLACvtfcHk0ljTHktCzQMyKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXpvVWhtQ%253D%253D&md5=75a8dc99dd9e83f3a3054b0230551894</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1128%2FIAI.65.2.806-810.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.65.2.806-810.1997%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DS.%2BM.%26aulast%3DKottom%26aufirst%3DT.%2BJ.%26aulast%3DNolan%26aufirst%3DL.%2BK.%26aulast%3DYoung%26aufirst%3DK.%2BD.%26atitle%3DDecreased%2520Intracellular%2520Survival%2520of%2520an%2520FkpA%2520Mutant%2520of%2520Salmonella%2520typhimurium%2520Copenhagen%26jtitle%3DInfect.%2520Immun.%26date%3D1997%26volume%3D65%26issue%3D2%26spage%3D806%26epage%3D810%26doi%3D10.1128%2FIAI.65.2.806-810.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuzenroeder, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flower, R.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of Two Immunophilin-Like Genes, ilpA and fkpA, on a Single 3.9-kilobase Fragment of Aeromonas hydrophila Genomic DNA</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>179</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3397</span>– <span class="NLM_lpage">3403</span>, <span class="refDoi"> DOI: 10.1128/JB.179.11.3397-3403.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.179.11.3397-3403.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9171380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2sXjsF2jtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=1997&pages=3397-3403&issue=11&author=C.+Wongauthor=M.+W.+Heuzenroederauthor=D.+M.+Quinnauthor=R.+Flower&title=Cloning+and+Characterization+of+Two+Immunophilin-Like+Genes%2C+ilpA+and+fkpA%2C+on+a+Single+3.9-kilobase+Fragment+of+Aeromonas+hydrophila+Genomic+DNA&doi=10.1128%2FJB.179.11.3397-3403.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of two immunophilin-like genes, ilpA and fkpA, on a single 3.9-kilobase fragment of Aeromonas hydrophila genomic DNA</span></div><div class="casAuthors">Wong, Christopher Y. F.; Heuzenroeder, Michael W.; Quinn, Diana M.; Flower, Robert L. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3397-3403</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Antiserum to Aeromonas hydrophila A6 cell envelopes was shown in a previous study (C. Y. F. Wong, G. Mayrhofer, M. W. Heuzenroeder, H. M. Atkinson, D. M. Quinn, and R. L. P. Flower, FEMS Immunol. Med. Microbiol. 15:233-241, 1996) to protect mice against lethal infection by this organism.  In this study, colony blot anal. of an A. hydrophila genomic library using antiserum to A. hydrophila A6 cell envelopes revealed a cosmid clone expressing a 30-kDa protein which has not been described previously in aeromonads.  The nucleotide sequence of a 3.9-kb fragment derived from this cosmid which expressed the 30-kDa protein revealed two potential open reading frames (ORFs) with homol. to known immunophilin proteins.  ORF1 encoded a 212-amino-acid protein (mol. mass, 22.4 kDa) with 56% identity to the immunophilin SlyD protein of Escherichia coli.  ORF1 was subsequently designated ilpA (immunophilin-like protein).  ORF3 encoded a potential gene product of 268 amino acids with a typical signal sequence and a predicted mol. size of 28.7 kDa.  The inferred amino acid sequence showed 46% identity with the sequence of the FkpA protein of E. coli and 40% identity with the sequence of the macrophage infectivity potentiator (Mip) protein of Legionella pneumophila.  ORF3 was designated fkpA (FK506 binding protein) by analogy with the E. coli FkpA protein.  Expression of the FkpA protein was confirmed by Western blot (immunoblot) anal., which detected a 30-kDa protein, with antiserum to the Mip protein of Legionella longbeachae and a specific antiserum to an A. hydrophila 30-kDa membrane protein.  PCR and Southern anal. showed that a DNA sequence encoding FkpA was found in all 178 aeromonads of diverse origins tested.  A nonpolar insertion mutation in the fkpA gene did not attenuate virulence in a suckling mouse model nor did it affect the expression of hemolysins or DNase.  This suggests that either the fkpA gene is not essential in the virulence of A. hydrophila under these conditions or there are other genes in A. hydrophila coding for proteins with similar functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonG0mpONHCnbVg90H21EOLACvtfcHk0lil78P5VbGizw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjsF2jtb4%253D&md5=9b33a4d1161436a0c45df913a9c1582b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1128%2FJB.179.11.3397-3403.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.179.11.3397-3403.1997%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DC.%26aulast%3DHeuzenroeder%26aufirst%3DM.%2BW.%26aulast%3DQuinn%26aufirst%3DD.%2BM.%26aulast%3DFlower%26aufirst%3DR.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520Two%2520Immunophilin-Like%2520Genes%252C%2520ilpA%2520and%2520fkpA%252C%2520on%2520a%2520Single%25203.9-kilobase%2520Fragment%2520of%2520Aeromonas%2520hydrophila%2520Genomic%2520DNA%26jtitle%3DJ.%2520Bacteriol.%26date%3D1997%26volume%3D179%26issue%3D11%26spage%3D3397%26epage%3D3403%26doi%3D10.1128%2FJB.179.11.3397-3403.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mineshiba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanimoto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naruishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokeguchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashiba, S.</span></span> <span> </span><span class="NLM_article-title">Highly Expressed Genes in a Rough-Colony-Forming Phenotype of Aggregatibacter actinomycetemcomitans: Implication of a mip-Like Gene for the Invasion of Host Tissue</span>. <i>FEMS Immunol. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1111/j.1574-695X.2009.00624.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1574-695X.2009.00624.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19903198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVCisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=226-236&issue=2&author=T.+Maedaauthor=H.+Maedaauthor=K.+Yamabeauthor=J.+Mineshibaauthor=I.+Tanimotoauthor=T.+Yamamotoauthor=K.+Naruishiauthor=S.+Kokeguchiauthor=S.+Takashiba&title=Highly+Expressed+Genes+in+a+Rough-Colony-Forming+Phenotype+of+Aggregatibacter+actinomycetemcomitans%3A+Implication+of+a+mip-Like+Gene+for+the+Invasion+of+Host+Tissue&doi=10.1111%2Fj.1574-695X.2009.00624.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Highly expressed genes in a rough-colony-forming phenotype of Aggregatibacter actinomycetemcomitans: implication of a mip-like gene for the invasion of host tissue</span></div><div class="casAuthors">Maeda, Takemasa; Maeda, Hiroshi; Yamabe, Kokoro; Mineshiba, Junji; Tanimoto, Ichiro; Yamamoto, Tadashi; Naruishi, Koji; Kokeguchi, Susumu; Takashiba, Shogo</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Immunology and Medical Microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">226-236</span>CODEN:
                <span class="NLM_cas:coden">FIMIEV</span>;
        ISSN:<span class="NLM_cas:issn">0928-8244</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aggregatibacter actinomycetemcomitans, a potent pathogen of periodontitis, typically grows as a rough and adherent colony on primary isolated cultures.  The colony transforms into a smooth phenotype during repeated subculture.  In this study, we aimed to identify highly expressed genes in the rough-colony-forming phenotype for isolation of host-induced genes.  Using a cDNA-subtractive hybridization technique, three genes, homologous to a macrophage infectivity potentiator gene (mip), peroxiredoxin gene (prx) and outer membrane protein gene (ompA), were identified.  The expression levels of these genes in the rough-colony-forming phenotype were 4-10-fold higher as compared with the smooth-colony-forming phenotype.  Attention was focused on the mip-like gene, and a recombinant protein and a deficient mutant were constructed.  The recombinant protein reacted with sera from patients with periodontitis, suggesting the prodn. of the Mip-like protein in periodontal lesions.  Viable quant. invasion assay demonstrated that the viable cell counts of the wild-type strain that invaded HeLa cells were more than fourfold as compared with the mip-deficient mutant.  The expression of the mip-like gene, prx-like gene and ompA-like gene may be enhanced in the host, and the mip-like gene may play an important role in the infection of A. actinomycetemcomitans, esp. in its invasion of the epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryuHzqu5ol1LVg90H21EOLACvtfcHk0lil78P5VbGizw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVCisLs%253D&md5=2a50419da6808b1231d50cb5ad0f87a9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-695X.2009.00624.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-695X.2009.00624.x%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DYamabe%26aufirst%3DK.%26aulast%3DMineshiba%26aufirst%3DJ.%26aulast%3DTanimoto%26aufirst%3DI.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNaruishi%26aufirst%3DK.%26aulast%3DKokeguchi%26aufirst%3DS.%26aulast%3DTakashiba%26aufirst%3DS.%26atitle%3DHighly%2520Expressed%2520Genes%2520in%2520a%2520Rough-Colony-Forming%2520Phenotype%2520of%2520Aggregatibacter%2520actinomycetemcomitans%253A%2520Implication%2520of%2520a%2520mip-Like%2520Gene%2520for%2520the%2520Invasion%2520of%2520Host%2520Tissue%26jtitle%3DFEMS%2520Immunol.%2520Med.%2520Microbiol.%26date%3D2010%26volume%3D58%26issue%3D2%26spage%3D226%26epage%3D236%26doi%3D10.1111%2Fj.1574-695X.2009.00624.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Begley, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abendroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muruthi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safford, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moen, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staker, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorimer, D. D.</span></span> <span> </span><span class="NLM_article-title">A Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial Immunophilins</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1458</span>– <span class="NLM_lpage">1467</span>, <span class="refDoi"> DOI: 10.1128/AAC.01875-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.01875-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=24366729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFyjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1458-1467&issue=3&author=D.+W.+Begleyauthor=D.+Foxauthor=D.+Jennerauthor=C.+Juliauthor=P.+G.+Pierceauthor=J.+Abendrothauthor=M.+Muruthiauthor=K.+Saffordauthor=V.+Andersonauthor=K.+Atkinsauthor=S.+R.+Barnesauthor=S.+O.+Moenauthor=A.+C.+Raymondauthor=R.+Stacyauthor=P.+J.+Mylerauthor=B.+L.+Stakerauthor=N.+J.+Harmerauthor=I.+H.+Norvilleauthor=U.+Holzgrabeauthor=M.+Sarkar-Tysonauthor=T.+E.+Edwardsauthor=D.+D.+Lorimer&title=A+Structural+Biology+Approach+Enables+the+Development+of+Antimicrobials+Targeting+Bacterial+Immunophilins&doi=10.1128%2FAAC.01875-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins</span></div><div class="casAuthors">Begley, Darren W.; Fox, David; Jenner, Dominic; Juli, Christina; Pierce, Phillip G.; Abendroth, Jan; Muruthi, Muigai; Safford, Kris; Anderson, Vanessa; Atkins, Kateri; Barnes, Steve R.; Moen, Spencer O.; Raymond, Amy C.; Stacy, Robin; Myler, Peter J.; Staker, Bart L.; Harmer, Nicholas J.; Norville, Isobel H.; Holzgrabe, Ulrike; Sarkar-Tyson, Mitali; Edwards, Thomas E.; Lorimer, Donald D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1458-1467, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Macrophage infectivity potentiators (Mips) are immunophilin proteins and essential virulence factors for a range of pathogenic organisms.  We applied a structural biol. approach to characterize a Mip from Burkholderia pseudomallei (BpML1), the causative agent of melioidosis.  Crystal structure and NMR analyses of BpML1 in complex with known macrocyclics and other derivs. led to the identification of a key chem. scaffold.  This scaffold possesses inhibitory potency for BpML1 without the immunosuppressive components of related macrocyclic agents.  Biophys. characterization of a compd. series with this scaffold allowed binding site specificity in soln. and potency detns. for rank ordering the set.  The best compds. in this series possessed a low-micromolar affinity for BpML1, bound at the site of enzymic activity, and inhibited a panel of homologous Mip proteins from other pathogenic bacteria, without demonstrating toxicity in human macrophages.  Importantly, the in vitro activity of BpML1 was reduced by these compds., leading to decreased macrophage infectivity and intracellular growth of Burkholderia pseudomallei.  These compds. offer the potential for activity against a new class of antimicrobial targets and present the utility of a structure-based approach for novel antimicrobial drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX6Ocol4-wGrVg90H21EOLACvtfcHk0lil78P5VbGizw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFyjsLs%253D&md5=30b1b8b8dee0a14575d44118f21eb6f5</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1128%2FAAC.01875-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01875-13%26sid%3Dliteratum%253Aachs%26aulast%3DBegley%26aufirst%3DD.%2BW.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DJenner%26aufirst%3DD.%26aulast%3DJuli%26aufirst%3DC.%26aulast%3DPierce%26aufirst%3DP.%2BG.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DMuruthi%26aufirst%3DM.%26aulast%3DSafford%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DV.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DBarnes%26aufirst%3DS.%2BR.%26aulast%3DMoen%26aufirst%3DS.%2BO.%26aulast%3DRaymond%26aufirst%3DA.%2BC.%26aulast%3DStacy%26aufirst%3DR.%26aulast%3DMyler%26aufirst%3DP.%2BJ.%26aulast%3DStaker%26aufirst%3DB.%2BL.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DT.%2BE.%26aulast%3DLorimer%26aufirst%3DD.%2BD.%26atitle%3DA%2520Structural%2520Biology%2520Approach%2520Enables%2520the%2520Development%2520of%2520Antimicrobials%2520Targeting%2520Bacterial%2520Immunophilins%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D3%26spage%3D1458%26epage%3D1467%26doi%3D10.1128%2FAAC.01875-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jäger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweimer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rösch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">Pipecolic Acid Derivatives as Small-Molecule Inhibitors of the Legionella MIP Protein</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1021/jm101156y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101156y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=277-283&issue=1&author=C.+Juliauthor=M.+Sippelauthor=J.+J%C3%A4gerauthor=A.+Thieleauthor=M.+Weiwadauthor=K.+Schweimerauthor=P.+R%C3%B6schauthor=M.+Steinertauthor=C.+A.+Sotrifferauthor=U.+Holzgrabe&title=Pipecolic+Acid+Derivatives+as+Small-Molecule+Inhibitors+of+the+Legionella+MIP+Protein&doi=10.1021%2Fjm101156y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Pipecolic Acid Derivatives As Small-Molecule Inhibitors of the Legionella MIP Protein</span></div><div class="casAuthors">Juli, Christina; Sippel, Martin; Jaeger, Jens; Thiele, Alexandra; Weiwad, Matthias; Schweimer, Kristian; Roesch, Paul; Steinert, Michael; Sotriffer, Christoph A.; Holzgrabe, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">277-283</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The macrophage infectivity potentiator (MIP) protein is a major virulence factor of Legionella pneumophila, the causative agent of Legionnaires' disease. MIP belongs to the FK506-binding proteins (FKBP) and is necessary for optimal intracellular survival and lung tissue dissemination of L. pneumophila.  We aimed to identify new small-mol. inhibitors of MIP by starting from known FKBP12 ligands.  Computational anal., synthesis, and biol. testing of pipecolic acid derivs. revealed a promising scaffold for new MIP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9jZwK850-Q7Vg90H21EOLACvtfcHk0lht0G_kqk6zLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL7N&md5=bfe0d0ae70dc777f63e03e0ab24ee8cc</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm101156y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101156y%26sid%3Dliteratum%253Aachs%26aulast%3DJuli%26aufirst%3DC.%26aulast%3DSippel%26aufirst%3DM.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DJ.%26aulast%3DThiele%26aufirst%3DA.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DSchweimer%26aufirst%3DK.%26aulast%3DR%25C3%25B6sch%26aufirst%3DP.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DPipecolic%2520Acid%2520Derivatives%2520as%2520Small-Molecule%2520Inhibitors%2520of%2520the%2520Legionella%2520MIP%2520Protein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D277%26epage%3D283%26doi%3D10.1021%2Fjm101156y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seufert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bzdyl, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozjak-Pavlovic, V.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Macrophage Infectivity Potentiator-Like PPIases Affect Neisserial and Chlamydial Pathogenicity</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2016.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.ijantimicag.2016.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27516227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1OktbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2016&pages=401-408&issue=4&author=A.+Reimerauthor=F.+Seufertauthor=M.+Weiwadauthor=J.+Ebertauthor=N.+M.+Bzdylauthor=C.+M.+Kahlerauthor=M.+Sarkar-Tysonauthor=U.+Holzgrabeauthor=T.+Rudelauthor=V.+Kozjak-Pavlovic&title=Inhibitors+of+Macrophage+Infectivity+Potentiator-Like+PPIases+Affect+Neisserial+and+Chlamydial+Pathogenicity&doi=10.1016%2Fj.ijantimicag.2016.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity</span></div><div class="casAuthors">Reimer, Anastasija; Seufert, Florian; Weiwad, Matthias; Ebert, Jutta; Bzdyl, Nicole M.; Kahler, Charlene M.; Sarkar-Tyson, Mitali; Holzgrabe, Ulrike; Rudel, Thomas; Kozjak-Pavlovic, Vera</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pathogenic bacteria Chlamydia trachomatis, Neisseria gonorrhoeae and Neisseria meningitidis express the surface-exposed macrophage infectivity potentiator (MIP)-like protein, which plays a role in their pathogenicity.  MIP exhibits a peptidyl-prolyl isomerase (PPIase) activity that is inhibited by rapamycin and FK506.  In this study, pipecolic acid derivs. were tested for their activity against the chlamydial and neisserial MIP.  Two MIP inhibitors were identified, PipN3 and PipN4, that affected the developmental cycle of C. trachomatis in HeLa cells.  Furthermore, the authors could show that deletion of neisserial MIP or addn. of the two MIP inhibitors affected the survival of N. gonorrhoeae in the presence of neutrophils.  Furthermore, both compds. inhibited the adherence, invasion and/or survival of N. meningitidis in epithelial cells.  These results confirm the importance of MIP-like proteins in infection and indicate the relevance of pipecolic acid derivs. as antimicrobials against C. trachomatis, N. gonorrhoeae and N. meningitidis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_3bh-FhY0zrVg90H21EOLACvtfcHk0lht0G_kqk6zLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1OktbbF&md5=7b0ae2a3b9fd3174d0e17dd0d2cb3611</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2016.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2016.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DReimer%26aufirst%3DA.%26aulast%3DSeufert%26aufirst%3DF.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DEbert%26aufirst%3DJ.%26aulast%3DBzdyl%26aufirst%3DN.%2BM.%26aulast%3DKahler%26aufirst%3DC.%2BM.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DRudel%26aufirst%3DT.%26aulast%3DKozjak-Pavlovic%26aufirst%3DV.%26atitle%3DInhibitors%2520of%2520Macrophage%2520Infectivity%2520Potentiator-Like%2520PPIases%2520Affect%2520Neisserial%2520and%2520Chlamydial%2520Pathogenicity%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2016%26volume%3D48%26issue%3D4%26spage%3D401%26epage%3D408%26doi%3D10.1016%2Fj.ijantimicag.2016.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seufert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweimer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruhn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rösch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span> <span> </span><span class="NLM_article-title">Development, Synthesis and Structure–Activity-Relationships of Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Legionella pneumophila and Burkholderia pseudomallei</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5134</span>– <span class="NLM_lpage">5147</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmc.2016.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27591009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5134-5147&issue=21&author=F.+Seufertauthor=M.+Kuhnauthor=M.+Heinauthor=M.+Weiwadauthor=M.+Vivoliauthor=I.+H.+Norvilleauthor=M.+Sarkar-Tysonauthor=L.+E.+Marshallauthor=K.+Schweimerauthor=H.+Bruhnauthor=P.+R%C3%B6schauthor=N.+J.+Harmerauthor=C.+A.+Sotrifferauthor=U.+Holzgrabe&title=Development%2C+Synthesis+and+Structure%E2%80%93Activity-Relationships+of+Inhibitors+of+the+Macrophage+Infectivity+Potentiator+%28Mip%29+Proteins+of+Legionella+pneumophila+and+Burkholderia+pseudomallei&doi=10.1016%2Fj.bmc.2016.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Development, synthesis and structure-activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei</span></div><div class="casAuthors">Seufert, Florian; Kuhn, Maximilian; Hein, Michael; Weiwad, Matthias; Vivoli, Mirella; Norville, Isobel H.; Sarkar-Tyson, Mitali; Marshall, Laura E.; Schweimer, Kristian; Bruhn, Heike; Roesch, Paul; Harmer, Nicholas J.; Sotriffer, Christoph A.; Holzgrabe, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5134-5147</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The bacteria Burkholderia pseudomallei and Legionella pneumophila cause severe diseases like melioidosis and Legionnaire's disease with high mortality rates despite antibiotic treatment.  Due to increasing antibiotic resistances against these and other Gram-neg. bacteria, alternative therapeutical strategies are in urgent demand.  As a virulence factor, the macrophage infectivity potentiator (Mip) protein constitutes an attractive target.  The Mip proteins of B. pseudomallei and L. pneumophila exhibit peptidyl-prolyl cis/trans isomerase (PPIase) activity and belong to the PPIase superfamily.  In previous studies, the pipecolic acid moiety proved to be a valuable scaffold for inhibiting this PPIase activity.  Thus, a library of pipecolic acid derivs. was established guided by structural information and computational analyses of the binding site and possible binding modes.  Stability and toxicity considerations were taken into account in iterative extensions of the library.  Synthesis and evaluation of the compds. in PPIase assays resulted in highly active inhibitors.  The activities can be interpreted in terms of a common binding mode obtained by docking calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqCr2sKUqiHbVg90H21EOLACvtfcHk0ljj8X05jNBzOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrbK&md5=4bbc17527edeab318e8764becc065648</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DSeufert%26aufirst%3DF.%26aulast%3DKuhn%26aufirst%3DM.%26aulast%3DHein%26aufirst%3DM.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DVivoli%26aufirst%3DM.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DL.%2BE.%26aulast%3DSchweimer%26aufirst%3DK.%26aulast%3DBruhn%26aufirst%3DH.%26aulast%3DR%25C3%25B6sch%26aufirst%3DP.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DDevelopment%252C%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity-Relationships%2520of%2520Inhibitors%2520of%2520the%2520Macrophage%2520Infectivity%2520Potentiator%2520%2528Mip%2529%2520Proteins%2520of%2520Legionella%2520pneumophila%2520and%2520Burkholderia%2520pseudomallei%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5134%26epage%3D5147%26doi%3D10.1016%2Fj.bmc.2016.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swindells, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Findlay, J. A.</span></span> <span> </span><span class="NLM_article-title">The X-ray Crystal Structure of Rapamycin, C51H79NO13</span>. <i>Can. J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2491</span>– <span class="NLM_lpage">2492</span>, <span class="refDoi"> DOI: 10.1139/v78-407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1139%2Fv78-407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaE1MXit1ymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1978&pages=2491-2492&issue=18&author=D.+N.+Swindellsauthor=P.+S.+Whiteauthor=J.+A.+Findlay&title=The+X-ray+Crystal+Structure+of+Rapamycin%2C+C51H79NO13&doi=10.1139%2Fv78-407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The x-ray crystal structure of rapamycin, C51H79NO13</span></div><div class="casAuthors">Swindells, D. C. Neil; White, Peter S.; Findlay, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2491-2</span>CODEN:
                <span class="NLM_cas:coden">CJCHAG</span>;
        ISSN:<span class="NLM_cas:issn">0008-4042</span>.
    </div><div class="casAbstract">The x-ray crystallog. of antifungal antibiotic rapamycin (I) indicates that it is a completely new type of macrolide antibiotic of formula C51H79NO13.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUQjEBO0HV_rVg90H21EOLACvtfcHk0ljj8X05jNBzOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXit1ymtA%253D%253D&md5=acd80b2ed2d2b32049b7fa0cbfb9069f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1139%2Fv78-407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv78-407%26sid%3Dliteratum%253Aachs%26aulast%3DSwindells%26aufirst%3DD.%2BN.%26aulast%3DWhite%26aufirst%3DP.%2BS.%26aulast%3DFindlay%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520X-ray%2520Crystal%2520Structure%2520of%2520Rapamycin%252C%2520C51H79NO13%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1978%26volume%3D56%26issue%3D18%26spage%3D2491%26epage%3D2492%26doi%3D10.1139%2Fv78-407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marusawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taga, T.</span></span> <span> </span><span class="NLM_article-title">Structure of FK506, a Novel Immunosuppressant Isolated from Streptomyces</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5033</span>, <span class="refDoi"> DOI: 10.1021/ja00250a050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00250a050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2sXlslGktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5031-5033&issue=16&author=H.+Tanakaauthor=A.+Kurodaauthor=H.+Marusawaauthor=H.+Hatanakaauthor=T.+Kinoauthor=T.+Gotoauthor=M.+Hashimotoauthor=T.+Taga&title=Structure+of+FK506%2C+a+Novel+Immunosuppressant+Isolated+from+Streptomyces&doi=10.1021%2Fja00250a050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of FK506, a novel immunosuppressant isolated from Streptomyces</span></div><div class="casAuthors">Tanaka, Hirokazu; Kuroda, Akio; Marusawa, Hiroshi; Hatanaka, Hiroshi; Kino, Toru; Goto, Toshio; Hashimoto, Masashi; Taga, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5031-3</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The structure I of FK506, a novel macrocyclic lactone isolated from Streptomyces tsukubaensis No. 9993 and which has immunosuppressant activity, was deduced on the basis of chem. and spectroscopic evidence.  The relative configuration was detd. by an x-ray crystal anal. of I and the abs. configuration was established by the fact that hydrolysis of I gave L-pipecolic acid.  The structure is unique in respect of contg. a hemiketal-masked α,β-diketoamide functionality incorporated in a 23-membered ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxGkL2OY6uD7Vg90H21EOLACvtfcHk0lhuJSCQhfPIPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlslGktr8%253D&md5=ca5492f7d8762dffc2e507d0345fa943</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja00250a050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00250a050%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DKuroda%26aufirst%3DA.%26aulast%3DMarusawa%26aufirst%3DH.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DKino%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DStructure%2520of%2520FK506%252C%2520a%2520Novel%2520Immunosuppressant%2520Isolated%2520from%2520Streptomyces%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26issue%3D16%26spage%3D5031%26epage%3D5033%26doi%3D10.1021%2Fja00250a050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondragon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of Calcineurin–Cyclophilin–Cyclosporin Shows Common but Distinct Recognition of Immunophilin–Drug Complexes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">12037</span>– <span class="NLM_lpage">12042</span>, <span class="refDoi"> DOI: 10.1073/pnas.192206699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1073%2Fpnas.192206699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12218175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=12037-12042&issue=19&author=Q.+Huaiauthor=H.-Y.+Kimauthor=Y.+Liuauthor=Y.+Zhaoauthor=A.+Mondragonauthor=J.+O.+Liuauthor=H.+Ke&title=Crystal+Structure+of+Calcineurin%E2%80%93Cyclophilin%E2%80%93Cyclosporin+Shows+Common+but+Distinct+Recognition+of+Immunophilin%E2%80%93Drug+Complexes&doi=10.1073%2Fpnas.192206699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes</span></div><div class="casAuthors">Huai, Qing; Kim, Hwa-Young; Liu, Yudong; Zhao, Yingdong; Mondragon, Angelo; Liu, Jun O.; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">12037-12042</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the common target for two immunophilin-immunosuppressant complexes, cyclophilin A-cyclosporin A (CyPA-CsA) and FKBP-FK506.  How the two structurally distinct immunophilin-drug complexes bind the same target has remained unknown.  We report the crystal structure of calcineurin (CN) in complex with CyPA-CsA at 2.8-Å resoln.  The CyPA-CsA complex binds to a composite surface formed by the catalytic and regulatory subunits of CN, where the complex of FK506 and its binding protein FKBP also binds.  While the majority of the CN residues involved in the binding are common for both immunophilin-immunosuppressant complexes, a significant no. of the residues are distinct.  Unlike FKBP-FK506, CyPA-CsA interacts with Arg-122 at the active site of CN, implying direct involvement of CyPA-CsA in the regulation of CN catalysis.  The simultaneous interaction of CyPA with both the composite surface and the active site of CN suggests that the composite surface may serve as a substrate recognition site responsible for the narrow substrate specificity of CN.  The comparison of CyPA-CsA-CN with FKBP-FK506-CN significantly contributes to understanding the mol. basis of regulation of CN activity by the immunophilin-immunosuppressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSjhnlTGw4urVg90H21EOLACvtfcHk0lhuJSCQhfPIPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlCltbk%253D&md5=9cc518ce524b0e84963cc891a9d1415d</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192206699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192206699%26sid%3Dliteratum%253Aachs%26aulast%3DHuai%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DH.-Y.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMondragon%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DCrystal%2520Structure%2520of%2520Calcineurin%25E2%2580%2593Cyclophilin%25E2%2580%2593Cyclosporin%2520Shows%2520Common%2520but%2520Distinct%2520Recognition%2520of%2520Immunophilin%25E2%2580%2593Drug%2520Complexes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D19%26spage%3D12037%26epage%3D12042%26doi%3D10.1073%2Fpnas.192206699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huai, Q.</span></span> <span> </span><span class="NLM_article-title">Structures of Calcineurin and its Complexes with Immunophilins–Immunosuppressants</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>311</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1095</span>– <span class="NLM_lpage">1102</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)01537-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0006-291X%2803%2901537-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14623295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVeit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2003&pages=1095-1102&issue=4&author=H.+Keauthor=Q.+Huai&title=Structures+of+Calcineurin+and+its+Complexes+with+Immunophilins%E2%80%93Immunosuppressants&doi=10.1016%2FS0006-291X%2803%2901537-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of calcineurin and its complexes with immunophilins-immunosuppressants</span></div><div class="casAuthors">Ke, Hengming; Huai, Qing</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1095-1102</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">A review.  Calcineurin (CN) is a Ca2+/calmodulin-dependent serine/threonine protein phosphatase and is involved in many physiol. processes such as T-cell activation and cardiac hypertrophy.  The crystal structures of CN and its complexes with FKBP12-FK506 and cyclophilin-cyclosporin showed that the two structurally unrelated immunophilins-immunosuppressants bind to a common composite surface made up of the residues from both catalytic subunit and regulatory subunit of CN.  The recognition of the immunophilins and immunosuppressive drugs is achieved by common but few distinct CN residues.  However, the binding pattern of FKBP12-FK506 such as hydrogen bonding is significantly different from that of CyPA-CsA.  This common but distinct recognition may indicate capacity of the compn. surface for binding of other inhibitory proteins.  The recognition site and the active site are adjacent and form an "L" shaped cleft.  This implies that the immunophilin recognition site may also serve as a recognition site to define the narrow substrate specificity of calcineurin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVJZtsbMaambVg90H21EOLACvtfcHk0lhuJSCQhfPIPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVeit74%253D&md5=ff7d8adae67e24833ea631d834930d18</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901537-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901537-7%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DH.%26aulast%3DHuai%26aufirst%3DQ.%26atitle%3DStructures%2520of%2520Calcineurin%2520and%2520its%2520Complexes%2520with%2520Immunophilins%25E2%2580%2593Immunosuppressants%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D311%26issue%3D4%26spage%3D1095%26epage%3D1102%26doi%3D10.1016%2FS0006-291X%2803%2901537-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehajpal, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suthanthiran, M.</span></span> <span> </span><span class="NLM_article-title">Which Way for Drug-Mediated Immunosuppression?</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1016/0952-7915(94)90085-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0952-7915%2894%2990085-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7826535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=784-790&issue=5&author=V.+K.+Sharmaauthor=B.+Liauthor=A.+Khannaauthor=P.+K.+Sehajpalauthor=M.+Suthanthiran&title=Which+Way+for+Drug-Mediated+Immunosuppression%3F&doi=10.1016%2F0952-7915%2894%2990085-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Which way for drug-mediated immunosuppression?</span></div><div class="casAuthors">Sharma, Vijay K.; Li, Baogui; Khanna, Ashwani; Sehajpal, Prabodh K.; Suthanthiran, Manikkam</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">784-90</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">A review with 53 refs.  The basic immunosuppressive protocol involves the use of multiple drugs, each directed at a discrete site in the T-cell activation cascade.  The prevailing paradigm regarding the mechanisms of action of immunosuppressants is that they function to prevent allograft rejection of preventing cell activation, proliferation and/or cytokine prodn.  A new hypothesis is that some of the immunosuppressants might function by stimulating the expression of immunosuppressive mols. and/or cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfUUybKNwQALVg90H21EOLACvtfcHk0ljaqtB1-Z83SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWju74%253D&md5=453b309c0d3a30bbdc79a1ccea582cdd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0952-7915%2894%2990085-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0952-7915%252894%252990085-X%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DV.%2BK.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DSehajpal%26aufirst%3DP.%2BK.%26aulast%3DSuthanthiran%26aufirst%3DM.%26atitle%3DWhich%2520Way%2520for%2520Drug-Mediated%2520Immunosuppression%253F%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1994%26volume%3D6%26issue%3D5%26spage%3D784%26epage%3D790%26doi%3D10.1016%2F0952-7915%2894%2990085-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span> <span> </span><span class="NLM_article-title">FKBP Family Proteins: Immunophilins with Versatile Biological Functions</span>. <i>Neurosignals</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1159/000123041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1159%2F000123041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18635947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegu7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=318-325&issue=4&author=C.+B.+Kangauthor=Y.+Hongauthor=S.+Dhe-Paganonauthor=H.+S.+Yoon&title=FKBP+Family+Proteins%3A+Immunophilins+with+Versatile+Biological+Functions&doi=10.1159%2F000123041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP Family Proteins: Immunophilins with Versatile Biological Functions</span></div><div class="casAuthors">Kang, Cong Bao; Hong, Ye; Dhe-Paganon, Sirano; Yoon, Ho Sup</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Immunophilins consist of a family of highly conserved proteins binding with immunosuppressive drugs such as FK506, rapamycin and cyclosporin A. FK506-binding protein (FKBP) is one of two major immunophilins and most of FKBP family members bind FK506 and show peptidylprolyl cis/trans isomerase (PPIase) activity.  Small size FKBP family members contain only FK506-binding domain, while FKBPs with large mol. wts. possess extra domains such as tetratricopeptide repeat domains, calmodulin binding and transmembrane motifs.  FKBPs are involved in several biochem. processes including protein folding, receptor signaling, protein trafficking and transcription.  FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands.  The roles of immunophilins in protein transportation and apoptosis through their mol. interactions with receptors or proteins have emerged recently.  Moreover, therapeutic implications of immunophilin ligands in treating neurodegenerative disorders have been accumulating.  FK506 and its derivs. with no immunosuppressive activities bind to the conserved active sites of the canonical FKBP members such as FKBP12, which shows PPIase activity.  These immunophilin ligands show variable efficacy in animal models for Parkinson's disease, dementia, and spinal cord injury, where the canonical immunophilins function as chaperones and are assoc. with the protein folding and modulation of oxidative stress.  On the other hand, in the noncanonical FKBP members such as FKBP38, FK506-binding site is not conserved and shows neither PPIase activity nor affinity to FK506.  Interestingly, the small mol.-mediated inhibition of the noncanonical member of FKBP family appears to cause neuronal protection and induce proliferation of neuronal stem cells in a rat focal cerebral ischemia model.  Currently, the mechanisms of actions remain unclear.  This review focuses on mol. characteristics of the canonical and noncanonical FKBP family members and the biol. functions of their ligands in performing neuroprotective and neurotrophic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQb9fhZ9y9bVg90H21EOLACvtfcHk0ljaqtB1-Z83SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegu7jN&md5=817eb2315f334f15b7aad9a9f1124c13</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1159%2F000123041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000123041%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DC.%2BB.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26atitle%3DFKBP%2520Family%2520Proteins%253A%2520Immunophilins%2520with%2520Versatile%2520Biological%2520Functions%26jtitle%3DNeurosignals%26date%3D2008%26volume%3D16%26issue%3D4%26spage%3D318%26epage%3D325%26doi%3D10.1159%2F000123041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wandless, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burakoff, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>250</i></span> (<span class="NLM_issue">4980</span>),  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">559</span>, <span class="refDoi"> DOI: 10.1126/science.1700475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.1700475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1700475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXhslaltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1990&pages=556-559&issue=4980&author=B.+E.+Biererauthor=P.+K.+Somersauthor=T.+J.+Wandlessauthor=S.+J.+Burakoffauthor=S.+L.+Schreiber&title=Probing+Immunosuppressant+Action+with+a+Nonnatural+Immunophilin+Ligand&doi=10.1126%2Fscience.1700475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Probing immunosuppressant action with a nonnatural immunophilin ligand</span></div><div class="casAuthors">Bierer, Barbara E.; Somers, Patricia K.; Wandless, Thomas J.; Burakoff, Steven J.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">4980</span>),
    <span class="NLM_cas:pages">556-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The immunosuppressants FK506 and rapamycin bind to the same immunophilin, FK506 binding protein (FKBP), and inhibit distinct signal transduction pathways in T lymphocytes.  A nonnatural immunophilin ligand, 506BD, which contains only the common structural elements of FK506 and rapamycin, was synthesized and found to be a high-affinity ligand of FKBP and a potent inhibitor of FKBP rotamase activity.  Whereas 506BD does not interfere with T cell activation, it does block the immunosuppressive effects of both FK506 and rapamycin.  Thus, the common immunophilin binding element of these immunosuppressants, which is responsible for rotamase inhibition, is fused to different effector elements, resulting in the inhibition of different signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9rkttxhLXKLVg90H21EOLACvtfcHk0liPiUvFLcn3EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslaltA%253D%253D&md5=f9a1b701c5cd04c06b65bc0e701565be</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1126%2Fscience.1700475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1700475%26sid%3Dliteratum%253Aachs%26aulast%3DBierer%26aufirst%3DB.%2BE.%26aulast%3DSomers%26aufirst%3DP.%2BK.%26aulast%3DWandless%26aufirst%3DT.%2BJ.%26aulast%3DBurakoff%26aufirst%3DS.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DProbing%2520Immunosuppressant%2520Action%2520with%2520a%2520Nonnatural%2520Immunophilin%2520Ligand%26jtitle%3DScience%26date%3D1990%26volume%3D250%26issue%3D4980%26spage%3D556%26epage%3D559%26doi%3D10.1126%2Fscience.1700475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span> <span> </span><span class="NLM_article-title">Chemistry and Biology of the Immunophilins and their Immunosuppressive Ligands</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>251</i></span> (<span class="NLM_issue">4991</span>),  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1126/science.1702904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.1702904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1702904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXhsVWjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1991&pages=283-287&issue=4991&author=S.+L.+Schreiber&title=Chemistry+and+Biology+of+the+Immunophilins+and+their+Immunosuppressive+Ligands&doi=10.1126%2Fscience.1702904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of the immunophilins and their immunosuppressive ligands</span></div><div class="casAuthors">Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">4991</span>),
    <span class="NLM_cas:pages">283-7</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review and discussion with 57 refs.  Cyclosporin A, FK506, and rapamycin are inhibitors of specific signal transduction pathways that lead to T lymphocyte activation.  These immunosuppressive agents bind with high affinity to cytoplasmic receptors termed immunophilins (immunosuppressant binding proteins).  Studies in this area have focused on the structural basis for the mol. recognition of immunosuppressants by immunophilins and the biol. consequences of their interactions.  Defining the biol. roles of this emerging family of receptors and their ligands may illuminate the process of protein trafficking in cells and the mechanisms of signal transmission through the cytoplasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMdTsEre1d3rVg90H21EOLACvtfcHk0liPiUvFLcn3EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsVWjs7w%253D&md5=b69959b27d3f361863dcb6c2f0de9289</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1126%2Fscience.1702904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1702904%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DChemistry%2520and%2520Biology%2520of%2520the%2520Immunophilins%2520and%2520their%2520Immunosuppressive%2520Ligands%26jtitle%3DScience%26date%3D1991%26volume%3D251%26issue%3D4991%26spage%3D283%26epage%3D287%26doi%3D10.1126%2Fscience.1702904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>273</i></span> (<span class="NLM_issue">5272</span>),  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1126/science.273.5272.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1126%2Fscience.273.5272.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8662507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1Crs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=239-242&issue=5272&author=J.+Choiauthor=J.+Chenauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Structure+of+the+FKBP12-Rapamycin+Complex+Interacting+with+Binding+Domain+of+Human+FRAP&doi=10.1126%2Fscience.273.5272.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP</span></div><div class="casAuthors">Choi, Jungwon; Chen, Jie; Schreiber, Stuart L.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">5272</span>),
    <span class="NLM_cas:pages">239-242</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Rapamycin, a potent immunosuppressive agent, binds two proteins: the FK506-binding protein (FKBP12) and the FKBP-rapamycin-assocd. protein (FRAP).  A crystal structure of the ternary complex of human FKBP12, rapamycin, and the FKBP12-rapamycin-binding (FRB) domain of human FRAP at a resoln. of 2.7 angstroms revealed the two proteins bound together as a result of the ability of rapamycin to occupy two different hydrophobic binding pockets simultaneously.  The structure shows extensive interactions between rapamycin and both proteins, but fewer interactions between the proteins.  The structure of the FRB domain of FRAP clarifies both rapamycin-independent and -dependent effects obsd. for mutants of FRAP and its homologs in the family of proteins related to the ataxia-telangiectasis mutant gene product, and it illustrates how a small cell-permeable mol. can mediate protein dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwBLM2PsItYLVg90H21EOLACvtfcHk0liPiUvFLcn3EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1Crs7k%253D&md5=c72a82e14c09d9a705215b4ac0525336</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1126%2Fscience.273.5272.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.273.5272.239%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520FKBP12-Rapamycin%2520Complex%2520Interacting%2520with%2520Binding%2520Domain%2520of%2520Human%2520FRAP%26jtitle%3DScience%26date%3D1996%26volume%3D273%26issue%3D5272%26spage%3D239%26epage%3D242%26doi%3D10.1126%2Fscience.273.5272.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standaert, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karplus, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Atomic Structures of the Human Immunophilin FKBP-12 Complexes with FK506 and Rapamycin</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>229</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1993.1012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1006%2Fjmbi.1993.1012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7678431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1993&pages=105-124&issue=1&author=G.+D.+Van%0ADuyneauthor=R.+F.+Standaertauthor=P.+A.+Karplusauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Atomic+Structures+of+the+Human+Immunophilin+FKBP-12+Complexes+with+FK506+and+Rapamycin&doi=10.1006%2Fjmbi.1993.1012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin</span></div><div class="casAuthors">Van Duyne, Gregory D.; Standaert, Robert F.; Karplus, P. Andrew; Schreiber, Stuart L.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-24</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">High resoln. structures for the complexes formed by the immunosuppressive agents FK506 and rapamycin with the human immunophilin FKBP-12 have been detd. by X-ray diffraction.  FKBP-12 has a novel fold comprised of a five-stranded β-sheet wrapping around a short α-helix with an overall conical shape.  Both FK506 and rapamycin bind in the cavity defined by the β-sheet, α-helix and three loops.  Both FK506 and rapamycin bind in similar fashion with a set of hydrogen bonds and an unusual carbonyl binding pocket.  Bound FK506 has a different conformation than free (cryst.) FK506 while rapamycin's bound conformation is virtually identical to that of unbound rapamycin.  FKBP-12 is a peptidyl-prolyl isomerase (PPIase), and the structures of the complexes suggest ways in which this catalytic activity could operate.  The different complexes are active in suppressing different steps of T cell activation, an activity seemingly unconnected with the PPIase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo3bBH2sCbrVg90H21EOLACvtfcHk0likmpE7GHlt4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKnsr4%253D&md5=6500d557923abae9cf3ca4d103cc145e</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1993.1012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1993.1012%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DStandaert%26aufirst%3DR.%2BF.%26aulast%3DKarplus%26aufirst%3DP.%2BA.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DAtomic%2520Structures%2520of%2520the%2520Human%2520Immunophilin%2520FKBP-12%2520Complexes%2520with%2520FK506%2520and%2520Rapamycin%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D229%26issue%3D1%26spage%3D105%26epage%3D124%26doi%3D10.1006%2Fjmbi.1993.1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mech, C.</span></span> <span> </span><span class="NLM_article-title">Determination of Enzymatic Catalysis for the Cis-Trans-Isomerization of Peptide Binding in Proline-Containing Peptides</span>. <i>Biomed. Biochim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1101</span>– <span class="NLM_lpage">1111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=6395866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL2MXhtVymtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1984&pages=1101-1111&author=G.+Fischerauthor=H.+Bangauthor=C.+Mech&title=Determination+of+Enzymatic+Catalysis+for+the+Cis-Trans-Isomerization+of+Peptide+Binding+in+Proline-Containing+Peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of enzyme catalysis for cis-trans-isomerization of peptide bonds using proline-containing peptides</span></div><div class="casAuthors">Fischer, G.; Bang, H.; Mech, C.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedica Biochimica Acta</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1101-11</span>CODEN:
                <span class="NLM_cas:coden">BBIADT</span>;
        ISSN:<span class="NLM_cas:issn">0232-766X</span>.
    </div><div class="casAbstract">The rates of cis to trans interconversion of Glt-(Ala)n-Pro-Phe-4-nitroanilines (n = 1-3, Glt = glutaryl) were estd. by a 2-step process with chymotrypsin as the trans-substrate cleaving activity.  Pig kidney and several other tissues contained demonstrable catalytic activity for the cis to trans interconversion of proline-contg. peptides.  The active protein fraction was purified 38-fold from pig kidney cortex by (NH4)2SO4 pptn. and a series of column chromatog. techniques.  Activity was detected against the cis to trans interconversion of Glt-Ala-Pro-Phe-4-nitroanilide, Glt-Ala-Ala-Pro-Phe-4-nitroanilide, and Glt-Ala-Ala-Ala-Pro-Phe-4-nitroanilide to different extents.  No activity was found with Phe-Pro-4-nitroanilide.  With respect to the substrate specificity, this enzyme must be classified as a peptidyl-prolyl cis-trans-isomerase.  The enzyme was strongly inactivated by p-chloromercuribenzoate, SDS, Hg2+, and Cu2+ ions, but was not inhibited by metal chelators, diisopropylphosphorofluoridate, and chlorotosylamidophenylbutane.  The activity is abolished by incubation with trypsin.  The enzyme is heat sensitive at 50°.  A new type of enzyme which catalyze conformational interconversions is thus proposed.  The possible location of the enzyme on ribosomal particles is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3rEtrJSA3JLVg90H21EOLACvtfcHk0likmpE7GHlt4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhtVymtLw%253D&md5=b90e923a65cf08661587cd4572afdeeb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DBang%26aufirst%3DH.%26aulast%3DMech%26aufirst%3DC.%26atitle%3DDetermination%2520of%2520Enzymatic%2520Catalysis%2520for%2520the%2520Cis-Trans-Isomerization%2520of%2520Peptide%2520Binding%2520in%2520Proline-Containing%2520Peptides%26jtitle%3DBiomed.%2520Biochim.%2520Acta%26date%3D1984%26volume%3D43%26spage%3D1101%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span> <span> </span><span class="NLM_article-title">A Miniaturized Peptidyl-Prolyl Isomerase Enzyme Assay</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>536</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.ab.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28803887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2nsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=536&publication_year=2017&pages=59-68&author=M.+Vivoliauthor=J.+Renouauthor=A.+Chevalierauthor=I.+H.+Norvilleauthor=S.+Diazauthor=C.+Juliauthor=H.+Atkinsauthor=U.+Holzgrabeauthor=P.-Y.+Renardauthor=M.+Sarkar-Tysonauthor=N.+J.+Harmer&title=A+Miniaturized+Peptidyl-Prolyl+Isomerase+Enzyme+Assay&doi=10.1016%2Fj.ab.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">A miniaturized peptidyl-prolyl isomerase enzyme assay</span></div><div class="casAuthors">Vivoli, Mirella; Renou, Julien; Chevalier, Arnaud; Norville, Isobel H.; Diaz, Suraya; Juli, Christina; Atkins, Helen; Holzgrabe, Ulrike; Renard, Pierre-Yves; Sarkar-Tyson, Mitali; Harmer, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">536</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-68</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prolyl-peptidyl isomerases (PPIases) are enzymes that are found in all living organisms.  They form an essential part of the cellular protein folding homeostasis machinery.  PPIases are assocd. with many important human diseases, e.g. cardiovascular disease, cancer and Alzheimer's.  The development of novel PPIase inhibitors has been limited by the lack of a rapid, lab.-based assay for these enzymes, as their substrates and products are challenging to distinguish.  A well described continuous assay, coupled with the hydrolysis of a peptide by chymotrypsin is highly effective, but comparatively slow.  To address this, we developed an improved version of the traditional assay using a temp. controlled plate reader.  This assay allows semi-automated medium throughput assays in an academic lab. for 84 samples per day.  The assay shows lower errors, with an av. Z' of 0.72.  We further developed the assay using a fluorogenic peptide-based FRET probe.  This provides an extremely sensitive PPIase assay using substrate at 200 nM, which approaches single turnover conditions.  The fluorescent probe achieves an excellent quenching efficiency of 98.6%, and initial expts. showed acceptable Z' of 0.31 and 0.30 for cyclophilin A and hFKBP12 resp.  The assays provide an improved toolset for the quant., biochem. anal. of PPIases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1P0AZy-FPdLVg90H21EOLACvtfcHk0likmpE7GHlt4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2nsr%252FE&md5=c91498089b309e1ca1f0941752ec1324</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DVivoli%26aufirst%3DM.%26aulast%3DRenou%26aufirst%3DJ.%26aulast%3DChevalier%26aufirst%3DA.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DDiaz%26aufirst%3DS.%26aulast%3DJuli%26aufirst%3DC.%26aulast%3DAtkins%26aufirst%3DH.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DRenard%26aufirst%3DP.-Y.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26atitle%3DA%2520Miniaturized%2520Peptidyl-Prolyl%2520Isomerase%2520Enzyme%2520Assay%26jtitle%3DAnal.%2520Biochem.%26date%3D2017%26volume%3D536%26spage%3D59%26epage%3D68%26doi%3D10.1016%2Fj.ab.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luengo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konialian, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozamus, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggleston, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Kinetic Evlauation of High-Affinity FKBP Ligands and the X-Ray Crystal Structures of Their Complexes with FKBP12</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9925</span>– <span class="NLM_lpage">9938</span>, <span class="refDoi"> DOI: 10.1021/ja00075a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00075a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXhtlCju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=9925-9938&author=D.+A.+Holtauthor=J.+I.+Luengoauthor=D.+S.+Yamashitaauthor=H.+J.+Ohauthor=A.+L.+Konialianauthor=H.+K.+Yenauthor=L.+W.+Rozamusauthor=M.+Brandtauthor=M.+J.+Bossardauthor=M.+A.+Levyauthor=D.+S.+Egglestonauthor=J.+Liangauthor=W.+Schultzauthor=T.+J.+Stoutauthor=J.+Clardy&title=Design%2C+Synthesis+and+Kinetic+Evlauation+of+High-Affinity+FKBP+Ligands+and+the+X-Ray+Crystal+Structures+of+Their+Complexes+with+FKBP12&doi=10.1021%2Fja00075a008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12</span></div><div class="casAuthors">Holt, Dennis A.; Luengo, Juan I.; Yamashita, Dennis S.; Oh, Hye Ja; Konialian, Arda L.; Yen, Hwa Kwo; Rozamus, Leonard W.; Brandt, Martin; Bossard, Mary J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9925-38</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The high-affinity FKBP12 ligands I [R = Et, R1 = 1-hydroxycyclohexyl, cyclohexyl, CMe2Et; R = 3-cyclohexylpropyl, (CH2)3Ph, (CH2)3C6H2(OMe)3-3,4,5, (R)-CH(CMe2CH:CH2)CH2CH2Ph, (R)- and (S)-CHPhCH2CH2Ph, (R)- and (S)-1-cyclohexyl-3-phenyl-1-propyl] and II [X = (CH2)3, (CH2)5, (R)- and (S)-CH(CH2CH2Ph)C6H4O-m] were prepd.  These compds. potently inhibit the cis-trans-peptidylprolyl isomerase (rotamase) activity catalyzed by FKBP12 with inhibition consts. (Ki,app) as low as 1 nM, yet they possess remarkable structural simplicity relative to FK506 and rapamycin, from which they are conceptually derived.  The at. structures of three FKBP12-ligand complexes and of one unbound ligand were detd. by X-ray crystallog. and are compared to the FKBP12-FK506 and FKBP12-rapamycin complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMo4l1GweibVg90H21EOLACvtfcHk0ljVZsq70vUxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtlCju7c%253D&md5=5dfa7a210f55bbaddeadc14a90ab28ab</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fja00075a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00075a008%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DOh%26aufirst%3DH.%2BJ.%26aulast%3DKonialian%26aufirst%3DA.%2BL.%26aulast%3DYen%26aufirst%3DH.%2BK.%26aulast%3DRozamus%26aufirst%3DL.%2BW.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DLevy%26aufirst%3DM.%2BA.%26aulast%3DEggleston%26aufirst%3DD.%2BS.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DSchultz%26aufirst%3DW.%26aulast%3DStout%26aufirst%3DT.%2BJ.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Kinetic%2520Evlauation%2520of%2520High-Affinity%2520FKBP%2520Ligands%2520and%2520the%2520X-Ray%2520Crystal%2520Structures%2520of%2520Their%2520Complexes%2520with%2520FKBP12%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D9925%26epage%3D9938%26doi%3D10.1021%2Fja00075a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Microbial Peptidyl-Prolyl Cis/Trans Isomerases (PPIases): Virulence Factors and Potential Alternative Drug Targets</span>. <i>Microbiol. Mol. Biol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">544</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1128/MMBR.00015-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FMMBR.00015-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=25184565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWqsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2014&pages=544-571&issue=3&author=C.+M.+%C3%9Cnalauthor=M.+Steinert&title=Microbial+Peptidyl-Prolyl+Cis%2FTrans+Isomerases+%28PPIases%29%3A+Virulence+Factors+and+Potential+Alternative+Drug+Targets&doi=10.1128%2FMMBR.00015-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets</span></div><div class="casAuthors">Uenal, Can M.; Steinert, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology and Molecular Biology Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">544-571, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">MMBRF7</span>;
        ISSN:<span class="NLM_cas:issn">1098-5557</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Initially discovered in the context of immunomodulation, peptidyl-prolyl cis/trans isomerases (PPIases) were soon identified as enzymes catalyzing the rate-limiting protein folding step at peptidyl bonds preceding proline residues.  Intense searches revealed that PPIases are a superfamily of proteins consisting of three structurally distinguishable families with representatives in every described species of prokaryote and eukaryote and, recently, even in some giant viruses.  Despite the clear-cut enzymic activity and ubiquitous distribution of PPIases, reports on solely PPIase-dependent biol. roles remain scarce.  Nevertheless, they have been found to be involved in a plethora of biol. processes, such as gene expression, signal transduction, protein secretion, development, and tissue regeneration, underscoring their general importance.  Hence, it is not surprising that PPIases have also been identified as virulence-assocd. proteins.  The extent of contribution to virulence is highly variable and dependent on the pleiotropic roles of a single PPIase in the resp. pathogen.  The main objective of this review is to discuss this variety in virulence-related bacterial and protozoan PPIases as well as the involvement of host PPIases in infectious processes.  Moreover, a special focus is given to Legionella pneumophila macrophage infectivity potentiator (Mip) and Mip-like PPIases of other pathogens, as the bestcharacterized virulence-related representatives of this family.  Finally, the potential of PPIases as alternative drug targets and first tangible results are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4SmfajVI9PrVg90H21EOLACvtfcHk0ljVZsq70vUxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWqsbrI&md5=220c39860c9411024ccac4ef5df1a3b0</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1128%2FMMBR.00015-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMMBR.00015-14%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%2BM.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DMicrobial%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%2520%2528PPIases%2529%253A%2520Virulence%2520Factors%2520and%2520Potential%2520Alternative%2520Drug%2520Targets%26jtitle%3DMicrobiol.%2520Mol.%2520Biol.%2520Rev.%26date%3D2014%26volume%3D78%26issue%3D3%26spage%3D544%26epage%3D571%26doi%3D10.1128%2FMMBR.00015-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babine, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleckman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moomaw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and X-Ray Crystallographic Studies of Novel FKBP-12 Ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1016/0960-894X(95)00290-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0960-894X%2895%2900290-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFGksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=1719-1724&issue=15&author=R.+E.+Babineauthor=T.+Bleckmanauthor=C.+Kissingerauthor=R.+Showalterauthor=L.+Pelletierauthor=C.+Lewisauthor=K.+Tuckerauthor=E.+Moomawauthor=H.+Pargeauthor=J.+E.+Villafranca&title=Design%2C+Synthesis+and+X-Ray+Crystallographic+Studies+of+Novel+FKBP-12+Ligands&doi=10.1016%2F0960-894X%2895%2900290-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and x-ray crystallographic studies of novel FKBP-12 ligands</span></div><div class="casAuthors">Babine, Robert E.; Bleckman, T. M.; Kissinger, C. R.; Showalter, R.; Pelletier, L. A.; Lewis, C.; Tucker, Kathleen; Moomaw, Ellen; Parge, H. E.; Villafranca, J. Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1719-24</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">By using the crystal structure of FKBP-12, a novel class of ligands I (X = O, NMe, S, SO2; R = Ph, substituted Ph, CH2Ph, 2-imidazolyl, 4-pyridyl) was designed, prepd., and evaluated.  The crystal structure of the complex between I (X = S; R = 4-pyridyl) and FKBP-12 is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtzuQsLHM0ErVg90H21EOLACvtfcHk0ljVZsq70vUxQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFGksbg%253D&md5=a27165989214e2b7a1fc028ccb7d1aba</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900290-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900290-A%26sid%3Dliteratum%253Aachs%26aulast%3DBabine%26aufirst%3DR.%2BE.%26aulast%3DBleckman%26aufirst%3DT.%26aulast%3DKissinger%26aufirst%3DC.%26aulast%3DShowalter%26aufirst%3DR.%26aulast%3DPelletier%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DTucker%26aufirst%3DK.%26aulast%3DMoomaw%26aufirst%3DE.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520X-Ray%2520Crystallographic%2520Studies%2520of%2520Novel%2520FKBP-12%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26issue%3D15%26spage%3D1719%26epage%3D1724%26doi%3D10.1016%2F0960-894X%2895%2900290-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theuerkorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinsohn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiwad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila</span>. <i>Front. Bioeng. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">41</span>, <span class="refDoi"> DOI: 10.3389/fbioe.2015.00041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffbioe.2015.00041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=25870856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC2MjktVSjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=41&author=J.+Raschauthor=M.+Theuerkornauthor=C.+%C3%9Cnalauthor=N.+Heinsohnauthor=S.+Tranauthor=G.+Fischerauthor=M.+Weiwadauthor=M.+Steinert&title=Novel+Cycloheximide+Derivatives+Targeting+the+Moonlighting+Protein+Mip+Exhibit+Specific+Antimicrobial+Activity+Against+Legionella+pneumophila&doi=10.3389%2Ffbioe.2015.00041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cycloheximide Derivatives Targeting the Moonlighting Protein Mip Exhibit Specific Antimicrobial Activity Against Legionella pneumophila</span></div><div class="casAuthors">Rasch Janine; Heinsohn Natascha; Tran Stefan; Theuerkorn Martin; Unal Can; Fischer Gunter; Weiwad Matthias; Steinert Michael</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in bioengineering and biotechnology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41</span>
        ISSN:<span class="NLM_cas:issn">2296-4185</span>.
    </div><div class="casAbstract">Macrophage infectivity potentiator (Mip) and Mip-like proteins are virulence factors in a wide range of pathogens including Legionella pneumophila.  These proteins belong to the FK506 binding protein (FKBP) family of peptidyl-prolyl-cis/trans-isomerases (PPIases).  In L. pneumophila, the PPIase activity of Mip is required for invasion of macrophages, transmigration through an in vitro lung-epithelial barrier, and full virulence in the guinea pig infection model.  Additionally, Mip is a moonlighting protein that binds to collagen IV in the extracellular matrix.  Here, we describe the development and synthesis of cycloheximide derivatives with adamantyl moieties as novel FKBP ligands, and analyze their effect on the viability of L. pneumophila and other bacteria.  All compounds efficiently inhibited PPIase activity of the prototypic human FKBP12 as well as Mip with IC50-values as low as 180 nM and 1.7 μM, respectively.  Five of these derivatives inhibited the growth of L. pneumophila at concentrations of 30-40 μM, but exhibited no effect on other tested bacterial species indicating a specific spectrum of antibacterial activity.  The derivatives carrying a 3,5-dimethyladamantan-1-[yl]acetamide substitution (MT_30.32), and a 3-ethyladamantan-1-[yl]acetamide substitution (MT_30.51) had the strongest effects in PPIase- and liquid growth assays.  MT_30.32 and MT_30.51 were also inhibitory in macrophage infection studies without being cytotoxic.  Accordingly, by applying a combinatorial approach, we were able to generate novel, hybrid inhibitors consisting of cycloheximide and adamantane, two known FKBP inhibitors that interact with different parts of the PPIase domain, respectively.  Interestingly, despite the proven Mip-inhibitory activity, the viability of a Mip-deficient strain was affected to the same degree as its wild type.  Hence, we also propose that cycloheximide derivatives with adamantyl moieties are potent PPIase inhibitors with multiple targets in L. pneumophila.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaqxR1PPJECacY7HFp97qMfW6udTcc2ebyEhg2mvxidrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjktVSjsw%253D%253D&md5=37534335b0428a948ec06e9fd8626c59</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3389%2Ffbioe.2015.00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffbioe.2015.00041%26sid%3Dliteratum%253Aachs%26aulast%3DRasch%26aufirst%3DJ.%26aulast%3DTheuerkorn%26aufirst%3DM.%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%26aulast%3DHeinsohn%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DWeiwad%26aufirst%3DM.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DNovel%2520Cycloheximide%2520Derivatives%2520Targeting%2520the%2520Moonlighting%2520Protein%2520Mip%2520Exhibit%2520Specific%2520Antimicrobial%2520Activity%2520Against%2520Legionella%2520pneumophila%26jtitle%3DFront.%2520Bioeng.%2520Biotechnol.%26date%3D2015%26volume%3D3%26spage%3D41%26doi%3D10.3389%2Ffbioe.2015.00041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyrwa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Küllertz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiericke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Cytotoxic Evaluation of Cycloheximide Derivatives as Potential Inhibitors of FKBP12 with Neuroregenerative Properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3615</span>– <span class="NLM_lpage">3622</span>, <span class="refDoi"> DOI: 10.1021/jm991038t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991038t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK1MXltV2lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3615-3622&issue=18&author=C.+Christnerauthor=R.+Wyrwaauthor=S.+Marschauthor=G.+K%C3%BCllertzauthor=R.+Thierickeauthor=S.+Grableyauthor=D.+Schumannauthor=G.+Fischer&title=Synthesis+and+Cytotoxic+Evaluation+of+Cycloheximide+Derivatives+as+Potential+Inhibitors+of+FKBP12+with+Neuroregenerative+Properties&doi=10.1021%2Fjm991038t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Cytotoxic Evaluation of Cycloheximide Derivatives as Potential Inhibitors of FKBP12 with Neuroregenerative Properties</span></div><div class="casAuthors">Christner, Claudia; Wyrwa, Ralf; Marsch, Silvia; Kuellertz, Gerhard; Thiericke, Ralf; Grabley, Susanne; Schumann, Dieter; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3615-3622</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the new finding that the protein synthesis inhibitor cycloheximide I (R = H) is able to competitively inhibit hFKBP12 (Ki = 3.4 μM) and homologous enzymes, a series of derivs. has been synthesized.  The effect of the compds. on the activity of hFKBP12 and their cytotoxicity against eukaryotic cell lines (mouse L-929 fibroblasts, K-562 leukemic cells) were detd.  As a result, several less toxic or nontoxic cycloheximide derivs. were identified by N-substitution of the glutarimide moiety and exhibit IC50 values in the range of 22.0-4.4 μM for inhibition of hFKBP12.  Among these compds. cycloheximide ethanoate I [R = EtOCOCH2 (II), Ki = 4.1 μM], which exerted FKBP12 inhibition to an extent comparable to that of cycloheximide I, was found to cause an approx. 1000-fold weaker inhibitory effect on eukaryotic protein synthesis (IC50 = 115 μM).  II was able to significantly speed nerve regeneration in a rat sciatic nerve neurotomy model at dosages of 30 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zPyFcJwQ9LVg90H21EOLACvtfcHk0lgnGeIVlb4eDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltV2lsLs%253D&md5=08eebb8f803cee09a895f1ae0a333d43</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm991038t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991038t%26sid%3Dliteratum%253Aachs%26aulast%3DChristner%26aufirst%3DC.%26aulast%3DWyrwa%26aufirst%3DR.%26aulast%3DMarsch%26aufirst%3DS.%26aulast%3DK%25C3%25BCllertz%26aufirst%3DG.%26aulast%3DThiericke%26aufirst%3DR.%26aulast%3DGrabley%26aufirst%3DS.%26aulast%3DSchumann%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520Cytotoxic%2520Evaluation%2520of%2520Cycloheximide%2520Derivatives%2520as%2520Potential%2520Inhibitors%2520of%2520FKBP12%2520with%2520Neuroregenerative%2520Properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D18%26spage%3D3615%26epage%3D3622%26doi%3D10.1021%2Fjm991038t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Titball, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span> <span> </span><span class="NLM_article-title">The Structure of a Burkholderia pseudomallei Immunophilin–Inhibitor Complex Reveals New Approaches to Antimicrobial Development</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>437</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1042/BJ20110345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1042%2FBJ20110345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21574961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVektro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2011&pages=413-422&issue=3&author=I.+H.+Norvilleauthor=K.+O%E2%80%99Sheaauthor=M.+Sarkar-Tysonauthor=S.+Zhengauthor=R.+W.+Titballauthor=G.+Varaniauthor=N.+J.+Harmer&title=The+Structure+of+a+Burkholderia+pseudomallei+Immunophilin%E2%80%93Inhibitor+Complex+Reveals+New+Approaches+to+Antimicrobial+Development&doi=10.1042%2FBJ20110345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development</span></div><div class="casAuthors">Norville, Isobel H.; O'Shea, Katherine; Sarkar-Tyson, Mitali; Zheng, Su-Xin; Titball, Richard W.; Varani, Gabriele; Harmer, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-422</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Mips (macrophage infectivity potentiators) are a subset of immunophilins assocd. with virulence in a range of micro-organisms.  These proteins possess peptidylprolyl isomerase activity and are inhibited by drugs including rapamycin and tacrolimus.  We detd. the structure of the Mip homolog [BpML1 (Burkholderia pseudomallei Mip-like protein 1)] from the human pathogen and biowarfare threat B. pseudomallei by NMR and x-ray crystallog.  The crystal structure suggests that key catalytic residues in the BpML1 active site have unexpected conformational flexibility consistent with a role in catalysis.  The structure further revealed BpML1 binding to a helical peptide, in a manner resembling the physiol. interaction of human TGFβRI (transforming growth factor β receptor I) with the human immunophilin FKBP12 (FK506-binding protein 12).  Furthermore, the structure of BpML1 bound to the class inhibitor cycloheximide N-ethylethanoate showed that this inhibitor mimics such a helical peptide, in contrast with the extended prolyl-peptide mimicking shown by inhibitors such as tacrolimus.  We suggest that Mips, and potentially other bacterial immunophilins, participate in protein-protein interactions in addn. to their peptidylprolyl isomerase activity, and that some roles of Mip proteins in virulence are independent of their peptidylprolyl isomerase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkl3Cu0LAflbVg90H21EOLACvtfcHk0lgnGeIVlb4eDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVektro%253D&md5=54f78e3c153d3fa7126e4256ae3b4127</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1042%2FBJ20110345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110345%26sid%3Dliteratum%253Aachs%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DTitball%26aufirst%3DR.%2BW.%26aulast%3DVarani%26aufirst%3DG.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520Structure%2520of%2520a%2520Burkholderia%2520pseudomallei%2520Immunophilin%25E2%2580%2593Inhibitor%2520Complex%2520Reveals%2520New%2520Approaches%2520to%2520Antimicrobial%2520Development%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D437%26issue%3D3%26spage%3D413%26epage%3D422%26doi%3D10.1042%2FBJ20110345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konialian-Beck, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozamus, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krog, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erhard, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossard, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luengo, J. I.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Studies of Synthetic FKBP Ligands as Peptidyl-Prolyl Isomerase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)80135-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0960-894X%2801%2980135-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXktVShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=315-320&issue=2&author=D.+A.+Holtauthor=A.+L.+Konialian-Beckauthor=H.-J.+Ohauthor=H.-K.+Yenauthor=L.+W.+Rozamusauthor=A.+J.+Krogauthor=K.+F.+Erhardauthor=E.+Ortizauthor=M.+A.+Levyauthor=M.+Brandtauthor=M.+J.+Bossardauthor=J.+I.+Luengo&title=Structure-Activity+Studies+of+Synthetic+FKBP+Ligands+as+Peptidyl-Prolyl+Isomerase+Inhibitors&doi=10.1016%2FS0960-894X%2801%2980135-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies of synthetic FKBP ligands as peptidyl-prolyl isomerase inhibitors</span></div><div class="casAuthors">Holt, Dennis A.; Konialian-Beck, Arda L.; Oh, Hye-Ja; Yen, Hwa-Kwo; Rozamus, Leonard W.; Krog, Arnold J.; Erhard, Karl F.; Ortiz, Elizabeth; Levy, Mark A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">315-20</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    </div><div class="casAbstract">A series of non-macrocyclic pipecolyl α-ketoamides were prepd. and evaluated as FKBP cis-trans peptidyl-prolyl isomerase inhibitors.  These compds. exhibited inhibition consts. as low as 2 nM.  Their design was based on a consideration of the common FKBP-binding elements of FK506 and rapamycin.  Structure-activity relationships are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_06XFe8kOFLVg90H21EOLACvtfcHk0li3h6j_9TmWMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktVShsLo%253D&md5=0219535a44a4ce656b1a974fcf355dfd</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2980135-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252980135-9%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DD.%2BA.%26aulast%3DKonialian-Beck%26aufirst%3DA.%2BL.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DYen%26aufirst%3DH.-K.%26aulast%3DRozamus%26aufirst%3DL.%2BW.%26aulast%3DKrog%26aufirst%3DA.%2BJ.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DOrtiz%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DM.%2BA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DBossard%26aufirst%3DM.%2BJ.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26atitle%3DStructure-Activity%2520Studies%2520of%2520Synthetic%2520FKBP%2520Ligands%2520as%2520Peptidyl-Prolyl%2520Isomerase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26issue%3D2%26spage%3D315%26epage%3D320%26doi%3D10.1016%2FS0960-894X%2801%2980135-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wintermeyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span> <span> </span><span class="NLM_article-title">Influence of Site Specifically Altered Mip Proteins on Intracellular Survival of Legionella pneumophila in Eukaryotic Cells</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4576</span>– <span class="NLM_lpage">4583</span>, <span class="refDoi"> DOI: 10.1128/IAI.63.12.4576-4583.1995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.63.12.4576-4583.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7591108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXpslClsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1995&pages=4576-4583&issue=12&author=E.+Wintermeyerauthor=B.+Ludwigauthor=M.+Steinertauthor=B.+Schmidtauthor=G.+Fischerauthor=J.+Hacker&title=Influence+of+Site+Specifically+Altered+Mip+Proteins+on+Intracellular+Survival+of+Legionella+pneumophila+in+Eukaryotic+Cells&doi=10.1128%2FIAI.63.12.4576-4583.1995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells</span></div><div class="casAuthors">Wintermeyer, Eva; Ludwig, Birgit; Steinert, Michael; Schmidt, Bettina; Fischer, Gunter; Hacker, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4576-83</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">L. pneumophila, the causative agent of Legionnaires' disease, is able to survive intracellularly in eukaryotic cells such as monocytes, macrophages, and protozoan organisms.  The Mip (macrophage infectivity potentiator) protein represents a factor of L. pneumophila necessary for optimal intracellular survival.  Interestingly, Mip belongs to the substance class of FK 506-binding proteins and exhibits peptidyl-prolyl cis/trans isomerase (PPIase) activity that can be inhibited by the immunosuppressant FK 506.  In order to identify amino acids most likely to be involved in the enzymic activity of Mip, site-directed mutagenized Mip proteins were constructed and characterized.  An Asp-142 to Leu-142 mutation and a Tyr-185 to Ala-185 substitution resulted in strongly reduced PPIase activity of the recombinant Mip proteins (5.3 and 0.6% of the activity of the wild-type Mip, resp.).  Genes coding for the wild-type and for site-directed-mutagenized Mip proteins were used to complement 3 different Mip-neg. mutants of L. pneumophila.  While Mip protein expression could be restored in the corresponding complementants, significant Mip-specific PPIase activity could be detected only in Mip mutants complemented with wild-type mip genes.  To investigate the influence of the PPIase activity of Mip on intracellular survival of L. pneumophila, invasion assays were performed using the macrophage-like cell line U937, human blood monocytes, and Acanthamoeba castellanii.  The Mip-neg. mutants were approx. 50- to 100-fold less infective for A. castellanii and for human mononuclear phagocytes in vitro than their isogenic Mip-pos. parental strains.  The wild-type invasion rate could be restored by introducing an intact copy of the mip gene into Mip-neg. strains.  In addn., no differences in intracellular survival were obsd. between the wild-type isolates and the Legionella strains exhibiting strongly reduced PPIase activity.  These data indicate that the enzymic activity of Mip does not contribute to intracellular survival of L. pneumophila.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXCfawlvswNrVg90H21EOLACvtfcHk0li3h6j_9TmWMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpslClsrk%253D&md5=61bbec0b0229d0ad465dc97b994020cb</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1128%2FIAI.63.12.4576-4583.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.63.12.4576-4583.1995%26sid%3Dliteratum%253Aachs%26aulast%3DWintermeyer%26aufirst%3DE.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26atitle%3DInfluence%2520of%2520Site%2520Specifically%2520Altered%2520Mip%2520Proteins%2520on%2520Intracellular%2520Survival%2520of%2520Legionella%2520pneumophila%2520in%2520Eukaryotic%2520Cells%26jtitle%3DInfect.%2520Immun.%26date%3D1995%26volume%3D63%26issue%3D12%26spage%3D4576%26epage%3D4583%26doi%3D10.1128%2FIAI.63.12.4576-4583.1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marks, A. R.</span></span> <span> </span><span class="NLM_article-title">Cellular Functions of Immunophilins</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1152/physrev.1996.76.3.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1152%2Fphysrev.1996.76.3.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8757784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28XltVagsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1996&pages=631-649&issue=3&author=A.+R.+Marks&title=Cellular+Functions+of+Immunophilins&doi=10.1152%2Fphysrev.1996.76.3.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular functions of immunophilins</span></div><div class="casAuthors">Marks, Andrew R.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-649</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 161 refs.  Immunophilins are members of a highly conserved family of proteins all of which are cis-trans peptidylprolyl isomerases.  The prototypic members of the immunophilin family, cyclophilin A and FKBP12, were discovered on the basis of their ability to bind and mediate the immunosuppressive effects of the drugs, cyclosporin, FK506, and rapamycin.  However, the prolyl isomerase activity of these proteins is not involved in any of the immunosuppressive effects.  Indeed, despite the fact that all members of the family are prolyl isomerases, the cellular role of this enzymic function has not been clearly defined.  In many cases, immunophilins are widely expressed and are present at high levels in some tissues.  Moreover, whereas the no. of proteins that belong to the immunophilin family continues to grow, the natural cellular functions of all but a few remain obscure.  An example where immunophilins do appear to have a defined cellular role, in the absence of immunosuppressive ligands, is the modulation of intracellular Ca2+ release channel function by FKBP12 and FKBP12.6.  In this case, FKBPs are integral parts of 3 types of Ca2+ release channel complexes, skeletal and cardiac ryanodine receptors and the inositol 1,4,5-trisphosphate receptor.  In each case, FKBPs modulate channel function possibly by enhancing the cooperativity between subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHPBkjksRz8bVg90H21EOLACvtfcHk0li3h6j_9TmWMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltVagsrY%253D&md5=251fabbea8ddd15e12876de18c1d68b1</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1996.76.3.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1996.76.3.631%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DA.%2BR.%26atitle%3DCellular%2520Functions%2520of%2520Immunophilins%26jtitle%3DPhysiol.%2520Rev.%26date%3D1996%26volume%3D76%26issue%3D3%26spage%3D631%26epage%3D649%26doi%3D10.1152%2Fphysrev.1996.76.3.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolos, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">FKBP Ligands—Where We Are and Where to Go?</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1425</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffphar.2018.01425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30568592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1425&author=J.+M.+Kolosauthor=A.+M.+Vollauthor=M.+Bauderauthor=F.+Hausch&title=FKBP+Ligands%E2%80%94Where+We+Are+and+Where+to+Go%3F&doi=10.3389%2Ffphar.2018.01425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">FKBP Ligands-where we are and where to go?</span></div><div class="casAuthors">Kolos, Juergen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1425</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  In recent years, many members of the FK506-binding protein (FKBP) family were increasingly linked to various diseases.  The binding domain of FKBPs differs only in a few amino acid residues, but their biol. roles are versatile.  High-affinity ligands with selectivity between close homologs are scarce.  This review will give an overview of the most prominent ligands developed for FKBPs and highlight a perspective for future developments.  More precisely, human FKBPs and correlated diseases will be discussed as well as microbial FKBPs in the context of anti-bacterial and anti-fungal therapeutics.  The last section gives insights into high-affinity ligands as chem. tools and dimerizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBr9H6aE3nrVg90H21EOLACvtfcHk0ljXloUfI0aQfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1OlurrK&md5=72403a782e5d7e96352188f9e88821d9</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01425%26sid%3Dliteratum%253Aachs%26aulast%3DKolos%26aufirst%3DJ.%2BM.%26aulast%3DVoll%26aufirst%3DA.%2BM.%26aulast%3DBauder%26aufirst%3DM.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DFKBP%2520Ligands%25E2%2580%2594Where%2520We%2520Are%2520and%2520Where%2520to%2520Go%253F%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26spage%3D1425%26doi%3D10.3389%2Ffphar.2018.01425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pomplun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hähle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klages, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieß, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toh, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausch, F.</span></span> <span> </span><span class="NLM_article-title">Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3660</span>– <span class="NLM_lpage">3673</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3660-3673&issue=8&author=S.+Pomplunauthor=C.+Sippelauthor=A.+H%C3%A4hleauthor=D.+Tayauthor=K.+Shimaauthor=A.+Klagesauthor=C.+M.+%C3%9Cnalauthor=B.+Rie%C3%9Fauthor=H.+T.+Tohauthor=G.+Hansenauthor=H.+S.+Yoonauthor=A.+Bracherauthor=P.+Preiserauthor=J.+Ruppauthor=M.+Steinertauthor=F.+Hausch&title=Chemogenomic+Profiling+of+Human+and+Microbial+FK506-Binding+Proteins&doi=10.1021%2Facs.jmedchem.8b00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins</span></div><div class="casAuthors">Pomplun, Sebastian; Sippel, Claudia; Haehle, Andreas; Tay, Donald; Shima, Kensuke; Klages, Alina; Uenal, Can Murat; Riess, Benedikt; Toh, Hui Ting; Hansen, Guido; Yoon, Ho Sup; Bracher, Andreas; Preiser, Peter; Rupp, Jan; Steinert, Michael; Hausch, Felix</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3660-3673</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl isomerase activities and act as coreceptors for immunosuppressants.  Microbial macrophage-infectivity-potentiator (Mip)-type FKBPs can enhance infectivity.  However, developing druglike ligands for FKBPs or Mips has proven difficult, and many FKBPs and Mips still lack biol. useful ligands.  To explore the scope and potential of C5-substituted [4.3.1]-aza-bicyclic sulfonamides as a broadly applicable class of FKBP inhibitors, we developed a new synthesis method for the bicyclic core scaffold and used it to prep. an FKBP- and Mip-focused library.  This allowed us to perform a systematic structure-activity-relationship anal. across key human FKBPs and microbial Mips, yielding highly improved inhibitors for all the FKBPs studied.  A cocrystal structure confirmed the mol.-binding mode of the core structure and explained the affinity gained as a result of the preferred substituents.  The best FKBP and Mip ligands showed promising antimalarial, antileginonellal, and antichlamydial properties in cellular models of infectivity, suggesting that substituted [4.3.1]-aza-bicyclic sulfonamides could be a novel class of anti-infectives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_KYmjlu3wrrVg90H21EOLACvtfcHk0ljXloUfI0aQfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWru7o%253D&md5=1961bd1a6f7aa868b5dd58319600b840</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00137%26sid%3Dliteratum%253Aachs%26aulast%3DPomplun%26aufirst%3DS.%26aulast%3DSippel%26aufirst%3DC.%26aulast%3DH%25C3%25A4hle%26aufirst%3DA.%26aulast%3DTay%26aufirst%3DD.%26aulast%3DShima%26aufirst%3DK.%26aulast%3DKlages%26aufirst%3DA.%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%2BM.%26aulast%3DRie%25C3%259F%26aufirst%3DB.%26aulast%3DToh%26aufirst%3DH.%2BT.%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DYoon%26aufirst%3DH.%2BS.%26aulast%3DBracher%26aufirst%3DA.%26aulast%3DPreiser%26aufirst%3DP.%26aulast%3DRupp%26aufirst%3DJ.%26aulast%3DSteinert%26aufirst%3DM.%26aulast%3DHausch%26aufirst%3DF.%26atitle%3DChemogenomic%2520Profiling%2520of%2520Human%2520and%2520Microbial%2520FK506-Binding%2520Proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D8%26spage%3D3660%26epage%3D3673%26doi%3D10.1021%2Facs.jmedchem.8b00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, C. T.</span></span> <span> </span><span class="NLM_article-title">Human and Escherichia coli Cyclophilins: Sensitivity to Inhibition by the Immunosuppressant Cyclosporin A Correlates with a Specific Tryptophan Residue</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2306</span>– <span class="NLM_lpage">2310</span>, <span class="refDoi"> DOI: 10.1021/bi00223a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00223a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3MXhtFCkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1991&pages=2306-2310&issue=9&author=J.+Liuauthor=C.+M.+Chenauthor=C.+T.+Walsh&title=Human+and+Escherichia+coli+Cyclophilins%3A+Sensitivity+to+Inhibition+by+the+Immunosuppressant+Cyclosporin+A+Correlates+with+a+Specific+Tryptophan+Residue&doi=10.1021%2Fbi00223a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Human and Escherichia coli cyclophilins:  sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue</span></div><div class="casAuthors">Liu, Jun; Chen, Chih Ming; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2306-10</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">The human T-cell protein cyclophilin shows high affinity for and is the proposed target of the major immunosuppressant drug cyclosporin A (CsA).  Cyclophilin also has peptidyl prolyl cis-trans isomerase (PPIase) activity that is inhibited by CsA with an IC50 of 6 nM, while by contrast a homologous PPIase from Escherichia coli has been found to be much less sensitive to CsA, shown here to be 500-fold less potent at an IC50 of 3000 nM.  This E. coli rotamase lacks the single highly conserved tryptophan residue of eukaryotic cyclophilins, and it is shown here that mutation of the natural F112 to W112 enhances E. coli rotamase susceptibility to CsA inhibition by 23-fold.  Correspondingly, the human W121 mutations to F121 or A121 yield cyclophilins with 75- and 200-fold decreased sensitivity to CsA, while kcat/Km values of rotamase activity in a tetrapeptide assay drop only 2- and 13-fold, resp.  This complementary gain and loss of CsA sensitivity to mutation to or from tryptophan validate the indole side chain as a major determinant in immunosuppressant drug recognition and the sepn. of PPIase catalytic efficiency from CsA affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe28ffDNC8ebVg90H21EOLACvtfcHk0ljXloUfI0aQfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtFCkt7w%253D&md5=aa75576c6569680c3f2214536149dbbf</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fbi00223a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00223a003%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BM.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DHuman%2520and%2520Escherichia%2520coli%2520Cyclophilins%253A%2520Sensitivity%2520to%2520Inhibition%2520by%2520the%2520Immunosuppressant%2520Cyclosporin%2520A%2520Correlates%2520with%2520a%2520Specific%2520Tryptophan%2520Residue%26jtitle%3DBiochemistry%26date%3D1991%26volume%3D30%26issue%3D9%26spage%3D2306%26epage%3D2310%26doi%3D10.1021%2Fbi00223a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brune, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Prolyl Cis-Trans Isomerase from Bacillus subtilis. A Prokaryotic Enzyme that is Highly Sensitive to Cyclosporin A</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>309</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(92)80779-G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0014-5793%2892%2980779-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1516692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXnsF2guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1992&pages=231-234&issue=3&author=M.+Herrlerauthor=H.+Bangauthor=K.+Bruneauthor=G.+Fischerauthor=M.+A.+Marahiel&title=Peptidyl-Prolyl+Cis-Trans+Isomerase+from+Bacillus+subtilis.+A+Prokaryotic+Enzyme+that+is+Highly+Sensitive+to+Cyclosporin+A&doi=10.1016%2F0014-5793%2892%2980779-G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl-prolyl cis-trans isomerase from Bacillus subtilis.  A prokaryotic enzyme that is highly sensitive to cyclosporin A</span></div><div class="casAuthors">Herrler, Michael; Bang, Holger; Brune, Kay; Fischer, Gunter; Marahiel, Mohamed A.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Cyclophilins are members of a class of proteins with peptidyl-prolyl cis-trans isomerase (PPIase) activity.  These enzymes bind the immunosuppressive agent, cyclosporin A (CsA), which acts as a competitive inhibitor.  The peptidyl-prolyl cis-trans isomerase from Bacillus subtilis was purified to homogeneity in a 4-step purifn. procedure, which resulted in a 100-fold protein purifn. with a yield of 5%.  Coomassie blue-stained SDS-PAGE revealed a single band of about 18 kDa.  PPIase activity was detd. using synthetic peptides as substrates in a 2-step reaction coupled to chymotrypsin.  Treatment of B. subtilis PPIase with CsA revealed an inhibition const. of 175 nM, which differs from cyclophilin of enterobacteria such as Escherichia coli or Salmonella typhimurium and is in the range of human enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYAkhgKQ76gbVg90H21EOLACvtfcHk0lhXZ3ycUQnwxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXnsF2guw%253D%253D&md5=77f1115f84e2083425d19ab3b3fcedcd</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2892%2980779-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252892%252980779-G%26sid%3Dliteratum%253Aachs%26aulast%3DHerrler%26aufirst%3DM.%26aulast%3DBang%26aufirst%3DH.%26aulast%3DBrune%26aufirst%3DK.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DPeptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520from%2520Bacillus%2520subtilis.%2520A%2520Prokaryotic%2520Enzyme%2520that%2520is%2520Highly%2520Sensitive%2520to%2520Cyclosporin%2520A%26jtitle%3DFEBS%2520Lett.%26date%3D1992%26volume%3D309%26issue%3D3%26spage%3D231%26epage%3D234%26doi%3D10.1016%2F0014-5793%2892%2980779-G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and Characterization of ppiB, a Bacillus subtilis Gene which Encodes a Cyclosporine A-Sensitive Peptidyl-Prolyl Cis-Trans Isomerase</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1073</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1994.tb00384.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1994.tb00384.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8022278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADyaK2c3ptlOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1994&pages=1073-1083&issue=6&author=M.+Herrlerauthor=H.+Bangauthor=M.+A.+Marahiel&title=Cloning+and+Characterization+of+ppiB%2C+a+Bacillus+subtilis+Gene+which+Encodes+a+Cyclosporine+A-Sensitive+Peptidyl-Prolyl+Cis-Trans+Isomerase&doi=10.1111%2Fj.1365-2958.1994.tb00384.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and characterization of ppiB, a Bacillus subtilis gene which encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase</span></div><div class="casAuthors">Herrler M; Bang H; Marahiel M A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular microbiology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1073-83</span>
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">Sequencing of N-terminal and internal peptide fragments of the purified 17 kDa Bacillus subtilis peptidyl-prolyl cis-trans isomerase (PPIase) revealed sequence identity to conserved regions of a number of eukaryotic and prokaryotic cyclophilins.  Using two oligonucleotide primers corresponding to the N-terminus and a highly conserved internal amino acid sequence, polymerase chain reactions (PCR) with B. subtilis genomic DNA were carried out.  The resultant PCR fragment of 335 bp was cloned, sequenced and subsequently used as a probe for screening a lambda Zap II gene library of B. subtilis.  Two overlapping positive clones of 5 and 7 kb containing the B. subtilis PPIase gene (ppiB), which is 432 bp in length and encodes a protein of 144 amino acid residues, were identified and two distinct transcriptional initiation sites at the 5' end of ppiB were mapped.  The entire region (35 kb) between spoVA and serA was recently sequenced in B. subtilis, and an open reading frame (ORF) that encodes a putative peptidyl-prolyl cis-trans isomerase at about 210 degrees on the B. subtilis genetic map was located.  This putative PPIase is identical to PPiB.  We have overexpressed the ppiB gene in Escherichia coli, purified the encoded protein to apparent homology and shown that it exhibits PPIase activity.  In addition, the recombinant PPiB shows a significant inhibition of PPIase activity by cyclosporin A (CsA) at a level comparable to that observed for the B. subtilis enzyme.  Interestingly the B. subtilis PPIase shows about 40% identity to eukaryotic PPIases and less similarity to those of Gram-negative bacteria (27-32% identity).  Like other interruption mutants of yeast and Neurospora, which lack a functional cyclophilin gene, a B. subtilis mutant containing ppiB::cat, a cat-interrupted copy of ppiB in the chromosome, is viable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJywNOE7R26QHqQV89nF-2fW6udTcc2eaKny6S0_2DO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3ptlOktA%253D%253D&md5=3dffba0b3d5d229854961380e9f84b30</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1994.tb00384.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1994.tb00384.x%26sid%3Dliteratum%253Aachs%26aulast%3DHerrler%26aufirst%3DM.%26aulast%3DBang%26aufirst%3DH.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DCloning%2520and%2520Characterization%2520of%2520ppiB%252C%2520a%2520Bacillus%2520subtilis%2520Gene%2520which%2520Encodes%2520a%2520Cyclosporine%2520A-Sensitive%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%26jtitle%3DMol.%2520Microbiol.%26date%3D1994%26volume%3D11%26issue%3D6%26spage%3D1073%26epage%3D1083%26doi%3D10.1111%2Fj.1365-2958.1994.tb00384.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galat, A.</span></span> <span> </span><span class="NLM_article-title">Compression of Large Sets of Sequence Data Reveals Fine Diversification of Functional Profiles in Multigene Families of Proteins: A Study for Peptidyl-Prolyl Cis/Trans Isomerases (PPIase)</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">59</span>, <span class="refDoi"> DOI: 10.3390/biom9020059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Fbiom9020059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvVehtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=59&issue=2&author=A.+Galat&title=Compression+of+Large+Sets+of+Sequence+Data+Reveals+Fine+Diversification+of+Functional+Profiles+in+Multigene+Families+of+Proteins%3A+A+Study+for+Peptidyl-Prolyl+Cis%2FTrans+Isomerases+%28PPIase%29&doi=10.3390%2Fbiom9020059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Compression of large sets of sequence data reveals fine diversification of functional profiles in multigene families of proteins: a study for peptidyl-prolyl cis/trans isomerases (PPIase)</span></div><div class="casAuthors">Galat, Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59/1-59/15</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In this tech. note, we describe analyzes of more than 15,000 sequences of FK506- binding proteins (FKBP) and cyclophilins, also known as peptidyl-prolyl cis/trans isomerases (PPIases).  We have developed a novel way of displaying relative changes of amino acid (AA)- residues at a given sequence position by using heat-maps.  This type of representation allows simultaneous estn. of conservation level in a given sequence position in the entire group of functionally-related paralogues (multigene family of proteins).  We have also proposed that at least two FKBPs, namely FKBP36, encoded by the gene and FKBP51, encoded by the Fkbp5 gene, can form dimers bound via a disulfide bridge in the nucleus.  This type of dimer may have some crucial function in the regulation of some nuclear complexes at different stages of the cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFKnWkYjvMWbVg90H21EOLACvtfcHk0lhXZ3ycUQnwxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvVehtrY%253D&md5=8edf6c9d469d7fac571a5a5ec3fcafa5</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.3390%2Fbiom9020059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom9020059%26sid%3Dliteratum%253Aachs%26aulast%3DGalat%26aufirst%3DA.%26atitle%3DCompression%2520of%2520Large%2520Sets%2520of%2520Sequence%2520Data%2520Reveals%2520Fine%2520Diversification%2520of%2520Functional%2520Profiles%2520in%2520Multigene%2520Families%2520of%2520Proteins%253A%2520A%2520Study%2520for%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases%2520%2528PPIase%2529%26jtitle%3DBiomolecules%26date%3D2019%26volume%3D9%26issue%3D2%26spage%3D59%26doi%3D10.3390%2Fbiom9020059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campagna-Slater, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finerty, P. J.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paramanathan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempel, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenmesser, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span> <span> </span><span class="NLM_article-title">Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">e1000439</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1000439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pbio.1000439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20676357" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=e1000439&issue=7&author=T.+L.+Davisauthor=J.+R.+Walkerauthor=V.+Campagna-Slaterauthor=P.+J.+Finertyauthor=R.+Paramanathanauthor=G.+Bernsteinauthor=F.+MacKenzieauthor=W.+Tempelauthor=H.+Ouyangauthor=W.+H.+Leeauthor=E.+Z.+Eisenmesserauthor=S.+Dhe-Paganon&title=Structural+and+Biochemical+Characterization+of+the+Human+Cyclophilin+Family+of+Peptidyl-Prolyl+Isomerases&doi=10.1371%2Fjournal.pbio.1000439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1000439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1000439%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DT.%2BL.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DCampagna-Slater%26aufirst%3DV.%26aulast%3DFinerty%26aufirst%3DP.%2BJ.%26aulast%3DParamanathan%26aufirst%3DR.%26aulast%3DBernstein%26aufirst%3DG.%26aulast%3DMacKenzie%26aufirst%3DF.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DOuyang%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3DEisenmesser%26aufirst%3DE.%2BZ.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26atitle%3DStructural%2520and%2520Biochemical%2520Characterization%2520of%2520the%2520Human%2520Cyclophilin%2520Family%2520of%2520Peptidyl-Prolyl%2520Isomerases%26jtitle%3DPLoS%2520Biol.%26date%3D2010%26volume%3D8%26issue%3D7%26spage%3De1000439%26doi%3D10.1371%2Fjournal.pbio.1000439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ünal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagöz, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berges, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priebe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Acuña, J. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänsch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinert, M.</span></span> <span> </span><span class="NLM_article-title">Pleiotropic Clostridioides difficile Cyclophilin PpiB Controls Cysteine-Tolerance, Toxin Production, the Central Metabolism and Multiple Stress Responses</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">340</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3389%2Ffphar.2019.00340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=31024308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGlsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=340&author=C.+M.+%C3%9Cnalauthor=M.+S.+Karag%C3%B6zauthor=M.+Bergesauthor=C.+Priebeauthor=J.+M.+B.+de+Acu%C3%B1aauthor=J.+Wissingauthor=L.+J%C3%A4nschauthor=D.+Jahnauthor=M.+Steinert&title=Pleiotropic+Clostridioides+difficile+Cyclophilin+PpiB+Controls+Cysteine-Tolerance%2C+Toxin+Production%2C+the+Central+Metabolism+and+Multiple+Stress+Responses&doi=10.3389%2Ffphar.2019.00340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Pleiotropic Clostridioides difficile cyclophilin PpiB controls cysteine- tolerance, toxin production, the central metabolism and multiple stress responses</span></div><div class="casAuthors">Uenal, Can Murat; Karagoz, Mustafa Safa; Berges, Mareike; Priebe, Christina; Borrero de Acuna, Jose Manuel; Wissing, Josef; Jaensch, Lothar; Jahn, Dieter; Steinert, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">340</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The Gram-pos. pathogen Clostridioides difficile is the main bacterial agent of nosocomial antibiotic assocd. diarrhea.  Bacterial peptidyl-prolyl-cis/trans-isomerases (PPIases) are well established modulators of virulence that influence the outcome of human pathologies during infections.  Here, we present the first interactomic network of the sole cyclophilin-type PPIase of C. difficile (CdPpiB) and show that it has diverse interaction partners including major enzymes of the amino acid-dependent energy (LdhA, EtfAB, Had, Acd) and the glucose-derived (Fba, GapA, Pfo, Pyk, Pyc) central metab.  Proteins of the general (UspA), oxidative (Rbr1,2,3, Dsr), alk. (YloU, YphY) and cold shock (CspB) response were found bound to CdPpiB.  The transcriptional (Lrp), translational (InfC, RFF) and folding (GroS, DnaK) control proteins were also found attached.  For a crucial enzyme of cysteine metab., O-acetylserine sulfhydrylase (CysK), the global transcription regulator Lrp and the flagellar subunit FliC, these interactions were independently confirmed using a bacterial two hybrid system.  The active site residues F50, F109, and F110 of CdPpiB were shown to be important for the interaction with the residue P87 of Lrp.  CysK activity after heat denaturation was restored by interaction with CdPpiB.  In accordance, tolerance toward cell wall stress caused by the exposure to amoxicillin was reduced.  In the absence of CdPpiB, C. difficile was more susceptible toward L-cysteine.  At the same time, the cysteinemediated suppression of toxin prodn. ceased resulting in higher cytotoxicity.  In summary, the cyclophilin-type PPIase of C. difficile (CdPpiB) coordinates major cellular processes via its interaction with major regulators of transcription, translation, protein folding, stress response and the central metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgF5HU3xSW0rVg90H21EOLACvtfcHk0li0uiQ00j6P_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGlsLbL&md5=90d1ada2393012eb1596f12f6b6323f8</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00340%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%259Cnal%26aufirst%3DC.%2BM.%26aulast%3DKarag%25C3%25B6z%26aufirst%3DM.%2BS.%26aulast%3DBerges%26aufirst%3DM.%26aulast%3DPriebe%26aufirst%3DC.%26aulast%3Dde%2BAcu%25C3%25B1a%26aufirst%3DJ.%2BM.%2BB.%26aulast%3DWissing%26aufirst%3DJ.%26aulast%3DJ%25C3%25A4nsch%26aufirst%3DL.%26aulast%3DJahn%26aufirst%3DD.%26aulast%3DSteinert%26aufirst%3DM.%26atitle%3DPleiotropic%2520Clostridioides%2520difficile%2520Cyclophilin%2520PpiB%2520Controls%2520Cysteine-Tolerance%252C%2520Toxin%2520Production%252C%2520the%2520Central%2520Metabolism%2520and%2520Multiple%2520Stress%2520Responses%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D340%26doi%3D10.3389%2Ffphar.2019.00340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göthel, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marahiel, M. A.</span></span> <span> </span><span class="NLM_article-title">Histidine 109 in Peptidyl-Prolyl Cis-Trans Isomerase of Bacillus subtilis Plays an Important Role in Catalysis and in Cyclosporin A Binding</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.1574-6968.1997.tb12635.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1574-6968.1997.tb12635.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=9297832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVKnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1997&pages=139-144&issue=1&author=T.+V.+Achenbachauthor=S.+F.+G%C3%B6thelauthor=M.+A.+Marahiel&title=Histidine+109+in+Peptidyl-Prolyl+Cis-Trans+Isomerase+of+Bacillus+subtilis+Plays+an+Important+Role+in+Catalysis+and+in+Cyclosporin+A+Binding&doi=10.1111%2Fj.1574-6968.1997.tb12635.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Histidine 109 in peptidyl-prolyl cis-trans isomerase of Bacillus subtilis plays an important role in catalysis and in cyclosporin A binding</span></div><div class="casAuthors">Achenbach, Tatjana V.; Goethel, Sven F.; Marahiel, Mohamed A.</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-144</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Peptidylprolyl isomerase (PPI)/cyclophilin of B. subtilis has a moderate affinity to cyclosporin A (IC50: 120 nM) and low catalytic activity (kcat/Km: 1.1 μM-1 s-1) when compared to other ubiquitous PPIs.  The active site residues (Val-52, His-90, and His-109), which are not conserved within other PPIs, were found to play an important role in cyclosporin A binding and catalytic activity.  Here, the authors report on double mutations of these residues, which greatly improved cyclosporin A affinity and catalytic activity.  The H90N/H109W mutation displayed an IC50 value of 46 nM, whereas the V52M/H109F mutation exhibited >18-fold higher catalytic activity than that detected for wild-type PPI.  Mutations H109W and H109F of B. subtilis PPI showed no change in cyclosporin A affinity and catalytic activity between pH 6 and 8.  In contrast, wild-type PPI (H109) showed up to 10-fold redn. below pH 7.5, both in cyclosporin A affinity and in catalytic activity.  These findings clearly underline the importance of the unique His-109 residue in the B. subtilis enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkLENAcRxvk7Vg90H21EOLACvtfcHk0li0uiQ00j6P_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVKnt7o%253D&md5=ee09822374e83fab7ae28e3a7858875a</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-6968.1997.tb12635.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-6968.1997.tb12635.x%26sid%3Dliteratum%253Aachs%26aulast%3DAchenbach%26aufirst%3DT.%2BV.%26aulast%3DG%25C3%25B6thel%26aufirst%3DS.%2BF.%26aulast%3DMarahiel%26aufirst%3DM.%2BA.%26atitle%3DHistidine%2520109%2520in%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520of%2520Bacillus%2520subtilis%2520Plays%2520an%2520Important%2520Role%2520in%2520Catalysis%2520and%2520in%2520Cyclosporin%2520A%2520Binding%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D1997%26volume%3D154%26issue%3D1%26spage%3D139%26epage%3D144%26doi%3D10.1111%2Fj.1574-6968.1997.tb12635.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reffuveille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leneveu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auffray, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rincé, A.</span></span> <span> </span><span class="NLM_article-title">Lipoproteins of Enterococcus faecalis: Bioinformatic Identification, Expression Analysis and Relation to Virulence</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>157</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3001</span>– <span class="NLM_lpage">3013</span>, <span class="refDoi"> DOI: 10.1099/mic.0.053314-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2Fmic.0.053314-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21903750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2011&pages=3001-3013&issue=11&author=F.+Reffuveilleauthor=C.+Leneveuauthor=S.+Chevalierauthor=Y.+Auffrayauthor=A.+Rinc%C3%A9&title=Lipoproteins+of+Enterococcus+faecalis%3A+Bioinformatic+Identification%2C+Expression+Analysis+and+Relation+to+Virulence&doi=10.1099%2Fmic.0.053314-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoproteins of Enterococcus faecalis: bioinformatic identification, expression analysis and relation to virulence</span></div><div class="casAuthors">Reffuveille, Fany; Leneveu, Charlene; Chevalier, Sylvie; Auffray, Yanick; Rince, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3001-3013</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  Enterococcus faecalis is a ubiquitous bacterium that is capable of surviving in a broad range of natural environments, including the human host, as either a natural commensal or an opportunistic pathogen involved in severe hospital-acquired infections.  How such opportunistic pathogens cause fatal infections is largely unknown but it is likely that they are equipped with sophisticated systems to perceive external signals and interact with eukaryotic cells.  Accordingly, being partially exposed at the cell exterior, some surface-assocd. proteins are involved in several steps of the infection process.  Among them are lipoproteins, representing about 25 % of the surface-assocd. proteins, which could play a major role in bacterial virulence processes.  This review focuses on the identification of 90 lipoprotein-encoding genes in the genome of the E. faecalis V583 clin. strain and their putative roles, and provides a transcriptional comparison of microarray data performed in environmental conditions including blood and urine.  Thus, these data suggest a potential involvement of lipoproteins in E. faecalis virulence, making them serious candidates for vaccine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9uMIqARK_m7Vg90H21EOLACvtfcHk0lhUej8Af7lV2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqtL%252FI&md5=2303a4b2a75b0215a1e820d3bff43463</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.053314-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.053314-0%26sid%3Dliteratum%253Aachs%26aulast%3DReffuveille%26aufirst%3DF.%26aulast%3DLeneveu%26aufirst%3DC.%26aulast%3DChevalier%26aufirst%3DS.%26aulast%3DAuffray%26aufirst%3DY.%26aulast%3DRinc%25C3%25A9%26aufirst%3DA.%26atitle%3DLipoproteins%2520of%2520Enterococcus%2520faecalis%253A%2520Bioinformatic%2520Identification%252C%2520Expression%2520Analysis%2520and%2520Relation%2520to%2520Virulence%26jtitle%3DMicrobiology%26date%3D2011%26volume%3D157%26issue%3D11%26spage%3D3001%26epage%3D3013%26doi%3D10.1099%2Fmic.0.053314-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reffuveille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanguinetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posteraro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auffray, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rince, A.</span></span> <span> </span><span class="NLM_article-title">Involvement of Peptidylprolyl Cis/Trans Isomerases in Enterococcus faecalis Virulence</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1728</span>– <span class="NLM_lpage">1735</span>, <span class="refDoi"> DOI: 10.1128/IAI.06251-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.06251-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22331431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=1728-1735&issue=5&author=F.+Reffuveilleauthor=N.+Connilauthor=M.+Sanguinettiauthor=B.+Posteraroauthor=S.+Chevalierauthor=Y.+Auffrayauthor=A.+Rince&title=Involvement+of+Peptidylprolyl+Cis%2FTrans+Isomerases+in+Enterococcus+faecalis+Virulence&doi=10.1128%2FIAI.06251-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of peptidylprolyl cis/trans isomerases in Enterococcus faecalis virulence</span></div><div class="casAuthors">Reffuveille, Fany; Connil, Nathalie; Sanguinetti, Maurizio; Posteraro, Brunella; Chevalier, Sylvie; Auffray, Yanick; Rince, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1728-1735</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Peptidylprolyl cis/trans isomerases (PPIases) are enzymes involved in protein folding.  Anal. of the genome sequence of Enterococcus faecalis V583 allowed for identification of 3 PPIases carrying genes.  Ef2898 encodes an intracellular PPIase which was not shown to be important for the E. faecalis stress response or virulence.  The other two PPIases, the parvulin family rotamase EF0685 and the cyclophilin family member EF1534, are expected to be surface-exposed proteins.  They were shown to be important for virulence and resistance to NaCl.  A Δef0685 Δef1534 mutant was also more resistant to oxidative stress, was able to grow under a high manganese concn., and showed altered resistance to ampicillin and quinolone antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_KJ9ktOV_mLVg90H21EOLACvtfcHk0lhUej8Af7lV2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKms7g%253D&md5=90b303d59a740f92ae884252a95f097f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1128%2FIAI.06251-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.06251-11%26sid%3Dliteratum%253Aachs%26aulast%3DReffuveille%26aufirst%3DF.%26aulast%3DConnil%26aufirst%3DN.%26aulast%3DSanguinetti%26aufirst%3DM.%26aulast%3DPosteraro%26aufirst%3DB.%26aulast%3DChevalier%26aufirst%3DS.%26aulast%3DAuffray%26aufirst%3DY.%26aulast%3DRince%26aufirst%3DA.%26atitle%3DInvolvement%2520of%2520Peptidylprolyl%2520Cis%252FTrans%2520Isomerases%2520in%2520Enterococcus%2520faecalis%2520Virulence%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26issue%3D5%26spage%3D1728%26epage%3D1735%26doi%3D10.1128%2FIAI.06251-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukouhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, T.</span></span> <span> </span><span class="NLM_article-title">Surface Lipoprotein PpiA of Streptococcus mutans Suppresses Scavenger Receptor MARCO-Dependent Phagocytosis by Macrophages</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4933</span>– <span class="NLM_lpage">4940</span>, <span class="refDoi"> DOI: 10.1128/IAI.05693-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.05693-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21986627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=4933-4940&issue=12&author=T.+Mukouharaauthor=T.+Arimotoauthor=K.+Choauthor=M.+Yamamotoauthor=T.+Igarashi&title=Surface+Lipoprotein+PpiA+of+Streptococcus+mutans+Suppresses+Scavenger+Receptor+MARCO-Dependent+Phagocytosis+by+Macrophages&doi=10.1128%2FIAI.05693-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Surface lipoprotein PpiA of Streptococcus mutans suppresses scavenger receptor MARCO-dependent phagocytosis by macrophages</span></div><div class="casAuthors">Mukouhara, Tadashi; Arimoto, Takafumi; Cho, Kasei; Yamamoto, Matsuo; Igarashi, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4933-4940</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Streptococcus mutans is assocd. with the initiation and progression of human dental caries and is occasionally isolated from the blood of patients with bacteremia and infective endocarditis.  For the pathogen to survive in the infected host, surface lipoproteins of S. mutans are likely to play important roles in interactions with the innate immune system.  To clarify the role that a putative lipoprotein, peptidyl-prolyl cis/trans-isomerase (PpiA), of S. mutans plays in the macrophage response, we investigated the response of THP-1-derived macrophages to S. mutans challenge.  The deletion of the gene encoding Lgt eliminated PpiA on the cell surface of S. mutans, which implies that PpiA is a lipoprotein that is lipid anchored in the cell membrane by Lgt.  Human and murine peritoneal macrophages both showed higher phagocytic activities for the ppiA and lgt mutants than the wild type, which indicates that the presence of PpiA reduces S. mutans phagocytosis.  In addn., infection with S. mutans markedly induced mRNAs of macrophage receptor with collagenous structure (MARCO) and scavenger receptor A (SR-A) in human macrophages.  In particular, transcriptional and translational levels of MARCO in human macrophages infected with the ppiA mutant were higher than those in macrophages infected with the wild type.  Phagocytosis of S. mutans by human macrophages markedly decreased after treatment with anti-MARCO IgG.  These results demonstrate that the S. mutans lipoprotein PpiA contributes to suppression of MARCO-mediated phagocytosis of this bacterium by macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvMX358Sb6NbVg90H21EOLACvtfcHk0lhUej8Af7lV2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksrvJ&md5=9f4ae47e422e04d6ad53b1c9575c9516</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1128%2FIAI.05693-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05693-11%26sid%3Dliteratum%253Aachs%26aulast%3DMukouhara%26aufirst%3DT.%26aulast%3DArimoto%26aufirst%3DT.%26aulast%3DCho%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DIgarashi%26aufirst%3DT.%26atitle%3DSurface%2520Lipoprotein%2520PpiA%2520of%2520Streptococcus%2520mutans%2520Suppresses%2520Scavenger%2520Receptor%2520MARCO-Dependent%2520Phagocytosis%2520by%2520Macrophages%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26issue%3D12%26spage%3D4933%26epage%3D4940%26doi%3D10.1128%2FIAI.05693-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adrian, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estevão, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogenboezem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luijendijk, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamphausen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmidt, S.</span></span> <span> </span><span class="NLM_article-title">The Streptococcal Lipoprotein Rotamase A (SlrA) is a Functional Peptidyl-Prolyl Isomerase Involved in Pneumococcal Colonization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1074/jbc.M510014200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M510014200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16260779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Whsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=968-976&issue=2&author=P.+W.+Hermansauthor=P.+V.+Adrianauthor=C.+Albertauthor=S.+Estev%C3%A3oauthor=T.+Hoogenboezemauthor=I.+H.+Luijendijkauthor=T.+Kamphausenauthor=S.+Hammerschmidt&title=The+Streptococcal+Lipoprotein+Rotamase+A+%28SlrA%29+is+a+Functional+Peptidyl-Prolyl+Isomerase+Involved+in+Pneumococcal+Colonization&doi=10.1074%2Fjbc.M510014200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">The Streptococcal Lipoprotein Rotamase A (SlrA) Is a Functional Peptidyl-prolyl Isomerase Involved in Pneumococcal Colonization</span></div><div class="casAuthors">Hermans, Peter W. M.; Adrian, Peter V.; Albert, Christa; Estevao, Silvia; Hoogenboezem, Theo; Luijendijk, Ingrid H. T.; Kamphausen, Thilo; Hammerschmidt, Sven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">968-976</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Streptococcus pneumoniae expresses two surface-exposed lipoproteins, PpmA and SlrA, which share homol. with distinct families of peptidyl-prolyl isomerases (PPIases).  In this study, we demonstrated for the first time that the lipoprotein cyclophilin, SlrA, can catalyze the cis-trans isomerization of proline contg. tetrapeptides and that SlrA contributes to pneumococcal colonization.  The substrate specificity of SlrA is typical for prokaryotic and eukaryotic cyclophilins, with Suc-Ala-Ala-Pro-Phe-p-nitroanilide (pNA) being the most rapidly catalyzed substrate.  In a mouse pneumonia model the slrA knock-out D39ΔslrA did not cause significant differences in the survival times of mice compared with the isogenic wild-type strain.  In contrast, a detailed anal. of bacterial outgrowth over time in the nasopharynx, airways, lungs, blood, and spleen showed a rapid elimination of slrA mutants from the upper airways but did not reveal significant differences in the lungs, blood, and spleen.  These results suggested that SlrA is involved in colonization but does not contribute significantly to invasive pneumococcal disease.  In cell culture infection expts., the absence of SlrA impaired adherence to pneumococcal disease-specific epithelial and endothelial non-professional cell lines.  Adherence of the slrA mutant could not be restored by exogenously added SlrA.  Strikingly, deficiency in SlrA did not reduce binding activity to host target proteins, but resulted in enhanced uptake by professional phagocytes.  In conclusion, SlrA is a functional, cyclophilin-type PPIase and contributes to pneumococcal virulence in the first stage of infection, namely, colonization of the upper airways, most likely by modulating the biol. function of important virulence proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1KvmGV8V4ILVg90H21EOLACvtfcHk0lhUej8Af7lV2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Whsg%253D%253D&md5=690761952d72a069876eb859e0d022eb</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M510014200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M510014200%26sid%3Dliteratum%253Aachs%26aulast%3DHermans%26aufirst%3DP.%2BW.%26aulast%3DAdrian%26aufirst%3DP.%2BV.%26aulast%3DAlbert%26aufirst%3DC.%26aulast%3DEstev%25C3%25A3o%26aufirst%3DS.%26aulast%3DHoogenboezem%26aufirst%3DT.%26aulast%3DLuijendijk%26aufirst%3DI.%2BH.%26aulast%3DKamphausen%26aufirst%3DT.%26aulast%3DHammerschmidt%26aufirst%3DS.%26atitle%3DThe%2520Streptococcal%2520Lipoprotein%2520Rotamase%2520A%2520%2528SlrA%2529%2520is%2520a%2520Functional%2520Peptidyl-Prolyl%2520Isomerase%2520Involved%2520in%2520Pneumococcal%2520Colonization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D2%26spage%3D968%26epage%3D976%26doi%3D10.1074%2Fjbc.M510014200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Involvement of Lipoprotein PpiA of Streptococcus gordonii in Evasion of Phagocytosis by Macrophages</span>. <i>Mol. Oral Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">391</span>, <span class="refDoi"> DOI: 10.1111/omi.12031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fomi.12031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23734737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlensbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=379-391&issue=5&author=K.+Choauthor=T.+Arimotoauthor=T.+Igarashiauthor=M.+Yamamoto&title=Involvement+of+Lipoprotein+PpiA+of+Streptococcus+gordonii+in+Evasion+of+Phagocytosis+by+Macrophages&doi=10.1111%2Fomi.12031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of lipoprotein PpiA of Streptococcus gordonii in evasion of phagocytosis by macrophages</span></div><div class="casAuthors">Cho, K.; Arimoto, T.; Igarashi, T.; Yamamoto, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oral Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-391</span>CODEN:
                <span class="NLM_cas:coden">MOMOBT</span>;
        ISSN:<span class="NLM_cas:issn">2041-1006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Streptococcus gordonii is a commensal gram-pos. bacterium that resides in the human oral cavity, and is one of the most common causes of infective endocarditis (IE).  Bacterial surface mols. play an important role in establishing IE, and several S. gordonii proteins have been implicated in binding to host cells during the establishment of IE.  In this study, we identified a putative lipoprotein, peptidyl-prolyl cis/trans isomerase (PpiA), and clarified its role in evasion of phagocytosis by macrophages.  Attenuation of the gene encoding prolipoprotein diacylglyceryl transferase (Lgt) altered the localization of PpiA from the cell surface to the culture supernatant, indicating that PpiA is lipid-anchored in the cell membrane by Lgt.  Both human and murine macrophages showed higher phagocytic activity towards ppiA and lgt mutants than the wild-type, indicating that the presence of PpiA suppresses phagocytosis of S. gordonii.  Human macrophages treated with dextran sulfate had significantly impaired phagocytosis of S. gordonii, suggesting that class A scavenger receptors in human macrophages are involved in the phagocytosis of S. gordonii.  These results provide evidence that S. gordonii lipoprotein PpiA plays an important role in inhibiting phagocytic engulfment and in evasion of the host immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2IdAONQbWPLVg90H21EOLACvtfcHk0li-l44F5B1D3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlensbvE&md5=bf32b412d5aef209fd17484afc9705ec</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1111%2Fomi.12031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fomi.12031%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DK.%26aulast%3DArimoto%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DInvolvement%2520of%2520Lipoprotein%2520PpiA%2520of%2520Streptococcus%2520gordonii%2520in%2520Evasion%2520of%2520Phagocytosis%2520by%2520Macrophages%26jtitle%3DMol.%2520Oral%2520Microbiol.%26date%3D2013%26volume%3D28%26issue%3D5%26spage%3D379%26epage%3D391%26doi%3D10.1111%2Fomi.12031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keogh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzeciak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Null, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. K.</span></span> <span> </span><span class="NLM_article-title">Novel Regulation of Alpha-Toxin and the Phenol-Soluble Modulins by Peptidyl-Prolyl Cis/Trans Isomerase Enzymes in Staphylococcus aureus</span>. <i>Toxins</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">343</span>, <span class="refDoi"> DOI: 10.3390/toxins11060343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Ftoxins11060343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlCi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=343&issue=6&author=R.+A.+Keoghauthor=R.+L.+Zapfauthor=E.+Trzeciakauthor=G.+G.+Nullauthor=R.+E.+Wiemelsauthor=R.+K.+Carroll&title=Novel+Regulation+of+Alpha-Toxin+and+the+Phenol-Soluble+Modulins+by+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+Enzymes+in+Staphylococcus+aureus&doi=10.3390%2Ftoxins11060343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Novel regulation of alpha-toxin and the phenol-soluble modulins by peptidyl-prolyl cis/trans isomerase enzymes in Staphylococcus aureus</span></div><div class="casAuthors">Keogh, Rebecca A.; Zapf, Rachel L.; Trzeciak, Emily; Null, Gillian G.; Wiemels, Richard E.; Carroll, Ronan K.</div><div class="citationInfo"><span class="NLM_cas:title">Toxins</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">343</span>CODEN:
                <span class="NLM_cas:coden">TOXIB7</span>;
        ISSN:<span class="NLM_cas:issn">2072-6651</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Peptidyl-prolyl cis/trans isomerases (PPIases) are enzymes that catalyze the cis-to-trans isomerization around proline bonds, allowing proteins to fold into their correct confirmation.  Previously, we identified two PPIase enzymes in Staphylococcus aureus (PpiB and PrsA) that are involved in the regulation of virulence determinants and have shown that PpiB contributes to S. aureus virulence in a murine abscessmodel of infection.  Here, we further examine the role of these PPIases in S. aureus virulence and, in particular, their regulation of hemolytic toxins.  Using murine abscess and systemic models of infection, we show that a ppiB mutant in a USA300 background is attenuated for virulence but that a prsA mutant is not.  Deletion of the ppiB gene leads to decreased bacterial survival in macrophages and nasal epithelial cells, while there is no significant difference when prsA is deleted.  Anal. of culture supernatants reveals that a ppiBmutant strain has reduced levels of the phenol-sol. modulins and that both ppiB and prsA mutants have reduced alpha-toxin activity.  Finally, we perform immunopptn. to identify cellular targets of PpiB and PrsA.  Results suggest a novel role for PpiB in S. aureus protein secretion.  Collectively, our results demonstrate that PpiB and PrsA influence S. aureus toxins via distinct mechanisms, and that PpiB but not PrsA contributes to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsBQkc3xRCrVg90H21EOLACvtfcHk0li-l44F5B1D3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlCi&md5=debb88e7649795cdbd4c7aee725e7a87</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.3390%2Ftoxins11060343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Ftoxins11060343%26sid%3Dliteratum%253Aachs%26aulast%3DKeogh%26aufirst%3DR.%2BA.%26aulast%3DZapf%26aufirst%3DR.%2BL.%26aulast%3DTrzeciak%26aufirst%3DE.%26aulast%3DNull%26aufirst%3DG.%2BG.%26aulast%3DWiemels%26aufirst%3DR.%2BE.%26aulast%3DCarroll%26aufirst%3DR.%2BK.%26atitle%3DNovel%2520Regulation%2520of%2520Alpha-Toxin%2520and%2520the%2520Phenol-Soluble%2520Modulins%2520by%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520Enzymes%2520in%2520Staphylococcus%2520aureus%26jtitle%3DToxins%26date%3D2019%26volume%3D11%26issue%3D6%26spage%3D343%26doi%3D10.3390%2Ftoxins11060343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keogh, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittekind, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. K.</span></span> <span> </span><span class="NLM_article-title">The Intracellular Cyclophilin PpiB Contributes to the Virulence of Staphylococcus aureus Independently of its Peptidyl-Prolyl Cis/Trans Isomerase Activity</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">e00379</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1128/IAI.00379-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00379-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30104214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVeiu7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=e00379-18&issue=11&author=R.+A.+Keoghauthor=R.+L.+Zapfauthor=R.+E.+Wiemelsauthor=M.+A.+Wittekindauthor=R.+K.+Carroll&title=The+Intracellular+Cyclophilin+PpiB+Contributes+to+the+Virulence+of+Staphylococcus+aureus+Independently+of+its+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+Activity&doi=10.1128%2FIAI.00379-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The intracellular cyclophilin PpiB contributes to the virulence of Staphylococcus aureus independently of its peptidyl-prolyl cis/trans isomerase activity</span></div><div class="casAuthors">Keogh, Rebecca A.; Zapf, Rachel L.; Wiemels, Richard E.; Wittekind, Marcus A.; Carroll, Ronan K.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e00379-18/1-e00379-18/13</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Staphylococcus aureus cyclophilin PpiB is an intracellular peptidyl prolyl cis/trans isomerase (PPIase) that has previously been shown to contribute to secreted nuclease and hemolytic activity.  In this study, we investigated the contribution of PpiB to S. aureus virulence.  Using a murine abscess model of infection, we demonstrated that a ppiB mutant is attenuated for virulence.  We went on to investigate the mechanism through which PpiB protein contributes to virulence, in particular the contribution of PpiB PPIase activity.  We detd. the amino acid residues that are important for PpiB PPIase activity and showed that a single amino acid substitution (F64A) completely abrogates PPIase activity.  Using purified PpiB F64A protein in vitro, we showed that PPIase activity only partially contributes to Nuc refolding and that PpiB also possesses PPIase-independent activity.  Using allelic exchange, we introduced the F64A substitution onto the S. aureus chromosome, generating a strain that produces enzymically inactive PpiB.  Anal. of the PpiB F64A strain revealed that PPIase activity is not required for hemolysis of human blood or virulence in a mouse.  Together, these results demonstrate that PpiB contributes to S. aureus virulence via a mechanism unrelated to prolyl isomerase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVF2_6Eaxiv7Vg90H21EOLACvtfcHk0li-l44F5B1D3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVeiu7vN&md5=f1cf08c4382ba3c7f0b99a17b4046ee8</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1128%2FIAI.00379-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00379-18%26sid%3Dliteratum%253Aachs%26aulast%3DKeogh%26aufirst%3DR.%2BA.%26aulast%3DZapf%26aufirst%3DR.%2BL.%26aulast%3DWiemels%26aufirst%3DR.%2BE.%26aulast%3DWittekind%26aufirst%3DM.%2BA.%26aulast%3DCarroll%26aufirst%3DR.%2BK.%26atitle%3DThe%2520Intracellular%2520Cyclophilin%2520PpiB%2520Contributes%2520to%2520the%2520Virulence%2520of%2520Staphylococcus%2520aureus%2520Independently%2520of%2520its%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520Activity%26jtitle%3DInfect.%2520Immun.%26date%3D2018%26volume%3D86%26issue%3D11%26spage%3De00379%26epage%3D18%26doi%3D10.1128%2FIAI.00379-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiemels, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cech, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, R. K.</span></span> <span> </span><span class="NLM_article-title">An Intracellular Peptidyl-Prolyl Cis/Trans Isomerase is Required for Folding and Activity of the Staphylococcus aureus Secreted Virulence Factor Nuclease</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>199</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">e00453</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1128/JB.00453-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.00453-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27795319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVaqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2017&pages=e00453-16&issue=1&author=R.+E.+Wiemelsauthor=S.+M.+Cechauthor=N.+M.+Meyerauthor=C.+A.+Burkeauthor=A.+Weissauthor=A.+R.+Parksauthor=L.+N.+Shawauthor=R.+K.+Carroll&title=An+Intracellular+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+is+Required+for+Folding+and+Activity+of+the+Staphylococcus+aureus+Secreted+Virulence+Factor+Nuclease&doi=10.1128%2FJB.00453-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">An intracellular peptidyl-prolyl cis/trans isomerase is required for folding and activity of the Staphylococcus aureus secreted virulence factor nuclease</span></div><div class="casAuthors">Wiemels, Richard E.; Cech, Stephanie M.; Meyer, Nikki M.; Burke, Caleb A.; Weiss, Andy; Parks, Anastacia R.; Shaw, Lindsey N.; Carroll, Ronan K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e00453-16/1-e00453-16/15</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">1098-5530</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Staphylococcus aureus is an important human pathogen that relies on a large repertoire of secreted and cell wall-assocd. proteins for pathogenesis.  Consequently, the ability of the organism to cause disease is absolutely dependent on its ability to synthesize and successfully secrete these proteins.  In this study, we investigate the role of peptidyl-prolyl cis/trans isomerases (PPIases) on the activity of the S. aureus secreted virulence factor nuclease (Nuc).  We identify a staphylococcal cyclophilin-type PPIase (PpiB) that is required for optimal activity of Nuc.  Disruption of ppiB results in decreased nuclease activity in culture supernatants; however, the levels of Nuc protein are not altered, suggesting that the decrease in activity results from misfolding of Nuc in the absence of PpiB.  We go on to demonstrate that PpiB exhibits PPIase activity in vitro, is localized to the bacterial cytosol, and directly interacts with Nuc in vitro to accelerate the rate of Nuc refolding.  Finally, we demonstrate an addnl. role for PpiB in S. aureus hemolysis and demonstrate that the S. aureus parvulin-type PPIase PrsA also plays a role in the activity of secreted virulence factors.  The deletion of prsA leads to a decrease in secreted protease and phospholipase activity, similar to that obsd. in other Gram-pos. pathogens.  Together, these results demonstrate, for the 1st time to our knowledge, that PPIases play an important role in the secretion of virulence factors in S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozfz6iW4I13LVg90H21EOLACvtfcHk0ljdiZZ1aNTjSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVaqtLk%253D&md5=d91a6643575cf71d48cd50a9f5d662ff</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1128%2FJB.00453-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00453-16%26sid%3Dliteratum%253Aachs%26aulast%3DWiemels%26aufirst%3DR.%2BE.%26aulast%3DCech%26aufirst%3DS.%2BM.%26aulast%3DMeyer%26aufirst%3DN.%2BM.%26aulast%3DBurke%26aufirst%3DC.%2BA.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DParks%26aufirst%3DA.%2BR.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26aulast%3DCarroll%26aufirst%3DR.%2BK.%26atitle%3DAn%2520Intracellular%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520is%2520Required%2520for%2520Folding%2520and%2520Activity%2520of%2520the%2520Staphylococcus%2520aureus%2520Secreted%2520Virulence%2520Factor%2520Nuclease%26jtitle%3DJ.%2520Bacteriol.%26date%3D2017%26volume%3D199%26issue%3D1%26spage%3De00453%26epage%3D16%26doi%3D10.1128%2FJB.00453-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bzdyl, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norville, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarovich, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, T. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar-Tyson, M.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Prolyl Isomerase ppiB Is Essential for Proteome Homeostasis and Virulence in Burkholderia pseudomallei</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">e00528</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1128/IAI.00528-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00528-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=31331957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Gjt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=e00528-19&issue=10&author=N.+M.+Bzdylauthor=N.+E.+Scottauthor=I.+H.+Norvilleauthor=A.+E.+Scottauthor=T.+Atkinsauthor=S.+Pangauthor=D.+S.+Sarovichauthor=G.+Coombsauthor=T.+J.+J.+Inglisauthor=C.+M.+Kahlerauthor=M.+Sarkar-Tyson&title=Peptidyl-Prolyl+Isomerase+ppiB+Is+Essential+for+Proteome+Homeostasis+and+Virulence+in+Burkholderia+pseudomallei&doi=10.1128%2FIAI.00528-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl-prolyl isomerase ppiB is essential for proteome homeostasis and virulence in Burkholderia pseudomallei</span></div><div class="casAuthors">Bzdyl, Nicole M.; Scott, Nichollas E.; Norville, Isobel H.; Scott, Andrew E.; Atkins, Timothy; Pang, Stanley; Sarovich, Derek S.; Coombs, Geoffrey; Inglis, Timothy J. J.; Kahler, Charlene M.; Sarkar-Tyson, Mitali</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e00528-19</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">1098-5522</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Burkholderia pseudomallei is the causative agent of melioidosis, a disease endemic to Southeast Asia and northern Australia.  Mortality rates in these areas are high even with antimicrobial treatment, and there are few options for effective therapy.  Therefore, there is a need to identify antibacterial targets for the development of novel treatments.  Cyclophilins are a family of highly conserved enzymes important in multiple cellular processes.  Cyclophilins catalyze the cis-trans isomerization of xaa-proline bonds, a rate-limiting step in protein folding which has been shown to be important for bacterial virulence.  B. pseudomallei carries a putative cyclophilin B gene, ppiB, the role of which was investigated.  A B. pseudomallei ΔppiB (BpsΔppiB) mutant strain demonstrates impaired biofilm formation and reduced motility.  Macrophage invasion and survival assays showed that although the BpsΔppiB strain retained the ability to infect macrophages, it had reduced survival and lacked the ability to spread cell to cell, indicating ppiB is essential for B. pseudomallei virulence.  This is reflected in the BALB/c mouse infection model, demonstrating the requirement of ppiB for in vivo disease dissemination and progression.  Proteomic anal. demonstrates that the loss of PpiB leads to pleiotropic effects, supporting the role of PpiB in maintaining proteome homeostasis.  The loss of PpiB leads to decreased abundance of multiple virulence determinants, including flagellar machinery and alterations in type VI secretion system proteins.  In addn., the loss of ppiB leads to increased sensitivity toward multiple antibiotics, including meropenem and doxycycline, highlighting ppiB inhibition as a promising antivirulence target to both treat B. pseudomallei infections and increase antibiotic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrANn15KCVVMbVg90H21EOLACvtfcHk0ljdiZZ1aNTjSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Gjt7fL&md5=4d03005df3774c826a617cfd923593f3</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1128%2FIAI.00528-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00528-19%26sid%3Dliteratum%253Aachs%26aulast%3DBzdyl%26aufirst%3DN.%2BM.%26aulast%3DScott%26aufirst%3DN.%2BE.%26aulast%3DNorville%26aufirst%3DI.%2BH.%26aulast%3DScott%26aufirst%3DA.%2BE.%26aulast%3DAtkins%26aufirst%3DT.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DSarovich%26aufirst%3DD.%2BS.%26aulast%3DCoombs%26aufirst%3DG.%26aulast%3DInglis%26aufirst%3DT.%2BJ.%2BJ.%26aulast%3DKahler%26aufirst%3DC.%2BM.%26aulast%3DSarkar-Tyson%26aufirst%3DM.%26atitle%3DPeptidyl-Prolyl%2520Isomerase%2520ppiB%2520Is%2520Essential%2520for%2520Proteome%2520Homeostasis%2520and%2520Virulence%2520in%2520Burkholderia%2520pseudomallei%26jtitle%3DInfect.%2520Immun.%26date%3D2019%26volume%3D87%26issue%3D10%26spage%3De00528%26epage%3D19%26doi%3D10.1128%2FIAI.00528-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Söderberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianciotto, N. P.</span></span> <span> </span><span class="NLM_article-title">A Legionella pneumophila Peptidyl-Prolyl Cis-Trans Isomerase Present in Culture Supernatants is Necessary for Optimal Growth at Low Temperatures</span>. <i>Appl. Environ. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1634</span>– <span class="NLM_lpage">1638</span>, <span class="refDoi"> DOI: 10.1128/AEM.02512-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAEM.02512-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18165359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1akurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1634-1638&issue=5&author=M.+A.+S%C3%B6derbergauthor=N.+P.+Cianciotto&title=A+Legionella+pneumophila+Peptidyl-Prolyl+Cis-Trans+Isomerase+Present+in+Culture+Supernatants+is+Necessary+for+Optimal+Growth+at+Low+Temperatures&doi=10.1128%2FAEM.02512-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">A Legionella pneumophila peptidyl-prolyl cis-trans isomerase present in culture supernatants is necessary for optimal growth at low temperatures</span></div><div class="casAuthors">Soderberg, Maria A.; Cianciotto, Nicholas P.</div><div class="citationInfo"><span class="NLM_cas:title">Applied and Environmental Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1634-1638</span>CODEN:
                <span class="NLM_cas:coden">AEMIDF</span>;
        ISSN:<span class="NLM_cas:issn">0099-2240</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Several Legionella pneumophila proteins were highly expressed in low-temp. supernatants.  One of these proteins was the peptidyl-prolyl isomerase PpiB.  Mutants lacking ppiB exhibited reduced growth at 17°C.  Since PpiB lacked a signal sequence and was present in 17°C supernatants of type II and type IV secretion mutants, this protein may be secreted by a novel mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfpvnnqApoAbVg90H21EOLACvtfcHk0ljdiZZ1aNTjSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1akurg%253D&md5=e09e23cbdcc7f5cc963ab64a67088448</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1128%2FAEM.02512-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAEM.02512-07%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B6derberg%26aufirst%3DM.%2BA.%26aulast%3DCianciotto%26aufirst%3DN.%2BP.%26atitle%3DA%2520Legionella%2520pneumophila%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520Present%2520in%2520Culture%2520Supernatants%2520is%2520Necessary%2520for%2520Optimal%2520Growth%2520at%2520Low%2520Temperatures%26jtitle%3DAppl.%2520Environ.%2520Microbiol.%26date%3D2008%26volume%3D74%26issue%3D5%26spage%3D1634%26epage%3D1638%26doi%3D10.1128%2FAEM.02512-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tradler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücknagel, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schierhorn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Küllertz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">A Cyclophilin-Like Peptidyl-Prolyl Cis/Trans Isomerase from Legionella pneumophila–Characterization, Molecular Cloning and Overexpression</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1147</span>– <span class="NLM_lpage">1160</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.1996.00061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1046%2Fj.1365-2958.1996.00061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8898384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK28XmtVKit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1996&pages=1147-1160&issue=6&author=B.+Schmidtauthor=T.+Tradlerauthor=J.+U.+Rahfeldauthor=B.+Ludwigauthor=B.+Jainauthor=K.+Mannauthor=K.+P.+R%C3%BCcknagelauthor=B.+Janowskiauthor=A.+Schierhornauthor=G.+K%C3%BCllertzauthor=J.+Hackerauthor=G.+Fischer&title=A+Cyclophilin-Like+Peptidyl-Prolyl+Cis%2FTrans+Isomerase+from+Legionella+pneumophila%E2%80%93Characterization%2C+Molecular+Cloning+and+Overexpression&doi=10.1046%2Fj.1365-2958.1996.00061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">A cyclophilin-like peptidyl-prolyl cis/trans isomerase from Legionella pneumophila - characterization, molecular cloning and overexpression</span></div><div class="casAuthors">Schmidt, Bettina; Tradler, Thomas; Rahfeld, Jens-U.; Ludwig, Birgit; Jain, Bunty; Mann, Karlheinz; Ruecknagel, K. Peter; Janowski, Bernhard; Schlierhorn, Angelika; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1147-1160</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">Legionella pneumophila is the causative agent of a severe form of pneumonia in humans (Legionnaires' disease).  A major virulence factor, the Mip protein (FK506-binding protein, FKBP25mem), belongs to the enzyme family of peptidyl-prolyl cis/trans isomerases (PPlases).  This study shows that L. pneumophila Philadelphia I possesses an addnl. cytoplasmic PPlase at a level of enzyme activity comparable to that of FKBP25mem.  The N-terminal amino acid sequence of the purified protein was obtained by Edman degrdn. and showed that the protein is a member of the cyclophilin family of PPlases.  The lcy gene (Legionella cyclophilin) was cloned and sequenced.  It encodes a putative 164-amino-acid protein with a mol. mass of 17,968 Da called L. pneumophila cyclophilin 18 (L.p. Cyp18).  Amino acid sequence comparison displays considerable similarity to the cytoplasmic and the periplasmic cyclophilins of Escherichia coli with 60.5 and 51.5% identity, resp.  The substrate specificity and inhibition by cyclosporin A revealed a pattern that is typically found for other bacterial cyclophilins.  An L. pneumophila Cyp18 deriv. with a 19-amino-acid polypeptide extension including a 6-histidine tag and an enterokinase cleavage site exhibits PPlase activity when produced at high levels in E. coli K-12.  After removal of the extension by enterokinase, the properties of the recombinant Cyp18 were indistinguishable from those of the authentic enzyme.  In order to investigate the influence of Cyp18 on intracellular survival of L. pneumophila an lcy-neg. L. pneumophila strain was constructed.  Compared with the wild-type strain, the mutant did not exhibit a significant phenotype but was 10-fold less invasive for Acanthamoeba castellanii.  Like human cyclophilin, the L. p. Cyp18 exhibits nuclease activity, but this enzymic activity does not appear to be linked with the native structure of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTsRprkgYjLVg90H21EOLACvtfcHk0liJUCMyg7qP6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtVKit7s%253D&md5=042cf0dd9b4116803ae3ae5a7e6677b5</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.1996.00061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.1996.00061.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DTradler%26aufirst%3DT.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DJain%26aufirst%3DB.%26aulast%3DMann%26aufirst%3DK.%26aulast%3DR%25C3%25BCcknagel%26aufirst%3DK.%2BP.%26aulast%3DJanowski%26aufirst%3DB.%26aulast%3DSchierhorn%26aufirst%3DA.%26aulast%3DK%25C3%25BCllertz%26aufirst%3DG.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DA%2520Cyclophilin-Like%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerase%2520from%2520Legionella%2520pneumophila%25E2%2580%2593Characterization%252C%2520Molecular%2520Cloning%2520and%2520Overexpression%26jtitle%3DMol.%2520Microbiol.%26date%3D1996%26volume%3D21%26issue%3D6%26spage%3D1147%26epage%3D1160%26doi%3D10.1046%2Fj.1365-2958.1996.00061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezyri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grados, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpusas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Structure-Function Analysis of the Periplasmic Escherichia coli Cyclophilin PpiA in Relation to Biofilm Formation</span>. <i>J. Mol. Microbiol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1159/000478858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1159%2F000478858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28889121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1cbmsVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=228-236&issue=4&author=A.+Skagiaauthor=E.+Vezyriauthor=K.+Gradosauthor=A.+Venierakiauthor=M.+Karpusasauthor=P.+Katinakisauthor=M.+Dimou&title=Structure-Function+Analysis+of+the+Periplasmic+Escherichia+coli+Cyclophilin+PpiA+in+Relation+to+Biofilm+Formation&doi=10.1159%2F000478858"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Function Analysis of the Periplasmic Escherichia coli Cyclophilin PpiA in Relation to Biofilm Formation</span></div><div class="casAuthors">Skagia Aggeliki; Vezyri Eleni; Grados Konstantinos; Venieraki Anastasia; Karpusas Michael; Katinakis Panagiotis; Dimou Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular microbiology and biotechnology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">228-236</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The presence of peptidyl-prolyl cis/trans isomerases (PPIases, EC: 5.2.1.8) in all domains of life indicates their biological importance.  Cyclophilin PpiA, present in the periplasm of gram-negative bacteria, possesses PPIase activity but its physiological functions are still not clearly defined.  Here, we demonstrate that the ΔppiA deletion strain from Escherichia coli exhibits an increased ability for biofilm formation and enhanced swimming motility compared to the wild-type strain.  To identify structural features of PpiA which are necessary for the negative modulation of biofilm formation, we constructed a series of mutant PpiA proteins using a combination of error-prone and site-directed mutagenesis approaches.  We show that the negative effect of PpiA on biofilm formation is not dependent on its PPIase activity, since PpiA mutants with a reduced PPIase activity are able to complement the ΔppiA strain during biofilm growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLErnixfNh_K69lAbTj9rGfW6udTcc2ebiA5lm-TRPt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbmsVamtQ%253D%253D&md5=f59a0c726562b37d82ce871592284b00</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1159%2F000478858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000478858%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DVezyri%26aufirst%3DE.%26aulast%3DGrados%26aufirst%3DK.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DStructure-Function%2520Analysis%2520of%2520the%2520Periplasmic%2520Escherichia%2520coli%2520Cyclophilin%2520PpiA%2520in%2520Relation%2520to%2520Biofilm%2520Formation%26jtitle%3DJ.%2520Mol.%2520Microbiol.%2520Biotechnol.%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D228%26epage%3D236%26doi%3D10.1159%2F000478858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezyri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkinou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpusas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Analysis of Cyclophilin PpiB Mutants Supports an In Vivo Function not Limited to Prolyl Isomerization Activity</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1111/gtc.12452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fgtc.12452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27868330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVymt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=32-44&issue=1&author=A.+Skagiaauthor=E.+Vezyriauthor=M.+Sigalaauthor=A.+Kokkinouauthor=M.+Karpusasauthor=A.+Venierakiauthor=P.+Katinakisauthor=M.+Dimou&title=Structural+and+Functional+Analysis+of+Cyclophilin+PpiB+Mutants+Supports+an+In+Vivo+Function+not+Limited+to+Prolyl+Isomerization+Activity&doi=10.1111%2Fgtc.12452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analysis of cyclophilin PpiB mutants supports an in vivo function not limited to prolyl isomerization activity</span></div><div class="casAuthors">Skagia, Aggeliki; Vezyri, Eleni; Sigala, Markezina; Kokkinou, Areti; Karpusas, Michael; Venieraki, Anastasia; Katinakis, Panagiotis; Dimou, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-44</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1365-2443</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Escherichia coli cyclophilin PpiB is a peptidyl-prolyl cis/trans isomerase (PPIase, EC: 5.2.1.8), involved in the neg. modulation of various bacterial processes, such as swimming and swarming motility and biofilm formation ability.  In this study, we show that PpiB possesses also a chaperone function as it can prevent the thermal denaturation of citrate synthase even with essentially eliminated PPIase activity.  We demonstrate, using active site mutations, that the PPIase activity of PpiB is required in all processes, except for the neg. effect on swimming, indicating a possible isomerase-independent function.  Addnl., we show that the reduced PPIase activity of PpiB does not prevent the assocn. with all prey proteins tested and that the PPIase active site is not involved necessarily in each assocn.  We also used a random mutagenesis approach, to identify amino acid residues apart from the catalytic site, which are necessary for PpiB function.  The combination of enzymic studies concerning the PPIase and chaperone activities of each mutant protein, with structural analyses based on 3D models, provided further insights into the effects of the mutations on the function of PpiB and showed the importance of structural features in addn. to the catalytic site, for its in vivo role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr52EEu8UdYfrVg90H21EOLACvtfcHk0liJUCMyg7qP6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVymt7fL&md5=5bac8a7e7eda22eeef4ce3770a0d15e9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12452%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DVezyri%26aufirst%3DE.%26aulast%3DSigala%26aufirst%3DM.%26aulast%3DKokkinou%26aufirst%3DA.%26aulast%3DKarpusas%26aufirst%3DM.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DStructural%2520and%2520Functional%2520Analysis%2520of%2520Cyclophilin%2520PpiB%2520Mutants%2520Supports%2520an%2520In%2520Vivo%2520Function%2520not%2520Limited%2520to%2520Prolyl%2520Isomerization%2520Activity%26jtitle%3DGenes%2520Cells%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D32%26epage%3D44%26doi%3D10.1111%2Fgtc.12452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zografou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasseas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Functional Analysis of the Cyclophilin PpiB Role in Bacterial Cell Division</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">810</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1111/gtc.12514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fgtc.12514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28752912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1enu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=810-824&issue=9&author=A.+Skagiaauthor=C.+Zografouauthor=A.+Venierakiauthor=C.+Fasseasauthor=P.+Katinakisauthor=M.+Dimou&title=Functional+Analysis+of+the+Cyclophilin+PpiB+Role+in+Bacterial+Cell+Division&doi=10.1111%2Fgtc.12514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of the cyclophilin PpiB role in bacterial cell division</span></div><div class="casAuthors">Skagia, Aggeliki; Zografou, Chrysoula; Venieraki, Anastasia; Fasseas, Costas; Katinakis, Panagiotis; Dimou, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">810-824</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1365-2443</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Escherichia coli PpiB is a peptidyl-prolyl cis/trans isomerase (PPIase, EC: 5.2.1.8) with chaperone activity.  Here, we show that the ΔppiB deletion strain and the PpiB over-expression wild-type strain are both characterized by defects in cell division involving milder or severe cell filamentation, resp.  Using various PpiB mutants, we show that the PPIase activity of PpiB is necessary for the obsd. cell filamentation, whereas other structural features apart from the active site are also important for this phenotype.  Early divisome components zipA and ftsZ showed decreased expression in ΔppiB cells, whereas the corresponding proteins partially suppressed the division phenotype of ΔppiB cells as well.  Although PpiB itself has no obvious specific affinity for the septal ring as a GFP translational fusion showed a diffuse cytoplasmic localization, it interacts with FtsZ employing the C-terminal FtsZ domain, decreases its GTPase activity and when over-expressed shows an inhibitory effect on the proper FtsZ localization at future division sites.  Furthermore, addnl. putative PpiB prey proteins are able to partially restore the ΔppiB phenotype indicating that PpiB is able to control bacterial cell division by probably modulating the function of various other proteins which are indirectly assocd. with the process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMWEMzAgrZlrVg90H21EOLACvtfcHk0lhvy02bLLZv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1enu7%252FI&md5=422107ead1f61f7b56e0502da96c7247</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12514%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DZografou%26aufirst%3DC.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DFasseas%26aufirst%3DC.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DFunctional%2520Analysis%2520of%2520the%2520Cyclophilin%2520PpiB%2520Role%2520in%2520Bacterial%2520Cell%2520Division%26jtitle%3DGenes%2520Cells%26date%3D2017%26volume%3D22%26issue%3D9%26spage%3D810%26epage%3D824%26doi%3D10.1111%2Fgtc.12514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skagia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zografou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezyri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venieraki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katinakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimou, M.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin PpiB is Involved in Motility and Biofilm Formation Via its Functional Association with Certain Proteins</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1111/gtc.12383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fgtc.12383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27306110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvFChsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=833-851&issue=8&author=A.+Skagiaauthor=C.+Zografouauthor=E.+Vezyriauthor=A.+Venierakiauthor=P.+Katinakisauthor=M.+Dimou&title=Cyclophilin+PpiB+is+Involved+in+Motility+and+Biofilm+Formation+Via+its+Functional+Association+with+Certain+Proteins&doi=10.1111%2Fgtc.12383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin PpiB is involved in motility and biofilm formation via its functional association with certain proteins</span></div><div class="casAuthors">Skagia, Aggeliki; Zografou, Chrysoula; Vezyri, Eleni; Venieraki, Anastasia; Katinakis, Panagiotis; Dimou, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">833-851</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1365-2443</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PpiB belongs to the superfamily of peptidyl-prolyl cis/trans isomerases (PPIases, EC: 5.2.1.8), which catalyze the rate-limiting protein folding step at peptidyl-prolyl bonds and control several biol. processes.  In this study, we show that PpiB acts as a neg. effector of motility and biofilm formation ability of Escherichia coli.  We identify multicopy suppressors of each ΔppiB phenotype among putative PpiB prey proteins which upon deletion are often characterized by analogous phenotypes.  Many putative preys show similar gene expression in wild-type and ΔppiB genetic backgrounds implying possible post-translational modifications by PpiB.  We further conducted in vivo and in vitro interaction screens to det. which of them represent true preys.  For DnaK, acetyl-CoA carboxylase, biotin carboxylase subunit (AccC) and phosphate acetyltransferase (Pta) we also showed a direct role of PpiB in the functional control of these proteins because it increased the measured enzyme activity of each protein and further interfered with DnaK localization and the correct folding of AccC.  Taken together, these results indicate that PpiB is involved in diverse regulatory mechanisms to neg. modulate motility and biofilm formation via its functional assocn. with certain protein substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreAIkEq-kAZbVg90H21EOLACvtfcHk0lhvy02bLLZv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvFChsLs%253D&md5=2e07db56eacf569220ed40afd5b66480</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12383%26sid%3Dliteratum%253Aachs%26aulast%3DSkagia%26aufirst%3DA.%26aulast%3DZografou%26aufirst%3DC.%26aulast%3DVezyri%26aufirst%3DE.%26aulast%3DVenieraki%26aufirst%3DA.%26aulast%3DKatinakis%26aufirst%3DP.%26aulast%3DDimou%26aufirst%3DM.%26atitle%3DCyclophilin%2520PpiB%2520is%2520Involved%2520in%2520Motility%2520and%2520Biofilm%2520Formation%2520Via%2520its%2520Functional%2520Association%2520with%2520Certain%2520Proteins%26jtitle%3DGenes%2520Cells%26date%3D2016%26volume%3D21%26issue%3D8%26spage%3D833%26epage%3D851%26doi%3D10.1111%2Fgtc.12383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kok, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffels, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vosman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellingwerf, K. J.</span></span> <span> </span><span class="NLM_article-title">A Gene of Acinetobacter calcoaceticus BD413 Encodes a Periplasmic Peptidyl-Prolyl Cis-Trans Isomerase of the Cyclophilin Sub-Class that is not Essential for Growth</span>. <i>Biochim. Biophys. Acta, Gene Struct. Expression</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>1219</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1016/0167-4781(94)90218-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0167-4781%2894%2990218-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7948017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXitlWlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1219&publication_year=1994&pages=601-606&issue=3&author=R.+G.+Kokauthor=V.+M.+Christoffelsauthor=B.+Vosmanauthor=K.+J.+Hellingwerf&title=A+Gene+of+Acinetobacter+calcoaceticus+BD413+Encodes+a+Periplasmic+Peptidyl-Prolyl+Cis-Trans+Isomerase+of+the+Cyclophilin+Sub-Class+that+is+not+Essential+for+Growth&doi=10.1016%2F0167-4781%2894%2990218-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A gene of Acinetobacter calcoaceticus BD413 encodes a periplasmic peptidyl-prolyl cis-trans isomerase of the cyclophilin sub-class that is not essential for growth</span></div><div class="casAuthors">Kok, Ruben G.; Christoffels, Vincent M.; Vosman, Ben; Hellingwerf, Klaas J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Gene Structure and Expression</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">1219</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-6</span>CODEN:
                <span class="NLM_cas:coden">BBGSD5</span>;
        ISSN:<span class="NLM_cas:issn">0167-4781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Downstream of the Acinetobacter calcoaceticus estA gene, encoding a cell-bound esterase, an open reading frame (orf) was identified, which may encode a protein with a mass of 20.4 kDa.  This protein shows extensive similarity to both prokaryotic and eukaryotic peptidyl-prolyl cis-trans isomerases (PPIases) of the cyclophilin sub-class, esp. to the periplasmic rotamase (RotA) of Escherichia coli.  A putative signal sequence suggests that the product of the Acinetobacter gene, the authors termed rotA, is located outside the cytoplasm.  Transcription of the gene is initiated from a promoter, just upstream of the rotA orf.  The observation that two A. calcoaceticus rotA deletion mutants display no apparent mutant phenotype, suggests that this PPIase is not essential for growth of the organism.  These mutants, to the knowledge, are the first prokaryotic PPIase mutants reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmVrVw1llxa7Vg90H21EOLACvtfcHk0lhvy02bLLZv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitlWlsbw%253D&md5=74a4daedb4caaa044f5ebe5dce97a6a7</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0167-4781%2894%2990218-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-4781%252894%252990218-6%26sid%3Dliteratum%253Aachs%26aulast%3DKok%26aufirst%3DR.%2BG.%26aulast%3DChristoffels%26aufirst%3DV.%2BM.%26aulast%3DVosman%26aufirst%3DB.%26aulast%3DHellingwerf%26aufirst%3DK.%2BJ.%26atitle%3DA%2520Gene%2520of%2520Acinetobacter%2520calcoaceticus%2520BD413%2520Encodes%2520a%2520Periplasmic%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520of%2520the%2520Cyclophilin%2520Sub-Class%2520that%2520is%2520not%2520Essential%2520for%2520Growth%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gene%2520Struct.%2520Expression%26date%3D1994%26volume%3D1219%26issue%3D3%26spage%3D601%26epage%3D606%26doi%3D10.1016%2F0167-4781%2894%2990218-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roset, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia Fernandez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DelVecchio, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briones, G.</span></span> <span> </span><span class="NLM_article-title">Intracellularly Induced Cyclophilins Play an Important Role in Stress Adaptation and Virulence of Brucella abortus</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1128/IAI.01125-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.01125-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23230297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Snt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=521-530&issue=2&author=M.+S.+Rosetauthor=L.+Garcia+Fernandezauthor=V.+G.+DelVecchioauthor=G.+Briones&title=Intracellularly+Induced+Cyclophilins+Play+an+Important+Role+in+Stress+Adaptation+and+Virulence+of+Brucella+abortus&doi=10.1128%2FIAI.01125-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellularly induced cyclophilins play an important role in stress adaptation and virulence of Brucella abortus</span></div><div class="casAuthors">Roset, Mara S.; Fernandez, Lucia Garcia; DelVecchio, Vito G.; Briones, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">521-530</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Brucella is an intracellular bacterial pathogen that causes the worldwide zoonotic disease brucellosis.  Brucella virulence relies on its ability to transition to an intracellular lifestyle within host cells.  Thus, this pathogen must sense its intracellular localization and then reprogram gene expression for survival within the host cell.  A comparative proteomic investigation was performed to identify differentially expressed proteins potentially relevant for Brucella intracellular adaptation.  Two proteins identified as cyclophilins (CypA and CypB) were overexpressed in the intracellular environment of the host cell in comparison to lab.-grown Brucella.  To define the potential role of cyclophilins in Brucella virulence, a double-deletion mutant was constructed and its resulting phenotype was characterized.  The Brucella abortus ΔcypAB mutant displayed increased sensitivity to environmental stressors, such as oxidative stress, pH, and detergents.  In addn., the B. abortus ΔcypAB mutant strain had a reduced growth rate at lower temp., a phenotype assocd. with defective expression of cyclophilins in other microorganisms.  The B. abortus ΔcypAB mutant also displays reduced virulence in BALB/c mice and defective intracellular survival in HeLa cells.  These findings suggest that cyclophilins are important for Brucella virulence and survival in the host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHTvW-tE1lsrVg90H21EOLACvtfcHk0lhpz35cAkuJ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Snt7k%253D&md5=482ebc52cfe73b60862c277a2a9a925b</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1128%2FIAI.01125-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.01125-12%26sid%3Dliteratum%253Aachs%26aulast%3DRoset%26aufirst%3DM.%2BS.%26aulast%3DGarcia%2BFernandez%26aufirst%3DL.%26aulast%3DDelVecchio%26aufirst%3DV.%2BG.%26aulast%3DBriones%26aufirst%3DG.%26atitle%3DIntracellularly%2520Induced%2520Cyclophilins%2520Play%2520an%2520Important%2520Role%2520in%2520Stress%2520Adaptation%2520and%2520Virulence%2520of%2520Brucella%2520abortus%26jtitle%3DInfect.%2520Immun.%26date%3D2013%26volume%3D81%26issue%3D2%26spage%3D521%26epage%3D530%26doi%3D10.1128%2FIAI.01125-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhaduri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maji, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhetaria, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhasmana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Virdi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, Y.</span></span> <span> </span><span class="NLM_article-title">Mycobacterium tuberculosis Cyclophilin A Uses Novel Signal Sequence for Secretion and Mimics Eukaryotic Cyclophilins for Interaction with Host Protein Repertoire</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">e88090</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0088090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pone.0088090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=24505389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWgsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e88090&issue=2&author=A.+Bhaduriauthor=R.+Misraauthor=A.+Majiauthor=P.+J.+Bhetariaauthor=S.+Mishraauthor=G.+Aroraauthor=L.+K.+Singhauthor=N.+Dhasmanaauthor=N.+Dubeyauthor=J.+S.+Virdiauthor=Y.+Singh&title=Mycobacterium+tuberculosis+Cyclophilin+A+Uses+Novel+Signal+Sequence+for+Secretion+and+Mimics+Eukaryotic+Cyclophilins+for+Interaction+with+Host+Protein+Repertoire&doi=10.1371%2Fjournal.pone.0088090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Mycobacterium tuberculosis cyclophilin a uses novel signal sequence for secretion and mimics eukaryotic cyclophilins for interaction with host protein repertoire</span></div><div class="casAuthors">Bhaduri, Asani; Misra, Richa; Maji, Abhijit; Bhetaria, Preetida J.; Mishra, Sonakshi; Arora, Gunjan; Singh, Lalit Kumar; Dhasmana, Neha; Dubey, Neha; Virdi, Jugsharan Singh; Singh, Yogendra</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e88090/1-e88090/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cyclophilins are prolyl isomerases with multitude of functions in different cellular processes and pathol. conditions.  Cyclophilin A (PpiA) of Mycobacterium tuberculosis is secreted during infection in intraphagosomal niche.  However, our understanding about the evolutionary origin, secretory mechanism or the interactome of M. tuberculosis PpiA is limited.  This study demonstrates through phylogenetic and structural analyses that PpiA has more proximity to human cyclophilins than the prokaryotic counterparts.  The authors report a unique N-terminal sequence (MADCDSVTNSP) present in pathogenic mycobacterial PpiA and absent in non-pathogenic strains.  This sequence stretch was shown to be essential for PpiA secretion.  The overexpression of full-length PpiA from M. tuberculosis in non-pathogenic Mycobacterium smegmatis resulted in PpiA secretion while truncation of the N-terminal stretch obstructed the secretion.  In addn., presence of an ESX pathway substrate motif in M. tuberculosis PpiA suggested possible involvement of Type VII secretion system.  Site-directed mutagenesis of key residues in this motif in full-length PpiA also hindered the secretion in M. smegmatis.  Bacterial two-hybrid screens with human lung cDNA library as target were utilized to identify interaction partners of PpiA from host repertoire, and a no. of substrates with functional representation in iron storage, signal transduction and immune responses were detected.  The extensive host interactome coupled with the sequence and structural similarity to human cyclophilins is strongly suggestive of PpiA being deployed by M. tuberculosis as an effector mimic against the host cyclophilins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUUjNhQOIArVg90H21EOLACvtfcHk0lhpz35cAkuJ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWgsLfJ&md5=8967929be39d7dbc30a9cd63af67efc6</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0088090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0088090%26sid%3Dliteratum%253Aachs%26aulast%3DBhaduri%26aufirst%3DA.%26aulast%3DMisra%26aufirst%3DR.%26aulast%3DMaji%26aufirst%3DA.%26aulast%3DBhetaria%26aufirst%3DP.%2BJ.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DArora%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DL.%2BK.%26aulast%3DDhasmana%26aufirst%3DN.%26aulast%3DDubey%26aufirst%3DN.%26aulast%3DVirdi%26aufirst%3DJ.%2BS.%26aulast%3DSingh%26aufirst%3DY.%26atitle%3DMycobacterium%2520tuberculosis%2520Cyclophilin%2520A%2520Uses%2520Novel%2520Signal%2520Sequence%2520for%2520Secretion%2520and%2520Mimics%2520Eukaryotic%2520Cyclophilins%2520for%2520Interaction%2520with%2520Host%2520Protein%2520Repertoire%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3De88090%26doi%3D10.1371%2Fjournal.pone.0088090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammirati, E.</span></span> <span> </span><span class="NLM_article-title">Cyclosporine in Transplantation—A History of Converging Timelines</span>. <i>J. Biol. Regul. Homeostatic Agents</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22217983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XislCitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=493-504&author=D.+Colomboauthor=E.+Ammirati&title=Cyclosporine+in+Transplantation%E2%80%94A+History+of+Converging+Timelines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclosporine in transplantation - a history of converging timelines</span></div><div class="casAuthors">Colombo, D.; Ammirati, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Regulators and Homeostatic Agents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">JBRAER</span>;
        ISSN:<span class="NLM_cas:issn">0393-974X</span>.
    
            (<span class="NLM_cas:orgname">BIOLIFE, s.a.s.</span>)
        </div><div class="casAbstract">A review.  Discovery and pharmacol. development of cyclosporine was conducted by Jean Borel and colleagues in the 1970s.  Cyclosporine is the first compd. to inhibit the lymphocytes specifically and reversibly, and represents the prototype of a new generation of immunosuppressive drugs: the calcineurine inhibitors.  Historical chronol. of successes in clin. application of cyclosporine and development of solid-organ transplantation are retraced here, underscoring the converging timelines of this drug and these interventions.  In 1978-79 the first successful results of the use of cyclosporine in kidney were reported.  Cyclosporine was the first single drug able to control rejection.  In 1982-83 first trials demonstrated the benefit from treatment with cyclosporine in kidney recipients compared to azathioprine and steroids.  In the 1980s solid-organ transplantation entered the "cyclosporine era" with unhoped-for results in heart transplantation.  The present review focuses also on cyclosporine-based regimen of immunosuppression, adverse side effects and safety in pregnancy in subjects under treatment with cyclosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1YSwrBWVwKLVg90H21EOLACvtfcHk0ljTzBzbc__Tsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XislCitb8%253D&md5=8cca6bbb53cec167f387c069ce484bcb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DD.%26aulast%3DAmmirati%26aufirst%3DE.%26atitle%3DCyclosporine%2520in%2520Transplantation%25E2%2580%2594A%2520History%2520of%2520Converging%2520Timelines%26jtitle%3DJ.%2520Biol.%2520Regul.%2520Homeostatic%2520Agents%26date%3D2011%26volume%3D25%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyasu, S.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Action of Cyclosporine</span>. <i>Immunopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/S0162-3109(00)00192-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS0162-3109%2800%2900192-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10878286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlKkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2000&pages=119-125&issue=2%E2%80%933&author=S.+Matsudaauthor=S.+Koyasu&title=Mechanisms+of+Action+of+Cyclosporine&doi=10.1016%2FS0162-3109%2800%2900192-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of action of cyclosporine</span></div><div class="casAuthors">Matsuda, S.; Koyasu, S.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">119-125</span>CODEN:
                <span class="NLM_cas:coden">IMMUDP</span>;
        ISSN:<span class="NLM_cas:issn">0162-3109</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with ∼90 refs.  Cyclosporine (cyclosporin A, CsA) has potent immunosuppressive properties, reflecting its ability to block the transcription of cytokine genes in activated T cells.  It is well established that CsA through formation of a complex with cyclophilin inhibits the phosphatase activity of calcineurin, which regulates nuclear translocation and subsequent activation of NFAT transcription factors.  In addn. to the calcineurin/NFAT pathway, recent studies indicate that CsA also blocks the activation of JNK and p38 signaling pathways triggered by antigen recognition, making CsA a highly specific inhibitor of T cell activation.  Here we discuss the action of CsA on JNK and p38 activation pathways.  We also argue the potential of CsA and its natural counterparts as pharmacol. probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Y0c5-UmKabVg90H21EOLACvtfcHk0ljTzBzbc__Tsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlKkt7s%253D&md5=756ce95c9104825ad1050b9d43114837</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2800%2900192-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252800%252900192-2%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DS.%26aulast%3DKoyasu%26aufirst%3DS.%26atitle%3DMechanisms%2520of%2520Action%2520of%2520Cyclosporine%26jtitle%3DImmunopharmacology%26date%3D2000%26volume%3D47%26issue%3D2%25E2%2580%25933%26spage%3D119%26epage%3D125%26doi%3D10.1016%2FS0162-3109%2800%2900192-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, G. R.</span></span> <span> </span><span class="NLM_article-title">The Mechanism of Action of Cyclosporin A and FK506</span>. <i>Immunol. Today</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1016/0167-5699(92)90111-J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0167-5699%2892%2990111-J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1374612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK38XisVOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1992&pages=136-142&issue=4&author=S.+L.+Schreiberauthor=G.+R.+Crabtree&title=The+Mechanism+of+Action+of+Cyclosporin+A+and+FK506&doi=10.1016%2F0167-5699%2892%2990111-J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of action of cyclosporin A and FK506</span></div><div class="casAuthors">Schreiber, Stuart L.; Crabtree, Gerald R.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">136-42</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    </div><div class="casAbstract">A review with 80 refs.  Cyclosporin A (CsA) and FK506 are powerful suppressors of the immune system, most notably of T cells.  They act at a point in activation that lies between receptor ligation and the transcription of early genes.  Recent findings that indicate CsA and FK506 operate as prodrugs are discussed: they bind endogenous intracellular receptors, the immunophilins, and the resulting complex targets the protein phosphatase, calcineurin, to exert the immunosuppressive effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFf8-CJpSiYrVg90H21EOLACvtfcHk0ljTzBzbc__Tsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisVOksb8%253D&md5=faacba90d38767f48f8d0c343c8b8aa8</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2F0167-5699%2892%2990111-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-5699%252892%252990111-J%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCrabtree%26aufirst%3DG.%2BR.%26atitle%3DThe%2520Mechanism%2520of%2520Action%2520of%2520Cyclosporin%2520A%2520and%2520FK506%26jtitle%3DImmunol.%2520Today%26date%3D1992%26volume%3D13%26issue%3D4%26spage%3D136%26epage%3D142%26doi%3D10.1016%2F0167-5699%2892%2990111-J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paeshuyse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalfaro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span> <span> </span><span class="NLM_article-title">The Non-Immunosuppressive Cyclosporin DEBIO-025 is a Potent Inhibitor of Hepatitis C Virus Replication In Vitro</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1002/hep.21102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fhep.21102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16557546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvV2is70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=761-770&issue=4&author=J.+Paeshuyseauthor=A.+Kaulauthor=E.+De+Clercqauthor=B.+Rosenwirthauthor=J.+M.+Dumontauthor=P.+Scalfaroauthor=R.+Bartenschlagerauthor=J.+Neyts&title=The+Non-Immunosuppressive+Cyclosporin+DEBIO-025+is+a+Potent+Inhibitor+of+Hepatitis+C+Virus+Replication+In+Vitro&doi=10.1002%2Fhep.21102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro</span></div><div class="casAuthors">Paeshuyse, Jan; Kaul, Artur; De Clercq, Erik; Rosenwirth, Brigitte; Dumont, Jean-Maurice; Scalfaro, Pietro; Bartenchlager, Ralf; Neyts, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-770</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Cyclosporin A (CsA) inhibits the in vitro replication of HCV subgenomic replicons.  We here report on the potent anti-HCV activity of the non-immunosuppressive cyclosporin DEBIO-025.  The 50% effective concn. for inhibition of HCV subgenomic replicon replication in Huh 5-2 cells (luciferase assay) by DEBIO-025 was 0.27 ± 0.03 μg/mL and for CsA 2.8 ± 0.4 μg/mL.  The concn. that reduced the growth of exponentially proliferating Huh 5-2 cells by 50% was greater than 27 μg/mL for DEBIO-025 and 12 ± 6 μg/mL for CsA, resulting in a selectivity index of approx. 900 for DEBIO-025 and 40 for CsA.  The superior activity of DEBIO-025, as compared with CsA, was corroborated by monitoring HCV RNA levels in Huh 5-2, two other HCV subgenomic replicon-contg. cell lines, and by monitoring the luciferase signal and viral antigen prodn. in hepatoma cells that had been infected with an infectious full-length chimeric HCV construct.  The combination of interferon alpha 2a with either CsA or DEBIO-025 resulted in an additive to slightly synergistic antiviral activity.  DEBIO-025, at concns. of 0.5 and 1 μg/mL, was able to clear cells from their HCV replicon within three to four passages, whereas treatment with CsA at the same concns. for seven consecutive passages did not result in clearance of the HCV replicon.  In conclusion, DEBIO-025, a compd. that is also endowed with potent anti-HIV activity and is well tolerated in animals and humans, may form an attractive new option for the therapy of HCV infections, particularly in HCV/HIV co-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm7ye6ckOcSbVg90H21EOLACvtfcHk0lh79wPWn45zkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvV2is70%253D&md5=4d6822134e90969a7251204eefc954ed</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2Fhep.21102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.21102%26sid%3Dliteratum%253Aachs%26aulast%3DPaeshuyse%26aufirst%3DJ.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DDumont%26aufirst%3DJ.%2BM.%26aulast%3DScalfaro%26aufirst%3DP.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DNeyts%26aufirst%3DJ.%26atitle%3DThe%2520Non-Immunosuppressive%2520Cyclosporin%2520DEBIO-025%2520is%2520a%2520Potent%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520Replication%2520In%2520Vitro%26jtitle%3DHepatology%26date%3D2006%26volume%3D43%26issue%3D4%26spage%3D761%26epage%3D770%26doi%3D10.1002%2Fhep.21102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quesniaux, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreier, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Regenmortel, M. H.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin Binds to the Region of Cyclosporine Involved in its Immunosuppressive Activity</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1359</span>– <span class="NLM_lpage">1365</span>, <span class="refDoi"> DOI: 10.1002/eji.1830170921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Feji.1830170921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=3308488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL1cXhsVejsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1987&pages=1359-1365&issue=9&author=V.+F.+Quesniauxauthor=M.+H.+Schreierauthor=R.+M.+Wengerauthor=P.+C.+Hiestandauthor=M.+W.+Hardingauthor=M.+H.+Van+Regenmortel&title=Cyclophilin+Binds+to+the+Region+of+Cyclosporine+Involved+in+its+Immunosuppressive+Activity&doi=10.1002%2Feji.1830170921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity</span></div><div class="casAuthors">Quesniaux, Valerie F. J.; Schreier, Max H.; Wenger, Roland M.; Hiestand, Peter C.; Harding, Matthew W.; Van Regenmortel, Marc H. V.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Immunology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1359-65</span>CODEN:
                <span class="NLM_cas:coden">EJIMAF</span>;
        ISSN:<span class="NLM_cas:issn">0014-2980</span>.
    </div><div class="casAbstract">In the present study, a quant. immunoassay for cyclophilin was developed which made it possible to compare its relative affinity for cyclosporine and any of its analogs.  The binding of cyclophilin to cyclosporine coated on a solid phase was revealed by anticyclophilin rabbit antiserum followed by antiglobulin-enzyme conjugate.  This reaction was inhibited by addn. of free cyclosporine or certain cyclosporine analogs.  By studying the binding of cyclophilin to more than 50 cyclosporine derivs. modified singly on each of the 11 amino acid residues, it was shown that cyclophilin binds to the residues of cyclosporine known to be crit. for its immunosuppressive activity.  Thus, cyclophilin as a highly discriminating stereospecific binding protein for cyclosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriVEkBdt0P_rVg90H21EOLACvtfcHk0liRVdAyUVLYcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhsVejsLc%253D&md5=67f1289e9393d4c2e0e61cda02b9c190</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Feji.1830170921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.1830170921%26sid%3Dliteratum%253Aachs%26aulast%3DQuesniaux%26aufirst%3DV.%2BF.%26aulast%3DSchreier%26aufirst%3DM.%2BH.%26aulast%3DWenger%26aufirst%3DR.%2BM.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DHarding%26aufirst%3DM.%2BW.%26aulast%3DVan%2BRegenmortel%26aufirst%3DM.%2BH.%26atitle%3DCyclophilin%2520Binds%2520to%2520the%2520Region%2520of%2520Cyclosporine%2520Involved%2520in%2520its%2520Immunosuppressive%2520Activity%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D1987%26volume%3D17%26issue%3D9%26spage%3D1359%26epage%3D1365%26doi%3D10.1002%2Feji.1830170921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">7145</span>– <span class="NLM_lpage">7159</span>, <span class="refDoi"> DOI: 10.1021/jm500223x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500223x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7145-7159&issue=17&author=Z.+K.+Sweeneyauthor=J.+Fuauthor=B.+Wiedmann&title=From+Chemical+Tools+to+Clinical+Medicines%3A+Nonimmunosuppressive+Cyclophilin+Inhibitors+Derived+from+the+Cyclosporin+and+Sanglifehrin+Scaffolds&doi=10.1021%2Fjm500223x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds</span></div><div class="casAuthors">Sweeney, Zachary K.; Fu, Jiping; Wiedmann, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7145-7159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cyclophilins are widely expressed enzymes that catalyze the interconversion of the cis and trans peptide bonds of prolines.  The immunosuppressive natural products cyclosporine A and sanglifehrin A inhibit the enzymic activity of the cyclophilins.  Chem. modification of both the cyclosporine and sanglifehrin scaffolds has produced many analogs that inhibit cyclophilins in vitro but have reduced immunosuppressive properties.  Three nonimmunosuppressive cyclophilin inhibitors (alisporivir, SCY-635, and NIM811) have demonstrated clin. efficacy for the treatment of hepatitis C infection.  Addnl. candidates are in various stages of preclin. development for the treatment of hepatitis C or myocardial reperfusion injury.  Recent publications suggest that cyclophilin inhibitors may have utility for the treatment of diverse viral infections, inflammatory indications, and cancer.  In this review, we document the structure-activity relationships of the nonimmunosuppressive cyclosporins and sanglifehrins in clin. and preclin. development.  Aspects of the pharmacokinetic behavior and chem. biol. of these drug candidates are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX8HG6odes7Vg90H21EOLACvtfcHk0liRVdAyUVLYcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKgs74%253D&md5=c011a3ad8d4db9481fb5f99c1e917759</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm500223x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500223x%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DFrom%2520Chemical%2520Tools%2520to%2520Clinical%2520Medicines%253A%2520Nonimmunosuppressive%2520Cyclophilin%2520Inhibitors%2520Derived%2520from%2520the%2520Cyclosporin%2520and%2520Sanglifehrin%2520Scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D17%26spage%3D7145%26epage%3D7159%26doi%3D10.1021%2Fjm500223x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furegati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprzyk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yifru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span> <span> </span><span class="NLM_article-title">Potent Nonimmunosuppressive Cyclophilin Inhibitors with Improved Pharmaceutical Properties and Decreased Transporter Inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8503</span>– <span class="NLM_lpage">8516</span>, <span class="refDoi"> DOI: 10.1021/jm500862r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500862r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8503-8516&issue=20&author=J.+Fuauthor=M.+Tjandraauthor=C.+Beckerauthor=D.+Bednarczykauthor=M.+Capparelliauthor=R.+Ellingauthor=I.+Hannaauthor=R.+Fujimotoauthor=M.+Furegatiauthor=S.+Karurauthor=T.+Kasprzykauthor=M.+Knappauthor=K.+Leungauthor=X.+Liauthor=P.+Luauthor=W.+Mergoauthor=C.+Miaultauthor=S.+Ngauthor=D.+Parkerauthor=Y.+Pengauthor=S.+Roggoauthor=A.+Rivkinauthor=R.+L.+Simmonsauthor=M.+Wangauthor=B.+Wiedmannauthor=A.+H.+Weissauthor=L.+Xiaoauthor=L.+Xieauthor=W.+Xuauthor=A.+Yifruauthor=S.+Yangauthor=B.+Zhouauthor=Z.+K.+Sweeney&title=Potent+Nonimmunosuppressive+Cyclophilin+Inhibitors+with+Improved+Pharmaceutical+Properties+and+Decreased+Transporter+Inhibition&doi=10.1021%2Fjm500862r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition</span></div><div class="casAuthors">Fu, Jiping; Tjandra, Meiliana; Becker, Christopher; Bednarczyk, Dallas; Capparelli, Michael; Elling, Robert; Hanna, Imad; Fujimoto, Roger; Furegati, Markus; Karur, Subramanian; Kasprzyk, Theresa; Knapp, Mark; Leung, Kwan; Li, Xiaolin; Lu, Peichao; Mergo, Wosenu; Miault, Charlotte; Ng, Simon; Parker, David; Peng, Yunshan; Roggo, Silvio; Rivkin, Alexey; Simmons, Robert L.; Wang, Michael; Wiedmann, Brigitte; Weiss, Andrew H.; Xiao, Linda; Xie, Lili; Xu, Wenjian; Yifru, Aregahegn; Yang, Shengtian; Zhou, Bo; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8503-8516</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonimmunosuppressive cyclophilin inhibitors have demonstrated efficacy for the treatment of hepatitis C infection (HCV).  However, alisporivir, cyclosporin A, and most other cyclosporins are potent inhibitors of OATP1B1, MRP2, MDR1, and other important drug transporters.  Redn. of the side chain hydrophobicity of the P4 residue preserves cyclophilin binding and antiviral potency while decreasing transporter inhibition.  Representative inhibitor 33 (NIM258) is a less potent transporter inhibitor relative to previously described cyclosporins, retains anti-HCV activity in cell culture, and has an acceptable pharmacokinetic profile in rats and dogs.  An X-ray structure of 33 bound to rat cyclophilin D is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJTTMugCPY6bVg90H21EOLACvtfcHk0liRVdAyUVLYcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsb3L&md5=80688933869bade9ce2684db9ca82cb6</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm500862r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500862r%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DTjandra%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBednarczyk%26aufirst%3DD.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DElling%26aufirst%3DR.%26aulast%3DHanna%26aufirst%3DI.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DFuregati%26aufirst%3DM.%26aulast%3DKarur%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DT.%26aulast%3DKnapp%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DMiault%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWiedmann%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DPotent%2520Nonimmunosuppressive%2520Cyclophilin%2520Inhibitors%2520with%2520Improved%2520Pharmaceutical%2520Properties%2520and%2520Decreased%2520Transporter%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8503%26epage%3D8516%26doi%3D10.1021%2Fjm500862r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepanier, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ure, D. R.</span></span> <span> </span><span class="NLM_article-title">A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>371</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.261099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1124%2Fjpet.119.261099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=31406003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2019&pages=231-241&issue=2&author=J.+Kuoauthor=M.+Bobardtauthor=U.+Chatterjiauthor=P.+R.+Mayoauthor=D.+J.+Trepanierauthor=R.+T.+Fosterauthor=P.+Gallayauthor=D.+R.+Ure&title=A+Pan-Cyclophilin+Inhibitor%2C+CRV431%2C+Decreases+Fibrosis+and+Tumor+Development+in+Chronic+Liver+Disease+Models&doi=10.1124%2Fjpet.119.261099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">A pan-cyclophilin inhibitor, CRV431, decreases fibrosis and tumor development in chronic liver disease modelss</span></div><div class="casAuthors">Kuo, Joseph; Bobardt, Michael; Chatterji, Udayan; Mayo, Patrick R.; Trepanier, Daniel J.; Foster, Robert T.; Gallay, Philippe; Ure, Daren R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-241</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous studies show that cyclophilins contribute to many pathol. processes, and cyclophilin inhibitors demonstrate therapeutic activities in many exptl. models.  However, no drug with cyclophilin inhibition as the primary mode of action has advanced completely through clin. development to market.  In this study, we present findings on the cyclophilin inhibitor, CRV431, that highlight its potential as a drug candidate for chronic liver diseases.  CRV431 was found to potently inhibit all cyclophilin isoforms tested-A, B, D, and G.  Inhibitory const. or IC50 values ranged from 1 to 7 nM, which was up to 13 times more potent than the parent compd., cyclosporine A (CsA), from which CRV431 was derived.  Other CRV431 advantages over CsA as a nontransplant drug candidate were significantly diminished immunosuppressive activity, less drug transporter inhibition, and reduced cytotoxicity potential.  Oral dosing to mice and rats led to good blood exposures and a 5- to 15-fold accumulation of CRV431 in liver compared with blood concns. across a wide range of CRV431 dosing levels.  Most importantly, CRV431 decreased liver fibrosis in a 6-wk carbon tetrachloride model and in a mouse model of nonalcoholic steatohepatitis (NASH).  Addnl., CRV431 administration during a late, oncogenic stage of the NASH disease model resulted in a 50% redn. in the no. and size of liver tumors.  These findings are consistent with CRV431 targeting fibrosis and cancer through multiple, cyclophilin-mediated mechanisms and support the development of CRV431 as a safe and effective drug candidate for liver diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY9VqpwJ0rObVg90H21EOLACvtfcHk0lhJqJ55sYCObQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmtrfM&md5=808c7817c15ed6c84393f0f4bced2485</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.261099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.261099%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DJ.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DMayo%26aufirst%3DP.%2BR.%26aulast%3DTrepanier%26aufirst%3DD.%2BJ.%26aulast%3DFoster%26aufirst%3DR.%2BT.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DUre%26aufirst%3DD.%2BR.%26atitle%3DA%2520Pan-Cyclophilin%2520Inhibitor%252C%2520CRV431%252C%2520Decreases%2520Fibrosis%2520and%2520Tumor%2520Development%2520in%2520Chronic%2520Liver%2520Disease%2520Models%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26volume%3D371%26issue%3D2%26spage%3D231%26epage%3D241%26doi%3D10.1124%2Fjpet.119.261099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatsch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmid, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiestand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaksche, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peichl, P.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Human Immunodeficiency Virus Type 1 Replication by SDZ NIM 811, a Nonimmunosuppressive Cyclosporine Analog</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1763</span>– <span class="NLM_lpage">1772</span>, <span class="refDoi"> DOI: 10.1128/AAC.38.8.1763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.38.8.1763" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7527198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXlvFGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=1763-1772&issue=8&author=B.+Rosenwirthauthor=A.+Billichauthor=R.+Datemaauthor=P.+Donatschauthor=F.+Hammerschmidauthor=R.+Harrisonauthor=P.+Hiestandauthor=H.+Jakscheauthor=P.+Mayerauthor=P.+Peichl&title=Inhibition+of+Human+Immunodeficiency+Virus+Type+1+Replication+by+SDZ+NIM+811%2C+a+Nonimmunosuppressive+Cyclosporine+Analog&doi=10.1128%2FAAC.38.8.1763"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppresive cyclosporine analog</span></div><div class="casAuthors">Rosenwirth, Brigitte; Billich, Andreas; Datema, Roelf; Donatsch, Peter; Hammerschmid, Franz; Harrison, Richard; Hiestand, Peter; Jaksche, Herbert; Mayer, Peter; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1763-72</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    </div><div class="casAbstract">(Me-Ile-4)cyclosporin (SDZ NIM 811) is a 4-substituted cyclosporin which is devoid of immunosuppressive activity but retains full capacity for binding to cyclophilin and exhibits potent anti-human immunodeficiency virus type 1 (HIV-1) activity.  SDZ NIM 811 selectively inhibits HIV-1 replication in T4 lymphocyte cell lines, in a monocytic cell line, and in HeLa T4 cells.  Furthermore, its antiviral activity against lab. strains and against clin. isolates from geog. distinct regions in primary T4 lymphocytes and in primary monocytes (50 inhibitory concn. = 0.011 to 0.057 μg/mL) was demonstrated.  SDZ NIM 811 does not inhibit proviral gene expression or virus-specific enzyme functions, either free or bound to cyclophilin.  The compd. does not influence CD4 expression or inhibit fusion between virus-infected ad uninfected cells.  SDZ NIM 811 was, however, found to block formation of infectious particles from chronically infected cells.  Oral administration to mice, rats, dogs and monkeys resulted in levels in blood considerably exceeding the drug concn., which completely blocked virus replication in primary cells.  SDZ NIM 811 caused changes of toxicity parameters in rats to a smaller degree than cyclosporine (formerly cyclosporin A).  Thus, the potent and selective anti-HIV-1 activity of SDZ NIM 811 and its favorable pharmacokinetic behavior together with its lower nephrotoxicity than that of cyclosporine make this compd. a promising candidate for development as an anti-HIV drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXexjevqslpLVg90H21EOLACvtfcHk0lhJqJ55sYCObQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlvFGjtrY%253D&md5=bcd9550aed98340fc820e7ef9dc5bd77</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1128%2FAAC.38.8.1763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.38.8.1763%26sid%3Dliteratum%253Aachs%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DDatema%26aufirst%3DR.%26aulast%3DDonatsch%26aufirst%3DP.%26aulast%3DHammerschmid%26aufirst%3DF.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DJaksche%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DPeichl%26aufirst%3DP.%26atitle%3DInhibition%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Type%25201%2520Replication%2520by%2520SDZ%2520NIM%2520811%252C%2520a%2520Nonimmunosuppressive%2520Cyclosporine%2520Analog%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1994%26volume%3D38%26issue%3D8%26spage%3D1763%26epage%3D1772%26doi%3D10.1128%2FAAC.38.8.1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosli, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawen, A.</span></span> <span> </span><span class="NLM_article-title">[Melle4]Cyclosporin, a Novel Natural Cyclosporin with Anti-HIV Activity: Structural Elucidation, Biosynthesis and Biological Properties</span>. <i>Antiviral Chem. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1177/095632029400500507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1177%2F095632029400500507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2cXmslWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=331-339&issue=5&author=R.+Traberauthor=H.+Kobelauthor=H.+R.+Loosliauthor=H.+Sennauthor=B.+Rosenwirthauthor=A.+Lawen&title=%5BMelle4%5DCyclosporin%2C+a+Novel+Natural+Cyclosporin+with+Anti-HIV+Activity%3A+Structural+Elucidation%2C+Biosynthesis+and+Biological+Properties&doi=10.1177%2F095632029400500507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">[Melle4]Cyclosporin, a novel natural cyclosporin with anti-HIV activity: structural elucidation, biosynthesis and biological properties</span></div><div class="casAuthors">Traber, R.; Kobel, H.; Loosli, H.-R.; Senn, H.; Rosenwirth, B.; Lawen, A.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">331-9</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    </div><div class="casAbstract">From fermns. of Tolypocladium niveum supplemented with D-threonine, a novel natural cyclosporin, [Melle4]cyclosporin, was isolated.  Its structural elucidation is based on amino acid anal. and spectroscopic data; the amino acid sequence was deduced from two-dimensional NMR investigations applied to the iso-deriv. of [Melle4]cyclosporin which, in contrast to the natural product, is present as one homogeneous conformation in soln.  We show that one of the four N-methyl-L-leucine units of cyclosporin A, namely that in position 4, is replaced by N-methyl-L-isoleucine.  The putative mechanism by which D-threonine induces in vivo biosynthesis of [Melle4]cyclosporin was achieved using the previously described enzymic system, thereby demonstrating the high affinity of cyclosporin synthetase for isoleucine in position 4.  In a long series of cyclosporins obtained by in vitro and in vivo biosynthesis, [Melle4]cyclosporin represents the first example that is devoid of immunosuppressive efficacy while retaining strong binding to cyclophilin.  It exerts potent in vitro anti-HIV-1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrew2_oamlMRrVg90H21EOLACvtfcHk0lhJqJ55sYCObQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslWgtro%253D&md5=4fcf3c537311da87b4a32e14301135c7</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1177%2F095632029400500507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F095632029400500507%26sid%3Dliteratum%253Aachs%26aulast%3DTraber%26aufirst%3DR.%26aulast%3DKobel%26aufirst%3DH.%26aulast%3DLoosli%26aufirst%3DH.%2BR.%26aulast%3DSenn%26aufirst%3DH.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DLawen%26aufirst%3DA.%26atitle%3D%255BMelle4%255DCyclosporin%252C%2520a%2520Novel%2520Natural%2520Cyclosporin%2520with%2520Anti-HIV%2520Activity%253A%2520Structural%2520Elucidation%252C%2520Biosynthesis%2520and%2520Biological%2520Properties%26jtitle%3DAntiviral%2520Chem.%2520Chemother.%26date%3D1994%26volume%3D5%26issue%3D5%26spage%3D331%26epage%3D339%26doi%3D10.1177%2F095632029400500507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poullennec, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01329</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01329" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptlWrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1000-1017&issue=3&author=V.+A.+Steadmanauthor=S.+B.+Pettitauthor=K.+G.+Poullennecauthor=L.+Lazaridesauthor=A.+J.+Keatsauthor=D.+K.+Deanauthor=S.+J.+Stanwayauthor=C.+A.+Austinauthor=J.+A.+Sanvoisinauthor=G.+M.+Wattauthor=H.+G.+Fliriauthor=A.+C.+Liclicanauthor=D.+Jinauthor=M.+H.+Wongauthor=S.+A.+Leavittauthor=Y.+J.+Leeauthor=Y.+Tianauthor=C.+R.+Freyauthor=T.+C.+Applebyauthor=U.+Schmitzauthor=P.+Jansaauthor=R.+L.+Mackmanauthor=B.+E.+Schultz&title=Discovery+of+Potent+Cyclophilin+Inhibitors+Based+on+the+Structural+Simplification+of+Sanglifehrin+A&doi=10.1021%2Facs.jmedchem.6b01329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A</span></div><div class="casAuthors">Steadman, Victoria A.; Pettit, Simon B.; Poullennec, Karine G.; Lazarides, Linos; Keats, Andrew J.; Dean, David K.; Stanway, Steven J.; Austin, Carol A.; Sanvoisin, Jonathan A.; Watt, Gregory M.; Fliri, Hans G.; Liclican, Albert C.; Jin, Debi; Wong, Melanie H.; Leavitt, Stephanie A.; Lee, Yu-Jen; Tian, Yang; Frey, Christian R.; Appleby, Todd C.; Schmitz, Uli; Jansa, Petr; Mackman, Richard L.; Schultz, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1000-1017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclophilin inhibition has been a target for the treatment of hepatitis C and other diseases, but the generation of potent, drug-like mols. through chem. synthesis has been challenging.  In this study, a set of macrocyclic cyclophilin inhibitors was synthesized based on the core structure of the natural product sanglifehrin A.  Initial compd. optimization identified the valine-m-tyrosine-piperazic acid tripeptide (Val-m-Tyr-Pip) in the sanglifehrin core, stereocenters at C14 and C15, and the hydroxyl group of the m-tyrosine (m-Tyr) residue as key contributors to compd. potency.  Replacing the C18-C21 diene unit of sanglifehrin with a styryl group led to potent compds. that displayed a novel binding mode in which the styrene moiety engaged in a π-stacking interaction with Arg55 of cyclophilin A (Cyp A), and the m-Tyr residue was displaced into solvent.  This observation allowed further simplifications of the scaffold to generate new lead compds. in the search for orally bioavailable cyclophilin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorJXRBXLoC-rVg90H21EOLACvtfcHk0ljfI00FgWmxYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptlWrsg%253D%253D&md5=7b3c1ccee76ff6da98064783c0710fd6</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01329%26sid%3Dliteratum%253Aachs%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DPettit%26aufirst%3DS.%2BB.%26aulast%3DPoullennec%26aufirst%3DK.%2BG.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DA.%2BJ.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26aulast%3DSanvoisin%26aufirst%3DJ.%2BA.%26aulast%3DWatt%26aufirst%3DG.%2BM.%26aulast%3DFliri%26aufirst%3DH.%2BG.%26aulast%3DLiclican%26aufirst%3DA.%2BC.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLeavitt%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DFrey%26aufirst%3DC.%2BR.%26aulast%3DAppleby%26aufirst%3DT.%2BC.%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520Potent%2520Cyclophilin%2520Inhibitors%2520Based%2520on%2520the%2520Structural%2520Simplification%2520of%2520Sanglifehrin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D3%26spage%3D1000%26epage%3D1017%26doi%3D10.1021%2Facs.jmedchem.6b01329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span> <span> </span><span class="NLM_article-title">Profile of Alisporivir and its Potential in the Treatment of Hepatitis C</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S30946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.2147%2FDDDT.S30946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23440335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslCitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=105-115&author=P.+A.+Gallayauthor=K.+Lin&title=Profile+of+Alisporivir+and+its+Potential+in+the+Treatment+of+Hepatitis+C&doi=10.2147%2FDDDT.S30946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Profile of alisporivir and its potential in the treatment of hepatitis C</span></div><div class="casAuthors">Gallay, Philippe A.; Lin, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-115</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Two classes of hepatitis C antiviral agents currently exist, i.e., direct-acting antivirals and host-targeting antivirals.  Direct-acting antivirals target viral proteins including NS3/NS4A protease, NS5B polymerase and NS5A protein, while host-targeting antivirals target various host proteins crit. for replication of the hepatitis C virus (HCV).  Alisporivir is the most advanced host-targeting antiviral in clin. development.  Alisporivir blocks HCV replication by neutralizing the peptidyl-prolyl isomerase activity of the abundant host cytosolic protein, cyclophilin A.  Due to its unique mechanism of antiviral action, alisporivir is pangenotypic, provides a high barrier for development of viral resistance, and does not permit cross-resistance to direct-acting antivirals.  Alisporivir has an excellent pharmacokinetic and safety profile.  Phase I and II clin. studies have demonstrated that alisporivir causes a dramatic redn. in viral loads in HCV-infected patients.  Alisporivir was shown to be highly potent in treatment-naive and treatment-experienced patients with genotype 1 as well as in those with genotypes 2 or 3.  Low viral breakthrough rates were obsd. and the most frequent clin. and lab. adverse events assocd. with alisporivir in combination with pegylated interferon-alpha and ribavirin were similar to those assocd. with pegylated interferon-alpha and ribavirin used alone.  A lab. abnormality obsd. in some patients receiving alisporivir is hyperbilirubinemia, which is related to transporter inhibition and not to liver toxicity.  The most recent clin. results suggest that alisporivir plus other direct-acting antivirals should provide a successful treatment option for difficult-to-treat populations, such as nonresponders to prior interferon-alpha therapy and patients with cirrhosis.  In conclusion, alisporivir represents an attractive candidate component of future interferon-free regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-CPcaDXEJbVg90H21EOLACvtfcHk0ljfI00FgWmxYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslCitrY%253D&md5=e1f3a8dc6bdbd47b845bcc3f6af5381d</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S30946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S30946%26sid%3Dliteratum%253Aachs%26aulast%3DGallay%26aufirst%3DP.%2BA.%26aulast%3DLin%26aufirst%3DK.%26atitle%3DProfile%2520of%2520Alisporivir%2520and%2520its%2520Potential%2520in%2520the%2520Treatment%2520of%2520Hepatitis%2520C%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2013%26volume%3D7%26spage%3D105%26epage%3D115%26doi%3D10.2147%2FDDDT.S30946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poullennec, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannizzaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiva, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunbar, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fliri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Highton, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanvoisin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9473</span>– <span class="NLM_lpage">9499</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00802</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00802" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVChtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9473-9499&issue=21&author=R.+L.+Mackmanauthor=V.+A.+Steadmanauthor=D.+K.+Deanauthor=P.+Jansaauthor=K.+G.+Poullennecauthor=T.+Applebyauthor=C.+Austinauthor=C.+A.+Blakemoreauthor=R.+Caiauthor=C.+Cannizzaroauthor=G.+Chinauthor=J.+C.+Chivaauthor=N.+A.+Dunbarauthor=H.+Fliriauthor=A.+J.+Hightonauthor=H.+Huiauthor=M.+Jiauthor=H.+Jinauthor=K.+Karkiauthor=A.+J.+Keatsauthor=L.+Lazaridesauthor=Y.+J.+Leeauthor=A.+Liclicanauthor=M.+Mishauthor=B.+Murrayauthor=S.+B.+Pettitauthor=P.+Pyunauthor=M.+Sangiauthor=R.+Santosauthor=J.+Sanvoisinauthor=U.+Schmitzauthor=A.+Schrierauthor=D.+Siegelauthor=D.+Sperandioauthor=G.+Stepanauthor=Y.+Tianauthor=G.+M.+Wattauthor=H.+Yangauthor=B.+E.+Schultz&title=Discovery+of+a+Potent+and+Orally+Bioavailable+Cyclophilin+Inhibitor+Derived+from+the+Sanglifehrin+Macrocycle&doi=10.1021%2Facs.jmedchem.8b00802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and orally bioavailable cyclophilin inhibitor derived from the sanglifehrin macrocycle</span></div><div class="casAuthors">Mackman, Richard L.; Steadman, Victoria A.; Dean, David K.; Jansa, Petr; Poullennec, Karine G.; Appleby, Todd; Austin, Carol; Blakemore, Caroline A.; Cai, Ruby; Cannizzaro, Carina; Chin, Gregory; Chiva, Jean-Yves C.; Dunbar, Neil A.; Fliri, Hans; Highton, Adrian J.; Hui, Hon; Ji, Mingzhe; Jin, Haolun; Karki, Kapil; Keats, Andrew J.; Lazarides, Linos; Lee, Yu-Jen; Liclican, Albert; Mish, Michael; Murray, Bernard; Pettit, Simon B.; Pyun, Peter; Sangi, Michael; Santos, Rex; Sanvoisin, Jonathan; Schmitz, Uli; Schrier, Adam; Siegel, Dustin; Sperandio, David; Stepan, George; Tian, Yang; Watt, Gregory M.; Yang, Hai; Schultz, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9473-9499</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclophilins are a family of peptidyl-prolyl isomerases that are implicated in a wide range of diseases including hepatitis C.  Our aim was to discover through total synthesis an orally bioavailable, non-immunosuppressive cyclophilin (Cyp) inhibitor with potent anti-hepatitis C virus (HCV) activity that could serve as part of an all oral antiviral combination therapy.  An initial lead (I) derived from the sanglifehrin A macrocycle was optimized using structure based design to produce a potent and orally bioavailable inhibitor (II).  The macrocycle ring size was reduced by one atom, and an internal hydrogen bond drove improved permeability and drug-like properties. II demonstrates potent Cyp inhibition (Kd = 5 nM), potent anti-HCV 2a activity (EC50 = 98 nM), and high oral bioavailability in rat (100%) and dog (55%).  The synthetic accessibility and properties of II support its potential as an anti-HCV agent and for interrogating the role of Cyp inhibition in a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEpEZcwXK8z7Vg90H21EOLACvtfcHk0lhW3cKIv1wH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVChtbrI&md5=616cf72e0d2766e159769166c98a9e86</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00802%26sid%3Dliteratum%253Aachs%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSteadman%26aufirst%3DV.%2BA.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DPoullennec%26aufirst%3DK.%2BG.%26aulast%3DAppleby%26aufirst%3DT.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBlakemore%26aufirst%3DC.%2BA.%26aulast%3DCai%26aufirst%3DR.%26aulast%3DCannizzaro%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DG.%26aulast%3DChiva%26aufirst%3DJ.%2BC.%26aulast%3DDunbar%26aufirst%3DN.%2BA.%26aulast%3DFliri%26aufirst%3DH.%26aulast%3DHighton%26aufirst%3DA.%2BJ.%26aulast%3DHui%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DKeats%26aufirst%3DA.%2BJ.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DMish%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DPettit%26aufirst%3DS.%2BB.%26aulast%3DPyun%26aufirst%3DP.%26aulast%3DSangi%26aufirst%3DM.%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DSanvoisin%26aufirst%3DJ.%26aulast%3DSchmitz%26aufirst%3DU.%26aulast%3DSchrier%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DD.%26aulast%3DStepan%26aufirst%3DG.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWatt%26aufirst%3DG.%2BM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Orally%2520Bioavailable%2520Cyclophilin%2520Inhibitor%2520Derived%2520from%2520the%2520Sanglifehrin%2520Macrocycle%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D21%26spage%3D9473%26epage%3D9499%26doi%3D10.1021%2Facs.jmedchem.8b00802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallansch, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalfaro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besseghir, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P. A.</span></span> <span> </span><span class="NLM_article-title">Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-Cyclophilin-Resistant in Owl Monkey Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">40293</span>– <span class="NLM_lpage">40300</span>, <span class="refDoi"> DOI: 10.1074/jbc.M506314200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M506314200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16199531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Gjs7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=40293-40300&issue=48&author=U.+Chatterjiauthor=M.+D.+Bobardtauthor=R.+Stanfieldauthor=R.+G.+Ptakauthor=L.+A.+Pallanschauthor=P.+A.+Wardauthor=M.+J.+Jonesauthor=C.+A.+Stoddartauthor=P.+Scalfaroauthor=J.+M.+Dumontauthor=K.+Besseghirauthor=B.+Rosenwirthauthor=P.+A.+Gallay&title=Naturally+Occurring+Capsid+Substitutions+Render+HIV-1+Cyclophilin+A+Independent+in+Human+Cells+and+TRIM-Cyclophilin-Resistant+in+Owl+Monkey+Cells&doi=10.1074%2Fjbc.M506314200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells</span></div><div class="casAuthors">Chatterji, Udayan; Bobardt, Michael D.; Stanfield, Robyn; Ptak, Roger G.; Pallansch, Luke A.; Ward, Priscilla A.; Jones, Maureen J.; Stoddart, Cheryl A.; Scalfaro, Pietro; Dumont, Jean-Maurice; Besseghir, Kamel; Rosenwirth, Brigitte; Gallay, Philippe A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">40293-40300</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">In this study, we asked if a naturally occurring HIV-1 variant exists that circumvents CypA dependence in human cells.  To address this issue, we sought viruses for CypA independence using Debio-025, a cyclosporine A (CsA) analog that disrupts CypA-capsid interaction.  Surprisingly, viral variants from the Main group replicate even in the presence of the drug.  Sequencing analyses revealed that these viruses encode capsid substitutions within the CypA-binding site (V86P/H87Q/I91V/M96I).  When we introduced these substitutions into viruses that normally rely on CypA for replication, these mutants no longer depended on CypA, suggesting that naturally occurring capsid substitutions obviate the need for CypA.  This is the first demonstration that isolates from the Main group naturally develop CypA-independent strategies to replicate in human cells.  Surprisingly, we found that these capsid substitutions render HIV-1 capable of infecting Owl monkey (OMK) cells that highly restrict HIV-1.  OMK cell resistance to HIV-1 is mediated via TRIM-Cyp, which arose from a retrotransposition of CypA into the TRIM5 α gene.  Interestingly, satn. expts. suggest that the Pro86/Gln87/Val91/Ile96 capsid core is "invisible" to TRIM-Cyp.  This study demonstrates that specific capsid substitutions can release HIV-1 from both CypA dependence in human cells and TRIM-Cyp restriction in monkey cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojVkKwpMEydbVg90H21EOLACvtfcHk0lhW3cKIv1wH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Gjs7vN&md5=9fa9607b2ba33c28d7f82e2ef7afc101</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M506314200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M506314200%26sid%3Dliteratum%253Aachs%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DBobardt%26aufirst%3DM.%2BD.%26aulast%3DStanfield%26aufirst%3DR.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DPallansch%26aufirst%3DL.%2BA.%26aulast%3DWard%26aufirst%3DP.%2BA.%26aulast%3DJones%26aufirst%3DM.%2BJ.%26aulast%3DStoddart%26aufirst%3DC.%2BA.%26aulast%3DScalfaro%26aufirst%3DP.%26aulast%3DDumont%26aufirst%3DJ.%2BM.%26aulast%3DBesseghir%26aufirst%3DK.%26aulast%3DRosenwirth%26aufirst%3DB.%26aulast%3DGallay%26aufirst%3DP.%2BA.%26atitle%3DNaturally%2520Occurring%2520Capsid%2520Substitutions%2520Render%2520HIV-1%2520Cyclophilin%2520A%2520Independent%2520in%2520Human%2520Cells%2520and%2520TRIM-Cyclophilin-Resistant%2520in%2520Owl%2520Monkey%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D48%26spage%3D40293%26epage%3D40300%26doi%3D10.1074%2Fjbc.M506314200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawitz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godofsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praestgaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, T. G.</span></span> <span> </span><span class="NLM_article-title">Safety, Pharmacokinetics, and Antiviral Activity of the Cyclophilin Inhibitor NIM811 Alone or in Combination with Pegylated Interferon in HCV-Infected Patients Receiving 14 Days of Therapy</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2011.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.antiviral.2011.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21255610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVymtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=238-245&issue=3&author=E.+Lawitzauthor=E.+Godofskyauthor=R.+Rouzierauthor=T.+Marburyauthor=T.+Nguyenauthor=J.+Keauthor=M.+Huangauthor=J.+Praestgaardauthor=D.+Serraauthor=T.+G.+Evans&title=Safety%2C+Pharmacokinetics%2C+and+Antiviral+Activity+of+the+Cyclophilin+Inhibitor+NIM811+Alone+or+in+Combination+with+Pegylated+Interferon+in+HCV-Infected+Patients+Receiving+14+Days+of+Therapy&doi=10.1016%2Fj.antiviral.2011.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy</span></div><div class="casAuthors">Lawitz, Eric; Godofsky, Eliot; Rouzier, Regine; Marbury, Thomas; Nguyen, Tuan; Ke, June; Huang, Mei Mei; Praestgaard, Jens; Serra, Denise; Evans, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-245</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: Cyclophilin inhibitors have shown activity against a variety of viruses, including HCV.  NIM811, a novel, non-immunosuppressive cyclophilin inhibitor was studied in ascending doses in a randomized, double-blind, placebo-controlled 14-day trial in genotype 1 HCV patients.  Doses of 10 up to 600 mg were given orally once or twice daily as monotherapy (9:3 randomization of NIM811:placebo). 600 mg or placebo bid for 14 days was then co-administered with pegylated interferon α (PEG-IFN-α) administered on days 1 and 8 to genotype 1 relapsers.  Results: NIM811 was well tolerated at all doses.  Although lack of antiviral effect was noted in the monotherapy arms, liver transaminase normalization occurred at doses over 75 mg.  Mild, clin. non-significant elevations of bilirubin, and significant declines in platelet nos. were obsd. in the 400 and 600 mg bid groups.  In the combination group, the mean HCV RNA decline was 2.85 log, compared to a 0.56 log in the PEG-IFN alone arm.  The mean ALT (alanine transaminase) declined significantly by day 14 in the combination, but was unchanged in the PEG-IFN alone group.  In the combination therapy group, the mean platelets were 203 × 109/L at baseline and fell to 105 × 109/L by day 14; for patients treated with PEG-IFN the values were 177 × 109 and 139 × 109/L.  There was a significant increase in bilirubin, although this did not reach clin. concerning levels.  There were no severe or serious adverse events.  The pharmacokinetics in both monotherapy and combination arms were dose linear and not affected by PEG-INF.  Conclusion: NIM811 monotherapy resulted in a normalization of liver transaminases in the absence of significant virol. response.  The combination of NIM811 and pegylated interferon-α showed significant antiviral activity compared to interferon alone in genotype 1 HCV relapsers.  The use of oral cyclophilin inhibitors as part of a combination regime for treatment of hepatitis C, esp. to deter resistance, holds promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfmLT5LneqM7Vg90H21EOLACvtfcHk0lhW3cKIv1wH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVymtL0%253D&md5=a11997c788ef8b85f345fb2230ddbc60</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2011.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2011.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DGodofsky%26aufirst%3DE.%26aulast%3DRouzier%26aufirst%3DR.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DKe%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DPraestgaard%26aufirst%3DJ.%26aulast%3DSerra%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DT.%2BG.%26atitle%3DSafety%252C%2520Pharmacokinetics%252C%2520and%2520Antiviral%2520Activity%2520of%2520the%2520Cyclophilin%2520Inhibitor%2520NIM811%2520Alone%2520or%2520in%2520Combination%2520with%2520Pegylated%2520Interferon%2520in%2520HCV-Infected%2520Patients%2520Receiving%252014%2520Days%2520of%2520Therapy%26jtitle%3DAntiviral%2520Res.%26date%3D2011%26volume%3D89%26issue%3D3%26spage%3D238%26epage%3D245%26doi%3D10.1016%2Fj.antiviral.2011.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin Inhibitors: an Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2558</span>– <span class="NLM_lpage">2577</span>, <span class="refDoi"> DOI: 10.3390/v4112558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.3390%2Fv4112558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23202494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=2558-2577&issue=11&author=S.+Hopkinsauthor=P.+Gallay&title=Cyclophilin+Inhibitors%3A+an+Emerging+Class+of+Therapeutics+for+the+Treatment+of+Chronic+Hepatitis+C+Infection&doi=10.3390%2Fv4112558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection</span></div><div class="casAuthors">Hopkins, Sam; Gallay, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2558-2577</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The advent of the replicon system together with advances in cell culture have contributed significantly to our understanding of the function of virally-encoded structural and nonstructural proteins in the replication cycle of the hepatitis C virus.  In addn., in vitro systems have been used to identify several host proteins whose expression is crit. for supporting such diverse activities as viral entry, RNA replication, particle assembly and the release of infectious virions.  Among all known host proteins that participate in the HCV replication cycle, cyclophilins are unique because they constitute the only host target that has formed the basis of pharmaceutical drug discovery and drug development programs.  The introduction of the nonimmunosuppressive cyclophilin inhibitors into clin. testing has confirmed the clin. utility of CsA-based inhibitors for the treatment of individuals with chronic hepatitis C infection and has yielded new insights into their mechanism(s) of action.  This review describes the biochem. evidence for the potential roles played by cyclophilins in supporting HCV RNA replication and summarizes clin. trial results obtained with the first generation of nonimmunosuppressive cyclophilin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZzgAJ1L1MN7Vg90H21EOLACvtfcHk0lisL5g16K16Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSrtrrE&md5=ec08cd3fcb01f3d38ee8a04e98c9195a</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.3390%2Fv4112558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv4112558%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DS.%26aulast%3DGallay%26aufirst%3DP.%26atitle%3DCyclophilin%2520Inhibitors%253A%2520an%2520Emerging%2520Class%2520of%2520Therapeutics%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Hepatitis%2520C%2520Infection%26jtitle%3DViruses%26date%3D2012%26volume%3D4%26issue%3D11%26spage%3D2558%26epage%3D2577%26doi%3D10.3390%2Fv4112558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flisiak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaroszewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flisiak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapinski, T.</span></span> <span> </span><span class="NLM_article-title">Update on Alisporivir in Treatment of Viral Hepatitis C</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1517/13543784.2012.658641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1517%2F13543784.2012.658641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22316207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFSrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=375-382&issue=3&author=R.+Flisiakauthor=J.+Jaroszewiczauthor=I.+Flisiakauthor=T.+Lapinski&title=Update+on+Alisporivir+in+Treatment+of+Viral+Hepatitis+C&doi=10.1517%2F13543784.2012.658641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Update on in treatment of viral hepatitis C</span></div><div class="casAuthors">Flisiak, Robert; Jaroszewicz, Jerzy; Flisiak, Iwona; Lapinnski, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-382</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: There are two classes of anti-hepatitis C virus (HCV) agents currently in development: direct-acting antivirals (DAA) and host-targeting antivirals (HTA).  Cyclophilin inhibitor , previously known as Debio-025 is the most advanced HTA in development.Areas covered: Exptl. and clin. studies demonstrated that ALV has high genetic barrier and no cross-resistance to DAA.  Pharmacokinetic studies showed a profile suitable for once-daily administration.  Phase I and II studies confirmed strong HCV suppression and that addn. of ALV to pegylated IFNα (PegIFNα) and ribavirin (RBV) can improve their efficacy significantly.  ALV was well tolerated and prevalence of the most frequent clin. and lab. adverse events was similar to PegIFNα/RBV.  Hyperbilirubinemia was the only significant adverse event related to ALV, but it was transient, reversible and not assocd. with hepatotoxicity or cholestasis.Expert opinion: ALV is pangenotypic, with once-daily administration and safe, therefore medication can be easy and flexible.  There is still a need of data in difficult-to-treat populations and genetic studies allowing selection of possible non-responders.  Registration of ALV for IFN-based treatment is expected within 3 years, but ALV is also a good candidate for IFN-sparing combinations with DAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBrbSV1cltlLVg90H21EOLACvtfcHk0lisL5g16K16Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFSrt7c%253D&md5=7431ebf29cbe1e8fdbe2c48235292213</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1517%2F13543784.2012.658641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2012.658641%26sid%3Dliteratum%253Aachs%26aulast%3DFlisiak%26aufirst%3DR.%26aulast%3DJaroszewicz%26aufirst%3DJ.%26aulast%3DFlisiak%26aufirst%3DI.%26aulast%3DLapinski%26aufirst%3DT.%26atitle%3DUpdate%2520on%2520Alisporivir%2520in%2520Treatment%2520of%2520Viral%2520Hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26issue%3D3%26spage%3D375%26epage%3D382%26doi%3D10.1517%2F13543784.2012.658641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capparelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lochmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luneau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivkin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuerch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, Z. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjandra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yifru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurcher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallou, F.</span></span> <span> </span><span class="NLM_article-title">Development of a Cyclosporin A Derivative with Excellent Anti-Hepatitis C Virus Potency</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmc.2017.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28919180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFSrs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=957-969&issue=4&author=J.+Fuauthor=C.+Beckerauthor=L.+Caoauthor=M.+Capparelliauthor=R.+Denayauthor=R.+Fujimotoauthor=Y.+Gaiauthor=Z.+Gaoauthor=C.+Guenatauthor=S.+Karurauthor=H.+Kimauthor=W.+Liauthor=X.+Liauthor=W.+Liauthor=T.+Lochmannauthor=A.+Luauthor=P.+Luauthor=A.+Luneauauthor=N.+Meierauthor=W.+Mergoauthor=S.+Ngauthor=D.+Parkerauthor=Y.+Pengauthor=B.+Rissauthor=A.+Rivkinauthor=S.+Roggoauthor=H.+Schroederauthor=F.+Schuerchauthor=R.+L.+Simmonsauthor=F.+Sunauthor=Z.+K.+Sweeneyauthor=M.+Tjandraauthor=M.+Wangauthor=R.+Wangauthor=A.+H.+Weissauthor=N.+Wengerauthor=Q.+Wuauthor=X.+Xiongauthor=S.+Xuauthor=W.+Xuauthor=A.+Yifruauthor=J.+Zhaoauthor=J.+Zhouauthor=C.+Zurcherauthor=F.+Gallou&title=Development+of+a+Cyclosporin+A+Derivative+with+Excellent+Anti-Hepatitis+C+Virus+Potency&doi=10.1016%2Fj.bmc.2017.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potency</span></div><div class="casAuthors">Fu, Jiping; Becker, Christopher; Cao, Li; Capparelli, Michael; Denay, Regis; Fujimoto, Roger; Gai, Yu; Gao, Zhaobo; Guenat, Christian; Karur, Subramanian; Kim, Hongyong; Li, Weikuan; Li, Xiaolin; Li, Wei; Lochmann, Thomas; Lu, Amy; Lu, Peichao; Luneau, Alexandre; Meier, Nicole; Mergo, Wosenu; Ng, Simon; Parker, David; Peng, Yunshan; Riss, Bernard; Rivkin, Alexey; Roggo, Silvio; Schroeder, Harald; Schuerch, Friedrich; Simmons, Robert L.; Sun, Feng; Sweeney, Zachary K.; Tjandra, Meiliana; Wang, Michael; Wang, Ruidong; Weiss, Andrew H.; Wenger, Nicolas; Wu, Quanbing; Xiong, Xin; Xu, Su; Xu, Wenjian; Yifru, Aregahegn; Zhao, Jibin; Zhou, Jianguang; Zurcher, Christian; Gallou, Fabrice</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">957-969</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic modification of cyclosporin A at P3-P4 positions led to the discovery of NIM258, a next generation cyclophilin inhibitor with excellent anti-hepatitis C virus potency, with decreased transporter inhibition, and pharmacokinetics suitable for coadministration with other drugs.  Herein is disclosed the evolution of the synthetic strategy to from the original medicinal chem. route, designed for late diversification, to a convergent and robust development synthesis.  The chiral centers in the P4 fragment were constructed by an asym. chelated Claisen rearrangement in the presence of quinidine as the chiral ligand.  Identification of advanced cryst. intermediates enabled practical supply of key intermediates.  Finally, macrocyclization was carried out at 10% wt. concn. by a general and unconventional "slow release" concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiv_fCt-rcP7Vg90H21EOLACvtfcHk0lisL5g16K16Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFSrs7jL&md5=e9c4d273d2c88444436a3050a77a2589</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DCapparelli%26aufirst%3DM.%26aulast%3DDenay%26aufirst%3DR.%26aulast%3DFujimoto%26aufirst%3DR.%26aulast%3DGai%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DGuenat%26aufirst%3DC.%26aulast%3DKarur%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLochmann%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DLuneau%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DN.%26aulast%3DMergo%26aufirst%3DW.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DRiss%26aufirst%3DB.%26aulast%3DRivkin%26aufirst%3DA.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DSchroeder%26aufirst%3DH.%26aulast%3DSchuerch%26aufirst%3DF.%26aulast%3DSimmons%26aufirst%3DR.%2BL.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTjandra%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DA.%2BH.%26aulast%3DWenger%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DZurcher%26aufirst%3DC.%26aulast%3DGallou%26aufirst%3DF.%26atitle%3DDevelopment%2520of%2520a%2520Cyclosporin%2520A%2520Derivative%2520with%2520Excellent%2520Anti-Hepatitis%2520C%2520Virus%2520Potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D4%26spage%3D957%26epage%3D969%26doi%3D10.1016%2Fj.bmc.2017.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin Cabrejas, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutzi Eme, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Sanglifehrin-Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-Ray Crystal Structure, and Binding Data</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3849</span>– <span class="NLM_lpage">3859</span>, <span class="refDoi"> DOI: 10.1021/ja021327y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja021327y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Oqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=3849-3859&issue=13&author=R.+Sedraniauthor=J.+Kallenauthor=L.+M.+Martin+Cabrejasauthor=C.+D.+Papageorgiouauthor=F.+Seniaauthor=S.+Rohrbachauthor=D.+Wagnerauthor=B.+Thaiauthor=A.+M.+Jutzi+Emeauthor=J.+Franceauthor=L.+Obererauthor=G.+Rihsauthor=G.+Zenkeauthor=J.+Wagner&title=Sanglifehrin-Cyclophilin+Interaction%3A+Degradation+Work%2C+Synthetic+Macrocyclic+Analogues%2C+X-Ray+Crystal+Structure%2C+and+Binding+Data&doi=10.1021%2Fja021327y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Sanglifehrin-Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray Crystal Structure, and Binding Data</span></div><div class="casAuthors">Sedrani, Richard; Kallen, Joerg; Cabrejas, Luisa M. Martin; Papageorgiou, Charles D.; Senia, Francesco; Rohrbach, Stefan; Wagner, Dieter; Thai, Binh; Eme, Anne-Marie Jutzi; France, Julien; Oberer, Lukas; Rihs, Grety; Zenke, Gerhard; Wagner, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3849-3859</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sanglifehrin A (SFA) is a novel immunosuppressive natural product isolated from Streptomyces sp. A92-308110.  SFA has a very strong affinity for cyclophilin A (IC50 = 6.9±0.9 nM) but is structurally different from cyclosporin A (CsA) and exerts its immunosuppressive activity via a novel mechanism.  SFA has a complex mol. structure consisting of a 22-membered macrocycle, bearing in position 23 a nine-carbon tether terminated by a highly substituted spirobicyclic moiety.  Selective oxidative cleavage of the C26:C27 exocyclic double bond affords the spirolactam contg. fragment (I) and macrolide (II).  The affinity of II for cyclophilin (IC50 = 29±2.1 nM) is essentially identical to SFA, which indicates that the interaction between SFA and cyclophilin A is mediated exclusively by the macrocyclic portion of the mol.  This observation was confirmed by the x-ray crystal structure resolved at 2.1 Å of cyclophilin A complexed to macrolide (III), a close analog of II.  The x-ray crystal structure showed that macrolide III binds to the same deep hydrophobic pocket of cyclophilin A as CsA.  Addnl. valuable details of the structure-activity relation were obtained by two different chem. approaches: (1) degrdn. work on macrolide II or (2) synthesis of a library of macrolide analogs using the ring-closing metathesis reaction as the key step.  Altogether, it appears that the complex macrocyclic fragment of SFA is a highly optimized combination of multiple functionalities including an (E,E)-diene, a short polypropionate fragment, and an unusual tripeptide unit, which together provide an extremely strong affinity for cyclophilin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC0LnYEI6dN7Vg90H21EOLACvtfcHk0lhw0rcZ4cpX8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Oqsbo%253D&md5=4e474f008fc663b5ceefb3f8a027d81f</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fja021327y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja021327y%26sid%3Dliteratum%253Aachs%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DMartin%2BCabrejas%26aufirst%3DL.%2BM.%26aulast%3DPapageorgiou%26aufirst%3DC.%2BD.%26aulast%3DSenia%26aufirst%3DF.%26aulast%3DRohrbach%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DD.%26aulast%3DThai%26aufirst%3DB.%26aulast%3DJutzi%2BEme%26aufirst%3DA.%2BM.%26aulast%3DFrance%26aufirst%3DJ.%26aulast%3DOberer%26aufirst%3DL.%26aulast%3DRihs%26aufirst%3DG.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DSanglifehrin-Cyclophilin%2520Interaction%253A%2520Degradation%2520Work%252C%2520Synthetic%2520Macrocyclic%2520Analogues%252C%2520X-Ray%2520Crystal%2520Structure%252C%2520and%2520Binding%2520Data%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26issue%3D13%26spage%3D3849%26epage%3D3859%26doi%3D10.1021%2Fja021327y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedrani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span> <span> </span><span class="NLM_article-title">Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 A Resolution</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">21965</span>– <span class="NLM_lpage">21971</span>, <span class="refDoi"> DOI: 10.1074/jbc.M501623200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M501623200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=15772070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksl2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=21965-21971&issue=23&author=J.+Kallenauthor=R.+Sedraniauthor=G.+Zenkeauthor=J.+Wagner&title=Structure+of+Human+Cyclophilin+A+in+Complex+with+the+Novel+Immunosuppressant+Sanglifehrin+A+at+1.6+A+Resolution&doi=10.1074%2Fjbc.M501623200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 Å Resolution</span></div><div class="casAuthors">Kallen, Joerg; Sedrani, Richard; Zenke, Gerhard; Wagner, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">21965-21971</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sanglifehrin A (SFA) is a novel immunosuppressant isolated from Streptomyces sp. that binds strongly to the human immunophilin cyclophilin A (CypA).  SFA exerts its immunosuppressive activity through a mode of action different from that of all other known immunophilin-binding substances, namely cyclosporine A (CsA), FK506, and rapamycin.  The authors have detd. the crystal structure of human CypA in complex with SFA at 1.6 Å resoln.  The high resoln. of the structure revealed the abs. configuration at all 17 chiral centers of SFA as well as the details of the CypA/SFA interactions.  In particular, it was shown that the 22-membered macrocycle of SFA is deeply embedded in the same binding site as CsA and forms six direct hydrogen bonds with CypA.  The effector domain of SFA, on the other hand, has a chem. and three-dimensional structure very different from CsA, already strongly suggesting different immunosuppressive mechanisms.  Furthermore, two CypA·SFA complexes form a dimer in the crystal as well as in soln. as shown by light scattering and size exclusion chromatog. expts.  This observation raises the possibility that the dimer of CypA·SFA complexes is the mol. species mediating the immunosuppressive effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQPAV1em05LVg90H21EOLACvtfcHk0lhw0rcZ4cpX8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksl2hs7s%253D&md5=252fd4e34c59eefa8276fda3c61012db</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501623200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501623200%26sid%3Dliteratum%253Aachs%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520Human%2520Cyclophilin%2520A%2520in%2520Complex%2520with%2520the%2520Novel%2520Immunosuppressant%2520Sanglifehrin%2520A%2520at%25201.6%2520A%2520Resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D23%26spage%3D21965%26epage%3D21971%26doi%3D10.1074%2Fjbc.M501623200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Immecke, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechtel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoche, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackstein, H.</span></span> <span> </span><span class="NLM_article-title">The Cyclophilin-Binding Agent Sanglifehrin A is a Dendritic Cell Chemokine and Migration Inhibitor</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">e18406</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0018406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pone.0018406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21483789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVeltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18406&issue=3&author=S.+N.+Immeckeauthor=N.+Baalauthor=J.+Wilhelmauthor=J.+Bechtelauthor=A.+Knocheauthor=G.+Beinauthor=H.+Hackstein&title=The+Cyclophilin-Binding+Agent+Sanglifehrin+A+is+a+Dendritic+Cell+Chemokine+and+Migration+Inhibitor&doi=10.1371%2Fjournal.pone.0018406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor</span></div><div class="casAuthors">Immecke, Sabrina N.; Baal, Nelli; Wilhelm, Jochen; Bechtel, Juliane; Knoche, Angela; Bein, Gregor; Hackstein, Holger</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e18406</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Sanglifehrin A (SFA) is a cyclophilin-binding immunosuppressant but the immunobiol. of action is poorly understood.  We and others have reported that SFA inhibits IL-12 prodn. and antigen uptake in dendritic cells (DC) and exhibits lower activity against lymphocytes.  Here we show that SFA suppresses DC chemokine prodn. and migration.  Gene expression anal. and subsequent protein level confirmation revealed that SFA suppressed CCL5, CCL17, CCL19, CXCL9 and CXCL10 expression in human monocyte-derived DC (moDC).  A systems biol. anal., Onto Express, confirmed that SFA interferes with chemokine-chemokine receptor gene expression with the highest impact.  Direct comparison with the related agent cyclosporine A (CsA) and dexamethasone indicated that SFA uniquely suppresses moDC chemokine expression.  Competitive expts. with a 100-fold molar excess of CsA and with N-methyl-val-4-cyclosporin, representing a nonimmunosuppressive deriv. of CsA indicated chemokine suppression through a cyclophilin-A independent pathway.  Functional assays confirmed reduced migration of CD4+ Tcells and moDCs to supernatant of SFA-exposed moDCs.  Vice versa, SFA-exposed moDC exhibited reduced migration against CCL19.  Moreover, SFA suppressed expression of the ectoenzyme CD38 that was reported to regulate DC migration and cytokine prodn.  These results identify SFA as a DC chemokine and migration inhibitor and provide novel insight into the immunobiol. of SFA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob5W8lLIjWLLVg90H21EOLACvtfcHk0libmE_ejnmY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVeltLY%253D&md5=ecb412e2f51e18127acb196d74983123</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0018406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0018406%26sid%3Dliteratum%253Aachs%26aulast%3DImmecke%26aufirst%3DS.%2BN.%26aulast%3DBaal%26aufirst%3DN.%26aulast%3DWilhelm%26aufirst%3DJ.%26aulast%3DBechtel%26aufirst%3DJ.%26aulast%3DKnoche%26aufirst%3DA.%26aulast%3DBein%26aufirst%3DG.%26aulast%3DHackstein%26aufirst%3DH.%26atitle%3DThe%2520Cyclophilin-Binding%2520Agent%2520Sanglifehrin%2520A%2520is%2520a%2520Dendritic%2520Cell%2520Chemokine%2520and%2520Migration%2520Inhibitor%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3De18406%26doi%3D10.1371%2Fjournal.pone.0018406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strittmatter, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesniaux, V. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zurini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanglier, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehr, T.</span></span> <span> </span><span class="NLM_article-title">Sanglifehrin A, a Novel Cyclophilin-Binding Compound Showing Immunosuppressive Activity with a New Mechanism of Action</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>166</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">7165</span>– <span class="NLM_lpage">7171</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.166.12.7165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.4049%2Fjimmunol.166.12.7165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11390463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=7165-7171&issue=12&author=G.+Zenkeauthor=U.+Strittmatterauthor=S.+Fuchsauthor=V.+F.+Quesniauxauthor=V.+Brinkmannauthor=W.+Schulerauthor=M.+Zuriniauthor=A.+Enzauthor=A.+Billichauthor=J.+J.+Sanglierauthor=T.+Fehr&title=Sanglifehrin+A%2C+a+Novel+Cyclophilin-Binding+Compound+Showing+Immunosuppressive+Activity+with+a+New+Mechanism+of+Action&doi=10.4049%2Fjimmunol.166.12.7165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action</span></div><div class="casAuthors">Zenke, Gerhard; Strittmatter, Ulrike; Fuchs, Serge; Quesniaux, Valerie F. J.; Brinkmann, Volker; Schuler, Walter; Zurini, Mauro; Enz, Albert; Billich, Andreas; Sanglier, Jean-Jacques; Fehr, Theo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7165-7171</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The authors report here on the characterization of the novel immunosuppressant Sanglifehrin A (SFA).  SFA is a representative of a class of macrolides produced by actinomycetes that bind to cyclophilin A (CypA), the binding protein of the fungal cyclic peptide cyclosporin A (CsA).  SFA interacts with high affinity with the CsA binding side of CypA and inhibits its peptidyl-prolyl isomerase activity.  The mode of action of SFA is different from known immunosuppressive drugs.  It has no effect on the phosphatase activity of calcineurin, the target of the immunosuppressants CsA and FK506 when complexed to their binding proteins CypA and FK binding protein, resp.  Moreover, its effects are independent of binding of cyclophilin.  SFA inhibits alloantigen-stimulated T cell proliferation but acts at a later stage than CsA and FK506.  In contrast to these drugs, SFA does not affect IL-2 transcription or secretion.  However, it blocks IL-2-dependent proliferation and cytokine prodn. of T cells, in this respect resembling rapamycin.  SFA inhibits the proliferation of mitogen-activated B cells, but, unlike rapamycin, it has no effect on CD154/IL-4-induced Ab synthesis.  The activity of SFA is also different from that of other known late-acting immunosuppressants, e.g., mycophenolate mofetil or brequinar, as it does not affect de novo purine and pyrimidine biosynthesis.  In summary, the authors have identified a novel immunosuppressant, which represents, in addn. to CsA, FK506 and rapamycin, a fourth class of immunophilin-binding metabolites with a new, yet undefined mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0KrU7iDIlLLVg90H21EOLACvtfcHk0libmE_ejnmY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOntb0%253D&md5=b792dd757a17b1aa62e422080d27a6a3</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.166.12.7165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.166.12.7165%26sid%3Dliteratum%253Aachs%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DStrittmatter%26aufirst%3DU.%26aulast%3DFuchs%26aufirst%3DS.%26aulast%3DQuesniaux%26aufirst%3DV.%2BF.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DSchuler%26aufirst%3DW.%26aulast%3DZurini%26aufirst%3DM.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DSanglier%26aufirst%3DJ.%2BJ.%26aulast%3DFehr%26aufirst%3DT.%26atitle%3DSanglifehrin%2520A%252C%2520a%2520Novel%2520Cyclophilin-Binding%2520Compound%2520Showing%2520Immunosuppressive%2520Activity%2520with%2520a%2520New%2520Mechanism%2520of%2520Action%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D166%26issue%3D12%26spage%3D7165%26epage%3D7171%26doi%3D10.4049%2Fjimmunol.166.12.7165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaither, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borawski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balabanis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joberty, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baryza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, B.</span></span> <span> </span><span class="NLM_article-title">Multiple Cyclophilins Involved in Different Cellular Pathways Mediate HCV Replication</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>397</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2009.10.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.virol.2009.10.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19932913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2010&pages=43-55&issue=1&author=L.+A.+Gaitherauthor=J.+Borawskiauthor=L.+J.+Andersonauthor=K.+A.+Balabanisauthor=P.+Devayauthor=G.+Jobertyauthor=C.+Rauauthor=M.+Schirleauthor=T.+Bouwmeesterauthor=C.+Mickaninauthor=S.+Zhaoauthor=C.+Vickersauthor=L.+Leeauthor=G.+Dengauthor=J.+Baryzaauthor=R.+A.+Fujimotoauthor=K.+Linauthor=T.+Comptonauthor=B.+Wiedmann&title=Multiple+Cyclophilins+Involved+in+Different+Cellular+Pathways+Mediate+HCV+Replication&doi=10.1016%2Fj.virol.2009.10.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple cyclophilins involved in different cellular pathways mediate HCV replication</span></div><div class="casAuthors">Gaither, L. Alex; Borawski, Jason; Anderson, Leah J.; Balabanis, Kara A.; Devay, Piroska; Joberty, Gerard; Rau, Christina; Schirle, Markus; Bouwmeester, Tewis; Mickanin, Craig; Zhao, Shan Chuan; Vickers, Chad; Lee, Lac; Deng, Gejing; Baryza, Jeremy; Fujimoto, Roger A.; Lin, Kai; Compton, Teresa; Wiedmann, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-55</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Three cyclophilin inhibitors (DEBIO-025, SCY635, and NIM811) are currently in clin. trials for hepatitis C therapy.  The mechanism of action of these, however, is not completely understood.  There are at least 16 cyclophilins expressed in human cells which are involved in a diverse set of cellular processes.  Large-scale siRNA expts., chemoproteomic assays with cyclophilin binding compds., and mRNA profiling of HCV replicon contg. cells were used to identify the cyclophilins that are instrumental to HCV replication.  The previously reported cyclophilin A was confirmed and addnl. cyclophilin contg. pathways were identified.  Together, the expts. provide strong evidence that NIM811 reduces viral replication by inhibition of multiple cyclophilins and pathways with protein trafficking as the most strongly and persistently affected pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNp3ZT5AY_lrVg90H21EOLACvtfcHk0libmE_ejnmY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFejtw%253D%253D&md5=1c440922dff7d216599718deec0cdee2</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2009.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2009.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DGaither%26aufirst%3DL.%2BA.%26aulast%3DBorawski%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DBalabanis%26aufirst%3DK.%2BA.%26aulast%3DDevay%26aufirst%3DP.%26aulast%3DJoberty%26aufirst%3DG.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DVickers%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DBaryza%26aufirst%3DJ.%26aulast%3DFujimoto%26aufirst%3DR.%2BA.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DCompton%26aufirst%3DT.%26aulast%3DWiedmann%26aufirst%3DB.%26atitle%3DMultiple%2520Cyclophilins%2520Involved%2520in%2520Different%2520Cellular%2520Pathways%2520Mediate%2520HCV%2520Replication%26jtitle%3DVirology%26date%3D2010%26volume%3D397%26issue%3D1%26spage%3D43%26epage%3D55%26doi%3D10.1016%2Fj.virol.2009.10.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-e-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paeshuyse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piraee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suthar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warneck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B.</span></span> <span> </span><span class="NLM_article-title">Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin Family</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1975</span>– <span class="NLM_lpage">1981</span>, <span class="refDoi"> DOI: 10.1128/AAC.01627-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.01627-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21383094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCls7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=1975-1981&issue=5&author=M.+A.+Gregoryauthor=M.+Bobardtauthor=S.+Obeidauthor=U.+Chatterjiauthor=N.+J.+Coatesauthor=T.+Fosterauthor=P.+Gallayauthor=P.+Leyssenauthor=S.+J.+Mossauthor=J.+Neytsauthor=M.+Nur-e-Alamauthor=J.+Paeshuyseauthor=M.+Piraeeauthor=D.+Sutharauthor=T.+Warneckauthor=M.+Q.+Zhangauthor=B.+Wilkinson&title=Preclinical+Characterization+of+Naturally+Occurring+Polyketide+Cyclophilin+Inhibitors+from+the+Sanglifehrin+Family&doi=10.1128%2FAAC.01627-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family</span></div><div class="casAuthors">Gregory, Matthew A.; Bobardt, Michael; Obeid, Susan; Chatterji, Udayan; Coates, Nigel J.; Foster, Teresa; Gallay, Philippe; Leyssen, Pieter; Moss, Steven J.; Neyts, Johan; Nur-e-Alam, Mohammad; Paeshuyse, Jan; Piraee, Mahmood; Suthar, Dipen; Warneck, Tony; Zhang, Ming-Qiang; Wilkinson, Barrie</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1975-1981</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cyclophilin inhibitors currently in clin. trials for hepatitis C virus (HCV) are all analogs of cyclosporine (CsA).  Sanglifehrins are a group of naturally occurring cyclophilin binding polyketides that are structurally distinct from the cyclosporines and are produced by a microorganism amenable to biosynthetic engineering for lead optimization and large-scale prodn. by fermn.  Preclin. characterization of the potential utility of this class of compds. for the treatment of HCV revealed that the natural sanglifehrins A to D are all more potent than CsA at disrupting formation of the NS5A-CypA, -CypB, and -CypD complexes and at inhibition of CypA, CypB, and CypD isomerase activity.  In particular, sanglifehrin B (SfB) was 30- to 50-fold more potent at inhibiting the isomerase activity of all Cyps tested than CsA and was also shown to be a more potent inhibitor of the 1b subgenomic replicon (50% effective concns. [EC50s] of 0.070 μM and 0.16 μM in Huh 5-2 and Huh 9-13 cells, resp.).  Physicochem. and mouse pharmacokinetic analyses revealed low oral bioavailability (F < 4%) and low soly. (<25 μM), although the half-lives (t1/2) of SfA and SfB in mouse blood after i.v. (i.v.) dosing were long (t1/2 > 5 h).  These data demonstrate that naturally occurring sanglifehrins are suitable lead compds. for the development of novel analogs that are less immunosuppressive and that have improved metab. and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp40pGLgUiK7Vg90H21EOLACvtfcHk0ljskHGkwR-Ehg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCls7fN&md5=e17c16ba8040d20c3ff835274a4c1016</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1128%2FAAC.01627-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01627-10%26sid%3Dliteratum%253Aachs%26aulast%3DGregory%26aufirst%3DM.%2BA.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DObeid%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DCoates%26aufirst%3DN.%2BJ.%26aulast%3DFoster%26aufirst%3DT.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DPaeshuyse%26aufirst%3DJ.%26aulast%3DPiraee%26aufirst%3DM.%26aulast%3DSuthar%26aufirst%3DD.%26aulast%3DWarneck%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DWilkinson%26aufirst%3DB.%26atitle%3DPreclinical%2520Characterization%2520of%2520Naturally%2520Occurring%2520Polyketide%2520Cyclophilin%2520Inhibitors%2520from%2520the%2520Sanglifehrin%2520Family%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26issue%3D5%26spage%3D1975%26epage%3D1981%26doi%3D10.1128%2FAAC.01627-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bobardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coates, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nur-e-Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suthar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yongsheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warneck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, M. A.</span></span> <span> </span><span class="NLM_article-title">Sangamides, a New Class of Cyclophilin-Inhibiting Host-Targeted Antivirals for Treatment of HCV Infection</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1039/C1MD00227A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1039%2FC1MD00227A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSlt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=944-949&issue=8&author=S.+J.+Mossauthor=M.+Bobardtauthor=P.+Leyssenauthor=N.+Coatesauthor=U.+Chatterjiauthor=X.+Dejianauthor=T.+Fosterauthor=J.+Liuauthor=M.+Nur-e-Alamauthor=D.+Sutharauthor=C.+Yongshengauthor=T.+Warneckauthor=M.-Q.+Zhangauthor=J.+Neytsauthor=P.+Gallayauthor=B.+Wilkinsonauthor=M.+A.+Gregory&title=Sangamides%2C+a+New+Class+of+Cyclophilin-Inhibiting+Host-Targeted+Antivirals+for+Treatment+of+HCV+Infection&doi=10.1039%2FC1MD00227A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection</span></div><div class="casAuthors">Moss, Steven J.; Bobardt, Michael; Leyssen, Pieter; Coates, Nigel; Chatterji, Udayan; Xie, Dejian; Foster, Teresa; Liu, Jinlun; Nur-e-Alam, Mohammad; Suthar, Dipen; Chen, Yongsheng; Warneck, Tony; Zhang, Ming-Qiang; Neyts, Johan; Gallay, Philippe; Wilkinson, Barrie; Gregory, Matthew A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">944-949</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sangamides are amide derivs. of sanglifehrin A, a cyclophilin-binding polyketide natural product which is structurally distinct from cyclosporine A. Cyclosporine A is the starting point for the synthesis of cyclophilin inhibitors such as alisporivir, currently in development for the treatment of HCV infection.  We report here initial results of the optimization program which led to identification of the sangamides, compds. that exhibit significantly improved potential for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4f6CS9dAItbVg90H21EOLACvtfcHk0ljskHGkwR-Ehg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSlt7zN&md5=79871e6747c3bc22c875f64b8f6b5ebb</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC1MD00227A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1MD00227A%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DS.%2BJ.%26aulast%3DBobardt%26aufirst%3DM.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DCoates%26aufirst%3DN.%26aulast%3DChatterji%26aufirst%3DU.%26aulast%3DDejian%26aufirst%3DX.%26aulast%3DFoster%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNur-e-Alam%26aufirst%3DM.%26aulast%3DSuthar%26aufirst%3DD.%26aulast%3DYongsheng%26aufirst%3DC.%26aulast%3DWarneck%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.-Q.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DGallay%26aufirst%3DP.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DGregory%26aufirst%3DM.%2BA.%26atitle%3DSangamides%252C%2520a%2520New%2520Class%2520of%2520Cyclophilin-Inhibiting%2520Host-Targeted%2520Antivirals%2520for%2520Treatment%2520of%2520HCV%2520Infection%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D8%26spage%3D944%26epage%3D949%26doi%3D10.1039%2FC1MD00227A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed-Belkacem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colliandre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahnou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevers, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cala, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douguet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourguet, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krimm, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawlotsky, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J. F.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Discovery of a New Family of Non-Peptidic Small-Molecule Cyclophilin Inhibitors with Potent Antiviral Activities</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12777</span>, <span class="refDoi"> DOI: 10.1038/ncomms12777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fncomms12777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27652979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12777&author=A.+Ahmed-Belkacemauthor=L.+Colliandreauthor=N.+Ahnouauthor=Q.+Neversauthor=M.+Gelinauthor=Y.+Bessinauthor=R.+Brilletauthor=O.+Calaauthor=D.+Douguetauthor=W.+Bourguetauthor=I.+Krimmauthor=J.+M.+Pawlotskyauthor=J.+F.+Guichou&title=Fragment-Based+Discovery+of+a+New+Family+of+Non-Peptidic+Small-Molecule+Cyclophilin+Inhibitors+with+Potent+Antiviral+Activities&doi=10.1038%2Fncomms12777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities</span></div><div class="casAuthors">Ahmed-Belkacem, Abdelhakim; Colliandre, Lionel; Ahnou, Nazim; Nevers, Quentin; Gelin, Muriel; Bessin, Yannick; Brillet, Rozenn; Cala, Olivier; Douguet, Dominique; Bourguet, William; Krimm, Isabelle; Pawlotsky, Jean-Michel; Guichou, Jean- Francois</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12777</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilins are peptidyl-prolyl cis/trans isomerases (PPIase) that catalyze the interconversion of the peptide bond at proline residues.  Several cyclophilins play a pivotal role in the life cycle of a no. of viruses.  The existing cyclophilin inhibitors, all derived from cyclosporine A or sanglifehrin A, have disadvantages, including their size, potential for side effects unrelated to cyclophilin inhibition and drug-drug interactions, unclear antiviral spectrum and manufg. issues.  Here we use a fragment-based drug discovery approach using nucleic magnetic resonance, X-ray crystallog. and structure-based compd. optimization to generate a new family of non-peptidic, small-mol. cyclophilin inhibitors with potent in vitro PPIase inhibitory activity and antiviral activity against hepatitis C virus, human immunodeficiency virus and coronaviruses.  This family of compds. has the potential for broad-spectrum, high-barrier-to-resistance treatment of viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyow1ByjcKUbVg90H21EOLACvtfcHk0litrfQEqN3uYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKmt7vO&md5=f984a686b75eea86431cd048f82f11c5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fncomms12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12777%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed-Belkacem%26aufirst%3DA.%26aulast%3DColliandre%26aufirst%3DL.%26aulast%3DAhnou%26aufirst%3DN.%26aulast%3DNevers%26aufirst%3DQ.%26aulast%3DGelin%26aufirst%3DM.%26aulast%3DBessin%26aufirst%3DY.%26aulast%3DBrillet%26aufirst%3DR.%26aulast%3DCala%26aufirst%3DO.%26aulast%3DDouguet%26aufirst%3DD.%26aulast%3DBourguet%26aufirst%3DW.%26aulast%3DKrimm%26aufirst%3DI.%26aulast%3DPawlotsky%26aufirst%3DJ.%2BM.%26aulast%3DGuichou%26aufirst%3DJ.%2BF.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520New%2520Family%2520of%2520Non-Peptidic%2520Small-Molecule%2520Cyclophilin%2520Inhibitors%2520with%2520Potent%2520Antiviral%2520Activities%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12777%26doi%3D10.1038%2Fncomms12777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahlin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergstrom, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1007/s11095-011-0564-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1007%2Fs11095-011-0564-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21861202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=411-426&issue=2&author=M.+Karlgrenauthor=G.+Ahlinauthor=C.+A.+Bergstromauthor=R.+Svenssonauthor=J.+Palmauthor=P.+Artursson&title=In+Vitro+and+In+Silico+Strategies+to+Identify+OATP1B1+Inhibitors+and+Predict+Clinical+Drug-Drug+Interactions&doi=10.1007%2Fs11095-011-0564-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions</span></div><div class="casAuthors">Karlgren, Maria; Ahlin, Gustav; Bergstroem, Christel A. S.; Svensson, Richard; Palm, Johan; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">411-426</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To establish in vitro and in silico models that predict clin. drug-drug interactions (DDIs) with the OATP1B1 (SLCO1B1) transporter.  Methods: The inhibitory effect of 146 drugs and drug-like compds. on OATP1B1-mediated transport was studied in HEK293 cells.  A computational model was developed to predict OATP1B1 inhibition.  Concn.-dependent effects were investigated for six compds.; clin. DDIs were predicted by calcg. change in exposure (i.e. R-values) in eight different ways.  Results: Sixty-five compds. were identified as OATP1B1 inhibitors at 20 μM.  The computational model predicted the test set with 80% accuracy for inhibitors and 91% for non-inhibitors.  In vitro-in vivo comparisons underscored the importance of using drugs with known clin. effects as refs.  Thus, ref. drugs, cyclosporin A, gemfibrozil, and fenofibrate, provided an inhibition interval to which three antiviral drugs, atazanavir, lopinavir, and amprenavir, could be compared and their clin. DDIs with OATP1B1 classified.  Conclusions: Twenty-two new OATP1B1 inhibitors were identified, a predictive OATP1B1 inhibition in silico model was developed, and successful predictions of clin. DDIs were obtained with OATP1B1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZVO33bM9iobVg90H21EOLACvtfcHk0litrfQEqN3uYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKitrrK&md5=e688f0827c6c046dfe5e6532a17bdc47</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs11095-011-0564-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-011-0564-9%26sid%3Dliteratum%253Aachs%26aulast%3DKarlgren%26aufirst%3DM.%26aulast%3DAhlin%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DC.%2BA.%26aulast%3DSvensson%26aufirst%3DR.%26aulast%3DPalm%26aufirst%3DJ.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Silico%2520Strategies%2520to%2520Identify%2520OATP1B1%2520Inhibitors%2520and%2520Predict%2520Clinical%2520Drug-Drug%2520Interactions%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26issue%3D2%26spage%3D411%26epage%3D426%26doi%3D10.1007%2Fs11095-011-0564-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shore, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandalaneni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latawiec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javed, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criddle, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, R.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2596</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01801</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01801" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs12jsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2596-2611&issue=6&author=E.+R.+Shoreauthor=M.+Awaisauthor=N.+M.+Kershawauthor=R.+R.+Gibsonauthor=S.+Pandalaneniauthor=D.+Latawiecauthor=L.+Wenauthor=M.+A.+Javedauthor=D.+N.+Criddleauthor=N.+Berryauthor=P.+M.+O%E2%80%99Neillauthor=L.+Y.+Lianauthor=R.+Sutton&title=Small+Molecule+Inhibitors+of+Cyclophilin+D+To+Protect+Mitochondrial+Function+as+a+Potential+Treatment+for+Acute+Pancreatitis&doi=10.1021%2Facs.jmedchem.5b01801"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis</span></div><div class="casAuthors">Shore, Emma R.; Awais, Muhammad; Kershaw, Neil M.; Gibson, Robert R.; Pandalaneni, Sravan; Latawiec, Diane; Wen, Li; Javed, Muhammad A.; Criddle, David N.; Berry, Neil; O'Neill, Paul M.; Lian, Lu-Yun; Sutton, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2596-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Opening of the mitochondrial permeability transition pore (MPTP) causes mitochondrial dysfunction and necrosis in acute pancreatitis (AP), a condition without specific drug treatment.  Cyclophilin D (CypD) is a mitochondrial matrix peptidyl-prolyl isomerase that regulates the MPTP and is a drug target for AP.  We have synthesized urea-based small mol. inhibitors of cyclophilins and tested them against CypD using binding and isomerase activity assays.  Thermodn. profiles of the CypD/inhibitor interactions were detd. by isothermal titrn. calorimetry.  Seven new high-resoln. crystal structures of CypD-inhibitor complexes were obtained to guide compd. optimization.  Compds. 4, 13, 14, and 19 were tested in freshly isolated murine pancreatic acinar cells (PACs) to det. inhibition of toxin-induced loss of mitochondrial membrane potential (ΔΨm) and necrotic cell death pathway activation.  Compd. 19 was found to have a Kd of 410 nM and a favorable thermodn. profile, and it showed significant protection of ΔΨm and reduced necrosis of murine as well as human PACs.  Compd. 19 holds significant promise for future lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOALCctyBii7Vg90H21EOLACvtfcHk0litrfQEqN3uYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs12jsLg%253D&md5=fb9489a647a3f30978a9be44ea36a9fe</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01801%26sid%3Dliteratum%253Aachs%26aulast%3DShore%26aufirst%3DE.%2BR.%26aulast%3DAwais%26aufirst%3DM.%26aulast%3DKershaw%26aufirst%3DN.%2BM.%26aulast%3DGibson%26aufirst%3DR.%2BR.%26aulast%3DPandalaneni%26aufirst%3DS.%26aulast%3DLatawiec%26aufirst%3DD.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DJaved%26aufirst%3DM.%2BA.%26aulast%3DCriddle%26aufirst%3DD.%2BN.%26aulast%3DBerry%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26aulast%3DLian%26aufirst%3DL.%2BY.%26aulast%3DSutton%26aufirst%3DR.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Cyclophilin%2520D%2520To%2520Protect%2520Mitochondrial%2520Function%2520as%2520a%2520Potential%2520Treatment%2520for%2520Acute%2520Pancreatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D6%26spage%3D2596%26epage%3D2611%26doi%3D10.1021%2Facs.jmedchem.5b01801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malone, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wear, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florance, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barran, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkinshaw, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, N. J.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Conformationally Constrained Cyclophilin Inhibitors Showing a Cyclosporin-A Phenotype in C. elegans</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1002/cbic.201000413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fcbic.201000413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21337480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=802-810&issue=5&author=C.+J.+Dunsmoreauthor=K.+J.+Maloneauthor=K.+R.+Baileyauthor=M.+A.+Wearauthor=H.+Floranceauthor=S.+Shirranauthor=P.+E.+Barranauthor=A.+P.+Pageauthor=M.+D.+Walkinshawauthor=N.+J.+Turner&title=Design+and+Synthesis+of+Conformationally+Constrained+Cyclophilin+Inhibitors+Showing+a+Cyclosporin-A+Phenotype+in+C.+elegans&doi=10.1002%2Fcbic.201000413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Conformationally Constrained Cyclophilin Inhibitors Showing a Cyclosporin-A Phenotype in C. elegans</span></div><div class="casAuthors">Dunsmore, Colin J.; Malone, Kirk J.; Bailey, Kevin R.; Wear, Martin A.; Florance, Hannah; Shirran, Sally; Barran, Perdita E.; Page, Antony P.; Walkinshaw, Malcolm D.; Turner, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">802-810</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Cyclophilin A (CypA) is a member of the immunophilin family of proteins and receptor for the immunosuppressant drug cyclosporin A (CsA).  Here we describe the design and synthesis of a new class of small-mol. inhibitors for CypA that are based upon a dimedone template.  Electrospray mass spectrometry is utilized as an initial screen to quantify the protein affinity of the ligands.  Active inhibitors and fluorescently labeled derivs. are then used as chem. probes for investigating the biol. role of cyclophilins in the nematode Caenorhabditis elegans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd10HS1yxA9bVg90H21EOLACvtfcHk0lipaoAq_s4U4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGgs7c%253D&md5=adf1ec2723731749ded3d233295354c0</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201000413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201000413%26sid%3Dliteratum%253Aachs%26aulast%3DDunsmore%26aufirst%3DC.%2BJ.%26aulast%3DMalone%26aufirst%3DK.%2BJ.%26aulast%3DBailey%26aufirst%3DK.%2BR.%26aulast%3DWear%26aufirst%3DM.%2BA.%26aulast%3DFlorance%26aufirst%3DH.%26aulast%3DShirran%26aufirst%3DS.%26aulast%3DBarran%26aufirst%3DP.%2BE.%26aulast%3DPage%26aufirst%3DA.%2BP.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DTurner%26aufirst%3DN.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Conformationally%2520Constrained%2520Cyclophilin%2520Inhibitors%2520Showing%2520a%2520Cyclosporin-A%2520Phenotype%2520in%2520C.%2520elegans%26jtitle%3DChemBioChem%26date%3D2011%26volume%3D12%26issue%3D5%26spage%3D802%26epage%3D810%26doi%3D10.1002%2Fcbic.201000413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavanieu, A.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design, Synthesis, and Biological Evaluation of Novel Inhibitors of Human Cyclophilin A</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">900</span>– <span class="NLM_lpage">910</span>, <span class="refDoi"> DOI: 10.1021/jm050716a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050716a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=900-910&issue=3&author=J.+F.+Guichouauthor=J.+Viaudauthor=C.+Mettlingauthor=G.+Subraauthor=Y.+L.+Linauthor=A.+Chavanieu&title=Structure-Based+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+Inhibitors+of+Human+Cyclophilin+A&doi=10.1021%2Fjm050716a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A</span></div><div class="casAuthors">Guichou, Jean-Francois; Viaud, Julien; Mettling, Clement; Subra, Guy; Lin, Yea-Lih; Chavanieu, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">900-910</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclophilin A is involved in many cellular processes, including protein folding and intracellular transports.  Because cyclophilin A has been shown to interact with HIV-1 gag proteins and to enhance the viral infectivity, nonimmunosuppressive cyclophilin A ligands may represent a new class of therapeutic agents against HIV.  In this paper, a virtual screening using structure- and pharmacophore-based design to identify original nonpeptidic cyclophilin ligands is reported.  Following a lead identification of compds. 1-(3-benzyloxypyridin-2-yl)-3-(3-chlorophenyl)urea [I; R1 = H, R2 = Cl (II)] and 1-(3-benzyloxypyridin-2-yl)-3-(3-trifluoromethylphenyl)urea [I; R1 = H, R2 = CF3 (III)] (IC50 = 0.3 μM), a series of mols. were synthesized from a diarylurea scaffold and evaluated for their in vitro ability to inhibit the cis-trans isomerase activity of cyclophilin A.  Mol. modifications provided several more potent compds., in particular analogs I (R1 = NO2, R2 = H) and I (R1 = CO2Et, R2 = H) with IC50 of 14 and 20 nM, resp.  Then, the effect of analogs II and III (R1 = H, R2 = CF3) on HIV virion infectivity in both immortalized and primary cells was evaluated.  Both II and III reduced virion infectivity in the replication-defective one-round infection assay, but only II impaired wild-type HIV infection in human peripheral blood mononuclear cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2EkYyZ2-5HbVg90H21EOLACvtfcHk0lipaoAq_s4U4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGnsw%253D%253D&md5=c8afc21956e023e7950007e7a06da51e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm050716a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050716a%26sid%3Dliteratum%253Aachs%26aulast%3DGuichou%26aufirst%3DJ.%2BF.%26aulast%3DViaud%26aufirst%3DJ.%26aulast%3DMettling%26aufirst%3DC.%26aulast%3DSubra%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DY.%2BL.%26aulast%3DChavanieu%26aufirst%3DA.%26atitle%3DStructure-Based%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520Inhibitors%2520of%2520Human%2520Cyclophilin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D3%26spage%3D900%26epage%3D910%26doi%3D10.1021%2Fjm050716a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using De Novo Drug Design Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">5295</span>– <span class="NLM_lpage">5298</span>, <span class="refDoi"> DOI: 10.1021/jm9008295</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9008295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5295-5298&issue=17&author=S.+Niauthor=Y.+Yuanauthor=J.+Huangauthor=X.+Maoauthor=M.+Lvauthor=J.+Zhuauthor=X.+Shenauthor=J.+Peiauthor=L.+Laiauthor=H.+Jiangauthor=J.+Li&title=Discovering+Potent+Small+Molecule+Inhibitors+of+Cyclophilin+A+Using+De+Novo+Drug+Design+Approach&doi=10.1021%2Fjm9008295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach</span></div><div class="casAuthors">Ni, Shuaishuai; Yuan, Yaxia; Huang, Jin; Mao, Xiaona; Lv, Maosheng; Zhu, Jin; Shen, Xu; Pei, Jianfeng; Lai, Luhua; Jiang, Hualiang; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5295-5298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work describes an integrated approach of de novo drug design, chem. synthesis, and bioassay for quick identification of a series of novel small mol. cyclophilin A (CypA) inhibitors (1-3).  The activities of the two most potent CypA inhibitors, 3h and 3i (I) are 2.59 and 1.52 nM, resp., which are about 16 and 27 times more potent than that of cyclosporin A.  This study clearly demonstrates the power of our de novo drug design strategy and the related program LigBuilder 2.0 in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8NECkXQBFc7Vg90H21EOLACvtfcHk0lipaoAq_s4U4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWntb3K&md5=efed32e984fc74810f9d110dbeb94616</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm9008295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008295%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovering%2520Potent%2520Small%2520Molecule%2520Inhibitors%2520of%2520Cyclophilin%2520A%2520Using%2520De%2520Novo%2520Drug%2520Design%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D17%26spage%3D5295%26epage%3D5298%26doi%3D10.1021%2Fjm9008295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücknagel, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelbert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Confirmation of the Existence of a Third Family Among Peptidyl-Prolyl Cis/Trans Isomerases. Amino Acid Sequence and Recombinant Production of Parvulin</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>352</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(94)00932-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2F0014-5793%2894%2900932-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=7925971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK2MXhtFKhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1994&pages=180-184&issue=2&author=J.-U.+Rahfeldauthor=K.+P.+R%C3%BCcknagelauthor=B.+Schelbertauthor=B.+Ludwigauthor=J.+Hackerauthor=K.+Mannauthor=G.+Fischer&title=Confirmation+of+the+Existence+of+a+Third+Family+Among+Peptidyl-Prolyl+Cis%2FTrans+Isomerases.+Amino+Acid+Sequence+and+Recombinant+Production+of+Parvulin&doi=10.1016%2F0014-5793%2894%2900932-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin</span></div><div class="casAuthors">Rahfeld, Jens-U.; Ruecknagel, Karl Peter; Schelbert, Birte; Ludwig, Birgit; Hacker, Joerg; Mann, Karlheinz; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-4</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">In addn. to the major cyclophilin-like peptidyl-prolyl cis/trans isomerases (PPIases) of Escherichia coli, an enzyme of very low relative mol. mass (10.1 kDa) was discovered in this organism which gave first indication of the existence of a novel family in this enzyme class.  In the present report, the chem. detd. amino acid sequence was detd. of 4 peptides derived from the 10.1-kDa protein by the treatment with either CNBr or endoproteinase Lys-C.  Together with a continuous run of 75 amino acids starting N-terminally, the sequence of the mature enzyme, 92 residues in length, was elucidated.  Cloning and detn. of the primary structure of a DNA fragment encoding this enzyme were also performed.  Overexpression of the enzyme by using multicopies of plasmid pSEP38 in E. coli and detecting an enhanced PPIase activity attributed to the 10.1-kDa enzyme provided addnl. proof that the 92 amino acid protein was a PPIase.  The enzyme was called parvulin (lat.: parvulus, very small).  Homol. analyses indicated that several parvulin-like proteins could be found in the database screened.  To further elucidate the functional role of PPIases it might be of some importance that homologous proteins like the PrtM protein of Lactococcus lactis and the PrsA lipoprotein of Bacillus subtilis are known to be involved in the protein export and maturation machinery of the bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc9vnyB0ZGpLVg90H21EOLACvtfcHk0lgB5eG2RwpTrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtFKhtbg%253D&md5=55ab2bfff124990da4341b27d76f453a</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900932-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900932-5%26sid%3Dliteratum%253Aachs%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26aulast%3DR%25C3%25BCcknagel%26aufirst%3DK.%2BP.%26aulast%3DSchelbert%26aufirst%3DB.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DHacker%26aufirst%3DJ.%26aulast%3DMann%26aufirst%3DK.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DConfirmation%2520of%2520the%2520Existence%2520of%2520a%2520Third%2520Family%2520Among%2520Peptidyl-Prolyl%2520Cis%252FTrans%2520Isomerases.%2520Amino%2520Acid%2520Sequence%2520and%2520Recombinant%2520Production%2520of%2520Parvulin%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D352%26issue%3D2%26spage%3D180%26epage%3D184%26doi%3D10.1016%2F0014-5793%2894%2900932-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matern, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barion, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens-Kneip, S.</span></span> <span> </span><span class="NLM_article-title">PpiD is a Player in the Network of Periplasmic Chaperones in Escherichia coli</span>. <i>BMC Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">251</span>, <span class="refDoi"> DOI: 10.1186/1471-2180-10-251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1186%2F1471-2180-10-251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20920237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC3cbgt1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=251&issue=1&author=Y.+Maternauthor=B.+Barionauthor=S.+Behrens-Kneip&title=PpiD+is+a+Player+in+the+Network+of+Periplasmic+Chaperones+in+Escherichia+coli&doi=10.1186%2F1471-2180-10-251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">PpiD is a player in the network of periplasmic chaperones in Escherichia coli</span></div><div class="casAuthors">Matern Yvonne; Barion Birgitta; Behrens-Kneip Susanne</div><div class="citationInfo"><span class="NLM_cas:title">BMC microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">251</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The inner membrane-anchored periplasmic folding factor PpiD is described as a parvulin-like peptidyl prolyl isomerase (PPIase) that assists in the maturation of the major beta-barrel outer membrane proteins (OMPs) of Escherichia coli.  More recent work however, calls these findings into question.  Here, we re-examined the role of PpiD in the E. coli periplasm by analyzing its functional interplay with other folding factors that influence OMP maturation as well as general protein folding in the periplasmic compartment of the cell, such as SurA, Skp, and DegP.  RESULTS:  The analysis of the effects of both deletion and overexpression of ppiD on cell envelope phenotypes revealed that PpiD in contrast to prior observations plays only a minor role, if any, in the maturation of OMPs and cannot compensate for the lack of SurA in the periplasm.  On the other hand, our results show that overproduction of PpiD rescues a surA skp double mutant from lethality.  In the presence of increased PpiD levels surA skp cells show reduced activities of both the SigmaE-dependent and the Cpx envelope stress responses, and contain increased amounts of folded species of the major OMP OmpA.  These effects require the anchoring of PpiD in the inner membrane but are independent of its parvulin-like PPIase domain.  Moreover, a PpiD protein lacking the PPIase domain also complements the growth defects of an fkpA ppiD surA triple PPIase mutant and exhibits chaperone activity in vitro.  In addition, PpiD appears to collaborate with DegP, as deletion of ppiD confers a temperature-dependent conditional synthetic phenotype in a degP mutant.  CONCLUSIONS:  This study provides first direct evidence that PpiD functions as a chaperone and contributes to the network of periplasmic chaperone activities without being specifically involved in OMP maturation.  Consistent with previous work, our data support a model in which the chaperone function of PpiD is used to aid in the early periplasmic folding of many newly translocated proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqfTKufo_Bisve_zCu79I8fW6udTcc2eZdEvwWrgVSBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbgt1KhsQ%253D%253D&md5=4a2d9e385c12d3adace9c7153b5b4be8</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1186%2F1471-2180-10-251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2180-10-251%26sid%3Dliteratum%253Aachs%26aulast%3DMatern%26aufirst%3DY.%26aulast%3DBarion%26aufirst%3DB.%26aulast%3DBehrens-Kneip%26aufirst%3DS.%26atitle%3DPpiD%2520is%2520a%2520Player%2520in%2520the%2520Network%2520of%2520Periplasmic%2520Chaperones%2520in%2520Escherichia%2520coli%26jtitle%3DBMC%2520Microbiol.%26date%3D2010%26volume%3D10%26issue%3D1%26spage%3D251%26doi%3D10.1186%2F1471-2180-10-251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volokhina, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grijpstra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stork, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilders, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommassen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M. P.</span></span> <span> </span><span class="NLM_article-title">Role of the Periplasmic Chaperones Skp, SurA, and DegQ in Outer Membrane Protein Biogenesis in Neisseria meningitidis</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1612</span>– <span class="NLM_lpage">1621</span>, <span class="refDoi"> DOI: 10.1128/JB.00532-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.00532-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21296967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVyrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2011&pages=1612-1621&issue=7&author=E.+B.+Volokhinaauthor=J.+Grijpstraauthor=M.+Storkauthor=I.+Schildersauthor=J.+Tommassenauthor=M.+P.+Bos&title=Role+of+the+Periplasmic+Chaperones+Skp%2C+SurA%2C+and+DegQ+in+Outer+Membrane+Protein+Biogenesis+in+Neisseria+meningitidis&doi=10.1128%2FJB.00532-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the periplasmic chaperones Skp, SurA, and DegO in outer membrane protein biogenesis in Neisseria meningitidis</span></div><div class="casAuthors">Volokhina, Elena B.; Grijpstra, Jan; Stork, Michel; Schilders, Ingrid; Tommassen, Jan; Bos, Martine P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1612-1621</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The periplasmic chaperones Skp, SurA, and DegP are implicated in the biogenesis of outer membrane proteins (OMPs) in Escherichia coli.  Here, the authors investigated whether these chaperones exert similar functions in Neisseria meningitidis.  Although N. meningitidis does not contain a homolog of the protease/chaperone DegP, it does possess a homolog of another E. coli protein, DegQ, which can functionally replace DegP when overproduced.  Hence, the authors examd. whether in N. meningitidis, DegQ acts as a functional homolog of DegP.  Single skp, surA, and degQ mutants were easily obtained, showing that none of these chaperones is essential in N. meningitidis.  Furthermore, all combinations of double mutants were generated and no synthetic lethality was obsd.  The absence of SurA or DegQ did not affect OMP biogenesis.  In contrast, the absence of Skp resulted in severely lower levels of the porins PorA and PorB but not of other OMPs.  These decreased levels were not due to proteolytic activity of DegQ, since porin levels remained low in a skp degQ double mutant, indicating that neisserial DegQ is not a functional homolog of E. coli DegP.  The absence of Skp resulted in lower expression of the porB gene, as shown by using a PporBM-lacZ fusion.  The authors found no cross-species complementation when Skp of E. coli or N. meningitidis was heterologously expressed in skp mutants, indicating that Skp functions in a species-specific manner.  The results demonstrate an important role for Skp but not for SurA or DegQ in OMP biogenesis in N. meningitidis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoakBGDj6SWMLVg90H21EOLACvtfcHk0lgB5eG2RwpTrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVyrtLc%253D&md5=d6de9b7e4b54bbb6af00d71483d713aa</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1128%2FJB.00532-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00532-10%26sid%3Dliteratum%253Aachs%26aulast%3DVolokhina%26aufirst%3DE.%2BB.%26aulast%3DGrijpstra%26aufirst%3DJ.%26aulast%3DStork%26aufirst%3DM.%26aulast%3DSchilders%26aufirst%3DI.%26aulast%3DTommassen%26aufirst%3DJ.%26aulast%3DBos%26aufirst%3DM.%2BP.%26atitle%3DRole%2520of%2520the%2520Periplasmic%2520Chaperones%2520Skp%252C%2520SurA%252C%2520and%2520DegQ%2520in%2520Outer%2520Membrane%2520Protein%2520Biogenesis%2520in%2520Neisseria%2520meningitidis%26jtitle%3DJ.%2520Bacteriol.%26date%3D2011%26volume%3D193%26issue%3D7%26spage%3D1612%26epage%3D1621%26doi%3D10.1128%2FJB.00532-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jousselin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinho, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosato, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renzoni, A.</span></span> <span> </span><span class="NLM_article-title">The Staphylococcus aureus Chaperone PrsA is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1656</span>– <span class="NLM_lpage">1666</span>, <span class="refDoi"> DOI: 10.1128/AAC.02333-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.02333-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVylsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1656-1666&issue=3&author=A.+Jousselinauthor=C.+Manzanoauthor=A.+Bietteauthor=P.+Reedauthor=M.+G.+Pinhoauthor=A.+E.+Rosatoauthor=W.+L.+Kelleyauthor=A.+Renzoni&title=The+Staphylococcus+aureus+Chaperone+PrsA+is+a+New+Auxiliary+Factor+of+Oxacillin+Resistance+Affecting+Penicillin-Binding+Protein+2A&doi=10.1128%2FAAC.02333-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A</span></div><div class="casAuthors">Jousselin, Ambre; Manzano, Caroline; Biette, Alexandra; Reed, Patricia; Pinho, Mariana G.; Rosato, Adriana E.; Kelley, William L.; Renzoni, Adriana</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1656-1666</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Expression of the methicillin-resistant S. aureus (MRSA) phenotype results from the expression of the extra penicillin-binding protein 2A (PBP2A), which is encoded by mecA and acquired horizontally on part of the SCCmec cassette.  PBP2A can catalyze dd-transpeptidation of peptidoglycan (PG) because of its low affinity for β-lactam antibiotics and can functionally cooperate with the PBP2 transglycosylase in the biosynthesis of PG.  Here, we focus upon the role of the membrane-bound PrsA foldase protein as a regulator of β-lactam resistance expression.  Deletion of prsA altered oxacillin resistance in 3 different SCCmec backgrounds and, more importantly, caused a decrease in PBP2A membrane amts. without affecting mecA mRNA levels.  The N- and C-terminal domains of PrsA were found to be crit. features for PBP2A protein membrane levels and oxacillin resistance.  We propose that PrsA has a role in posttranscriptional maturation of PBP2A, possibly in the export and(or) folding of newly synthesized PBP2A.  This addnl. level of control in the expression of the mecA-dependent MRSA phenotype constitutes an opportunity to expand the strategies to design anti-infective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKSE_MfdXsP7Vg90H21EOLACvtfcHk0ljkdOeZvlI7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVylsLc%253D&md5=faafbead601eaa7f6b703f0bf44913e4</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1128%2FAAC.02333-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02333-15%26sid%3Dliteratum%253Aachs%26aulast%3DJousselin%26aufirst%3DA.%26aulast%3DManzano%26aufirst%3DC.%26aulast%3DBiette%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DP.%26aulast%3DPinho%26aufirst%3DM.%2BG.%26aulast%3DRosato%26aufirst%3DA.%2BE.%26aulast%3DKelley%26aufirst%3DW.%2BL.%26aulast%3DRenzoni%26aufirst%3DA.%26atitle%3DThe%2520Staphylococcus%2520aureus%2520Chaperone%2520PrsA%2520is%2520a%2520New%2520Auxiliary%2520Factor%2520of%2520Oxacillin%2520Resistance%2520Affecting%2520Penicillin-Binding%2520Protein%25202A%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26issue%3D3%26spage%3D1656%26epage%3D1666%26doi%3D10.1128%2FAAC.02333-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jousselin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renzoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrey, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monod, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, W. L.</span></span> <span> </span><span class="NLM_article-title">The Posttranslocational Chaperone Lipoprotein PrsA is Involved in Both Glycopeptide and Oxacillin Resistance in Staphylococcus aureus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3629</span>– <span class="NLM_lpage">3640</span>, <span class="refDoi"> DOI: 10.1128/AAC.06264-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FAAC.06264-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22526301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3629-3640&issue=7&author=A.+Jousselinauthor=A.+Renzoniauthor=D.+O.+Andreyauthor=A.+Monodauthor=D.+P.+Lewauthor=W.+L.+Kelley&title=The+Posttranslocational+Chaperone+Lipoprotein+PrsA+is+Involved+in+Both+Glycopeptide+and+Oxacillin+Resistance+in+Staphylococcus+aureus&doi=10.1128%2FAAC.06264-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus</span></div><div class="casAuthors">Jousselin, Ambre; Renzoni, Adriana; Andrey, Diego O.; Monod, Antoinette; Lew, Daniel P.; Kelley, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3629-3640</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Understanding in detail the factors which permit Staphylococcus aureus to counteract cell wall-active antibiotics is a prerequisite to elaborating effective strategies to prolong the usefulness of these drugs and define new targets for pharmacol. intervention.  Methicillin-resistant S. aureus (MRSA) strains are major pathogens of hospital-acquired and community-acquired infections and are most often treated with glycopeptides (vancomycin and teicoplanin) because of their resistance to most penicillins and a limited arsenal of clin. proven alternatives.  In this study, we examd. PrsA, a lipid-anchored protein of the parvulin PPIase family (peptidyl-prolyl cis/trans isomerase) found ubiquitously in all Gram-pos. species, in which it assists posttranslocational folding at the outer surface of the cytoplasmic membrane.  We show by both genetic and biochem. assays that prsA is directly regulated by the VraRS two-component sentinel system of cell wall stress.  Disruption of prsA is tolerated by S. aureus, and its loss results in no detectable overt macroscopic changes in cell wall architecture or growth rate under nonstressed growth conditions.  Disruption of prsA leads, however, to notable alterations in the sensitivity to glycopeptides and dramatically decreases the resistance of COL (MRSA) to oxacillin.  Quant. transcriptional anal. reveals that prsA and vraR are coordinately upregulated in a panel of stable lab. and clin. glycopeptide-intermediate S. aureus (GISA) strains compared to their susceptible parents.  Collectively, our results point to a role for prsA as a facultative facilitator of protein secretion or extracellular folding and provide a framework for understanding why prsA is a key element of the VraRS-mediated cell wall stress response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpShVC4DfeGg7Vg90H21EOLACvtfcHk0ljkdOeZvlI7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2is74%253D&md5=ddd8851423d51c9e0b7d3c8a419ecbd0</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1128%2FAAC.06264-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.06264-11%26sid%3Dliteratum%253Aachs%26aulast%3DJousselin%26aufirst%3DA.%26aulast%3DRenzoni%26aufirst%3DA.%26aulast%3DAndrey%26aufirst%3DD.%2BO.%26aulast%3DMonod%26aufirst%3DA.%26aulast%3DLew%26aufirst%3DD.%2BP.%26aulast%3DKelley%26aufirst%3DW.%2BL.%26atitle%3DThe%2520Posttranslocational%2520Chaperone%2520Lipoprotein%2520PrsA%2520is%2520Involved%2520in%2520Both%2520Glycopeptide%2520and%2520Oxacillin%2520Resistance%2520in%2520Staphylococcus%2520aureus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26issue%3D7%26spage%3D3629%26epage%3D3640%26doi%3D10.1128%2FAAC.06264-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. C.</span></span> <span> </span><span class="NLM_article-title">Exoproteome Profiling Reveals the Involvement of the Foldase PrsA in the Cell Surface Properties and Pathogenesis of Staphylococcus aureus</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5–6</span>),  <span class="NLM_fpage">1700195</span>, <span class="refDoi"> DOI: 10.1002/pmic.201700195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fpmic.201700195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29334195" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=1700195&issue=5%E2%80%936&author=M.+H.+Linauthor=C.+C.+Liauthor=J.+C.+Shuauthor=H.+W.+Chuauthor=C.+C.+Liuauthor=C.+C.+Wu&title=Exoproteome+Profiling+Reveals+the+Involvement+of+the+Foldase+PrsA+in+the+Cell+Surface+Properties+and+Pathogenesis+of+Staphylococcus+aureus&doi=10.1002%2Fpmic.201700195"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1002%2Fpmic.201700195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.201700195%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BC.%26aulast%3DShu%26aufirst%3DJ.%2BC.%26aulast%3DChu%26aufirst%3DH.%2BW.%26aulast%3DLiu%26aufirst%3DC.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BC.%26atitle%3DExoproteome%2520Profiling%2520Reveals%2520the%2520Involvement%2520of%2520the%2520Foldase%2520PrsA%2520in%2520the%2520Cell%2520Surface%2520Properties%2520and%2520Pathogenesis%2520of%2520Staphylococcus%2520aureus%26jtitle%3DProteomics%26date%3D2018%26volume%3D18%26issue%3D5%25E2%2580%25936%26spage%3D1700195%26doi%3D10.1002%2Fpmic.201700195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hyyryläinen, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciniak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahncke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietiäinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seppala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapot-Chartier, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuipers, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span> <span> </span><span class="NLM_article-title">Penicillin-Binding Protein Folding is Dependent on the PrsA Peptidyl-Prolyl Cis-Trans Isomerase in Bacillus subtilis</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2010.07188.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2010.07188.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20487272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Citrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=108-127&issue=1&author=H.+L.+Hyyryl%C3%A4inenauthor=B.+C.+Marciniakauthor=K.+Dahnckeauthor=M.+Pieti%C3%A4inenauthor=P.+Courtinauthor=M.+Vitikainenauthor=R.+Seppalaauthor=A.+Ottoauthor=D.+Becherauthor=M.+P.+Chapot-Chartierauthor=O.+P.+Kuipersauthor=V.+P.+Kontinen&title=Penicillin-Binding+Protein+Folding+is+Dependent+on+the+PrsA+Peptidyl-Prolyl+Cis-Trans+Isomerase+in+Bacillus+subtilis&doi=10.1111%2Fj.1365-2958.2010.07188.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Penicillin-binding protein folding is dependent on the PrsA peptidyl-prolyl cis-trans isomerase in Bacillus subtilis</span></div><div class="casAuthors">Hyyrylainen, Hanne-Leena; Marciniak, Bogumila C.; Dahncke, Kathleen; Pietiainen, Milla; Courtin, Pascal; Vitikainen, Marika; Seppala, Raili; Otto, Andreas; Becher, Dorte; Chapot-Chartier, Marie-Pierre; Kuipers, Oscar P.; Kontinen, Vesa P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-127</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The PrsA protein is a membrane-anchored peptidylprolyl cis-trans isomerase in Bacillus subtilis and most other Gram-pos. bacteria.  It catalyzes the post-translocational folding of exported proteins and is essential for normal growth of B. subtilis.  The authors studied the mechanism behind this indispensability.  They constructed a viable prsA null mutant in the presence of a high concn. of magnesium.  Various changes in cell morphol. in the absence of PrsA suggested that PrsA is involved in the biosynthesis of the cylindrical lateral wall.  Consistently, four penicillin-binding proteins (PBP2a, PBP2b, PBP3 and PBP4) were unstable in the absence of PrsA, while muropeptide anal. revealed a 2% decrease in the peptidoglycan cross-linkage index.  Misfolded PBP2a was detected in PrsA-depleted cells, indicating that PrsA is required for the folding of this PBP either directly or indirectly.  Furthermore, strongly increased uniform staining of cell wall with a fluorescent vancomycin was obsd. in the absence of PrsA.  The authors also demonstrated that PrsA is a dimeric or oligomeric protein which is localized at distinct spots organized in a helical pattern along the cell membrane.  These results suggest that PrsA is essential for normal growth most probably as PBP folding is dependent on this PPlase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWDiEz3UXHV7Vg90H21EOLACvtfcHk0ljkdOeZvlI7PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Citrs%253D&md5=1fd49d453540c96424006e4b3e203808</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2010.07188.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2010.07188.x%26sid%3Dliteratum%253Aachs%26aulast%3DHyyryl%25C3%25A4inen%26aufirst%3DH.%2BL.%26aulast%3DMarciniak%26aufirst%3DB.%2BC.%26aulast%3DDahncke%26aufirst%3DK.%26aulast%3DPieti%25C3%25A4inen%26aufirst%3DM.%26aulast%3DCourtin%26aufirst%3DP.%26aulast%3DVitikainen%26aufirst%3DM.%26aulast%3DSeppala%26aufirst%3DR.%26aulast%3DOtto%26aufirst%3DA.%26aulast%3DBecher%26aufirst%3DD.%26aulast%3DChapot-Chartier%26aufirst%3DM.%2BP.%26aulast%3DKuipers%26aufirst%3DO.%2BP.%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26atitle%3DPenicillin-Binding%2520Protein%2520Folding%2520is%2520Dependent%2520on%2520the%2520PrsA%2520Peptidyl-Prolyl%2520Cis-Trans%2520Isomerase%2520in%2520Bacillus%2520subtilis%26jtitle%3DMol.%2520Microbiol.%26date%3D2010%26volume%3D77%26issue%3D1%26spage%3D108%26epage%3D127%26doi%3D10.1111%2Fj.1365-2958.2010.07188.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">Bacillus subtilis PrsA is Required In Vivo as an Extracytoplasmic Chaperone for Secretion of Active Enzymes Synthesized Either With or Without Pro-Sequences</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">957</span>– <span class="NLM_lpage">966</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01640.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1993.tb01640.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8102773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFWjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=957-966&issue=5&author=M.+Jacobsauthor=J.+B.+Andersenauthor=V.+Kontinenauthor=M.+Sarvas&title=Bacillus+subtilis+PrsA+is+Required+In+Vivo+as+an+Extracytoplasmic+Chaperone+for+Secretion+of+Active+Enzymes+Synthesized+Either+With+or+Without+Pro-Sequences&doi=10.1111%2Fj.1365-2958.1993.tb01640.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Bacillus subtilis PrsA is required in vivo as an extracytoplasmic chaperone for secretion of active enzymes synthesized either with or without prosequences</span></div><div class="casAuthors">Jacobs, M.; Andersen, J. B.; Kontinen, V.; Sarvas, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">957-66</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">In prsA (protein secretion) mutants of Bacillus subtilis, decreased levels of exoproteins, including α-amylase and subtilisins, are found extracellularly.  The effect of prsA on subtilisin secretion is elaborated here.  Extracytoplasmic folding and secretion of active subtilisin is assisted by the N-terminal pro-sequence of its precursor.  The product of the prsA gene is addnl. required for these processes in vivo.  Inducible expression of different subtilisin-alk. phosphatase fusion genes in the prsA3 mutant was examd.  There was massive degrdn. of the fusion proteins, and a lack of enzymic activity in the protein secreted.  Apparently, PrsA is a novel chaperone with a predicted extracytoplasmic location, and is important in vivo for the proper conformation of various exoproteins, including those with pro-sequence (like subtilisin) and those without (like α-amylase).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofwmvO7IB3crVg90H21EOLACvtfcHk0lgBOYjGeHgi0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFWjsrc%253D&md5=82e9771d71bc5f4c7af94b215b5d09a4</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01640.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01640.x%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DJ.%2BB.%26aulast%3DKontinen%26aufirst%3DV.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DBacillus%2520subtilis%2520PrsA%2520is%2520Required%2520In%2520Vivo%2520as%2520an%2520Extracytoplasmic%2520Chaperone%2520for%2520Secretion%2520of%2520Active%2520Enzymes%2520Synthesized%2520Either%2520With%2520or%2520Without%2520Pro-Sequences%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D8%26issue%3D5%26spage%3D957%26epage%3D966%26doi%3D10.1111%2Fj.1365-2958.1993.tb01640.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saris, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">A Gene (prsA) of Bacillus subtilis Involved in a Novel, Late Stage of Protein Export</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1273</span>– <span class="NLM_lpage">1283</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1991.tb01901.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1991.tb01901.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1956302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK38Xht1aisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=1273-1283&issue=5&author=V.+Kontinenauthor=P.+Sarisauthor=M.+Sarvas&title=A+Gene+%28prsA%29+of+Bacillus+subtilis+Involved+in+a+Novel%2C+Late+Stage+of+Protein+Export&doi=10.1111%2Fj.1365-2958.1991.tb01901.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A gene (prsA) of Bacillus subtilis involved in a novel, late stage of protein export</span></div><div class="casAuthors">Kontinen, V. P.; Saris, P.; Sarvas, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1273-83</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">A gene locus of B. subtilis identified by mutations (prs) conferring a defect in protein secretion was closed from a lambdaGEM-11 expression library.  The sites of 3 closely linked prs mutations (prs-3, prs-29, and prs-40) were found to reside in a 5.3 kb DNA fragment, which also complemented the secretion defect in prs-3 and prs-29 mutants.  Partial sequencing of the fragment showed that these 3 mutations affect 1 distinct gene (prsA) encoding a putative protein of 292 amino acids (33 kDa).  Sequence anal. indicated the PrsA protein to be a lipoprotein located outside the cytoplasmic membrane.  Thirty percent identity was shown to the PrtM protein of Lactococcus lactis, which is involved in the maturation of an exported proteinase.  The phenotypes of prsA mutants and the structural similarity of PrsA with PrtM suggest that PrsA may have a novel function at a late phase in protein export.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruflf2gvc5k7Vg90H21EOLACvtfcHk0lgBOYjGeHgi0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht1aisr0%253D&md5=ab1e6dcef093fb9a74ff60b78ddcd77d</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1991.tb01901.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1991.tb01901.x%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%26aulast%3DSaris%26aufirst%3DP.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DA%2520Gene%2520%2528prsA%2529%2520of%2520Bacillus%2520subtilis%2520Involved%2520in%2520a%2520Novel%252C%2520Late%2520Stage%2520of%2520Protein%2520Export%26jtitle%3DMol.%2520Microbiol.%26date%3D1991%26volume%3D5%26issue%3D5%26spage%3D1273%26epage%3D1283%26doi%3D10.1111%2Fj.1365-2958.1991.tb01901.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">The PrsA Lipoprotein is Essential for Protein Secretion in Bacillus subtilis and Sets a Limit for High-Level Secretion</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">737</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.1993.tb01616.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.1993.tb01616.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=8332065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Oktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=727-737&issue=4&author=V.+P.+Kontinenauthor=M.+Sarvas&title=The+PrsA+Lipoprotein+is+Essential+for+Protein+Secretion+in+Bacillus+subtilis+and+Sets+a+Limit+for+High-Level+Secretion&doi=10.1111%2Fj.1365-2958.1993.tb01616.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">The PrsA lipoprotein is essential for protein secretion in Bacillus subtilis and sets a limit for high-level secretion</span></div><div class="casAuthors">Kontinen, Vesa P.; Sarvas, Matti</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">727-37</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    </div><div class="casAbstract">Mutations of the prsA gene of B. subtilis have indicated that the gene is involved in protein secretion and it encodes a novel component of the cellular secretion machinery.  It is now demonstrated that the gene product is a membrane-assocd. lipoprotein, presumably bound to the outer face of the cytoplasmic membrane.  Expts. to inactivate the prsA gene with insertions indicated that it is indispensable for viability.  The cellular level of PrsA protein was decreased in prsA mutants with decreased level of exoproteins, consistent with an essential function in protein secretion.  An increased amt. of cellular PrsA protein was introduced by increasing the copy no. of prsA in B. subtilis.  This enhanced, from 6- to 2-fold, the secretion of α-amylases and a protease in strains that expressed high levels of these exoenzymes.  This suggests that PrsA protein is the rate-limiting component of the secretion machinery, a finding that is of considerable biotechnol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr25y5Vb0kX5LVg90H21EOLACvtfcHk0lgBOYjGeHgi0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Oktr0%253D&md5=cd957ade93fc108e75b0206461d2293a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.1993.tb01616.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.1993.tb01616.x%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DThe%2520PrsA%2520Lipoprotein%2520is%2520Essential%2520for%2520Protein%2520Secretion%2520in%2520Bacillus%2520subtilis%2520and%2520Sets%2520a%2520Limit%2520for%2520High-Level%2520Secretion%26jtitle%3DMol.%2520Microbiol.%26date%3D1993%26volume%3D8%26issue%3D4%26spage%3D727%26epage%3D737%26doi%3D10.1111%2Fj.1365-2958.1993.tb01616.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappalainen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seppala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antelmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savilahti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span> <span> </span><span class="NLM_article-title">Structure-Function Analysis of PrsA Reveals Roles for the Parvulin-Like and Flanking N-and C-Terminal Domains in Protein Folding and Secretion in Bacillus subtilis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">19302</span>– <span class="NLM_lpage">19314</span>, <span class="refDoi"> DOI: 10.1074/jbc.M400861200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M400861200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=14976191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVKmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=19302-19314&issue=18&author=M.+Vitikainenauthor=I.+Lappalainenauthor=R.+Seppalaauthor=H.+Antelmannauthor=H.+Boerauthor=S.+Tairaauthor=H.+Savilahtiauthor=M.+Heckerauthor=M.+Vihinenauthor=M.+Sarvasauthor=V.+P.+Kontinen&title=Structure-Function+Analysis+of+PrsA+Reveals+Roles+for+the+Parvulin-Like+and+Flanking+N-and+C-Terminal+Domains+in+Protein+Folding+and+Secretion+in+Bacillus+subtilis&doi=10.1074%2Fjbc.M400861200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function analysis of PrsA reveals roles for the parvulin-like and flanking N- and C-terminal domains in protein folding and secretion in Bacillus subtilis</span></div><div class="casAuthors">Vitikainen, Marika; Lappalainen, Ilkka; Seppala, Raili; Antelmann, Haike; Boer, Harry; Taira, Suvi; Savilahti, Harri; Hecker, Michael; Vihinen, Mauno; Sarvas, Matti; Kontinen, Vesa P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">19302-19314</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The PrsA protein of B. subtilis is an essential membrane-bound lipoprotein that is assumed to assist post-translocational folding of exported proteins and stabilize them in the compartment between the cytoplasmic membrane and cell wall.  This folding activity is consistent with the homol. of a segment of PrsA with parvulin-type peptidylprolyl cis/trans isomerases (PPIases).  Here, mol. modeling showed that the parvulin-like region could adopt a parvulin-type fold with structurally conserved active site residues.  PrsA exhibited PPIase activity in a manner dependent on the parvulin-like domain.  The authors constructed deletion, peptide insertion, and amino acid substitution mutations and demonstrated that the parvulin-like domain as well as flanking N- and C-terminal domains were essential for in vivo PrsA function in protein secretion and growth.  Surprisingly, none of the predicted active site residues of the parvulin-like domain was essential for growth and protein secretion, although several active site mutations reduced or abolished the PPIase activity or the ability of PrsA to catalyze proline-limited protein folding in vitro.  These results indicate that PrsA is a PPIase, but the essential role in vivo seems to depend on some non-PPIase activity of both the parvulin-like and flanking domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRzQuvLMbDLVg90H21EOLACvtfcHk0li1qxY1vSPLIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVKmurY%253D&md5=84cfabdeddb956c7f4e705bd80afa4db</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M400861200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M400861200%26sid%3Dliteratum%253Aachs%26aulast%3DVitikainen%26aufirst%3DM.%26aulast%3DLappalainen%26aufirst%3DI.%26aulast%3DSeppala%26aufirst%3DR.%26aulast%3DAntelmann%26aufirst%3DH.%26aulast%3DBoer%26aufirst%3DH.%26aulast%3DTaira%26aufirst%3DS.%26aulast%3DSavilahti%26aufirst%3DH.%26aulast%3DHecker%26aufirst%3DM.%26aulast%3DVihinen%26aufirst%3DM.%26aulast%3DSarvas%26aufirst%3DM.%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26atitle%3DStructure-Function%2520Analysis%2520of%2520PrsA%2520Reveals%2520Roles%2520for%2520the%2520Parvulin-Like%2520and%2520Flanking%2520N-and%2520C-Terminal%2520Domains%2520in%2520Protein%2520Folding%2520and%2520Secretion%2520in%2520Bacillus%2520subtilis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D18%26spage%3D19302%26epage%3D19314%26doi%3D10.1074%2Fjbc.M400861200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pummi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Airaksinen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahlström, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span> <span> </span><span class="NLM_article-title">Quantitation of the Capacity of the Secretion Apparatus and Requirement for PrsA in Growth and Secretion of α-Amylase in Bacillus subtilis</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>183</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1881</span>– <span class="NLM_lpage">1890</span>, <span class="refDoi"> DOI: 10.1128/JB.183.6.1881-1890.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.183.6.1881-1890.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=11222585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvVeksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2001&pages=1881-1890&issue=6&author=M.+Vitikainenauthor=T.+Pummiauthor=U.+Airaksinenauthor=E.+Wahlstr%C3%B6mauthor=H.+Wuauthor=M.+Sarvasauthor=V.+P.+Kontinen&title=Quantitation+of+the+Capacity+of+the+Secretion+Apparatus+and+Requirement+for+PrsA+in+Growth+and+Secretion+of+%CE%B1-Amylase+in+Bacillus+subtilis&doi=10.1128%2FJB.183.6.1881-1890.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of α-amylase in Bacillus subtilis</span></div><div class="casAuthors">Vitikainen, Marika; Pummi, Tiina; Airaksinen, Ulla; Wahlstrom, Eva; Wu, Hongyan; Sarvas, Matti; Kontinen, Vesa P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1881-1890</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Regulated expression of AmyQ α-amylase of Bacillus amyloliquefaciens was used to examine the capacity of the protein secretion app. of B. subtilis.  One B. subtilis cell was found to secrete maximally 10 fg of AmyQ per h.  The signal peptidase SipT limits the rate of processing of the signal peptide.  Another limit is set by PrsA lipoprotein.  The wild-type level of PrsA was 2 × 104 mols. per cell.  Decreasing the cellular level of PrsA did not decrease the capacity of the protein translocation or signal peptide processing steps but dramatically affected secretion in a posttranslocational step.  There was a linear correlation between the no. of cellular PrsA mols. and the no. of secreted AmyQ mols. over a wide range of prsA and amyQ expression levels.  Significantly, even when amyQ was expressed at low levels, overprodn. of PrsA enhanced its secretion.  The finding is consistent with a reversible interaction between PrsA and AmyQ.  The high cellular level of PrsA suggests a chaperone-like function.  PrsA was also found to be essential for the viability of B. subtilis.  Drastic depletion of PrsA resulted in altered cellular morphol. and ultimately in cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxlIKq1l3xJLVg90H21EOLACvtfcHk0li1qxY1vSPLIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvVeksL4%253D&md5=ce922b228a47bcd57ea4df0467bb50de</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1128%2FJB.183.6.1881-1890.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.183.6.1881-1890.2001%26sid%3Dliteratum%253Aachs%26aulast%3DVitikainen%26aufirst%3DM.%26aulast%3DPummi%26aufirst%3DT.%26aulast%3DAiraksinen%26aufirst%3DU.%26aulast%3DWahlstr%25C3%25B6m%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSarvas%26aufirst%3DM.%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26atitle%3DQuantitation%2520of%2520the%2520Capacity%2520of%2520the%2520Secretion%2520Apparatus%2520and%2520Requirement%2520for%2520PrsA%2520in%2520Growth%2520and%2520Secretion%2520of%2520%25CE%25B1-Amylase%2520in%2520Bacillus%2520subtilis%26jtitle%3DJ.%2520Bacteriol.%26date%3D2001%26volume%3D183%26issue%3D6%26spage%3D1881%26epage%3D1890%26doi%3D10.1128%2FJB.183.6.1881-1890.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontinen, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvas, M.</span></span> <span> </span><span class="NLM_article-title">Mutants of Bacillus subtilis Defective in Protein Export</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2333</span>– <span class="NLM_lpage">2344</span>, <span class="refDoi"> DOI: 10.1099/00221287-134-8-2333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2F00221287-134-8-2333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaL1cXlsVKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1988&pages=2333-2344&issue=8&author=V.+P.+Kontinenauthor=M.+Sarvas&title=Mutants+of+Bacillus+subtilis+Defective+in+Protein+Export&doi=10.1099%2F00221287-134-8-2333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Mutants of Bacillus subtilis defective in protein export</span></div><div class="casAuthors">Kontinen, Vesa P.; Sarvas, Matti</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Microbiology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2333-44</span>CODEN:
                <span class="NLM_cas:coden">JGMIAN</span>;
        ISSN:<span class="NLM_cas:issn">0022-1287</span>.
    </div><div class="casAbstract">Bacillus Strains were isolated that have mutations (designated prs) that decrease secretion of α-amylase and have a pleiotropic effect on the secretion of other exoproteins.  The seven mutants were selected in a strain of B. subtilis which overproduces α-amylase due to the presence of an α-amylase gene on a multicopy plasmid.  The mutations were mapped to four different chromosomal loci.  The phenotype of the mutants, esp. their pleiotropic effects and the accumulation of α-amylase precursor, indicated that they have defects in the mechanism of protein export.  Double mutants with certain pairwise combinations of mutations in different loci had additive effects of secretion, suggesting that these prs genes encode different components of the secretion pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouFNZxu9MXP7Vg90H21EOLACvtfcHk0li1qxY1vSPLIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsVKis7s%253D&md5=8a91afcb0cd7b17f3b3111cd6b161914</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1099%2F00221287-134-8-2333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F00221287-134-8-2333%26sid%3Dliteratum%253Aachs%26aulast%3DKontinen%26aufirst%3DV.%2BP.%26aulast%3DSarvas%26aufirst%3DM.%26atitle%3DMutants%2520of%2520Bacillus%2520subtilis%2520Defective%2520in%2520Protein%2520Export%26jtitle%3DMicrobiology%26date%3D1988%26volume%3D134%26issue%3D8%26spage%3D2333%26epage%3D2344%26doi%3D10.1099%2F00221287-134-8-2333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag, N. E.</span></span> <span> </span><span class="NLM_article-title">Listeria monocytogenes PrsA2 is Required for Virulence Factor Secretion and Bacterial Viability Within the Host Cell Cytosol</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4944</span>– <span class="NLM_lpage">4957</span>, <span class="refDoi"> DOI: 10.1128/IAI.00532-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00532-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20823208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSntbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=4944-4957&issue=11&author=F.+Alonzoauthor=N.+E.+Freitag&title=Listeria+monocytogenes+PrsA2+is+Required+for+Virulence+Factor+Secretion+and+Bacterial+Viability+Within+the+Host+Cell+Cytosol&doi=10.1128%2FIAI.00532-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Listeria monocytogenes PrsA2 is required for virulence factor secretion and bacterial viability within the host cell cytosol</span></div><div class="casAuthors">Alonzo, Francis, III; Freitag, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4944-4957</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In the course of establishing its replication niche within the cytosol of infected host cells, the facultative intracellular bacterial pathogen Listeria monocytogenes must efficiently regulate the secretion and activity of multiple virulence factors.  L. monocytogenes encodes two predicted posttranslocation secretion chaperones, PrsA1 and PrsA2, and evidence suggests that PrsA2 has been specifically adapted for bacterial pathogenesis.  PrsA-like chaperones have been identified in a no. of Gram-pos. bacteria, where they are reported to function at the bacterial membrane-cell wall interface to assist in the folding of proteins translocated across the membrane; in some cases, these proteins have been found to be essential for bacterial viability.  In this study, the contributions of PrsA2 and PrsA1 to L. monocytogenes growth and protein secretion were investigated in vitro and in vivo.  Neither PrsA2 nor PrsA1 was found to be essential for L. monocytogenes growth in broth culture; however, optimal bacterial viability was found to be dependent upon PrsA2 for L. monocytogenes located within the cytosol of host cells.  Proteomic analyses of prsA2 mutant strains in the presence of a mutationally activated allele of the virulence regulator PrfA revealed a crit. requirement for PrsA activity under conditions of PrfA activation, an event which normally takes place within the host cell cytosol.  Despite a high degree of amino acid similarity, no detectable degree of functional overlap was obsd. between PrsA2 and PrsA1.  The results indicate a crit. requirement for PrsA2 under conditions relevant to host cell infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdCZHXpLnCX7Vg90H21EOLACvtfcHk0lip7KXQ20Rg3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSntbjK&md5=4d90775e0d8d7083a18ed91b16a6cc8b</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1128%2FIAI.00532-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00532-10%26sid%3Dliteratum%253Aachs%26aulast%3DAlonzo%26aufirst%3DF.%26aulast%3DFreitag%26aufirst%3DN.%2BE.%26atitle%3DListeria%2520monocytogenes%2520PrsA2%2520is%2520Required%2520for%2520Virulence%2520Factor%2520Secretion%2520and%2520Bacterial%2520Viability%2520Within%2520the%2520Host%2520Cell%2520Cytosol%26jtitle%3DInfect.%2520Immun.%26date%3D2010%26volume%3D78%26issue%3D11%26spage%3D4944%26epage%3D4957%26doi%3D10.1128%2FIAI.00532-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Port, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag, N. E.</span></span> <span> </span><span class="NLM_article-title">The Posttranslocation Chaperone PrsA2 Contributes to Multiple Facets of Listeria monocytogenes Pathogenesis</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2612</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1128/IAI.00280-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.00280-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19451247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFams7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=2612-2623&issue=7&author=F.+Alonzoauthor=G.+C.+Portauthor=M.+Caoauthor=N.+E.+Freitag&title=The+Posttranslocation+Chaperone+PrsA2+Contributes+to+Multiple+Facets+of+Listeria+monocytogenes+Pathogenesis&doi=10.1128%2FIAI.00280-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The posttranslocation chaperone PrsA2 contributes to multiple facets of Listeria monocytogenes pathogenesis</span></div><div class="casAuthors">Alonzo, Francis, III; Port, Gary C.; Cao, Min; Freitag, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2612-2623</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Listeria monocytogenes is an intracellular bacterial pathogen whose virulence depends on the regulated expression of numerous secreted bacterial factors.  As for other gram-pos. bacteria, many proteins secreted by L. monocytogenes are translocated across the bacterial membrane in an unfolded state to the compartment existing between the membrane and the cell wall.  This compartment presents a challenging environment for protein folding due to its high d. of neg. charge, high concns. of cations, and low pH.  We recently identified PrsA2 as a gene product required for L. monocytogenes virulence.  PrsA2 was identified based on its increased secretion by strains contg. a mutationally activated form of prfA, the key regulator of L. monocytogenes virulence gene expression.  The prsA2 gene product is one of at least two predicted peptidyl-prolyl cis/trans-isomerases encoded by L. monocytogenes; these proteins function as posttranslocation protein chaperones and/or foldases.  In this study, we demonstrate that PrsA2 plays a unique and important role in L. monocytogenes pathogenesis by promoting the activity and stability of at least two crit. secreted virulence factors: listeriolysin O (LLO) and a broad-specificity phospholipase.  Loss of PrsA2 activity severely attenuated virulence in mice and impaired bacterial cell-to-cell spread in host cells.  In contrast, mutants lacking prsA1 resembled wild-type bacteria with respect to intracellular growth and cell-to-cell spread as well as virulence in mice.  PrsA2 is thus distinct from PrsA1 in its unique requirement for the stability and full activity of L. monocytogenes-secreted factors that contribute to host infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8Uqivqm2RyrVg90H21EOLACvtfcHk0lip7KXQ20Rg3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFams7g%253D&md5=08f0a879cad6595791c2ed12ff8e8545</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1128%2FIAI.00280-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00280-09%26sid%3Dliteratum%253Aachs%26aulast%3DAlonzo%26aufirst%3DF.%26aulast%3DPort%26aufirst%3DG.%2BC.%26aulast%3DCao%26aufirst%3DM.%26aulast%3DFreitag%26aufirst%3DN.%2BE.%26atitle%3DThe%2520Posttranslocation%2520Chaperone%2520PrsA2%2520Contributes%2520to%2520Multiple%2520Facets%2520of%2520Listeria%2520monocytogenes%2520Pathogenesis%26jtitle%3DInfect.%2520Immun.%26date%3D2009%26volume%3D77%26issue%3D7%26spage%3D2612%26epage%3D2623%26doi%3D10.1128%2FIAI.00280-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, F.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xayarath, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whisstock, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitag, N. E.</span></span> <span> </span><span class="NLM_article-title">Functional Analysis of the Listeria monocytogenes Secretion Chaperone PrsA2 and its Multiple Contributions to Bacterial Virulence</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1530</span>– <span class="NLM_lpage">1548</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2011.07665.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1111%2Fj.1365-2958.2011.07665.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21545417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVChsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=1530-1548&issue=6&author=F.+Alonzoauthor=B.+Xayarathauthor=J.+C.+Whisstockauthor=N.+E.+Freitag&title=Functional+Analysis+of+the+Listeria+monocytogenes+Secretion+Chaperone+PrsA2+and+its+Multiple+Contributions+to+Bacterial+Virulence&doi=10.1111%2Fj.1365-2958.2011.07665.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analysis of the Listeria monocytogenes secretion chaperone PrsA2 and its multiple contributions to bacterial virulence</span></div><div class="casAuthors">Alonzo, Francis, III; Xayarath, Bobbi; Whisstock, James C.; Freitag, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1530-1548</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">As an organism that has evolved to live in environments ranging from soil to the cytosol of mammalian cells, Listeria monocytogenes must regulate the secretion and activity of protein products that promote survival within these habitats.  The post-translocation chaperone PrsA2 has been adapted to assist in the folding and activity of L. monocytogenes secreted proteins required for bacterial replication within host cells.  Here we present the first structure/function investigation of the contributions of PrsA2 to protein secretion and activity as well as to bacterial virulence.  Domain swap expts. with the closely related L. monocytogenes PrsA1 protein combined with targeted mutagenesis indicate distinct functional roles for the PrsA2 peptidyl-prolyl isomerase (PPIase) and the N- and C-terminal domains in pathogenesis.  In contrast to other PrsA-like proteins described thus far in the literature, an abs. in vivo requirement for PrsA2 PPIase activity is evident in mouse infection models.  This work illustrates the diversity of function assocd. with L. monocytogenes PrsA2 that serves to promote bacterial life within the infected host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTOnHO-9lQrVg90H21EOLACvtfcHk0lip7KXQ20Rg3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVChsbg%253D&md5=c66965727987f384646afb85098626d4</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2011.07665.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2011.07665.x%26sid%3Dliteratum%253Aachs%26aulast%3DAlonzo%26aufirst%3DF.%26aulast%3DXayarath%26aufirst%3DB.%26aulast%3DWhisstock%26aufirst%3DJ.%2BC.%26aulast%3DFreitag%26aufirst%3DN.%2BE.%26atitle%3DFunctional%2520Analysis%2520of%2520the%2520Listeria%2520monocytogenes%2520Secretion%2520Chaperone%2520PrsA2%2520and%2520its%2520Multiple%2520Contributions%2520to%2520Bacterial%2520Virulence%26jtitle%3DMol.%2520Microbiol.%26date%3D2011%26volume%3D80%26issue%3D6%26spage%3D1530%26epage%3D1548%26doi%3D10.1111%2Fj.1365-2958.2011.07665.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cron, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bootsma, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghout, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammerschmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, P. W.</span></span> <span> </span><span class="NLM_article-title">Surface-Associated Lipoprotein PpmA of Streptococcus pneumoniae is Involved in Colonization in a Strain-Specific Manner</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">2401</span>– <span class="NLM_lpage">2410</span>, <span class="refDoi"> DOI: 10.1099/mic.0.026765-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1099%2Fmic.0.026765-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19389773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFemsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2009&pages=2401-2410&author=L.+E.+Cronauthor=H.+J.+Bootsmaauthor=N.+Noskeauthor=P.+Burghoutauthor=S.+Hammerschmidtauthor=P.+W.+Hermans&title=Surface-Associated+Lipoprotein+PpmA+of+Streptococcus+pneumoniae+is+Involved+in+Colonization+in+a+Strain-Specific+Manner&doi=10.1099%2Fmic.0.026765-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Surface-associated lipoprotein PpmA of Streptococcus pneumoniae is involved in colonization in a strain-specific manner</span></div><div class="casAuthors">Cron, L. E.; Bootsma, H. J.; Noske, N.; Burghout, P.; Hammerschmidt, S.; Hermans, P. W. M.</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2401-2410</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Streptococcus pneumoniae produces two surface-assocd. lipoproteins that share homol., with two distinct families of peptidyl-prolyl isomerases (PPlases), the streptococcal lipoprotein rotamase A (SlrA) and the putative proteinase maturation protein A (PpmA).  Previously, the authors have demonstrated that SlrA has PPlase activity, and that the enzyme plays a role in pneumococcal virulence.  Here, they investigated the contribution of PpmA to pneumococcal pathogenesis.  Pneumococcal mutants of D39 and TIGR4 lacking the gene encoding PpmA were less capable of persisting in the nasopharynx of mice, demonstrating the contribution of PpmA to pneumococcal colonization.  This observation was partially confirmed in vitro, as the pneumococcal mutants NCTC10319ΔppmA and TIGR4ΔcpsΔppmA, but not D39ΔcpsΔppmA, were impaired in adherence to Detroit 562 pharyngeal cells.  This suggests that the contribution of PpmA to pneumococcal colonization is not solely the result of its role in adherence to epithelial cells.  Deficiency in PpmA did not result in reduced binding to various extracellular matrix and serum proteins.  Similar to SlrA, we obsd. that PpmA was involved in immune evasion.  Uptake of PpmA-deficient D39Δcps and NCTC10319 by human polymorphonuclear leukocytes was significantly enhanced compared to the isogenic wild-types.  In addn., ingestion of D39ΔppmA, but not that of either NCTC10319ΔppmA or TIGR4ΔppmA, by murine macrophage cell line J774 was also enhanced, whereas intracellular killing remained unaffected.  We conclude that PpmA contributes to the early stages of infection, i.e. colonization.  The contribution of PpmA to virulence can be explained by its strain-specific role in adherence to epithelial cells and contribution to the evasion of phagocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs22mkYITPNLVg90H21EOLACvtfcHk0ljYO0EVbWtrTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFemsL4%253D&md5=844d8e65c5cc591d930e4a598b4a4f46</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.026765-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.026765-0%26sid%3Dliteratum%253Aachs%26aulast%3DCron%26aufirst%3DL.%2BE.%26aulast%3DBootsma%26aufirst%3DH.%2BJ.%26aulast%3DNoske%26aufirst%3DN.%26aulast%3DBurghout%26aufirst%3DP.%26aulast%3DHammerschmidt%26aufirst%3DS.%26aulast%3DHermans%26aufirst%3DP.%2BW.%26atitle%3DSurface-Associated%2520Lipoprotein%2520PpmA%2520of%2520Streptococcus%2520pneumoniae%2520is%2520Involved%2520in%2520Colonization%2520in%2520a%2520Strain-Specific%2520Manner%26jtitle%3DMicrobiology%26date%3D2009%26volume%3D155%26spage%3D2401%26epage%3D2410%26doi%3D10.1099%2Fmic.0.026765-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Justice, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunstad, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duguay, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkner, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultgren, S. J.</span></span> <span> </span><span class="NLM_article-title">Periplasmic Peptidyl Prolyl Cis-Trans Isomerases are not Essential for Viability, but SurA is Required for Pilus Biogenesis in Escherichia coli</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>187</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">7680</span>– <span class="NLM_lpage">7686</span>, <span class="refDoi"> DOI: 10.1128/JB.187.22.7680-7686.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.187.22.7680-7686.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16267292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WnurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2005&pages=7680-7686&issue=22&author=S.+S.+Justiceauthor=D.+A.+Hunstadauthor=J.+R.+Harperauthor=A.+R.+Duguayauthor=J.+S.+Pinknerauthor=J.+Bannauthor=C.+Friedenauthor=T.+J.+Silhavyauthor=S.+J.+Hultgren&title=Periplasmic+Peptidyl+Prolyl+Cis-Trans+Isomerases+are+not+Essential+for+Viability%2C+but+SurA+is+Required+for+Pilus+Biogenesis+in+Escherichia+coli&doi=10.1128%2FJB.187.22.7680-7686.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli</span></div><div class="casAuthors">Justice, Sheryl S.; Hunstad, David A.; Harper, Jill Reiss; Duguay, Amy R.; Pinkner, Jerome S.; Bann, James; Frieden, Carl; Silhavy, Thomas J.; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7680-7686</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In Escherichia coli, FkpA, PpiA, PpiD, and SurA are the four known periplasmic cis-trans prolyl isomerases.  These isomerases facilitate proper protein folding by increasing the rate of transition of proline residues between the cis and trans states.  Genetic inactivation of all four periplasmic isomerases resulted in a viable strain that exhibited a decreased growth rate and increased susceptibility to certain antibiotics.  Levels of the outer membrane proteins LamB and OmpA in the quadruple mutant were indistinguishable from those in the surA single mutant.  In addn., expression of P and type 1 pili (adhesive organelles produced by uropathogenic strains of E. coli and assembled by the chaperone/usher pathway) were severely diminished in the absence of the four periplasmic isomerases.  Maturation of the usher was significantly impaired in the outer membranes of strains devoid of all four periplasmic isomerases, resulting in a defect in pilus assembly.  Moreover, this defect in pilus assembly and usher stability could be attributed to the absence of SurA.  The data presented here suggest that the four periplasmic isomerases are not essential for growth under lab. conditions but may have significant roles in survival in environmental and pathogenic niches, as indicated by the effect on pilus prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDCqVaua1PGbVg90H21EOLACvtfcHk0ljYO0EVbWtrTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WnurbE&md5=3a5e65b1cf908ba8bf553fb546773941</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1128%2FJB.187.22.7680-7686.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.187.22.7680-7686.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJustice%26aufirst%3DS.%2BS.%26aulast%3DHunstad%26aufirst%3DD.%2BA.%26aulast%3DHarper%26aufirst%3DJ.%2BR.%26aulast%3DDuguay%26aufirst%3DA.%2BR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DBann%26aufirst%3DJ.%26aulast%3DFrieden%26aufirst%3DC.%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DPeriplasmic%2520Peptidyl%2520Prolyl%2520Cis-Trans%2520Isomerases%2520are%2520not%2520Essential%2520for%2520Viability%252C%2520but%2520SurA%2520is%2520Required%2520for%2520Pilus%2520Biogenesis%2520in%2520Escherichia%2520coli%26jtitle%3DJ.%2520Bacteriol.%26date%3D2005%26volume%3D187%26issue%3D22%26spage%3D7680%26epage%3D7686%26doi%3D10.1128%2FJB.187.22.7680-7686.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tormo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almiron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolter, R.</span></span> <span> </span><span class="NLM_article-title">surA, an Escherichia coli Gene Essential for Survival in Stationary Phase</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4339</span>– <span class="NLM_lpage">4347</span>, <span class="refDoi"> DOI: 10.1128/JB.172.8.4339-4347.1990</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.172.8.4339-4347.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=2165476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFahsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1990&pages=4339-4347&issue=8&author=A.+Tormoauthor=M.+Almironauthor=R.+Kolter&title=surA%2C+an+Escherichia+coli+Gene+Essential+for+Survival+in+Stationary+Phase&doi=10.1128%2FJB.172.8.4339-4347.1990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">surA, an Escherichia coli gene essential for survival in stationary phase</span></div><div class="casAuthors">Tormo, Antonio; Almiron, Marta; Kolter, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4339-47</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    </div><div class="casAbstract">Mutations in genes not required for exponential growth but essential for survival in stationary phase were isolated in an effort to understand the ability of wild-type E. coli cells to remain viable during prolonged periods of nutritional deprivation.  The phenotype of these mutations is referred to as Sur- (survival) and the genes are designated sur.  The detailed anal. of one of these mutations is presented here.  The mutation (surA1) caused by insertion of a mini-Tn10 element defined a new gene located near 1 min on the E. coli chromosome.  It was located directly upstream of pdxA and formed part of a complex operon.  Evidence is presented supporting the interpretation that cells harboring the surA1 mutation die during stationary phase while similar insertion mutations in other genes of the operon do not lead to a Sur- phenotype.  Strains harboring surA1 had a normal doubling time in both rich and minimal medium, but cultures lost viability after several days in stationary phase.  Anal. of revertants and suppressors of surA1, which arose after prolonged incubation in stationary phase, indicates that DNA rearrangements (excisions and duplications) occurred in cultures of this strain even when the viable-cell counts were below 102 cells per mL.  Cells contg. suppressing mutations then grew in the same culture to 108 cells per mL, taking over the population.  The implications of these observations to the understanding of stationary-phase mutagenesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriKnkNZfGaNLVg90H21EOLACvtfcHk0ljYO0EVbWtrTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFahsb4%253D&md5=fcc9b0375c8ace55372d116022f6be7c</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1128%2FJB.172.8.4339-4347.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.172.8.4339-4347.1990%26sid%3Dliteratum%253Aachs%26aulast%3DTormo%26aufirst%3DA.%26aulast%3DAlmiron%26aufirst%3DM.%26aulast%3DKolter%26aufirst%3DR.%26atitle%3DsurA%252C%2520an%2520Escherichia%2520coli%2520Gene%2520Essential%2520for%2520Survival%2520in%2520Stationary%2520Phase%26jtitle%3DJ.%2520Bacteriol.%26date%3D1990%26volume%3D172%26issue%3D8%26spage%3D4339%26epage%3D4347%26doi%3D10.1128%2FJB.172.8.4339-4347.1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunstad, D. A.</span></span> <span> </span><span class="NLM_article-title">Components of SurA Required for Outer Membrane Biogenesis in Uropathogenic Escherichia coli</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">e3359</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0003359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1371%2Fjournal.pone.0003359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18836534" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e3359&issue=10&author=K.+M.+Wattsauthor=D.+A.+Hunstad&title=Components+of+SurA+Required+for+Outer+Membrane+Biogenesis+in+Uropathogenic+Escherichia+coli&doi=10.1371%2Fjournal.pone.0003359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0003359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0003359%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DK.%2BM.%26aulast%3DHunstad%26aufirst%3DD.%2BA.%26atitle%3DComponents%2520of%2520SurA%2520Required%2520for%2520Outer%2520Membrane%2520Biogenesis%2520in%2520Uropathogenic%2520Escherichia%2520coli%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26issue%3D10%26spage%3De3359%26doi%3D10.1371%2Fjournal.pone.0003359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sydenham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatfield, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, G.</span></span> <span> </span><span class="NLM_article-title">Salmonella enterica Serovar Typhimurium SurA Mutants are Attenuated and Effective Live Oral Vaccines</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1128/IAI.68.3.1109-1115.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.68.3.1109-1115.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10678914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVKktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2000&pages=1109-1115&issue=3&author=M.+Sydenhamauthor=G.+Douceauthor=F.+Boweauthor=S.+Ahmedauthor=S.+Chatfieldauthor=G.+Dougan&title=Salmonella+enterica+Serovar+Typhimurium+SurA+Mutants+are+Attenuated+and+Effective+Live+Oral+Vaccines&doi=10.1128%2FIAI.68.3.1109-1115.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines</span></div><div class="casAuthors">Sydenham, Mark; Douce, Gillian; Bowe, Frances; Ahmed, Saddif; Chatfield, Steve; Dougan, Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1109-1115</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A previously described attenuated TnphoA mutant (BRD441) of Salmonella enterica serovar Typhimurium C5 was characterized, and the transposon was shown to be inserted in surA, a gene which encodes a peptidylprolyl-cis,trans-isomerase.  A defined surA deletion mutation was introduced into S. enterica serovar Typhimurium C5 and the mutant strain, named S. enterica serovar Typhimurium BRD1115, was extensively characterized both in vitro and in vivo.  S. enterica serovar Typhimurium BRD1115 was defective in the ability to adhere to and invade eukaryotic cells.  Furthermore, S. enterica serovar Typhimurium BRD1115 was attenuated by at least 3 log units when administered orally or i.v. to BALB/c mice.  Complementation of the mutation with a plasmid carrying the intact surA gene almost completely restored the virulence of BRD1115.  In addn., S. enterica serovar Typhimurium BRD1115 demonstrated potential as a vaccine candidate, since mice immunized with BRD1115 were protected against subsequent challenge with S. enterica serovar Typhimurium C5.  S. enterica serovar Typhimurium BRD1115 also showed potential as a vehicle for the effective delivery of heterologous antigens, such as the nontoxic, protective fragment C domain of tetanus toxin, to the murine immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc6JbUPczPMrVg90H21EOLACvtfcHk0lj5d2XUyyQRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVKktb4%253D&md5=87bba53011961505cb8548ecffdc187c</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1128%2FIAI.68.3.1109-1115.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.68.3.1109-1115.2000%26sid%3Dliteratum%253Aachs%26aulast%3DSydenham%26aufirst%3DM.%26aulast%3DDouce%26aufirst%3DG.%26aulast%3DBowe%26aufirst%3DF.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DChatfield%26aufirst%3DS.%26aulast%3DDougan%26aufirst%3DG.%26atitle%3DSalmonella%2520enterica%2520Serovar%2520Typhimurium%2520SurA%2520Mutants%2520are%2520Attenuated%2520and%2520Effective%2520Live%2520Oral%2520Vaccines%26jtitle%3DInfect.%2520Immun.%26date%3D2000%26volume%3D68%26issue%3D3%26spage%3D1109%26epage%3D1115%26doi%3D10.1128%2FIAI.68.3.1109-1115.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purdy, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, S. M.</span></span> <span> </span><span class="NLM_article-title">IcsA Surface Presentation in Shigella flexneri Requires the Periplasmic Chaperones DegP, Skp, and SurA</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>189</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5566</span>– <span class="NLM_lpage">5573</span>, <span class="refDoi"> DOI: 10.1128/JB.00483-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FJB.00483-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17526712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos1Crtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2007&pages=5566-5573&issue=15&author=G.+E.+Purdyauthor=C.+R.+Fisherauthor=S.+M.+Payne&title=IcsA+Surface+Presentation+in+Shigella+flexneri+Requires+the+Periplasmic+Chaperones+DegP%2C+Skp%2C+and+SurA&doi=10.1128%2FJB.00483-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">IcsA surface presentation in Shigella flexneri requires the periplasmic chaperones DegP, Skp, and SurA</span></div><div class="casAuthors">Purdy, Georgiana E.; Fisher, Carolyn R.; Payne, Shelley M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">189</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5566-5573</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A Shigella flexneri degP mutant, which was defective for plaque formation in Henle cell monolayers, had a reduced amt. of IcsA detectable on the bacterial surface with antibody.  However, the mutant secreted IcsA to the outer membrane at wild-type levels.  This suggests that IcsA adopts an altered conformation in the outer membrane of the degP mutant with reduced exposure on the cell surface.  IcsA is, therefore, unlikely to be accessible to actin-nucleating proteins within the eukaryotic cell cytoplasm, which is required for bacterial movement within the host cell and cell-to-cell spread.  The degP mutant was somewhat more sensitive to detergents, antibiotics, and the antimicrobial peptide magainin, indicating that the degP phenotype was not limited to IcsA surface presentation.  The plaque defect of the degP mutant, which is independent of DegP protease activity, was suppressed by overexpression of the periplasmic chaperone Skp but not by SurA.  S. flexneri skp and surA mutants failed to form plaques in Henle cell monolayers and were defective in cell surface presentation and polar localization of IcsA.  Therefore, the three periplasmic folding factors DegP, Skp, and SurA were all required for IcsA localization and plaque formation by S. flexneri.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVbgylfG0V2bVg90H21EOLACvtfcHk0lj5d2XUyyQRTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos1Crtbk%253D&md5=3ebe33db3d88897c848fd700e73b4be7</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1128%2FJB.00483-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00483-07%26sid%3Dliteratum%253Aachs%26aulast%3DPurdy%26aufirst%3DG.%2BE.%26aulast%3DFisher%26aufirst%3DC.%2BR.%26aulast%3DPayne%26aufirst%3DS.%2BM.%26atitle%3DIcsA%2520Surface%2520Presentation%2520in%2520Shigella%2520flexneri%2520Requires%2520the%2520Periplasmic%2520Chaperones%2520DegP%252C%2520Skp%252C%2520and%2520SurA%26jtitle%3DJ.%2520Bacteriol.%26date%3D2007%26volume%3D189%26issue%3D15%26spage%3D5566%26epage%3D5573%26doi%3D10.1128%2FJB.00483-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkönig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smet-Nocca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobecq, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieruszeski, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sénéchal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landrieu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob-Dubuisson, F.</span></span> <span> </span><span class="NLM_article-title">The Peptidyl–Prolyl Isomerase and Chaperone Par27 of Bordetella pertussis as the Prototype for a New Group of Parvulins</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>376</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2007.10.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jmb.2007.10.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18164725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2ns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2008&pages=414-426&issue=2&author=H.+Hodakauthor=A.+Wohlk%C3%B6nigauthor=C.+Smet-Noccaauthor=H.+Drobecqauthor=J.-M.+Wieruszeskiauthor=M.+S%C3%A9n%C3%A9chalauthor=I.+Landrieuauthor=C.+Lochtauthor=M.+Jaminauthor=F.+Jacob-Dubuisson&title=The+Peptidyl%E2%80%93Prolyl+Isomerase+and+Chaperone+Par27+of+Bordetella+pertussis+as+the+Prototype+for+a+New+Group+of+Parvulins&doi=10.1016%2Fj.jmb.2007.10.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The Peptidyl-Prolyl Isomerase and Chaperone Par27 of Bordetella pertussis as the Prototype for a New Group of Parvulins</span></div><div class="casAuthors">Hodak, Helene; Wohlkonig, Alexandre; Smet-Nocca, Caroline; Drobecq, Herve; Wieruszeski, Jean-Michel; Senechal, Magalie; Landrieu, Isabelle; Locht, Camille; Jamin, Marc; Jacob-Dubuisson, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">414-426</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Proteins that pass through the periplasm in an unfolded state are highly sensitive to proteolysis and aggregation and, therefore, often require protection by chaperone-like proteins.  The periplasm of Gram-neg. bacteria is well equipped with ATP-independent chaperones and folding catalysts, including peptidyl-prolyl isomerases (PPIases).  The filamentous hemagglutinin of Bordetella pertussis, which is secreted by the two-partner secretion pathway, crosses the periplasm in an unfolded conformation.  By affinity chromatog., we identified a new periplasmic PPIase of the parvulin family, Par27, which binds to an unfolded filamentous hemagglutinin fragment.  Par27 differs from previously characterized bacterial and eukaryotic parvulins.  Its central parvulin-like domain is flanked by atypical N- and C-terminal extensions that are found in a no. of putative PPIases present mostly in β proteobacteria.  Par27 displays both PPIase and chaperone activities in vitro.  In vivo, Par27 might function as a general periplasmic chaperone in B. pertussis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQrGescYP8h7Vg90H21EOLACvtfcHk0liRWGZF36Vkkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2ns7k%253D&md5=11bc155dad78c5024d42aac56fc560c6</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2007.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2007.10.088%26sid%3Dliteratum%253Aachs%26aulast%3DHodak%26aufirst%3DH.%26aulast%3DWohlk%25C3%25B6nig%26aufirst%3DA.%26aulast%3DSmet-Nocca%26aufirst%3DC.%26aulast%3DDrobecq%26aufirst%3DH.%26aulast%3DWieruszeski%26aufirst%3DJ.-M.%26aulast%3DS%25C3%25A9n%25C3%25A9chal%26aufirst%3DM.%26aulast%3DLandrieu%26aufirst%3DI.%26aulast%3DLocht%26aufirst%3DC.%26aulast%3DJamin%26aufirst%3DM.%26aulast%3DJacob-Dubuisson%26aufirst%3DF.%26atitle%3DThe%2520Peptidyl%25E2%2580%2593Prolyl%2520Isomerase%2520and%2520Chaperone%2520Par27%2520of%2520Bordetella%2520pertussis%2520as%2520the%2520Prototype%2520for%2520a%2520New%2520Group%2520of%2520Parvulins%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D376%26issue%3D2%26spage%3D414%26epage%3D426%26doi%3D10.1016%2Fj.jmb.2007.10.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obi, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, M. S.</span></span> <span> </span><span class="NLM_article-title">Demarcating SurA Activities Required for Outer Membrane Targeting of Yersinia pseudotuberculosis Adhesins</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2308</span>, <span class="refDoi"> DOI: 10.1128/IAI.01208-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1128%2FIAI.01208-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23589578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=2296-2308&issue=7&author=I.+R.+Obiauthor=M.+S.+Francis&title=Demarcating+SurA+Activities+Required+for+Outer+Membrane+Targeting+of+Yersinia+pseudotuberculosis+Adhesins&doi=10.1128%2FIAI.01208-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Demarcating SurA activities required for outer membrane targeting of Yersinia pseudotuberculosis adhesins</span></div><div class="casAuthors">Obi, Ikenna R.; Francis, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2296-2308</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">SurA is a periplasmic protein folding factor involved in chaperoning and trafficking of outer membrane proteins across the Gram-neg. bacterial periplasm.  In addn., SurA also possesses peptidyl-prolyl cis/trans isomerase activity.  The authors have previously reported that in enteropathogenic Yersinia pseudotuberculosis, SurA is needed for bacterial virulence and envelope integrity.  The authors studied the role of SurA in the assembly of important Yersinia adhesins.  Using genetic mutation, biochem. characterization, and an in vitro-based bacterial host cell assocn. assay, surface localization of the invasin adhesin was shown to be dependent on SurA.  As a surA deletion also has some impact on the levels of individual components of the BAM complex in the Yersinia outer membrane, abolished invasin surface assembly could reflect both a direct loss of SurA-dependent periplasmic targeting and a potentially compromised BAM complex assembly platform in the outer membrane.  To various degrees, the assembly of two other adhesins, Ail and the pH 6 antigen fibrillum PsaA, also depends on SurA.  Consequently, loss of SurA leads to a dramatic redn. in Yersinia attachment to eukaryotic host cells.  Genetic complementation of surA deletion mutants indicated a prominent role for SurA chaperone function in outer membrane protein assembly.  Significantly, the N terminus of SurA contributed most of this SurA chaperone function.  Despite a dominant chaperoning role, it was also evident that SurA isomerization activity did make a modest contribution to this assembly process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob6A1qQqv4ubVg90H21EOLACvtfcHk0liRWGZF36Vkkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajsLzP&md5=9fbf158bad73ce0a0a0dbc5186492c95</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1128%2FIAI.01208-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.01208-12%26sid%3Dliteratum%253Aachs%26aulast%3DObi%26aufirst%3DI.%2BR.%26aulast%3DFrancis%26aufirst%3DM.%2BS.%26atitle%3DDemarcating%2520SurA%2520Activities%2520Required%2520for%2520Outer%2520Membrane%2520Targeting%2520of%2520Yersinia%2520pseudotuberculosis%2520Adhesins%26jtitle%3DInfect.%2520Immun.%26date%3D2013%26volume%3D81%26issue%3D7%26spage%3D2296%26epage%3D2308%26doi%3D10.1128%2FIAI.01208-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obi, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordfelth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, M. S.</span></span> <span> </span><span class="NLM_article-title">Varying Dependency of Periplasmic Peptidyl-Prolyl Cis–Trans Isomerases in Promoting Yersinia pseudotuberculosis Stress Tolerance and Pathogenicity</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>439</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">332</span>, <span class="refDoi"> DOI: 10.1042/BJ20110767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1042%2FBJ20110767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21726196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yku77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2011&pages=321-332&issue=2&author=I.+R.+Obiauthor=R.+Nordfelthauthor=M.+S.+Francis&title=Varying+Dependency+of+Periplasmic+Peptidyl-Prolyl+Cis%E2%80%93Trans+Isomerases+in+Promoting+Yersinia+pseudotuberculosis+Stress+Tolerance+and+Pathogenicity&doi=10.1042%2FBJ20110767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Varying dependency of periplasmic peptidylprolyl cis-trans isomerases in promoting Yersinia pseudotuberculosis stress tolerance and pathogenicity</span></div><div class="casAuthors">Obi, Ikenna R.; Nordfelth, Roland; Francis, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">439</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-332</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Periplasmic PPIases (peptidylprolyl cis-trans isomerases) catalyze the cis-trans isomerization of peptidyl-prolyl bonds, which is a rate-limiting step during protein folding.  We demonstrate that the surA, ppiA, ppiD, fkpA and fklB alleles each encode a periplasmic PPIase in the bacterial pathogen Yersinia pseudotuberculosis.  Of these, four were purified to homogeneity.  Purified SurA, FkpA and FklB, but not PpiD, displayed detectable PPIase activity in vitro.  Significantly, only Y. pseudotuberculosis lacking surA caused drastic alterations to the outer membrane protein profile and FA (fatty acid) compn.  They also exhibited aberrant cellular morphol., leaking LPS (lipopolysaccharide) into the extracellular environment.  The SurA PPIase is therefore most crit. for maintaining Y. pseudotuberculosis envelope integrity during routine culturing.  On the other hand, bacteria lacking either surA or all of the genes ppiA, ppiD, fkpA and fklB were sensitive to hydrogen peroxide and were attenuated in mice infections.  Thus Y. pseudotuberculosis exhibits both SurA-dependent and -independent requirements for periplasmic PPIase activity to ensure in vivo survival and a full virulence effect in a mammalian host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv4gdZ-spK6LVg90H21EOLACvtfcHk0liRWGZF36Vkkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yku77E&md5=2953215f282f7e89ebab3395cda746fb</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1042%2FBJ20110767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110767%26sid%3Dliteratum%253Aachs%26aulast%3DObi%26aufirst%3DI.%2BR.%26aulast%3DNordfelth%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DM.%2BS.%26atitle%3DVarying%2520Dependency%2520of%2520Periplasmic%2520Peptidyl-Prolyl%2520Cis%25E2%2580%2593Trans%2520Isomerases%2520in%2520Promoting%2520Yersinia%2520pseudotuberculosis%2520Stress%2520Tolerance%2520and%2520Pathogenicity%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D439%26issue%3D2%26spage%3D321%26epage%3D332%26doi%3D10.1042%2FBJ20110767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazemian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourmand, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siadat, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahdavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazdi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majelan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afshar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaseri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Getso, M. I.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning and Immunogenicity Evaluation of PpiC, GeLE, and VS87_01105 Proteins of Enterococcus faecalis as Vaccine Candidates</span>. <i>Iran. Biomed. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">353</span>, <span class="refDoi"> DOI: 10.29252/ibj.23.5.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.29252%2Fibj.23.5.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2019&pages=343-353&issue=5&author=H.+Kazemianauthor=M.+R.+Pourmandauthor=S.+D.+Siadatauthor=M.+Mahdaviauthor=M.+H.+Yazdiauthor=P.+A.+Majelanauthor=D.+Afsharauthor=M.+Yaseriauthor=M.+Davariauthor=M.+I.+Getso&title=Molecular+Cloning+and+Immunogenicity+Evaluation+of+PpiC%2C+GeLE%2C+and+VS87_01105+Proteins+of+Enterococcus+faecalis+as+Vaccine+Candidates&doi=10.29252%2Fibj.23.5.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.29252%2Fibj.23.5.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.29252%252Fibj.23.5.6%26sid%3Dliteratum%253Aachs%26aulast%3DKazemian%26aufirst%3DH.%26aulast%3DPourmand%26aufirst%3DM.%2BR.%26aulast%3DSiadat%26aufirst%3DS.%2BD.%26aulast%3DMahdavi%26aufirst%3DM.%26aulast%3DYazdi%26aufirst%3DM.%2BH.%26aulast%3DMajelan%26aufirst%3DP.%2BA.%26aulast%3DAfshar%26aufirst%3DD.%26aulast%3DYaseri%26aufirst%3DM.%26aulast%3DDavari%26aufirst%3DM.%26aulast%3DGetso%26aufirst%3DM.%2BI.%26atitle%3DMolecular%2520Cloning%2520and%2520Immunogenicity%2520Evaluation%2520of%2520PpiC%252C%2520GeLE%252C%2520and%2520VS87_01105%2520Proteins%2520of%2520Enterococcus%2520faecalis%2520as%2520Vaccine%2520Candidates%26jtitle%3DIran.%2520Biomed.%2520J.%26date%3D2019%26volume%3D23%26issue%3D5%26spage%3D343%26epage%3D353%26doi%3D10.29252%2Fibj.23.5.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datsenko, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Construction of Escherichia coli K-12 In-Frame, Single-Gene Knockout Mutants: the Keio Collection</span>. <i>Mol. Syst. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2006.0008</span>, <span class="refDoi"> DOI: 10.1038/msb4100050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fmsb4100050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=16738554" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=2006.0008&issue=1&author=T.+Babaauthor=T.+Araauthor=M.+Hasegawaauthor=Y.+Takaiauthor=Y.+Okumuraauthor=M.+Babaauthor=K.+A.+Datsenkoauthor=M.+Tomitaauthor=B.+L.+Wannerauthor=H.+Mori&title=Construction+of+Escherichia+coli+K-12+In-Frame%2C+Single-Gene+Knockout+Mutants%3A+the+Keio+Collection&doi=10.1038%2Fmsb4100050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fmsb4100050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmsb4100050%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DAra%26aufirst%3DT.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTakai%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DDatsenko%26aufirst%3DK.%2BA.%26aulast%3DTomita%26aufirst%3DM.%26aulast%3DWanner%26aufirst%3DB.%2BL.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DConstruction%2520of%2520Escherichia%2520coli%2520K-12%2520In-Frame%252C%2520Single-Gene%2520Knockout%2520Mutants%253A%2520the%2520Keio%2520Collection%26jtitle%3DMol.%2520Syst.%2520Biol.%26date%3D2006%26volume%3D2%26issue%3D1%26spage%3D2006.0008%26doi%3D10.1038%2Fmsb4100050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span> <span> </span><span class="NLM_article-title">Defining the Roles of the Periplasmic Chaperones SurA, Skp, and DegP in Escherichia coli</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2473</span>– <span class="NLM_lpage">2484</span>, <span class="refDoi"> DOI: 10.1101/gad.1581007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1101%2Fgad.1581007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=17908933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKrtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2473-2484&issue=19&author=J.+G.+Sklarauthor=T.+Wuauthor=D.+Kahneauthor=T.+J.+Silhavy&title=Defining+the+Roles+of+the+Periplasmic+Chaperones+SurA%2C+Skp%2C+and+DegP+in+Escherichia+coli&doi=10.1101%2Fgad.1581007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli</span></div><div class="casAuthors">Sklar, Joseph G.; Wu, Tao; Kahne, Daniel; Silhavy, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2473-2484</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Integral β-barrel proteins (OMPs) are a major class of outer membrane proteins in Gram-neg. bacteria.  In Escherichia coli, these proteins are synthesized in the cytoplasm, translocated across the inner membrane via the Sec machinery, and assembled in the outer membrane through an unknown mechanism that requires the outer membrane YaeT complex and the periplasmic chaperones SurA, DegP, and Skp.  Here, we have established the relationship between these three chaperones providing insight into the mechanism of OMP biogenesis using depletion anal.  Depletion of SurA alone results in a marked decrease in outer membrane d., while the loss of DegP and Skp has no effect on outer membrane compn.  Furthermore, we demonstrate that SurA and YaeT interact directly in vivo.  Based on these results, we suggest that SurA is the primary chaperone responsible for the periplasmic transit of the bulk mass of OMPs to the YaeT complex.  The role of Skp and DegP is amplified in the absence of SurA.  Evidence presented suggests that DegP/Skp function to rescue OMPs that fall off the SurA pathway.  The seemingly redundant periplasmic chaperones do function in parallel, but the relative importance of the primary function of each pathway depends on whether or not cells are under stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2opsuBX_ju7Vg90H21EOLACvtfcHk0lgFxyi-E_vnDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKrtL3I&md5=52149f8fdbdf7251ce0b5e2f3dec5e11</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1101%2Fgad.1581007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1581007%26sid%3Dliteratum%253Aachs%26aulast%3DSklar%26aufirst%3DJ.%2BG.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKahne%26aufirst%3DD.%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26atitle%3DDefining%2520the%2520Roles%2520of%2520the%2520Periplasmic%2520Chaperones%2520SurA%252C%2520Skp%252C%2520and%2520DegP%2520in%2520Escherichia%2520coli%26jtitle%3DGenes%2520Dev.%26date%3D2007%26volume%3D21%26issue%3D19%26spage%3D2473%26epage%3D2484%26doi%3D10.1101%2Fgad.1581007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vertommen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverrier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collet, J. F.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Role of the Escherichia coli Periplasmic Chaperone SurA using Differential Proteomics</span>. <i>Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2432</span>– <span class="NLM_lpage">2443</span>, <span class="refDoi"> DOI: 10.1002/pmic.200800794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fpmic.200800794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19343722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=2432-2443&issue=9&author=D.+Vertommenauthor=N.+Ruizauthor=P.+Leverrierauthor=T.+J.+Silhavyauthor=J.+F.+Collet&title=Characterization+of+the+Role+of+the+Escherichia+coli+Periplasmic+Chaperone+SurA+using+Differential+Proteomics&doi=10.1002%2Fpmic.200800794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the role of the Escherichia coli periplasmic chaperone SurA using differential proteomics</span></div><div class="casAuthors">Vertommen, Didier; Ruiz, Natividad; Leverrier, Pauline; Silhavy, Thomas J.; Collet, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Proteomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2432-2443</span>CODEN:
                <span class="NLM_cas:coden">PROTC7</span>;
        ISSN:<span class="NLM_cas:issn">1615-9853</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Little is known on how β-barrel proteins are assembled in the outer membrane (OM) of Gram-neg. bacteria.  SurA has been proposed to be the primary chaperone escorting the bulk mass of OM proteins across the periplasm.  However, the impact of SurA deletion on the global OM proteome has not been detd., thereby limiting our understanding of the function of SurA.  By using a differential proteomics approach based on 2-D LC-MSn, we compared the relative abundance of 64 OM proteins, including 23 β-barrel proteins, in wild-type and surA strains.  Unexpectedly, we found that the loss of SurA affects the abundance of eight β-barrel proteins.  Of all the decreased proteins, FhuA and LptD are the only two for which the decreased protein abundance cannot be attributed, at least in part, to decreased mRNA levels in the surA strain.  In the case of LptD, an essential protein involved in OM biogenesis, our data support a role for SurA in the assembly of this protein and suggest that LptD is a true SurA substrate.  Based on our results, we propose a revised model in which only a subset of OM proteins depends on SurA for proper folding and insertion in the OM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2VqT_VriKarVg90H21EOLACvtfcHk0lgFxyi-E_vnDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVChsLk%253D&md5=e4f2e1fe49b881c320430bb190f8cc75</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fpmic.200800794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpmic.200800794%26sid%3Dliteratum%253Aachs%26aulast%3DVertommen%26aufirst%3DD.%26aulast%3DRuiz%26aufirst%3DN.%26aulast%3DLeverrier%26aufirst%3DP.%26aulast%3DSilhavy%26aufirst%3DT.%2BJ.%26aulast%3DCollet%26aufirst%3DJ.%2BF.%26atitle%3DCharacterization%2520of%2520the%2520Role%2520of%2520the%2520Escherichia%2520coli%2520Periplasmic%2520Chaperone%2520SurA%2520using%2520Differential%2520Proteomics%26jtitle%3DProteomics%26date%3D2009%26volume%3D9%26issue%3D9%26spage%3D2432%26epage%3D2443%26doi%3D10.1002%2Fpmic.200800794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Baño, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcalá, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cisneros, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horcajada, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tórtola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirelis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuenca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peña, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llanos, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantón, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, A.</span></span> <span> </span><span class="NLM_article-title">Community Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli</span>. <i>Arch. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">1897</span>– <span class="NLM_lpage">1902</span>, <span class="refDoi"> DOI: 10.1001/archinte.168.17.1897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1001%2Farchinte.168.17.1897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18809817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtF2rur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2008&pages=1897-1902&issue=17&author=J.+Rodr%C3%ADguez-Ba%C3%B1oauthor=J.+C.+Alcal%C3%A1author=J.+M.+Cisnerosauthor=F.+Grillauthor=A.+Oliverauthor=J.+P.+Horcajadaauthor=T.+T%C3%B3rtolaauthor=B.+Mirelisauthor=G.+Navarroauthor=M.+Cuencaauthor=M.+Esteveauthor=C.+Pe%C3%B1aauthor=A.+C.+Llanosauthor=R.+Cant%C3%B3nauthor=A.+Pascual&title=Community+Infections+Caused+by+Extended-Spectrum+%CE%B2-Lactamase-Producing+Escherichia+coli&doi=10.1001%2Farchinte.168.17.1897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli</span></div><div class="casAuthors">Rodriguez-Bano, Jesus; Alcala, Juan C.; Cisneros, Jose M.; Grill, Fabio; Oliver, Antonio; Horcajada, Juan P.; Tortola, Teresa; Mirelis, Beatriz; Navarro, Gemma; Cuenca, Maria; Esteve, Maria; Pena, Carmen; Llanos, Ana C.; Canton, Rafael; Pascual, Alvaro</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Internal Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1897-1902</span>CODEN:
                <span class="NLM_cas:coden">AIMDAP</span>;
        ISSN:<span class="NLM_cas:issn">0003-9926</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is an increasingly important group of community pathogens worldwide.  These organisms are frequently resistant to many of the antimicrobial agents usually recommended for the treatment of infections caused by E coli, such as penicillins, cephalosporins, fluoroquinolones, and trimethoprim-sulfamethoxazole.  Data concerning risk factors, clin. features, and therapeutic options for such infections are scarce.  A case-control study was performed to investigate the risk factors for all types of community-acquired infections caused by ESBL-producing E coli in 11 Spanish hospitals from Feb. 2002 to May 2003.  Controls were randomly chosen from among outpatients with a clin. sample not yielding ESBL-producing E coli.  The clin. features of these infections were investigated in the case patients.  The efficacy of fosfomycin tromethamine and amoxicillin-clavulanate potassium was observationally studied in patients with cystitis.  A total of 122 cases were included.  Risk factors selected by multivariate anal. included the following: age older than 60 years; female sex; diabetes mellitus; recurrent urinary tract infections (UTIs); previous invasive procedures of the urinary tract; follow-up in outpatient clinic; and previous receipt of aminopenicillins, cephalosporins, and fluoroquinolones.  Urinary tract infections accounted for 93% of the cases; 6% of the patients were bacteremic and 10% needed hospitalization.  The cure rate of patients with cystitis was 93% with fosfomycin therapy (all isolates were susceptible); among patients treated with amoxicillin-clavulanate, cure rates were 93% for those with susceptible isolates (min. inhibitory concn. ≤8 μg/mL) and 56% for those with intermediate or resistant isolates (min. inhibitory concn. ≥16 μg/mL) (P = .02).  In predisposed patients, ESBL-producing E coli is a notable cause of community-acquired infection, and particularly UTI.  Fosfomycin and amoxicillin-clavulanate appear to be effective for cystitis caused by susceptible isolates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6OXF87GbT4LVg90H21EOLACvtfcHk0lj9B_0KPyOH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtF2rur7F&md5=8ccad2fd624eab92c60df972f9f655bb</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1001%2Farchinte.168.17.1897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchinte.168.17.1897%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Ba%25C3%25B1o%26aufirst%3DJ.%26aulast%3DAlcal%25C3%25A1%26aufirst%3DJ.%2BC.%26aulast%3DCisneros%26aufirst%3DJ.%2BM.%26aulast%3DGrill%26aufirst%3DF.%26aulast%3DOliver%26aufirst%3DA.%26aulast%3DHorcajada%26aufirst%3DJ.%2BP.%26aulast%3DT%25C3%25B3rtola%26aufirst%3DT.%26aulast%3DMirelis%26aufirst%3DB.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DCuenca%26aufirst%3DM.%26aulast%3DEsteve%26aufirst%3DM.%26aulast%3DPe%25C3%25B1a%26aufirst%3DC.%26aulast%3DLlanos%26aufirst%3DA.%2BC.%26aulast%3DCant%25C3%25B3n%26aufirst%3DR.%26aulast%3DPascual%26aufirst%3DA.%26atitle%3DCommunity%2520Infections%2520Caused%2520by%2520Extended-Spectrum%2520%25CE%25B2-Lactamase-Producing%2520Escherichia%2520coli%26jtitle%3DArch.%2520Intern.%2520Med.%26date%3D2008%26volume%3D168%26issue%3D17%26spage%3D1897%26epage%3D1902%26doi%3D10.1001%2Farchinte.168.17.1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rottier, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ammerlaan, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonten, M. J.</span></span> <span> </span><span class="NLM_article-title">Effects of Confounders and Intermediates on the Association of Bacteraemia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae and Patient Outcome: a Meta-Analysis</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1320</span>, <span class="refDoi"> DOI: 10.1093/jac/dks065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1093%2Fjac%2Fdks065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=22396430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1311-1320&issue=6&author=W.+C.+Rottierauthor=H.+S.+Ammerlaanauthor=M.+J.+Bonten&title=Effects+of+Confounders+and+Intermediates+on+the+Association+of+Bacteraemia+Caused+by+Extended-Spectrum+%CE%B2-Lactamase-Producing+Enterobacteriaceae+and+Patient+Outcome%3A+a+Meta-Analysis&doi=10.1093%2Fjac%2Fdks065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of confounders and intermediates on the association of bacteremia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis</span></div><div class="casAuthors">Rottier, Wouter C.; Ammerlaan, Heidi S. M.; Bonten, Marc J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1311-1320</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Bacteremia caused by Enterobacteriaceae (EB) producing extended-spectrum β-lactamase (ESBL+) has been assocd. with higher mortality compared with non-ESBL-producing (ESBL-) EB bacteremia in observational studies.  We conducted a systematic review and meta-anal. of these studies to assess how adjusting for confounding in multivariate analyses affects the pooled est., and whether multivariate analyses that include intermediates in the causal pathway of outcome (sepsis severity and inadequate empirical therapy) have lower ests. of attributable mortality.  PubMed search on 23 Nov. 2010 followed by manually searching ref. lists of included studies.  Study eligibility criteria Cohort studies published in English with sep. mortality rates for ESBL+ and ESBL- EB bacteremia.  Random-effects pooling of unadjusted and adjusted ORs followed by subgroup analyses to explore effects of adjustment procedures on adjusted ORs.  The pooled OR for the unadjusted mortality assocd. with ESBL prodn. was 2.35 (95% CI 1.90-2.91, I2 = 42%, 32 studies).  The pooled adjusted OR was 1.52 (95% CI 1.15-2.01, I2 = 32%, 15 studies).  Adjustment for more intermediates was assocd. with decreasing ORs.  The pooled OR for the analyses adjusting for inadequate empirical therapy was 1.37 (95% CI 1.04-1.82).  Conclusions ESBL prodn. in EB bacteremia is assocd. with a higher mortality compared with bacteremia with ESBL- EB, although the est. of this assocn. is affected by adjustment procedures.  Adjustment for inadequate empirical therapy leads to a redn. in ORs, indicating that higher mortality is likely to be mediated through this phenomenon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbndAdIkiqAbVg90H21EOLACvtfcHk0lj9B_0KPyOH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2qt74%253D&md5=e2db4e94813a9addfb61eb3b80b0b939</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks065%26sid%3Dliteratum%253Aachs%26aulast%3DRottier%26aufirst%3DW.%2BC.%26aulast%3DAmmerlaan%26aufirst%3DH.%2BS.%26aulast%3DBonten%26aufirst%3DM.%2BJ.%26atitle%3DEffects%2520of%2520Confounders%2520and%2520Intermediates%2520on%2520the%2520Association%2520of%2520Bacteraemia%2520Caused%2520by%2520Extended-Spectrum%2520%25CE%25B2-Lactamase-Producing%2520Enterobacteriaceae%2520and%2520Patient%2520Outcome%253A%2520a%2520Meta-Analysis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26issue%3D6%26spage%3D1311%26epage%3D1320%26doi%3D10.1093%2Fjac%2Fdks065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">The Isomerase PIN1 Controls Numerous Cancer-Driving Pathways and is a Unique Drug Target</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnrc.2016.49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27256007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XptV2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=463-478&issue=7&author=X.+Z.+Zhouauthor=K.+P.+Lu&title=The+Isomerase+PIN1+Controls+Numerous+Cancer-Driving+Pathways+and+is+a+Unique+Drug+Target&doi=10.1038%2Fnrc.2016.49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</span></div><div class="casAuthors">Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">463-478</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Targeted drugs have changed cancer treatment but are often ineffective in the long term against solid tumors, largely because of the activation of heterogeneous oncogenic pathways.  A central common signalling mechanism in many of these pathways is proline-directed phosphorylation, which is regulated by many kinases and phosphatases.  The structure and function of these phosphorylated proteins are further controlled by a single proline isomerase: PIN1.  PIN1 is overactivated in cancers and it promotes cancer and cancer stem cells by disrupting the balance of oncogenes and tumor suppressors.  This review discusses the roles of PIN1 in cancer and the potential of PIN1 inhibitors to restore this balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUoqPfQTmR7Vg90H21EOLACvtfcHk0lj9B_0KPyOH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptV2isLo%253D&md5=d43428a5099591624980fede9c91fbab</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.49%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DThe%2520Isomerase%2520PIN1%2520Controls%2520Numerous%2520Cancer-Driving%2520Pathways%2520and%2520is%2520a%2520Unique%2520Drug%2520Target%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26issue%3D7%26spage%3D463%26epage%3D478%26doi%3D10.1038%2Fnrc.2016.49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A.</span></span> <span> </span><span class="NLM_article-title">Pin1 Inhibitors: Pitfalls, Progress and Cellular Pharmacology</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">4283</span>– <span class="NLM_lpage">4291</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2013.05.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23796453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVShsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4283-4291&issue=15&author=J.+D.+Mooreauthor=A.+Potter&title=Pin1+Inhibitors%3A+Pitfalls%2C+Progress+and+Cellular+Pharmacology&doi=10.1016%2Fj.bmcl.2013.05.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 inhibitors: Pitfalls, progress and cellular pharmacology</span></div><div class="casAuthors">Moore, Jonathan D.; Potter, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4283-4291</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Compelling data supports the hypothesis that Pin1 inhibitors will be useful for the therapy of cancer: Pin1 deficient mice resist the induction of breast cancers normally evoked by expression of MMTV-driven Ras or Erb2 alleles.  While Pin1 poses challenges for drug discovery, several groups have identified potent antagonists by structure based drug design, significant progress has been made designing peptidic inhibitors and a no. of natural products have been found that blockade Pin1, notably epigallocatchechin gallate (EGCG), a major flavonoid in green tea.  Here we critically discuss the modes of action and likely specificity of these compds., concluding that a suitable chem. biol. tool for probing the function of Pin1 has yet to be found.  We conclude by outlining some open questions regarding the target validation of Pin1 and the prospects for identification of improved inhibitors in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8su1BMHiwErVg90H21EOLACvtfcHk0lj9B_0KPyOH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVShsbfP&md5=d078f5975ede469ad74619eb7e6de031</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.088%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DPin1%2520Inhibitors%253A%2520Pitfalls%252C%2520Progress%2520and%2520Cellular%2520Pharmacology%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4283%26epage%3D4291%26doi%3D10.1016%2Fj.bmcl.2013.05.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunyak, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestwicki, J. E.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9622</span>– <span class="NLM_lpage">9644</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKms73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9622-9644&issue=21&author=B.+M.+Dunyakauthor=J.+E.+Gestwicki&title=Peptidyl-Proline+Isomerases+%28PPIases%29%3A+Targets+for+Natural+Products+and+Natural+Product-Inspired+Compounds&doi=10.1021%2Facs.jmedchem.6b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds</span></div><div class="casAuthors">Dunyak, Bryan M.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9622-9644</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptidyl-proline isomerases (PPIases) are a chaperone superfamily comprising the FK506-binding proteins (FKBPs), cyclophilins, and parvulins.  PPIases catalyze the cis/trans isomerization of proline, acting as a regulatory switch during folding, activation, and/or degrdn. of many proteins.  These "clients" include proteins with key roles in cancer, neurodegeneration, and psychiatric disorders, suggesting that PPIase inhibitors could be important therapeutics.  However, the active site of PPIases is shallow, solvent-exposed, and well conserved between family members, making selective inhibitor design challenging.  Despite these hurdles, macrocyclic natural products, including FK506, rapamycin, and cyclosporin, bind PPIases with nanomolar or better affinity.  De novo attempts to derive new classes of inhibitors have been somewhat less successful, often showcasing the "undruggable" features of PPIases.  Interestingly, the most potent of these next-generation mols. tend to integrate features of the natural products, including macrocyclization or proline mimicry strategies.  Here, we review recent developments and ongoing challenges in the inhibition of PPIases, with a focus on how natural products might inform the creation of potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz44xLeDGfhLVg90H21EOLACvtfcHk0lgaBEoNoW30sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKms73J&md5=b4c6336096f9558926d965d73fb6b7da</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00411%26sid%3Dliteratum%253Aachs%26aulast%3DDunyak%26aufirst%3DB.%2BM.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DPeptidyl-Proline%2520Isomerases%2520%2528PPIases%2529%253A%2520Targets%2520for%2520Natural%2520Products%2520and%2520Natural%2520Product-Inspired%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D21%26spage%3D9622%26epage%3D9644%26doi%3D10.1021%2Facs.jmedchem.6b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campaner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rustighi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zannini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalid, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valsasina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cucchi, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pippione, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giabbai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storici, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carloni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Incalci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappuzzello, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Sal, G.</span></span> <span> </span><span class="NLM_article-title">A Covalent PIN1 Inhibitor Selectively Targets Cancer Cells by a Dual Mechanism of Action</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">15772</span>, <span class="refDoi"> DOI: 10.1038/ncomms15772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fncomms15772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28598431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmslSgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=15772&author=E.+Campanerauthor=A.+Rustighiauthor=A.+Zanniniauthor=A.+Cristianiauthor=S.+Piazzaauthor=Y.+Cianiauthor=O.+Kalidauthor=G.+Golanauthor=E.+Balogluauthor=S.+Shachamauthor=B.+Valsasinaauthor=U.+Cucchiauthor=A.+C.+Pippioneauthor=M.+L.+Lolliauthor=B.+Giabbaiauthor=P.+Storiciauthor=P.+Carloniauthor=G.+Rossettiauthor=F.+Benvenutiauthor=E.+Belloauthor=M.+D%E2%80%99Incalciauthor=E.+Cappuzzelloauthor=A.+Rosatoauthor=G.+Del+Sal&title=A+Covalent+PIN1+Inhibitor+Selectively+Targets+Cancer+Cells+by+a+Dual+Mechanism+of+Action&doi=10.1038%2Fncomms15772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action</span></div><div class="casAuthors">Campaner Elena; Rustighi Alessandra; Zannini Alessandro; Cristiani Alberto; Piazza Silvano; Ciani Yari; Del Sal Giannino; Campaner Elena; Zannini Alessandro; Del Sal Giannino; Kalid Ori; Golan Gali; Baloglu Erkan; Shacham Sharon; Valsasina Barbara; Cucchi Ulisse; Pippione Agnese Chiara; Lolli Marco Lucio; Giabbai Barbara; Storici Paola; Carloni Paolo; Rossetti Giulia; Rossetti Giulia; Rossetti Giulia; Benvenuti Federica; Bello Ezia; D'Incalci Maurizio; Cappuzzello Elisa; Rosato Antonio; Rosato Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15772</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The prolyl isomerase PIN1, a critical modifier of multiple signalling pathways, is overexpressed in the majority of cancers and its activity strongly contributes to tumour initiation and progression.  Inactivation of PIN1 function conversely curbs tumour growth and cancer stem cell expansion, restores chemosensitivity and blocks metastatic spread, thus providing the rationale for a therapeutic strategy based on PIN1 inhibition.  Notwithstanding, potent PIN1 inhibitors are still missing from the arsenal of anti-cancer drugs.  By a mechanism-based screening, we have identified a novel covalent PIN1 inhibitor, KPT-6566, able to selectively inhibit PIN1 and target it for degradation.  We demonstrate that KPT-6566 covalently binds to the catalytic site of PIN1.  This interaction results in the release of a quinone-mimicking drug that generates reactive oxygen species and DNA damage, inducing cell death specifically in cancer cells.  Accordingly, KPT-6566 treatment impairs PIN1-dependent cancer phenotypes in vitro and growth of lung metastasis in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeCgKMDdtGrcULxIEhxUjPfW6udTcc2eb7yf4CX8WG2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmslSgtA%253D%253D&md5=36747881bb866fc653478916352b6f96</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1038%2Fncomms15772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms15772%26sid%3Dliteratum%253Aachs%26aulast%3DCampaner%26aufirst%3DE.%26aulast%3DRustighi%26aufirst%3DA.%26aulast%3DZannini%26aufirst%3DA.%26aulast%3DCristiani%26aufirst%3DA.%26aulast%3DPiazza%26aufirst%3DS.%26aulast%3DCiani%26aufirst%3DY.%26aulast%3DKalid%26aufirst%3DO.%26aulast%3DGolan%26aufirst%3DG.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DValsasina%26aufirst%3DB.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DPippione%26aufirst%3DA.%2BC.%26aulast%3DLolli%26aufirst%3DM.%2BL.%26aulast%3DGiabbai%26aufirst%3DB.%26aulast%3DStorici%26aufirst%3DP.%26aulast%3DCarloni%26aufirst%3DP.%26aulast%3DRossetti%26aufirst%3DG.%26aulast%3DBenvenuti%26aufirst%3DF.%26aulast%3DBello%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Incalci%26aufirst%3DM.%26aulast%3DCappuzzello%26aufirst%3DE.%26aulast%3DRosato%26aufirst%3DA.%26aulast%3DDel%2BSal%26aufirst%3DG.%26atitle%3DA%2520Covalent%2520PIN1%2520Inhibitor%2520Selectively%2520Targets%2520Cancer%2520Cells%2520by%2520a%2520Dual%2520Mechanism%2520of%2520Action%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D15772%26doi%3D10.1038%2Fncomms15772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, P.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of the Human Parvulins Pin1 and Par14/17</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>399</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1515/hsz-2017-0137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1515%2Fhsz-2017-0137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29040060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslSju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=2018&pages=101-125&issue=2&author=A.+Matenaauthor=E.+Rehicauthor=D.+Honigauthor=B.+Kambaauthor=P.+Bayer&title=Structure+and+Function+of+the+Human+Parvulins+Pin1+and+Par14%2F17&doi=10.1515%2Fhsz-2017-0137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the human parvulins Pin1 and Par14/17</span></div><div class="casAuthors">Matena, Anja; Rehic, Edisa; Hoenig, Dana; Kamba, Bianca; Bayer, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-125</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Parvulins belong to the family of peptidyl-prolyl cis/trans isomerases (PPIases) assisting in protein folding and in regulating the function of a broad variety of proteins in all branches of life.  The human representatives Pin1 and Par14/17 are directly involved in processes influencing cellular maintenance and cell fate decisions such as cell-cycle progression, metabolic pathways and ribosome biogenesis.  This review on human parvulins summarizes the current knowledge of these enzymes and intends to oppose the well-studied Pin1 to its less well-examd. homolog human Par14/17 with respect to structure, catalytic and cellular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV720QKhIJMLVg90H21EOLACvtfcHk0lhPmVC3a44ehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslSju7o%253D&md5=f86512448b520d5a23d6ab965661b4e0</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2017-0137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2017-0137%26sid%3Dliteratum%253Aachs%26aulast%3DMatena%26aufirst%3DA.%26aulast%3DRehic%26aufirst%3DE.%26aulast%3DHonig%26aufirst%3DD.%26aulast%3DKamba%26aufirst%3DB.%26aulast%3DBayer%26aufirst%3DP.%26atitle%3DStructure%2520and%2520Function%2520of%2520the%2520Human%2520Parvulins%2520Pin1%2520and%2520Par14%252F17%26jtitle%3DBiol.%2520Chem.%26date%3D2018%26volume%3D399%26issue%3D2%26spage%3D101%26epage%3D125%26doi%3D10.1515%2Fhsz-2017-0137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Sluijs, P.</span></span> <span> </span><span class="NLM_article-title">Juglone Inactivates Cysteine-Rich Proteins Required for Progression Through Mitosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">21714</span>– <span class="NLM_lpage">21724</span>, <span class="refDoi"> DOI: 10.1074/jbc.M710264200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M710264200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=18539601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFWrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=21714-21724&issue=31&author=C.+Filaauthor=C.+Metzauthor=P.+van+der+Sluijs&title=Juglone+Inactivates+Cysteine-Rich+Proteins+Required+for+Progression+Through+Mitosis&doi=10.1074%2Fjbc.M710264200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis</span></div><div class="casAuthors">Fila, Claudia; Metz, Corina; van der Sluijs, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">21714-21724</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The parvulin peptidyl-prolyl isomerase Pin1 catalyzes cis-trans isomerization of p(S/T)-P bonds and might alter conformation and function of client proteins.  Since the trans conformation of p(S/T)-P bonds is preferred by protein phosphatase 2A (PP2A), Pin1 may facilitate PP2A-mediated dephosphorylation.  Juglone irreversibly inhibits parvulins and is often used to study the function of Pin1 in vivo.  The drug prevents dephosphorylation of mitotic phosphoproteins, perhaps because they bind Pin1 and are dephosphorylated by PP2A.  We show here however that juglone inhibited post-mitotic dephosphorylation and the exit of mitosis, independent of Pin1.  This effect involved covalent modification of sulfhydryl groups in proteins essential for metaphase/anaphase transition.  Particularly cytoplasmic proteins with a high cysteine content were vulnerable to the drug.  Alkylation of sulfhydryl groups altered the conformation of such proteins, as evidenced by the disappearance of antibody epitopes on tubulin and the mitotic checkpoint component BubR1.  The latter activates the anaphase-promoting complex/cyclosome, which degrades regulatory proteins, such as cyclin B1 and securins, and is required for mitotic exit.  Indeed, juglone-treated cells failed to assemble a mitotic spindle, which correlated with perturbed microtubule dynamics, loss of immunodetectable tubulin, and formation of tubulin aggregates.  Juglone also prevented degrdn. of cyclin B1, independently of the Mps1-controlled mitotic spindle checkpoint.  Since juglone affected cell cycle progression at several levels, more specific drugs need to be developed for studies of Pin1 function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_CYTjs-XCaLVg90H21EOLACvtfcHk0lhPmVC3a44ehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFWrtr0%253D&md5=5c6ef075f4129b155a67420f7db2ae91</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M710264200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M710264200%26sid%3Dliteratum%253Aachs%26aulast%3DFila%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BSluijs%26aufirst%3DP.%26atitle%3DJuglone%2520Inactivates%2520Cysteine-Rich%2520Proteins%2520Required%2520for%2520Progression%2520Through%2520Mitosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D31%26spage%3D21714%26epage%3D21724%26doi%3D10.1074%2Fjbc.M710264200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wildemann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoller, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanghanel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span> <span> </span><span class="NLM_article-title">Nanomolar Inhibitors of the Peptidyl Prolyl Cis/Trans Isomerase Pin1 from Combinatorial Peptide Libraries</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2147</span>– <span class="NLM_lpage">2150</span>, <span class="refDoi"> DOI: 10.1021/jm060036n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060036n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD28Xitl2itLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2147-2150&issue=7&author=D.+Wildemannauthor=F.+Erdmannauthor=B.+H.+Alvarezauthor=G.+Stollerauthor=X.+Z.+Zhouauthor=J.+Fanghanelauthor=M.+Schutkowskiauthor=K.+P.+Luauthor=G.+Fischer&title=Nanomolar+Inhibitors+of+the+Peptidyl+Prolyl+Cis%2FTrans+Isomerase+Pin1+from+Combinatorial+Peptide+Libraries&doi=10.1021%2Fjm060036n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomolar Inhibitors of the Peptidyl Prolyl Cis/Trans Isomerase Pin1 from Combinatorial Peptide Libraries</span></div><div class="casAuthors">Wildemann, Dirk; Erdmann, Frank; Hernandez Alvarez, Birte; Stoller, Gerlind; Zhou, Xiao Z.; Fanghaenel, Joerg; Schutkowski, Mike; Lu, Kun P.; Fischer, Gunter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2147-2150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The peptidyl prolyl cis/trans isomerase Pin1 has been implicated in the development of cancer, Alzheimer's disease and asthma, but highly specific and potent Pin1 inhibitors remain to be identified.  Here, by screening a combinatorial peptide library, we identified a series of nanomolar peptidic inhibitors.  Nonproteinogenic amino acids, incorporated into 5-mer to 8-mer oligopeptides contg. a D-phosphothreonine as a central template, yielded selective inhibitors that blocked cell cycle progression in HeLa cells in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDg0JZfbs9RbVg90H21EOLACvtfcHk0lhPmVC3a44ehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xitl2itLg%253D&md5=1b6e0c69ced4c6bff5a0680f77d0a763</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Fjm060036n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060036n%26sid%3Dliteratum%253Aachs%26aulast%3DWildemann%26aufirst%3DD.%26aulast%3DErdmann%26aufirst%3DF.%26aulast%3DAlvarez%26aufirst%3DB.%2BH.%26aulast%3DStoller%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DFanghanel%26aufirst%3DJ.%26aulast%3DSchutkowski%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DFischer%26aufirst%3DG.%26atitle%3DNanomolar%2520Inhibitors%2520of%2520the%2520Peptidyl%2520Prolyl%2520Cis%252FTrans%2520Isomerase%2520Pin1%2520from%2520Combinatorial%2520Peptide%2520Libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D7%26spage%3D2147%26epage%3D2150%26doi%3D10.1021%2Fjm060036n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildemann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdecia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for High-Affinity Peptide Inhibition of Human Pin1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1021/cb7000044</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb7000044" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFSltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=320-328&issue=5&author=Y.+Zhangauthor=S.+Daumauthor=D.+Wildemannauthor=X.+Z.+Zhouauthor=M.+A.+Verdeciaauthor=M.+E.+Bowmanauthor=C.+Luckeauthor=T.+Hunterauthor=K.+P.+Luauthor=G.+Fischerauthor=J.+P.+Noel&title=Structural+Basis+for+High-Affinity+Peptide+Inhibition+of+Human+Pin1&doi=10.1021%2Fcb7000044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for high-affinity peptide inhibition of human Pin1</span></div><div class="casAuthors">Zhang, Yan; Daum, Sebastian; Wildemann, Dirk; Zhou, Xiao Zhen; Verdecia, Mark A.; Bowman, Marianne E.; Lucke, Christian; Hunter, Tony; Lu, Kun-Ping; Fischer, Gunter; Noel, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">320-328</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human Pin1 is a key regulator of cell-cycle progression and plays growth-promoting roles in human cancers.  High-affinity inhibitors of Pin1 may provide a unique opportunity for disrupting oncogenic pathways.  Here the authors report two high-resoln. x-ray crystal structures of human Pin1 bound to nonnatural peptide inhibitors.  The structures of the bound high-affinity peptides identify a type-1 β-turn conformation for Pin1 prolyl peptide isomerase domain-peptide binding and an extensive mol. interface for high-affinity recognition.  Moreover, these structures suggest chem. elements that may further improve the affinity and pharmacol. properties of future peptide-based Pin inhibitors.  Finally, an intramol. hydrogen bond obsd. in both peptide complexes mimics the cyclic conformation of FK506 and rapamycin.  Both FK506 and rapamycin are clin. important inhibitors of other peptidyl-prolyl cis-trans isomerases.  This comparative discovery suggests that a cyclic peptide polyketide bridge, like that found in FK506 and rapamycin or a similar linkage, may significantly improve the binding affinity of structure-based Pin1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLtJ1MDtcTcbVg90H21EOLACvtfcHk0lhPmVC3a44ehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFSltLY%253D&md5=597094a0bfb5d80583a21dadeadc7c60</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fcb7000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb7000044%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDaum%26aufirst%3DS.%26aulast%3DWildemann%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DVerdecia%26aufirst%3DM.%2BA.%26aulast%3DBowman%26aufirst%3DM.%2BE.%26aulast%3DLucke%26aufirst%3DC.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DFischer%26aufirst%3DG.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520Basis%2520for%2520High-Affinity%2520Peptide%2520Inhibition%2520of%2520Human%2520Pin1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26issue%3D5%26spage%3D320%26epage%3D328%26doi%3D10.1021%2Fcb7000044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Membrane Permeable Cyclic Peptidyl Inhibitors Against Human Peptidyl-Prolyl Isomerase Pin1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2494</span>– <span class="NLM_lpage">2501</span>, <span class="refDoi"> DOI: 10.1021/jm901778v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901778v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlKiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2494-2501&issue=6&author=T.+Liuauthor=Y.+Liuauthor=H.+Y.+Kaoauthor=D.+Pei&title=Membrane+Permeable+Cyclic+Peptidyl+Inhibitors+Against+Human+Peptidyl-Prolyl+Isomerase+Pin1&doi=10.1021%2Fjm901778v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane Permeable Cyclic Peptidyl Inhibitors against Human Peptidylprolyl Isomerase Pin1</span></div><div class="casAuthors">Liu, Tao; Liu, Yu; Kao, Hung-Ying; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2494-2501</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptidylprolyl isomerase Pin1 regulates the function and/or stability of phosphoproteins by altering the conformation of specific pSer/pThr-Pro peptide bonds.  In this work, a cyclic peptide library was synthesized and screened against the catalytic domain of human Pin1.  The selected inhibitors contained a consensus motif of D-pThr-Pip-Nal (where Pip is L-piperidine-2-carboxylic acid and Nal is L-2-naphthylalanine).  Representative compds. were tested for binding to Pin1 by isothermal titrn. calorimetry and inhibition of Pin1 activity, and the most potent inhibitors had KD (and KI) values in the low nanomolar range.  Treatment of breast cancer cells with the inhibitors, which were rendered membrane permeable by attachment of an octaarginine sequence, inhibited cell proliferation and increased the protein levels of two previously established Pin1 substrates, PML and SMRT.  Finally, a second generation of cell permeable Pin1 inhibitors was designed by replacing the noncrit. residues within the cyclic peptide ring with arginine residues and shown to have antiproliferative activity against the cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHy73i3_6BkLVg90H21EOLACvtfcHk0liqPlHfJrHfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlKiurc%253D&md5=2af6a30c6399cb98689e3c0cdc7879cf</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1021%2Fjm901778v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901778v%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKao%26aufirst%3DH.%2BY.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DMembrane%2520Permeable%2520Cyclic%2520Peptidyl%2520Inhibitors%2520Against%2520Human%2520Peptidyl-Prolyl%2520Isomerase%2520Pin1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D6%26spage%3D2494%26epage%3D2501%26doi%3D10.1021%2Fjm901778v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briesewitz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrios, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhiang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">423</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1021/cb3005275</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb3005275" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1akur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=423-431&issue=2&author=Z.+Qianauthor=T.+Liuauthor=Y.+Y.+Liuauthor=R.+Briesewitzauthor=A.+M.+Barriosauthor=S.+M.+Jhiangauthor=D.+Pei&title=Efficient+Delivery+of+Cyclic+Peptides+into+Mammalian+Cells+with+Short+Sequence+Motifs&doi=10.1021%2Fcb3005275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Delivery of Cyclic Peptides into Mammalian Cells with Short Sequence Motifs</span></div><div class="casAuthors">Qian, Ziqing; Liu, Tao; Liu, Yu-Yu; Briesewitz, Roger; Barrios, Amy M.; Jhiang, Sissy M.; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">423-431</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptides hold great potential as therapeutic agents and research tools, but their broad application has been limited by poor membrane permeability.  Here, we report a potentially general approach for intracellular delivery of cyclic peptides.  Short peptide motifs rich in arginine and hydrophobic residues (e.g., FΦRRRR, where Φ is l-2-naphthylalanine), when embedded into small- to medium-sized cyclic peptides (7-13 amino acids), bound to the plasma membrane of mammalian cultured cells and were subsequently internalized by the cells.  Confocal microscopy and a newly developed peptide internalization assay demonstrated that cyclic peptides contg. these transporter motifs were translocated into the cytoplasm and nucleus at efficiencies 2-5-fold higher than that of nonaarginine (R9).  Furthermore, incorporation of the FΦRRRR motif into a cyclic peptide contg. a phosphocoumaryl aminopropionic acid (pCAP) residue generated a cell permeable, fluorogenic probe for detecting intracellular protein tyrosine phosphatase activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouUMFM_wJk9bVg90H21EOLACvtfcHk0liqPlHfJrHfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1akur%252FO&md5=80f723598b2afcf4503bbb026a7290e9</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Fcb3005275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3005275%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DBriesewitz%26aufirst%3DR.%26aulast%3DBarrios%26aufirst%3DA.%2BM.%26aulast%3DJhiang%26aufirst%3DS.%2BM.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DEfficient%2520Delivery%2520of%2520Cyclic%2520Peptides%2520into%2520Mammalian%2520Cells%2520with%2520Short%2520Sequence%2520Motifs%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3D423%26epage%3D431%26doi%3D10.1021%2Fcb3005275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bedewy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abou-Taleb, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammad, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Generation of a Cell-Permeable Cycloheptapeptidyl Inhibitor Against the Peptidyl-Prolyl Isomerase Pin1</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4540</span>– <span class="NLM_lpage">4543</span>, <span class="refDoi"> DOI: 10.1039/C7OB00430C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1039%2FC7OB00430C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=28517007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotValu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=4540-4543&issue=21&author=W.+Bedewyauthor=H.+Liaoauthor=N.+A.+Abou-Talebauthor=S.+F.+Hammadauthor=T.+Nasrauthor=D.+Pei&title=Generation+of+a+Cell-Permeable+Cycloheptapeptidyl+Inhibitor+Against+the+Peptidyl-Prolyl+Isomerase+Pin1&doi=10.1039%2FC7OB00430C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1</span></div><div class="casAuthors">Bedewy, Walaa; Liao, Hui; Abou-Taleb, Nageh A.; Hammad, Sherif F.; Nasr, Tamer; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4540-4543</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cyclic peptides are capable of binding and modulating challenging drug targets including protein-protein interactions.  However, their lack of membrane permeability prevents their application against intracellular targets.  In this study, we show that it is possible to design a cell-permeable and biol. active cycloheptapeptide inhibitor against the intracellular enzyme peptidyl-prolyl isomerase Pin1 by integrating cell-penetrating and target-binding sequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DJxspjoHyrVg90H21EOLACvtfcHk0liqPlHfJrHfPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotValu78%253D&md5=7ba307be4f57d40b73767e98b16db9eb</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1039%2FC7OB00430C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7OB00430C%26sid%3Dliteratum%253Aachs%26aulast%3DBedewy%26aufirst%3DW.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DAbou-Taleb%26aufirst%3DN.%2BA.%26aulast%3DHammad%26aufirst%3DS.%2BF.%26aulast%3DNasr%26aufirst%3DT.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DGeneration%2520of%2520a%2520Cell-Permeable%2520Cycloheptapeptidyl%2520Inhibitor%2520Against%2520the%2520Peptidyl-Prolyl%2520Isomerase%2520Pin1%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2017%26volume%3D15%26issue%3D21%26spage%3D4540%26epage%3D4543%26doi%3D10.1039%2FC7OB00430C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Cell-Permeable Bicyclic Peptide Inhibitors Against Intracellular Proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">9830</span>– <span class="NLM_lpage">9833</span>, <span class="refDoi"> DOI: 10.1021/ja503710n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja503710n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9830-9833&issue=28&author=W.+Lianauthor=B.+Jiangauthor=Z.+Qianauthor=D.+Pei&title=Cell-Permeable+Bicyclic+Peptide+Inhibitors+Against+Intracellular+Proteins&doi=10.1021%2Fja503710n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-Permeable Bicyclic Peptide Inhibitors against Intracellular Proteins</span></div><div class="casAuthors">Lian, Wenlong; Jiang, Bisheng; Qian, Ziqing; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">9830-9833</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptides have great potential as therapeutic agents and research tools but are generally impermeable to the cell membrane.  Fusion of cyclic peptides with a cyclic cell-penetrating peptide produces bicyclic peptides that are cell-permeable and retain the ability to recognize specific intracellular targets.  Application of this strategy to protein tyrosine phosphatase 1B (PTP1B) and a peptidyl-prolyl cis-trans isomerase (Pin1) isomerase resulted in potent, selective, proteolytically stable, and biol. active inhibitors against the enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRmCZ_CIlJirVg90H21EOLACvtfcHk0lj5J-Ne324Wog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOjsbrN&md5=a8f8e1f0344958dbfeaefef43741d589</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1021%2Fja503710n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja503710n%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DZ.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DCell-Permeable%2520Bicyclic%2520Peptide%2520Inhibitors%2520Against%2520Intracellular%2520Proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D28%26spage%3D9830%26epage%3D9833%26doi%3D10.1021%2Fja503710n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor Against Peptidyl-Prolyl Isomerase Pin1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6306</span>– <span class="NLM_lpage">6312</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6306-6312&issue=15&author=B.+Jiangauthor=D.+Pei&title=A+Selective%2C+Cell-Permeable+Nonphosphorylated+Bicyclic+Peptidyl+Inhibitor+Against+Peptidyl-Prolyl+Isomerase+Pin1&doi=10.1021%2Facs.jmedchem.5b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1</span></div><div class="casAuthors">Jiang, Bisheng; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6306-6312</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pin1 regulates the levels and functions of phosphoproteins by catalyzing phosphorylation-dependent cis/trans isomerization of peptidyl-prolyl bonds.  Previous Pin1 inhibitors contained phosphoamino acids, which are metabolically unstable and have poor membrane permeability.  In this work, the authors report a cell-permeable and metabolically stable nonphosphorylated bicyclic peptide as a potent and selective Pin1 inhibitor, which inhibited the intracellular Pin1 activity in cultured mammalian cells but had little effect on other isomerases such as Pin4, FKBP12, or cyclophilin A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK8No2ty2NM7Vg90H21EOLACvtfcHk0lj5J-Ne324Wog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2lt77P&md5=735a73f73d5aa05ab7f046e7e693b135</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00411%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DA%2520Selective%252C%2520Cell-Permeable%2520Nonphosphorylated%2520Bicyclic%2520Peptidyl%2520Inhibitor%2520Against%2520Peptidyl-Prolyl%2520Isomerase%2520Pin1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D15%26spage%3D6306%26epage%3D6312%26doi%3D10.1021%2Facs.jmedchem.5b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Understanding Cell Penetration of Cyclic Peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">10241</span>– <span class="NLM_lpage">10287</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.9b00008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.9b00008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=10241-10287&issue=17&author=P.+G.+Doughertyauthor=A.+Sahniauthor=D.+Pei&title=Understanding+Cell+Penetration+of+Cyclic+Peptides&doi=10.1021%2Facs.chemrev.9b00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Cell Penetration of Cyclic Peptides</span></div><div class="casAuthors">Dougherty, Patrick G.; Sahni, Ashweta; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10241-10287</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Approx. 75% of all disease-relevant human proteins, including those involved in intracellular protein-protein interactions (PPIs), are undruggable with the current drug modalities (i.e., small mols. and biologics).  Macrocyclic peptides provide a potential soln. to these undruggable targets because their larger sizes (relative to conventional small mols.) endow them the capability of binding to flat PPI interfaces with antibody-like affinity and specificity.  Powerful combinatorial library technologies have been developed to routinely identify cyclic peptides as potent, specific inhibitors against proteins including PPI targets.  However, with the exception of a very small set of sequences, the vast majority of cyclic peptides are impermeable to the cell membrane, preventing their application against intracellular targets.  This Review examines common structural features that render most cyclic peptides membrane impermeable, as well as the unique features that allow the minority of sequences to enter the cell interior by passive diffusion, endocytosis/endosomal escape, or other mechanisms.  We also present the current state of knowledge about the mol. mechanisms of cell penetration, the various strategies for designing cell-permeable, biol. active cyclic peptides against intracellular targets, and the assay methods available to quantify their cell-permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0NDA9U7-1YrVg90H21EOLACvtfcHk0lj5J-Ne324Wog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D&md5=65f68a9b69f3f7f33641b6a91835b1dd</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.9b00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.9b00008%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DP.%2BG.%26aulast%3DSahni%26aufirst%3DA.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DUnderstanding%2520Cell%2520Penetration%2520of%2520Cyclic%2520Peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26issue%3D17%26spage%3D10241%26epage%3D10287%26doi%3D10.1021%2Facs.chemrev.9b00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiler, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etzkorn, F. A.</span></span> <span> </span><span class="NLM_article-title">Conformationally Locked Isostere of PhosphoSer-Cis-Pro Inhibits Pin1 23-fold Better than PhosphoSer-Trans-Pro Isostere</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">47</span>),  <span class="NLM_fpage">15533</span>– <span class="NLM_lpage">15542</span>, <span class="refDoi"> DOI: 10.1021/ja046396m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja046396m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlOisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=15533-15542&issue=47&author=X.+J.+Wangauthor=B.+Xuauthor=A.+B.+Mullinsauthor=F.+K.+Neilerauthor=F.+A.+Etzkorn&title=Conformationally+Locked+Isostere+of+PhosphoSer-Cis-Pro+Inhibits+Pin1+23-fold+Better+than+PhosphoSer-Trans-Pro+Isostere&doi=10.1021%2Fja046396m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally Locked Isostere of PhosphoSer-cis-Pro Inhibits Pin1 23-Fold Better than PhosphoSer-trans-Pro Isostere</span></div><div class="casAuthors">Wang, Xiaodong J.; Xu, Bailing; Mullins, Ashley B.; Neiler, Freda K.; Etzkorn, Felicia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">15533-15542</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stereoisomeric cis and trans substrate analogs for Pin1 were designed and synthesized.  The central phosphoSer-Pro core of the Pin1 substrate was replaced by cis and trans amide isosteres in Ac-Phe-Phe-pSer-ψ[(Z and E)CH:C]-Pro-Arg-NH2, 1 and 2, peptidomimetics.  They were synthesized on solid phase in 17% yield for the cis analog 1, and 16% yield for the trans analog 2.  A second trans amide isostere with a C-terminal N-methylamide 3 was synthesized in 7% yield.  The protease-coupled Pin1 assay showed that all three compds. inhibited the Pin1 peptidyl-prolyl isomerase (PPIase) enzymic activity.  The cis isostere 1 was 23 times more potent (Ki = 1.74±0.08 μM) than its trans counterpart 2 (Ki = 40±2 μM) in competitive inhibition of Pin1.  These results suggest that the catalytic site of Pin1 binds cis substrates more tightly in aq. soln.  Antiproliferative activity toward the A2780 human ovarian cancer cell line by the cis and trans analogs correlates with Pin1 inhibition results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR69CE2ChtL7Vg90H21EOLACvtfcHk0ljDdQTean0BpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlOisLs%253D&md5=f6032101e5c92c159d3cee993b704654</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1021%2Fja046396m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja046396m%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DMullins%26aufirst%3DA.%2BB.%26aulast%3DNeiler%26aufirst%3DF.%2BK.%26aulast%3DEtzkorn%26aufirst%3DF.%2BA.%26atitle%3DConformationally%2520Locked%2520Isostere%2520of%2520PhosphoSer-Cis-Pro%2520Inhibits%2520Pin1%252023-fold%2520Better%2520than%2520PhosphoSer-Trans-Pro%2520Isostere%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D47%26spage%3D15533%26epage%3D15542%26doi%3D10.1021%2Fja046396m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etzkorn, F. A.</span></span> <span> </span><span class="NLM_article-title">Pin1 as an Anticancer Drug Target</span>. <i>Drug News Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.1358/dnp.2009.22.7.1414594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1358%2Fdnp.2009.22.7.1414594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19890497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOmt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=399-407&issue=7&author=G.+G.+Xuauthor=F.+A.+Etzkorn&title=Pin1+as+an+Anticancer+Drug+Target&doi=10.1358%2Fdnp.2009.22.7.1414594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 as an anticancer drug target</span></div><div class="casAuthors">Xu, Guoyan G.; Etzkorn, Felicia A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Pin1 specifically catalyzes the cis/trans isomerization of phospho-Ser/Thr-Pro bonds and plays an important role in many cellular events through the effects of conformational change on the function of its biol. substrates, including cell division cycle 25 C (Cdc25C), c-Jun and p53.  Pin1 is overexpressed in many human cancer tissues, including breast, prostate and lung cancer.  Its expression correlates with cyclin D1 levels, which contribute to cell transformation.  Overexpression of Pin1 promotes tumor growth, while inhibition of Pin1 causes tumor cell apoptosis.  Pin1 plays an important role in oncogenesis and therefore may serve as an effective anticancer target.  Many inhibitors of Pin1 have been discovered, including several classes of designed inhibitors (alkene isosteres, reduced amides, indanyl ketones) and natural products (juglone, pepticinnamin E analogs, PiB and its derivs. obtained from a library screen).  Pin1 inhibitors could be used as a novel type of anticancer drug by blocking cell cycle progression.  Therefore, Pin1 represents a new diagnostic and therapeutic anticancer drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokZhI1yjKrcLVg90H21EOLACvtfcHk0ljDdQTean0BpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOmt73N&md5=bc132881bbbfd7810a485188178b15b9</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2009.22.7.1414594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2009.22.7.1414594%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DG.%2BG.%26aulast%3DEtzkorn%26aufirst%3DF.%2BA.%26atitle%3DPin1%2520as%2520an%2520Anticancer%2520Drug%2520Target%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2009%26volume%3D22%26issue%3D7%26spage%3D399%26epage%3D407%26doi%3D10.1358%2Fdnp.2009.22.7.1414594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagostino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marakovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mroczkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanarsdale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popoff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piraino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margosiak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Los, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Novel Human Pin1 Inhibitors (I)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5613</span>– <span class="NLM_lpage">5616</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2009.08.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19729306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5613-5616&issue=19&author=C.+Guoauthor=X.+Houauthor=L.+Dongauthor=E.+Dagostinoauthor=S.+Greasleyauthor=R.+Ferreauthor=J.+Marakovitsauthor=M.+C.+Johnsonauthor=D.+Matthewsauthor=B.+Mroczkowskiauthor=H.+Pargeauthor=T.+Vanarsdaleauthor=I.+Popoffauthor=J.+Pirainoauthor=S.+Margosiakauthor=J.+Thomsonauthor=G.+Losauthor=B.+W.+Murray&title=Structure-Based+Design+of+Novel+Human+Pin1+Inhibitors+%28I%29&doi=10.1016%2Fj.bmcl.2009.08.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel human Pin1 inhibitors (I)</span></div><div class="casAuthors">Guo, Chuangxing; Hou, Xinjun; Dong, Liming; Dagostino, Eleanor; Greasley, Samantha; Ferre, RoseAnn; Marakovits, Joseph; Johnson, M. Catherine; Matthews, David; Mroczkowski, Barbara; Parge, Hans; Van Arsdale, Todd; Popoff, Ian; Piraino, Joseph; Margosiak, Stephen; Thomson, James; Los, Gerrit; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5613-5616</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pin1 is a member of the cis-trans peptidyl-prolyl isomerase family with potential anti-cancer therapeutic value.  Structure-based de novo design and optimization of novel Pin1 inhibitors, e.g., I, are reported.  Without a viable lead from internal screenings, a series of novel Pin1 inhibitors by interrogating and exploring a protein crystal structure of Pin1 is designed.  The ligand efficiency of the initial concept mol. was optimized with integrated SBDD and parallel chem. approaches, resulting in a more attractive lead series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy51a1X9SYC7Vg90H21EOLACvtfcHk0ljDdQTean0BpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur%252FM&md5=6fbb8e918fd39293dc419dfa0747a937</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.034%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DDagostino%26aufirst%3DE.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DMarakovits%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BC.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DVanarsdale%26aufirst%3DT.%26aulast%3DPopoff%26aufirst%3DI.%26aulast%3DPiraino%26aufirst%3DJ.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DThomson%26aufirst%3DJ.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Human%2520Pin1%2520Inhibitors%2520%2528I%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5613%26epage%3D5616%26doi%3D10.1016%2Fj.bmcl.2009.08.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marakovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagostino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraynov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of Novel Human Pin1 Inhibitors (II)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2010.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20207139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslGmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2210-2214&issue=7&author=L.+Dongauthor=J.+Marakovitsauthor=X.+Houauthor=C.+Guoauthor=S.+Greasleyauthor=E.+Dagostinoauthor=R.+Ferreauthor=M.+C.+Johnsonauthor=E.+Kraynovauthor=J.+Thomsonauthor=V.+Pathakauthor=B.+W.+Murray&title=Structure-Based+Design+of+Novel+Human+Pin1+Inhibitors+%28II%29&doi=10.1016%2Fj.bmcl.2010.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel human Pin1 inhibitors (II)</span></div><div class="casAuthors">Dong, Liming; Marakovits, Joseph; Hou, Xinjun; Guo, Chuangxing; Greasley, Samantha; Dagostino, Eleanor; Ferre, RoseAnn; Johnson, M. Catherine; Kraynov, Eugenia; Thomson, James; Pathak, Ved; Murray, Brion W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2210-2214</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Following the discovery of a novel series of phosphate-contg. small mol. Pin1 inhibitors, the drug design strategy shifted to replacement of the phosphate group with an isostere with potential better pharmaceutical properties.  The initial loss in potency of carboxylate analogs was likely due to weaker charge-charge interactions in the putative phosphate binding pocket and was subsequently recovered by structure-based optimization of ligand-protein interactions in the proline binding site, leading to the discovery of a sub-micromolar non-phosphate small mol. Pin1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgilRHkGBuYbVg90H21EOLACvtfcHk0lhyBCayOpyuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslGmt7s%253D&md5=d16f5beec12a17a38bca7e84e09ddb0d</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DL.%26aulast%3DMarakovits%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DDagostino%26aufirst%3DE.%26aulast%3DFerre%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DM.%2BC.%26aulast%3DKraynov%26aufirst%3DE.%26aulast%3DThomson%26aufirst%3DJ.%26aulast%3DPathak%26aufirst%3DV.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Human%2520Pin1%2520Inhibitors%2520%2528II%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2210%26epage%3D2214%26doi%3D10.1016%2Fj.bmcl.2010.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunns, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrace, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matossova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of Cell-Active Phenyl-Imidazole Pin1 Inhibitors by Structure-Guided Fragment Evolution</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6483</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2010.09.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=20932746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6483-6488&issue=22&author=A.+Potterauthor=V.+Oldfieldauthor=C.+Nunnsauthor=C.+Fromontauthor=S.+Rayauthor=C.+J.+Northfieldauthor=C.+J.+Bryantauthor=S.+F.+Scraceauthor=D.+Robinsonauthor=N.+Matossovaauthor=L.+Bakerauthor=P.+Dokurnoauthor=A.+E.+Surgenorauthor=B.+Davisauthor=C.+M.+Richardsonauthor=J.+B.+Murrayauthor=J.+D.+Moore&title=Discovery+of+Cell-Active+Phenyl-Imidazole+Pin1+Inhibitors+by+Structure-Guided+Fragment+Evolution&doi=10.1016%2Fj.bmcl.2010.09.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution</span></div><div class="casAuthors">Potter, Andrew; Oldfield, Victoria; Nunns, Claire; Fromont, Christophe; Ray, Stuart; Northfield, Christopher J.; Bryant, Christopher J.; Scrace, Simon F.; Robinson, David; Matossova, Natalia; Baker, Lisa; Dokurno, Pawel; Surgenor, Allan E.; Davis, Ben; Richardson, Christine M.; Murray, James B.; Moore, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6483-6488</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pin1 is an emerging oncol. target strongly implicated in Ras and ErbB2-mediated tumorigenesis.  Pin1 isomerizes bonds linking phospho-serine/threonine moieties to proline enabling it to play a key role in proline-directed kinase signalling.  Here we report a novel series of Pin1 inhibitors based on a Ph imidazole acid core that contains sub-μM inhibitors.  Compds. have been identified that block prostate cancer cell growth under conditions where Pin1 is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6tUxclpvVtLVg90H21EOLACvtfcHk0lhyBCayOpyuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7bN&md5=ee4cd613389f2933ea806c617eaf1769</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.063%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DOldfield%26aufirst%3DV.%26aulast%3DNunns%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DBryant%26aufirst%3DC.%2BJ.%26aulast%3DScrace%26aufirst%3DS.%2BF.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DMatossova%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520of%2520Cell-Active%2520Phenyl-Imidazole%2520Pin1%2520Inhibitors%2520by%2520Structure-Guided%2520Fragment%2520Evolution%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6483%26epage%3D6488%26doi%3D10.1016%2Fj.bmcl.2010.09.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueritz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunns, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrace, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matassova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dokurno, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. D.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Design of Alpha-Amino Acid-Derived Pin1 Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bmcl.2009.11.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19969456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=586-590&issue=2&author=A.+J.+Potterauthor=S.+Rayauthor=L.+Gueritzauthor=C.+L.+Nunnsauthor=C.+J.+Bryantauthor=S.+F.+Scraceauthor=N.+Matassovaauthor=L.+Bakerauthor=P.+Dokurnoauthor=D.+A.+Robinsonauthor=A.+E.+Surgenorauthor=B.+Davisauthor=J.+B.+Murrayauthor=C.+M.+Richardsonauthor=J.+D.+Moore&title=Structure-Guided+Design+of+Alpha-Amino+Acid-Derived+Pin1+Inhibitors&doi=10.1016%2Fj.bmcl.2009.11.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of α-amino acid-derived Pin1 inhibitors</span></div><div class="casAuthors">Potter, Andrew J.; Ray, Stuart; Gueritz, Louisa; Nunns, Claire L.; Bryant, Christopher J.; Scrace, Simon F.; Matassova, Natalia; Baker, Lisa; Dokurno, Pawel; Robinson, David A.; Surgenor, Allan E.; Davis, Ben; Murray, James B.; Richardson, Christine M.; Moore, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">586-590</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The peptidyl prolyl cis/trans isomerase Pin1 is a promising mol. target for anti-cancer therapeutics.  Here we report the structure-guided evolution of an indole 2-carboxylic acid fragment hit into a series of α-benzimidazolyl-substituted amino acids.  Examples inhibited Pin1 activity with IC50 <100 nM, but were inactive on cells.  Replacement of the benzimidazole ring with a naphthyl group resulted in a 10-50-fold loss in ligand potency, but these examples downregulated biomarkers of Pin1 activity and blocked proliferation of PC3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaxl5WF47R9LVg90H21EOLACvtfcHk0lhyBCayOpyuOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbjF&md5=3006dad4fda09dffe5bd6be7ede1ecb7</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.090%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DA.%2BJ.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DGueritz%26aufirst%3DL.%26aulast%3DNunns%26aufirst%3DC.%2BL.%26aulast%3DBryant%26aufirst%3DC.%2BJ.%26aulast%3DScrace%26aufirst%3DS.%2BF.%26aulast%3DMatassova%26aufirst%3DN.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DDokurno%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DMoore%26aufirst%3DJ.%2BD.%26atitle%3DStructure-Guided%2520Design%2520of%2520Alpha-Amino%2520Acid-Derived%2520Pin1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D586%26epage%3D590%26doi%3D10.1016%2Fj.bmcl.2009.11.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takamiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Pin1 and Par14 Peptidyl Prolyl Isomerase Inhibitors Block Cell Proliferation</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(02)00310-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2FS1074-5521%2802%2900310-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12573694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1SmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=15-24&issue=1&author=T.+Uchidaauthor=M.+Takamiyaauthor=M.+Takahashiauthor=H.+Miyashitaauthor=H.+Ikedaauthor=T.+Teradaauthor=Y.+Matsuoauthor=M.+Shirouzuauthor=S.+Yokoyamaauthor=F.+Fujimoriauthor=T.+Hunter&title=Pin1+and+Par14+Peptidyl+Prolyl+Isomerase+Inhibitors+Block+Cell+Proliferation&doi=10.1016%2FS1074-5521%2802%2900310-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 and Par14 Peptidyl Prolyl Isomerase Inhibitors Block Cell Proliferation</span></div><div class="casAuthors">Uchida, Takafumi; Takamiya, Mari; Takahashi, Morito; Miyashita, Hitoshi; Ikeda, Hisafumi; Terada, Toru; Matsuo, Yo; Shirouzu, Mikako; Yokoyama, Shigeyuki; Fujimori, Fumihiro; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Disruption of the parvulin family peptidyl prolyl isomerase (PPIase) Pin1 gene delays reentry into the cell cycle when quiescent primary mouse embryo fibroblasts are stimulated with serum.  Since Pin1 regulates cell cycle progression, a Pin1 inhibitor would be expected to block cell proliferation.  To identify such inhibitors, we screened a chem. compd. library for mols. that inhibited human Pin1 PPIase activity in vitro.  We found a set of compds. that inhibited Pin1 PPIase activity in vitro with low μM IC50s and inhibited the growth of several cancer lines.  Among the inhibitors, PiB, diethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo[lmn] phenanthroline-2,7-diacetate Et 1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn] phenanthroline-(2H,7H)-diacetate, had the least nonspecific toxicity.  These results suggest that Pin1 inhibitors could be used as a novel type of anticancer drug that acts by blocking cell cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV0Do36G7blbVg90H21EOLACvtfcHk0lhTGtc71s4b9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1SmtQ%253D%253D&md5=65a6d7e955f32ec1231c012d49cbe0d1</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900310-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900310-1%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DT.%26aulast%3DTakamiya%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DMiyashita%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DFujimori%26aufirst%3DF.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DPin1%2520and%2520Par14%2520Peptidyl%2520Prolyl%2520Isomerase%2520Inhibitors%2520Block%2520Cell%2520Proliferation%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D1%26spage%3D15%26epage%3D24%26doi%3D10.1016%2FS1074-5521%2802%2900310-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, T.</span></span> <span> </span><span class="NLM_article-title">Dipentamethylene Thiuram Monosulfide is a Novel Inhibitor of Pin1</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>384</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">394</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2009.04.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.bbrc.2009.04.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19422802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVCqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2009&pages=394-398&issue=3&author=Y.+Tataraauthor=Y.+C.+Linauthor=Y.+Bambaauthor=T.+Moriauthor=T.+Uchida&title=Dipentamethylene+Thiuram+Monosulfide+is+a+Novel+Inhibitor+of+Pin1&doi=10.1016%2Fj.bbrc.2009.04.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1</span></div><div class="casAuthors">Tatara, Yota; Lin, Yi-Chin; Bamba, Yoshimasa; Mori, Tadashi; Uchida, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">394-398</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pin1 is involved in eukaryotic cell proliferation by changing the structure and function of phosphorylated proteins.  PiB, the Pin1 specific inhibitor, blocks cancer cell proliferation.  However, low soly. of PiB in DMSO has limited studies of its effectiveness.  We screened for addnl. Pin1 inhibitors and identified the DMSO-sol. compd. dipentamethylene thiuram monosulfide (DTM) that inhibits Pin1 activity with an EC50 value of 4.1 μM.  Mol. modeling and enzyme kinetic anal. indicated that DTM competitively inhibits Pin1 activity, with a Ki value of 0.05 μM.  The KD value of DTM with Pin1 was detd. to be 0.06 μM by SPR technol.  Moreover, DTM specifically inhibited peptidyl-prolyl cis/trans isomerase activity in HeLa cells.  FACS anal. showed that DTM induced G0 arrest of the HCT116 cells.  Our results suggest that DTM has the potential to guide the development of novel antifungal and/or anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKyR6-TAv7h7Vg90H21EOLACvtfcHk0lhTGtc71s4b9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVCqs78%253D&md5=638a29e63c73abc7a4fd6e769d0d6a75</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.04.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.04.144%26sid%3Dliteratum%253Aachs%26aulast%3DTatara%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DBamba%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DUchida%26aufirst%3DT.%26atitle%3DDipentamethylene%2520Thiuram%2520Monosulfide%2520is%2520a%2520Novel%2520Inhibitor%2520of%2520Pin1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D384%26issue%3D3%26spage%3D394%26epage%3D398%26doi%3D10.1016%2Fj.bbrc.2009.04.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kats, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nechama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarnerio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozkurt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moerke, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rego, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo-Coco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandolfi, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Active Pin1 is a Key Target of All-Trans Retinoic Acid in Acute Promyelocytic Leukemia and Breast Cancer</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1038/nm.3839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fnm.3839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=25849135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=457-466&issue=5&author=S.+Weiauthor=S.+Kozonoauthor=L.+Katsauthor=M.+Nechamaauthor=W.+Liauthor=J.+Guarnerioauthor=M.+Luoauthor=M.+H.+Youauthor=Y.+Yaoauthor=A.+Kondoauthor=H.+Huauthor=G.+Bozkurtauthor=N.+J.+Moerkeauthor=S.+Caoauthor=M.+Reschkeauthor=C.+H.+Chenauthor=E.+M.+Regoauthor=F.+Lo-Cocoauthor=L.+C.+Cantleyauthor=T.+H.+Leeauthor=H.+Wuauthor=Y.+Zhangauthor=P.+P.+Pandolfiauthor=X.+Z.+Zhouauthor=K.+P.+Lu&title=Active+Pin1+is+a+Key+Target+of+All-Trans+Retinoic+Acid+in+Acute+Promyelocytic+Leukemia+and+Breast+Cancer&doi=10.1038%2Fnm.3839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</span></div><div class="casAuthors">Wei, Shuo; Kozono, Shingo; Kats, Lev; Nechama, Morris; Li, Wenzong; Guarnerio, Jlenia; Luo, Manli; You, Mi-Hyeon; Yao, Yandan; Kondo, Asami; Hu, Hai; Bozkurt, Gunes; Moerke, Nathan J.; Cao, Shugeng; Reschke, Markus; Chen, Chun-Hau; Rego, Eduardo M.; Lo-Coco, Francesco; Cantley, Lewis C.; Lee, Tae Ho; Wu, Hao; Zhang, Yan; Pandolfi, Pier Paolo; Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">457-466</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A common key regulator of oncogenic signaling pathways in multiple tumor types is the unique isomerase Pin1.  However, available Pin1 inhibitors lack the required specificity and potency for inhibiting Pin1 function in vivo.  By using mechanism-based screening, here we find that all-trans retinoic acid (ATRA)-a therapy for acute promyelocytic leukemia (APL) that is considered the first example of targeted therapy in cancer, but whose drug target remains elusive-inhibits and degrades active Pin1 selectively in cancer cells by directly binding to the substrate phosphate- and proline-binding pockets in the Pin1 active site.  ATRA-induced Pin1 ablation degrades the protein encoded by the fusion oncogene PML-RARA and treats APL in APL cell and animal models as well as in human patients.  ATRA-induced Pin1 ablation also potently inhibits triple-neg. breast cancer cell growth in human cells and in animal models by acting on many Pin1 substrate oncogenes and tumor suppressors.  Thus, ATRA simultaneously blocks multiple Pin1-regulated cancer-driving pathways, an attractive property for treating aggressive and drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc0ia_X46okbVg90H21EOLACvtfcHk0lhTGtc71s4b9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFSqurg%253D&md5=03ded9956ae56f280e2c1bfee7672444</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1038%2Fnm.3839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3839%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%26aulast%3DKozono%26aufirst%3DS.%26aulast%3DKats%26aufirst%3DL.%26aulast%3DNechama%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGuarnerio%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DM.%2BH.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKondo%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DBozkurt%26aufirst%3DG.%26aulast%3DMoerke%26aufirst%3DN.%2BJ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DReschke%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DRego%26aufirst%3DE.%2BM.%26aulast%3DLo-Coco%26aufirst%3DF.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DActive%2520Pin1%2520is%2520a%2520Key%2520Target%2520of%2520All-Trans%2520Retinoic%2520Acid%2520in%2520Acute%2520Promyelocytic%2520Leukemia%2520and%2520Breast%2520Cancer%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26issue%3D5%26spage%3D457%26epage%3D466%26doi%3D10.1038%2Fnm.3839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balis, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feusner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aronson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reaman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenton, R. M.</span></span> <span> </span><span class="NLM_article-title">Phase I and Pharmacokinetic Evaluation of All-Trans-Retinoic Acid in Pediatric Patients with Cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1673</span>, <span class="refDoi"> DOI: 10.1200/JCO.1992.10.11.1666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1200%2FJCO.1992.10.11.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1403049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADyaK3s%252FhvFChtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1992&pages=1666-1673&issue=11&author=M.+A.+Smithauthor=P.+C.+Adamsonauthor=F.+M.+Balisauthor=J.+Feusnerauthor=L.+Aronsonauthor=R.+F.+Murphyauthor=M.+E.+Horowitzauthor=G.+Reamanauthor=G.+D.+Hammondauthor=R.+M.+Fenton&title=Phase+I+and+Pharmacokinetic+Evaluation+of+All-Trans-Retinoic+Acid+in+Pediatric+Patients+with+Cancer&doi=10.1200%2FJCO.1992.10.11.1666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer</span></div><div class="casAuthors">Smith M A; Adamson P C; Balis F M; Feusner J; Aronson L; Murphy R F; Horowitz M E; Reaman G; Hammond G D; Fenton R M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1666-73</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Recent reports of the dramatic antitumor effect of all-trans-retinoic acid (RA) in patients with acute promyelocytic leukemia (APL) have renewed interest in the oncologic indications for retinoids.  Furthermore, a variety of pediatric tumors are responsive to RA in vitro, which provides additional rationale for a phase I evaluation of RA in children with cancer that is refractory to standard therapy.  PATIENTS AND METHODS:  A phase I trial of RA administered orally twice daily for 28-day treatment courses was performed.  Cohorts of at least three pediatric cancer patients were entered at successive RA dose levels (from 45 to 80 mg/m2/d) until dose-limiting toxicity (DLT) was consistently observed.  RESULTS:  The maximum-tolerated dose (MTD) of RA was 60 mg/m2/d.  Three of eight patients at the 80-mg/m2/d dose level developed reversible pseudotumor cerebri that necessitated discontinuation of the agent.  Both patients with APL achieved complete remission (CR), whereas no patients with solid tumors had objective responses.  Pharmacokinetic studies demonstrated a relatively short terminal half-life for RA (45 minutes), with diminution in plasma levels after chronic dosing.  CONCLUSIONS:  The MTD and recommended phase II dose for RA in children is 60 mg/m2/d given twice daily.  Reversible CNS toxicity related to RA-induced pseudotumor cerebri is dose-limiting.  Two children with APL achieved a CR to RA, which supports the inclusion of pediatric patients in clinical trials that evaluate the use of RA for patients with APL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRiJ2bQIpU6kMzK395ZObgVfW6udTcc2ea5YR_BPgwHkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FhvFChtA%253D%253D&md5=55d46bb190262170c778e6e4cf64b9ff</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1200%2FJCO.1992.10.11.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.1992.10.11.1666%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DAdamson%26aufirst%3DP.%2BC.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26aulast%3DFeusner%26aufirst%3DJ.%26aulast%3DAronson%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DR.%2BF.%26aulast%3DHorowitz%26aufirst%3DM.%2BE.%26aulast%3DReaman%26aufirst%3DG.%26aulast%3DHammond%26aufirst%3DG.%2BD.%26aulast%3DFenton%26aufirst%3DR.%2BM.%26atitle%3DPhase%2520I%2520and%2520Pharmacokinetic%2520Evaluation%2520of%2520All-Trans-Retinoic%2520Acid%2520in%2520Pediatric%2520Patients%2520with%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D1992%26volume%3D10%26issue%3D11%26spage%3D1666%26epage%3D1673%26doi%3D10.1200%2FJCO.1992.10.11.1666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">A Novel Controlled Release Formulation of the Pin1 Inhibitor ATRA to Improve Liver Cancer Therapy by Simultaneously Blocking Multiple Cancer Pathways</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2017.11.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.jconrel.2017.11.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=29170140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFajsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2018&pages=405-422&author=D.+Yangauthor=W.+Luoauthor=J.+Wangauthor=M.+Zhengauthor=X.+H.+Liaoauthor=N.+Zhangauthor=W.+Luauthor=L.+Wangauthor=A.+Z.+Chenauthor=W.+G.+Wuauthor=H.+Liuauthor=S.+B.+Wangauthor=X.+Z.+Zhouauthor=K.+P.+Lu&title=A+Novel+Controlled+Release+Formulation+of+the+Pin1+Inhibitor+ATRA+to+Improve+Liver+Cancer+Therapy+by+Simultaneously+Blocking+Multiple+Cancer+Pathways&doi=10.1016%2Fj.jconrel.2017.11.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways</span></div><div class="casAuthors">Yang, Dayun; Luo, Wensong; Wang, Jichuang; Zheng, Min; Liao, Xin-Hua; Zhang, Nan; Lu, Wenxian; Wang, Long; Chen, Ai-Zheng; Wu, Wen-Guo; Liu, Hekun; Wang, Shi-Bin; Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">405-422</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the second leading cause of cancer deaths worldwide largely due to lack of effective targeted drugs to simultaneously block multiple cancer-driving pathways.  The identification of all-trans retinoic acid (ATRA) as a potent Pin1 inhibitor provides a promising candidate for HCC targeted therapy because Pin1 is overexpressed in most HCC and activates numerous cancer-driving pathways.  However, the efficacy of ATRA against solid tumors is limited due to its short half-life of 45 min in humans.  A slow-releasing ATRA formulation inhibits solid tumors such as HCC, but can be used only in animals.  Here, we developed a one-step, cost-effective route to produce a novel biocompatible, biodegradable, and non-toxic controlled release formulation of ATRA for effective HCC therapy.  We used supercrit. carbon dioxide process to encapsulate ATRA in largely uniform poly L-lactic acid (PLLA) microparticles, with the efficiency of 91.4% and yield of 68.3%, and ∼ 4-fold higher Cmax and AUC over the slow-releasing ATRA formulation.  ATRA-PLLA microparticles had good biocompatibility, and significantly enhanced the inhibitory potency of ATRA on HCC cell growth, improving IC50 by over 3-fold.  ATRA-PLLA microparticles exerted its efficacy likely through degrading Pin1 and inhibiting multiple Pin1-regulated cancer pathways and cell cycle progression.  Indeed, Pin1 knock-down abolished ATRA inhibitory effects on HCC cells and ATRA-PLLA did not inhibit normal liver cells, as expected because ATRA selectively inhibits active Pin1 in cancer cells.  Moreover ATRA-PLLA microparticles significantly enhanced the efficacy of ATRA against HCC tumor growth in mice through reducing Pin1, with a better potency than the slow-releasing ATRA formulation, consistent with its improved pharmacokinetic profiles.  This study illustrates an effective platform to produce controlled release formulation of anti-cancer drugs, and ATRA-PLLA microparticles might be a promising targeted drug for HCC therapy as PLLA is biocompatible, biodegradable and nontoxic to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QOesAHAoq7Vg90H21EOLACvtfcHk0ljtG7YrS86Bfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFajsLfL&md5=f6b89850089afed918ec8d68264dcb4b</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2017.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2017.11.031%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DX.%2BH.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DA.%2BZ.%26aulast%3DWu%26aufirst%3DW.%2BG.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%2BB.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DA%2520Novel%2520Controlled%2520Release%2520Formulation%2520of%2520the%2520Pin1%2520Inhibitor%2520ATRA%2520to%2520Improve%2520Liver%2520Cancer%2520Therapy%2520by%2520Simultaneously%2520Blocking%2520Multiple%2520Cancer%2520Pathways%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2018%26volume%3D269%26spage%3D405%26epage%3D422%26doi%3D10.1016%2Fj.jconrel.2017.11.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massefski, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doctor, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span> <span> </span><span class="NLM_article-title">Arsenic Targets Pin1 and Cooperates with Retinoic Acid to Inhibit Cancer-Driving Pathways and Tumor-Initiating Cells</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3069</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05402-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fs41467-018-05402-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=30093655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ms12nsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3069&issue=1&author=S.+Kozonoauthor=Y.+M.+Linauthor=H.+S.+Seoauthor=B.+Pinchauthor=X.+Lianauthor=C.+Qiuauthor=M.+K.+Herbertauthor=C.+H.+Chenauthor=L.+Tanauthor=Z.+J.+Gaoauthor=W.+Massefskiauthor=Z.+M.+Doctorauthor=B.+P.+Jacksonauthor=Y.+Chenauthor=S.+Dhe-Paganonauthor=K.+P.+Luauthor=X.+Z.+Zhou&title=Arsenic+Targets+Pin1+and+Cooperates+with+Retinoic+Acid+to+Inhibit+Cancer-Driving+Pathways+and+Tumor-Initiating+Cells&doi=10.1038%2Fs41467-018-05402-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</span></div><div class="casAuthors">Kozono Shingo; Lin Yu-Min; Lian Xiaolan; Qiu Chenxi; Herbert Megan K; Chen Chun-Hau; Gao Ziang Jeff; Lu Kun Ping; Zhou Xiao Zhen; Kozono Shingo; Lin Yu-Min; Lian Xiaolan; Qiu Chenxi; Herbert Megan K; Chen Chun-Hau; Gao Ziang Jeff; Lu Kun Ping; Zhou Xiao Zhen; Seo Hyuk-Soo; Pinch Benika; Tan Li; Massefski Walter; Doctor Zainab M; Dhe-Paganon Sirano; Pinch Benika; Lian Xiaolan; Lian Xiaolan; Chen Yuanzhong; Lu Kun Ping; Qiu Chenxi; Lu Kun Ping; Zhou Xiao Zhen; Jackson Brian P</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3069</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) combination safely cures fatal acute promyelocytic leukemia, but their mechanisms of action and efficacy are not fully understood.  ATRA inhibits leukemia, breast, and liver cancer by targeting isomerase Pin1, a master regulator of oncogenic signaling networks.  Here we show that ATO targets Pin1 and cooperates with ATRA to exert potent anticancer activity.  ATO inhibits and degrades Pin1, and suppresses its oncogenic function by noncovalent binding to Pin1's active site.  ATRA increases cellular ATO uptake through upregulating aquaporin-9.  ATO and ATRA, at clinically safe doses, cooperatively ablate Pin1 to block numerous cancer-driving pathways and inhibit the growth of triple-negative breast cancer cells and tumor-initiating cells in cell and animal models including patient-derived orthotopic xenografts, like Pin1 knockout, which is substantiated by comprehensive protein and microRNA analyses.  Thus, synergistic targeting of Pin1 by ATO and ATRA offers an attractive approach to combating breast and other cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIUnXfwZaCRg5nADWVYHg1fW6udTcc2ebNlgNHfrtqXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ms12nsQ%253D%253D&md5=3f6b63a8f502af29d2d0526dcb17352d</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05402-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05402-2%26sid%3Dliteratum%253Aachs%26aulast%3DKozono%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DY.%2BM.%26aulast%3DSeo%26aufirst%3DH.%2BS.%26aulast%3DPinch%26aufirst%3DB.%26aulast%3DLian%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DHerbert%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DZ.%2BJ.%26aulast%3DMassefski%26aufirst%3DW.%26aulast%3DDoctor%26aufirst%3DZ.%2BM.%26aulast%3DJackson%26aufirst%3DB.%2BP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DK.%2BP.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26atitle%3DArsenic%2520Targets%2520Pin1%2520and%2520Cooperates%2520with%2520Retinoic%2520Acid%2520to%2520Inhibit%2520Cancer-Driving%2520Pathways%2520and%2520Tumor-Initiating%2520Cells%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D3069%26doi%3D10.1038%2Fs41467-018-05402-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Urusova, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zykova, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">Epigallocatechin-Gallate Suppresses Tumorigenesis by Directly Targeting Pin1</span>. <i>Cancer Prev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1366</span>– <span class="NLM_lpage">1377</span>, <span class="refDoi"> DOI: 10.1158/1940-6207.CAPR-11-0301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1158%2F1940-6207.CAPR-11-0301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=21750208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12ktbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=1366-1377&issue=9&author=D.+V.+Urusovaauthor=J.+H.+Shimauthor=D.+J.+Kimauthor=S.+K.+Jungauthor=T.+A.+Zykovaauthor=A.+Carperauthor=A.+M.+Bodeauthor=Z.+Dong&title=Epigallocatechin-Gallate+Suppresses+Tumorigenesis+by+Directly+Targeting+Pin1&doi=10.1158%2F1940-6207.CAPR-11-0301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1</span></div><div class="casAuthors">Urusova, Darya V.; Shim, Jung-Hyun; Kim, Dong Joon; Jung, Sung Keun; Zykova, Tatyana A.; Carper, Andria; Bode, Ann M.; Dong, Zigang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1366-1377</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The most active anticancer component in green tea is epigallocatechin-3-gallate (EGCG).  The human peptidyl prolyl cis/trans isomerase (Pin1) plays a crit. role in oncogenic signaling.  Herein, we report the X-ray crystal structure of the Pin1/EGCG complex resolved at 1.9 Å resoln.  Notably, the structure revealed the presence of EGCG in both the WW and PPIase domains of Pin1.  The direct binding of EGCG with Pin1 was confirmed and the interaction inhibited Pin1 PPIase activity.  In addn., proliferation of cells expressing Pin1 was inhibited and tumor growth in a xenograft mouse model was suppressed.  The binding of EGCG with Arg17 in the WW domain prevented the binding of c-Jun, a well-known Pin1 substrate.  EGCG treatment corresponded with a decreased abundance of cyclin D1 and diminution of 12-O-tetradecanoylphorbol-l3-acetate-induced AP-1 or NF-κB promoter activity in cells expressing Pin1.  Overall, these results showed that EGCG directly suppresses the tumor-promoting effect of Pin1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGRULfb5orgLVg90H21EOLACvtfcHk0ljfimzebotZ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12ktbzF&md5=c0ec8e7b93fa4e925e5df83d542ef340</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-11-0301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-11-0301%26sid%3Dliteratum%253Aachs%26aulast%3DUrusova%26aufirst%3DD.%2BV.%26aulast%3DShim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DJung%26aufirst%3DS.%2BK.%26aulast%3DZykova%26aufirst%3DT.%2BA.%26aulast%3DCarper%26aufirst%3DA.%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DEpigallocatechin-Gallate%2520Suppresses%2520Tumorigenesis%2520by%2520Directly%2520Targeting%2520Pin1%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2011%26volume%3D4%26issue%3D9%26spage%3D1366%26epage%3D1377%26doi%3D10.1158%2F1940-6207.CAPR-11-0301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span> <span> </span><span class="NLM_article-title">Interaction Between Pin1 and its Natural Product Inhibitor Epigallocatechin-3-Gallate by Spectroscopy and Molecular Dynamics Simulations</span>. <i>Spectrochim. Acta, Part A</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1016/j.saa.2016.06.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1016%2Fj.saa.2016.06.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=27372509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSgu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2016&pages=134-143&author=L.+Xiauthor=Y.+Wangauthor=Q.+Heauthor=Q.+Zhangauthor=L.+Du&title=Interaction+Between+Pin1+and+its+Natural+Product+Inhibitor+Epigallocatechin-3-Gallate+by+Spectroscopy+and+Molecular+Dynamics+Simulations&doi=10.1016%2Fj.saa.2016.06.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between Pin1 and its natural product inhibitor epigallocatechin-3-gallate by spectroscopy and molecular dynamics simulations</span></div><div class="casAuthors">Xi, Lei; Wang, Yu; He, Qing; Zhang, Qingyan; Du, Linfang</div><div class="citationInfo"><span class="NLM_cas:title">Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134-143</span>CODEN:
                <span class="NLM_cas:coden">SAMCAS</span>;
        ISSN:<span class="NLM_cas:issn">1386-1425</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The binding of epigallocatechin 3-gallate (EGCG) to wild-type peptidylprolyl isomerase Pin1 in soln. was studied by spectroscopic methods and mol. dynamics simulations to explore the binding mode and inhibition mechanism.  The binding consts. and no. of binding sites per Pin1 for EGCG were calcd. through the Stern-Volmer equation.  The values of binding free energy and thermodn. parameters were calcd. and indicated that H-bonds, electrostatic interactions, and van der Waals interactions played major roles in the binding process.  The alterations of Pin1 secondary structure in the presence of EGCG were confirmed by far-UV CD spectroscopy.  The binding model at the at.-level revealed that EGCG was bound by Glu-12, Lys-13, Arg-14, Met-15, and Arg-17 in the Pin1 WW domain.  Furthermore, EGCG could also interact with Arg-69, Asp-112, Cys-113, and Ser-114 in the Pin1 isomerase domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbZkpXyj1vPLVg90H21EOLACvtfcHk0ljfimzebotZ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSgu7rF&md5=e474f5ffbb769a7fce28642ba8f455d3</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2Fj.saa.2016.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.saa.2016.06.036%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DDu%26aufirst%3DL.%26atitle%3DInteraction%2520Between%2520Pin1%2520and%2520its%2520Natural%2520Product%2520Inhibitor%2520Epigallocatechin-3-Gallate%2520by%2520Spectroscopy%2520and%2520Molecular%2520Dynamics%2520Simulations%26jtitle%3DSpectrochim.%2520Acta%252C%2520Part%2520A%26date%3D2016%26volume%3D169%26spage%3D134%26epage%3D143%26doi%3D10.1016%2Fj.saa.2016.06.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melito, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ready, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span> <span> </span><span class="NLM_article-title">Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">19673</span>– <span class="NLM_lpage">19684</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.443895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1074%2Fjbc.M112.443895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=23671287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKmsLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=19673-19684&issue=27&author=J.+A.+Kilgoreauthor=X.+Duauthor=L.+Melitoauthor=S.+Weiauthor=C.+Wangauthor=H.+G.+Chinauthor=B.+Posnerauthor=S.+Pradhanauthor=J.+M.+Readyauthor=N.+S.+Williams&title=Identification+of+DNMT1+Selective+Antagonists+Using+a+Novel+Scintillation+Proximity+Assay&doi=10.1074%2Fjbc.M112.443895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay</span></div><div class="casAuthors">Kilgore, Jessica A.; Du, Xinlin; Melito, Lisa; Wei, Shuguang; Wang, Changguang; Chin, Hang Gyeong; Posner, Bruce; Pradhan, Sriharsa; Ready, Joseph M.; Williams, Noelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">19673-19684</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A novel scintillation proximity high throughput assay (SPA) to identify inhibitors of DNA methyltransferase was developed and used to screen over 180,000 compds.  The majority of the validated hits shared a quinone core and several were found to generate the reactive oxygen species, H2O2.  Inhibition of the prodn. of H2O2 by the addn. of catalase blocked the ability of this group of compds. to inhibit DNA methyltransferase (DNMT) activity.  However, a related compd., SW155246, was identified that existed in an already reduced form of the quinone.  This compd. did not generate H2O2, and catalase did not block its ability to inhibit DNA methyltransferase.  SW155246 showed a 30-fold preference for inhibition of human DNMT1 vs. human or murine DNMT3A or -3B, inhibited global methylation in HeLa cells, and reactivated expression of the tumor suppressor gene RASSF1A in A549 cells.  To the authors' knowledge, this work represents the first description of selective chem. inhibitors of the DNMT1 enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodp6ODITC6hLVg90H21EOLACvtfcHk0ljDkynfNs1clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKmsLjP&md5=45e90f8b7d6c458a45ce4bd7103819e7</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.443895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.443895%26sid%3Dliteratum%253Aachs%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DMelito%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChin%26aufirst%3DH.%2BG.%26aulast%3DPosner%26aufirst%3DB.%26aulast%3DPradhan%26aufirst%3DS.%26aulast%3DReady%26aufirst%3DJ.%2BM.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26atitle%3DIdentification%2520of%2520DNMT1%2520Selective%2520Antagonists%2520Using%2520a%2520Novel%2520Scintillation%2520Proximity%2520Assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D27%26spage%3D19673%26epage%3D19684%26doi%3D10.1074%2Fjbc.M112.443895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balam Muñoz, B.</span>; <span class="NLM_string-name">Albores, A.</span></span> <span> </span><span class="NLM_article-title">DNA Damage Caused by Polycyclic Aromatic Hydrocarbons: Mechanisms and Markers, Selected Topics in DNA Repair</span>. In  <i>Selected Topics in DNA Repair</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. C.</span></span>, Ed.; <span class="NLM_publisher-name">IntechOpen</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.5772/22527</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.5772%2F22527" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=125-144&author=B.+Balam+Mu%C3%B1oz&author=A.+Alboresauthor=C.+C.+Chen&title=Selected+Topics+in+DNA+Repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.5772%2F22527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F22527%26sid%3Dliteratum%253Aachs%26aulast%3DBalam%2BMu%25C3%25B1oz%26aufirst%3DB.%26atitle%3DDNA%2520Damage%2520Caused%2520by%2520Polycyclic%2520Aromatic%2520Hydrocarbons%253A%2520Mechanisms%2520and%2520Markers%252C%2520Selected%2520Topics%2520in%2520DNA%2520Repair%26btitle%3DSelected%2520Topics%2520in%2520DNA%2520Repair%26aulast%3DChen%26aufirst%3DC.%2BC.%26pub%3DIntechOpen%26date%3D2011%26spage%3D125%26epage%3D144%26doi%3D10.5772%2F22527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun-Kyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soohoo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balastik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastorino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K. P.</span></span> <span> </span><span class="NLM_article-title">Essential role of Pin1 in the regulation of TRF1 Stability and Telomere Maintenance</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1038/ncb1818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1038%2Fncb1818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19060891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=97-105&issue=1&author=T.+H.+Leeauthor=A.+Tun-Kyiauthor=R.+Shiauthor=J.+Limauthor=C.+Soohooauthor=G.+Finnauthor=M.+Balastikauthor=L.+Pastorinoauthor=G.+Wulfauthor=X.+Z.+Zhouauthor=K.+P.+Lu&title=Essential+role+of+Pin1+in+the+regulation+of+TRF1+Stability+and+Telomere+Maintenance&doi=10.1038%2Fncb1818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance</span></div><div class="casAuthors">Lee, Tae Ho; Tun-Kyi, Adrian; Shi, Rong; Lim, Jormay; Soohoo, Christina; Finn, Greg; Balastik, Martin; Pastorino, Lucia; Wulf, Gerburg; Zhou, Xiao Zhen; Lu, Kun Ping</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Telomeres are essential for maintaining cellular proliferative capacity and their loss has been implicated in ageing.  A key regulator in telomere maintenance is the telomeric protein TRF1, which was also identified as Pin2 in a screen for Pin1.  Pin1 is a unique prolyl isomerase that regulates protein conformation and function after phosphorylation.  However, little is known about the role of Pin1 in telomere regulation or the modulation of TRF1 by upstream signals.  Here we identify TRF1 as a major conserved substrate for Pin1 during telomere maintenance and ageing.  Pin1 inhibition renders TRF1 resistant to protein degrdn., enhances TRF1 binding to telomeres, and leads to gradual telomere loss in human cells and in mice.  Pin1-deficient mice also show widespread premature ageing phenotypes within just one generation, similar to those in telomerase-deficient mice after 4-5 consecutive generations.  Thus, Pin1 is an essential regulator of TRF1 stability, telomere maintenance and ageing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv8l7UyzuPNbVg90H21EOLACvtfcHk0ljDkynfNs1clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGqsg%253D%253D&md5=984cbc06e38dfdb3332d029a3cbbfd3e</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fncb1818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1818%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BH.%26aulast%3DTun-Kyi%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DSoohoo%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DG.%26aulast%3DBalastik%26aufirst%3DM.%26aulast%3DPastorino%26aufirst%3DL.%26aulast%3DWulf%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DX.%2BZ.%26aulast%3DLu%26aufirst%3DK.%2BP.%26atitle%3DEssential%2520role%2520of%2520Pin1%2520in%2520the%2520regulation%2520of%2520TRF1%2520Stability%2520and%2520Telomere%2520Maintenance%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2009%26volume%3D11%26issue%3D1%26spage%3D97%26epage%3D105%26doi%3D10.1038%2Fncb1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Means, A. R.</span></span> <span> </span><span class="NLM_article-title">Pin1 Regulates the Timing of Mammalian Primordial Germ Cell Proliferation</span>. <i>Development</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3579</span>– <span class="NLM_lpage">3586</span>, <span class="refDoi"> DOI: 10.1242/dev.00584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1242%2Fdev.00584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=12810604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Whuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2003&pages=3579-3586&issue=15&author=F.+W.+Atchisonauthor=B.+Capelauthor=A.+R.+Means&title=Pin1+Regulates+the+Timing+of+Mammalian+Primordial+Germ+Cell+Proliferation&doi=10.1242%2Fdev.00584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Pin1 regulates the timing of mammalian primordial germ cell proliferation</span></div><div class="casAuthors">Atchison, Fawn W.; Capel, Blanche; Means, Anthony R.</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3579-3586</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Primordial germ cells (PGCs) give rise to male and female germ cells to transmit the genome from generation to generation.  Defects in PGC development often result in infertility.  In the mouse embryo, PGCs undergo proliferation and expansion during and after their migration to the gonads from 8.5 to 13.5 days post coitum (dpc).  We show that a peptidyl-prolyl isomerase, Pin1, is involved in the regulation of mammalian PGC proliferation.  We discovered that both the male and female Pin1-/- mice had profound fertility defects.  Investigation of the reproductive organs revealed significantly fewer germ cells in the adult Pin1-/- testes and ovaries than in wild type or heterozygotes, which resulted from Pin1-/- males and females being born with severely reduced no. of gonocytes and oocytes.  Further studies in 8.5 to 13.5 dpc Pin1-/- embryos showed that PGCs were allocated properly at the base of the allantois, but their cell expansion was progressively impaired, resulting in a markedly reduced no. of PGCs at 13.5 dpc.  Analyses using markers of cell cycle parameters and apoptosis revealed that Pin1-/- PGCs did not undergo cell cycle arrest or apoptosis.  Instead, Pin1-/- PGCs had a lower BrdU labeling index compared with wild-type PGCs.  We conclude that PGCs have a prolonged cell cycle in the absence of Pin1, which translates into fewer cell divisions and strikingly fewer Pin1-/- PGCs by the end of the proliferative phase.  These results indicate that Pin1 regulates the timing of PGC proliferation during mouse embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRf3Q-lWuZzLVg90H21EOLACvtfcHk0ljDkynfNs1clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Whuro%253D&md5=e7747ac0b78c645bc3c3d7715311faee</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1242%2Fdev.00584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.00584%26sid%3Dliteratum%253Aachs%26aulast%3DAtchison%26aufirst%3DF.%2BW.%26aulast%3DCapel%26aufirst%3DB.%26aulast%3DMeans%26aufirst%3DA.%2BR.%26atitle%3DPin1%2520Regulates%2520the%2520Timing%2520of%2520Mammalian%2520Primordial%2520Germ%2520Cell%2520Proliferation%26jtitle%3DDevelopment%26date%3D2003%26volume%3D130%26issue%3D15%26spage%3D3579%26epage%3D3586%26doi%3D10.1242%2Fdev.00584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weininger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakob, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, F. X.</span></span> <span> </span><span class="NLM_article-title">The Prolyl Isomerase Domain of PpiD from Escherichia coli Shows a Parvulin Fold but is Devoid of Catalytic Activity</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1002/pro.277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=10.1002%2Fpro.277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=19866485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=6-18&issue=1&author=U.+Weiningerauthor=R.+P.+Jakobauthor=M.+Kovermannauthor=J.+Balbachauthor=F.+X.+Schmid&title=The+Prolyl+Isomerase+Domain+of+PpiD+from+Escherichia+coli+Shows+a+Parvulin+Fold+but+is+Devoid+of+Catalytic+Activity&doi=10.1002%2Fpro.277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">The prolyl isomerase domain of PpiD from Escherichia coli shows a parvulin fold but is devoid of catalytic activity</span></div><div class="casAuthors">Weininger, Ulrich; Jakob, Roman P.; Kovermann, Michael; Balbach, Jochen; Schmid, Franz X.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-18</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PpiD is a periplasmic folding helper protein of Escherichia coli.  It consists of an N-terminal helix that anchors PpiD in the inner membrane near the SecYEG translocon, followed by three periplasmic domains.  The second domain (residues 264-357) shows homol. to parvulin-like prolyl isomerases.  This domain is a well-folded, stable protein and follows a simple two-state folding mechanism.  In its soln. structure, as detd. by NMR spectroscopy, it resembles most closely the first parvulin domain of the SurA protein, which resides in the periplasm of E. coli as well.  A previously reported prolyl isomerase activity of PpiD could not be reproduced when using improved protease-free peptide assays or assays with refolding proteins as substrates.  However, the parvulin domain of PpiD interacts with a proline-contg. tetrapeptide, and as identified by NMR resonance shift anal., the binding site colocalized with the catalytic sites of other parvulins.  In its structure, the parvulin domain of PpiD resembles most closely the inactive first parvulin domain of SurA, which is part of the chaperone unit of this protein and presumably involved in substrate recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU_a6w_xNIkrVg90H21EOLACvtfcHk0lhTqFlx7H5QpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGgtg%253D%253D&md5=bfa80d9f330215efd375286788ec47b8</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1002%2Fpro.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.277%26sid%3Dliteratum%253Aachs%26aulast%3DWeininger%26aufirst%3DU.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DKovermann%26aufirst%3DM.%26aulast%3DBalbach%26aufirst%3DJ.%26aulast%3DSchmid%26aufirst%3DF.%2BX.%26atitle%3DThe%2520Prolyl%2520Isomerase%2520Domain%2520of%2520PpiD%2520from%2520Escherichia%2520coli%2520Shows%2520a%2520Parvulin%2520Fold%2520but%2520is%2520Devoid%2520of%2520Catalytic%2520Activity%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26issue%3D1%26spage%3D6%26epage%3D18%26doi%3D10.1002%2Fpro.277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UQB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UQB','PDB','3UQB'); return false;">PDB: 3UQB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G50" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G50','PDB','4G50'); return false;">PDB: 4G50</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1FKB','PDB','1FKB'); return false;">PDB: 1FKB</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00911&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00911%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00911" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a6b6e8dcfd193","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
